Citrus Sinensis ID: 006514
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 642 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAL3 | 649 | Cysteine-rich receptor-li | yes | no | 0.981 | 0.970 | 0.669 | 0.0 | |
| Q9FNE1 | 651 | Cysteine-rich receptor-li | no | no | 0.897 | 0.884 | 0.440 | 1e-137 | |
| Q9CAL2 | 646 | Cysteine-rich receptor-li | no | no | 0.886 | 0.880 | 0.437 | 1e-135 | |
| Q9M0G5 | 625 | Putative cysteine-rich re | no | no | 0.883 | 0.907 | 0.407 | 1e-127 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.886 | 0.925 | 0.402 | 1e-118 | |
| Q9T0J1 | 665 | Cysteine-rich receptor-li | no | no | 0.883 | 0.852 | 0.359 | 2e-93 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.852 | 0.872 | 0.358 | 6e-91 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.791 | 0.791 | 0.373 | 4e-90 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.817 | 0.773 | 0.358 | 5e-90 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.957 | 0.911 | 0.343 | 4e-89 |
| >sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 865 bits (2235), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/641 (66%), Positives = 517/641 (80%), Gaps = 11/641 (1%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
+FL+ SL ++ GD R V +TC LEHN + +VPNFV TME IS Q++TSGFG+
Sbjct: 17 LMFLLSSLR---QITGDARARAVKVTCSPLLEHNETAYVPNFVATMEKISTQVQTSGFGV 73
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A+TG+G D NYGLAQCYGDL L DCVLCYAEART+LPQCYP NGGRI+LDGCFMR+ENYS
Sbjct: 74 ALTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYS 133
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F+ EY+GPED VCGN TRKN +F ++ R+ + AV A GGYAR + + ++SA
Sbjct: 134 FYNEYKGPEDSIVCGNTTRKNKTFGDAVRQGLRNAVTEASGTGGYARASAKAGESESESA 193
Query: 185 YVLVNCWKTLNSSSCEACLANASASIL-GCLPWSEGRALNTGCFMRYSDKDFLNKEPGKG 243
+VL NCW+TL+ SC+ CL NASAS++ GCLPWSEGRAL+TGCF+RYSD+DFLNK P G
Sbjct: 194 FVLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNG 253
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNF 303
RSRG + IVVSV+S++VV +G+ + + K+R+I+RKRRGS D EK+ KTL D SLNF
Sbjct: 254 RSRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNF 313
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNII 363
KYSTLEKATGSFD ANKLGQGGFGTVYKGVLPDGR+IAVKRLFFNNRHRA +FYNEVN+I
Sbjct: 314 KYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMI 373
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
S+VEHKNLVRLLGCSCSGPESLLVYE+L N+SLDRFIFD + KTL W++RY II+GT E
Sbjct: 374 STVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAE 433
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GLVYLHEQS ++IIHRDIKASNILLDS+L+AKIADFGLARSFQ+DKSHISTAIAGTLGYM
Sbjct: 434 GLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYM 493
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543
APEYLAHGQLTE DVYSFG+L+LEIVTG+QN +SK S+Y+DSL+T WKHFQ+G +E++
Sbjct: 494 APEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKI 553
Query: 544 YDKNLMLHNYHDSN-VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML-TTEEQLPGPTS 601
YD NL + +DS+ +K E+ R + +GLLCTQE PSLRP MS++L ML EE LP P++
Sbjct: 554 YDPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSN 613
Query: 602 PPFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
PPF+DER MEL D +S AS+A +S SS Y R
Sbjct: 614 PPFMDERVMELRDG-----SDGDSAGCASLATVSQSSFYGR 649
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1255), Expect = e-137, Method: Compositional matrix adjust.
Identities = 270/613 (44%), Positives = 357/613 (58%), Gaps = 37/613 (6%)
Query: 4 AFLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSI-FVPNFVTTMENISEQMRTSGF 62
+F FL L + D R + CG + + ++ ++P FV M ++S ++ T F
Sbjct: 18 SFFFLP----FLSSSSDDQRTTVSGLFCGGRSKSSADPNYIPTFVEDMHSLSLKLTTRRF 73
Query: 63 GLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSEN 122
S I Y L QC+ DLS DC LCYA ART +P+C P + RI+LDGCF+R E
Sbjct: 74 ATESLNSTTSI-YALIQCHDDLSPSDCQLCYAIARTRIPRCLPSSSARIFLDGCFLRYET 132
Query: 123 YSFFGE-YEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAAN 181
Y F+ E D C N T + F + R A GG+ A
Sbjct: 133 YEFYDESVSDASDSFSCSNDTVLDPRFGFQVSETAARV---AVRKGGFGV-------AGE 182
Query: 182 KSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPG 241
+ L CW++L C CL A + C+ EGRA+NTGC++RYSD F N G
Sbjct: 183 NGVHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGCYLRYSDHKFYN---G 239
Query: 242 KGR-------SRGMIAAIVVSVVS-ALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLV 293
G ++G+I AIV++ + +++L VI T+V K + E++ G +
Sbjct: 240 DGHHKFHVLFNKGVIVAIVLTTSAFVMLILLATYVIMTKVSKTKQ-EKRNLG-----LVS 293
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA 353
+ N+ FKY TLEKAT F LGQGG GTV+ G+LP+G+ +AVKRL FN R
Sbjct: 294 RKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWV 353
Query: 354 ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK 413
F+NEVN+IS ++HKNLV+LLGCS GPESLLVYE++PN+SLD+F+FD +++K L W +
Sbjct: 354 EEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFDESQSKVLNWSQ 413
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
R IILGT EGL YLH S +RIIHRDIK SN+LLD +L KIADFGLAR F DK+H+S
Sbjct: 414 RLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHLS 473
Query: 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWK 533
T IAGTLGYMAPEY+ GQLTEKADVYSFG+L+LEI G + N T LL W
Sbjct: 474 TGIAGTLGYMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRINAFVPE--TGHLLQRVWN 531
Query: 534 HFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593
+ R+ E D L + E + + VGLLCTQ +PSLRP+M V++MLT
Sbjct: 532 LYTLNRLVEALDPCLKDEFLQVQGSEAEACKVLRVGLLCTQASPSLRPSMEEVIRMLTER 591
Query: 594 E-QLPGPTSPPFI 605
+ +P PTSPPF+
Sbjct: 592 DYPIPSPTSPPFL 604
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1244), Expect = e-135, Method: Compositional matrix adjust.
Identities = 264/604 (43%), Positives = 365/604 (60%), Gaps = 35/604 (5%)
Query: 21 DPRVHTVNITCGHQLE--HNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGLA 78
D R TV C ++ S+FV NF+ M+ +S + G+G V G+G Y
Sbjct: 21 DSRGDTVAQICNNRTTTPQQRSLFVTNFLAAMDAVSPLVEAKGYGQVVNGTGNLTVYAYG 80
Query: 79 QCYGDLSLLDCVLCYAEARTLLPQCYPYN----GGRIYLDGCFMRSENYSFFGEYEGPED 134
+C DL DC LC+A+ + +P+C P+ GG+++ DGC++R ++Y+F+ E +D
Sbjct: 81 ECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIRYDDYNFYNETLSLQD 140
Query: 135 RAVCG----NGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNC 190
R VC G + + F+++A + V A NGG+ V N + + L C
Sbjct: 141 RTVCAPKEITGVNR-TVFRDNAAELVKNMSVEAVRNGGFYAGFVD---RHNVTVHGLAQC 196
Query: 191 WKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEP-------GKG 243
W+TLN S C CL+ AS I CL EGR L+ GC+MR+S + F N G
Sbjct: 197 WETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGH 256
Query: 244 RSRGMIAAIVVSVVS-ALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLN 302
G+I A+ SVV+ L+V A G ++ R K++ E+K+ GS L N +L
Sbjct: 257 NHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAKKQR-EKKQLGS-----LFMLANKSNLC 310
Query: 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI 362
F Y LE+AT F + NKLGQGG G+VYKGVL +G+ +AVKRLFFN + +F+NEVN+
Sbjct: 311 FSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNL 370
Query: 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
IS V+HKNLV+LLGCS +GPESLLVYE++ NQSL ++F + L W KR++IILGT
Sbjct: 371 ISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILGTA 430
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
EG+ YLHE+S +RIIHRDIK SNILL+ +IADFGLAR F EDK+HISTAIAGTLGY
Sbjct: 431 EGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLGY 490
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542
MAPEY+ G+LTEKADVYSFG+L++E++TG++NN + S+L W ++ VEE
Sbjct: 491 MAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAF--VQDAGSILQSVWSLYRTSNVEE 548
Query: 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSP 602
D L D+ K E R + +GLLC Q RP MS V++M+ ++ PT P
Sbjct: 549 AVDPIL-----GDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKGSLEIHTPTQP 603
Query: 603 PFID 606
PF++
Sbjct: 604 PFLN 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 250/614 (40%), Positives = 369/614 (60%), Gaps = 47/614 (7%)
Query: 23 RVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGLAQCYG 82
R+ + C + N + ++ ++ I MR FG G + Y L+QC
Sbjct: 28 RIDVLGYICNNGTVSNEEAYRRSYQINLDAIRGDMRHVKFGTHEHGDPPERMYVLSQCVS 87
Query: 83 DLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAVCGNGT 142
DLS +C LC++ A LL QC+P GG +LDGCF+R++NYSF+ E +D +C +
Sbjct: 88 DLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASDK 147
Query: 143 RKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEAC 202
K++ F+ ++ V +AP + G++ ++ G + + Y L CW+TLN C+ C
Sbjct: 148 EKSAEFKGLVKEVTKSIVEAAPYSRGFSVAKM---GIRDLTVYGLGVCWRTLNDELCKLC 204
Query: 203 LANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRSRGMIAA----------I 252
LA+ + S+ CLP EG ALN GC++RYS+ F N+ RG++A
Sbjct: 205 LADGALSVTSCLPSKEGFALNAGCYLRYSNYTFYNE-------RGLLAMSFTKENLTYIF 257
Query: 253 VVSVVSALVVLAVGIVIGTRVWKQRSIERKRR----------GSNDAEKLVKTLNDDS-- 300
V+S+V L + A G G + + S ++K + G EK +++ +S
Sbjct: 258 VISMVGVLAI-AAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKESESICTESHL 316
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
++F+YSTL+KAT +F+E+ KLG GG+G V+KG L DGREIA+KRL + + +NE+
Sbjct: 317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++IS +HKNLVRLLGC + S +VYEFL N SLD +F+ K K L W+KR IILG
Sbjct: 377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI------ST 474
T EGL YLHE K IIHRDIKASNILLD + + KI+DFGLA+ + E I +
Sbjct: 437 TAEGLEYLHETCK--IIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
+IAGTLGYMAPEY++ G+L+ K D YSFG+L+LEI +G +NN+ ++ ++L+T WK
Sbjct: 495 SIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKC 554
Query: 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML-TTE 593
F + ++EE+ DK++ + K E+ R + +GLLCTQE+P LRPTMS+V+QM+ +T+
Sbjct: 555 FASNKMEEMIDKDM-----GEDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSSTD 609
Query: 594 EQLPGPTSPPFIDE 607
LP PT PPF+ +
Sbjct: 610 IVLPTPTKPPFLHD 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 247/614 (40%), Positives = 353/614 (57%), Gaps = 45/614 (7%)
Query: 11 SLLMLVRVAGDPRVHTVNITC---GHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVT 67
S L+L+ G + C H L + S + F+ M ++++ + L V
Sbjct: 15 SFLVLLATVGSSSSSESLLNCQPLDHHLVNPSRLL--GFLRAMSSVNDFITNDK--LWVV 70
Query: 68 GSGLDIN---YGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
S D++ Y QC DLS+ DC C+ E+R L + +GGRI+ D CF+R ++
Sbjct: 71 SSITDVSPPIYVFLQCREDLSVSDCRHCFNESRLELERKCSGSGGRIHSDRCFLRFDDRD 130
Query: 125 FFGEYEGPE-DRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKS 183
F E+ P D+A C F +A++ A NGG+ V ++
Sbjct: 131 FSEEFVDPTFDKANCEETGTGFGEFWRFLDEALVNVTLKAVKNGGFGAASV----IKTEA 186
Query: 184 AYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNK----E 239
Y L CW+TL+ ++C CL NA +S+ C E RA TGC+++YS F + +
Sbjct: 187 VYALAQCWQTLDENTCRECLVNARSSLRAC-DGHEARAFFTGCYLKYSTHKFFDDAAEHK 245
Query: 240 PGKGRSRGMIAAIVVSV----VSALVVLAVGIVIGTRV---WKQRSIERKRRGSNDAEKL 292
P + + ++ + V+ L + A+ + I T + R + RKR+ +
Sbjct: 246 PDADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSLGAFISYRRVSRKRKAQVPS--- 302
Query: 293 VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR 352
+NFKY LEKAT SF ++ KLGQGG G+VYKG+LPDGR +AVK+LFFN R
Sbjct: 303 -------CVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFFNTREW 355
Query: 353 AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
A F+NEVN+IS V+HKNLVRLLGCS GP+SLLVYE++ N+SLD+ +F L+W+
Sbjct: 356 ADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVHILSWK 415
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
+R+ II+G EGL YLH S+++IIHRDIK SNILLD L KIADFGL RS DK+
Sbjct: 416 QRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGTDKTQT 475
Query: 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW 532
+T IAGTLGY+APEYL GQLTEKADVY+FG+L++EIVTG++NN ++ T S+L W
Sbjct: 476 NTGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVTGKKNN--AFTQGTSSVLYSVW 533
Query: 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
+HF+A ++ D L S V+ E L+ + +GLLC Q + LRP+MS ++ ML
Sbjct: 534 EHFKANTLDRSIDPRL-----KGSFVEEEALKVLQIGLLCVQSSVELRPSMSEIVFMLQN 588
Query: 593 EE-QLPGPTSPPFI 605
++ + P PPF+
Sbjct: 589 KDSKFEYPKQPPFL 602
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 221/614 (35%), Positives = 328/614 (53%), Gaps = 47/614 (7%)
Query: 62 FGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEA-RTLLPQCYPYNGGRIYLDGCFMRS 120
+ ++V S +N ++QC GD+ L C+ C A A + L+ C I+ D C R
Sbjct: 66 YNISVGDSDEKVN-SISQCRGDVKLEVCINCIAMAGKRLVTLCPVQKEAIIWYDKCTFRY 124
Query: 121 ENYSFFGEYEGPEDRAVCG--NGTRKNSSFQESARKAV--MRAVASAPSNGGYARVQVQV 176
N + F E ++ G N T S+++S R + ++ AS V +
Sbjct: 125 SNRTIFNRLEISPHTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGET 184
Query: 177 SGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGR-ALNTGCFMRYSDKDF 235
SG + ++ + LV C ++ C CL+ A I C G ++ C + Y+ F
Sbjct: 185 SGPSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRF 244
Query: 236 LN--------------KEPGKG---------RSRGMIAAIVVSVVSALVVLAVGIVIGTR 272
+ P K ++RG+ A++ + S + ++ + IV+
Sbjct: 245 YDPVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASAS-VAIVVLFIVLLVV 303
Query: 273 VWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKG 332
K R E R N E + ++ DS+ F +S L+ AT F NKLG+GGFG VYKG
Sbjct: 304 FLKLRRKENIRNSENKHEN--ENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKG 361
Query: 333 VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392
VL DG++IAVKRL N + F NE +++ ++H+NLV+LLG S G E LLVYEFLP
Sbjct: 362 VLSDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLP 421
Query: 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
+ SLD+FIFD + L WE RY+II G GL+YLH+ S++RIIHRD+KASNILLD +
Sbjct: 422 HTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEM 481
Query: 453 RAKIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
KIADFG+AR F D + + I GT GYMAPEY+ HGQ + K DVYSFG+L+LEI+
Sbjct: 482 TPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEII 541
Query: 511 TGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGL 570
+G++N+ + + L++ W++++ G L DK LM + + SN+ ++R I++GL
Sbjct: 542 SGKKNSGFSSEDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNM---IMRCINIGL 598
Query: 571 LCTQENPSLRPTMSRVLQMLTTEE-QLPGPTSPPFIDERTMELHDNCYDPCCPMNSGAHA 629
LC QE + RP+M+ V+ ML L P+ P F H N + G +A
Sbjct: 599 LCVQEKVAERPSMASVVLMLDGHTIALSEPSKPAFFS------HSNAVS-DSSSSLGHNA 651
Query: 630 SVANM-SNSSLYPR 642
+N SN+ LYPR
Sbjct: 652 KTSNYNSNTELYPR 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 216/603 (35%), Positives = 309/603 (51%), Gaps = 56/603 (9%)
Query: 39 SSIFVPNFVTTMENIS--EQMRTSGFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYA-E 95
+S ++ N T + ++S ++GF A G D GL C GD+S C C A
Sbjct: 40 NSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFS 99
Query: 96 ARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGE--YEGPEDR-----AVCGNGTRKNSSF 148
L QC Y D C +R + + Y+G R ++ N + F
Sbjct: 100 INDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDF 159
Query: 149 QESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASA 208
S AS+P V+ + A ++ Y LV C L C +CL S+
Sbjct: 160 VSSTMNQAAVKAASSPRK----FYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLE--SS 213
Query: 209 SILGCLPWSEGRALNTGCFMRYSDKDFLNKE------------------------PGKG- 243
L L + GR L + C RY F N+ PGK
Sbjct: 214 IKLMPLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSW 273
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNF 303
S ++ AIV++++ A ++L G RV K N + +SL
Sbjct: 274 NSNVLVVAIVLTILVAALLLIAGYCFAKRV--------KNSSDNAPAFDGDDITTESLQL 325
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNII 363
Y + AT F E NK+GQGGFG VYKG +G E+AVKRL ++ F NEV ++
Sbjct: 326 DYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQGDTEFKNEVVVV 385
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
+ ++H+NLVRLLG S G E +LVYE++PN+SLD F+FD AK L W +RY++I G
Sbjct: 386 AKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWTRRYKVIGGIAR 445
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IAGTLGY 482
G++YLH+ S++ IIHRD+KASNILLD+ + K+ADFGLAR F D++ +T+ I GT GY
Sbjct: 446 GILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQENTSRIVGTFGY 505
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542
MAPEY HGQ + K+DVYSFG+L+LEI++G++NN ++ L+T W+ + G +
Sbjct: 506 MAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTHAWRLWSNGTALD 565
Query: 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE-QLPGPTS 601
L D ++ D+ K EV+R IH+ LLC QE+P+ RP +S + MLT+ LP P
Sbjct: 566 LVDPIII-----DNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTVTLPVPLQ 620
Query: 602 PPF 604
P F
Sbjct: 621 PGF 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 211/565 (37%), Positives = 300/565 (53%), Gaps = 57/565 (10%)
Query: 76 GLAQCYGDLSL-LDCVLCYAEA-RTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPE 133
+A C GD+ DC+ C A + L+ C I+L+ C R + G+ E
Sbjct: 79 AIALCRGDVKPNQDCISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSRIILGQME--- 135
Query: 134 DRAVCGNGTRKNSSF--QESARKAVMRAVAS--APSNGGYARVQVQVSGAANKSAYVLVN 189
V + T N S +E K + + S A + +V+ + + Y L
Sbjct: 136 --PVPFSYTSSNVSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVKFAAGVKGTIYALAQ 193
Query: 190 CWKTLNSSSCEACLANASASILGCLPW-SEGRALNTGCFMRYSDKDFLN-------KEP- 240
C L+ S C CLA A + C + G N C+ R+ F + K+P
Sbjct: 194 CTPDLSESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPL 253
Query: 241 --------------GKGRSRGMIAAIV--VSVVSALVVLAVGIVIGTRVWKQRSIERKRR 284
K RS+ +I A+V V+++ LV L + + +++ K
Sbjct: 254 SSHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKR-----RRKKKTLKEN 308
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKR 344
N+ E + DSL+F + T+ AT F NK+G+GGFG VYKG LPDG EIAVKR
Sbjct: 309 AENEFE------STDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKR 362
Query: 345 LFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSA 404
L ++ A F EV +++ ++HKNLV+L G S E LLVYEF+PN SLDRF+FD
Sbjct: 363 LSIHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPI 422
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
K K L WEKRY II+G GL+YLHE S+ IIHRD+K+SN+LLD ++ KI+DFG+AR
Sbjct: 423 KQKQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQ 482
Query: 465 FQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523
F D + ++ + GT GYMAPEY HG+ + K DVYSFG+L+LEI+TG++N+ E
Sbjct: 483 FDFDNTQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEG 542
Query: 524 TDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583
TD L T W+++ G EL D L+ HD K E ++ + + L C QENP+ RPTM
Sbjct: 543 TD-LPTFAWQNWIEGTSMELIDPVLL--QTHD---KKESMQCLEIALSCVQENPTKRPTM 596
Query: 584 SRVLQMLTTE---EQLPGPTSPPFI 605
V+ ML+++ QLP P+ P F
Sbjct: 597 DSVVSMLSSDSESRQLPKPSQPGFF 621
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (851), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 206/575 (35%), Positives = 302/575 (52%), Gaps = 50/575 (8%)
Query: 75 YGLAQCYGDLSLLDCVLCY-AEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYE-GP 132
Y + C ++ DCV C AR L QC ++ C R N + +G E P
Sbjct: 83 YAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWYTHCMFRYSNRTIYGRKETNP 142
Query: 133 EDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAAN---KSAYVLVN 189
+ G N E ++ ++ + + GG R Q +G+A+ + Y V
Sbjct: 143 TKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFYGTVQ 202
Query: 190 CWKTLNSSSCEACLANASASILGCLPWSEG-RALNTGCFMRYSDKDF------LNKEP-- 240
C L+ C CL +I C G R + C R+ F L +P
Sbjct: 203 CTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEPDPPA 262
Query: 241 ------------------GKGRSRGMIAAIVVSVVSALVVLAVGIVIGTRV----WKQRS 278
GKG S+ +IA ++ ++ AL+ + + +V+ R +K +
Sbjct: 263 IQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKV 322
Query: 279 IERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGR 338
+ + + AE N +SL + TL+ AT +F N+LG+GGFG+VYKGV P G+
Sbjct: 323 LGKSPLSGSIAEDEFS--NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQ 380
Query: 339 EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398
EIAVKRL N+ F NE+ +++ ++H+NLVRL+G G E LLVYEF+ N SLD+
Sbjct: 381 EIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQ 440
Query: 399 FIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458
FIFD+ K + L W RY++I G GL+YLHE S+ RIIHRD+KASNILLD + KIAD
Sbjct: 441 FIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIAD 500
Query: 459 FGLARSFQEDKS---HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
FGLA+ F ++ ++ IAGT GYMAPEY HGQ + K DV+SFG+L++EI+TG++N
Sbjct: 501 FGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRN 560
Query: 516 NR--SKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCT 573
N S E + LL+ W+ ++ + + D +L + + E+LR IH+GLLC
Sbjct: 561 NNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLT------AGSRNEILRCIHIGLLCV 614
Query: 574 QENPSLRPTMSRVLQMLTTEE-QLPGPTSPPFIDE 607
QE+ + RPTM+ V ML + LP P P F+ E
Sbjct: 615 QESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLE 649
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 236/687 (34%), Positives = 348/687 (50%), Gaps = 72/687 (10%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISE--QMRTSGFG 63
LF V ++L V DP + +I +S ++ N T + ++S S F
Sbjct: 11 LFSVFLFMILKTVTSDP-TYLYHICPNTTTYSRNSSYLTNLRTVLSSLSSPNAAYASLFD 69
Query: 64 LAVTGSGLDIN--YGLAQCYGDLSLLDCVLCYA-EARTLLPQCYPYNGGRIYLDGCFMRS 120
A G D N YG+ C GD+S C C A A L +C I+ D C +R
Sbjct: 70 NAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRY 129
Query: 121 ENYSFFGEYE-GPEDRAVCGNGTRKN--SSFQESARKAVMR-AVASAPSNGGYARVQVQV 176
N S G+ P +N S F ES ++ AV +A S+ +A +
Sbjct: 130 SNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANF 189
Query: 177 SGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEG-RALNTGCFMRYSDKDF 235
+ ++ Y LV C L + CE+CL + C S G R + C RY F
Sbjct: 190 T--VFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPF 247
Query: 236 LNK------------------------EPGKGRSRGMIAAIVVSVVSALVVLAVGIVIGT 271
N+ E GKG++ +I + VS V+L +G
Sbjct: 248 YNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLL-----LGA 302
Query: 272 RVWKQRSIERKRRGSNDAEKLVKTLNDD------SLNFKYSTLEKATGSFDEANKLGQGG 325
W + R+R AE + L++D +L F++S +E AT F E+NKLG GG
Sbjct: 303 MCWL---LARRRNNKLSAE--TEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGG 357
Query: 326 FGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385
FG VYKG L G +A+KRL + A F NEV++++ ++H+NL +LLG G E +
Sbjct: 358 FGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKI 417
Query: 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445
LVYEF+PN+SLD F+FD+ K + L W++RY+II G G++YLH S++ IIHRD+KASN
Sbjct: 418 LVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASN 477
Query: 446 ILLDSRLRAKIADFGLARSFQEDKSHISTA-IAGTLGYMAPEYLAHGQLTEKADVYSFGM 504
ILLD+ + KI+DFG+AR F D++ +T I GT GYM+PEY HG+ + K+DVYSFG+
Sbjct: 478 ILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGV 537
Query: 505 LLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLR 564
L+LE++TG++N+ + L+T WK + EL D+ M N+ + EV+R
Sbjct: 538 LVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDE-AMRGNFQTN----EVIR 592
Query: 565 AIHVGLLCTQENPSLRPTMSRVLQMLTT-EEQLPGPTSPPFIDERTMELHDNCYDPCCPM 623
IH+ LLC QE+ S RP+M +L M+ + LP P F+ RTM+ + DP
Sbjct: 593 CIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIPKRSGFL-LRTMK---DSRDPRSGG 648
Query: 624 NSGAHA--------SVANMSNSSLYPR 642
++ H+ SV + S + +YPR
Sbjct: 649 SASDHSATSKSLPLSVDDSSITIVYPR 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 642 | ||||||
| 225425605 | 654 | PREDICTED: cysteine-rich receptor-like p | 0.992 | 0.974 | 0.758 | 0.0 | |
| 224144143 | 651 | predicted protein [Populus trichocarpa] | 0.992 | 0.978 | 0.777 | 0.0 | |
| 224107811 | 634 | predicted protein [Populus trichocarpa] | 0.970 | 0.982 | 0.761 | 0.0 | |
| 225425609 | 654 | PREDICTED: cysteine-rich receptor-like p | 0.993 | 0.975 | 0.755 | 0.0 | |
| 147765333 | 665 | hypothetical protein VITISV_031461 [Viti | 0.992 | 0.957 | 0.740 | 0.0 | |
| 147767573 | 654 | hypothetical protein VITISV_005913 [Viti | 0.993 | 0.975 | 0.755 | 0.0 | |
| 297739087 | 696 | unnamed protein product [Vitis vinifera] | 0.953 | 0.879 | 0.731 | 0.0 | |
| 356497745 | 652 | PREDICTED: cysteine-rich receptor-like p | 0.970 | 0.955 | 0.743 | 0.0 | |
| 356565986 | 626 | PREDICTED: cysteine-rich receptor-like p | 0.967 | 0.992 | 0.732 | 0.0 | |
| 351720648 | 594 | protein kinase family protein [Glycine m | 0.920 | 0.994 | 0.753 | 0.0 |
| >gi|225425605|ref|XP_002265829.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1032 bits (2668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/639 (75%), Positives = 550/639 (86%), Gaps = 2/639 (0%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
FLF++ +L ++ AGDPR + ITC +Q EHNS+IFVPNFV MENIS Q+RTSGFG+
Sbjct: 17 FLFII-TLSVIELSAGDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGV 75
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A++GSG D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR++NYS
Sbjct: 76 AISGSGPDANYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYS 135
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 136 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESA 195
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL +CW+TLN+SSC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 196 YVLADCWRTLNASSCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 255
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG + IVV VSA++VL V IG +WKQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 256 SRGTVIIIVVPAVSAVIVLLVLGAIGVYIWKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 315
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 316 YATLEKATGSFDNENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRHRAADFYNEVNIIS 375
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLLVYE+LPN+SLDRFIFD+ + K L WEKR EII+GT EG
Sbjct: 376 SVEHKNLVRLLGCSCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNWEKRCEIIIGTAEG 435
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLHE S RIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHI+TAIAGTLGYMA
Sbjct: 436 LAYLHENSTNRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHITTAIAGTLGYMA 495
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
PEYLAHGQLTEK DVYSFG+LLLEIVTGRQNNRSK SEY+DS++TI WKHFQ G +EEL+
Sbjct: 496 PEYLAHGQLTEKVDVYSFGVLLLEIVTGRQNNRSKTSEYSDSIVTIAWKHFQLGTLEELF 555
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT-TEEQLPGPTSPP 603
D NLMLHNYH+ N+K EVLR + + LLCTQE PSLRP+MS+ LQMLT +E LP PT+PP
Sbjct: 556 DPNLMLHNYHNGNIKNEVLRVMQIALLCTQEAPSLRPSMSKALQMLTKKDEHLPTPTNPP 615
Query: 604 FIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
FIDERTMEL++ C +P P+N+ SVANMS+SS YPR
Sbjct: 616 FIDERTMELNEACANPSYPLNAAISGSVANMSHSSFYPR 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224144143|ref|XP_002336113.1| predicted protein [Populus trichocarpa] gi|222873004|gb|EEF10135.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/639 (77%), Positives = 553/639 (86%), Gaps = 2/639 (0%)
Query: 5 FLFLVGSLLMLVRVA-GDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFG 63
F G +L+ RV GDPR TV + CG QLEHN++IFVPNFV TM NIS+QMR SGFG
Sbjct: 14 FFCFFGYVLLRERVVVGDPRSQTVQVMCGRQLEHNATIFVPNFVATMGNISDQMRASGFG 73
Query: 64 LAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENY 123
+AV+GSG DINYGLAQCYGDLSLLDCVLCYAEART+LPQCYPYNGGRIYLDGCFMR+ENY
Sbjct: 74 VAVSGSGPDINYGLAQCYGDLSLLDCVLCYAEARTVLPQCYPYNGGRIYLDGCFMRAENY 133
Query: 124 SFFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKS 183
SF+ EY GP D+AVCGN TRK+S+F ES R+AV +AV SA +N GYARVQ+ V G N+S
Sbjct: 134 SFYEEYLGPGDKAVCGNTTRKSSTFAESTRQAVSQAVTSASNNQGYARVQLTVPGT-NES 192
Query: 184 AYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKG 243
AYVL NCWKTLN+SSC ACL NA+ASILGCLPWSEGRAL TGCFMRYSD DFLN E G G
Sbjct: 193 AYVLANCWKTLNASSCRACLENATASILGCLPWSEGRALYTGCFMRYSDIDFLNDELGNG 252
Query: 244 RSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNF 303
SRG I IVVSV+S+LVVL +G+ IG +WK+R I +KRRGSN+A+K+ +TLND SLNF
Sbjct: 253 SSRGSIVIIVVSVISSLVVLGLGVSIGVYIWKRRYIMKKRRGSNEAQKVARTLNDSSLNF 312
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNII 363
KYSTLEKATGSFD+ NKLGQGGFG+VYKG LPDGREIAVKRLFFNNRHRA +FYNE+N+I
Sbjct: 313 KYSTLEKATGSFDDTNKLGQGGFGSVYKGALPDGREIAVKRLFFNNRHRAKDFYNELNMI 372
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
SSVEHKNLVRLLGCSCSGPESLLVYEFLPN+SLDRFIFD K K LTWEKRYEII GT E
Sbjct: 373 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNRSLDRFIFDQNKGKELTWEKRYEIITGTAE 432
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL YLH S IRIIHRDIKASNILLDSRLRAKIADFGLARSFQ+DKSHISTAIAGTLGYM
Sbjct: 433 GLAYLHMNSSIRIIHRDIKASNILLDSRLRAKIADFGLARSFQDDKSHISTAIAGTLGYM 492
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543
APEYLAHGQLTEK DVY FG+LLLEIVTGRQNNRSKNSEYT+SL+ +TWK FQAG VEEL
Sbjct: 493 APEYLAHGQLTEKVDVYGFGVLLLEIVTGRQNNRSKNSEYTESLVILTWKKFQAGTVEEL 552
Query: 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPP 603
YD NLMLHN+HD+NVK +V RA+HVGLLCTQ+ PSLRPTMS+ LQMLTTEE LP P++PP
Sbjct: 553 YDPNLMLHNHHDNNVKNDVKRAVHVGLLCTQKIPSLRPTMSKALQMLTTEEHLPRPSNPP 612
Query: 604 FIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
FIDE TMEL+D C DPC P+NSG AS+A + NSS +PR
Sbjct: 613 FIDEMTMELNDTCEDPCYPLNSGTSASIATIENSSFHPR 651
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107811|ref|XP_002314609.1| predicted protein [Populus trichocarpa] gi|222863649|gb|EEF00780.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1018 bits (2632), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/642 (76%), Positives = 540/642 (84%), Gaps = 19/642 (2%)
Query: 2 KKAFLFLVGSLLMLVRVA-GDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTS 60
+ F G +L+ RV GDPR TV + CG QLEHN++IFVPNFV TM NIS+QMR S
Sbjct: 11 QSIFFCFFGYVLLRERVVVGDPRSQTVQVMCGRQLEHNATIFVPNFVATMGNISDQMRAS 70
Query: 61 GFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRS 120
GFG+AV+GSG DINYGLAQCYGDLSLLDCVLCYAEART+LPQCYPYNGGRIYLDGCFMR+
Sbjct: 71 GFGVAVSGSGPDINYGLAQCYGDLSLLDCVLCYAEARTVLPQCYPYNGGRIYLDGCFMRA 130
Query: 121 ENYSFFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAA 180
ENYSF+ EY GP D+AVCGN TRK+S+F ES R+AV +AV SA +N GYARVQ+ V G
Sbjct: 131 ENYSFYEEYLGPGDKAVCGNTTRKSSTFAESTRQAVSQAVTSASNNQGYARVQLTVPGT- 189
Query: 181 NKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEP 240
N+SAYVL NCWKTLN+SSC ACL NA+ASILGCLPWSEGRAL TGCFMRYSD DFLN E
Sbjct: 190 NESAYVLANCWKTLNASSCRACLENATASILGCLPWSEGRALYTGCFMRYSDIDFLNDEL 249
Query: 241 GKGRSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDS 300
G G SRG+ G+ IG +WK+R I +KRRGSN+A+KL +TLND S
Sbjct: 250 GNGSSRGL-----------------GVSIGVYIWKRRYIMKKRRGSNEAQKLARTLNDSS 292
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
LNFKYSTLEK TGSFDE NKLGQGGFG+VYKG LPDGREIAVKRLFFNNRHRAA+FYNEV
Sbjct: 293 LNFKYSTLEKGTGSFDETNKLGQGGFGSVYKGALPDGREIAVKRLFFNNRHRAADFYNEV 352
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
N+ISSVEHKNLVRLLGCSCSGPESLLVYEFLPN+SLDRFIFD K K LTWEKRYEII G
Sbjct: 353 NMISSVEHKNLVRLLGCSCSGPESLLVYEFLPNRSLDRFIFDQNKGKELTWEKRYEIITG 412
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
T EGL YLH S IRIIHRDIKASNILLDSRLRAKIADFGLARSFQ+DKSHISTAIAGTL
Sbjct: 413 TAEGLAYLHMNSSIRIIHRDIKASNILLDSRLRAKIADFGLARSFQDDKSHISTAIAGTL 472
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRV 540
GYMAPEYLAHGQLTEK DVY FG+LLLEIVTGRQNNRSKNSEYT+SL+ +TWK FQAG V
Sbjct: 473 GYMAPEYLAHGQLTEKVDVYGFGVLLLEIVTGRQNNRSKNSEYTESLVILTWKKFQAGTV 532
Query: 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPT 600
EELYD NLMLHN+HD+NV +V RA+HVGLLCTQE PSLRPTMS+ LQMLTTEE LP P+
Sbjct: 533 EELYDPNLMLHNHHDNNVMNDVKRAVHVGLLCTQEIPSLRPTMSKALQMLTTEEHLPRPS 592
Query: 601 SPPFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
+PPFIDE TMEL+D C DPC P+NSG AS+A + NSS +PR
Sbjct: 593 NPPFIDEMTMELNDICEDPCYPLNSGTSASIATIENSSFHPR 634
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425609|ref|XP_002265910.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera] gi|297739089|emb|CBI28578.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/639 (75%), Positives = 543/639 (84%), Gaps = 1/639 (0%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
F + +L ++ AGDPR T+ + CG+Q EHNS+IFV NFV MENIS QMRTSGFG+
Sbjct: 16 LFFFILTLSVIELSAGDPRSRTIQMMCGNQREHNSTIFVINFVAMMENISNQMRTSGFGV 75
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
AV GS D YGLAQCYGDLSLLDCVLCYAEART LPQC+P+ GRIYLDGCFMR++NYS
Sbjct: 76 AVLGSAPDATYGLAQCYGDLSLLDCVLCYAEARTFLPQCFPFTTGRIYLDGCFMRAQNYS 135
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 136 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVMVPGTANESA 195
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL NCW+TLN+ SC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 196 YVLANCWRTLNAISCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 255
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG I IVVS VSA++VL VG IG + KQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 256 SRGTIIIIVVSAVSAVIVLLVGGAIGVYILKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 315
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD ANKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 316 YATLEKATGSFDNANKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIIS 375
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLL+YEFLPN+SLDRFIFD+ + K L WEKR EII GT EG
Sbjct: 376 SVEHKNLVRLLGCSCSGPESLLIYEFLPNKSLDRFIFDTNRGKALNWEKRCEIITGTAEG 435
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
LVYLHE SKIRIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHISTAIAGTLGYMA
Sbjct: 436 LVYLHENSKIRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 495
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
PEYLAHGQLTEKADVYSFG+LLLEI TGRQNNRSK +EY+DSL+TI WKHFQ G +EEL+
Sbjct: 496 PEYLAHGQLTEKADVYSFGVLLLEIATGRQNNRSKTAEYSDSLVTIAWKHFQLGTLEELF 555
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT-TEEQLPGPTSPP 603
D NLMLHN+ + N+K EVLR + +GLLCTQE PSLRP+MS+ LQMLT +E LP PTSPP
Sbjct: 556 DPNLMLHNHDNGNIKNEVLRVMQIGLLCTQEVPSLRPSMSKALQMLTKKDEHLPTPTSPP 615
Query: 604 FIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
FIDERTMEL++ C +P P+N+ S A++S+SS YPR
Sbjct: 616 FIDERTMELNEACENPSYPLNAAISGSDASISHSSFYPR 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765333|emb|CAN71641.1| hypothetical protein VITISV_031461 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/652 (74%), Positives = 548/652 (84%), Gaps = 15/652 (2%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
FLF++ +L ++ AGDPR + ITC +Q EHNS+IFVPNFV MENIS Q+RTSGFG+
Sbjct: 15 FLFII-TLSVIELSAGDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGV 73
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A++GSG D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR++NYS
Sbjct: 74 AISGSGPDANYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYS 133
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 134 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESA 193
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL +CW+TLN+SSC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 194 YVLADCWRTLNASSCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 253
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRG-------------SNDAEK 291
SRG + IVV V A++VL V IG +WKQR I++KRRG SNDA K
Sbjct: 254 SRGTVIIIVVPAVXAVIVLLVLGAIGVYIWKQRKIQKKRRGKKILENKFLFENGSNDAIK 313
Query: 292 LVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH 351
LVKTL+D SLNFKY+TLEKATGSFD NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRH
Sbjct: 314 LVKTLHDSSLNFKYATLEKATGSFDNENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRH 373
Query: 352 RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTW 411
RAA+FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE+LPN+SLDRFIFD+ + K L W
Sbjct: 374 RAADFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNW 433
Query: 412 EKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471
EKR EII+GT EGL YLHE S RIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSH
Sbjct: 434 EKRCEIIIGTAEGLAYLHENSTNRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSH 493
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT 531
I+TAIAGTLGYMAPEYLAHGQLTEK DVYSFG+LLLEIVTGRQNNRSK EY+DSJ+TI
Sbjct: 494 ITTAIAGTLGYMAPEYLAHGQLTEKXDVYSFGVLLLEIVTGRQNNRSKTXEYSDSJVTIA 553
Query: 532 WKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
WKHFQ G +EEL+D NLMLHNYH+ N+K EVLR + + LLCTQE PSLRP+MS+ LQMLT
Sbjct: 554 WKHFQLGTLEELFDPNLMLHNYHNGNIKNEVLRVMQIALLCTQEAPSLRPSMSKALQMLT 613
Query: 592 -TEEQLPGPTSPPFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
+E LP PT+PPFIDERTMEL++ C +P P+N+ SVANMS+SS YPR
Sbjct: 614 KKDEHLPTPTNPPFIDERTMELNEACANPSYPLNAAISGSVANMSHSSFYPR 665
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767573|emb|CAN64526.1| hypothetical protein VITISV_005913 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2581), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/639 (75%), Positives = 543/639 (84%), Gaps = 1/639 (0%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
F + +L ++ AGDPR T+ + CG+Q EHNS+IFV NFV MENIS QMRTSGFG+
Sbjct: 16 LFFFILTLSVIELSAGDPRSRTIQMMCGNQREHNSTIFVINFVAMMENISNQMRTSGFGV 75
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
AV GS D YGLAQCYGDLSLLDCVLCYAEART LPQC+P+ GRIYLDGCFMR++NYS
Sbjct: 76 AVLGSAPDATYGLAQCYGDLSLLDCVLCYAEARTFLPQCFPFTTGRIYLDGCFMRAQNYS 135
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 136 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVMVPGTANESA 195
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL NCW+TLN+ SC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 196 YVLANCWRTLNAISCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 255
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG I IVVS VSA++VL VG IG + KQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 256 SRGTIIIIVVSAVSAVIVLLVGGAIGVYILKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 315
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD ANKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 316 YATLEKATGSFDNANKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIIS 375
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLL+YEFLPN+SLDRFIFD+ + K L WEKR EII GT EG
Sbjct: 376 SVEHKNLVRLLGCSCSGPESLLIYEFLPNKSLDRFIFDTNRGKALNWEKRCEIITGTAEG 435
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
LVYLHE SKIRIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHISTAIAGTLGYMA
Sbjct: 436 LVYLHENSKIRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 495
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
PEYLAHGQLTEKADVYSFG+LLLEI TGRQNNRSK +EY+DSL+TI WKHFQ G +EEL+
Sbjct: 496 PEYLAHGQLTEKADVYSFGVLLLEIXTGRQNNRSKTAEYSDSLVTIAWKHFQLGTLEELF 555
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT-TEEQLPGPTSPP 603
D NLMLHN+ + N+K EVLR + +GLLCTQE PSLRP+MS+ LQMLT +E LP PTSPP
Sbjct: 556 DPNLMLHNHDNGNIKNEVLRVMQIGLLCTQEVPSLRPSMSKALQMLTKKDEHLPTPTSPP 615
Query: 604 FIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
FIDERTMEL++ C +P P+N+ S A++S+SS YPR
Sbjct: 616 FIDERTMELNEACENPSYPLNAAISGSDASISHSSFYPR 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739087|emb|CBI28576.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2537), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/638 (73%), Positives = 529/638 (82%), Gaps = 26/638 (4%)
Query: 5 FLFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGL 64
FLF++ +L ++ AGDPR + ITC +Q EHNS+IFVPNFV MENIS Q+RTSGFG+
Sbjct: 85 FLFII-TLSVIELSAGDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGV 143
Query: 65 AVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYS 124
A++GSG D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR++NYS
Sbjct: 144 AISGSGPDANYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYS 203
Query: 125 FFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSA 184
F EY GP D A+CGN TRKNS+FQESAR+A+ +AVA AP+N GYAR +V V G AN+SA
Sbjct: 204 FIEEYTGPSDHALCGNETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESA 263
Query: 185 YVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
YVL +CW+TLN+SSC ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKEP G
Sbjct: 264 YVLADCWRTLNASSCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGS 323
Query: 245 SRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG + IVV VSA++VL V IG +WKQR I++KRRGSNDA KLVKTL+D SLNFK
Sbjct: 324 SRGTVIIIVVPAVSAVIVLLVLGAIGVYIWKQRKIQKKRRGSNDAIKLVKTLHDSSLNFK 383
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
Y+TLEKATGSFD NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIIS
Sbjct: 384 YATLEKATGSFDNENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRHRAADFYNEVNIIS 443
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
SVEHKNLVRLLGCSCSGPESLLVYE+LPN+SLDRFIFD+ + K L WEKR EII+GT EG
Sbjct: 444 SVEHKNLVRLLGCSCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNWEKRCEIIIGTAEG 503
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLHE S RIIHRDIKASNILLDS++RAKIADFGLARSFQEDKSHI+TAIAGTLGYMA
Sbjct: 504 LAYLHENSTNRIIHRDIKASNILLDSKMRAKIADFGLARSFQEDKSHITTAIAGTLGYMA 563
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
PEYLAHGQLTEK DVYSFG+LLLEIVTGRQNNRSK SEY+DS++TI WKHFQ G +EEL+
Sbjct: 564 PEYLAHGQLTEKVDVYSFGVLLLEIVTGRQNNRSKTSEYSDSIVTIAWKHFQLGTLEELF 623
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPF 604
D NLMLHNYH+ N+K EVLR + + LLCTQE PSLRP+M
Sbjct: 624 DPNLMLHNYHNGNIKNEVLRVMQIALLCTQEAPSLRPSM--------------------- 662
Query: 605 IDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
TMEL++ C +P P+N+ SVANMS+SS YPR
Sbjct: 663 ----TMELNEACANPSYPLNAAISGSVANMSHSSFYPR 696
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497745|ref|XP_003517719.1| PREDICTED: cysteine-rich receptor-like protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2496), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/628 (74%), Positives = 533/628 (84%), Gaps = 5/628 (0%)
Query: 18 VAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGL 77
+ +PR TV ITCGH+LEHN++IFVPNFV TME IS++MR +GFG A+ G+G D NYGL
Sbjct: 27 IIAEPRAKTVLITCGHELEHNTTIFVPNFVATMEKISDEMRKTGFGTAIVGTGPDTNYGL 86
Query: 78 AQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAV 137
AQCYGDLSLLDCVLCYAEART+LPQC+PYN GRI+LDGCFMR+ENYSFF EY GP DRAV
Sbjct: 87 AQCYGDLSLLDCVLCYAEARTVLPQCFPYNSGRIFLDGCFMRAENYSFFNEYTGPGDRAV 146
Query: 138 CGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSS 197
CGN TRKNSSF +A +AV+RAV AP+N GYA+ V V+G N+SAYVL +CW+TL+ S
Sbjct: 147 CGNTTRKNSSFHAAAMQAVLRAVQDAPNNKGYAKGNVAVAGTTNQSAYVLADCWRTLDKS 206
Query: 198 SCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRSRGMIAAIVVSVV 257
SC+ACL NAS+SILGCLPW EGRALNTGCFMRYSD DFLNKE G SRG + IV++VV
Sbjct: 207 SCKACLENASSSILGCLPWQEGRALNTGCFMRYSDTDFLNKEQENGSSRGNVVVIVIAVV 266
Query: 258 SALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE 317
S++ VL VG+ IG +WKQR I++KRRGSNDA+KL KTL +++LNFKYSTL+KAT SF E
Sbjct: 267 SSVTVLVVGVTIGVYIWKQRYIQKKRRGSNDAKKLAKTLQNNNLNFKYSTLDKATESFHE 326
Query: 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
NKLGQGGFGTVYKGVL DGREIAVKRLFFNNRHRAA+FYNEVNIISSVEHKNLVRLLGC
Sbjct: 327 NNKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIISSVEHKNLVRLLGC 386
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
SCSGPESLLVYEFLPN+SLDR+IFD K K L WE RYEII+GT EGLVYLHE SK RII
Sbjct: 387 SCSGPESLLVYEFLPNRSLDRYIFDKNKGKELNWENRYEIIIGTAEGLVYLHENSKTRII 446
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKA 497
HRDIKASNILLD++LRAKIADFGLARSFQED+SHISTAIAGTLGYMAPEYLAHGQLTEKA
Sbjct: 447 HRDIKASNILLDAKLRAKIADFGLARSFQEDQSHISTAIAGTLGYMAPEYLAHGQLTEKA 506
Query: 498 DVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS- 556
DVYSFG+LLLEIVT RQNNRSK SEY+DSL+T+ WKHFQAG E+L+D NL L H+S
Sbjct: 507 DVYSFGVLLLEIVTARQNNRSKASEYSDSLVTVAWKHFQAGTSEQLFDPNLDLQEDHNSN 566
Query: 557 -NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT-TEEQLPGPTSPPFIDERTMELHD 614
NVK E++R +H+GLLCTQE PSLRP+MS+ LQMLT EE L P++PPF+DE TMELHD
Sbjct: 567 VNVKDEIIRVVHIGLLCTQEVPSLRPSMSKALQMLTKKEEHLDAPSNPPFLDESTMELHD 626
Query: 615 NCYDPCCPMNSGAHASVANMSNSSLYPR 642
DP P+ A S+A MS+SS YPR
Sbjct: 627 TSGDPFYPLT--APDSIATMSHSSFYPR 652
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565986|ref|XP_003551216.1| PREDICTED: cysteine-rich receptor-like protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2433), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/627 (73%), Positives = 533/627 (85%), Gaps = 6/627 (0%)
Query: 20 GDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSG-LDINYGLA 78
+PR TVNITC ++LEHN++IFVPNFV TME ISEQMR +G+G AV G+G D NYGLA
Sbjct: 2 AEPRARTVNITCNNKLEHNTTIFVPNFVATMEKISEQMRNTGYGTAVVGTGGPDTNYGLA 61
Query: 79 QCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSFFGEYEGPEDRAVC 138
QCYGDLSLLDCVLCYAEART+LPQC+PYNGGRIYLDGCFMR+ENYSF+ EY GP D+AVC
Sbjct: 62 QCYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAENYSFYDEYIGPGDKAVC 121
Query: 139 GNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSS 198
GN TRK++SFQ +A+KAV+ AV +A +N GYAR +V V+G N +AYVL NCW++L++ S
Sbjct: 122 GNTTRKSTSFQAAAKKAVLSAVQAAANNKGYARKEVFVAGTTNDAAYVLANCWRSLDTRS 181
Query: 199 CEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGRSRGMIAAIVVSVVS 258
C ACL NAS+SILGCLPWSEGRALNTGCFMRYSD DFLNKE G S G + IVV+VVS
Sbjct: 182 CRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEQENGSSGGNVLVIVVAVVS 241
Query: 259 ALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEA 318
+++VL VGI I + K R I+ KRRGSNDAEKL K+L+ +SLNFKYSTLEKAT SFDEA
Sbjct: 242 SVIVLVVGIAIVVYIRKHRYIQMKRRGSNDAEKLAKSLHHNSLNFKYSTLEKATNSFDEA 301
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
NKLGQGGFGTVYKGVL DGREIA+KRL+FNNRHRAA+F+NEVNIISSVEHKNLVRLLGCS
Sbjct: 302 NKLGQGGFGTVYKGVLADGREIAIKRLYFNNRHRAADFFNEVNIISSVEHKNLVRLLGCS 361
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
CSGPESLL+YE+LPN+SLDRFIFD K + L W+KRY+II+GT EGLVYLHE S IRIIH
Sbjct: 362 CSGPESLLIYEYLPNRSLDRFIFDKNKGRELNWDKRYDIIIGTAEGLVYLHENSNIRIIH 421
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIKASNILLD++LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD
Sbjct: 422 RDIKASNILLDAKLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 481
Query: 499 VYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNV 558
VYSFG+LLLEI+TGR NNRSK SEY+DSL+T+TWKHFQ+G E+L D L++ + H SN
Sbjct: 482 VYSFGVLLLEIITGRLNNRSKASEYSDSLVTMTWKHFQSGTAEQLIDPCLVVDDNHRSNF 541
Query: 559 KYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ---LPGPTSPPFIDERTMELHDN 615
K E+LR +H+GLLCTQE PSLRP+MS+ L+MLT +E+ L P++PPFIDE TMELHD
Sbjct: 542 KNEILRVLHIGLLCTQEIPSLRPSMSKALKMLTKKEEHLDLEAPSNPPFIDESTMELHDQ 601
Query: 616 CYDPCCPMNSGAHASVANMSNSSLYPR 642
DP P+N A S+A MS+SS Y R
Sbjct: 602 NDDPFYPLN--AEDSLATMSHSSFYAR 626
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351720648|ref|NP_001235136.1| protein kinase family protein [Glycine max] gi|223452426|gb|ACM89540.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 921 bits (2381), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/596 (75%), Positives = 509/596 (85%), Gaps = 5/596 (0%)
Query: 50 MENISEQMRTSGFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGG 109
ME IS++MR +GFG A+ G+G D NYGLAQCYGDLSLLDCVLCYAEART+LPQC+PYN G
Sbjct: 1 MEKISDEMRKTGFGTAIVGTGPDTNYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNSG 60
Query: 110 RIYLDGCFMRSENYSFFGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGY 169
RI+LDGCFMR+ENYSFF EY GP DRAVCGN TRKNSSFQ +AR+AV+RAV AP+N GY
Sbjct: 61 RIFLDGCFMRAENYSFFNEYLGPGDRAVCGNTTRKNSSFQAAARQAVLRAVQDAPNNKGY 120
Query: 170 ARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMR 229
A+ V V+G N+SAYVL +CW+TL+ SC+ACL NAS+SILGCLPWSEGRALNTGCFMR
Sbjct: 121 AKGNVAVAGTTNQSAYVLADCWRTLDKRSCKACLENASSSILGCLPWSEGRALNTGCFMR 180
Query: 230 YSDKDFLNKEPGKGRSRGMIAAIVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDA 289
YSD DFLNKE G S G + IV++VVS+++V VG+ IG +WKQR+I++KRRGSNDA
Sbjct: 181 YSDTDFLNKEQENGSSSGNVVVIVIAVVSSVIVSVVGVTIGVYIWKQRNIQKKRRGSNDA 240
Query: 290 EKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN 349
EKL KTL +++LNFKYSTL+KAT SF E NKLGQGGFGTVYKGVL DGREIAVKRLFFNN
Sbjct: 241 EKLAKTLQNNNLNFKYSTLDKATESFHENNKLGQGGFGTVYKGVLADGREIAVKRLFFNN 300
Query: 350 RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTL 409
RHRAA+FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN+SLDR+IFD K K L
Sbjct: 301 RHRAADFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNRSLDRYIFDKNKGKEL 360
Query: 410 TWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469
WEKRYEII+GT EGLVYLHE SK RIIHRDIKASNILLD++LRAKIADFGLARSFQEDK
Sbjct: 361 NWEKRYEIIIGTAEGLVYLHENSKTRIIHRDIKASNILLDAKLRAKIADFGLARSFQEDK 420
Query: 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG+LLLEIVT RQNNRSK SEY+DSL+T
Sbjct: 421 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGVLLLEIVTARQNNRSKASEYSDSLVT 480
Query: 530 ITWKHFQAGRVEELYDKNLMLHNYHDS--NVKYEVLRAIHVGLLCTQENPSLRPTMSRVL 587
+ WKHFQAG E+L+D NL L H+S NVK E+LR +H+GLLCTQE SLRP+MS+ L
Sbjct: 481 VAWKHFQAGTAEQLFDPNLDLQEDHNSNVNVKDEILRVVHIGLLCTQEVSSLRPSMSKAL 540
Query: 588 QMLT-TEEQLPGPTSPPFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
QMLT EE L P++PPF+DE TMELHD DP P+ A S+A MS+SS YPR
Sbjct: 541 QMLTKKEEDLVAPSNPPFLDESTMELHDTSGDPFYPLT--APDSIATMSHSSFYPR 594
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 642 | ||||||
| TAIR|locus:2026821 | 649 | CRK2 "cysteine-rich RLK (RECEP | 0.979 | 0.969 | 0.656 | 9.9e-229 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.971 | 0.965 | 0.405 | 1.1e-121 | |
| TAIR|locus:2139845 | 625 | AT4G28670 [Arabidopsis thalian | 0.467 | 0.48 | 0.515 | 2e-117 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.554 | 0.535 | 0.454 | 7e-92 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.526 | 0.5 | 0.471 | 2.7e-86 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.535 | 0.509 | 0.432 | 9.2e-86 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.465 | 0.446 | 0.483 | 3.1e-85 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.475 | 0.449 | 0.482 | 6.4e-85 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.554 | 0.526 | 0.440 | 1.3e-84 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.526 | 0.512 | 0.445 | 3.1e-83 |
| TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2207 (782.0 bits), Expect = 9.9e-229, P = 9.9e-229
Identities = 420/640 (65%), Positives = 503/640 (78%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLA 65
+FL+ SL ++ GD R V +TC LEHN + +VPNFV TME IS Q++TSGFG+A
Sbjct: 18 MFLLSSLR---QITGDARARAVKVTCSPLLEHNETAYVPNFVATMEKISTQVQTSGFGVA 74
Query: 66 VTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIYLDGCFMRSENYSF 125
+TG+G D NYGLAQCYGDL L DCVLCYAEART+LPQCYP NGGRI+LDGCFMR+ENYSF
Sbjct: 75 LTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSF 134
Query: 126 FGEYEGPEDRAVCGNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAY 185
+ EY+GPED VCGN TRKN +F ++ R+ + AV A GGYAR + + ++SA+
Sbjct: 135 YNEYKGPEDSIVCGNTTRKNKTFGDAVRQGLRNAVTEASGTGGYARASAKAGESESESAF 194
Query: 186 VLVNCWKTLNSSSCEACLANASASIL-GCLPWSEGRALNTGCFMRYSDKDFLNKEPGKGR 244
VL NCW+TL+ SC+ CL NASAS++ GCLPWSEGRAL+TGCF+RYSD+DFLNK P GR
Sbjct: 195 VLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGR 254
Query: 245 SRGMXXXXXXXXXXXXXXXXXXXXXXTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFK 304
SRG + K+R+I+RKRRGS D EK+ KTL D SLNFK
Sbjct: 255 SRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFK 314
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIIS 364
YSTLEKATGSFD ANKLGQGGFGTVYKGVLPDGR+IAVKRLFFNNRHRA +FYNEVN+IS
Sbjct: 315 YSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMIS 374
Query: 365 SVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
+VEHKNLVRLLGCSCSGPESLLVYE+L N+SLDRFIFD + KTL W++RY II+GT EG
Sbjct: 375 TVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEG 434
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
LVYLHEQS ++IIHRDIKASNILLDS+L+AKIADFGLARSFQ+DKSHISTAIAGTLGYMA
Sbjct: 435 LVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYMA 494
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
PEYLAHGQLTE DVYSFG+L+LEIVTG+QN +SK S+Y+DSL+T WKHFQ+G +E++Y
Sbjct: 495 PEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKIY 554
Query: 545 DKNLMLHNYHDSNV-KYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ-LPGPTSP 602
D NL + +DS++ K E+ R + +GLLCTQE PSLRP MS++L ML +E+ LP P++P
Sbjct: 555 DPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNP 614
Query: 603 PFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
PF+DER MEL D D +S AS+A +S SS Y R
Sbjct: 615 PFMDERVMELRDGS-DG----DSAGCASLATVSQSSFYGR 649
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
Identities = 265/653 (40%), Positives = 371/653 (56%)
Query: 6 LFLVGSLLMLVRVAGDPRVHTVNITCGHQLE--HNSSIFVPNFVTTMENISEQMRTSGFG 63
L L+ L + V+ D R TV C ++ S+FV NF+ M+ +S + G+G
Sbjct: 7 LLLILGLFISPSVS-DSRGDTVAQICNNRTTTPQQRSLFVTNFLAAMDAVSPLVEAKGYG 65
Query: 64 LAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLLPQCYPYN----GGRIYLDGCFMR 119
V G+G Y +C DL DC LC+A+ + +P+C P+ GG+++ DGC++R
Sbjct: 66 QVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIR 125
Query: 120 SENYSFFGEYEGPEDRAVCGNG--TRKNSS-FQESARKAVMRAVASAPSNGGYARVQVQV 176
++Y+F+ E +DR VC T N + F+++A + V A NGG+ V
Sbjct: 126 YDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVEAVRNGGFYAGFVD- 184
Query: 177 SGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFMRYSDKDFL 236
N + + L CW+TLN S C CL+ AS I CL EGR L+ GC+MR+S + F
Sbjct: 185 --RHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKFY 242
Query: 237 NKEPGKGRSRGMXXXXXXXXXXXXXXXXXXXXXXTR----VWKQRSIERKRRGSNDAEKL 292
N G S G + K+R +K+R L
Sbjct: 243 NNS-GNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHA-KKQREKKQLGSL 300
Query: 293 VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR 352
N +L F Y LE+AT F + NKLGQGG G+VYKGVL +G+ +AVKRLFFN +
Sbjct: 301 FMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQW 360
Query: 353 AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
+F+NEVN+IS V+HKNLV+LLGCS +GPESLLVYE++ NQSL ++F + L W
Sbjct: 361 VDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWA 420
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
KR++IILGT EG+ YLHE+S +RIIHRDIK SNILL+ +IADFGLAR F EDK+HI
Sbjct: 421 KRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHI 480
Query: 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW 532
STAIAGTLGYMAPEY+ G+LTEKADVYSFG+L++E++TG++NN S+L W
Sbjct: 481 STAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQD--AGSILQSVW 538
Query: 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
++ VEE D ++ N++ K E R + +GLLC Q RP MS V++M+
Sbjct: 539 SLYRTSNVEEAVDP-ILGDNFN----KIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKG 593
Query: 593 EEQLPGPTSPPFIDERTM-ELHDNCYDPCCPMN--SGAHASVANMSNSSLYPR 642
++ PT PPF++ ++ E+ P + SG+ + +S PR
Sbjct: 594 SLEIHTPTQPPFLNPGSVVEMRKMMMTPTTNQSNSSGSRSDYITEGSSFFEPR 646
|
|
| TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 2.0e-117, Sum P(2) = 2.0e-117
Identities = 162/314 (51%), Positives = 225/314 (71%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
++F+YSTL+KAT +F+E+ KLG GG+G V+KG L DGREIA+KRL + + +NE+
Sbjct: 317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++IS +HKNLVRLLGC + S +VYEFL N SLD +F+ K K L W+KR IILG
Sbjct: 377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-----KSHIS-T 474
T EGL YLHE KI IHRDIKASNILLD + + KI+DFGLA+ + E S +S +
Sbjct: 437 TAEGLEYLHETCKI--IHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
+IAGTLGYMAPEY++ G+L+ K D YSFG+L+LEI +G +NN+ ++ ++L+T WK
Sbjct: 495 SIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKC 554
Query: 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT-TE 593
F + ++EE+ DK++ D++ K E+ R + +GLLCTQE+P LRPTMS+V+QM++ T+
Sbjct: 555 FASNKMEEMIDKDMG----EDTD-KQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSSTD 609
Query: 594 EQLPGPTSPPFIDE 607
LP PT PPF+ +
Sbjct: 610 IVLPTPTKPPFLHD 623
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 785 (281.4 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
Identities = 169/372 (45%), Positives = 230/372 (61%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL 334
K R E R N E + ++ DS+ F +S L+ AT F NKLG+GGFG VYKGVL
Sbjct: 306 KLRRKENIRNSENKHEN--ENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVL 363
Query: 335 PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394
DG++IAVKRL N + F NE +++ ++H+NLV+LLG S G E LLVYEFLP+
Sbjct: 364 SDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHT 423
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454
SLD+FIFD + L WE RY+II G GL+YLH+ S++RIIHRD+KASNILLD +
Sbjct: 424 SLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTP 483
Query: 455 KIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
KIADFG+AR F D + + I GT GYMAPEY+ HGQ + K DVYSFG+L+LEI++G
Sbjct: 484 KIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISG 543
Query: 513 RQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLC 572
++N+ + + L++ W++++ G L DK LM + + SN+ ++R I++GLLC
Sbjct: 544 KKNSGFSSEDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNM---IMRCINIGLLC 600
Query: 573 TQENPSLRPTMSRVLQMLTTEE-QLPGPTSPPFIDERTMELHDNCY-DPCCPMNSGAHAS 630
QE + RP+M+ V+ ML L P+ P F H N D + A S
Sbjct: 601 VQEKVAERPSMASVVLMLDGHTIALSEPSKPAFFS------HSNAVSDSSSSLGHNAKTS 654
Query: 631 VANMSNSSLYPR 642
N SN+ LYPR
Sbjct: 655 NYN-SNTELYPR 665
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 2.7e-86, Sum P(2) = 2.7e-86
Identities = 163/346 (47%), Positives = 223/346 (64%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYN 358
DSL Y T++ AT F E+NK+G+GGFG VYKG +G+E+AVKRL N+R A F
Sbjct: 337 DSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKT 396
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
EV +++ ++H+NLVRLLG S G E +LVYE++PN+SLD +FD K L W +RY II
Sbjct: 397 EVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNII 456
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IA 477
G G++YLH+ S++ IIHRD+KASNILLD+ + KIADFG+AR F D++ +T+ I
Sbjct: 457 GGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIV 516
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537
GT GYMAPEY HGQ + K+DVYSFG+L+LEI++GR+N+ S+ LLT TW+ +
Sbjct: 517 GTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTN 576
Query: 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE-QL 596
+L D L+ +N +S EV+R IH+GLLC QE+P+ RPT+S V MLT+ L
Sbjct: 577 RTALDLVDP-LIANNCQNS----EVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTL 631
Query: 597 PGPTSPPFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
P P P F + + D S AS+ + + LYPR
Sbjct: 632 PVPRQPGFFIQSSPVKDPTDSDQSTTTKS-TPASIDDELITDLYPR 676
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 725 (260.3 bits), Expect = 9.2e-86, Sum P(2) = 9.2e-86
Identities = 158/365 (43%), Positives = 229/365 (62%)
Query: 283 RRGSNDAEKLVKTLNDD------SLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD 336
RR +N + L++D +L F++S +E AT F E+NKLG GGFG VYKG L
Sbjct: 309 RRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLIT 368
Query: 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
G +A+KRL + A F NEV++++ ++H+NL +LLG G E +LVYEF+PN+SL
Sbjct: 369 GETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSL 428
Query: 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456
D F+FD+ K + L W++RY+II G G++YLH S++ IIHRD+KASNILLD+ + KI
Sbjct: 429 DYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKI 488
Query: 457 ADFGLARSFQEDKSHISTA-IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
+DFG+AR F D++ +T I GT GYM+PEY HG+ + K+DVYSFG+L+LE++TG++N
Sbjct: 489 SDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKN 548
Query: 516 NRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQE 575
+ + L+T WK + EL D+ M N+ + EV+R IH+ LLC QE
Sbjct: 549 SSFYEEDGLGDLVTYVWKLWVENSPLELVDE-AMRGNFQTN----EVIRCIHIALLCVQE 603
Query: 576 NPSLRPTMSRVLQMLTT-EEQLPGPTSPPFIDERTMELHDNCYDPCCPMNSGAHASVANM 634
+ S RP+M +L M+ + LP P F+ RTM+ D+ DP SG AS +
Sbjct: 604 DSSERPSMDDILVMMNSFTVTLPIPKRSGFL-LRTMK--DS-RDP----RSGGSASDHSA 655
Query: 635 SNSSL 639
++ SL
Sbjct: 656 TSKSL 660
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 3.1e-85, Sum P(2) = 3.1e-85
Identities = 148/306 (48%), Positives = 210/306 (68%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYN 358
DSL Y T++ AT F E+NK+GQGGFG VYKG L DG E+AVKRL ++ F N
Sbjct: 332 DSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKN 391
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
EV +++ ++H+NLVRLLG G E +LVYE++PN+SLD F+FD AK L W +RY+II
Sbjct: 392 EVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKII 451
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IA 477
G G++YLH+ S++ IIHRD+KASNILLD+ + KIADFG+AR F D++ +T+ I
Sbjct: 452 GGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIV 511
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537
GT GYM+PEY HGQ + K+DVYSFG+L+LEI++G++N+ ++ L++ W +
Sbjct: 512 GTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSN 571
Query: 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE-QL 596
GR EL D ++ ++ + EV+R +H+GLLC QE+P+ RPT+S ++ MLT+ L
Sbjct: 572 GRPLELVDPAIV-----ENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTL 626
Query: 597 PGPTSP 602
P P P
Sbjct: 627 PVPRQP 632
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 6.4e-85, Sum P(2) = 6.4e-85
Identities = 153/317 (48%), Positives = 209/317 (65%)
Query: 297 NDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANF 356
N +SL + TL+ AT +F N+LG+GGFG+VYKGV P G+EIAVKRL N+ F
Sbjct: 339 NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEF 398
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE 416
NE+ +++ ++H+NLVRL+G G E LLVYEF+ N SLD+FIFD+ K + L W RY+
Sbjct: 399 KNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYK 458
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS--HIST 474
+I G GL+YLHE S+ RIIHRD+KASNILLD + KIADFGLA+ F ++ H T
Sbjct: 459 MIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFT 518
Query: 475 A-IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR--SKNSEYTDSLLTIT 531
+ IAGT GYMAPEY HGQ + K DV+SFG+L++EI+TG++NN S E + LL+
Sbjct: 519 SRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWV 578
Query: 532 WKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
W+ ++ + + D +L + + E+LR IH+GLLC QE+ + RPTM+ V ML
Sbjct: 579 WRSWREDTILSVIDPSLT------AGSRNEILRCIHIGLLCVQESAATRPTMATVSLMLN 632
Query: 592 TEE-QLPGPTSPPFIDE 607
+ LP P P F+ E
Sbjct: 633 SYSFTLPTPLRPAFVLE 649
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 1.3e-84, Sum P(2) = 1.3e-84
Identities = 163/370 (44%), Positives = 224/370 (60%)
Query: 281 RKRRGSNDAEKLVKTLND----DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD 336
+K R + + E L + +D SL F + +E AT F E NKLGQGGFG VYKG+ P
Sbjct: 313 KKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPS 372
Query: 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
G ++AVKRL + F NEV +++ ++H+NLVRLLG E +LVYEF+PN+SL
Sbjct: 373 GVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSL 432
Query: 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456
D FIFDS L W +RY+II G G++YLH+ S++ IIHRD+KA NILL + AKI
Sbjct: 433 DYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKI 492
Query: 457 ADFGLARSFQEDKSHISTA-IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515
ADFG+AR F D++ +T I GT GYM+PEY +GQ + K+DVYSFG+L+LEI++G++N
Sbjct: 493 ADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKN 552
Query: 516 NRSKNSEYTDS--LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCT 573
+ + T + L+T TW+ + G EL D + NY + EV R IH+ LLC
Sbjct: 553 SNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFR-DNYRIN----EVSRCIHIALLCV 607
Query: 574 QENPSLRPTMSRVLQMLTTEE-QLPGPTSPPFIDERTMELHDNCYDPCCPMNSGAHASVA 632
QE RPTMS ++QMLTT L P P F + D +N+ A SV
Sbjct: 608 QEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLS-INTSALCSVD 666
Query: 633 NMSNSSLYPR 642
+ S +++ PR
Sbjct: 667 DASITNVTPR 676
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
Identities = 154/346 (44%), Positives = 212/346 (61%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYN 358
+SL Y ++ AT F E NK+G+GGFG VYKG +G E+AVKRL + F N
Sbjct: 320 ESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKN 379
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
EV +++++ HKNLVR+LG S E +LVYE++ N+SLD F+FD AK L W +RY II
Sbjct: 380 EVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHII 439
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA-IA 477
G G++YLH+ S++ IIHRD+KASNILLD+ + KIADFG+AR F D++ +T+ I
Sbjct: 440 GGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIV 499
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537
GT GYM+PEY GQ + K+DVYSFG+L+LEI++GR+NN ++ L+T W+ ++
Sbjct: 500 GTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRN 559
Query: 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ-L 596
G +L D + DS K EV+R H+GLLC QE+P RP MS + MLT+ L
Sbjct: 560 GTALDLVDPFIA-----DSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMAL 614
Query: 597 PGPTSPPFIDERTMELHDNCYDPCCPMNSGAHASVANMSNSSLYPR 642
P P P F R+ + N S+ + S S L PR
Sbjct: 615 PAPQQPGFF-VRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9CAL3 | CRK2_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6692 | 0.9813 | 0.9707 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 642 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-40 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 4e-53
Identities = 72/193 (37%), Positives = 105/193 (54%), Gaps = 10/193 (5%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVRLLGCS 378
LG+GGFGTVY G+++A+K + + E+ I+ + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
LV E+ SL + + L+ ++ I+L +EGL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 439 RDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEK 496
RD+K NILLDS + K+ADFGL++ DKS + T I GT YMAPE L G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEK 174
Query: 497 ADVYSFGMLLLEI 509
+D++S G++L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 8e-50
Identities = 85/278 (30%), Positives = 117/278 (42%), Gaps = 36/278 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR----AANFYNEVNIISSVEHKNLVRL 374
KLG G FGTVYK G+ +AVK R E+ I+ + H N+VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKI--LKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ LV E+ L ++ ++ L+ ++ +I L + GL YLH
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL- 493
IIHRD+K NILLD KIADFGLA+ + S T GT YMAPE L G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGY 176
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
K DV+S G++L E++TG+ + +L + L
Sbjct: 177 GPKVDVWSLGVILYELLTGKP----------------PFSGENILDQLQLIRRILGPPLE 220
Query: 554 HDSNVKYEVLR-AIHV--GLLCTQENPSLRPTMSRVLQ 588
D A + L +PS RPT +LQ
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNK--DPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 2e-47
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLG 376
KLG+G FG VY G+ +A+K + + E+ I+ ++H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 377 CSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+ LV E+ L + +A+ + + L YLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEYLHSK 116
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K NILLD K+ADFGLAR + + GT YMAPE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVLLGK 171
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
+ D++S G++L E++TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 4e-46
Identities = 92/301 (30%), Positives = 132/301 (43%), Gaps = 67/301 (22%)
Query: 319 NKLGQGGFGTVYKGVLPDG----REIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
KLG+G FG VYKG L E+AVK L + R F E ++ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVEGLV 426
RLLG LV E++ L ++ F S + TL+ + + +G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG----- 481
YL + + +HRD+ A N L+ L KI+DFGL+R +D + T G
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIR 172
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAG 538
+MAPE L G T K+DV+SFG+LL EI T G S N E +L ++ + G
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEE----VL----EYLRKG 223
Query: 539 RV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ELY+ LML C Q +P RPT S +++ L
Sbjct: 224 YRLPKPEYCPDELYE--LMLS--------------------CWQLDPEDRPTFSELVERL 261
Query: 591 T 591
Sbjct: 262 E 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 8e-46
Identities = 89/297 (29%), Positives = 123/297 (41%), Gaps = 70/297 (23%)
Query: 320 KLGQGGFGTVYKGVL---PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVR 373
KLG+G FG VYKG L +G E AVK L F E +I+ + H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
LLG G +V E++P L F+ + LT + ++ L +G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY-----MAPEYL 488
+HRD+ A N L+ L KI+DFGL+R D G MAPE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSEYTDSLLTITWKHFQAGRV- 540
G+ T K+DV+SFG+LL EI T G N + + G
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL-------------ELLEDGYRL 223
Query: 541 -------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ELY+ LML C +P RPT S +++ L
Sbjct: 224 PRPENCPDELYE--LMLQ--------------------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 8e-44
Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 320 KLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRA-----ANFYNEVNIISSVEHK 369
KLG+G FG VYKG L E+AVK L + A F E I+ ++H
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL----KEDASEQQIEEFLREARIMRKLDHP 61
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
N+V+LLG +V E++ L ++ L+ L G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
+ IHRD+ A N L+ L KI+DFGL+R +D + + +MAPE L
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
G+ T K+DV+SFG+LL EI T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 320 KLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRA-----ANFYNEVNIISSVEHK 369
KLG+G FG VYKG L E+AVK L + A F E I+ ++H
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKLDHP 61
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
N+V+LLG ++V E++P L ++ + + K L+ L G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
+ IHRD+ A N L+ L KI+DFGL+R +D + + +MAPE L
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
G+ T K+DV+SFG+LL EI T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 319 NKLGQGGFGTVYKGVLPD-GREIAVKRLFF--NNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G FG+VY + D G +AVK + ++ E+ I+SS++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 376 GCSCS-GPESLLVY-EFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYL 428
G +L ++ E++ SL + + T + IL EGL YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-----IL---EGLAYL 117
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGTLGYMAPEY 487
H I+HRDIK +NIL+DS K+ADFG A+ + + + ++ GT +MAPE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ + AD++S G ++E+ TG+
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 4e-40
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 315 FDEANKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F+ K+G+GGFG VYK G+E+A+K + ++ + NE+ I+ +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G E +V EF SL + + +TLT + + ++GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IIHRDIKA+NILL S K+ DFGL+ + K+ + + GT +MAPE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT--MVGTPYWMAPEVINGKPY 174
Query: 494 TEKADVYSFGMLLLEIVTGR 513
KAD++S G+ +E+ G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 136 bits (341), Expect = 8e-35
Identities = 77/282 (27%), Positives = 117/282 (41%), Gaps = 27/282 (9%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
KLG+G FG VY D + +A+K L + F E+ I++S+ N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
LV E++ SL+ + + L+ + I+ + L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 436 IIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSH-----ISTAIAGTLGYMAPEYLA 489
IIHRDIK NILLD K+ DFGLA+ + S + + GT GYMAPE L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 490 HGQL---TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546
L + +D++S G+ L E++TG E S + T K
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL---PPFEGEKNSSATSQTLKIILEL------PT 232
Query: 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+ SN + A + ++P R + S L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 28/207 (13%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNLVRLL 375
+ +G+G FG VYKG+ L G +A+K++ A + E++++ +++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE---------IILGTVEGLV 426
G + ++ E+ N SL + I K++ + ++GL
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQVLQGLA 113
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLHEQ +IHRDIKA+NIL K+ADFG+A + S ++ GT +MAPE
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPE 169
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ + +D++S G ++E++TG
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLL 375
++G+G FG VY DG+ +K + +N + NEV I+ + H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKI 434
+ +V E+ L + I K E++ + + L YLH +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
+I+HRDIK NI L S K+ DFG+++ T + GT Y++PE +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 495 EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554
K+D++S G +L E+ T + F+ + EL K L Y
Sbjct: 182 YKSDIWSLGCVLYELCTLK-------------------HPFEGENLLELALKILKGQ-YP 221
Query: 555 DSNVKY-EVLRAIHVGLLCTQENPSLRPTMSRVLQM 589
+Y LR + LL Q++P RP+++++LQ
Sbjct: 222 PIPSQYSSELRNLVSSLL--QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
FD KLG+G +G+VYK + G+ +A+K E++I+ + +V
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIV 61
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA--KTLTWEKRYEIILGTVEGLVYLHE 430
+ G + +V E+ S + D K KTLT E+ I+ T++GL YLH
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ IHRDIKA NILL+ +AK+ADFG++ + + +T I GT +MAPE +
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQE 173
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
KAD++S G+ +E+ G+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 321 LGQGGFGTVYKGV-LPDGR----EIAVKRLFFNNRHRAAN--FYNEVNIISSVEHKNLVR 373
LG G FGTVYKGV +P+G +A+K L AN +E +++SV+H ++VR
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA----KTLTWEKRYEIILGTVEGLVYLH 429
LLG C + L+ + +P L ++ + L W + +G+ YL
Sbjct: 74 LLGI-CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYL 488
E+ R++HRD+ A N+L+ + KI DFGLA+ D+ + +MA E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
H T K+DV+S+G+ + E++T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 69/198 (34%), Positives = 106/198 (53%), Gaps = 7/198 (3%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
F KLG G FG V++G+ + +A+K L ++ + +F EV + + HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 375 LG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
CS P ++ E + SL F+ S + + L ++ EG+ YL EQ
Sbjct: 68 FAVCSVGEP-VYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IHRD+ A NIL+ L K+ADFGLAR +ED ++S+ + APE +HG
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAASHGTF 181
Query: 494 TEKADVYSFGMLLLEIVT 511
+ K+DV+SFG+LL E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G ++AVK L A F E I+ + H LV+L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAV-C 70
Query: 380 SGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S E + +V E++ SL F+ S + K L + ++ EG+ YL + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLTE 495
RD+ A NIL+ L KIADFGLAR ++D TA G + + APE +G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 496 KADVYSFGMLLLEIVT-GR 513
K+DV+SFG+LL EIVT GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 320 KLGQGGFGTVYKGVL-PDGREIAVKRLFF----NNRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG G VYK P G+ A+K++ R + E+ + S E +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCESPYVVKC 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-----EGLVYLH 429
G E +V E++ SL + K + E +L + +GL YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIP-----EPVLAYIARQILKGLDYLH 116
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA------GTLGYM 483
+K IIHRDIK SN+L++S+ KIADFG+++ + + GT+ YM
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYM 167
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+PE + + AD++S G+ LLE G+
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 65/194 (33%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS 380
+G+G FG V G G+++AVK L ++ A F E ++++++ H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 381 GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRD 440
G +V E++ SL ++ +A +T ++ L EG+ YL E+ +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 441 IKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVY 500
+ A N+L+ L AK++DFGLA+ + S + + + APE L + + K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKE--ASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 501 SFGMLLLEIVT-GR 513
SFG+LL EI + GR
Sbjct: 184 SFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+ K+G+G G VYK G+E+A+K++ +++ NE+ I+ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIVD 79
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G E +V E++ SL I + + + + ++GL YLH Q
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRDIK+ NILL K+ADFG A ++KS ++ + GT +MAPE +
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDY 193
Query: 494 TEKADVYSFGMLLLEIVTG 512
K D++S G++ +E+ G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 319 NKLGQGGFGTVYKGV--LPDGREIAVKRLFFNNRHRAAN---FYNEVNIISSVEHKNLVR 373
+LG G FG+V KGV + G+E+ V H AA F E ++++ ++H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
L+G C G +LV E P L +++ L E+ G+ YL +
Sbjct: 61 LIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK-----ELAHQVAMGMAYLESK 114
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYLA 489
+HRD+ A N+LL +R +AKI+DFG++R+ + AG L + APE +
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+G+ + K+DV+S+G+ L E +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/205 (33%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 321 LGQGGFGTVY----KGVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V K G+ A+K L R + E NI+S + H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLT--WEKRY--EIILGTVEGLVYL 428
L + E L LV E+ P L + +K + + Y EI+L L YL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLA----LEYL 109
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H II+RD+K NILLD+ K+ DFGLA+ + S +T GT Y+APE L
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVL 165
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ D +S G+LL E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 69/195 (35%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G ++A+K L + A F E N++ ++H LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P ++ E++ N SL F+ K LT K ++ EG+ ++ ++ IHR
Sbjct: 72 QEP-IYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKN---YIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ L KIADFGLAR ++++ + + APE + +G T K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL EIVT GR
Sbjct: 187 WSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAA-NFYNEVNIISSVEHKNLVRLL 375
NK+G G FG VY V L G +AVK + +N + +E+ ++ ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G + + E+ +L+ + + + + Y + L +EGL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQL--LEGLAYLHSH---G 119
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG---YMAPEYLAHGQ 492
I+HRDIK +NI LD K+ DFG A + + + + + G YMAPE + G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 493 LTEK---ADVYSFGMLLLEIVTGR 513
AD++S G ++LE+ TG+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 66/201 (32%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG VY D GRE+AVK++ F+ + E+ ++ +++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 375 LGCSCSGPESLLVY-EFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
GC E+L ++ E++P S+ D+ A +T+T + +I+ EG+ YLH
Sbjct: 70 YGCL-RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGYMAPEYLAH 490
I+HRDIK +NIL DS K+ DFG ++ Q S + ++ GT +M+PE ++
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 491 GQLTEKADVYSFGMLLLEIVT 511
KADV+S G ++E++T
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 80/284 (28%), Positives = 119/284 (41%), Gaps = 43/284 (15%)
Query: 320 KLGQGGFGTVYKG--VLPDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
KLG G FG V +G G+ I AVK L + +F E I+ S++H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT---WEKRYEIILGTVEGLVYLHEQ 431
G + P ++V E P SL + A L + +I G+ YL +
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R IHRD+ A NILL S + KI DFGL R+ +++ H + + APE L
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548
+ +DV+ FG+ L E+ T G + W ++ + DK
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE----------------PWAGLSGSQILKKIDKEG 217
Query: 549 -MLHNYHDSNVK-YEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
L Y V+ C NP+ RPT + + + L
Sbjct: 218 ERLERPEACPQDIYNVMLQ------CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH--------RAANFYNEVNIISSVEHKN 370
KLG+G +G VYK G +A+K++ +N R E++++ ++H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR------EISLLKELKHPN 59
Query: 371 LVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVE 423
+V+LL L LV+E+ + L +++ K++ ++ +L
Sbjct: 60 IVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ-----LL---R 109
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL Y H RI+HRD+K NIL++ K+ADFGLAR+F + + TL Y
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYR 165
Query: 484 APEYL--AHGQLTEKADVYSFGMLLLEIVTGR 513
APE L + T D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 319 NKLGQGGFGTVYKGVLP-----DGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNL 371
+LG+G FG V G ++AVK L +HR+ +F E+ I+ +++H+N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRS-DFEREIEILRTLDHENI 68
Query: 372 VRLLGCSCS--GPESLLVYEFLPNQSLD---RFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
V+ G G L+ E+LP+ SL + D K L + +G+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL---LFS--SQICKGMD 123
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YMA 484
YL Q R IHRD+ A NIL++S KI+DFGLA+ EDK + G + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVT 511
PE L + + +DV+SFG+ L E+ T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH--------RAANFYNEVNIISSVEHK 369
++G+G +G VYK G +A+K++ N R E+ ++ + H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR------EIKLLQKLRHP 58
Query: 370 NLVRLLG--CSCSGPESLLVYEFLPN--QSLDR---FIFDSAKAKTLTWEKRYEIILGTV 422
N+VRL S +V+E++ + L F ++ K +++
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM----KQLL---- 110
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
EGL YLH I+HRDIK SNIL+++ K+ADFGLAR + + S T TL Y
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 483 MAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
PE L + + D++S G +L E+ G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNL 371
F+ NK+G+G FG V+K V D R A+K++ + +R +E +++ ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+R + +V E+ N L + + + + L ++ + + + GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+I+HRDIK+ N+ LD+ KI D G+A+ D ++ + I GT Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDK 176
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
EK+DV++ G++L E TG+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 319 NKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
P ++ EF+ +L ++ + + + + + + YL +++ I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLT 494
HRD+ A N L+ K+ADFGL+R D TA AG + + APE LA+ + +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 495 EKADVYSFGMLLLEIVT 511
K+DV++FG+LL EI T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 6e-26
Identities = 65/192 (33%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G + ++AVK L A F E N++ +++H LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
++ E++ SL F+ K L K + EG+ Y+ ++ IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIERKN---YIHR 127
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+N+L+ L KIADFGLAR ++++ + + APE + G T K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 500 YSFGMLLLEIVT 511
+SFG+LL EIVT
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 320 KLGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLLG 376
KLG+G +G+VYK L D + A+K + + + + NE+ I++SV H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIR 435
G + +V E+ P L + I K + L E+ + I + + GL LHEQ +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
I+HRD+K++NILL + KI D G+++ K +++ GT YMAPE +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 496 KADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL------M 549
K+D++S G LL E+ T F+A +++L K +
Sbjct: 181 KSDIWSLGCLLYEMATFAPP-------------------FEARSMQDLRYKVQRGKYPPI 221
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
Y ++ I Q P LRP ++L
Sbjct: 222 PPIYSQ-----DLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 63/198 (31%), Positives = 108/198 (54%), Gaps = 13/198 (6%)
Query: 321 LGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+G G FG V +G L P +EI A+K L + + +F E +I+ +H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G +++ E++ N SLD+F+ T + ++ G G+ YL S++
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG--TLGYMAPEYLAHGQL 493
+HRD+ A NIL++S L K++DFGL+R ED T G + + APE +A+ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 494 TEKADVYSFGMLLLEIVT 511
T +DV+SFG+++ E+++
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 82/281 (29%), Positives = 137/281 (48%), Gaps = 47/281 (16%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRL 374
LG G FG+VY+G+ L DG AVK + + + E+ ++S ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 375 LGCSCSGPESLLVY-EFLPNQSLDRFI--FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LG ++L ++ E +P SL + + + S + R +I+LG L YLH++
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLG----LEYLHDR 121
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLAR---SFQEDKSHISTAIAGTLGYMAPEYL 488
+HRDIK +NIL+D+ K+ADFG+A+ F KS G+ +MAPE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-----FKGSPYWMAPEVI 173
Query: 489 AH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547
A G AD++S G +LE+ TG + S+ + +K ++ + + D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATG----KPPWSQLEG--VAAVFKIGRSKELPPIPD-- 225
Query: 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
H S+ + + C Q +PSLRPT + +L+
Sbjct: 226 ------HLSDEAKDFIL------KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V++G+ + +AVK L +F E I+ + H L++L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
+V E + SL ++ A + L + ++ G+ YL Q+ IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLTEK 496
D+ A N+L+ K+ADFGLAR +ED I A G + + APE + + + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED---IYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 497 ADVYSFGMLLLEIVT-GR 513
+DV+SFG+LL EIVT GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 38/278 (13%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA---ANFYNEVNIISSVEHKNLVRLLG 376
++G G FG V+ G + R++A+K + R A +F E ++ + H LV+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
LV+EF+ + L ++ A+ + E + L EG+ YL + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
IHRD+ A N L+ K++DFG+ R +D+ ST + + +PE + + + K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 497 ADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
+DV+SFG+L+ E+ + G+ NRS NSE +++ AG LY L
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETI--------NAGF--RLYKPRLA---- 226
Query: 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
S YE+++ C +E P RP+ S +L L
Sbjct: 227 --SQSVYELMQH------CWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKR----LFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
K+G+G FG VYKGVL E+AVK L + + + F E I+ +H N+V+L+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKLI 58
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G +V E +P SL F+ K LT +K ++ L G+ YL ++
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN--- 113
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT----LGYMAPEYLAHG 491
IHRD+ A N L+ KI+DFG++R E++ I T G + + APE L +G
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 492 QLTEKADVYSFGMLLLEIVTG 512
+ T ++DV+S+G+LL E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 18/200 (9%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEH---KNLVRLL 375
+G+G +G VY+G +P GR +A+K + + ++ EV ++S + N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE--IILGTVEGLVYLHEQSK 433
G GP ++ E+ S+ + KA + ++Y II + L Y+H K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPI--AEKYISVIIREVLVALKYIH---K 119
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+ +IHRDIKA+NIL+ + K+ DFG+A ++ S ST GT +MAPE + G+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKY 178
Query: 494 TE-KADVYSFGMLLLEIVTG 512
+ KAD++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 60/199 (30%), Positives = 113/199 (56%), Gaps = 14/199 (7%)
Query: 321 LGQGGFGTVYKGVL--PDGRE--IAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G G FG V++G+L P +E +A+K L + + R +F +E +I+ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ-DFLSEASIMGQFSHHNIIRL 71
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G ++++ E++ N +LD+++ D + + ++ G G+ YL S +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDM 126
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YMAPEYLAHGQ 492
+HRD+ A NIL++S L K++DFGL+R ++D T G + + APE +A+ +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 493 LTEKADVYSFGMLLLEIVT 511
T +DV+SFG+++ E+++
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 320 KLGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHR--AANFYNEVNIISSVEHKNLVRLLG 376
++G+G G V+K G +A+K++ E+ + + +H +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
G +LV E++P+ L + D + K Y +L ++G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHAN---GI 120
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ--LT 494
+HRD+K +N+L+ + KIADFGLAR F E++ + + T Y APE L +G
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YGARKYD 179
Query: 495 EKADVYSFGMLLLEIVTGR 513
D+++ G + E++ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 321 LGQGGFGTVYKGVL-PDGREIAVKRL--FFNNRHRAANF-YNEVNIISSVE-HKNLVRLL 375
+G+G F TV +E A+K L + + + E +++ + H +++L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 376 GCSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+ E+L V E+ PN L ++I D R+ + L YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-------RF-YAAEILLALEYLH 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA------------ 477
IIHRD+K NILLD + KI DFG A+ + S S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 478 -------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y++PE L + +D+++ G ++ +++TG+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 72/286 (25%), Positives = 127/286 (44%), Gaps = 40/286 (13%)
Query: 321 LGQGGFGTVYKGVLPD------GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVR 373
LGQG FG VY+G+ +A+K + N + F NE +++ ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTVEGLV 426
LLG +G +L+V E + L ++ ++ T +K ++ +G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAP 485
YL + + +HRD+ A N ++ L KI DFG+ R ++ D + +MAP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
E L G T K+DV+SFG++L E+ T Q + ++E + + +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------------EVLKF--VI 235
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
D + + + E++R +C Q NP +RPT ++ L
Sbjct: 236 DGGHLDLPENCPDKLLELMR------MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN---EVNIISSVEHKNLVRL 374
+G G VY + LP+ ++A+KR+ + + EV +S H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQSK 433
G E LV +L SL + S L E +L ++GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-EAIIATVLKEVLKGLEYLHSN-- 121
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQED---KSHISTAIAGTLGYMAPEYLAH 490
IHRDIKA NILL KIADFG++ S + + GT +MAPE +
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 491 GQ-LTEKADVYSFGMLLLEIVTGR 513
KAD++SFG+ +E+ TG
Sbjct: 181 VHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN------FYNEVNIISS 365
+ +LG G G V K + P G+ +AVK + N E++I+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-----RLEINEAIQKQILRELDILHK 55
Query: 366 VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEG 424
+V G + + + E++ SLD+ + + K I + ++G
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKG 112
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLHE+ KI IHRD+K SNIL++SR + K+ DFG++ ++ GT YMA
Sbjct: 113 LTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMA 167
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE + + K+D++S G+ L+E+ TGR
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 316 DEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVR 373
+ N++G G GTVYK + P GR A+K ++ N+ E+ I+ V H N+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 374 LLGCSCSGPESLLVYEFLPNQSLD-RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
E ++ EF+ SL+ I D + + IL G+ YLH +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ-----IL---SGIAYLHRR- 187
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY----L 488
I+HRDIK SN+L++S KIADFG++R + ++++ GT+ YM+PE L
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDL 244
Query: 489 AHGQLTEKA-DVYSFGMLLLEIVTGR 513
HG A D++S G+ +LE GR
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 44/280 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----NFYNEVNIISSVEHKNLVRLLG 376
LG G FG V+ G ++A+K + A +F E ++ + H NLV+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 377 -CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
C+ P +V E++ N L ++ + L E ++ E + YL
Sbjct: 67 VCTKQRP-IFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG--- 120
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
IHRD+ A N L+ K++DFGLAR +D+ S + + PE + + +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 496 KADVYSFGMLLLEIVTGRQN--NRSKNSEYTDSLLT--ITWKHFQAGRVEELYDKNLMLH 551
K+DV+SFG+L+ E+ + + R NSE +S+ ++ A E+Y +M
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP--TEVYT--IMYS 236
Query: 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
C E P RP ++L LT
Sbjct: 237 --------------------CWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ ++AVK + + A F E N++ +++H LV+L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P ++ EF+ SL F+ S + K + EG+ ++ +++ IHR
Sbjct: 72 KEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ + L KIADFGLAR ++++ + + APE + G T K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL+EIVT GR
Sbjct: 187 WSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 34/214 (15%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNI---ISSVEH 368
++E ++G+G +GTVYK L GR +A+K++ + E+ + + S EH
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 369 KNLVRLLGCSCSGPES------LLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRY 415
N+VRLL C GP + LV+E + +Q L ++ K L +
Sbjct: 61 PNIVRLLDV-CHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ--- 115
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
+L G+ +LH RI+HRD+K NIL+ S + KIADFGLAR + + + T+
Sbjct: 116 --LLR---GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTS 165
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
+ TL Y APE L D++S G + E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 321 LGQGGFGTVYK---GVLPD--GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G FG+V L D G +AVK+L + +F E+ I+ S++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 376 G-CSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVEGLVY 427
G C +G +L LV E+LP SL ++ D K + +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAP 485
L + R +HRD+ NIL++S R KI DFGL + +DK + G + + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523
E L + + +DV+SFG++L E+ T + S +E+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFF--NNRHRAANFYNEVNIISSVEHKN 370
E ++LG+G G+V K L + I + N E+ I S +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 371 LVRLLGCSCSGPESLLVY---EFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTV---- 422
+V+ G + S + E+ SLD I+ K + EK +LG +
Sbjct: 61 IVKYYG-AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK----VLGKIAESV 114
Query: 423 -EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
+GL YLH + +IIHRDIK SNILL + + K+ DFG++ S T GT
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFT-GTSF 168
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
YMAPE + + +DV+S G+ LLE+ R
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 9/207 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNL 371
++ +G+G FGTV K DG+ + K + + N +EVNI+ ++H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 372 VRLLGCSCSGPESLL--VYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTVEGLVYL 428
VR L V E+ L + I K + + E + I+ + L
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 429 H--EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
H ++HRD+K +NI LD+ K+ DFGLA+ D S T GT YM+PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPE 180
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
L H EK+D++S G L+ E+
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 311 ATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF--YNEVNIISSVE 367
++ KLG+G FG VYK + GR +A+K++ +N E+ I+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 368 HKNLVRLLGCSCSGPESLL-----VYEFLPNQSLD--------RFIFDSAKAKTLTWEKR 414
H N+V L+ + P+ VY P D ++ K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC------ 119
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
+L +EG+ YLHE I+HRDIKA+NIL+D++ KIADFGLAR + +
Sbjct: 120 --YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 475 AIAG----------TLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
G T Y PE L + T D++ G + E+ T R
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN-----EVNIISSVEH 368
+++ KLG+G + VYK GR +A+K++ R A + N E+ ++ ++H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N++ LL LV+EF+ L++ I D K+ LT +L T+ GL YL
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYL 118
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H I+HRD+K +N+L+ S K+ADFGLARSF ++ + T Y APE L
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174
Query: 489 AHG--QLTEKADVYSFGMLLLEIVTGR 513
G D++S G + E++
Sbjct: 175 -FGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 21/202 (10%)
Query: 321 LGQGGFGTVYKGV-LPDGREI----AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
LG G FGTVYKG+ +P+G + A+K L +A F +E I++S++H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEGLVYLHE 430
LG C P LV + +P+ L ++ + L W + +G++YL E
Sbjct: 75 LGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYLA 489
+ R++HRD+ A N+L+ S KI DFGLAR + D K + + + +MA E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+ + T ++DV+S+G+ + E++T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 62/201 (30%), Positives = 114/201 (56%), Gaps = 16/201 (7%)
Query: 321 LGQGGFGTVYKGVL--PDGREI--AVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G G FG V +G L P REI A+K L + + R +F +E +I+ +H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQFDHPNIIHL 70
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G +++ EF+ N +LD F+ + T+ + ++ G G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLSEMN-- 126
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--ISTAIAGTLG--YMAPEYLAH 490
+HRD+ A NIL++S L K++DFGL+R ++D S ++++ G + + APE +A+
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 491 GQLTEKADVYSFGMLLLEIVT 511
+ T +DV+S+G+++ E+++
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLG G FG V+ G ++AVK L + F E I+ + H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P +V E++ SL F+ D + + L ++ G+ Y+ ++ IHR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++++NIL+ L KIADFGLAR ++++ + + APE +G+ T K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR-----QNNR 517
+SFG+LL E+VT GR NNR
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNR 210
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKR--LFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
K+G+G +G VYK G +A+K+ L F + E+ ++ + H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ LV+EF+ + L + I D + L + ++GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL-AHGQLTE 495
+HRD+K N+L+++ K+ADFGLARSF + + T Y APE L +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYST 178
Query: 496 KADVYSFGMLLLEIVTGR 513
D++S G + E+++ R
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 321 LGQGGFGTVYKGVLPDGRE--IAVKRLFFNN-------RHRAANF---YNEVNII-SSVE 367
LG G FG VYK + + +A+K + +N R R + +EV II +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
H N+VR +V + + L + F K + T E+ + I + V L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH++ RI+HRD+ +NI+L + I DFGLA+ Q + T++ GT+ Y PE
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVT 511
+ + EKADV++FG +L ++ T
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
LG G FG VYK + G A K + + +F E++I+S +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
+ ++ EF +LD + + + LT + + +E L +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 440 DIKASNILLDSRLRAKIADFGL-ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE--- 495
D+KA NILL K+ADFG+ A++ + T I GT +MAPE +A +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 496 --KADVYSFGMLLLEIVTGR 513
KAD++S G+ L+E+
Sbjct: 186 DYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 315 FDEANK---LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN 370
+DE + LG+G +G VY L IA+K + + + E+ + S ++H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLD---RFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
+V+ LG + E +P SL R + K T + IL EGL Y
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLKY 123
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
LH+ +I+HRDIK N+L+++ KI+DFG ++ T GTL YMAPE
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPE 179
Query: 487 YLAHGQ--LTEKADVYSFGMLLLEIVTGR 513
+ G AD++S G ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA----ANFYNEVNIISSVEHKNLVRL 374
+G+G FG VYK + + +A+K + + A + E+ +S + +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G G + ++ E+ S D K L I+ + GL YLHE+ KI
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
HRDIKA+NILL K+ADFG++ S +T GT +MAPE +
Sbjct: 121 ---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQSGYD 176
Query: 495 EKADVYSFGMLLLEIVTG 512
EKAD++S G+ +E+ G
Sbjct: 177 EKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 321 LGQGGFGTVYKG----VLPDGRE--IAVKRL---FFNNRHRAANFYNEVNIISSVEHKNL 371
LG+G FG V+ G + P+ + +AVK L N+ + +F E ++++ +H+N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK--DFEREAELLTNFQHENI 70
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRF---------IFDSAKAKT--LTWEKRYEIILG 420
V+ G G ++V+E++ + L++F S + LT + +I +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGT 479
G+VYL Q +HRD+ N L+ L KI DFG++R + D +
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +M PE + + + T ++DV+SFG++L EI T G+Q
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 322 GQGGFGTVYKGVLPDGREI-AVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLL 375
G+G FG V D +++ A+K + N + N NE I+ + H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSK 433
LV + L L R+ + K + EI+L L YLH +
Sbjct: 67 YSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLA----LEYLHSK-- 119
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IIHRDIK NILLD + I DF +A D ++T+ +GT GYMAPE L
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGY 176
Query: 494 TEKADVYSFGMLLLEIVTGRQ----NNRSKNSEYTDSLLT 529
+ D +S G+ E + G++ ++R+ + T
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET 216
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 315 FDEANKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
D K+G+G G V GR++AVK++ + R +NEV I+ +H N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ G E +V EFL +L D + E+ + L ++ L +LH Q
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQED----KSHISTAIAGTLGYMAPEYLA 489
+IHRDIK+ +ILL S R K++DFG ++ KS + GT +MAPE ++
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPEVIS 188
Query: 490 HGQLTEKADVYSFGMLLLEIVTG 512
+ D++S G++++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 317 EANKLGQGGFGTVYKGVLPDGREIAVKR--LFFNNRHRAANFYN----EVNIISSVEHKN 370
+ LG+G +GTVY G+ G+ IAVK+ L +N A Y EV+++ S++H N
Sbjct: 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 371 LVRLLGCSCSGPESLLVY-EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+V+ LG +C ++ ++ EF+P S+ + + K + IL +G+ YLH
Sbjct: 64 IVQYLG-TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLH 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-----SFQEDKSHISTAIAGTLGYMA 484
++HRDIK +N++L K+ DFG AR S++ ++ GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE + K+D++S G + E+ TG+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLLGCS 378
LG G G+V K +P G +A K + + E+ I+ +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ + EF+ SLDR K + E +I + VEGL YL+ RI+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRI---YKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIK SNIL++SR + K+ DFG++ E + I+ GT YM+PE + G+ T K+D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 499 VYSFGMLLLEIVTGR 513
V+S G+ ++E+ G+
Sbjct: 185 VWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLGQG FG V+ G ++A+K L A F E I+ + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P +V EF+ SL F+ K L + ++ +G+ Y+ ++ IHR
Sbjct: 72 EEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ L KIADFGLAR ++++ + + APE +G+ T K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL E+VT GR
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 321 LGQGGFGTVYKGVL--PDGREIAVK----RLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G G FG V G L P REI V + + + R +F +E +I+ +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR-DFLSEASIMGQFDHPNIIHL 70
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G ++V E++ N SLD F+ T+ + ++ G G+ YL S +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYL---SDM 125
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YMAPEYLAHGQ 492
+HRD+ A NIL++S L K++DFGL+R ++D T G + + APE +A+ +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 493 LTEKADVYSFGMLLLEIVT 511
T +DV+S+G+++ E+++
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 32/214 (14%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRA------ANFYNEVNIISSVEHK 369
+G+G +G VY + + G +AVK++ RH + +E+ + ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 370 NLVRLLGCSCSGPESLLVY-EFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVE 423
N+V+ LG + E L ++ E++P S+ + F+ + T + +E
Sbjct: 69 NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAIAGTLGY 482
GL YLH + I+HRD+KA N+L+D+ KI+DFG+++ + + ++ G++ +
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 483 MAPE--YLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
MAPE + + K D++S G ++LE+ GR+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 31/213 (14%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFF-------NNRHRA--ANFYNEVNIISSVEHKN 370
+G G FG+VY G+ G +AVK++ +R R+ E+ ++ ++H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGL 425
+V+ LG S + E++P S+ + F+ + + ++GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF--------VRQILKGL 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST-----AIAGTL 480
YLH + IIHRDIK +NIL+D++ KI+DFG+++ + + T ++ G++
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+MAPE + T KAD++S G L++E++TG+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 15/197 (7%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
+G+G FG V +G G+++AVK + + +A F E +++ + HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA--FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 380 SGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
L +V E + +L F+ +A + + L EG+ YL +SK +++H
Sbjct: 70 H--NGLYIVMELMSKGNLVNFLRTRGRALVSV-IQLLQFSLDVAEGMEYL--ESK-KLVH 123
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD+ A NIL+ AK++DFGLAR ++ + + + APE L H + + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179
Query: 499 VYSFGMLLLEIVT-GRQ 514
V+S+G+LL E+ + GR
Sbjct: 180 VWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
P +V E++ SL F+ K L + ++ G+ Y+ ++ +HR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 500 YSFGMLLLEIVT-GR 513
+SFG+LL E+ T GR
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 321 LGQGGFGTVYKGV-LPDGR--EIAVKRLFFNNRHRAANFY---NEVNIISSVEHKNLVRL 374
LG G FGTV+KG+ +P+G +I V +R F + + + S++H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA----KTLTWEKRYEIILGTVEGLVYLHE 430
LG C G LV + P SL + + + L W + +G+ YL E
Sbjct: 75 LGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTLGYMAPEYLA 489
R++HR++ A NILL S +IADFG+A + +DK + + + +MA E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
G+ T ++DV+S+G+ + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++ ++G G +G VYK + G +A+K + E++++ H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE---GLVYLHE 430
G + +V E+ SL I+ T +I E GL YLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQ----VTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLA----RSFQEDKSHISTAIAGTLGYMAPE 486
K IHRDIK +NILL K+ADFG++ + + KS I GT +MAPE
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPE 171
Query: 487 YLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543
A G K D+++ G+ +E+ Q + +L I+ +F + L
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAEL-QPPMF-DLHPMRALFLISKSNFPPPK---L 226
Query: 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
DK +HD +K C ++P RPT +++LQ
Sbjct: 227 KDKEKWSPVFHDF-IK-----------KCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 26/228 (11%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
+F + KLG+G + TVYKG EI A+K + + + E++++ ++H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFI--------FDSAKAKTLTWEKRYEIILGTVE 423
VRL + + +LV+E++ ++ L +++ D K+ T++ ++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ + HE R++HRD+K N+L++ R K+ADFGLAR+F + S + TL Y
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYR 167
Query: 484 APEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
AP+ L + + D++S G ++ E++TGR N+E D LL I
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 321 LGQGGFGTVYKG--VLPDGRE----IAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVR 373
LG+G FG VYKG P+ R +A+K L N + F E ++S ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRYEIIL 419
LLG C+ P +L +E+L + L F+ D +L I +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAG 478
G+ YL S +HRD+ A N L+ L KI+DFGL+R + D + +
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
+ +M PE + +G+ T ++D++SFG++L EI
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 79/296 (26%), Positives = 119/296 (40%), Gaps = 52/296 (17%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNL 371
LG G FG VY+G+ ++AVK L + ++F E I+S H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEGLVY 427
VRL+G S ++ E + L F+ ++ + +LT + +G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 428 LHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARS-FQEDKSHISTAIAGTLGYM 483
L E IHRDI A N LL + AKIADFG+AR ++ + +M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIV-------TGRQNNRSKNSEYTDSLLTITWKHFQ 536
PE G T K DV+SFG+LL EI GR N + + +T
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEFVT----G 236
Query: 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
GR++ K Y ++ C Q P RP + +L+ +
Sbjct: 237 GGRLD--PPKGC-------PGPVYRIMTD------CWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 73/218 (33%), Positives = 113/218 (51%), Gaps = 32/218 (14%)
Query: 321 LGQGGFGTVYKG----VLPDGRE---IAVKRLFFNNRHRA-----ANFYNEVNIISSVEH 368
LG G FG VY+G +L G +AVK L R A F E +++S+ H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL----RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 369 KNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT----LTWEKRYEIILGTVE 423
N+V+LLG C + P+ +++ E + L ++ D+ + LT ++ +I L +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 424 GLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFGLARS-FQEDKSHISTAIA 477
G VYL ++ IHRD+ A N L+ D+ KI DFGLAR ++ D
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +MAPE L G+ T ++DV+SFG+L+ EI+T G+Q
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 70/207 (33%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 321 LGQGGFGTVYKGVL--PDGREI--AVKRLFFNNR----HRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G L DG++I AVK L NR F E I+ H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 373 RLLGCSCSGPES--LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII---LGTVEGLVY 427
LLG C E L+V ++ + L FI T+ ++I L +G+ Y
Sbjct: 60 SLLGI-CLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEY 113
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE---DKSHISTAIAGTLGYMA 484
L + + +HRD+ A N +LD K+ADFGLAR + H T + +MA
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVT 511
E L + T K+DV+SFG+LL E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKN 370
+F + K+G+G +G VYK G +A+K RL + E++++ + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+V+LL + + LV+EFL +Q L +F+ D++ + + ++GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
R++HRD+K N+L+++ K+ADFGLAR+F + + TL Y APE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 174
Query: 491 GQLTEKA-DVYSFGMLLLEIVTGR 513
+ A D++S G + E+VT R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 34/221 (15%)
Query: 321 LGQGGFGTVYKGV------LPDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V K +AVK L N + + +E N++ V H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIIL 419
L G CS GP LL+ E+ SL F+ +S K + L + +
Sbjct: 68 LYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 420 GTV--------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471
G + G+ YL E ++++HRD+ A N+L+ + KI+DFGL+R E+ S+
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 472 ISTAIAGT-LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ + + +MA E L T ++DV+SFG+LL EIVT
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 7e-21
Identities = 82/349 (23%), Positives = 158/349 (45%), Gaps = 41/349 (11%)
Query: 252 IVVSVVSALVVLAVGIVIGTRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKA 311
+ + A +VLA+ + + ++E KR + D + DS K T+
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG--TWELQFFDSKVSKSITINDI 688
Query: 312 TGSFDEANKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISS----- 365
S E N + +G G YKG + +G + VK + N+VN I S
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------------NDVNSIPSSEIAD 736
Query: 366 ---VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
++H N+V+L+G S + L++E++ ++L + + L+WE+R +I +G
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIA 790
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLG 481
+ L +LH + ++ ++ I++D + + L D K IS+A
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------ 843
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541
Y+APE +TEK+D+Y FG++L+E++TG+ + S++ + ++
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGK-SPADAEFGVHGSIVEWARYCYSDCHLD 902
Query: 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
D ++ + N E++ +++ L CT +P+ RP + VL+ L
Sbjct: 903 MWIDPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRAANFYNEVNIISSV 366
G+F K+G+G F VYK + L DGR +A+K++ + + R + E++++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ-DCLKEIDLLKQL 59
Query: 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGL 425
+H N+++ L E +V E L R I K K L E+ ++ + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
++H + RI+HRDIK +N+ + + K+ D GL R F K+ + ++ GT YM+P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175
Query: 486 EYLAHGQLTEKADVYSFGMLLLEI 509
E + K+D++S G LL E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRHRA--ANFYNEVNIISSVEHKN 370
+++ K+G+G +GTV+K + EI A+KR+ ++ ++ E+ ++ ++HKN
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+VRL S + LV+E+ +Q L ++ FDS + E + ++GL + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHS 117
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
++HRD+K N+L++ K+ADFGLAR+F S + TL Y P+ L
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 491 GQL-TEKADVYSFGMLLLEIVTG 512
+L + D++S G + E+
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+G+G G V GR++AVK + + R +NEV I+ +H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
G E ++ EFL +L D L E+ + ++ L YLH Q +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIK+ +ILL R K++DFG +D ++ GT +MAPE ++ + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 499 VYSFGMLLLEIVTG 512
++S G++++E+V G
Sbjct: 200 IWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTVY + + G+E+A+K++ + + NE+ ++ +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D + + E ++ L +LH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALEFLHSN--- 134
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 320 KLGQGGFGTVY----KGVLPDGRE--IAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG V+ +LP+ + +AVK L + +F E +++ ++H+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRF---------IFDSAKAKT---LTWEKRYEIILGT 421
G G L+V+E++ + L+RF I + LT + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTL 480
G+VYL + + +HRD+ N L+ L KI DFG++R + D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+M PE + + + T ++D++SFG++L EI T G+Q
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+G+G G V G+++AVK++ + R +NEV I+ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
G E +V EFL +L D + E+ + L + L YLH Q +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RDIK+ +ILL S R K++DFG ++ ++ GT +MAPE ++ + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 499 VYSFGMLLLEIVTG 512
++S G++++E++ G
Sbjct: 201 IWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 14/196 (7%)
Query: 320 KLGQGGFGTVYKGVL---PDGREIAVKRLFFNNRHRAAN--FYNEVNIISSVEHKNLVRL 374
+LG G FGTV KG+ + +AVK L +N A E N++ +++ +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G C +LV E L++F+ K K +T + E++ G+ YL E +
Sbjct: 62 IGI-CEAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYLAHGQ 492
+HRD+ A N+LL ++ AKI+DFGL+++ D+++ G + + APE + + +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 493 LTEKADVYSFGMLLLE 508
+ K+DV+SFG+L+ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 315 FDEANKLGQGGFGTV-YKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
D K+G+G G V V G+ +AVK++ + R +NEV I+ +H+N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ G E +V EFL +L D + E+ + L ++ L LH Q
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRDIK+ +ILL R K++DFG ++ ++ GT +MAPE ++
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLPY 193
Query: 494 TEKADVYSFGMLLLEIVTG 512
+ D++S G++++E+V G
Sbjct: 194 GPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLF--FNNRHRAANFYNEVNIISSV-EHKN 370
++ KLG+G +G V+K + +E+ A+K++F F N A + E+ + + +H N
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 371 LVRLLGC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVY 427
+V+LL + + + LV+E++ L I +A L KRY I+ ++ L Y
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLKALKY 122
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF----QEDKSHISTAIAGTLGYM 483
+H +IHRD+K SNILL+S R K+ADFGLARS + ++ + T T Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 484 APEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
APE L + T+ D++S G +L E++ G+
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 27/284 (9%)
Query: 321 LGQGGFGTV----YKGVLPD-GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG V Y G +AVK L + + + E+NI+ ++ H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 375 LGCSCSGPES--LLVYEFLPNQSLDRFI--FDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
GC L+ E++P SL ++ A+ L + ++ EG+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYL 488
Q IHRD+ A N+LLD+ KI DFGLA++ E + G + + A E L
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548
+ + +DV+SFG+ L E++T + +S ++ + ++ R+ EL ++ +
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLERGM 241
Query: 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
L N EV + C + RPT ++ +L
Sbjct: 242 RLPC--PKNCPQEVY---ILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 320 KLGQGGFGTVYKGVLPDGR---EIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVRLL 375
+LG G FG V KGV + ++A+K L N + E I+ +++ +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L++F+ S K +T E++ G+ YL ++
Sbjct: 62 GV-CEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYLAHGQL 493
+HRD+ A N+LL ++ AKI+DFGL+++ D S+ AG L + APE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 494 TEKADVYSFGMLLLE 508
+ ++DV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAA-NFYNEVN-IISSVEHKNLVRLLGC 377
+G+G FGTV K + G +AVKR+ + +++ ++ S + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI---ILG-----TVEGLVYLH 429
+ + E L + SLD+F K + + I ILG TV+ L YL
Sbjct: 72 LFREGDCWICME-LMDISLDKF------YKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
E +++IIHRD+K SNILLD K+ DFG++ + S T AG YMAPE +
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERID 180
Query: 490 HGQLTE---KADVYSFGMLLLEIVTGR 513
++DV+S G+ L E+ TG+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 86/296 (29%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 321 LGQGGFGTVYKGVL-----PDGR-EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLV 372
LG+G FG V K P+ +AVK L + ++ +E+ ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 373 RLLG-CSCSGPESLLV--------YEFL----PNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
LLG C+ GP ++V +FL P +TLT +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
G+ +L + + IHRD+ A N+L+ KIADFGLAR D HI T
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTT 192
Query: 480 LG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
G +MAPE L T ++DV+SFG+LL EI T S Y I
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYP----GIP--- 239
Query: 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
VEEL+ L+ Y + H+ C E PS RPT ++++ L
Sbjct: 240 -----VEELFK--LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNN-RHRAANFYNEVNIISSVEHKNLV 372
F + ++G+G FG VYKG+ +E+ A+K + + E+ ++S + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
R G G + ++ E+L S D K L I+ ++GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
KI HRDIKA+N+LL + K+ADFG+A + + +T + GT +MAPE +
Sbjct: 122 KI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 493 LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL--ML 550
KAD++S G+ +E+ G +D RV L KN L
Sbjct: 178 YDFKADIWSLGITAIELAKGE-------PPNSD---------LHPMRVLFLIPKNSPPTL 221
Query: 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+ K E + A C ++P RPT +L+
Sbjct: 222 EGQYSKPFK-EFVEA------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 32/271 (11%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-CS 378
+LG G FG V G ++A+K + F E ++ + H+ LV+L G C+
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
P +V E++ N L ++ + K + E+ EG+ YL +SK + IH
Sbjct: 70 KQRP-IYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYL--ESK-QFIH 123
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD+ A N L+D + K++DFGL+R +D+ S + + PE L + + + K+D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 499 VYSFGMLLLEIVT-GRQN-NRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556
V++FG+L+ E+ + G+ R NSE + G LY +L S
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVE--------KVSQGL--RLYRPHLA------S 227
Query: 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVL 587
Y ++ + C E RPT ++L
Sbjct: 228 EKVYAIMYS------CWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 61/191 (31%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379
LG+G FG V+KG L D +AVK + + F +E I+ +H N+V+L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 380 SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
+V E +P D F K L ++ + L G+ YL ++ IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHGQLTEKA 497
D+ A N L+ KI+DFG++R QED S++ + + APE L +G+ + ++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 498 DVYSFGMLLLE 508
DV+S+G+LL E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTV+ + + G+E+A+K++ + + NE+ ++ +++ N+V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D A+ + E ++ L +LH
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE--------CLQALEFLHAN--- 134
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ N+LL K+ DFG ++S ST + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFF--NNRHRAANFY----NEVNIISSVEHKNLVR 373
LG G F + Y+ + G +AVK++ + N E+ +++ + H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+LG +C L E++ S+ + K E +L GL YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN-- 122
Query: 434 IRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKS---HISTAIAGTLGYMAPEYLA 489
+IIHRD+K +N+L+DS R +IADFG A + + GT+ +MAPE L
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
Q DV+S G +++E+ T +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 61/204 (29%), Positives = 110/204 (53%), Gaps = 21/204 (10%)
Query: 321 LGQGGFGTV----YKGVLPDG----REIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNL 371
LG+G FG V Y P+G ++AVK L + + A+ E+ I+ ++ H+N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 372 VRLLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
V+ G C+ G + L+ EFLP+ SL ++ + L + +Y + + +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI--CKGMDYLG 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--ISTAIAGTLGYMAPEY 487
+ + +HRD+ A N+L++S + KI DFGL ++ + DK + + + + + APE
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 488 LAHGQLTEKADVYSFGMLLLEIVT 511
L + +DV+SFG+ L E++T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 321 LGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----H--KNLV 372
+G G G VYK G +AVK++ R N I+ ++ H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG-----TVEGLVY 427
+ G + + + E L + LD K E ILG V+ L Y
Sbjct: 78 KCYGYFITDSDVFICME-LMSTCLD-------KLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
L E K +IHRD+K SNILLD+ K+ DFG++ + K+ T AG YMAPE
Sbjct: 130 LKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPER 185
Query: 488 L----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524
+ + + +ADV+S G+ L+E+ TG+ ++ +E+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 66/299 (22%), Positives = 109/299 (36%), Gaps = 50/299 (16%)
Query: 320 KLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHRAANFYN----EVNIISSVEHKNLVRL 374
+G+G +G V K G +A+K+ F + EV ++ + H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 375 LGCSCSGPESLLVYEFLPN---QSLDRFI--FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
LV+E++ + L+ ++ W+ ++ + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCH 117
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
IIHRDIK NIL+ K+ DFG AR+ + + T T Y APE L
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 490 HGQLTEKA-DVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI----------------TW 532
K DV++ G ++ E++ G + D L I +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 533 KHFQAGRVEELYDKNLMLHNY--HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589
F E + Y S+ + L+A C + +P R T +LQ
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKA------CLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHRAAN-----FYNEVNIISSVEHKNLVRL 374
LG GGFG V V R A+K RH ++E I+ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC--VKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 375 LGCSCSGPESLLVY---EFLPNQSL-----DRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
+ + +Y E+ L DR +FD A+ I V
Sbjct: 59 Y---RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF--------YIACVVLAFE 107
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGTLGYMAP 485
YLH + II+RD+K N+LLDS K+ DFG A+ + K+ GT Y+AP
Sbjct: 108 YLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAP 161
Query: 486 EY-LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
E L G D +S G+LL E++TGR
Sbjct: 162 EIILNKGY-DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 9/203 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNL 371
+ + K+G+G +G VYKG G+ +A+K++ + + E++++ ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
V L L++EFL + L +++ K + + E + ++G+++ H +
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
R++HRD+K N+L+D++ K+ADFGLAR+F + T TL Y APE L
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGS 176
Query: 492 QL-TEKADVYSFGMLLLEIVTGR 513
+ D++S G + E+ T +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRHRAANFYN--EVNIISSVEHKNL 371
F++ N++G+G +G VY+ EI A+K++ +N + E+ ++ ++ H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 372 VRLL----GCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILG 420
V L G +S+ LV E+ Q L + F ++ K L L
Sbjct: 69 VELKEVVVGKHL---DSIFLVMEYC-EQDLASLLDNMPTPFSESQVKCLM--------LQ 116
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL YLHE IIHRD+K SN+LL + KIADFGLAR++ + T TL
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTL 172
Query: 481 GYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
Y APE L T D+++ G +L E++ +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 4e-19
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTVY + + G+E+A+K++ + + NE+ ++ ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D + + E ++ L +LH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALDFLHSN--- 134
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE---IAVKRLFFNN-RHRAANFYNEVNIISSVEHKN 370
F + ++G+G FG V+KG+ D R +A+K + + E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQS-LDRF---IFDSAKAKTLTWEKRYEIILGTVEGLV 426
+ + G G + ++ E+L S LD FD + T+ E ++GL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE--------ILKGLD 115
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + KI HRDIKA+N+LL + K+ADFG+A + + +T + GT +MAPE
Sbjct: 116 YLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516
+ KAD++S G+ +E+ G N
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 321 LGQGGFGTVYKGV-LPDGREI----AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
LG G FGTVYKG+ +PDG + A+K L N +A +E +++ V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEGLVYLHE 430
LG C LV + +P L ++ ++ L W + +G+ YL E
Sbjct: 75 LGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT--LGYMAPEYL 488
+R++HRD+ A N+L+ S KI DFGLAR D++ A G + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMALESI 183
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
H + T ++DV+S+G+ + E++T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG VY D GRE+AVK++ F+ E+ ++ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 375 LGCSCSGPESLL--VYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
GC E L E +P S+ D+ A + +T + +I+ EG+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHSN 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED--KSHISTAIAGTLGYMAPEYLA 489
I+HRDIK +NIL DS K+ DFG ++ Q ++ GT +M+PE ++
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
KAD++S G ++E++T +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 79/288 (27%), Positives = 117/288 (40%), Gaps = 52/288 (18%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRH---RAANFYNEVNIISSVEHKN 370
F + ++G G FG VY E+ A+K++ ++ + + + EV + + H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ GC + LV E+ + D I + K K L + I G ++GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY-LA 489
+I HRDIKA NILL K+ADFG A S + GT +MAPE LA
Sbjct: 134 HERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 490 --HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547
GQ K DV+S G+ +E+ A R L++ N
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL---------------------------AERKPPLFNMN 218
Query: 548 LMLHNYHDSNVKYEVLRAIHVGL-------LCTQENPSLRPTMSRVLQ 588
M YH + L + C Q+ P RP+ +L+
Sbjct: 219 AMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA---NFYNEVNIISSVEHKNLVRLLG 376
+LG G FG V+ G ++A+K + A +F E ++ + H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+V EF+ N L ++ + L+ + + EG+ YL S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---F 121
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
IHRD+ A N L+ S K++DFG+ R +D+ S+ + + PE + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 497 ADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556
+DV+SFG+L+ E+ T + K S Y + + I+ LY L S
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMISRGF-------RLYRPKLA------S 227
Query: 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
YEV+ C E P RPT + +L+ +T
Sbjct: 228 MTVYEVM------YSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 57/213 (26%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 320 KLGQGGFGTVY----KGVLPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG V+ + P+ +I AVK L + + +F+ E ++++++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFI----------FDSAKAKTLTWEKRYEIILGTVE 423
G G ++V+E++ + L++F+ + + LT + I
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGY 482
G+VYL Q +HRD+ N L+ L KI DFG++R + D + + +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
M PE + + + T ++DV+S G++L EI T G+Q
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV--LPDGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRL 374
+G+G FG VY+GV P+ +IAV N F E I+ +H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFI---FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+G + +V E P L ++ S +L Y L T L YL
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI---LYSYQLST--ALAYLE-- 124
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
R +HRDI A N+L+ S K+ DFGL+R +++ + ++ + +MAPE +
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 492 QLTEKADVYSFGMLLLEI 509
+ T +DV+ FG+ + EI
Sbjct: 184 RFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 321 LGQGGFGTVYKGVL--PDGR--EIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG+V +G L DG ++AVK + + F +E + +H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 375 LGCSCSG------PESLLVYEFLPNQSLDRFIFDSAKA---KTLTWEKRYEIILGTVEGL 425
+G P+ +++ F+ + L F+ S + L + + ++ G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMA 484
YL S IHRD+ A N +L + +ADFGL++ + IA + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVT 511
E LA T K+DV++FG+ + EI T
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNL 371
+ + K+G+G +G VYK G +A+K RL + + E++++ + H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE--KRYEIILGTVEGLVYLH 429
VRLL S + LV+EFL + L +++ DS+ L K Y + ++G+ Y H
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSY--LYQLLQGIAYCH 116
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
R++HRD+K N+L+D K+ADFGLAR+F + + TL Y APE L
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 172
Query: 490 HG-QLTEKADVYSFGMLLLEIVTGR 513
Q + D++S G + E+V R
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 42/288 (14%)
Query: 320 KLGQGGFGTVYKGVL-------PDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
+LGQG FG VY+G + R +AVK + + R F NE +++ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIF----DSAKAKTLTWEKRYEIILGTVE---G 424
VRLLG G +L+V E + + L ++ ++ E+I E G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GY 482
+ YL+ + + +HRD+ A N ++ KI DFG+ R E + G L +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRW 187
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542
MAPE L G T +D++SFG++L EI ++ + +Q G E
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEIT------------------SLAEQPYQ-GLSNE 228
Query: 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
K +M Y D R + +C Q NP +RPT ++ +L
Sbjct: 229 QVLKFVMDGGYLDQPDNCPE-RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF- 356
D F + +++ K+GQG FG V+K + +A+K++ N F
Sbjct: 1 DQYEFPFC---DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FP 55
Query: 357 ---YNEVNIISSVEHKNLVRLLGCSCSGPES---------LLVYEFLPNQSLDRFIFDSA 404
E+ I+ ++H+N+V L+ C + LV+EF L + S
Sbjct: 56 ITALREIKILQLLKHENVVNLIEI-CRTKATPYNRYKGSFYLVFEFC-EHDLAGLL--SN 111
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
K T + +++ + GL Y+H +I+HRD+KA+NIL+ K+ADFGLAR+
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168
Query: 465 F---QEDKSHISTAIAGTLGYMAPEYL 488
F + K + T TL Y PE L
Sbjct: 169 FSLSKNSKPNRYTNRVVTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 8/152 (5%)
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
E ++ +V H +++R+ SG + +V LP+ S D + + + +++ L ++ I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+EGL YLH Q RIIHRD+K NI ++ + I D G A+ + + +AG
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAG 218
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
T+ APE LA + KAD++S G++L E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 32/206 (15%)
Query: 320 KLGQGGFGTVYK------GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG G FG VYK G L + I K + ++ E+ I+++ H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQS 432
LLG + ++ EF P ++D + + + T E + ++I +E L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHSM- 129
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLA----RSFQEDKSHISTAIAGTLGYMAPEYL 488
+IIHRD+KA N+LL K+ADFG++ ++ Q S I GT +MAPE +
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVV 182
Query: 489 AHGQLTE-----KADVYSFGMLLLEI 509
+ + KAD++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 69/293 (23%)
Query: 321 LGQGGFG--TVYK----GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG T+Y+ L +E+ + RL R A NE+ I+S ++H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIAY 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFI----------FDS-AKAKTLTWEKRYEI--ILGT 421
F+ + +L I +D + K +E+ + +
Sbjct: 65 YN------------HFMDDNTL--LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V + Y+H+ I+HRDIK NI L K+ DFG+++ + S T + GT
Sbjct: 111 VSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPY 166
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR-- 539
YM+PE + K+D+++ G +L E++T ++ + N L + K Q
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQGNYTP 220
Query: 540 VEELYDKNL--MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
V +Y L ++H+ Q++P RPT VL
Sbjct: 221 VVSVYSSELISLVHS-------------------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG VY D GRE+A K++ F+ + E+ ++ +++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 375 LGC-SCSGPESLLVY-EFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
GC ++L ++ E++P S+ D+ A +++T + +I+ EG+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE---DKSHISTAIAGTLGYMAPEYL 488
I+HRDIK +NIL DS K+ DFG ++ Q + I + + GT +M+PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ KADV+S G ++E++T +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNNRH---RAANFYNEVNIISSVEHKN 370
F +++G G FG VY E+ AVK++ ++ + + + EV + ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ GC + LV E+ + D K L + I G ++GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY--- 487
+ I HRDIKA NILL + K+ADFG A KS + + GT +MAPE
Sbjct: 140 HNMI---HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILA 191
Query: 488 LAHGQLTEKADVYSFGMLLLEI 509
+ GQ K DV+S G+ +E+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 43/111 (38%), Positives = 59/111 (53%), Gaps = 26/111 (23%)
Query: 416 EIILGTV-----EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG--------LA 462
E ILG + GL YL E K +I+HRD+K SNIL++SR K+ DFG +A
Sbjct: 98 ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
Query: 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
SF GT YM+PE L T ++D++S G+ L+E+ GR
Sbjct: 156 NSF-----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 32/206 (15%)
Query: 320 KLGQGGFGTVYK------GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG G FG VYK GVL + I K + ++ E++I++S +H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG-TVEGLVYLHEQS 432
LL ++ EF ++D + + + T E + ++ T+E L YLHE
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN- 122
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLA----RSFQEDKSHISTAIAGTLGYMAPEYL 488
+IIHRD+KA NIL K+ADFG++ R+ Q S I GT +MAPE +
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVV 175
Query: 489 AHGQLTE-----KADVYSFGMLLLEI 509
+ KADV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREI----AVKRLFFNNRHRA-ANFYNEVNIISSVEH 368
F + LG G FGTVYKG+ +P+G ++ A+K L +A +E +++SV++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRYEIILGTVEG 424
++ RLLG C L+ + +P L ++ + L W + +G
Sbjct: 69 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYM 483
+ YL E+ R++HRD+ A N+L+ + KI DFGLA+ D K + + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVT 511
A E + H T ++DV+S+G+ + E++T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 9e-18
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+GQG GTVY + + G+E+A++++ + + NE+ ++ ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 379 CSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G E +V E+L SL + D + + E ++ L +LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALEFLHSN--- 135
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 495 EKADVYSFGMLLLEIVTG 512
K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 75/285 (26%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 320 KLGQGGFGTVY----KGVLPDGRE--IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
+LGQG FG VY KGV+ D E +A+K + R F NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTV-EGL 425
RLLG G +L++ E + L ++ ++ + K+ + G + +G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--YM 483
YL+ + +HRD+ A N ++ KI DFG+ R E + G L +M
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 188
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542
+PE L G T +DV+SFG++L EI T Q + ++E + + G +++
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------MEGGLLDK 242
Query: 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVL 587
+ ML +E++R +C Q NP +RP+ ++
Sbjct: 243 PDNCPDML---------FELMR------MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 320 KLGQGGFGTVY----KGVLP--DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG V+ + P D +AVK L +F E ++++++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRF----------IFDSAKAKT---LTWEKRYEIILG 420
G G ++V+E++ + L++F + D + L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGT 479
G+VYL Q +HRD+ N L+ + L KI DFG++R + D +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +M PE + + + T ++DV+SFG++L EI T G+Q
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 320 KLGQGGFGTVYKG--VLP---DGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+ FG +YKG LP + +A+K L NN + F E ++++ + H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIF--------------DSAKAKTLTWEKRYEIIL 419
LLG +++E+L L F+ D +L I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAG 478
G+ YL S +H+D+ A NIL+ +L KI+D GL+R + D +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +M PE + +G+ + +D++SFG++L EI +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFN-NRHRAANFYNEVNI-ISSVEHKNLVRLLGC 377
LG+G +G V K +P G +AVKR+ N +++I + SV+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 378 SCSGPESLLVYEFLPNQSLDRF---IFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ + E + + SLD+F ++D K T+ + +I + V+ L YLH + +
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSK--L 123
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY----LAH 490
+IHRD+K SN+L++ + K+ DFG+ S S T AG YMAPE L
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
K+DV+S G+ ++E+ TGR
Sbjct: 182 KGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G G +G V GR++A+K+L F + H A Y E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTYRELRLLKHMDHENVIGLLD 81
Query: 377 CSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
SL LV + L+ + K + L+ + ++ + GL Y+H
Sbjct: 82 VFTP-ASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YL 488
IIHRD+K SNI ++ KI DFGLAR T T Y APE L
Sbjct: 136 SA---GIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIML 188
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G ++ E++TG+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 38/220 (17%)
Query: 321 LGQGGFGTVYK----GVLPDGRE--IAVKRLFFNNRHRA-----ANFYNEVNIISSVEHK 369
+GQG FG V++ G+LP +AVK L + A A+F E +++ +H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAALMAEFDHP 68
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD-SAKAKT------------------LT 410
N+V+LLG G L++E++ L+ F+ S +A+ L+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 411 WEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDK 469
++ I G+ YL E+ + +HRD+ N L+ + KIADFGL+R+ + D
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
S A + +M PE + + + T ++DV+++G++L EI
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 315 FDEANKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRHRAA--NFYNEVNII---SSVE 367
++ ++G+G +G V+K + GR +A+KR+ + EV ++ + E
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 368 HKNLVRLLG-CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
H N+VRL C+ S + LV+E + +Q L ++ D + E +++ +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR--SFQEDKSHISTAIAGTL 480
GL +LH R++HRD+K NIL+ S + K+ADFGLAR SFQ T++ TL
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTL 173
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
Y APE L D++S G + E+
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRA--ANFYNEVNIISS 365
++ FD ++G+G +G VYK D G +A+K++ +N E+ I+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 366 VEHKNLVRLLGCSCSGPESL----------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
+ H+N+V L ++L LV+E++ D + ++ + + + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDH 117
Query: 416 --EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
+ +EGL Y H K +HRDIK SNILL+++ + K+ADFGLAR + ++S
Sbjct: 118 IKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 474 TAIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGR 513
T TL Y PE L + DV+S G +L E+ T +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 2e-17
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 48/219 (21%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G V V GR++A+K++ F++ A E+ ++ + H+N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL-- 65
Query: 378 SCSGPESL-------LVYEFLP---------NQSLD----RFIFDSAKAKTLTWEKRYEI 417
P S +V E + Q L ++ Y+I
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL-------------YQI 112
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TA 475
+ G L YLH + +IHRD+K SNIL++S KI DFGLAR D+ T
Sbjct: 113 LRG----LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 476 IAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGR 513
T Y APE L+ + T+ D++S G + E++T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS 380
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 381 GPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439
L +V E++ SL ++ ++ L + + L E + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 440 DIKASNILLDSRLRAKIADFGLAR--SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKA 497
D+ A N+L+ AK++DFGL + S +D + + + APE L + + K+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTAPEALREKKFSTKS 180
Query: 498 DVYSFGMLLLEIVT-GR 513
DV+SFG+LL EI + GR
Sbjct: 181 DVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 320 KLGQGGFGTVY-----KGV----LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN 370
+LG+G FGTVY K V L +EI V L N +A E ++S ++H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEGLVYLH 429
+V+ ++ E+ + LD + + KTL+ + E + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ RI+HRD+KA NI L + L KI DFG++R ++T GT YM+PE L
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALK 178
Query: 490 HGQLTEKADVYSFGMLLLEI 509
H K+D++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE---IAVKRLFFNNRH---RAANFYNEVNIISSVEH 368
F + ++G G FG VY D R +A+K++ ++ + + + EV + ++H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N + GC + LV E+ + D K L + I G ++GL YL
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY- 487
H + +IHRDIKA NILL + K+ADFG A S + GT +MAPE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 488 --LAHGQLTEKADVYSFGMLLLEI 509
+ GQ K DV+S G+ +E+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVK--RLFFNNRHRAANFYNEVNIISSVE---H 368
++ ++G G +GTVYK P G +A+K R+ N + EV ++ +E H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 369 KNLVRLLG-CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
N+VRL+ C+ S + LV+E + +Q L R D L E +++ +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDL-RTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAIAGTLGY 482
GL +LH I+HRD+K NIL+ S + K+ADFGLAR + ++ T + TL Y
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWY 173
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEI 509
APE L D++S G + E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE---IAVKRLFFNN-RHRAANFYNEVNIISSVEHKN 370
F + K+G+G FG V+KG+ D R +A+K + + E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ + G + ++ E+L S D + L + I+ ++GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ KI HRDIKA+N+LL K+ADFG+A D GT +MAPE +
Sbjct: 120 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 491 GQLTEKADVYSFGMLLLEIVTG 512
KAD++S G+ +E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 321 LGQGGFGTVYKGVLPD-GRE-----IAVKRLFFNNR--HRAANFYNEVNIISSV-EHKNL 371
LG G FG V + + +AVK L R A +E+ I+S + H+N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMSHLGNHENI 101
Query: 372 VRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
V LLG C+ GP L++ E+ L F+ + LT E +G+ +L
Sbjct: 102 VNLLGACTIGGP-ILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLA 489
++ IHRD+ A N+LL KI DFGLAR D +++ A + +MAPE +
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 490 HGQLTEKADVYSFGMLLLEIVT 511
+ T ++DV+S+G+LL EI +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 321 LGQGGFGTVYKG-VLPDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
LG G GTVYK L R +AVK + + +E+ I+ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ EF+ SLD ++ L I + V+GL YL ++I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLW---SLKILH 118
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD+K SN+L+++R + K+ DFG++ + I+ GT YMAPE ++ Q +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 499 VYSFGMLLLEIVTGR 513
V+S G+ +E+ GR
Sbjct: 176 VWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 320 KLGQGGFGTVY----KGVLP---------DGRE--IAVKRLFFNNRHRAAN-FYNEVNII 363
KLG+G FG V+ +G+ DG+ +AVK L + A N F E+ I+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
S +++ N++RLLG S ++ E++ N L++F+ T T I ++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT--HANNIPSVSIA 129
Query: 424 GLVYLHEQ--------SKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHIST 474
L+Y+ Q + + +HRD+ N L+ + KIADFG++R+ + D I
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +MA E + G+ T +DV++FG+ L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 37/216 (17%)
Query: 321 LGQGGFGTVYKGVLP-DGREIA-----VKRLFFNNRHRAANFYNEVNIISSV-EHKNLVR 373
+G+G FG V + ++ DG ++ +K N HR +F E+ ++ + H N++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR--DFAGELEVLCKLGHHPNIIN 67
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILG 420
LLG + + E+ P +L F+ S A TLT ++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
G+ YL E+ + IHRD+ A N+L+ L +KIADFGL+R + + T+
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTM 177
Query: 481 G-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G +MA E L + T K+DV+SFG+LL EIV+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 321 LGQGGFGTVY---KGVLPDGREI-AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+ +G +G V+ K D I +K+ +++ E +I+S + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
S G ++L LV E+LP L + D A+ EI+L L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI----AEIVLA----LEYLH- 110
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-------SFQEDKSHISTAIAGTLGYM 483
IIHRD+K NIL+DS K+ DFGL++ D I GT Y+
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTG 512
APE + ++ D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+LG G FG+VY G +A+K++ F + N EV + + EH N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLK 64
Query: 376 GCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
E V+E++ +L + + D K K + II ++GL ++
Sbjct: 65 -------EVFRENDELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHI 115
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-Y 487
H+ HRD+K N+L+ KIADFGLAR + + T T Y APE
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEIL 170
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR 513
L + D+++ G ++ E+ T R
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 321 LGQGGFGTV----YKGVLPDGREIAVKRLFFNN--RHR-AANFYNEVNIISSVEHKNLVR 373
LG G FG V +K G+ A+K L + + + NE I+ S+ H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 374 LLGCSCSGPESL-LVYEFLPNQSL-------DRFIFDSAKAKTLTWEKRY--EIILGTVE 423
L G S +L LV E++P L RF + Y +++L
Sbjct: 66 LYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRF--------PEPVARFYAAQVVLA--- 113
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L YLH I++RD+K N+LLDS KI DFG A+ + T + GT Y+
Sbjct: 114 -LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYT-LCGTPEYL 165
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTG 512
APE + + D ++ G+L+ E++ G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 31/217 (14%)
Query: 321 LGQGGFGTVYK----GVLPDGRE----IAVKRLFFNNRHR-AANFYNEVNIISSV-EHKN 370
LG+G FG V + G+ + +AVK L N + A+ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRFI-----------FDSAKA--KTLTWEKRYE 416
++ LLG C+ GP ++V E+ +L F+ FD K + L+++
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
G+ YL + R IHRD+ A N+L+ KIADFGLAR + + T+
Sbjct: 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS- 194
Query: 477 AGTL--GYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G L +MAPE L T ++DV+SFG+L+ EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLV 372
F++ ++LG G G V+K P G +A K + + N E+ ++ +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
G S E + E + SLD+ + KA + + ++ + ++GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
KI +HRD+K SNIL++SR K+ DFG++ + ++ + GT YM+PE L
Sbjct: 124 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 178
Query: 493 LTEKADVYSFGMLLLEIVTGR 513
+ ++D++S G+ L+E+ GR
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE-IAVK--RLFFNNRHRAANFYNEVNIISSVEHKNL 371
+++ K+G+G +G VYK E IA+K RL + + E++++ ++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHE 430
VRL S LV+E+L + L + + S AK K Y + + G+ Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHS 120
Query: 431 QSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YL 488
R++HRD+K N+L+D R A K+ADFGLAR+F + + TL Y APE L
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILL 176
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G + E+V +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 41/221 (18%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRL-FFNNRH-------RAANFYNEVNIIS 364
+++ N++ +G +G VY+ EI A+K+L + R E+NI+
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR------EINILL 59
Query: 365 SVEHKNLVRL----LGCSCSGPESL-LVYEFLPN--QSL-DRF--IFDSAKAKTLTWEKR 414
++H N+V + +G S + + +V E++ + +SL + F ++ K L
Sbjct: 60 KLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL----- 111
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
+L + G+ +LH+ I+HRD+K SN+LL++R KI DFGLAR + T
Sbjct: 112 ---MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-T 164
Query: 475 AIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
+ TL Y APE L + + D++S G + E++T +
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-RAANFYNEVNII-- 363
L TG F+ +G+G +G VYK G+ +A+K + + E NI+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNILRK 58
Query: 364 -SSVEHKNLVRLLGC------SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE 416
S+ H N+ G + + LV E S + D K KR +
Sbjct: 59 YSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLK 111
Query: 417 ------IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470
I+ T+ GL YLHE ++IHRDIK NILL K+ DFG++
Sbjct: 112 EEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168
Query: 471 HISTAIAGTLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
+T I GT +MAPE +A + + ++DV+S G+ +E+ G
Sbjct: 169 RRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 321 LGQGGFGTVYKGVL--PDGREIAVK----RLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
LG G FG + +G L P RE+ V R +++ R F E + +H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRL 71
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G G ++V E++ N +LD F+ L + ++ G G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMG-- 127
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG------YMAPEYL 488
+H+ + A +L++S L KI+ F R QEDKS AI T+ + APE +
Sbjct: 128 -YVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSE---AIYTTMSGKSPVLWAAPEAI 180
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
+ + +DV+SFG+++ E+++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 315 FDEANKLGQGGFGTVYK-GVLPDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLV 372
F+ ++LG G G V K P G +A K + + N E+ ++ +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
G S E + E + SLD+ + +AK + E ++ + + GL YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
K +I+HRD+K SNIL++SR K+ DFG++ + ++ + GT YM+PE L
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 178
Query: 493 LTEKADVYSFGMLLLEIVTGR 513
+ ++D++S G+ L+E+ GR
Sbjct: 179 YSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 321 LGQGGFGTVYKGVLP-DGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G FG V+ P DG+ +A+K++ F N + E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 378 ----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK--RYEIILGTVEGLVYLHEQ 431
E + V L L + I S + + K Y+I+ GL YLH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQIL----RGLKYLHSA 122
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRDIK N+L++S KI DFGLAR + D+S T T Y APE L
Sbjct: 123 ---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 492 Q-LTEKADVYSFGMLLLEIVTGR 513
+ T D++S G + E++ R
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 320 KLGQGGFGTVY------------KGVLPDGRE-----IAVKRLFFN-NRHRAANFYNEVN 361
KLG+G FG V+ K + +AVK L + + + +F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI--------FDSAKAKTLTWEK 413
I+S + N+ RLLG P ++ E++ N L++F+ + +K+L++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHI 472
+ G+ YL + +HRD+ N L+ KIADFG++R+ + D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +MA E + G+ T K+DV++FG+ L EI+T
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFN-NRHRAANFYN----EVNIISSVEHKNLVRL 374
LG+G FG VY D GRE+AVK++ F+ + + N E+ ++ ++ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 375 LGCSCSGPESLL--VYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
GC E L E++P S+ D+ A + +T +I+ +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHSN 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE---DKSHISTAIAGTLGYMAPEYL 488
I+HRDIK +NIL DS K+ DFG ++ Q + I + + GT +M+PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 489 AHGQLTEKADVYSFGMLLLEIVT 511
+ KADV+S ++E++T
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 52/288 (18%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKN 370
F + ++G G FG VY + + +A+K++ ++ + + + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++ GC + LV E+ + D K L + + G ++GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY--- 487
+ +IHRD+KA NILL K+ DFG A + GT +MAPE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547
+ GQ K DV+S G+ +E+ A R L++ N
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL---------------------------AERKPPLFNMN 218
Query: 548 LMLHNYHDSNVKYEVLRAIHVGLL-------CTQENPSLRPTMSRVLQ 588
M YH + + L++ H C Q+ P RPT +L+
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 33/214 (15%)
Query: 321 LGQGGFGTVYKG-VLPDGREI--AVKRLF-FNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+G+G FG V K + DG + A+KR+ + ++ +F E+ ++ + H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILGTV 422
G L E+ P+ +L F+ S + A TL+ ++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG- 481
G+ YL S+ + IHRD+ A NIL+ AKIADFGL+R QE + T+G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QE------VYVKKTMGR 184
Query: 482 ----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+MA E L + T +DV+S+G+LL EIV+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-16
Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 42/235 (17%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGR---EIAVKRLF--FNNRHRAANFYNEVNIISSVEHK 369
+ + ++G G +GTV + D R ++A+K+L+ F + A Y E+ ++ ++H+
Sbjct: 17 YRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----- 416
N++ LL F P+ SLDRF + K + EK E
Sbjct: 75 NVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
++ ++GL Y+H IIHRD+K N+ ++ KI DFGLAR Q D T
Sbjct: 123 LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSE--MTGY 175
Query: 477 AGTLGYMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
T Y APE L T+ D++S G ++ E++TG+ K ++ D L+ I
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP--LFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 37/223 (16%)
Query: 321 LGQGGFGTVYKGVLPDGRE----IAVKRL----FFNNRHRAANFYNEVNIISSVEHKNLV 372
LG+GG+G V++ G + A+K L N+ A+ E NI+ +V+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 373 RLLGCSCSGPESLLVYEFLPN----QSLDR---FIFDSAKAKTLTWEKRY--EIILGTVE 423
L+ +G + L+ E+L L+R F+ D+A Y EI L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF--------YLSEISLA--- 112
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L +LH+Q II+RD+K NILLD++ K+ DFGL + + + T GT+ YM
Sbjct: 113 -LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYM 167
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR----QNNRSKNSE 522
APE L + D +S G L+ +++TG NR K +
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRAANFYNEVNIISSVE 367
+F K+G+G F VY+ L DG +A+K++ + + RA + E++++ +
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 60
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLV 426
H N+++ E +V E L R I K K L EK ++ + L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
++H + R++HRDIK +N+ + + K+ D GL R F K+ + ++ GT YM+PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 487 YLAHGQLTEKADVYSFGMLLLEI 509
+ K+D++S G LL E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 38/281 (13%)
Query: 320 KLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHR-----AANFYNEVNIISSVEHKNLVR 373
++G+G FG V+ G L D +AVK R A F E I+ H N+VR
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
L+G +V E + Q D F + L ++ +++ G+ YL +SK
Sbjct: 58 LIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK 113
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHG 491
IHRD+ A N L+ + KI+DFG++R +ED + ST + + APE L +G
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 492 QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551
+ + ++DV+SFG+LL E SL + + + + E ++ + L
Sbjct: 172 RYSSESDVWSFGILLWE---------------AFSLGAVPYANLSNQQTREAIEQGVRLP 216
Query: 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
V R + C + +P RP+ S V Q L +
Sbjct: 217 C--PELCPDAVYRLM---ERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 96/346 (27%), Positives = 150/346 (43%), Gaps = 76/346 (21%)
Query: 321 LGQGGFGTVYK----GVLPD----GREIAVKRLFFNNRHR-AANFYNEVNIISSV-EHKN 370
LG+G FG V G+ D +AVK L + + ++ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRFI-----------FDSAK--AKTLTWEKRYE 416
++ LLG C+ GP +LV E+ +L ++ FD+ K + LT++
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTA 475
G+ YL Q + IHRD+ A N+L+ KIADFGLAR D +T
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535
+ +MAPE L T ++DV+SFG+LL EI T+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI------------------FTLGGSPY 237
Query: 536 QAGRVEELY----DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-------MS 584
VEEL+ + + M + ++ Y ++R C PS RPT +
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRE------CWHAVPSQRPTFKQLVEDLD 291
Query: 585 RVLQMLTTEEQLPGPTSPPFIDERTMELHDNCYDPCCPMNSGAHAS 630
RVL + +T+E L S PF Y P CP + + +S
Sbjct: 292 RVLTVTSTDEYL--DLSVPF----------EQYSPGCPDSPSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 69/242 (28%), Positives = 102/242 (42%), Gaps = 56/242 (23%)
Query: 321 LGQGGFGTVYKGVLPDGREI---AVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G FG+V +G L I AVK ++ R +F +E + +H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 376 GCSCSGPE--------------------SLLVYE-------FLPNQSLDRFIFDSAKAKT 408
G E S L+Y +LP Q L +F+ D A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS--- 123
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
G+ YL S IHRD+ A N +L+ + +ADFGL++
Sbjct: 124 ---------------GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 469 KSHISTAIAGT-LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS--KNSEYTD 525
+ IA + ++A E LA T K+DV+SFG+ + EI T Q +NSE D
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
Query: 526 SL 527
L
Sbjct: 226 YL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+GGFG V + G+ A K+L R NE I+ V + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 377 CSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+ + LV + L I F A+A +II G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYA----AQIICG----LEHLH 112
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ RI++RD+K N+LLD +I+D GLA + K AGT GYMAPE L
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQ 167
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
D ++ G L E++ GR
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 319 NKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+KLG+G + TVYKG L D +A+K + + A EV+++ ++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+ LV+E+L ++ L +++ D + + K + + + GL Y H + +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---K 124
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLT 494
++HRD+K N+L++ R K+ADFGLAR+ S + TL Y P+ L +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 495 EKADVYSFGMLLLEIVTGR 513
+ D++ G + E+ TGR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 315 FDEANKLGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHK 369
+ + +G G G V + VL G +AVK+L F N+ A Y E+ ++ V HK
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----I 417
N++ LL F P +SL+ F + D+ + + E +E +
Sbjct: 81 NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+ + G+ +LH IIHRD+K SNI++ S KI DFGLAR+ + + T
Sbjct: 129 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYV 183
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
T Y APE + E D++S G ++ E+V G
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G G V Y V G+ +A+K+L F N A Y E+ ++ V HKN++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 376 GCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----IILGTVE 423
F P +SL+ F + D+ + + + +E ++ +
Sbjct: 82 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ +LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE + E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 37/216 (17%)
Query: 321 LGQGGFGTVYKGVLP-DGREI--AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVR 373
+G+G FG V K + DG + A+KR+ + HR +F E+ ++ + H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIIN 60
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILG 420
LLG L E+ P+ +L F+ S + A TL+ ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
G+ YL ++ + IHRD+ A NIL+ AKIADFGL+R + + T+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 481 G-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
G +MA E L + T +DV+S+G+LL EIV+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G+V + G ++A+K+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 378 SCSGPESLLVYEF---LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
S +F +P D L+ +K ++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY-LAHGQL 493
IIHRD+K N+ ++ KI DFGLAR + T T Y APE L
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHY 192
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
+ D++S G ++ E++TG+ K +Y D L I
Sbjct: 193 NQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G G V Y +L R +A+K+L F N+ A Y E+ ++ V HKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 376 GCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----IILGTVE 423
F P +SL+ F + D+ + + E +E ++ +
Sbjct: 90 NV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ +LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 192
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE + E D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 314 SFDEANKLGQGGFGTVY------------KGVLPDGRE-----IAVKRLFFN-NRHRAAN 355
+F E KLG+G FG V+ K D +AVK L + N++ +
Sbjct: 8 TFKE--KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 356 FYNEVNIISSVEHKNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFI--------FDSAKA 406
F E+ I+S ++ N++RLL C S P ++ E++ N L++F+ + A
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMIT-EYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-F 465
T+++ + G+ YL S + +HRD+ N L+ KIADFG++R+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
D I + +M+ E + G+ T +DV++FG+ L EI+T
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRL----FFNNRHRAANFYNEVNIISSVEH 368
+F K+G+G F VY+ L D + +A+K++ + + R + E++++ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-DCVKEIDLLKQLNH 61
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVY 427
N+++ L E +V E L + I K K L E+ ++ + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
+H + R++HRDIK +N+ + + K+ D GL R F K+ + ++ GT YM+PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 177
Query: 488 LAHGQLTEKADVYSFGMLLLEI 509
+ K+D++S G LL E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 321 LGQGGFGTVY----KGVLPDGRE--IAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V+ KG+ +G E + VK L + + + F E+++ + HKN+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVEGLV 426
LLG C + P ++ E+ L +F+ + K L+ +++ + G+
Sbjct: 73 LLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAP 485
+L S R +HRD+ A N L+ S+ K++ L++ + + + A+ L ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVT 511
E + + K+DV+SFG+L+ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 36/207 (17%)
Query: 321 LGQGGFGTV---YKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G G V Y VL R +A+K+L F N+ A Y E+ ++ V HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 376 GCSCSGPESLLVYEFLPNQSLDRF--------IFDSAKAKTLTWEKRYE----IILGTVE 423
F P +SL+ F + D+ + + E +E ++ +
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ +LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIV 510
APE + E D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLV 372
+ + +G+G +G V P G ++A+K++ F ++ E+ I+ +H+N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 373 RLLGCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+L P S +V E + L + I K + L+ + + + GL
Sbjct: 67 GILDIIR--PPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGL 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF--QEDKSHISTAIAGTLGYM 483
Y+H + ++HRD+K SN+LL++ KI DFGLAR + D + T T Y
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 484 APEYLAHGQLTEKA-DVYSFGMLLLEIVTGR 513
APE + + + KA D++S G +L E+++ R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 63/206 (30%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 321 LGQGGFGTV----YKGVLPDGREIAVKRL---FFNNRHRAANFYNEVNI---ISSVEHKN 370
LG+G FG V YK G A+K L R + E I +S H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLV 426
LV L C + V E+ L I F +A V GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--------VVLGLQ 115
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLHE +I++RD+K N+LLD+ KIADFGL + ST GT ++APE
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPE 171
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTG 512
L T D + G+L+ E++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 323 QGGFGTVYKGVLPDG-----REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G FG ++ G+L D E+ VK + + + + E ++ + H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 377 CSCSGPESLLVYEFLPNQS-LDRF-----IFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
E V N L F + ++ + L+ ++ + + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--------Y 482
K +IH+DI A N ++D L+ KI D L+R H LG +
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CLGDNENRPVKW 185
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
MA E L + + + +DV+SFG+LL E++T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 51/229 (22%)
Query: 315 FDEANKLGQGGFGTVYKGVL---PDGREIAVKRLFFNNRHRAANF----YNEVNIISSVE 367
++ +G+G +G VYK DG+E A+K+ F ++ + E+ ++ ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60
Query: 368 HKNLVRLLG-CSCSGPESL-LVYEFLP---------NQSLDRFIFDSAKAKTLTWEKRYE 416
H+N+V L+ +S+ L++++ ++ R + K+L W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ---- 116
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLARSFQ------ 466
IL G+ YLH ++HRD+K +NIL+ R KI D GLAR F
Sbjct: 117 -IL---NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 467 --EDKSHISTAIAGTLGYMAPEYL--AHGQLTEKADVYSFGMLLLEIVT 511
D + T+ Y APE L A T+ D+++ G + E++T
Sbjct: 170 ADLDP------VVVTIWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-14
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 38 NSSIFVPNFVTTMENISEQMRTS---GFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYA 94
+S F N + ++S +S GF +G+ D YGLAQC GDLS DC C A
Sbjct: 15 ANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLA 74
Query: 95 EARTLLPQCYPYN-GGRIYLDGCFMRSENYSF 125
A + L +C P GGRI+ D CF+R E+Y F
Sbjct: 75 TAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 321 LGQGGFGTVY---KGVLPD-GREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNL 371
LGQG FG V+ K PD G+ A+K L +R R E +I++ V H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM---ERDILAEVNHPFI 60
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE-GLVYLHE 430
V+L + + L+ +FL L F + + E+ + L + L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ II+RD+K NILLD K+ DFGL++ D + + GT+ YMAPE +
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 491 GQLTEKADVYSFGMLLLEIVTG 512
T+ AD +SFG+L+ E++TG
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 12/204 (5%)
Query: 314 SFDEANKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKN 370
++ + KLG+G + TV+KG L + +A+K + + A EV+++ ++H N
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+V L + LV+E+L ++ L +++ D ++ K + + + GL Y H
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHR 122
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLA 489
+ +++HRD+K N+L++ R K+ADFGLAR+ S + TL Y P+ L
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ + + D++ G + E+ +GR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISS 365
+L T +++ +G+G +G VYK DG AVK + E NI+ S
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQS 74
Query: 366 V-EHKNLVRLLGC-----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
+ H N+V+ G G + LV E S+ + E IL
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 420 -GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
G + GL +LH RIIHRD+K +NILL + K+ DFG++ + +T++ G
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 190
Query: 479 TLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
T +MAPE +A Q + + DV+S G+ +E+ G
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 337 GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL-VYEFLP 392
G E+A+K L H+ A F E + + + H N+V LL + P L V+E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 393 NQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL--- 448
++L + D A L + ++L ++ L H Q I+HRD+K NI++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115
Query: 449 DSRLRAKIADFGL------ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502
R AK+ DFG+ R +T + GT Y APE L +T +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 503 GMLLLEIVTGR 513
G++ LE +TG+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVN 361
+ T+ + T + + +G G FG V G+ +A+K++ F+ A Y E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 362 IISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++ + H+N++ L S E + V E L L R + K Y+I+
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQIL-- 118
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
GL Y+H ++HRD+K SNIL++ KI DFGLAR Q+ T T
Sbjct: 119 --RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-IQD---PQMTGYVSTR 169
Query: 481 GYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGR 513
Y APE + Q + D++S G + E++ G+
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKN 370
++++ K+G+G +G VYK G+ +A+K RL + E++++ +
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 371 -LVRLLGC----SCSGPESL-LVYEFLPNQSLDRFI----------FDSAKAKTLTWEKR 414
+VRLL +G SL LV+E+L + L +F+ + K+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFM---- 116
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHIS 473
Y+++ G + + H K ++HRD+K N+L+D + KIAD GL R+F +
Sbjct: 117 YQLLKG----VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 474 TAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTG 512
I TL Y APE L + D++S G + E+
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPDGREI-AVKR-----LFFNNRHRAANFYNEVNIISSV 366
F ++GQGG+G V+ D EI A+KR LF N R + E +I+++
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR--HVLTERDILTTT 58
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ + LV+LL + E L L E++P + + R+ + E +
Sbjct: 59 KSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMA-EMFEAV 114
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
LHE + IHRD+K N L+D+ K+ DFGL++ + ++ G+ YMAP
Sbjct: 115 DALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAP 167
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTG 512
E L D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL---LG 376
LG G G V+ V D + +AVK++ + + E+ II ++H N+V++ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 377 CSCSG-PESL----------LVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGT 421
S S E + +V E++ L + A+ ++
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQ--------L 123
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL Y+H + ++HRD+K +N+ +++ L KI DFGLAR SH G +
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 481 G--YMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGR 513
Y +P L T+ D+++ G + E++TG+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 321 LGQGGFGTVY--------KGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG V+ K V+ ++I V+++ + R A N E ++ + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQN---ECQVLKLLSHPNII 62
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
++V E+ P +L +I + +L E I+ V+ L+ LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDED--TILHFFVQILLALHHVH 118
Query: 433 KIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K NILLD + KI DFG+++ KS T + GT Y++PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVV-GTPCYISPELCEGK 176
Query: 492 QLTEKADVYSFGMLLLEIVT 511
+K+D+++ G +L E+ +
Sbjct: 177 PYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 64/310 (20%)
Query: 321 LGQGGFGTVY--------KGVLPDGREIAVKRLFFNNRHR-AANFYNEVNIISSV-EHKN 370
LG+G FG V K + +AVK L + + ++ +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRFI-----------FDSAKA--KTLTWEKRYE 416
++ LLG C+ GP ++V E+ +L ++ +D A+ + +T++
Sbjct: 83 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTA 475
G+ YL Q + IHRD+ A N+L+ KIADFGLAR D +T
Sbjct: 142 CTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535
+ +MAPE L T ++DV+SFG+L+ EI T+ +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI------------------FTLGGSPY 240
Query: 536 QAGRVEELY----DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-------MS 584
VEEL+ + + M + +N Y ++R C PS RPT +
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD------CWHAIPSHRPTFKQLVEDLD 294
Query: 585 RVLQMLTTEE 594
R+L + T EE
Sbjct: 295 RILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 323 QGGFGTVY--KGVLPDGREIAVKRLFFNN---RHRAANFYNE-VNIISSVEHKNLVRLLG 376
+G FG+VY K G A+K L ++ +++ N E ++ E + +L
Sbjct: 6 KGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTL-----TWEKRYEIILGTVEGLVYLHEQ 431
S LV E+L I KTL W K+Y I V G+ LH++
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
IIHRDIK N+L+D K+ DFGL+R+ E+K GT Y+APE +
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGV 168
Query: 492 QLTEKADVYSFGMLLLEIVTG 512
+ +D +S G ++ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNII 363
T+ + + + +G G +G+V G +AVK+L F + A Y E+ ++
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLT 410
++H+N++ LL F P +SL+ F + + K + LT
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 411 WEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470
+ +I + GL Y+H IIHRD+K SN+ ++ KI DFGLAR ++
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM- 174
Query: 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
T T Y APE + + + D++S G ++ E++TGR
Sbjct: 175 ---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 34/300 (11%)
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAAN--FYNEV 360
KY L +G+G +G V K + G+ +A+K+ + + E+
Sbjct: 2 KYENLGL----------VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI 51
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
++ + H+NLV L+ LV+EF+ + LD L + + +
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQ 108
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ G+ + H + IIHRDIK NIL+ K+ DFG AR+ + T T
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATR 164
Query: 481 GYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ-AG 538
Y APE L +A D+++ G L+ E++TG D L I
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG--EPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 539 RVEELYDKNLMLHNYHDSNVK--------YEVLRAIHVGLL--CTQENPSLRPTMSRVLQ 588
R +E++ KN + VK + L + + L C + +P RP+ S++L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 40/102 (39%), Positives = 62/102 (60%), Gaps = 2/102 (1%)
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
K E+ + + E ++ L K+ II+RDIK NILLDS + DFGL++ F ED+
Sbjct: 103 KEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162
Query: 473 STAIAGTLGYMAPEYLAHGQLT-EKA-DVYSFGMLLLEIVTG 512
+ + GT+ YMAP+ + G +KA D +S G+L+ E++TG
Sbjct: 163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLLG 376
+KLG+G + TV+KG +A+K + + A EV+++ +++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ LV+E+L + L +++ + ++ K + L + GL Y H++ +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL--LRGLSYCHKR---KI 124
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLTE 495
+HRD+K N+L++ + K+ADFGLAR+ S + TL Y P+ L + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 496 KADVYSFGMLLLEIVTGR 513
D++ G +L E+ TGR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFN------------------NRHRAANFYNEVN 361
KLG+G FG V+ + + +++ + FN N++ +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI----------------FDSAK 405
I+S ++ N++RLLG ++ E++ N L++F+ +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 406 AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS- 464
+++ + L G+ YL S + +HRD+ N L+ L KIADFG++R+
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
+ D I + +MA E + G+ T +DV++FG+ L EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 42/116 (36%), Positives = 64/116 (55%), Gaps = 14/116 (12%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EIILG L ++H + +++RD+K +NILLD +I+D GLA F + K H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 476 IAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR---QNNRSKNSEYTDSL 527
GT GYMAPE L G AD +S G +L +++ G + +++K+ D +
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-13
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 2/98 (2%)
Query: 139 GNGTRKNSSFQESARKAVMRAVASAPSNGGYARVQVQVSGAANKSAYVLVNCWKTLNSSS 198
GN T NS+F ES A++ +++S ++ SGAA + Y L C L++S
Sbjct: 10 GNYTTANSTF-ESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASD 68
Query: 199 CEACLANASASILGCLPWS-EGRALNTGCFMRYSDKDF 235
C +CLA A + + C P GR CF+RY F
Sbjct: 69 CRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 39/98 (39%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+LG L +LHE+ II+RD+K N+LLDS KIADFG+ + ST
Sbjct: 104 EIVLG----LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST- 155
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L++ D ++ G+LL E++ G+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F + LG+GGFG V V G+ A K+L R + NE I+ V +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE-GLVYL 428
+V L + LV + L I+ +A E R + GL L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE--EGRAVFYAAEICCGLEDL 118
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H++ RI++RD+K NILLD +I+D GLA E ++ GT+GYMAPE +
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVV 173
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ + T D ++ G LL E++ G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV- 366
L G F+ +G G +G VYKG ++A ++ E+N++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 367 EHKNLVRLLGCSCS-GPESL-----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
H+N+ G P + LV EF S+ I + K TL E I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICRE 119
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL +LH+ ++IHRDIK N+LL K+ DFG++ +T I GT
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 175
Query: 481 GYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
+MAPE +A + + K+D++S G+ +E+ G
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 40/284 (14%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F+ ++G G +G VYK + G A+K + A E+ ++ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G + + EF SL + L+ + + T++GL YLH + K
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA------GTLGYMAPEY 487
+ HRDIK +NILL K+ADFG++ + I+ IA GT +MAPE
Sbjct: 128 M---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEV 177
Query: 488 LA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
A G + D+++ G+ +E+ + +L +T +FQ + L
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL--AELQPPMFDLHPMRALFLMTKSNFQPPK---LK 232
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
DK +++H H + +NP RPT ++LQ
Sbjct: 233 DKMKWSNSFH------------HFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 44/122 (36%), Positives = 67/122 (54%), Gaps = 19/122 (15%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EIIL L +LH K+ I++RDIK NILLDS + DFGL++ F ++ + +
Sbjct: 113 EIILA----LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 476 IAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGR-----QNNRSKNSEYTDS 526
GT+ YMAPE + HG+ D +S G+L+ E++TG + R+ SE +
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222
Query: 527 LL 528
+L
Sbjct: 223 IL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 321 LGQGGFGTVYKGVL---PD------GREIAVKRLFFNNRHRAA-NFYNEVNIISSVEHKN 370
LGQG F +YKGVL D G+E++V + HR + F+ +++S + HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
LV+L G C E+++V E++ LD F+ +L W + ++ L YL +
Sbjct: 63 LVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 431 QSKIRIIHRDIKASNILL-------DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
+ +++H ++ NIL+ K++D G+ + + + ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PWI 171
Query: 484 APEYLAHGQ--LTEKADVYSFGMLLLEI 509
APE + +GQ LT AD +SFG LLEI
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 315 FDEANKLGQGGFGTVY--KGVLPDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHK 369
++ K+G+G FG +Y K D +K + + + A+ EV +++ ++H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHP 59
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS-----AKAKTLTWEKRYEIILGTVEG 424
N+V +V E+ L + I ++ + L+W + + G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L ++H++ +I+HRDIK+ NI L + AK+ DFG+AR D ++ GT Y+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYL 169
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVT 511
+PE + K D++S G +L E+ T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA------------NF--YNEVNII 363
LG+G +G V K G+ +A+K++ +F E+ I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTV 422
+ ++H+N++ L+ G LV + + S + + D K LT + I+L +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVDR---KIRLTESQVKCILLQIL 129
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-------------QEDK 469
GL LH K +HRD+ +NI ++S+ KIADFGLAR + +
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 470 SHISTAIAGTLGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
T+ TL Y APE L + D++S G + E++TG+
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 320 KLGQGGFGTV----YKGVLPDGREIAVKRL--FFNNRHRAANFYNEVNIISSV-EHKNLV 372
+LGQG +G V + +A+K++ F+ + A E+ ++ HKN+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 373 RLLGCSCSGPES---LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
L P + L +YE L L + I + LT I + GL Y+H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIH 122
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK----SHISTAIAGTLGYMAP 485
+ ++HRD+K N+L+++ KI DFGLAR F E+ ++ +A T Y AP
Sbjct: 123 SAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAP 178
Query: 486 EYLAHGQLTEKA-DVYSFGMLLLEIVTGR 513
E + Q KA DV+S G +L E++ +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 320 KLGQGGFGTVYKGVLPDG---REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLL 375
++G G FG V G + G ++ VK L + + F E S++H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR------YEIILGTVEGLVYLH 429
G LLV EF P L ++ KA+ +T + EI L GL++LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH 117
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTLGYMAPEYL 488
+ + IH D+ N LL + L KI D+GL+ ++ED + L ++APE +
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 489 --AHGQL-----TEKADVYSFGMLLLEI 509
HG L T++++V+S G+ + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 15/120 (12%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EIILG L ++H + +++RD+K +NILLD +I+D GLA F + K H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 476 IAGTLGYMAPEYLAHGQLTE-KADVYSFGMLLLEIVTG----RQNNRSKNSEYTDSLLTI 530
GT GYMAPE L G + AD +S G +L +++ G RQ+ E LT+
Sbjct: 157 --GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 40/98 (40%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EII G L +LH++ II+RD+K N+LLD KIADFG+ + + ST
Sbjct: 104 EIICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST- 155
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L + E D +SFG+LL E++ G+
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR---SFQEDKSHISTAIAGTL 480
GL Y+H + +IHRD+K SN+L++ +I DFG+AR S + + T T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 481 GYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGRQ 514
Y APE L+ + T D++S G + E++ RQ
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLL 375
++LG+G +G+VYK VL P G +A+K + + + E++I+ +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G + E++ SLD+ + + + I V+GL +L E+ I
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI- 124
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL------A 489
IHRD+K +N+L++ + K+ DFG+ S S T I G YMAPE +
Sbjct: 125 -IHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVASLAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ T ++DV+S G+ +LE+ GR
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 28/277 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++ ++G G +G VYK L G AVK + + E+ ++ +H N+V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
G S + + E+ SL + L + Y + T++GL YLH + K
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL--QIAY-VCRETLQGLAYLHSKGK 127
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA---H 490
+ HRDIK +NILL K+ADFG+A + + I GT +MAPE A +
Sbjct: 128 M---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKN 183
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550
G + D+++ G+ +E+ + +L ++ +FQ ++++ +
Sbjct: 184 GGYNQLCDIWAVGITAIEL--AELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241
Query: 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVL 587
HN+ VK + + NP RPT R+L
Sbjct: 242 HNF----VKISLTK-----------NPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 21/226 (9%)
Query: 321 LGQGGFGTVYKGVLP----DGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRL 374
LG+G FG+V + L +++AVK L + F E + +H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 375 LGCSCSG------PESLLVYEFLPNQSLDRFIFDSAKAK---TLTWEKRYEIILGTVEGL 425
+G S P +++ F+ + L F+ S + TL + ++ G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMA 484
YL S IHRD+ A N +L+ + +ADFGL++ + D A + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS--KNSEYTDSLL 528
E LA T +DV++FG+ + EI+T Q + +NSE + L+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 43/223 (19%)
Query: 321 LGQGGFGTVYKGVLPDG-----------REIAVKRLFFNNRHR-AANFYNEVNIISSV-E 367
LG+G FG V V+ + ++AVK L + + ++ +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 368 HKNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEK 413
HKN++ LLG C+ GP ++V E+ +L ++ + L+++
Sbjct: 83 HKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
G+ YL + + IHRD+ A N+L+ KIADFGLAR D HI
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 194
Query: 474 TAIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
T G +MAPE L T ++DV+SFG+LL EI T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F LG+GGFG V V G+ A K+L R A NE I+ V +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTV 422
+V L + LV + L I FD +A EI G
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA----AEITCG-- 114
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
L LH + RI++RD+K NILLD +I+D GLA E ++ I + GT+GY
Sbjct: 115 --LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGY 167
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
MAPE + + + T D + G L+ E++ G+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 321 LGQGGFGTV----YKGVLPDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVR 373
+G+G +G V ++ DG++ +K+L N R R A E ++S ++H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAA-EQEAQLLSQLKHPNIVA 63
Query: 374 LLGCSCSGPESLL--VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
S G + LL V F L + K K L + E + L YLHE+
Sbjct: 64 YRE-SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K N+ L K+ D G+AR + ST I GT YM+PE ++
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNK 177
Query: 492 QLTEKADVYSFGMLLLEIVTGRQ--NNRSKNS 521
K+DV++ G + E+ T + N + NS
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 38/99 (38%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+L L +LH ++ II+RDIK NILLDS + DFGL++ F ++ + +
Sbjct: 113 EIVLA----LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 476 IAGTLGYMAPEYLAHGQL--TEKADVYSFGMLLLEIVTG 512
GT+ YMAPE + G + D +S G+L E++TG
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+++LH + I++RD+K N+LLD + +++D GLA ++ K+ T AGT GYM
Sbjct: 107 GILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYM 161
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE L + D ++ G + E+V GR
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTL 480
GL +LH + II+RD+K N++LD+ KIADFG+ + + K+ + GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE +A+ + D ++FG+LL E++ G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA-NFYNEVNIISSVEHKNL 371
S+++ KLG+G + TVYKG +G+ +A+K + E +++ ++H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 372 VRLLGCSCSGPESLLVYEFLPN---QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
V L + LV+E++ Q +D+ L E + + GL Y+
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDK------HPGGLHPENVKLFLFQLLRGLSYI 119
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-Y 487
H++ I+HRD+K N+L+ K+ADFGLAR+ + SH + TL Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVL 175
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTG 512
L + + D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
E++I+ ++ H+ ++ L+ +V +P D F + L E+ I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSG-PLPLEQAITIQ 191
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST---- 474
+E L YLH + IIHRD+K NI LD A + DFG A H T
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQCY 245
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT------GRQNNRS 518
+GTL +PE LA K D++S G++L E+ G+Q S
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 321 LGQGGFGTVYKGVLPDGRE-IAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G+V R+ +AVK+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 378 SCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEIILGTVEG 424
F P S++ F + + K + L+ E +I + G
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L Y+H IIHRD+K SN+ ++ +I DFGLAR ++ T T Y A
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRA 183
Query: 485 PEYLAHG-QLTEKADVYSFGMLLLEIVTGR 513
PE + + + D++S G ++ E++ G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-12
Identities = 65/250 (26%), Positives = 98/250 (39%), Gaps = 60/250 (24%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRL---FFNNRHRAANFYNEVNIISSVEH 368
+D +G+GG G VY P R +A+K++ N F E I + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 369 KNLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTL---TWEKR---------- 414
+V + CS P VY +P +I + K+L W+K
Sbjct: 62 PGIVPVYSICSDGDP----VYYTMP------YI-EGYTLKSLLKSVWQKESLSKELAEKT 110
Query: 415 --------YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF- 465
+ I T+E Y+H + ++HRD+K NILL I D+G A
Sbjct: 111 SVGAFLSIFHKICATIE---YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
Query: 466 --QEDKSHISTA--------------IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEI 509
+ED I I GT YMAPE L +E D+Y+ G++L ++
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 510 VTGRQNNRSK 519
+T R K
Sbjct: 225 LTLSFPYRRK 234
|
Length = 932 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 67/234 (28%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 321 LGQGGFGTVYKGVLP-DGREIAVKRL----FFNNRHRAANFYNEVNIIS-SVEHKNLVRL 374
LG+G FG V L GR AVK L + E I+S + H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTM-TEKRILSLARNHPFLTQL 61
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
C + V EF+ L I FD A+A+ E L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ II+RD+K N+LLD K+ADFG+ + + ST GT Y+APE L
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQ 169
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE------YTDSLLTITWKHFQA 537
D ++ G+LL E++ G ++N + D ++ TW A
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDA 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 46/175 (26%), Positives = 96/175 (54%), Gaps = 3/175 (1%)
Query: 338 REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLD 397
++ K + N+ +AA +E++ +++ +H +V+ S + LL+ E+ L+
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 398 RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457
+ I K L + + YE+ L + ++ L E +++HRD+K++NI L K+
Sbjct: 154 KQIKQRLKEH-LPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 458 DFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
DFG ++ + + S ++++ GT Y+APE + ++KAD++S G++L E++T
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 320 KLGQGGFGTVYKGVL------PDGREIAVKRLFFNNRHRAA---NFYNEVNIISSVEHKN 370
+LG+ FG VYKG L + +A+K L ++ F +E + S ++H N
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRYEI 417
+V LLG +++ + + L F+ D TL I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAI 476
+ G+ +L S ++H+D+ N+L+ +L KI+D GL R + D +
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
+ +M+PE + +G+ + +D++S+G++L E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 8/92 (8%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS--FQEDKSHISTAIAGTLG 481
GL +LH + II+RD+K N++LD KIADFG+ + F +++ ++ GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPD 161
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L + T D +SFG+LL E++ G+
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAAN------FYNEVNIISSVEHKNLV 372
+++G G FG V G G ++ R+ +A F EV + H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG--TVEGLVYLH 429
+ LG C S P LLV EF P L ++ + +K + GL++LH
Sbjct: 59 QCLGQCIESIP-YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAPEYL 488
+ IH D+ N L + L KI D+GLA + ED A L ++APE +
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 489 AHGQ-------LTEKADVYSFGMLLLEIVT 511
T+K++++S G+ + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 34/76 (44%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
IHRD+ A NILL KI DFGLAR +D ++ A L +MAPE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 496 KADVYSFGMLLLEIVT 511
++DV+SFG+LL EI +
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 21/231 (9%)
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA 353
++L+D L S L G F+ +G G +G VYKG ++A ++
Sbjct: 1 RSLDDIDL----SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE 56
Query: 354 ANFYNEVNIISSV-EHKNLVRLLGC----SCSGPES--LLVYEFLPNQSLDRFIFDSAKA 406
E+N++ H+N+ G S G + LV EF S+ + + K
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKG 115
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466
L + I + GL +LH ++IHRDIK N+LL K+ DFG++
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
Query: 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
+T I GT +MAPE +A + + ++D++S G+ +E+ G
Sbjct: 173 RTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 22/186 (11%)
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
+AKT + +E L ++ L+ +H +IHRDIK++NILL S K+ DFG ++
Sbjct: 133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192
Query: 465 FQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523
+ S + GT Y+APE ++KAD++S G+LL E++T + R + E
Sbjct: 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK---RPFDGEN 249
Query: 524 TDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583
+ ++ T AGR + L ++ E ++ I LL + +P RP+
Sbjct: 250 MEEVMHKTL----AGRYDPLPP-----------SISPE-MQEIVTALLSS--DPKRRPSS 291
Query: 584 SRVLQM 589
S++L M
Sbjct: 292 SKLLNM 297
|
Length = 496 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F LG+GGFG V V G+ A K+L R A NE I+ V +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTV 422
+V L + LV + L I FD +A I
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----------IFYAA 109
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E L + + RI++RD+K NILLD R +I+D GLA E ++ GT+GY
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGY 167
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
MAPE + + + T D + G L+ E++ G+
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 4/98 (4%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
+ GL +LH++ RII+RD+K N+LLD+ +I+D GLA ++ +S + AGT G
Sbjct: 107 ISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPG 162
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519
+MAPE L + D ++ G+ L E++ R R++
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGRE-IAVKRLFFNNRHR---AANFYNEVNIISSVEHKN 370
+ +G G FG V+ A+K + R + +NE ++ V H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGL 425
++RL ++ E++P L ++ F ++ E V L
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVCAL 114
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLH + I++RD+K NILLD K+ DFG A+ + D++ + GT Y+AP
Sbjct: 115 EYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTW---TLCGTPEYLAP 167
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520
E + + D ++ G+L+ E++ G N
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 54/232 (23%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V+ D ++ A+K L R++ A+ E +I++ + +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 377 CSCSGPESL-LVYEFLPNQSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYL 428
S E L LV E++P L + +F + Y E++L L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFYIAELVLA-------L 114
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS------------------ 470
K+ IHRDIK NIL+D+ K+ADFGL + + K
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 471 ----------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
+ + GT Y+APE L + D +S G++L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 321 LGQGGFGTVYKGVL--PDGREIAVKRLFFNNRHRA-ANFYNEVNIISSV-EHKNLVRLLG 376
+G+G +G V+K VL +G + AVK L + H E NI+ ++ +H N+V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 377 C-----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-----EGLV 426
+G + LV E S + D K E+ E I+ + GL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGS----VTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
+LH + IHRD+K +NILL + K+ DFG++ + +T++ GT +MAPE
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194
Query: 487 YLAHGQ-----LTEKADVYSFGMLLLEIVTG 512
+A Q + DV+S G+ +E+ G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 321 LGQGGFGTVYKGV---LPDGR-----EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
LGQG F ++KG+ + D E+ +K L ++R+ + +F+ +++S + HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
G G ES++V E++ SLD ++ + ++W + E+ L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 433 KIRIIHRDIKASNILL---DSRLRA-----KIADFGLARSFQEDKSHISTAIAGTLGYMA 484
+ H ++ A N+LL + R K++D G++ + K + I ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERIP----WVP 172
Query: 485 PEYLAHGQ-LTEKADVYSFGMLLLEIVTG 512
PE + + Q L+ AD +SFG L EI +G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 22/161 (13%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
IHRD+ A NILL KI DFGLAR + D +++ A + +MAPE + + T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 496 KADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHD 555
++DV+S+G+LL EI + +S Y + + K ++ ++E Y ML
Sbjct: 296 ESDVWSYGILLWEIFS------LGSSPYPG--MPVDSKFYKM--IKEGYR---MLSPECA 342
Query: 556 SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQL 596
+ Y+++++ C +P RPT +++Q++ E+QL
Sbjct: 343 PSEMYDIMKS------CWDADPLKRPTFKQIVQLI--EQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA-NFYNEVNIISSVEH 368
A S+ KLG+G + TVYKG+ +G+ +A+K + E +++ ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 369 KNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
N+V LL E+L V+E++ D + L + + GL Y
Sbjct: 63 ANIV-LLHDIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
+H Q I+HRD+K N+L+ K+ADFGLAR+ + S ++ TL Y P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDV 174
Query: 488 L-AHGQLTEKADVYSFGMLLLEIVTGR 513
L + D++ G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 10/210 (4%)
Query: 314 SFDEANKLGQGGFGTVYK-GVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
+F + LG+GGFG V V G+ A KRL R + NE I+ V +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+V L + LV + L I++ E+ + GL LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH 119
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ ++RD+K NILLD +I+D GLA E +S GT+GYMAPE L
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLN 174
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519
+ + T D + G L+ E++ G+ R +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL +LH + II+RD+K N++LDS KIADFG+ + D T GT Y+
Sbjct: 113 GLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYI 168
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE +A+ + D +++G+LL E++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 321 LGQGGFGTVYKGVLPD-GREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G+G +G V + ++A+K++ F+NR A E+ ++ ++H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK-- 70
Query: 378 SCSGPES-------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
P +VYE L + L + I S +TL+ + + + GL Y+H
Sbjct: 71 DIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ ++HRD+K SN+LL++ KI DFGLAR+ +K T T Y APE L +
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 491 -GQLTEKADVYSFGMLLLEIVTGRQ 514
+ T DV+S G + E++ GR+
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
GL +LH + II+RD+K N++LDS KIADFG+ + D T GT Y+
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYI 168
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
APE +A+ + D ++FG+LL E++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 67/254 (26%), Positives = 108/254 (42%), Gaps = 38/254 (14%)
Query: 287 NDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLF 346
N EK+V+ K L+ +D +G+G FG V +++ +L
Sbjct: 26 NRYEKIVR---------KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 347 FN----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI- 400
R +A F+ E +I++ +V+L C+ + L +V E++P L +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 401 -FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
+D + W K Y T E ++ L + +IHRD+K N+LLD K+ADF
Sbjct: 136 NYDVPE----KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 460 GLARSFQED-KSHISTAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGRQ 514
G E TA+ GT Y++PE L G + D +S G+ L E++ G
Sbjct: 187 GTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 243
Query: 515 NNRSKNSEYTDSLL 528
Y DSL+
Sbjct: 244 ----DTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQL 493
+ IHRD+ A NILL KI DFGLAR +D ++ A L +MAPE +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 494 TEKADVYSFGMLLLEIVT 511
T ++DV+SFG+LL EI +
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNR-----HRAANFYNEVNIISSVEH 368
+++ +K+G+G +G V+K + G+ +A+K+ F + + A E+ ++ ++H
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIA--LREIRMLKQLKH 59
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPN---QSLDRFI--FDSAKAKTLTWEKRYEIILGTVE 423
NLV L+ + LV+E+ + L++ K + W+ T++
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQ 111
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
+ + H+ + IHRD+K NIL+ + + K+ DFG AR + +A T Y
Sbjct: 112 AVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYR 167
Query: 484 APEYL-AHGQLTEKADVYSFGMLLLEIVTG 512
APE L Q DV++ G + E++TG
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EII G L +LH + I++RD+K NILLD+ KIADFG+ + + T
Sbjct: 104 EIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT- 155
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L + D +SFG+LL E++ G+
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 33/76 (43%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
+HRD+ A N+L+ KI DFGLAR D ++IS L +MAPE + + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 496 KADVYSFGMLLLEIVT 511
+DV+SFG+LL EI T
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVK--RLFFNNRHRAANF--YNEVNIISSVEH 368
++ + +KLG+G + TVYKG G+ +A+K RL A F E +++ ++H
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL---EHEEGAPFTAIREASLLKDLKH 62
Query: 369 KNLVRLLGCSCSGPESL-LVYEFLPN---QSLDRF--IFDSAKAKTLTWEKRYEIILGTV 422
N+V L ++L LV+E+L Q +D + ++ +
Sbjct: 63 ANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ--------LL 113
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG---T 479
GL Y H++ R++HRD+K N+L+ R K+ADFGLAR+ KS S + T
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVT 166
Query: 480 LGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGR 513
L Y P+ L + + D++ G + E+ TGR
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 77/296 (26%)
Query: 320 KLGQGGFGTVYKGVL----PDGR-----EIAVKRLFFNNRHRAANFYNEVNIISSVEHKN 370
K+G+G FG K +L DG+ EI + ++ R + EV ++S+++H N
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN 60
Query: 371 LVRL------LGC------SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
+V+ G C G + +Y+ + Q F D + L W +I
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGD---LYKKINAQRGVLFPED----QILDW--FVQIC 111
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
L L ++H++ +I+HRDIK+ NI L K+ DFG+AR T I G
Sbjct: 112 LA----LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-G 163
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH-FQA 537
T Y++PE + K+D+++ G +L E+ T KH F+A
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEM--------------------CTLKHAFEA 203
Query: 538 GRVEELYDKNLMLH----NYHDSNVKYEV-LRAIHVGLLCTQENPSLRPTMSRVLQ 588
G + KNL+L +Y + Y LR + L + NP RP+++ +L+
Sbjct: 204 GNM-----KNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQL 493
+ IHRD+ A NILL KI DFGLAR +D ++ A L +MAPE +
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 494 TEKADVYSFGMLLLEIVT 511
T ++DV+SFG+LL EI +
Sbjct: 259 TIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 32/74 (43%), Positives = 45/74 (60%), Gaps = 1/74 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
IHRD+ A N+LL AKI DFGLAR D +++ A + +MAPE + T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 496 KADVYSFGMLLLEI 509
++DV+S+G+LL EI
Sbjct: 294 QSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 290 EKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREI-AVKRLF-F 347
EK + + + + FD +G+G FG V +++ A+K L F
Sbjct: 29 EKAAEKITKLRMKAE---------DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 348 N--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSA 404
R +A F+ E +I++ + +V+L + + L +V E++P L + +
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYD 138
Query: 405 KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464
+ W + Y V L +H + IHRD+K N+LLD K+ADFG
Sbjct: 139 IPEK--WARFY--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 465 FQED-KSHISTAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTG 512
+ TA+ GT Y++PE L G + D +S G+ L E++ G
Sbjct: 192 MDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 47/215 (21%)
Query: 319 NKLGQGGFGTVYKG-VLPDGREIAVKRLFFNNRHR---AANFYNEVNIISSVE-HKNLVR 373
K+G+G F V K G+ A+K + + N E+ + + H N++R
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 374 LLGC---SCSGPESLL-------VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
L+ +G +L+ +YE + + + + K+ ++ ++
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQ--------LLK 111
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS------FQEDKSHISTAIA 477
L ++H + I HRDIK NIL+ + K+ADFG R + E +IST
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE---YISTR-- 162
Query: 478 GTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVT 511
Y APE L G K D+++ G + EI++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 7/155 (4%)
Query: 359 EVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEII 418
E +I+ ++ H ++++L G + L+ LP D + + +AK + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAICDILAIE 188
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+ + YLHE RIIHRDIKA NI ++ + DFG A + ++ AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
T+ APE LA D++S G++L E+ T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 317 EANKLGQGGFGTVYKGVLPDG---REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
E K+G+G +G VYK DG +E A+K++ +A E+ ++ ++H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIA 62
Query: 374 L--LGCSCSGPESLLVYEFLPNQSLDRFIFDSA-----KAKTLTWEKRYEIILGTVEGLV 426
L + S S + L++++ + F A K L ++ ++G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 427 YLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHIS--TAIAGTL 480
YLH ++HRD+K +NIL+ R R KIAD G AR F ++ + T
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 481 GYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVT 511
Y APE L + KA D+++ G + E++T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 23/167 (13%)
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK-RY---EIILGTVE 423
H LV L C + V EF+ L +F + + L E R+ EI L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA--- 108
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L +LHE+ II+RD+K N+LLD+ K+ D+G+ + ST GT Y+
Sbjct: 109 -LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR--------QNNRSKNSE 522
APE L D ++ G+L+ E++ GR +N +N+E
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 26/198 (13%)
Query: 325 GFGTVYKGVLPDGREIAVKRLFFNNRHRAANFY-NEVNIISSVEHKNLVRLLGCSCSGPE 383
G + +G R IA KR+ RAA NE+ + + H+N++++ E
Sbjct: 181 GVNSTNQGKPKCERLIA-KRV--KAGSRAAIQLENEILALGRLNHENILKI--------E 229
Query: 384 SLLVYE---FLPNQSLD----RFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+L E ++ Q D F++D A K + L + R I+ + + Y+H++
Sbjct: 230 EILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK-- 286
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
++IHRDIK NI L+ + + DFG A F++++ GT+ +PE LA
Sbjct: 287 -KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
Query: 494 TEKADVYSFGMLLLEIVT 511
E D++S G++LL++++
Sbjct: 346 CEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 68/254 (26%), Positives = 117/254 (46%), Gaps = 42/254 (16%)
Query: 276 QRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP 335
+RS D EK++ D+ +N S+ N +G G FG VY+ +
Sbjct: 39 ERSHNNNAGEDEDEEKMI----DNDIN------RSPNKSYKLGNIIGNGSFGVVYEAICI 88
Query: 336 DGRE-IAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL-----LGCSCSGPESL---L 386
D E +A+K++ + +++ E+ I+ ++ H N++ L C +++ +
Sbjct: 89 DTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144
Query: 387 VYEFLPNQSLDRFIFDSAK---AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKA 443
V EF+P Q++ +++ A+ A L K Y L L Y+H SK I HRD+K
Sbjct: 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIH--SKF-ICHRDLKP 198
Query: 444 SNILLDSRLRA-KIADFGLARSF---QEDKSHISTAIAGTLGYMAPE-YLAHGQLTEKAD 498
N+L+D K+ DFG A++ Q S+I + Y APE L T D
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHID 253
Query: 499 VYSFGMLLLEIVTG 512
++S G ++ E++ G
Sbjct: 254 LWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 29/235 (12%)
Query: 317 EANKLGQGGFGTVYKGVLPDG---REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
E K+G+G +G VYK DG R+ A+K++ +A E+ ++ ++H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVIS 62
Query: 374 L--LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY---- 427
L + S + + L++++ + F A +K ++ G V+ L+Y
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILD 119
Query: 428 -LHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHIS--TAIAGTL 480
+H ++HRD+K +NIL+ R R KIAD G AR F ++ + T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 481 GYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTG------RQNN-RSKNSEYTDSL 527
Y APE L + KA D+++ G + E++T RQ + ++ N + D L
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 321 LGQGGFGTVYKGVLP-DGREIAVKRL---FFNNRHRAANFYNEVNII-SSVEHKNLVRLL 375
+G+G FG V DG+ AVK L NR + E N++ +V+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+ + V +F+ L F + ++ + L YLH I
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
I++RD+K NILLDS+ + DFGL + +S +T GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 496 KADVYSFGMLLLEIVTG 512
D + G +L E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 321 LGQGGFGTVYKGVLPDGREI----AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V + D + I +++ +R + E +++ V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
S PE L LV F+ L + FD ++A+ T E L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRAR-----------FYTAELLCALEN 108
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
K +I+RD+K NILLD + + DFGL + +D +T GT Y+APE L
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLG 167
Query: 491 GQLTEKADVYSFGMLLLEIVTG 512
T+ D ++ G+LL E++TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV---RLLGC 377
LG+G FG V +L RE A + + A + II+ E + + R+L
Sbjct: 3 LGKGTFGKV---ILV--REKATGKYY------AMKILKKEVIIAKDEVAHTLTESRVLQN 51
Query: 378 SCSGPESLLVYEFLPNQSLDR--FIFDSAKAKTLTWEKRYEIILG----------TVEGL 425
+ + L Y F Q+ DR F+ + A L + E + V L
Sbjct: 52 TRHPFLTALKYSF---QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLH +++RD+K N++LD KI DFGL + D + + T GT Y+AP
Sbjct: 109 GYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 164
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D + G+++ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 44/236 (18%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN----NRHRAANFYNEVNIISSVEHKN 370
F+ +G+G FG V D I ++ + + A+ E +I+ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+V++ L+ EFLP + + K TL+ E I TV + +H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGL----------------------------- 461
+ IHRDIK N+LLD++ K++DFGL
Sbjct: 120 ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 462 -----ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
A ++++++ ++ + GT Y+APE + D +S G+++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 40/161 (24%)
Query: 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445
L+ EFLP + + K TLT E+ I TV + +H+ + IHRDIK N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131
Query: 446 ILLDSRLRAKIADFGL----------------------------------ARSFQEDKSH 471
+LLDS+ K++DFGL A +++ ++
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
++ + GT Y+APE + D +S G+++ E++ G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 53/236 (22%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V D I A+K+L + + + A+ E +I++ ++ +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY- 67
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
S L L+ E+LP + + K T T E+ I T+ + +H K+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIH---KLG 121
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST--------------------- 474
IHRDIK N+LLD++ K++DFGL + KSH +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 475 --------------AIA----GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
A+A GT Y+APE ++ D +S G+++ E++ G
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
G+ ++HE+ R++HRDIK+ NI L + K+ DFG AR ++ T + GT Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKN 520
PE + K+D++S G +L E+ T + Q N KN
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNL 371
F+ +G+G +G V K + +EI + F + N E+ ++ +++ +N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
V L + LV+E++ L+ + + EK I ++ + + H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP-EKVRSYIYQLIKAIHWCH-- 117
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
K I+HRDIK N+L+ K+ DFG AR+ E + T T Y +PE L
Sbjct: 118 -KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 492 QLTEKADVYSFGMLLLEIVTGR 513
+ D++S G +L E+ G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V L YLH + +++RDIK N++LD KI DFGL + D + + T GT
Sbjct: 105 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 160
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L D + G+++ E++ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G+G +G V + G ++A+K++ F + A E+ ++ + H ++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 378 SCSGPES-------LLVYEFLPNQSLDRFIFDSAKAKT-LTWEKRYEIILGTVEGLVYLH 429
P S +V+E L L + I KA LT E + + L Y+H
Sbjct: 68 ML--PPSRREFKDIYVVFE-LMESDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHIS-TAIAGTLGYMAPEY 487
+ + HRD+K NIL ++ + KI DFGLAR +F + + I T T Y APE
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 488 LA--HGQLTEKADVYSFGMLLLEIVTGR 513
+ T D++S G + E++TG+
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V L YLH + + ++RD+K N++LD KI DFGL + +D + + T GT
Sbjct: 105 VSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 161
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L D + G+++ E++ GR
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 58/301 (19%), Positives = 102/301 (33%), Gaps = 49/301 (16%)
Query: 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+ K P +AVK++ ++ + E+ ++H N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 379 CSGPESLLVYEFLPNQS---LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
E +V + S L + F + + I+ + L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI---AF-ILKDVLNALDYIH---SKG 121
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSF-QEDKSH-----ISTAIAGTLGYMAPEYLA 489
IHR +KAS+ILL + ++ + S + K + L +++PE L
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 490 ---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546
G EK+D+YS G+ E+ G + D T G V L DK
Sbjct: 182 QNLQG-YNEKSDIYSVGITACELANGHV-------PFKDMPATQMLLEKVRGTVPCLLDK 233
Query: 547 N-LMLHNYHDSNVKYEVLRAI------------------HVGLLCTQENPSLRPTMSRVL 587
+ L+ S + LC Q +P RP+ S++L
Sbjct: 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
Query: 588 Q 588
Sbjct: 294 N 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 63/239 (26%), Positives = 97/239 (40%), Gaps = 48/239 (20%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG VY+ D R I A+K L + A+ E NI+ ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTW---------EKRYEI-ILGTVEGLV 426
L + F + L + D L W E R + I V L
Sbjct: 61 ---------LKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
+LH+ I++RD+K NILLD+ + DFGL+++ D +T GT Y+APE
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPE 166
Query: 487 YLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544
L + T+ D +S G+L+ E+ G W F A +++Y
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG-------------------WSPFYAEDTQQMY 206
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 12/122 (9%)
Query: 401 FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460
FD +++ E L++LH +I+RD+K NILLD+ K+ADFG
Sbjct: 93 FDEPRSRFYAAE--------VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG 141
Query: 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520
+ + +T GT Y+APE L + D ++ G+L+ E++ G+ + N
Sbjct: 142 MCKE-GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
Query: 521 SE 522
+
Sbjct: 201 ED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG-TLGYMAPEYLAHGQLTE 495
+HRD+ A N+LL KI DFGLAR D +++S + +MAPE + T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 496 KADVYSFGMLLLEIVT 511
+DV+S+G+LL EI +
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
V L YLH +I++RD+K N++LD KI DFGL + D + + T GT
Sbjct: 105 VSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPE 160
Query: 482 YMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y+APE L D + G+++ E++ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 29/86 (33%), Positives = 47/86 (54%), Gaps = 7/86 (8%)
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + II+RD+K N+LLD++ K+ DFG A+ + + + GT Y+APE
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTG 512
+ + D ++ G+LL E + G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTA 475
II VE L LH K IIH DIK N+L D ++ R + D+GL + +
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSC 165
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
GTL Y +PE + D ++ G+L E++TG
Sbjct: 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 38/106 (35%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L YLH + I++RD+K NILLDS+ + DFGL + E ST GT Y+
Sbjct: 108 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYL 163
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS-EYTDSLL 528
APE L D + G +L E++ G S+N+ E D++L
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + II+RD+K NILLDS+ + DFGL + E ST GT Y+APE
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE 166
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN-SEYTDSLL 528
L D + G +L E++ G S++ +E D++L
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 26/240 (10%)
Query: 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN----NRHRAA 354
D++N K L ++ +G+G FG V R++ +L R +A
Sbjct: 30 DTIN-KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 355 NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI--FDSAKAKTLTWE 412
F+ E +I++ +V+L +V E++P L + +D + W
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE----KWA 144
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
+ Y T E ++ L + IHRD+K N+LLD K+ADFG ++
Sbjct: 145 RFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199
Query: 473 STAIAGTLGYMAPEYL----AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL 528
GT Y++PE L G + D +S G+ L E++ G Y DSL+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L YLHE+ II+RD+K N+LLDS K+ D+G+ + ++ GT Y+
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYI 163
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR--------QNNRSKNSE 522
APE L D ++ G+L+ E++ GR +N +N+E
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 4/86 (4%)
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + II+RD+K NILLDS+ + DFGL + E + ST GT Y+APE
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPE 166
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTG 512
L D + G +L E++ G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGR--EIAVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
F+ LG G FG V + +A+KR + + + ++E I++ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG----L 425
V L G LV EF+ F F L KR+ +G L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEF--FTF-------LRRNKRFPNDVGCFYAAQIVL 142
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
++ + QS + I++RD+K N+LLD K+ DFG A+ + + GT Y+AP
Sbjct: 143 IFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAP 197
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTG 512
E L + + AD ++ G+ + EI+ G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ +H ++ +HRDIK N+L+D K+ADFG A +K S GT Y
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 483 MAPEYL------AHGQLTEKADVYSFGMLLLEIVTGR 513
+APE L G + D +S G++ E++ GR
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ +H ++ +HRDIK N+LLD ++ADFG +D + S+ GT Y
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 483 MAPEYL-----AHGQLTEKADVYSFGMLLLEIVTG 512
++PE L G+ + D +S G+ + E++ G
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 7/143 (4%)
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
LV L C + LV E++ L +F + + L E L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ II+RD+K N+LLD+ K+ D+G+ + ST GT Y+APE L
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRG 170
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
+ D ++ G+L+ E++ GR
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 7e-08
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREI----AVKRLFFNNRHRAANFYNE 359
KY E ++ K+G G FG V+ +E A+ R ++ E
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIE 62
Query: 360 VNIISSVEHKNLVRLLG--CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YE 416
VN++ ++HKN+VR + + + + ++ EF L R I K E +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 417 IILGTVEGLVYLHE----QSKIRIIHRDIKASNILLDSRLR-----------------AK 455
I + L Y H + R++HRD+K NI L + +R AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 456 IADFGLARSFQ-EDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTG 512
I DFGL+++ E +H + GT Y +PE L H +K+D+++ G ++ E+ +G
Sbjct: 183 IGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 513 R 513
+
Sbjct: 240 K 240
|
Length = 1021 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ + ++ +HRDIK NIL+D ++ADFG ED + S+ GT Y
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 169
Query: 483 MAPEYL-----AHGQLTEKADVYSFGMLLLEIVTG 512
++PE L G+ + D +S G+ + E++ G
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 358 NEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI 417
+E ++ + H ++ LL G + LV LP D + + A+ + L + +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAI 476
+ + Y+H + IIHRDIK N+L++ + DFG A + S I
Sbjct: 266 ARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
AGT+ APE LA T D++S G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 321 LGQGGFGTVYKGVL-----------------------PDGREIAVKRLFFNNRHR--AAN 355
LGQG +Y G L +GRE+ V + HR A
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 356 FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
F+ +++S V H +L + G G E+++V EF+ + LD + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-------KIADFGL---ARSF 465
+ L YL +++ ++H ++ A NILL A K++D G+ A S
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 466 QEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEI 509
+E I ++APE + G L+ AD +SFG LLEI
Sbjct: 178 EERVERIP--------WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
E ++ + ++ +HRDIK N+LLD ++ADFG D + S GT Y
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169
Query: 483 MAPEYL-----AHGQLTEKADVYSFGMLLLEIVTG 512
++PE L G+ + D +S G+ + E++ G
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 51/280 (18%), Positives = 106/280 (37%), Gaps = 53/280 (18%)
Query: 329 VYKGVLPDGREIAVKRL-FFNNRHRAA--NFYNEVNIISSVEHKNLVRLLG----CSCSG 381
+YKG+ + +E+ ++ F+ H+ NE+ + ++ N++++ G
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI 441
P L+ E+ L + K K L+++ + ++ + +GL L+ ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149
Query: 442 KASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADV 499
+ + L+ + KI GL + + Y + + L + T K D+
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDI 205
Query: 500 YSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH---DS 556
YS G++L EI TG +N E+YD ++ N
Sbjct: 206 YSLGVVLWEIFTG--KIPFENLTTK-----------------EIYD-LIINKNNSLKLPL 245
Query: 557 N----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
+ +K V CT + RP + +L L+
Sbjct: 246 DCPLEIKCIVEA-------CTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 42/123 (34%)
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ--------EDKSHI------------ 472
K+ IHRDIK NIL+D K+ DFGL F+ + H
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 473 ----------------------STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIV 510
+ ++ GT Y+APE L T+ D +S G++L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 511 TGR 513
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 34/112 (30%), Positives = 48/112 (42%), Gaps = 29/112 (25%)
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL------------------- 461
TV L YLH I+HRD+K N+L+ S K+ DFGL
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 462 -ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
R F DK + GT Y+APE + + D ++ G++L E + G
Sbjct: 167 DTREFL-DKQ-----VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 62/253 (24%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 314 SFDEANKLGQGGFGTVY----KGVLPDGREIAVKRL------FFNNRHRAANFYNEVNII 363
F + LG+G G V+ KG G+ A+K L N R E I+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLT---EQEIL 55
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE--KRY--EIIL 419
++++H L L + LV ++ P L R + K L+ E + Y E++L
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFYAAEVLL 114
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILL-------------------DSRLRAKIADFG 460
L YLH I++RD+K NILL + +K G
Sbjct: 115 A----LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 461 LARSFQ-----EDKSHISTAIA----GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
RS E S + + GT Y+APE ++ D ++ G+LL E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 512 GRQNNRSKNSEYT 524
G + N + T
Sbjct: 228 GTTPFKGSNRDET 240
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 321 LGQGGFGTVYKGVLPD-----------GREIAVKRLFFNNRHR--AANFYNEVNIISSVE 367
LG+G +Y G+L +EI V + HR + F+ +++ V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
HK++V L G E+++V EF+ LD F+ + T W ++++ L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 428 LHEQSKIRIIHRDIKASNILL-------DSRLRAKIADFGL---ARSFQEDKSHISTAIA 477
L ++ ++H ++ NILL + K++D G+ S QE I
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP---- 173
Query: 478 GTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEI 509
++APE + + L+ AD +SFG L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 58/254 (22%), Positives = 98/254 (38%), Gaps = 66/254 (25%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFNN---RHRAANFYNEVNIISSVEHKN 370
F + LG G FG V D + + A+K L + R++ A+ E +I++ +++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRF-----IFDSAKAKTLTWEKRYEIILGTVEGL 425
+VRL V +++P + IF A+ E + VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-----LTCAVESV 117
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ------------------- 466
K+ IHRDIK NIL+D K+ DFGL F+
Sbjct: 118 ------HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 467 ------EDKSH---------------------ISTAIAGTLGYMAPEYLAHGQLTEKADV 499
D ++ ++ ++ GT Y+APE L T+ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 500 YSFGMLLLEIVTGR 513
+S G++L E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 34/146 (23%), Positives = 55/146 (37%), Gaps = 15/146 (10%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV--RLLGC 377
L G VY D +K +R + A+ EV I+ + K L ++L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLK--INPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
S S L+ E++ ++LD + E E + L LH+ + +
Sbjct: 62 GESDGWSYLLMEWIEGETLD-------EVSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111
Query: 438 HRDIKASNILLDSRLRAKIADFGLAR 463
H D+ NIL+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH + I+ RD+ +NILLD R ++ F ++ S A+ Y APE
Sbjct: 101 LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENM--YCAPEV 153
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR 513
+ TE D +S G +L E++TG+
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 40/217 (18%)
Query: 321 LGQGGFGTVY----------------KGVLPDGREIAVKRLFFNN---RHRAANFYNEVN 361
+G GGFG VY K + I ++ L +NN + A + N N
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK--AKTLTWEKRY--EI 417
I +H + + GC S + Y F+ L++ + ++ + + K+ I
Sbjct: 80 I----DHLGIPKYYGCG-SFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+ + L Y+HE I H DIK NI++D R I D+G+A F HI +
Sbjct: 132 MKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 478 ------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
GTL Y + +T + D+ S G +L+
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 68/255 (26%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRLFFN---NRHRAANFYNEVNIISSVEHKN 370
F + LG G FG V D + A+K L NR++ A+ E +I++ +++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 371 LVRLLGCSCSGPESL-LVYEFLPNQSLDRF-----IFDSAKAKTLTWEKRYEIILGTVEG 424
+V+L S ++L V +++P + +F A R+ I E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA-------RFYI----AEL 110
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ--------EDKSHI---- 472
+ + K+ IHRDIK NIL+D K+ DFGL F+ + SHI
Sbjct: 111 TLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 473 ----------------------------------STAIAGTLGYMAPEYLAHGQLTEKAD 498
+ ++ GT Y+APE L T+ D
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 499 VYSFGMLLLEIVTGR 513
+S G++L E++ G+
Sbjct: 231 WWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 50/202 (24%), Positives = 74/202 (36%), Gaps = 67/202 (33%)
Query: 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV------EGLVYLHEQSKIRIIHR 439
L+ EFLP L +T +Y+ V E ++ + K+ IHR
Sbjct: 78 LIMEFLPGGDL------------MTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 440 DIKASNILLDSRLRAKIADFGLARSFQE-------------------------------- 467
DIK NIL+D K++DFGL+ F +
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 468 ----DKSHIST----------AIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTG 512
K I+T + GT Y+APE +L G E D +S G ++ E + G
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFECLIG 244
Query: 513 RQNNRSKNSEYTDSLLTITWKH 534
S+NS T + I W+
Sbjct: 245 WPPFCSENSHETYRKI-INWRE 265
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 320 KLGQGGFGTVYKGVL---PDGREIAVKRLFFNNRHRAAN-FYNEVNIISSVEHKNLVRLL 375
++G G FG V + + VK L N + N F + + ++H N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDS----AKAKTLTWEKRY-EIILGTVEGLVYLHE 430
G LLV+E+ L ++ ++ L ++ EI G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTHMH- 116
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHISTAIAGTLGYMAPEYLA 489
K +H D+ N L S L K+ D+G+ S ++ED L ++APE +
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 490 --HGQL-----TEKADVYSFGMLLLEI 509
HG L T+ ++V++ G+ L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 19/109 (17%)
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD----FGLARSFQEDKS-- 470
I+ G + GL YLH+ IHR+IKAS+IL+ ++ + L R+ Q+ K
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 471 ---HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGR 513
ST++ L +++PE L +G K+D+YS G+ E+ TGR
Sbjct: 163 DFPQFSTSV---LPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 43/183 (23%), Positives = 66/183 (36%), Gaps = 56/183 (30%)
Query: 319 NKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
KLG+G FG VYK L + + +K+ A Y V I + + + R
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---------ATEYGAVEIWMN---ERVRR 185
Query: 374 LLGCSCS--------------GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
SC+ E LV+ + +L D ++K + +L
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTL----ADLMQSKEFPYNVE-PYLL 240
Query: 420 GTVEGLVY-LHEQSKI------------------RIIHRDIKASNILLDSRLRA-KIADF 459
G V+ L L ++KI I+HRD+K NI+ + KI D
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 460 GLA 462
G A
Sbjct: 301 GAA 303
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 22/114 (19%)
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----------------LRAKIADF 459
+II T L Y H +++ ++H D+K NIL+++ R +I D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
G D+ H TAI T Y +PE + D++S G ++ E+ TG+
Sbjct: 293 GGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 33/164 (20%), Positives = 60/164 (36%), Gaps = 35/164 (21%)
Query: 318 ANKLGQGGFGTVYKGVLPDGREIAVK---------------RLFFNNRHRAANFYNEVNI 362
K+G G VY + P GR++AVK R + ++ + Y V+
Sbjct: 96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLY--VSR 153
Query: 363 ISS-VEHKNLVRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
+++ E + L RL P+ + +V E++ L R + ++
Sbjct: 154 LAAEREFEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYR-----LRLDVENPDEIL 208
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
+ IL V I+H D+ NIL+ + D+
Sbjct: 209 DKILEEVRKAYRRG------IVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 17/39 (43%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463
L YLH IIHRD+K N+L+ + K+ DFGL++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 28/89 (31%), Positives = 39/89 (43%), Gaps = 18/89 (20%)
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILL--DSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
++ L L E HR K+ NILL D L+ G +F+ +
Sbjct: 24 LQCLGALREL------HRQAKSGNILLTWDGLLKL----DGSV-AFKTPEQSRPDPY--- 69
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLE 508
+MAPE + TEKAD+YS G+ L E
Sbjct: 70 --FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 642 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.08 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.2 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.19 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.14 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.11 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.07 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.9 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.89 | |
| PLN02236 | 344 | choline kinase | 96.84 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.3 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.69 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.6 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.54 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.51 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.48 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.26 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.16 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 94.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.93 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.49 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-57 Score=470.20 Aligned_cols=290 Identities=46% Similarity=0.734 Sum_probs=254.5
Q ss_pred CCCCcChhhHHHHcCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeee
Q 006514 299 DSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378 (642)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 378 (642)
....|++.++..+|++|+..+.||+|+||.||+|.+++|..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45569999999999999999999999999999999999999999988655433145699999999999999999999999
Q ss_pred ccCCC-ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEE
Q 006514 379 CSGPE-SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (642)
Q Consensus 379 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 457 (642)
.+.++ .+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99995 99999999999999999875443 89999999999999999999999998899999999999999999999999
Q ss_pred ecCCccccCC-CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh
Q 006514 458 DFGLARSFQE-DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 458 DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
|||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|+++.+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999976554 22221111 799999999999999999999999999999999999998887665555668999999999
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.+.+.+++|+.+....+ ....++.++.+++++|++.+|.+||+|.||+++|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~---~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEY---PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCC---ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999998763211 1126888899999999999999999999999999553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=389.52 Aligned_cols=253 Identities=33% Similarity=0.503 Sum_probs=204.4
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-CceEEEeecC
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-ESLLVYEFLP 392 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~ 392 (642)
...+.||+|+||+||+|.+.....||||++.... ....++|.+|+.+|.+++|||||+++|++.+.. ...|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445699999999999999644449999986543 222568999999999999999999999999988 7999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-cEEEEecCCccccCCCCCc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 471 (642)
+|+|.++++.. ....+++..+++|+.+||+||.|||++++ ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999764 46789999999999999999999999874 99999999999999998 99999999998765432 2
Q ss_pred ccccccCCccccChhhhc--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 472 ISTAIAGTLGYMAPEYLA--HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
..+...||+.|||||++. ...|+.|+|||||||+||||+||+.||..... ...+......+....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~------ 267 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPI------ 267 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCC------
Confidence 223368999999999999 66999999999999999999999999976543 1111111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
+.. ....+..++.+||+.||+.||++.+++..|+.
T Consensus 268 -----p~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 268 -----PKE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred -----Ccc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 111 22344556668999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=388.81 Aligned_cols=253 Identities=30% Similarity=0.481 Sum_probs=210.4
Q ss_pred ccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+...++||+|-||.||.|.++....||+|.+... ....+.|.+|+++|.+|+|+|||+++|+|..+..++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456789999999999999987779999998654 455678999999999999999999999999988999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 474 (642)
+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+......
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999976 34678999999999999999999999998 999999999999999999999999999966666655555
Q ss_pred cccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...... .+.+.++....+..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp~- 425 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLPR- 425 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCCC-
Confidence 5566789999999999999999999999999999999 77775543211 12233333333222
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
+...+. .+.+++..||+.+|++|||++.+...|+..
T Consensus 426 -P~~CP~---~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 426 -PEGCPD---EVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -CCCCCH---HHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 122222 345677899999999999999999888763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=384.37 Aligned_cols=249 Identities=29% Similarity=0.435 Sum_probs=210.4
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
..|...+.||+|||+.||.++. ..|+.||+|++... +....+.+.+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999996 78999999999653 4555677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
|++.+++|..++. +++.+++.++..+..||+.||.|||+++ |||||||..|+||++++++||+|||||.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999983 5689999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. ...+.+|||.|+|||++.....+..+||||+||+||-||.|++||+...- .+.++...
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------------------kety~~Ik 231 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------------------KETYNKIK 231 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------------------HHHHHHHH
Confidence 33 23568999999999999999999999999999999999999999976421 11111111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
..+...+.....++. +|+..+|+.||.+|||+++|+.+=
T Consensus 232 ~~~Y~~P~~ls~~A~---dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAK---DLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred hcCcccccccCHHHH---HHHHHHhcCCcccCCCHHHHhcCH
Confidence 111111233444444 455588999999999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.24 Aligned_cols=250 Identities=30% Similarity=0.429 Sum_probs=202.7
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-CceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-ESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 391 (642)
++..+.||+|..|+|||+.++ +++.+|+|++... +....+++.+|++++.+.+||+||+++|.|.... +..|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 444678999999999999975 6888999999543 5566678999999999999999999999999988 499999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
.+|+|++++.. .+.+++...-+|+.++++||.|||+ .+ ||||||||+||||+..|++||||||.+......
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999843 3679999999999999999999996 54 999999999999999999999999999876554
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
...+.+||..|||||.+++..|+.++||||||+.++|+.+|+-|+....+.... +.++++.....
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~--------------~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD--------------IFELLCAIVDE 297 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC--------------HHHHHHHHhcC
Confidence 345689999999999999999999999999999999999999998765222111 11111111111
Q ss_pred cccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.++. +.. .-...+..++-.||++||.+||++.|+++|
T Consensus 298 ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 PPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1100 111 112234456668999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=360.06 Aligned_cols=201 Identities=33% Similarity=0.547 Sum_probs=182.0
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.++|...++||+|.||+||+|+++ ++.+||||.+... .++..+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367889999999999999999964 6899999999765 5666777899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC------CcEEEEecCCc
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR------LRAKIADFGLA 462 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DfGla 462 (642)
|||.+|+|.++|+. .+.+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 458999999999999999999999998 9999999999999765 46899999999
Q ss_pred cccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
+..... ....+.+|++-|||||+++.++|+.|+|+||.|+|||||++|+.||....
T Consensus 163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 987743 33456899999999999999999999999999999999999999997544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=364.51 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=201.8
Q ss_pred HcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC-------hhhHHHHHHHHHHHhcCCccceeeeeeeeccCC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN-------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 382 (642)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||.+.... ......+.+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688889999999999999995 589999999986432 112234679999999999999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC---CcEEEEec
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADF 459 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~Df 459 (642)
..||||||++||.|.+.+. ..+.+.+..-.-++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999984 4566777788889999999999999999 9999999999999766 78999999
Q ss_pred CCccccCCCCCcccccccCCccccChhhhccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh
Q 006514 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 460 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
|+|+..+. .....+.+||+.|.|||++.... +..++|+||+|||||-+++|.+||.....+.. +. +...
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQIL 395 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHHh
Confidence 99998763 33456789999999999998654 34488999999999999999999976543220 10 1111
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.++ ....+ ..-.....+.++++-++|..||++|||+.|+++|
T Consensus 396 ~G~--------y~f~p---~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGR--------YAFGP---LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCc--------ccccC---hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111 11111 1112223345566779999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=393.41 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=210.6
Q ss_pred CCccccccccccCceEEEEEEcC------CCcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
.+....++||+|.||+||+|... +...||||.++..... ...+|.+|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45677789999999999999842 3467999999766544 7789999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-------c----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 386 LVYEFLPNQSLDRFIFDSA-------K----AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
||+|||..|+|.+||.... . ..+|+..+.+.|+.|||.||.||-++. +|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996321 1 233889999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006514 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 455 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 532 (642)
||+||||++..-..+.+ ....-.-+.+|||||.+..++||++||||||||+|||++| |+.|+.....++. -
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------I 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------I 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------H
Confidence 99999999976544443 3323445779999999999999999999999999999999 8888765433211 1
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ 595 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 595 (642)
.....+++ ++. ++.-...+..|++.||+.+|++||+++||-..|+....
T Consensus 716 e~i~~g~l---------L~~-----Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQL---------LSC-----PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCc---------ccC-----CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11222222 111 11223456678889999999999999999999987544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=343.70 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=207.4
Q ss_pred CCccccccccccCceEEEEEE-cCCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeee-eeccCCC-ceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLG-CSCSGPE-SLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 387 (642)
.+|.+.++||+|.||+|||+. +.+|..+|.|.+... +.+..+....|+.+|++|+|||||++++ .+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 358888999999999999999 578999999988643 4556678999999999999999999998 4445555 7899
Q ss_pred EeecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 388 YEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSK-IRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
|||+..|+|..++.... ..+.++++..|+++.|++.||.++|++-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999997643 34678999999999999999999998531 13999999999999999999999999999988
Q ss_pred CCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
..... .....+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||... ++.... +....+....+
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~-~KI~qgd~~~~-- 248 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLC-KKIEQGDYPPL-- 248 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHH-HHHHcCCCCCC--
Confidence 76544 345689999999999999999999999999999999999999999865 222221 22222221111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. + .....++-.++..|+..||+.||+...++..+..
T Consensus 249 ---p-----~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 ---P-----D---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---c-----H---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 0 1 2233455567778999999999996666655544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=381.54 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=213.2
Q ss_pred ccccccccccCceEEEEEEcC----CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 315 FDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
..+.+.||.|.||.||+|.++ ....||||.|+... +....+|+.|+.||.+++||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 466788999999999999975 23569999997664 4556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
||+||+|+.||+. +.+.+++.++..+..+||.||.||-+.+ +|||||.++||||+.+..+|++|||+++...++.
T Consensus 711 yMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999965 4467999999999999999999999999 9999999999999999999999999999776655
Q ss_pred Ccccccc--cCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 470 SHISTAI--AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 470 ~~~~~~~--~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
....++. .-+.+|.|||.+...++|.+||||||||+|||.++ |.+|+..... .++..-++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHHHHHHHh
Confidence 3333333 23568999999999999999999999999999988 8888754322 222223333
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 597 (642)
...+++ +.+-...+.+|++.|||+|-.+||.+.+|+.+|++....|
T Consensus 850 gyRLPp-----PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 850 GYRLPP-----PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ccCCCC-----CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 333222 2233456778999999999999999999999998865544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=342.98 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=202.9
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
.++|+..+.||+|+||+||.++.+ +++.+|+|++.+. .....+....|..+|.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367999999999999999999954 6888999998654 334567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+||+.||.|..+| .+.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 45578999999999999999999999999 99999999999999999999999999996544
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... .+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+..... +.+....
T Consensus 178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~---------------~~I~~~k 241 (357)
T KOG0598|consen 178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY---------------DKILKGK 241 (357)
T ss_pred CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH---------------HHHhcCc
Confidence 433 234589999999999999999999999999999999999999999765422110 1111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP----TMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP----s~~evl~~ 589 (642)
+. ..+.....+... ++...++.||++|. .+.+|-+|
T Consensus 242 ~~---~~p~~ls~~ard---ll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 LP---LPPGYLSEEARD---LLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CC---CCCccCCHHHHH---HHHHHhccCHHHhcCCCCChHHhhcC
Confidence 11 112223334444 44477899999995 56666544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.72 Aligned_cols=269 Identities=22% Similarity=0.330 Sum_probs=205.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
+.|+...++|+|+||.|||++.+ +|+.||||++..+. +...+-.++|+.+|++++|+|+|.|+.+|.....+.||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999976 69999999985443 3444567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|++..-|+++= .....++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.... .
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 99886666543 23456889999999999999999999998 99999999999999999999999999998775 3
Q ss_pred CcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc-
Q 006514 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN- 547 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~- 547 (642)
....+..+.|.+|.|||.+.+ .+|...+||||.||++.||++|.+.|.+..+-+.-.++......+.+ +-.+++...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p-rhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP-RHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH-HHHHHhccCC
Confidence 344567889999999999887 78999999999999999999999888665543332222222111110 001111110
Q ss_pred ----ccccccC-----CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 ----LMLHNYH-----DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ----~~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..+... +........-+++++..|++.||++|++-++++.|
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0000000 01111122245678889999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.68 Aligned_cols=270 Identities=27% Similarity=0.374 Sum_probs=205.6
Q ss_pred CCccccccccccCceEEEEEE-cCCCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 387 (642)
+.|+.+++||+|.||.|||++ ..+|+.||+|++.... .....-..+||.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457788899999999999999 4689999999997664 44455678999999999999999999988776 678999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+|||++ +|.-++.. ..-.++..++..++.|++.||.|+|+++ |+|||||.+|||||.+|.+||+|||||+.+..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 67776632 3457999999999999999999999999 99999999999999999999999999998887
Q ss_pred CCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhhhcC
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------TWKHFQAG 538 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~ 538 (642)
......+..+-|.+|.|||.+.+. .|+.+.|+||.||||.||++|++.+....+-.+...+.. .|+... -
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k-L 349 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK-L 349 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc-C
Confidence 776667778899999999999875 699999999999999999999998877654333221111 122000 0
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.....+.+.........+.........++|.-.+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000111111100000000000111233455556778899999999999976
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=354.06 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=210.4
Q ss_pred CCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
..|....+||+|..|.||.+. ..+++.||||++........+-+++|+.+|+..+|+|||++++.+...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346777899999999999998 4578999999998887777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++|+|.+++ ....+++.++..|..++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+......
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999998 3345999999999999999999999999 999999999999999999999999999887776654
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
..+.+|||.|||||++....|..|.||||||++++||+-|++||-...+ +...|.....+... +
T Consensus 426 -R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~P~-l-------- 489 (550)
T KOG0578|consen 426 -RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTPK-L-------- 489 (550)
T ss_pred -cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCCCC-c--------
Confidence 3457899999999999999999999999999999999999999865332 12222222222211 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+-++..+||+.||++||++.|+|+|
T Consensus 490 ----k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 ----KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1122222334456679999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=342.11 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=203.0
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC--CceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP--ESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e 389 (642)
.++...+.||+|.||.||++... +|+..|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999965 48999999886654344677899999999999999999999855555 5889999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-CCcEEEEecCCccccCC-
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQE- 467 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~- 467 (642)
|+++|+|.+++..... .+++..+..+..||++||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999955332 7999999999999999999999998 999999999999999 79999999999987764
Q ss_pred -CCCcccccccCCccccChhhhccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 468 -DKSHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 468 -~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
..........||+.|||||++..+. ...++|||||||++.||+||++||..... . ..+...........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--~---~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--E---AEALLLIGREDSLP---- 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--h---HHHHHHHhccCCCC----
Confidence 2222334578999999999999643 33599999999999999999999865310 0 01111111111001
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 597 (642)
..+.....+. .+++..|++.||++|||+.++++|.......+
T Consensus 243 -------~ip~~ls~~a---~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 -------EIPDSLSDEA---KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -------CCCcccCHHH---HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 1122233333 45667899999999999999999976544443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=349.30 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=213.5
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 387 (642)
.+|...+.||+|.|++|++++. ..++++|||++.+. .+...+-+..|-+.|.+| .||.|++|+-.|.+...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 5788899999999999999995 47899999998543 233344567899999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+||.++|+|.++|. +-+.+++.....++.+|+.||+|||+.| ||||||||+|||||+||++||+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999995 4478999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCc----------cc--ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhh
Q 006514 468 DKSH----------IS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535 (642)
Q Consensus 468 ~~~~----------~~--~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 535 (642)
.... .. ...+||..|.+||++.++..+..+|||+||||||+|+.|++||...++-.. ++
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-------Fq-- 297 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-------FQ-- 297 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-------HH--
Confidence 3221 12 457999999999999999999999999999999999999999987654211 11
Q ss_pred hcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc-------CCCCCCCCCCCccc
Q 006514 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT-------EEQLPGPTSPPFID 606 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~-------~~~~~~p~~p~~~~ 606 (642)
.+++-.... .....+.+.. |+...|..||.+|+|..+|-+|... +.+.+.|...||..
T Consensus 298 ------kI~~l~y~f----p~~fp~~a~d---Lv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p 362 (604)
T KOG0592|consen 298 ------KIQALDYEF----PEGFPEDARD---LIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKP 362 (604)
T ss_pred ------HHHHhcccC----CCCCCHHHHH---HHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCC
Confidence 111111111 2222334444 4446778999999999999998642 34555666666643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=337.91 Aligned_cols=263 Identities=27% Similarity=0.359 Sum_probs=208.1
Q ss_pred cCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.+.|+..+.||.|..++||+|. .+.++.||||++.... ....+.+.+|+..+..++||||++++.+|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3679999999999999999999 5678999999996543 3346889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
||.+|++.+++..... ..+++..+..|..++++||.|||++| .||||||+.||||+++|.+||+|||....+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999976544 34899999999999999999999999 9999999999999999999999999877654433
Q ss_pred Cc--cc-ccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 470 SH--IS-TAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 470 ~~--~~-~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.. .. .+.+||+.|||||+++. ..|+.|+||||||+...||.+|+.||....+-. .....+. +....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLq-n~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQ-NDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhc-CCCCCcc
Confidence 22 12 56799999999999653 469999999999999999999999998654311 1111111 1111111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
...+. .+.....-..+.+++-.||+.||++|||+++++++-
T Consensus 254 t~~~~-----~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 254 TSGLD-----KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cccCC-----hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 00000 111111222456777889999999999999999763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=347.34 Aligned_cols=270 Identities=23% Similarity=0.310 Sum_probs=207.6
Q ss_pred HcCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHH--HHHHHHHHhcCC-ccceeeeeeeeccCC-Cce
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN--FYNEVNIISSVE-HKNLVRLLGCSCSGP-ESL 385 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~ 385 (642)
..++|...++||.|.||.||+|+ ..+|+.||||+++..- ..+++ =++|+..|++++ ||||++|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678899999999999999999 4578999999885432 22333 367999999998 999999999999888 899
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+||||| ..+|.+++.++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+..
T Consensus 87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999999 56899999664 689999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccccCCccccChhhhc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHH-----HHhhhcC-
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT-----WKHFQAG- 538 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~- 538 (642)
..... .+..+.|.+|.|||++. .+-|+.+.|||++|||++|+.+-++.|-+..+-++...+--+ +..|..+
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 65544 35678999999999875 577999999999999999999999888665543222111111 1111111
Q ss_pred cchhhccccccccccCCC----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 539 RVEELYDKNLMLHNYHDS----NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
.+...+.-.+ ...... -......++++++..|+++||.+|||+.|.++|-.
T Consensus 239 ~La~~mnf~~--P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 239 NLASAMNFRF--PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHhccCC--CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 0111111000 000011 11123456678888999999999999999999853
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=314.87 Aligned_cols=281 Identities=27% Similarity=0.370 Sum_probs=212.1
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChh--hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.+|...++||+|.||.||+|++ .+|+.||||++...+.. -.....+|++.|+.++|+||+.|++++...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999994 58999999999765322 23457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
||+ .+|...+.+ +...++......++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 489888855 4568899999999999999999999999 9999999999999999999999999999987655
Q ss_pred CcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhc---Ccchhhc-
Q 006514 470 SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA---GRVEELY- 544 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~- 544 (642)
... +..+.|.+|.|||.+.+. +|+...||||.|||+.||+-|.+-|.+..+-+ ++ ...+..+.. ..+.++.
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL-~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QL-SKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HH-HHHHHHcCCCCcccCccccc
Confidence 432 233789999999998874 69999999999999999999877665543322 22 222222211 1111111
Q ss_pred -----cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCc
Q 006514 545 -----DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPF 604 (642)
Q Consensus 545 -----d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p~~p~~ 604 (642)
+-.....+.............+++...++..||.+|+|++|.++|=- ..+.|.|+.|.-
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y-f~~~P~pt~~~~ 295 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY-FKSLPLPTPPSK 295 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh-hhcCCCCCChhh
Confidence 10000000001112223344577888999999999999999998732 233565554433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=349.12 Aligned_cols=241 Identities=27% Similarity=0.439 Sum_probs=195.3
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCC
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 395 (642)
...+.||+|+.|.||+|++. ++.||||++..-+ ..+|+.|++|+||||+.+.|+|...+-++|||||++.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34567999999999999995 7899999873211 247889999999999999999999999999999999999
Q ss_pred hhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 006514 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475 (642)
Q Consensus 396 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 475 (642)
|.++|. ....+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++...... ....
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMS 270 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMS 270 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhh
Confidence 999994 4567888999999999999999999997 9999999999999999999999999988665442 2345
Q ss_pred ccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCC
Q 006514 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHD 555 (642)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 555 (642)
+.||..|||||++...+.++|+|||||||||||||||..|+........ .|.. .. +...+ +.+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGV-Gs-NsL~L---------pvP 333 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGV-GS-NSLHL---------PVP 333 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEec-cC-Ccccc---------cCc
Confidence 7899999999999999999999999999999999999999865432211 1110 00 00001 112
Q ss_pred CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 556 SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 556 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
....+... -|+.+||+..|.+||++++|+.||+-
T Consensus 334 stcP~Gfk---lL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 334 STCPDGFK---LLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCchHHH---HHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 22222332 34558999999999999999999976
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=372.61 Aligned_cols=257 Identities=29% Similarity=0.469 Sum_probs=206.3
Q ss_pred cCCccccccccccCceEEEEEEcC--CCc----EEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCc
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP--DGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~--~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 384 (642)
..+.+..+.||+|.||.||+|... +|. .||||.+... +.+...+|++|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667788999999999999954 343 4899988654 567778999999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 385 LLVYEFLPNQSLDRFIFDSA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
+|++|||++|+|..||.+.+ ....+....++.++.+||+|+.||+++. +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 1457899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcC
Q 006514 461 LARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAG 538 (642)
Q Consensus 461 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 538 (642)
||+........ ......-+..|||||.+..+.++.|+|||||||+|||++| |..|+....... +...+..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhC
Confidence 99954443333 2222244578999999999999999999999999999999 778876543211 11111111
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ++.. +... ..++.++++.||+.+|++||++..|++.+..
T Consensus 921 g-------RL~~----P~~C---P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 921 G-------RLDP----PSYC---PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred C-------ccCC----CCCC---ChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 1 1110 1222 2355688899999999999999999998766
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.47 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=200.4
Q ss_pred cCCccccccccccCceEEEEEEc------CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcC-CccceeeeeeeeccC-C
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG-P 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 382 (642)
.++|++.++||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999973 235689999986432 33456789999999999 899999999987764 4
Q ss_pred CceEEEeecCCCChhhhhhcccc---------------------------------------------------------
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAK--------------------------------------------------------- 405 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 405 (642)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864211
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccCCccc
Q 006514 406 --AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGY 482 (642)
Q Consensus 406 --~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y 482 (642)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788999999999999999999998 999999999999999999999999999865433222 22234567889
Q ss_pred cChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHH
Q 006514 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYE 561 (642)
Q Consensus 483 ~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 561 (642)
+|||++.+..++.++||||||++||||++ |..||....... . .......+.... . ... .
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~~---------~--~~~---~ 302 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRMR---------A--PEN---A 302 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCCC---------C--CCC---C
Confidence 99999999999999999999999999997 999986533211 0 111111111000 0 111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 562 VLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 562 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
...+.+++..||+.||++|||+.||++.|+.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2245678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=345.50 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=203.9
Q ss_pred HHHcCCccccccccccCceEEEEEEcCCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 309 EKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 309 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
+...+.+...+.||+|.||+||+|.|. ..||||++... ..+..+.|++|+..+++-+|.||+-+.|++.+.+. .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333445667789999999999999985 47999999654 45677899999999999999999999999988877 99
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
|+.++++.+|..+|+.. ...++..+.+.|+.||++||.|||.++ |||||||..||+|.+++.|||+||||+....
T Consensus 465 iTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 99999999999999754 367899999999999999999999998 9999999999999999999999999997644
Q ss_pred CCCCc-ccccccCCccccChhhhcc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 467 EDKSH-ISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
..... ......|...|||||+++. .+|+..+||||||+++|||++|..|+.....+.. + |.-++-.-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---i------fmVGrG~l 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---I------FMVGRGYL 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---E------EEeccccc
Confidence 32211 1223457889999999975 4699999999999999999999999984333211 1 11111100
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
..|.... ......++ .+|...||..++++||.+.+|+..|+..
T Consensus 611 ~pd~s~~-----~s~~pk~m---k~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 611 MPDLSKI-----RSNCPKAM---KRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred Cccchhh-----hccCHHHH---HHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 0111000 12233344 4556689999999999999999977663
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=341.62 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=207.4
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. .++..+.+.+|++++++++||||+.++++++...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999965 6788999988654 34556779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+.+ +|..+| ...+.++++....++.+++.||.|||+.. |+|||+||.|||++.++.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 999999 44578999999999999999999999997 9999999999999999999999999999887643
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
...+.+.|||-|||||...++.|+..+|+||+|||+||+++|++||.... +.+++...+.
T Consensus 155 -~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------------------i~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------------------ITQLVKSILK 214 (808)
T ss_pred -eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------------------HHHHHHHHhc
Confidence 34567899999999999999999999999999999999999999986421 1111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.. ...+......++.+....+++||.+|.|..+++.|-
T Consensus 215 d~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 215 DP---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CC---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 11 111123334556666788999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=336.86 Aligned_cols=276 Identities=30% Similarity=0.425 Sum_probs=203.1
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhc--CCccceeeeeeeeccCC----CceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISS--VEHKNLVRLLGCSCSGP----ESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~l 386 (642)
......+.||+|.||.||||++. ++.||||++. .+..+.|.+|-++++. ++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 45566788999999999999995 5999999984 4556778888888875 48999999999877665 8899
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ------SKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
|+||.+.|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 457899999999999999999999964 36789999999999999999999999999
Q ss_pred CccccCCCCCc-ccccccCCccccChhhhccCC-CC-----CcchHHHHHHHHHHHHhCCCCCCC-CCCcccchhHHHHH
Q 006514 461 LARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQ-LT-----EKADVYSFGMLLLEIVTGRQNNRS-KNSEYTDSLLTITW 532 (642)
Q Consensus 461 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDv~S~Gvll~elltG~~p~~~-~~~~~~~~l~~~~~ 532 (642)
+|..+...... .....+||.+|||||++.+.- +. .+.||||+|.|||||++....... ..++.....-..+-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988755443 223478999999999997642 32 368999999999999998765542 22222211111111
Q ss_pred HhhhcCcchhhccccccccccCCC-CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDS-NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQL 596 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 596 (642)
.+..-+.+.+++-..-..+.+.+. .....+..+.+.+-.||+.||+.|.|+.=|-+.+.....+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111111111111111110000010 1113355566778899999999999999998887664443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=343.64 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=204.9
Q ss_pred HHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc----Ch-hhHHHHHHHHHHHhcCC-ccceeeeeeeeccCC
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN----NR-HRAANFYNEVNIISSVE-HKNLVRLLGCSCSGP 382 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 382 (642)
...++|...+.||+|.||+|+.|.. .+|+.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999985 47899999966442 11 23456778999999998 999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCC
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGL 461 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGl 461 (642)
..++||||+.+|+|.+++.+ .+.+.+.....++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 467888999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ-LT-EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...... ..... ...+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~k-i~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRK-IRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHH-HhcCC
Confidence 99874 2223446789999999999999877 86 7899999999999999999999863211 11111 11111
Q ss_pred chhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 540 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
... +.... ...+..++.+|++.||.+|+|+.+|+++=
T Consensus 240 --------~~~----p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 240 --------FKI----PSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred --------ccC----CCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 110 11110 33455677799999999999999999653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.86 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=199.4
Q ss_pred CCccccccccccCceEEEEEEcCC-----------------CcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD-----------------GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRL 374 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 374 (642)
++|...++||+|+||.||++.+++ +..||+|.+... ......+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 346999988654 33445679999999999999999999
Q ss_pred eeeeccCCCceEEEeecCCCChhhhhhccc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 006514 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSA----------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438 (642)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH 438 (642)
++++...+..++||||+++|+|.+++.... ....++|...++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1235788999999999999999999998 999
Q ss_pred eccCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhC--CCC
Q 006514 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG--RQN 515 (642)
Q Consensus 439 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG--~~p 515 (642)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 22334567899999999989999999999999999999974 455
Q ss_pred CCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 516 NRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 516 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
+...... .........+.... ... . ...... ....+.+++.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~-~~~-----~--~~~~~~---~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQG-RQV-----Y--LFRPPP---CPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcc-ccc-----c--ccCCCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5433211 11111111111100 000 0 000111 1234567888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.22 Aligned_cols=261 Identities=30% Similarity=0.448 Sum_probs=203.6
Q ss_pred HcCCccccccccccCceEEEEEEcC--CC--cE-EEEEEeec---cChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP--DG--RE-IAVKRLFF---NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 382 (642)
...+....++||+|.||.||+|.+. ++ .. ||||.... .......+|.+|+++|++++|||||+++|+.....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3455666789999999999999964 22 23 89998874 34677889999999999999999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
.+++|||+++||+|.++|... ...++..+++.++.+.|.||+|||+++ +|||||.++|+|+..++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999543 236999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcch
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
+........ .....-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...... .+...+ ...+
T Consensus 310 ~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~--- 379 (474)
T KOG0194|consen 310 RAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNG--- 379 (474)
T ss_pred cCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcC---
Confidence 764411111 112235678999999999999999999999999999999 77777654321 110100 0111
Q ss_pred hhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 597 (642)
.... .+...+.++. .+...||..+|++||+|.+|.+.|+......
T Consensus 380 ------~r~~--~~~~~p~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 380 ------YRMP--IPSKTPKELA---KVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ------ccCC--CCCCCHHHHH---HHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 0000 0222333333 3444899999999999999999998854433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.86 Aligned_cols=245 Identities=17% Similarity=0.307 Sum_probs=194.2
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChh---hHHHHHHHHHHHhcCCccceeeeeeeecc----CCCceEEEee
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKNLVRLLGCSCS----GPESLLVYEF 390 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 390 (642)
...||+|++|.||+|.+ +|+.||||++...... ..+.|.+|+.++.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 6899999998654322 24678899999999999999999999876 3467899999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++|+|.+++.. ...+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999953 35789999999999999999999985 5 7899999999999999999999999998654322
Q ss_pred CcccccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+... ...... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~----i~~~~~------~ 240 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDL----IINKNN------S 240 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHH----HHhcCC------C
Confidence 23467899999999976 68999999999999999999999999754321 11111 100000 0
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.. . +..... .+.+++.+||+.||++|||+.||++.|+..
T Consensus 241 ~~---~-~~~~~~---~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 LK---L-PLDCPL---EIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC---C-CCcCcH---HHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 0 111122 355677799999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.87 Aligned_cols=269 Identities=22% Similarity=0.282 Sum_probs=202.0
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 67889999986432 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|++++.+..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 2356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHH----------HHhhhcC-
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT----------WKHFQAG- 538 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~----------~~~~~~~- 538 (642)
........|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+.... +..+...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHHHHhhhccc
Confidence 333334578999999999998899999999999999999999999987543211 111110 0000000
Q ss_pred cchhhccccccccc-cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEELYDKNLMLHN-YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~~~d~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.......+...... ............+.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 0000000012346778889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=310.65 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=180.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.+|+..+.||.|+||.|.+++.+ +|..+|+|++.... ..+.+...+|..+|+.+.||.++++.+.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888899999999999999965 68889999996553 344566789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|.|..+|+ +.+.+++....-++.+|+.||+|||+.+ |++|||||+|||||.+|.+||.|||+|+.....
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999994 4567999999999999999999999998 999999999999999999999999999977554
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
+.+.+|||.|+|||+++...+..++|-|||||++|||+.|.+||...+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3468999999999999999999999999999999999999999987654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.21 Aligned_cols=252 Identities=26% Similarity=0.351 Sum_probs=199.5
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999996 478999999886432 2334467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887542 2346899999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ........ ....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~--------~~~~ 223 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKE--------DQEE 223 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhc--------cccc
Confidence 2 234578999999999999999999999999999999999999997654321110 00000000 0000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 589 (642)
+ ..... ..+.+++..||+.||++||+ +++++++
T Consensus 224 ---~-~~~~s---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 ---Y-SEKFS---EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---C-CccCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 11111 23456777999999999997 8999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.37 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=200.3
Q ss_pred CCccccccccccCceEEEEEEcC----CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
++|++.+.||+|+||.||+|.++ .+..||+|.+.... ....+.|.+|+..+.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999853 45689999886542 34456799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++|+|.+++... ...+++..++.++.+++.||+|||+.+ ++||||||+|||++.++.+|++|||.......
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 357899999999999999999999998 99999999999999999999999998765432
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
..........++..|+|||.+.++.++.++||||||+++|||++ |+.||....... ... ....+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~------- 225 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK----AVEDGF------- 225 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHCCC-------
Confidence 22211222345678999999999999999999999999999875 999986543211 111 011110
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... .... ....+.+++..||+.+|++||++.+|++.|+.
T Consensus 226 --~~~--~~~~---~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 --RLP--APRN---CPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCC--CCCC---CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 000 0111 12245567789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.67 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=200.9
Q ss_pred CCccccccccccCceEEEEEEc------CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
++|+..+.||+|+||.||++++ .++..||||++.... ....+.+.+|+.++..+ +||||+++++++......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999973 245689999986432 33456788999999999 899999999999999999
Q ss_pred eEEEeecCCCChhhhhhcccc-----------------------------------------------------------
Q 006514 385 LLVYEFLPNQSLDRFIFDSAK----------------------------------------------------------- 405 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------- 405 (642)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999998854211
Q ss_pred -------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-
Q 006514 406 -------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH- 471 (642)
Q Consensus 406 -------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 471 (642)
...++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 125789999999999999999999998 999999999999999999999999999866443322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ++....+. ..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~----~~~~~~~~---------~~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKF----YKMIKEGY---------RM 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHH----HHHHHhCc---------cC
Confidence 1222345678999999999999999999999999999998 88887543221 111 11111111 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .... ...+.+++.+||+.||++|||+.||+++|+.
T Consensus 337 ~~--~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LS--PECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CC--CCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00 1111 1245677889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=330.72 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=203.1
Q ss_pred HcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
-.++|+.+..||+|+||.||.++- .+|+.+|+|++.+.. ..+.+.++.|-.+|.....|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 357899999999999999999995 478999999997653 4556678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
||||++||++..+| .+...|++.....++.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+....
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 56678999999999999999999999999 9999999999999999999999999985321
Q ss_pred C-----------------------CCC----cc-------------------cccccCCccccChhhhccCCCCCcchHH
Q 006514 467 E-----------------------DKS----HI-------------------STAIAGTLGYMAPEYLAHGQLTEKADVY 500 (642)
Q Consensus 467 ~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~s~~sDv~ 500 (642)
. +.. .. ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 00 0124799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCC
Q 006514 501 SFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLR 580 (642)
Q Consensus 501 S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R 580 (642)
|+|||+||||.|.+||....+... |..+.. .......+.......++. ++|.+|+. ||++|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T-------~rkI~n--------wr~~l~fP~~~~~s~eA~---DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET-------YRKIVN--------WRETLKFPEEVDLSDEAK---DLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHH--------HhhhccCCCcCcccHHHH---HHHHHHhc-CHHHh
Confidence 999999999999999987654322 221111 111111111222334444 45556666 99999
Q ss_pred C---CHHHHHHHh
Q 006514 581 P---TMSRVLQML 590 (642)
Q Consensus 581 P---s~~evl~~L 590 (642)
. .+.||-+|-
T Consensus 434 LG~~G~~EIK~HP 446 (550)
T KOG0605|consen 434 LGSKGAEEIKKHP 446 (550)
T ss_pred cCcccHHHHhcCC
Confidence 6 588888774
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=329.73 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=199.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999965 68999999986432 234456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++.....++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999843 456899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......+. .
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~--------~ 215 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGK--------L 215 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC--------c
Confidence 2 23568999999999998889999999999999999999999986543211 011111111 1
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~L 590 (642)
.. ..... ..+.+++..||+.||.+||+ +.++++|-
T Consensus 216 ~~----~~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 EF----PRHLD---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CC----CccCC---HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 00 11111 23456777999999999995 99999873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.13 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=203.8
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
..|...+.||+|.||.||||.+ ..++.||+|++... .....+++.+|+.++.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466778999999999999996 46889999999654 345567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+.+|++.+.|. ....+++....-+..++..||.|||.++ .+|||||+.||||..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999983 3344588888889999999999999998 99999999999999999999999999987766555
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
.. .+.+||+-|||||++....|+.|+||||||+..+||.+|.+|+....+. ++.-++-+...
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~P- 228 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAP- 228 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCC-
Confidence 44 6789999999999999889999999999999999999999998654331 11111111100
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+.... .-...+.+++-.||+.||+.||++.++++|
T Consensus 229 P~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 00001 112234566778999999999999999976
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=324.70 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=204.7
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++......+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688899999999999999998888899999875433 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++... ....+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999998543 3456899999999999999999999988 9999999999999999999999999998765433222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||++..+.++.++||||||+++|||+| |+.||...... .... ...... .. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~----~~~~~~-----~~----~ 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMS----ALQRGY-----RM----P 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHH----HHHcCC-----CC----C
Confidence 223446778999999998899999999999999999999 88888643221 1111 111110 00 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ... ....+.+++.+|++.+|++||++.+|.+.|+.
T Consensus 225 -~-~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 -R-MEN---CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -C-CCC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 011 12345678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=324.33 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=201.3
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|+..+.||+|+||.||++.++++..+|+|.+... ....+++.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357788899999999999999888889999987533 3334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+|+|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988542 246899999999999999999999998 9999999999999999999999999988654333222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~----~i~~~~~--~~~------ 222 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVE----MISRGFR--LYR------ 222 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCC--CCC------
Confidence 223345668999999998889999999999999999999 88888653321 1111 1111110 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... ....+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ---~~~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 ---PKL---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCC---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011 1124567888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.48 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=207.1
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.+|++.+.||+|.||.|-++.. ..|+.||||.+... +++..-.+.+|+++|..|+||||+.++.+|.+.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4688888999999999999995 68999999988654 4555566889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||..+|.|.+++ ...+.|++.+...++.||..|+.|+|.+. ++|||||.+|||||.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 44578999999999999999999999987 999999999999999999999999999887654
Q ss_pred CCcccccccCCccccChhhhccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
. ..++++|++-|.+||++.+.+| .+.+|-||+||+||-|+.|..||+..+.. .+ + +.+..+...
T Consensus 207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l---v-rQIs~GaYr------ 271 (668)
T KOG0611|consen 207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL---V-RQISRGAYR------ 271 (668)
T ss_pred c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH---H-HHhhccccc------
Confidence 3 3467899999999999999887 57899999999999999999999764321 11 1 111222111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
.+.... ...-|+.|||..||++|.|+.+|..|-.
T Consensus 272 -------EP~~PS---dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 -------EPETPS---DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -------CCCCCc---hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111112 2234667999999999999999998854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=381.78 Aligned_cols=262 Identities=24% Similarity=0.444 Sum_probs=211.1
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
...+...+.||+|+||.||+|+. .++..||||++...... ..+|+..+++++||||+++++++.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999996 57899999988543322 23468899999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++|+|.+++. .++|.++.+++.|+++||+|||....++|+||||||+||+++.++.+++. ||........
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999983 38999999999999999999996655569999999999999999988886 6655433221
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
....+++.|+|||++.+..++.++|||||||++|||+||+.|+..... ....+..|+...+........+|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 223678999999999999999999999999999999999999854332 2334555555545455555566665432
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
. ......+..++.+++.+||+.||++||||+||+++|+..
T Consensus 912 ~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 D---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred C---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2 123345677788999999999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=334.25 Aligned_cols=200 Identities=28% Similarity=0.457 Sum_probs=175.6
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|+..+.||+|+||.||+++.. +|..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999965 6888999988654 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++++|.+++.. ...+++..+..++.+++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999843 356899999999999999999999853 39999999999999999999999999987654322
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23456899999999999999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=341.08 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=200.3
Q ss_pred CCccccccccccCceEEEEEEc------CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
++|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688899999999999999873 23457999998643 333456788999999999 899999999999999999
Q ss_pred eEEEeecCCCChhhhhhccc------------------------------------------------------------
Q 006514 385 LLVYEFLPNQSLDRFIFDSA------------------------------------------------------------ 404 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------ 404 (642)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred -------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccc
Q 006514 405 -------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAI 476 (642)
Q Consensus 405 -------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~ 476 (642)
....+++.+.++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1134788999999999999999999998 999999999999999999999999999865433221 12223
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHD 555 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 555 (642)
.++..|+|||++.+..++.++||||||+++|||++ |+.||....... . .+.....+ ..... .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~---------~~~~~--~ 337 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRG---------YQMSR--P 337 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcc---------cCccC--C
Confidence 45678999999998999999999999999999998 999986532211 0 11111110 00000 1
Q ss_pred CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 556 SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 556 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... ...+.+++..||+.||++|||+.+|+++|+.
T Consensus 338 ~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 338 DFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 1345567789999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=336.27 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=212.3
Q ss_pred hhHHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCc
Q 006514 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 306 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 384 (642)
+..+-...++...++||.|-||.||.|.|+ -.-.||||.++ .+....++|+.|+.+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 334444456777889999999999999986 35679999884 4567789999999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
|||+|||.+|+|.++|.+.. +..++.-.++.++.||..||.||..++ +|||||.++|+||.++..+||+||||++.
T Consensus 339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999997643 456778888999999999999999988 99999999999999999999999999999
Q ss_pred cCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
+..+....-....-...|.|||-+....++.|+|||+|||+||||.| |..|+.... + . .+.++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-S---------qVY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-S---------QVYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-H---------HHHHH
Confidence 88776553333345678999999999999999999999999999999 655543321 1 1 12233
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
+.....+..+ .. -..++.+|++.||+++|.+||++.|+.+.++.
T Consensus 479 LEkgyRM~~P--eG---CPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 479 LEKGYRMDGP--EG---CPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HhccccccCC--CC---CCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 3333332221 11 23356778889999999999999999887754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.79 Aligned_cols=256 Identities=26% Similarity=0.470 Sum_probs=202.7
Q ss_pred CCccccccccccCceEEEEEEcCC------CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
++|+..+.||+|+||.||+|.... ...|++|.+.... ......|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999998542 2579999886432 344567899999999999999999999999988999
Q ss_pred EEEeecCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC
Q 006514 386 LVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~ 452 (642)
++|||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 156889999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCccccCCCCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHH
Q 006514 453 RAKIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTI 530 (642)
Q Consensus 453 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 530 (642)
.+||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ |..||...... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI-- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999986543322 22234456889999999998999999999999999999998 99998653321 111
Q ss_pred HHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 531 TWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 531 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
..+..+... .........+.+++.+||+.||++||++.||+++|+.
T Consensus 237 --~~i~~~~~~--------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 --EMIRSRQLL--------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCcC--------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111110 0011122355677889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.42 Aligned_cols=249 Identities=34% Similarity=0.568 Sum_probs=190.9
Q ss_pred ccccccccCceEEEEEEcC-----CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 317 EANKLGQGGFGTVYKGVLP-----DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
..+.||.|.||.||+|.+. .+..|+||.+... .....++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999975 3678999999543 344578899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++|+|.++|... ....+++..++.|+.||++||.|||+++ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999653 2467999999999999999999999998 99999999999999999999999999987633222
Q ss_pred -cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 471 -HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 471 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
...........|+|||.+....++.++||||||+++|||++ |+.|+...... . +. .....+.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~---~~-~~~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---E---II-EKLKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---H---HH-HHHHTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---cc-cccccccccee-----
Confidence 22333457789999999999999999999999999999999 67776543211 1 11 11111111000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.... ...+.+++..||+.||++||||.+|++.|
T Consensus 227 ------~~~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ------PDNC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------BTTS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ccch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111 22345677899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.01 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=205.2
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
+-|...+.||.|+.|.|-.|++ .+|+.+|||.+... .......+.+|+-+|+-+.|||+++|++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5588899999999999999995 58999999998654 2223456789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|-|.+++. +.+.+++.+..+.+.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 5578999999999999999999999998 999999999999999999999999999864433
Q ss_pred CCcccccccCCccccChhhhccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
....+.+|+|.|.+||++++.+| ..++||||.||||+.||||+.||+.++ ...|+ .+...|..+ +
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LL----lKV~~G~f~-M---- 231 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLL----LKVQRGVFE-M---- 231 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHH----HHHHcCccc-C----
Confidence 33456799999999999999987 568999999999999999999998432 22222 222222211 1
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
+.....++. +|+.+|+..||++|.|++||++|-
T Consensus 232 -------Ps~Is~eaQ---dLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 232 -------PSNISSEAQ---DLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -------CCcCCHHHH---HHHHHHhccCccccccHHHHhhCc
Confidence 223333444 455689999999999999999983
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.76 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.9
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
.+|...+.||+|+||.||++.+.++..+|+|.+.... ...+++.+|+.++.+++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577888999999999999998777789999886432 334679999999999999999999999998888999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+|+|.+++... ...+++..++.++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998542 236899999999999999999999998 9999999999999999999999999988654433222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.|+....... .......+... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL---------Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC---------C
Confidence 222345678999999998889999999999999999999 988876433211 01111111000 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
. ... ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~--~~~---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 R--PHL---ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C--CCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 011 1235567888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.97 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=206.6
Q ss_pred HHHcCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC--CccceeeeeeeeccCC----
Q 006514 309 EKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV--EHKNLVRLLGCSCSGP---- 382 (642)
Q Consensus 309 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~---- 382 (642)
+....+....+.||+|.||.||+|.+. |+.||||++.. .+++.+++|.++++.+ +|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344567888999999999999999995 89999999854 3346788999999875 9999999998765543
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEeccCCCCEEEcCCCcEEEE
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH-----EQSKIRIIHRDIKASNILLDSRLRAKIA 457 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 457 (642)
+++||++|.++|||.|+| ....++.+..++++..+|.||+||| .++++.|.|||||++||||..++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 578999999999999999 3478999999999999999999999 4688999999999999999999999999
Q ss_pred ecCCccccCCCCCc---ccccccCCccccChhhhccCC------CCCcchHHHHHHHHHHHHhCC----------CCCCC
Q 006514 458 DFGLARSFQEDKSH---ISTAIAGTLGYMAPEYLAHGQ------LTEKADVYSFGMLLLEIVTGR----------QNNRS 518 (642)
Q Consensus 458 DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~S~Gvll~elltG~----------~p~~~ 518 (642)
|+|||....++... .....+||.+|||||++...- --..+||||||+|+||+.-.. .||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999987776543 345679999999999997532 234689999999999997542 23322
Q ss_pred CCCcccchhHHHHHHhhhcCcchhhcc----ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 006514 519 KNSEYTDSLLTITWKHFQAGRVEELYD----KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 519 ~~~~~~~~l~~~~~~~~~~~~~~~~~d----~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 594 (642)
.-+ .+...+++.+ +.+....+..-...+.+..+.+++..||..||.-|-|+-.|-+.|....
T Consensus 439 ~Vp--------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 439 VVP--------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCC--------------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111 1112222222 1222222223334566777788999999999999999999998887643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.41 Aligned_cols=242 Identities=27% Similarity=0.367 Sum_probs=200.2
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 386 (642)
.++|...+.||+|.||+|+++..+ +++.+|||++++. .....+..+.|..++... +||.+++|+.++...+.+++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999965 6788999999765 345566778888888777 59999999999999999999
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
||||+.||++..+ .+...+++..+.-++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999994433 35578999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
.... .+.+.+|||.|||||++.+..|+..+|-|||||+||||+.|+.||...+++ +++|.
T Consensus 520 ~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~Fds 579 (694)
T KOG0694|consen 520 GQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVFDS 579 (694)
T ss_pred CCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHHHH
Confidence 3222 456789999999999999999999999999999999999999999865542 33333
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 583 (642)
.+.....-+... ..+.+.++.+.+..||++|.-+
T Consensus 580 I~~d~~~yP~~l---s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFL---SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcc---cHHHHHHHHHHhccCcccccCC
Confidence 333222222233 3344556668999999999765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.05 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=201.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||++.+. +++.||||++.... ......+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 58899999986432 234457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +...... ...+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~--~~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYW--KETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhc--cccccCCC
Confidence 22346799999999999999999999999999999999999999865432111 0000000 00011000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
. ..........+.+++..||+.+|++||++.+++++-
T Consensus 222 ~-----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 222 Y-----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred C-----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0 000001122445677789999999999999999884
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=298.07 Aligned_cols=264 Identities=23% Similarity=0.275 Sum_probs=210.2
Q ss_pred HcCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-----Cc
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ES 384 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 384 (642)
..++|.+.++||+|||+-||.++ ..+++.+|+|++...+.++.+..++|++..++++|||+++++++...+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34679999999999999999999 5688999999998888888899999999999999999999999876544 38
Q ss_pred eEEEeecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 385 LLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
||+++|...|+|.+.+.... ++..+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987543 3448999999999999999999999986 589999999999999999999999999987
Q ss_pred ccCCCCCc--------ccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006514 464 SFQEDKSH--------ISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 464 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 532 (642)
...-.-.. .......|..|.|||.+. +...++++|||||||+||+|+-|..||+.....+....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 64321110 112235688999999986 45689999999999999999999999975443221110
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
-.+....+..+ .... ....+.+++.+|++.||.+||++.+++..++..
T Consensus 253 --------LAv~n~q~s~P--~~~~---yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 --------LAVQNAQISIP--NSSR---YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------EeeeccccccC--CCCC---ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111111 1111 344566778899999999999999999988753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.66 Aligned_cols=282 Identities=23% Similarity=0.327 Sum_probs=204.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhh--HHHHHHHHHHHhcCCccceeeeeeeec--cCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR--AANFYNEVNIISSVEHKNLVRLLGCSC--SGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lv 387 (642)
++|+..+.|++|.||.||+|+++ +++.||+|+++...... --.-++||.+|.+.+|||||.+..+.. +-+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45888999999999999999975 78899999997554221 123579999999999999999988765 34568999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||++. +|..++... ...+...+...+..|+++|++|||..+ |+||||||+|+|++..|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999965 788887542 367889999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhhhcC
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------TWKHFQAG 538 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~ 538 (642)
.... .+..+-|.+|.|||.+.+. .|++..|+||+|||+.||+++++.|.+..+..+...+-. .|+.+..-
T Consensus 230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 6433 4567889999999999875 599999999999999999999988876554322211111 12222111
Q ss_pred cchh-hcccccccc----ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 006514 539 RVEE-LYDKNLMLH----NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFI 605 (642)
Q Consensus 539 ~~~~-~~d~~~~~~----~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p~~p~~~ 605 (642)
.... +--+..... .+......+ .-.++.-..+..||.+|-|++|.|+|=- ....|.|..|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse---~g~~Lln~llt~dP~kR~tA~~~L~h~~-F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSE---QGFDLLNKLLTYDPGKRITAEDGLKHEY-FRETPLPIDPSMF 376 (419)
T ss_pred chhhccccCCCCchhhhhhccccccch---hHHHHHHHHhccCccccccHHHhhcccc-cccCCCCCChhhc
Confidence 1100 000000000 000001112 2334555677889999999999998732 3334444444443
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.44 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=203.8
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.++|+..+.||+|++|.||+|.+.+++.||+|.+.... ...+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688899999999999999998778899999885433 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 356899999999999999999999998 999999999999999999999999999876533222
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+...... . ......... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~----~~~~~~~~~---------~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---E----VLQQVDQGY---------RM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCC---------CC
Confidence 1112223467999999998899999999999999999999 88887543211 0 111111110 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 ~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 P-----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred C-----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 001112356678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=334.57 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=200.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++++. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999965 68899999986432 234467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999998843 456889999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .+.....+. .
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~--------~ 232 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGR--------L 232 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCC--------c
Confidence 2 2357899999999999999999999999999999999999998643211 0 111111111 1
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~L 590 (642)
.. +.... ..+.+++..||+.||++||+ +.+++.|-
T Consensus 233 ~~----p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 KF----PNWFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred CC----CCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 10 11111 23456777999999999986 79998773
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=327.78 Aligned_cols=269 Identities=22% Similarity=0.324 Sum_probs=198.0
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999964 68899999886432 22345678999999999999999999999998899999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 488888743 2345789999999999999999999998 99999999999999999999999999976543222
Q ss_pred cccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHhhhcC-cc
Q 006514 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT--------ITWKHFQAG-RV 540 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~-~~ 540 (642)
. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||............. ..|+..... ..
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1 233567899999999875 568999999999999999999999986543221111000 011110000 00
Q ss_pred hhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.....+....... ...........++++.+|++.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCch-HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 00000112245677889999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.46 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.||+|+||.||++... +|+.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999954 7899999998643 2334556788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 474 (642)
+|..++. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 9988884 3457899999999999999999999998 99999999999999999999999999875332221 123
Q ss_pred cccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccC
Q 006514 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554 (642)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 554 (642)
...||+.|+|||++.++.++.++|||||||++|||++|+.||....... ... ...... ...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~----~~~~~~--------~~~---- 214 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----LILMEE--------IRF---- 214 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHhcCC--------CCC----
Confidence 4579999999999999999999999999999999999999986533211 100 000000 000
Q ss_pred CCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 555 DSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 555 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
...... .+.+++..||+.||++|| ++.+++++-
T Consensus 215 p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 215 PRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCCCH---HHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 111122 344666799999999998 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.89 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=207.5
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
..+|+..++||+|+||.||+|...+++.+++|.+..........+.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999998889999999987666656678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999653 3457899999999999999999999998 999999999999999999999999999766443222
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
.....++..|+|||.+..+.++.++||||||+++|||++ |+.|+...... ...... ..+ ...
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~---------~~~ 223 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI----TAG---------YRM 223 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----HhC---------CcC
Confidence 123346778999999998899999999999999999998 88888543311 111111 010 000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.........+.+++.+||+.||++|||+.++++.|+.
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 -----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0001112345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.80 Aligned_cols=242 Identities=22% Similarity=0.308 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 47899999998643 2334456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 474 (642)
+|.+++. +...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 9998884 3457899999999999999999999998 99999999999999999999999999875332221 223
Q ss_pred cccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccC
Q 006514 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554 (642)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 554 (642)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+. ...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~----~~~~~--------~~~---- 214 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL----ILMEE--------IRF---- 214 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH----HHcCC--------CCC----
Confidence 457999999999999999999999999999999999999998653211 11110 10110 000
Q ss_pred CCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 555 DSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 555 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
..... ..+.+++.+||+.||++|| ++.++++|
T Consensus 215 p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLS---PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11112 2345677799999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=329.09 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=207.7
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhh-HHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR-AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
....+.++||+|-||.|..+....+..||||.++...... ..+|.+|+++|.+++||||++|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456788999999999999999878999999997665444 488999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++|+|.+|+..+.. ..+......+|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||+++..-....+
T Consensus 618 EnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999965432 23566777889999999999999987 999999999999999999999999999976554443
Q ss_pred -ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 472 -ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 -~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.....+-+.+|||||.+..+++|.+||||+||+.+||+++ ..+|+....++.. +...-..+..+.....+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l---- 766 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVL---- 766 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceec----
Confidence 4445667889999999999999999999999999999876 5667654332211 11111111111111100
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
..+... ...+.++++.||..+-++||++++|..+|..
T Consensus 767 ----~~P~~c---p~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 767 ----SRPPAC---PQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred ----cCCCcC---cHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 001122 2345688999999999999999999998865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=316.71 Aligned_cols=271 Identities=25% Similarity=0.352 Sum_probs=205.4
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEee--ccChhhHHHHHHHHHHHhcCCccceeeeeeeecc-----CC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-----GP 382 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 382 (642)
....|...+.||+|.||.|+.+..+ +|+.||||++. .......++-.+|+.+|+.++|+||+.+.+++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666788999999999999964 78999999997 5677777889999999999999999999998765 35
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
..|+|+|+| ..+|.+++. .++.|+......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 679999999 678999883 3445999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-CcccccccCCccccChhhhc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHH-------
Q 006514 463 RSFQEDK-SHISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWK------- 533 (642)
Q Consensus 463 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~------- 533 (642)
+...... ....+..+.|.+|.|||++. ...||.+.||||.|||+.||++|++.|.+...-.+..++.....
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9876542 12346678899999999875 46799999999999999999999999877654333222222111
Q ss_pred -hhhcCcchhhccccccccccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 534 -HFQAGRVEELYDKNLMLHNYH--DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 534 -~~~~~~~~~~~d~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.. +...+.. ...........+++.-+||..||.+|+|++|.++|
T Consensus 253 ~~i~s~~ar~yi~s-lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKS-LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHh-CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111110 0000000 00001112234566668999999999999999987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.71 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=199.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCc----EEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
.+|+..+.||+|+||.||+|++. +++ .||+|.+... .....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999853 343 3899988643 344567799999999999999999999998764 5789
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998542 346889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcc-cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSHI-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
...... .....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+ ......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~------ 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKG------ 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCC------
Confidence 443321 122334678999999999999999999999999999998 99988643211 11 0111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 594 (642)
..... ... ....+.+++..||+.+|++||++.+|+..|....
T Consensus 228 ---~~~~~--~~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 ---ERLPQ--PPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CCCCC--CCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 011 1234567888999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=319.44 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=202.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+|+..++||+|+||.||+|.+. .++.|++|.+... ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778889999999999999964 5889999988643 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998542 2356899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+....... ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~---------~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGY---------RM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCC---------CC
Confidence 2222334678999999999999999999999999999998 88887543211 1111111110 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. . .... ...+.+++.+||+.+|++||++.+++++|+.
T Consensus 225 ~-~-~~~~---~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 E-R-PEGC---PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred C-C-CCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 0 0 1111 2345567789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=335.23 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=196.7
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|+..+.||+|+||.||++.. .+++.||+|... ...+.+|+.++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999996 468899999642 234678999999999999999999999999999999998
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 688887743 356899999999999999999999998 999999999999999999999999999754332222
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCccc----chhHHHHHHhhhc----------
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT----DSLLTITWKHFQA---------- 537 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~----~~l~~~~~~~~~~---------- 537 (642)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+........ ...+.........
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 23346799999999999999999999999999999999999988654321110 0001111000000
Q ss_pred Ccchhhcc---ccccccccCC---CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 538 GRVEELYD---KNLMLHNYHD---SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~~~~~~~d---~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....++.. ......+... .........+.+++.+||+.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0000000000 0011123356678889999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=334.54 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=196.3
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.|+..+.||+|+||+||++.. .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 46889999998643 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999843 356889999999999999999999998 9999999999999999999999999976432110
Q ss_pred C----------------------------------------------cccccccCCccccChhhhccCCCCCcchHHHHH
Q 006514 470 S----------------------------------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG 503 (642)
Q Consensus 470 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~G 503 (642)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 006514 504 MLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583 (642)
Q Consensus 504 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 583 (642)
|++|||++|+.||......... ...... ...+... .......+..+++.- +.|+..+|..||++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~~~~--~~~~~s~~~~dli~~-ll~~~~~~~~R~~~ 299 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINW-------ENTLHIP--PQVKLSPEAVDLITK-LCCSAEERLGRNGA 299 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHcc-------ccccCCC--CCCCCCHHHHHHHHH-HccCcccccCCCCH
Confidence 9999999999999754321110 000000 0000000 011122334443332 23777788889999
Q ss_pred HHHHHHh
Q 006514 584 SRVLQML 590 (642)
Q Consensus 584 ~evl~~L 590 (642)
.+|+.|-
T Consensus 300 ~~~l~hp 306 (381)
T cd05626 300 DDIKAHP 306 (381)
T ss_pred HHHhcCc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.87 Aligned_cols=266 Identities=25% Similarity=0.359 Sum_probs=192.5
Q ss_pred CccccccccccCceEEEEEEcC--CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcC---Cccceeeeeeeec-----cC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP--DGREIAVKRLFFNN--RHRAANFYNEVNIISSV---EHKNLVRLLGCSC-----SG 381 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~ 381 (642)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888999999999999999852 46889999886432 22234566777777665 6999999999875 23
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++|+||++ ++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 45789999996 6888888542 2346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh---cC
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ---AG 538 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~ 538 (642)
++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ +.... .... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~-~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKIL-DVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHH-HHhCCCChh
Confidence 9865433 222345689999999999988999999999999999999999999876543211 11111 0000 00
Q ss_pred cchh-h--ccccccccccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEE-L--YDKNLMLHNYH--DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~-~--~d~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+.. . ........... ..........+.+++.+|++.||++|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0 00000000000 00000111234578889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.31 Aligned_cols=269 Identities=23% Similarity=0.328 Sum_probs=195.3
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-----Cce
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ESL 385 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 385 (642)
+|+..+.||+|+||.||+|... +|+.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999954 7899999988532 2234456889999999999999999999875432 469
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+||||+. ++|.+++. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888874 3456899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc--ccccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHH--------HHHH
Q 006514 466 QEDKSH--ISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT--------ITWK 533 (642)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~ 533 (642)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ..+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 332221 2234679999999999876 678999999999999999999999986543211100000 0000
Q ss_pred hhhcCcchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 534 HFQAGRVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 534 ~~~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+......+.+.......... ..........+.+++..||+.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000111111111000000000 00000011235678889999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.56 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=202.8
Q ss_pred CCccccccccccCceEEEEEEcCC------CcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
.+|.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998633 478999998654433 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 386 LVYEFLPNQSLDRFIFDSA-----------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
+||||+++++|.+++.... ....+++.....++.+++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986422 2345889999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006514 455 KIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 455 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 532 (642)
||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |+.||...... .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH--
Confidence 9999999976533222 12233456788999999999999999999999999999999 99998643321 11111
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
...+.... . ... ....+.+++..||+.||++||++.||++.|+
T Consensus 237 --~~~~~~~~----------~-~~~---~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 --ITQGRLLQ----------R-PRT---CPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHcCCcCC----------C-CCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111100 0 011 1234567788999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=298.18 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=205.7
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
-++|++.+.||+|.||.||.|+. +++-.||+|++.+.. .+...++.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 36799999999999999999995 467889999996542 33346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+||.++|.|...|++. +.+.+++.....++.|+|.||.|+|.++ ||||||||+|+|++..+..||+|||-+..-..
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999653 4577889999999999999999999988 99999999999999999999999999876442
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
. ...+.+||..|.+||...+...+.++|+|++|++.||++.|.+||+...... .. .++..-.
T Consensus 177 ~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tY--------krI~k~~ 238 (281)
T KOG0580|consen 177 N---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TY--------KRIRKVD 238 (281)
T ss_pred C---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HH--------HHHHHcc
Confidence 2 2346899999999999999999999999999999999999999998654211 01 1111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+.. +..... .+.+++..|+..+|.+|.+..||++|
T Consensus 239 ~~~----p~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 LKF----PSTISG---GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccC----CcccCh---hHHHHHHHHhccCccccccHHHHhhh
Confidence 111 122223 33456779999999999999999987
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.27 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=200.8
Q ss_pred HcCCccccccccccCceEEEEEEcC------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 383 (642)
.+++|+..+.||+|+||.||+|.+. .+..||||++... ......++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 3567999987543 23345678999999999999999999999999999
Q ss_pred ceEEEeecCCCChhhhhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK-------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
.++||||+++++|.+++..... ...+++..++.++.++++||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234688999999999999999999988 999999999999999999999
Q ss_pred EecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006514 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKH 534 (642)
Q Consensus 457 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 534 (642)
+|||+++........ ......+++.|+|||++.++.++.++||||||+++|||++ |..|+...... ... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~----~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVL----RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HH
Confidence 999998765433222 1222345788999999999899999999999999999999 67787543221 111 11
Q ss_pred hhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
......... .... ...+.+++.+||+.||++|||+.|++++|+
T Consensus 234 ~~~~~~~~~-----------~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLDK-----------PDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCCC-----------CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111110000 1111 124567888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.47 Aligned_cols=271 Identities=27% Similarity=0.401 Sum_probs=200.8
Q ss_pred CCccccccccccCceEEEEEEc-----CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeecc--CCCce
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 385 (642)
.+|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 3578999999877666667789999999999999999999998654 34578
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
...... ......++..|+|||++.+..++.++||||||+++|||++|..++.......................+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 543322 111223445699999999889999999999999999999987765432211000000000000000000111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
+........ .... ...+.+++.+||+.+|++|||+.||++.|+..
T Consensus 239 ~~~~~~~~~--~~~~---~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPA--PPGC---PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCC--CCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111000 1111 23466788899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=311.33 Aligned_cols=269 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChh--hHHHHHHHHHHHhcCCccc-eeeeeeeeccCC------
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKN-LVRLLGCSCSGP------ 382 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------ 382 (642)
..|+..++||+|+||+||+|+. .+|+.||+|++...... .-....+|+.++++++|+| |++|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4577778899999999999995 47899999999765432 2345689999999999999 999999998877
Q ss_pred CceEEEeecCCCChhhhhhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
..++|+||+ ..+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 678999999 56899988654322 45777889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh---c
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ---A 537 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~ 537 (642)
|+.+.-.... .+..++|..|.|||++.+. .|+...||||+|||+.||++++..|....+. +++. ..+.... .
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~-~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLF-RIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHH-HHHHHcCCCCc
Confidence 9976644332 3456789999999999886 6999999999999999999998888765542 2222 2222211 1
Q ss_pred Ccchhhc---cccccccccC-CCCcHH----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 538 GRVEELY---DKNLMLHNYH-DSNVKY----EVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~~~~~~~---d~~~~~~~~~-~~~~~~----~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+..+. +-........ ...... .....++++.+|++.+|.+|.|++..++|
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1222211 1111000000 001111 11356788889999999999999999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=324.88 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=191.7
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||+|+||.||++... +++.||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 6889999988643 234456788999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 476 (642)
.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 998843 456899999999999999999999998 99999999999999999999999999875432222 22346
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .... ..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~-~~~~~~--------~~~~----~~ 214 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMY-RKILQE--------PLRF----PD 214 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHH-HHHHcC--------CCCC----CC
Confidence 7999999999999999999999999999999999999998653211 111 111111 0000 11
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPT---MSRVLQM 589 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~~ 589 (642)
... ..+.+++..||+.||++||+ +.|+++|
T Consensus 215 ~~~---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFD---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCC---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 122 23456677999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.90 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=199.2
Q ss_pred CCccccccccccCceEEEEEEcCC--CcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD--GREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
++|+..+.||+|+||.||+|.+++ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568899999999999999998543 368999988543 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999843 456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.
T Consensus 184 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~-------- 244 (340)
T PTZ00426 184 RT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGI-------- 244 (340)
T ss_pred Cc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCC--------
Confidence 22 2457999999999999888999999999999999999999999753321 1111111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
... +..... .+.+++..|++.||++|+ +++++++|-
T Consensus 245 ~~~----p~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 245 IYF----PKFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CCC----CCCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 110 111222 244667799999999995 899999873
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=318.92 Aligned_cols=254 Identities=27% Similarity=0.469 Sum_probs=202.2
Q ss_pred CCccccccccccCceEEEEEEcCC----CcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
++|+..+.||+|+||.||+|.++. ...||||.+... ......+|.+|+.++++++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998642 457999988644 334456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++++|.+++... ...+++..++.++.+++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998542 347899999999999999999999988 99999999999999999999999999998753
Q ss_pred CCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 468 DKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 468 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+ ......+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~------ 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGY------ 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCC------
Confidence 2222 2222345678999999999999999999999999999998 98887543211 11 11111110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.... . ......+.+++.+||+.+|++||++.||+++|+.
T Consensus 226 ---~~~~--~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 ---RLPP--P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ---CCCC--C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0000 0 1112345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.95 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=202.2
Q ss_pred cCCccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPE 383 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 383 (642)
.++|.+.++||+|+||.||+|++. .+..||||++.... ....+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999852 23479999986433 334567999999999996 9999999999999999
Q ss_pred ceEEEeecCCCChhhhhhcccc----------------------------------------------------------
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK---------------------------------------------------------- 405 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 405 (642)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred -----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC
Q 006514 406 -----------------------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (642)
Q Consensus 406 -----------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~ 450 (642)
...+++..++.++.|+++||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 134788899999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhH
Q 006514 451 RLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLL 528 (642)
Q Consensus 451 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~ 528 (642)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----- 347 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence 999999999999865433222 1223456788999999998899999999999999999997 888875432110
Q ss_pred HHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 529 TITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 529 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
..+.....+. ... ... .....+.+++..||+.||++||++.+|.++|+..
T Consensus 348 -~~~~~~~~~~---------~~~--~~~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 -TFYNKIKSGY---------RMA--KPD---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HHHHHHhcCC---------CCC--CCc---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0111111110 000 011 1123456788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=326.96 Aligned_cols=243 Identities=22% Similarity=0.300 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999954 6899999998643 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 474 (642)
+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99888843 457899999999999999999999998 99999999999999999999999999875432221 123
Q ss_pred cccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccC
Q 006514 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554 (642)
Q Consensus 475 ~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 554 (642)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ...... .. +
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~----~~~~~~--------~~---~- 214 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMED--------IK---F- 214 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHH----HhccCC--------cc---C-
Confidence 457999999999999999999999999999999999999998653221 1000 000000 00 0
Q ss_pred CCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 555 DSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 555 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
..... ..+.+++..||+.||++|| ++.++++|-
T Consensus 215 p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 215 PRTLS---ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCCC---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 11112 2345667799999999997 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.23 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=199.0
Q ss_pred CccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+|+..+.||+|+||.||++.++++..+|+|.+.... ....++.+|++++++++||||+++++++......++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477888999999999999998777889999875332 2345788999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999998542 246899999999999999999999998 99999999999999999999999999986543322211
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ....... ... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~-----~~~----~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSAG-----YRL----YR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHcC-----CcC----CC
Confidence 22234567999999999999999999999999999999 788876432211 0 0111111 000 00
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... ....+.+++.+||+.+|++|||+.||++.|.
T Consensus 223 --~~~---~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 --PKL---APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111 2235667888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.85 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=174.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||+||++... +++.||||++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 68899999986432 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999843 457899999999999999999999998 999999999999999999999999998754321
Q ss_pred CC----------------------------------cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCC
Q 006514 469 KS----------------------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514 (642)
Q Consensus 469 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~ 514 (642)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 006514 515 NNRSK 519 (642)
Q Consensus 515 p~~~~ 519 (642)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.60 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=174.5
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|+..++||+|+||.||++.+. +++.+|+|.+... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999965 6888999987654 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++|+|.+++.. ...+++.....++.+++.||.|||+.. .++||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999843 356889999999999999999999753 39999999999999999999999999987553321
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22356899999999999888999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=321.27 Aligned_cols=256 Identities=25% Similarity=0.449 Sum_probs=200.7
Q ss_pred CCccccccccccCceEEEEEEc-----CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
.+|+..+.||+|+||.||+|.+ .++..|++|.+... .......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 25678999988643 34445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC
Q 006514 387 VYEFLPNQSLDRFIFDSA--------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~ 452 (642)
||||+++++|.+++.... ....+++.+.+.++.+++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235889999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCccccCCCCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHH
Q 006514 453 RAKIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTI 530 (642)
Q Consensus 453 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 530 (642)
.+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |..||...... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543322 12233446778999999998889999999999999999999 88887543211 11111
Q ss_pred HHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 531 TWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 531 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
....... .. ..... ..+.+++.+||+.||++||++.+|+++|..
T Consensus 239 ----~~~~~~~---------~~--~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 ----VRKRQLL---------PC--SEDCP---PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC---------CC--CCCCC---HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111100 00 11111 245567789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.93 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=206.0
Q ss_pred CCccccccccccCceEEEEEEcC------CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
++|...+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778889999999999999742 355689998876666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc
Q 006514 387 VYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 453 (642)
||||+++++|.+++.... ....+++..++.++.+|+.||.|||+++ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1245899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHH
Q 006514 454 AKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTIT 531 (642)
Q Consensus 454 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 531 (642)
+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |+.|+....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 999999999765443221 2233456788999999999999999999999999999999 998875533211 1
Q ss_pred HHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 532 WKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 532 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
+.....+...+. . ......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 235 ~~~~~~~~~~~~-----------~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQGRVLER-----------P---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCC-----------C---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111112111110 0 01123456788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.52 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=202.2
Q ss_pred CccccccccccCceEEEEEEcC-C-CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-D-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999853 3 6788999876666666667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 392 PNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 392 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23456899999999999999999999998 99999999999999999999999999987654322
Q ss_pred -cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 471 -HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 471 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...+... +
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~-~~~~~~~----~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQ-VLYGKYD----P--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC----C---
Confidence 1234567999999999999999999999999999999999999998643211 11111 0011100 0
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. .... ...+.+++..||+.||++||++.+++.+
T Consensus 291 ---~-~~~~---s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 ---F-PCPV---SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---C-CccC---CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0 1111 1245567779999999999999999754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.80 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=198.4
Q ss_pred CccccccccccCceEEEEEEc----CCCcEEEEEEeecc----ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 314 SFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFN----NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
+|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++..+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999874 36789999998543 223345678899999999 599999999999999999
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998843 356899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC----- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC-----
Confidence 644433333456799999999999865 47899999999999999999999986543221111 111111000
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
++.+ ...... .+.+++.+||+.||++|| ++.++++|-
T Consensus 227 -~~~~------~~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 227 -DPPF------PSFIGP---EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -CCCC------CCCCCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 0000 111122 344667799999999999 788998874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.46 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=204.2
Q ss_pred CCccccccccccCceEEEEEEc------CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
.+|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999984 2345689998876666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 387 VYEFLPNQSLDRFIFDSA----------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
||||+++++|.+++.... +...+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999985422 2235899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006514 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKH 534 (642)
Q Consensus 457 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 534 (642)
+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....... . ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHH
Confidence 999999865433221 2223445778999999998899999999999999999999 888875433211 0 111
Q ss_pred hhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
...+..... .... ...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 235 i~~~~~~~~-----------~~~~---~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 ITQGRVLQR-----------PRTC---PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHcCCcCCC-----------CCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111111000 0111 12467788899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.09 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=191.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+|+..++||+|+||.||++++. +++.||||++.... ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566788999999999999964 78999999986443 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++|+|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 3567778899999999999999998 99999999999999999999999999987543322
Q ss_pred ccccccCCccccChhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 472 ISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+.. . ..... .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-~~~~~------~ 293 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-ICMSQ------P 293 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-HhccC------C
Confidence 1234578999999998753 224568999999999999999999987332211111100 0 00000 0
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.||++||++.||++|
T Consensus 294 --------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 --------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001112345677789999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=341.45 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=209.8
Q ss_pred cCCccccccccccCceEEEEEEcCCC-cEEEEEEeeccChhhHHHHHHHHHHHhcCC-ccceeeeeee-ecc------CC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDG-REIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGC-SCS------GP 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~ 382 (642)
..++++.+.|.+|||+.||.+.+..+ .++|+|++...++...+.+.+|+++|++|+ |||||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34577888999999999999997655 999999998889999999999999999996 9999999993 221 23
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
+.+|.||||++|.|-+++..+.... |++.++++|+.++++|+.+||.. +++|||||||-+||||+.+++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5689999999999999997655444 99999999999999999999988 578999999999999999999999999999
Q ss_pred cccCCCCC-cc-------cccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHH
Q 006514 463 RSFQEDKS-HI-------STAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT 531 (642)
Q Consensus 463 ~~~~~~~~-~~-------~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 531 (642)
........ .. .-...-|+.|+|||.+. +..+++|+|||+|||+||-|+-...||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 75433221 10 11234689999999874 56799999999999999999999999976421
Q ss_pred HHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCC
Q 006514 532 WKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPG 598 (642)
Q Consensus 532 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 598 (642)
..+++..... +.......++..||..||+.||++||++-+|++.+..+...+.
T Consensus 264 ---------laIlng~Y~~-----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ---------LAILNGNYSF-----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ---------eeEEeccccC-----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1222222221 1223344566677889999999999999999999877444433
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.49 Aligned_cols=253 Identities=23% Similarity=0.242 Sum_probs=199.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999964 78999999986432 234556889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 257899999999999999999999998 999999999999999999999999999876554
Q ss_pred CCcccccccCCccccChhhhc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 469 KSHISTAIAGTLGYMAPEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~-- 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRF-- 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCc--
Confidence 433334457899999999987 4567899999999999999999999986543211 00010000000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+. ......... .+.+++..|++ +|++||++.++++|
T Consensus 228 -----~~--~~~~~~~~~---~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 -----LK--FPEDPKVSS---DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----cC--CCCCCCCCH---HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 000111222 34455567887 99999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=319.50 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=198.1
Q ss_pred CCccccccccccCceEEEEEEcC-CCc----EEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
++|+..+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778889999999999999963 444 47778774332 334467888999999999999999999875 456789
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999854 2357899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
..... ......++..|+|||++.++.++.++||||||+++|||++ |+.|+....... .... +..+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~--~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGERL--A 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC--C
Confidence 33322 2234457788999999999999999999999999999998 988886532211 1111 1111100 0
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ 595 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 595 (642)
. .... ...+.+++.+||+.||++|||+.|+++.|.....
T Consensus 232 ~---------~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 Q---------PQIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C---------CCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 0011 1234567789999999999999999999987444
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.59 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=200.1
Q ss_pred CCccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcC-Cccceeeeeeeecc-CCC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCS-GPE 383 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-~~~ 383 (642)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999642 35789999886432 33446688999999999 89999999998764 456
Q ss_pred ceEEEeecCCCChhhhhhcccc----------------------------------------------------------
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK---------------------------------------------------------- 405 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 405 (642)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998853211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccCCccccC
Q 006514 406 AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMA 484 (642)
Q Consensus 406 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 484 (642)
...++|..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++......... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999998 999999999999999999999999999876443322 2223456778999
Q ss_pred hhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHH
Q 006514 485 PEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVL 563 (642)
Q Consensus 485 PE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 563 (642)
||++.+..++.++|||||||++|||++ |+.||....... . .......+... .. . .....
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~---------~~--~---~~~~~ 303 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRM---------RA--P---EYATP 303 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCC---------CC--C---ccCCH
Confidence 999999999999999999999999998 998886432211 0 11111111100 00 0 11123
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 564 RAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 564 ~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.+.+++++||+.+|++||++.||+++|+..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 466788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=323.79 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=197.6
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999965 789999999864432 233467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 677777643 2356889999999999999999999998 9999999999999999999999999987543322
Q ss_pred CcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC---cchhh--
Q 006514 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG---RVEEL-- 543 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~-- 543 (642)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+. ...+..... ..... .+...
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 H-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIFL-VLGTPNEDTWPGVHS 234 (303)
T ss_pred c-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHH-HhCCCChhhccchhh
Confidence 1 2233568999999999875 45889999999999999999999999754321 111111110 00000 00000
Q ss_pred ---ccccccccccCCCCcHH------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 544 ---YDKNLMLHNYHDSNVKY------EVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 ---~d~~~~~~~~~~~~~~~------~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.++... .......... ....+.+++..|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERF-TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccc-cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 0000000000 11234567789999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=343.11 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=204.1
Q ss_pred hhHHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC
Q 006514 306 STLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (642)
Q Consensus 306 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 382 (642)
.+.....++|.+.+.||+|+||.||++.. .+|+.||||++... .......+.+|+..+..++|+||++++..+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34445567999999999999999999985 47899999998643 3445567889999999999999999987665332
Q ss_pred --------CceEEEeecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc
Q 006514 383 --------ESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (642)
Q Consensus 383 --------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 453 (642)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 2579999999999999986532 2457899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006514 454 AKIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 454 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 532 (642)
+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence 99999999987644322 2234567999999999999999999999999999999999999998653211 1111
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. ...+... + . ..... ..+.+++..||+.||++||++.+++++
T Consensus 256 ~-~~~~~~~----~------~-~~~~~---~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 K-TLAGRYD----P------L-PPSIS---PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H-HhcCCCC----C------C-CCCCC---HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111100 0 0 11112 235567779999999999999999876
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.47 Aligned_cols=259 Identities=20% Similarity=0.356 Sum_probs=205.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.++++++||||+++++++......++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999964 7899999987532 3444567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 389 EFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
||+++++|.+++.... +...+++...+.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885422 2356889999999999999999999998 99999999999999999999999999887644
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ..+.. ...... .+
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~-~~~~~~-----~~- 226 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQ-KIEQCD-----YP- 226 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHH-HHhcCC-----CC-
Confidence 3221 223568889999999998889999999999999999999999985432211 11110 011000 00
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
..........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 -------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 -------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000111223456778899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=319.57 Aligned_cols=265 Identities=26% Similarity=0.428 Sum_probs=199.1
Q ss_pred cccccccccCceEEEEEEc-----CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceEE
Q 006514 316 DEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLV 387 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 387 (642)
...+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988652 367889999886543 34456788999999999999999999987654 347899
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999843 45999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 468 DKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 468 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
.... ......++..|+|||.+....++.++||||||+++|||++|..|+......... .............+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhhh
Confidence 3321 112234566799999999889999999999999999999999987654322111 1110000011111122222
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
....... ... ....+.+++..||+.+|++|||+++|++.|+..
T Consensus 239 ~~~~~~~--~~~---~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPC--PKN---CPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCC--CCC---CCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2111100 111 123456678899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=334.32 Aligned_cols=254 Identities=22% Similarity=0.274 Sum_probs=199.3
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
.++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999964 6889999998542 223345678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++|+|.+++.. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998843 35788889999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccCCccccChhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
..........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... . .+.......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~---- 263 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHK---- 263 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCC----
Confidence 333233456799999999998653 4789999999999999999999998754321 0 111111100
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSL--RPTMSRVLQML 590 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~L 590 (642)
..+. ........ ..+.+++..||+.+|.+ ||++.|+++|-
T Consensus 264 --~~~~--~~~~~~~s---~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 264 --NSLT--FPDDIEIS---KQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred --CcCC--CCCcCCCC---HHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0000 00011112 23445667899999988 99999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.34 Aligned_cols=253 Identities=27% Similarity=0.411 Sum_probs=200.6
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|++.++||+|+||.||+|.+.++..||+|++.... ...+.+.+|+.++++++||||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688999999999999999998777789999886432 23457899999999999999999999874 456799999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+|+|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999998542 2346899999999999999999999998 9999999999999999999999999998665433222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||+..++.++.++||||||+++|||++ |+.||...... .. ........ .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~~---------~-- 221 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGY---------R-- 221 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcCC---------C--
Confidence 223446778999999998999999999999999999999 77787543221 00 01110000 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
..........+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 00011123356688889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.88 Aligned_cols=253 Identities=29% Similarity=0.475 Sum_probs=200.3
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|++.++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999998865332 3467899999999999999999999875 456899999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999998542 2346899999999999999999999998 9999999999999999999999999998765433222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+ ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~---------~~~- 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ----VERG---------YRM- 222 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcC---------CCC-
Confidence 222345678999999988899999999999999999999 88888543211 11110 1100 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011112346678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=332.63 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=198.4
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-----Cce
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ESL 385 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 385 (642)
+|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 47899999988542 3344567889999999999999999999988766 689
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+|+||+. ++|.+.+. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777763 3457899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh--
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE-- 542 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 542 (642)
............+++.|+|||.+.+. .++.++|||||||++|||++|+.||......... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHH
Confidence 54433333445688999999998874 4799999999999999999999999764422111 10100000000000
Q ss_pred ---------hccccccccccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 543 ---------LYDKNLMLHNYH--DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 543 ---------~~d~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
+........... ..........+.+++.+||+.||++|||+.|+++|-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000000000000 000001123456788899999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.12 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=199.4
Q ss_pred cCCccccccccccCceEEEEEEcCC------CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCc
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 384 (642)
+++|...+.||+|+||.||+|.+.+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999753 5678999875443 34456799999999999999999999999998899
Q ss_pred eEEEeecCCCChhhhhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC---cEEEE
Q 006514 385 LLVYEFLPNQSLDRFIFDSAK----AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIA 457 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 457 (642)
++||||+++++|.+++..... ...+++..++.++.+|+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 236899999999999999999999998 99999999999998764 59999
Q ss_pred ecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhh
Q 006514 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHF 535 (642)
Q Consensus 458 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 535 (642)
|||+++........ .......+..|+|||++.++.++.++|||||||++|||++ |+.||....... +.. ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~----~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME----FV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH
Confidence 99999876332221 1112234568999999999999999999999999999997 888886533211 111 01
Q ss_pred hcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... ..... .... ...+.+++.+|++.+|++||++.+|+++|+
T Consensus 235 ~~~---------~~~~~--~~~~---~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG---------GRLDP--PKGC---PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC---------CcCCC--CCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 00000 0111 234567788999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.90 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=188.2
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +++.||||++.... ....+.+..|..++... +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57889999986432 23344556677777654 899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999988843 356899999999999999999999998 9999999999999999999999999997643322 223
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .... .... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~---~~~~-i~~~--------~~~---- 214 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---E---LFDS-ILND--------RPH---- 214 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---H---HHHH-HHcC--------CCC----
Confidence 3467999999999999989999999999999999999999998754321 1 1111 1000 000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMS-RVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~~ 589 (642)
....... .+.+++..||+.||++||++. +++++
T Consensus 215 ~~~~~~~---~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 215 FPRWISK---EAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCH---HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0111222 334566799999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=333.18 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=196.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... +|+.||||++... .......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999964 6899999998643 2334456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999843 356899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc-------------------------------------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh
Q 006514 469 KSH-------------------------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (642)
Q Consensus 469 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 511 (642)
... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 006514 512 GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT---MSRVLQ 588 (642)
Q Consensus 512 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~ 588 (642)
|+.||....... . ... ..... ..+. .........+. .+++..|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~---~---~~~-i~~~~------~~~~--~~~~~~~s~~~---~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE---T---YRK-IINWK------ETLQ--FPDEVPLSPEA---KDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH---H---HHH-HHcCC------CccC--CCCCCCCCHHH---HHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999986543211 0 000 00000 0000 00011122333 345556775 8999998 999988
Q ss_pred Hh
Q 006514 589 ML 590 (642)
Q Consensus 589 ~L 590 (642)
|-
T Consensus 296 h~ 297 (364)
T cd05599 296 HP 297 (364)
T ss_pred CC
Confidence 73
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.71 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=199.9
Q ss_pred CccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
+|...+.||+|+||.||+|+.. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999852 23578888876443 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCC
Q 006514 387 VYEFLPNQSLDRFIFDSA---------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (642)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885321 1235889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 006514 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEY 523 (642)
Q Consensus 446 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~ 523 (642)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999865433222 1222345678999999988889999999999999999999 88888543211
Q ss_pred cchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 524 TDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
..+...... ..... .. .....+.+++..||+.+|++||++.||++.|+.
T Consensus 237 ------~~~~~~~~~---------~~~~~--~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 237 ------RLFNLLKTG---------YRMER--PE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ------HHHHHHhCC---------CCCCC--CC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 111111111 00000 11 112346678889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=315.13 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=201.3
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC--------------hhhHHHHHHHHHHHhcCCccceeeeee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--------------RHRAANFYNEVNIISSVEHKNLVRLLG 376 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l~~ 376 (642)
-++|++...||+|.||.|-++.. .+++.||||++.... ....+...+|+.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 47899999999999999999995 478999999985432 112357889999999999999999999
Q ss_pred eecc--CCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 377 CSCS--GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 377 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
+..+ .+..|||+||+..|.+...- .....++..++++++.+++.||+|||.++ ||||||||+|+||+++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 9765 46789999999988775432 22333999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCccccCCCCCc----ccccccCCccccChhhhccCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 006514 455 KIADFGLARSFQEDKSH----ISTAIAGTLGYMAPEYLAHGQ----LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDS 526 (642)
Q Consensus 455 kl~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~ 526 (642)
||+|||.+..+...... .....+|||.|+|||...++. .+.+.||||+||.||-|+-|+.||.....-
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---- 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---- 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence 99999999876333211 123468999999999988743 356789999999999999999998653321
Q ss_pred hHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCC
Q 006514 527 LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ 595 (642)
Q Consensus 527 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 595 (642)
. . ...++...+.. +...+.-..+-+|++++|++||++|.+..+|..|......
T Consensus 326 --~-l--------~~KIvn~pL~f-----P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 --E-L--------FDKIVNDPLEF-----PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --H-H--------HHHHhcCcccC-----CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 0 0 11223333321 1222334455567889999999999999999999876433
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.26 Aligned_cols=243 Identities=28% Similarity=0.375 Sum_probs=193.7
Q ss_pred ccccccCceEEEEEEc----CCCcEEEEEEeecc----ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 319 NKLGQGGFGTVYKGVL----PDGREIAVKRLFFN----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 35789999998643 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999998843 456788899999999999999999998 99999999999999999999999999875433222
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .... +.......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~--------~~~~~~~~ 219 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDK--------ILKGKLNL 219 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHH--------HHcCCCCC
Confidence 2234579999999999998889999999999999999999999986543210 0111 11111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
..... ..+.+++..||+.||++|| ++.+++++-
T Consensus 220 ----~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 220 ----PPYLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ----CCCCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 11111 2345677899999999999 899998863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.54 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
+.||+|+||.||++.+. +++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 7899999987543 344456799999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc-ccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI-STA 475 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~ 475 (642)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999843 2346899999999999999999999998 9999999999999999999999999987644321111 111
Q ss_pred ccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccC
Q 006514 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554 (642)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 554 (642)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+....... ....... ..... .
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~---------~~~~~-~- 217 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQ---------GVRLP-C- 217 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHc---------CCCCC-C-
Confidence 223567999999999999999999999999999998 877775432110 0000100 00000 0
Q ss_pred CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 555 DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 555 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... ....+.+++.+|++.+|++|||+.+|+++|.
T Consensus 218 ~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PEL---CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111 1234567788999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.53 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=200.2
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|+..++||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5688999999999999999996 478899999987655555567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999998843 356899999999999999999999998 999999999999999999999999999866432221
Q ss_pred ccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 472 ISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.....|+..|+|||.+. ...++.++||||||+++|||++|+.|+......... ..+.....
T Consensus 163 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---------------~~~~~~~~ 226 (267)
T cd06646 163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---------------FLMSKSNF 226 (267)
T ss_pred -cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---------------eeeecCCC
Confidence 22346888999999884 345788999999999999999999997543211100 00000000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.... ..........+.+++.+||+.+|++||++++|+++|
T Consensus 227 ~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPK--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 000111123456778899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.84 Aligned_cols=254 Identities=30% Similarity=0.489 Sum_probs=202.4
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.++|...++||+|+||.||++..++++.||+|.+.... ...+.+.+|+.++++++||||+++++++. ....++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35688899999999999999998889999999886433 33467899999999999999999999864 45789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++.++..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 3457899999999999999999999988 999999999999999999999999999876533322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||++..+.++.++||||||+++|||++ |+.||....... .. ...... ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~ 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI----QNLERG---------YRM 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH----HHHHcC---------CCC
Confidence 2223446778999999998899999999999999999999 999986433211 10 011111 000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .... ...+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ~~--~~~~---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PR--PDNC---PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC--CCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 1111 1246677889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.84 Aligned_cols=203 Identities=25% Similarity=0.340 Sum_probs=175.2
Q ss_pred HHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
...++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 33467999999999999999999965 6789999988542 2233456889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+||||+++|+|.+++.. ..+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 35888999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCcccccccCCccccChhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 54333233456799999999998753 3789999999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=332.72 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=173.1
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.+|++.+.||+|+||.||++... +++.||||.+.... ......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999954 68999999885432 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 356888999999999999999999998 999999999999999999999999997533210
Q ss_pred C------------------------------------------CcccccccCCccccChhhhccCCCCCcchHHHHHHHH
Q 006514 469 K------------------------------------------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506 (642)
Q Consensus 469 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll 506 (642)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 006514 507 LEIVTGRQNNRSKN 520 (642)
Q Consensus 507 ~elltG~~p~~~~~ 520 (642)
|||++|+.||....
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.68 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=193.7
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 6789999998643 333445678899988877 799999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|..++. +...+++..+..++.+++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99988874 3457899999999999999999999998 99999999999999999999999999875332221 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcc--cchhHHHHHHhhhcCcchhhcccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY--TDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+.+........ ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~~- 224 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------RI- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------CC-
Confidence 34679999999999999999999999999999999999999986422111 11111122221111110 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPT------MSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~evl~~ 589 (642)
+... ...+.+++.+||+.||++||+ +.++++|
T Consensus 225 ---p~~~---~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 ---PRSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCC---CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111 223456777999999999998 5788776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.42 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChh
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLD 397 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 397 (642)
+.||+|+||.||+|..++++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998889999999886543 333457899999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccccccc
Q 006514 398 RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477 (642)
Q Consensus 398 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 477 (642)
+++... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988532 346899999999999999999999998 999999999999999999999999998754332222222234
Q ss_pred CCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 478 gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
++..|+|||++..+.++.++||||||+++|||++ |..||....... .......+. .... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~--~~ 217 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGY---------RMSC--PQ 217 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---------CCCC--CC
Confidence 4678999999999999999999999999999999 888885432110 011111110 0000 01
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
.....+.+++..|++.+|++||++.|+++.|.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 ---KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11235667888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.86 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +++.||+|++... .....+.+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999964 6889999998643 233445688899999998 799999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++. +...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 99988874 3457999999999999999999999998 99999999999999999999999999875322211 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcc--cchhHHHHHHhhhcCcchhhcccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY--TDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+........ ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QIRI- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CCCC-
Confidence 34679999999999999999999999999999999999999996432211 111111122111111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPT------MSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~evl~~ 589 (642)
+... ...+.+++..||+.||++||+ +.++++|
T Consensus 225 ---p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 ---PRSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---CCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111 123556777999999999987 7888876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.81 Aligned_cols=254 Identities=23% Similarity=0.422 Sum_probs=197.8
Q ss_pred ccccccccccCceEEEEEEcCC----CcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC-----
Q 006514 315 FDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE----- 383 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 383 (642)
|.+.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999988643 23445679999999999999999999998876554
Q ss_pred -ceEEEeecCCCChhhhhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEec
Q 006514 384 -SLLVYEFLPNQSLDRFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (642)
Q Consensus 384 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 459 (642)
.++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999885432 2346899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhc
Q 006514 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 460 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
|+++........ ......++..|+|||.+....++.++||||||+++|||++ |..|+...... .+.... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hc
Confidence 999876543322 1122345678999999988889999999999999999999 88887543211 111111 11
Q ss_pred CcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
+.... ........+.+++.+||+.||++|||+.||++.|+.
T Consensus 231 ~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRLK--------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCC--------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 10000 011122356778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.84 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=192.8
Q ss_pred cccccCceEEEEEEc---CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 320 KLGQGGFGTVYKGVL---PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~---~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+||+|+||.||+|.+ ++++.+|+|++... .....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999974 35788999988543 2344577999999999999999999999875 45678999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc--
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI-- 472 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-- 472 (642)
+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||.||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 356899999999999999999999998 9999999999999999999999999998765443321
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+. .....+. ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT----QMIESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHCCC---------CCC
Confidence 122234678999999988889999999999999999998 99998653221 111 1111111 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ..... ..+.+++.+||+.||++||++.+|.+.|++
T Consensus 219 -~-~~~~~---~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 -C-PQRCP---PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -C-CCCCC---HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0 11112 245567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.26 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=198.6
Q ss_pred CccccccccccCceEEEEEEcC------CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
+|...++||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 257899999865432 334668899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc
Q 006514 387 VYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 453 (642)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985311 1245889999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHH
Q 006514 454 AKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTIT 531 (642)
Q Consensus 454 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 531 (642)
+||+|||+++........ ......+++.|+|||++.++.++.++||||||+++|||++ |..|+...... ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~--- 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVI--- 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---
Confidence 999999998865433221 2233456789999999998899999999999999999998 77776543211 111
Q ss_pred HHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 532 WKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 532 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
....... .. .. .... ...+.+++..||+.+|++||++.+|+..|+.
T Consensus 237 -~~i~~~~--------~~--~~-~~~~---~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 -EMIRNRQ--------VL--PC-PDDC---PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHcCC--------cC--CC-CCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111 10 00 1111 2235567889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=331.27 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=201.7
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|...+.||+|+||.||++... +|+.||||++.... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 78999999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999854 367899999999999999999999988 999999999999999999999999999866543
Q ss_pred C----------------------------CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 469 K----------------------------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 469 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 112234579999999999999999999999999999999999999987543
Q ss_pred CcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 006514 521 SEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-MSRVLQML 590 (642)
Q Consensus 521 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~~L 590 (642)
... .+....... ..+.... ..... ..+.+++..|++ ||.+||+ +.+++++.
T Consensus 235 ~~~-------~~~~i~~~~------~~~~~p~--~~~~~---~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQE-------TYNKIINWK------ESLRFPP--DPPVS---PEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHH-------HHHHHhccC------CcccCCC--CCCCC---HHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 211 011111100 0000000 11112 234556678997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.60 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=203.4
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|++|.||++... +++.|++|.+... .....+.+.+|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999964 6899999988643 345567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2467899999999999999999999988 99999999999999999999999999887654332
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
. .....|++.|+|||++.++.++.++||||||+++|||++|+.|+...... . .......+...
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~--------- 219 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---A----LILKIIRGVFP--------- 219 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCCC---------
Confidence 2 23356889999999999999999999999999999999999998654311 0 01111111100
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+||+.+|++||++.+++++
T Consensus 220 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011122346678889999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.12 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=198.4
Q ss_pred CCccccccccccCceEEEEEEcCC---------------CcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD---------------GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLG 376 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~ 376 (642)
++|++.+.||+|+||.||++...+ ...||+|.+... .......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 124899988643 3344567999999999999999999999
Q ss_pred eeccCCCceEEEeecCCCChhhhhhccc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEE
Q 006514 377 CSCSGPESLLVYEFLPNQSLDRFIFDSA---------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (642)
Q Consensus 377 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NIL 447 (642)
++......++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985421 1124789999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCccc
Q 006514 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKNSEYT 524 (642)
Q Consensus 448 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~p~~~~~~~~~ 524 (642)
+++++.+||+|||++......... ......++..|+|||++..+.++.++||||||+++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 999999999999999765433221 1223345778999999998999999999999999999998 45565433221
Q ss_pred chhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 525 DSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 525 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
......-..+.... ....... ... ....+.+++.+||+.||++|||+.+|++.|.
T Consensus 240 -~~~~~~~~~~~~~~------~~~~~~~--~~~---~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQG------RQIYLSQ--TPL---CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhcc------ccccCCC--CCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111000 0000000 011 1235678889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=316.36 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=202.4
Q ss_pred cCCccccccccccCceEEEEEEcCC-----------------CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD-----------------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVR 373 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 373 (642)
..+|++.+.||+|+||.||++.+.+ +..||+|.+.... ....+++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999988542 2458999886543 345678999999999999999999
Q ss_pred eeeeeccCCCceEEEeecCCCChhhhhhccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCC
Q 006514 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSA--------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (642)
Q Consensus 374 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (642)
+++++..++..++++||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 006514 446 ILLDSRLRAKIADFGLARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKNSE 522 (642)
Q Consensus 446 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~p~~~~~~~ 522 (642)
|+++.++.++|+|||+++....... .......+++.|+|||++..+.++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876543322 12234456789999999998899999999999999999998 5566643321
Q ss_pred ccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 523 YTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 523 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
..........+.......... ........+.+++.+||+.||++|||+.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP-----------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccCC-----------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111111000000 00111235678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.60 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=194.3
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||+|+||+||++... +++.||+|.+.... ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 78899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 006514 397 DRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475 (642)
Q Consensus 397 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 475 (642)
.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875422 3457899999999999999999999998 999999999999999999999999999765443322 234
Q ss_pred ccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCC
Q 006514 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHD 555 (642)
Q Consensus 476 ~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 555 (642)
..|++.|+|||++.+..++.++||||||+++|||++|+.||......... ... .. .+......
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~-~~--------~~~~~~~~------ 219 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL-KQ--------RILNDSVT------ 219 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHH-HH--------hhcccCCC------
Confidence 57899999999999999999999999999999999999998654321110 000 00 01111000
Q ss_pred CCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 556 SNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 556 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
........+.+++..||+.||++|| +++++++|
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 -YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0011123455677799999999999 78888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.46 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=199.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 68999999986432 2233457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887542 2356899999999999999999999998 9999999999999999999999999988654322
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||......... ....... ....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~---------~~~~- 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRV---------KEDQ- 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHh---------hhcc-
Confidence 2 12346899999999999889999999999999999999999999754322110 0000000 0000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
..........+.+++..||+.||++|| ++.+++++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000011122345677899999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=323.00 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=206.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC-ceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE-SLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 388 (642)
++|...+.+|+|+||.++..+.+ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998864 67899999886542 3334467899999999999999999999999888 89999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
+|++||++.+.|.+. +...++++.+..|+.|++.|+.|||++. |+|||||+.||+++.+..+||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999664 3578999999999999999999999776 999999999999999999999999999998776
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. ...+++||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. .|+.-..+ ....+
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~--------~~~~P-- 225 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINR--------GLYSP-- 225 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhh--------ccCCC--
Confidence 53 345689999999999999999999999999999999999999998765422 11111110 01111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+..... .+..++..|++.+|+.||++.+++.+
T Consensus 226 -----lp~~ys~---el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -----LPSMYSS---ELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCccccH---HHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1222223 34445568999999999999999975
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.16 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=194.7
Q ss_pred cccccccccCceEEEEEEcCCC-c--EEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC------CCc
Q 006514 316 DEANKLGQGGFGTVYKGVLPDG-R--EIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------PES 384 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 384 (642)
.+.+.||+|+||.||+|.+.++ + .+|+|.+... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999997543 2 5899987543 345567899999999999999999999976432 246
Q ss_pred eEEEeecCCCChhhhhhcc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 385 LLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
++++||+++|+|.+++... .....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887432 12345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 462 ARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 462 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
++........ ......+++.|++||++.+..++.++||||||+++|||++ |+.||...... . .+.....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcCC
Confidence 9876543321 1223346778999999999999999999999999999999 78887542211 1 111111111
Q ss_pred chhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 540 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... . .... ...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 232 ~~~----------~-~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RLK----------Q-PPDC---LDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC----------C-CCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 100 0 1111 1235678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.90 Aligned_cols=259 Identities=28% Similarity=0.404 Sum_probs=203.3
Q ss_pred HcCCccccccccccCceEEEEEEcC------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 382 (642)
..++|+..+.||+|+||.||++... +...+|+|.+... ......++.+|+.++.++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999853 2367899988643 234456788999999999 7999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~ 449 (642)
..+++|||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 22457899999999999999999999988 99999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 006514 450 SRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSL 527 (642)
Q Consensus 450 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l 527 (642)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 9999999999999876543322 1222345678999999998899999999999999999998 888875432111
Q ss_pred HHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 528 LTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 528 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.......+. .. .........+.+++.+||+.||++|||+.||++.|+..
T Consensus 243 ---~~~~~~~~~---------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGY---------RM-----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCC---------cC-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111110 00 00111223566788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.19 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=192.9
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHH---hcCCccceeeeeeeeccCCCceEE
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNII---SSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999864 68999999986432 23345566676655 567899999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 356999999999999999999999998 99999999999999999999999999875332
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... . . ...... .
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~---~-~~i~~~--------~ 217 (324)
T cd05589 154 FGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---V---F-DSIVND--------E 217 (324)
T ss_pred CCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---H---H-HHHHhC--------C
Confidence 222 2234679999999999999999999999999999999999999986543211 0 0 001111 0
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
... ..... ..+.+++.+||+.||++|| ++.+++++.
T Consensus 218 ~~~----p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 218 VRY----PRFLS---REAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred CCC----CCCCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 000 11111 2345677799999999999 688888764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.66 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=206.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7899999987532 3344667899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 389 EFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
||+++++|.+++.... ....+++.+++.++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999885432 2456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... +.... .....+...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~------ 226 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEKCDYP------ 226 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHH-hhhhcCCCC------
Confidence 3221 22346888999999999888999999999999999999999998543311 11100 001111000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
..........+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 227 -------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 -------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 000011223455778899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=325.95 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.||+|+||.||++.. .+|+.||+|.+... .......+.+|+.++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 47899999998643 2334456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
+|.+++. +...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9998884 34578999999999999999999997 66 99999999999999999999999999875432222 12
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~----i~~~--------~~~~--- 215 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL----ILME--------EIRF--- 215 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHH----HhcC--------CCCC---
Confidence 34579999999999999999999999999999999999999986543211 1110 0000 0000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQML 590 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 590 (642)
...... .+.+++.+||+.||++|+ ++.++++|.
T Consensus 216 -p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 216 -PRTLSP---EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -CCCCCH---HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 111122 345667799999999996 999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.37 Aligned_cols=254 Identities=26% Similarity=0.492 Sum_probs=201.1
Q ss_pred CCccccccccccCceEEEEEEcC-CC---cEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DG---REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
++|+..+.||+|+||.||+|.+. ++ ..+++|.+... .....+.+.+|+.++++++||||+++++++......++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999964 33 36899988654 344456799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++++|.+++.. +...+++.++..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999854 2357899999999999999999999998 99999999999999999999999999986654
Q ss_pred CCCccc--ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 468 DKSHIS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 468 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
...... .....+..|+|||++..+.++.++||||||+++|||++ |+.|+...... . ........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~----~~~~i~~~------ 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---E----VMKAINDG------ 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---H----HHHHHhcC------
Confidence 332211 11223557999999998899999999999999999998 99998543221 0 11111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.... ........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 ---~~~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 227 ---FRLP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---CCCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0000 001112346688889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=311.21 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=204.2
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 57899999987542 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 389 EFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
||+++++|.+++.... ....+++..++.++.++++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885422 2456899999999999999999999998 99999999999999999999999999876544
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ .. .... .....+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~-----~~~~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL-CKKI-----EQCDYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HH-hhhh-----hcCCCCC
Confidence 3221 2234688899999999988899999999999999999999999864322100 00 0000 0000010
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .. .....+.+++.+||+.||++||||.+|++.+..
T Consensus 228 ~~-----~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 228 LP-----SD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CC-----cc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 00 11 122245567779999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.72 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 6789999998643 233445688999999888 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 99998874 3357999999999999999999999998 99999999999999999999999999875322211 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~--- 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRI--- 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCC---
Confidence 346799999999999999999999999999999999999999965433222222222222221111 000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPT------MSRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~evl~~ 589 (642)
+.... ..+.+++.+||+.||++||+ +.++++|
T Consensus 223 -p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 -PRFLS---VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11111 23456777999999999998 5688776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.15 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=200.7
Q ss_pred CCccccccccccCceEEEEEEcC------CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
.++...++||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999632 456789998876666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 387 VYEFLPNQSLDRFIFDSAK------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
++||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006514 455 KIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 455 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 532 (642)
||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A---IE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H---HH
Confidence 99999999765433221 1223345778999999999999999999999999999998 888875432211 0 00
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
. ...+. .... ..... ..+.+++.+||+.||++||++.||++.|+
T Consensus 236 ~-~~~~~---------~~~~--~~~~~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 C-ITQGR---------ELER--PRTCP---PEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HHcCc---------cCCC--CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 00000 0000 11111 23456778999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.22 Aligned_cols=263 Identities=29% Similarity=0.404 Sum_probs=195.4
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC-----ceEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE-----SLLV 387 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lv 387 (642)
.|...+.+|.|.||.||+|.+. ++++||||+...+.+.. -+|+++|+++.|||||+|+-++....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677889999999999999964 57999999986554322 369999999999999999988764322 2489
Q ss_pred EeecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCCcccc
Q 006514 388 YEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSF 465 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 465 (642)
|||||. +|.+++.+.. .+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 8888885421 2456777777789999999999999988 9999999999999977 89999999999987
Q ss_pred CCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcch---
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE--- 541 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--- 541 (642)
...... .....|.-|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.... +++..+. +.+.....+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIi-k~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEII-KVLGTPTREDIK 251 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHH-HHhCCCCHHHHh
Confidence 655443 34567889999999887 46999999999999999999999988775433 2232222 111111111
Q ss_pred -------hhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 542 -------ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 -------~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+...+.+.......-.......+.+++..++++.+|.+|.++.|++.|
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111122222211111112233456677789999999999999999976
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.67 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=196.7
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+|+..+.||+|+||.||++.. .+++.||+|.+... ......++.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999985 47889999988654 3344567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999986542 4678889999999999999999998 9999999999999999999999999997654322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....................... .+.+.
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-- 221 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP-- 221 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC--
Confidence 2335789999999999988999999999999999999999999865332211110000001000000 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.+++.+|++.+|++||+++|++++
T Consensus 222 ---~~~---~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ---VGQ---FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCc---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011 12245677889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.87 Aligned_cols=201 Identities=25% Similarity=0.402 Sum_probs=173.1
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999985 47899999998543 2334467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999843 356889999999999999999999998 999999999999999999999999998643211
Q ss_pred CCc----------------------------------------------ccccccCCccccChhhhccCCCCCcchHHHH
Q 006514 469 KSH----------------------------------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502 (642)
Q Consensus 469 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~ 502 (642)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 006514 503 GMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 503 Gvll~elltG~~p~~~~ 519 (642)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (377)
T cd05629 235 GAIMFECLIGWPPFCSE 251 (377)
T ss_pred chhhhhhhcCCCCCCCC
Confidence 99999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=314.02 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=200.6
Q ss_pred CCccccccccccCceEEEEEEc-CCCc----EEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
.+|+..+.||+|+||.||+|.+ .+|+ .||+|++... ......++.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4688889999999999999985 3454 4899988643 34445678999999999999999999998875 45789
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998542 356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... .+... +..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~--- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKGERL--- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCcC---
Confidence 43322 1122345678999999998999999999999999999998 88887543211 11111 1111000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 597 (642)
.. .. .....+.+++..||+.||++||++.++++.|+.....|
T Consensus 231 ------~~--~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ------PQ--PP---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CC--Cc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00 01 11224567788999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=309.53 Aligned_cols=253 Identities=29% Similarity=0.440 Sum_probs=199.2
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|...++||+|++|.||++.++++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999875433 33467889999999999999999999875 456789999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999998643 2345899999999999999999999998 9999999999999999999999999997654433222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||...++.++.++||||||+++|||++ |+.|+...... .. +....... .. .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~-----~~----~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EV----LEQVERGY-----RM----P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCC-----CC----C
Confidence 223346778999999998899999999999999999999 88887643221 11 11111110 00 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... .....+.+++.+||+.||++||++.+|++.|+.
T Consensus 224 --~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 --CPQ---GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCc---ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011 112345567789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=310.10 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=199.3
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC-----hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
++|...+.||+|++|.||++.. .+++++++|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999986 468999999885432 2234578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
|+||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 356889999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCCccc--ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSHIS--TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC----
Confidence 3222211 3356788999999999988999999999999999999999998643211 101110000000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+ ... ....+.+++..||+.+|.+|||+.+++++
T Consensus 226 -~~~------~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -PQL------PSH---VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCC------Ccc---CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 111 11234567779999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=296.46 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=201.5
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--------hhhHHHHHHHHHHHhcC-CccceeeeeeeeccC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--------RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 381 (642)
-..|+..+.||.|..+.|-+...+ +|++.|+|++.... ....+.-.+|+.+|+++ .||+|+++.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356788889999999999988854 78999999885321 12234456799999998 699999999999999
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++|+|.|+.|.|.++|. ..-.++++...+|+.|+.+|+.|||..+ |+||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999993 4567999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhh
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 535 (642)
+........ ....+|||+|+|||.+. ...|+..+|+|+.|||||-|+.|.+||..... + ......
T Consensus 170 a~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m--lMLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M--LMLRMI 240 (411)
T ss_pred eeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H--HHHHHH
Confidence 998766543 35689999999999985 34689999999999999999999999854211 0 111222
Q ss_pred hcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.+++.. . . .+.-.+......+++.+||+.||.+|.|++|++.|-
T Consensus 241 meGkyq-F-------~---speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 241 MEGKYQ-F-------R---SPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred Hhcccc-c-------C---CcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 222221 0 0 111112223344677799999999999999999873
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.91 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=203.5
Q ss_pred cCCccccccccccCceEEEEEEcCC-----CcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeecc-CCCc
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 384 (642)
.++|+..+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999765 688999988643 34456778999999999999999999998766 5678
Q ss_pred eEEEeecCCCChhhhhhccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEec
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKA-----KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 459 (642)
++++||+++++|.+++...... ..+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998653322 56899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhc
Q 006514 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 460 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
|+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+...... .+. .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHc
Confidence 999866443322 2223346778999999998889999999999999999999 99988643221 111 11111
Q ss_pred CcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
+. .... ... ....+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 235 ~~---------~~~~--~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GY---------RLAQ--PIN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CC---------CCCC--CCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 0000 001 112456788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=320.88 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=194.7
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCc-cceeeeeeeeccCCCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 388 (642)
+|+..+.||+|+||.||+|... +++.||||++... .....+.+..|..++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 5788999998643 23345668889999999976 46888999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 356899999999999999999999998 999999999999999999999999998753222
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ...... .
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~----~i~~~~--------~ 218 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQ----SIMEHN--------V 218 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCC--------C
Confidence 21 223457999999999999999999999999999999999999998653321 1111 011110 0
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM-----SRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~~ 589 (642)
.. ..... ..+.+++.+||+.||++||+. .++++|
T Consensus 219 ~~----~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 SY----PKSLS---KEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CC----CCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 11111 234567779999999999976 777765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.06 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=172.5
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.|+..++||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999996 468899999986432 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++|+|.+++.. ...+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 356889999999999999999999998 9999999999999999999999999975332100
Q ss_pred ----------------------------------------------CcccccccCCccccChhhhccCCCCCcchHHHHH
Q 006514 470 ----------------------------------------------SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG 503 (642)
Q Consensus 470 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~G 503 (642)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 006514 504 MLLLEIVTGRQNNRSK 519 (642)
Q Consensus 504 vll~elltG~~p~~~~ 519 (642)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (382)
T cd05625 236 VILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.86 Aligned_cols=202 Identities=25% Similarity=0.331 Sum_probs=174.7
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|...+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 6788999988542 2233455888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 356899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCcccccccCCccccChhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 469 KSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
.........||+.|+|||++.+ +.++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 3333334579999999999875 56889999999999999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.84 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=193.3
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||+|+.. +++.||||++... .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 5789999998643 233445677899998876 799999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|...+.. ...+++..+..++.+|+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999988843 456899999999999999999999998 99999999999999999999999999875432222 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. .....+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~----~~i~~~~--------~~~--- 215 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF----ESILHDD--------VLY--- 215 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCC--------CCC---
Confidence 34578999999999999999999999999999999999999997543211 11 1111110 000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHh
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRP-------TMSRVLQML 590 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-------s~~evl~~L 590 (642)
..... ..+.+++..||+.||++|| ++.+++++-
T Consensus 216 -p~~~~---~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 216 -PVWLS---KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred -CCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 11111 2345677799999999999 899998774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.60 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=192.1
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++..+ +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 6889999998643 223445677888888876 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999988843 356899999999999999999999998 99999999999999999999999999875432222 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... + ......+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~----~~~i~~~~--------~~~--- 215 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---L----FEAILNDE--------VVY--- 215 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H----HHHHhcCC--------CCC---
Confidence 34579999999999999999999999999999999999999987543211 0 11111111 000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTM------SRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~------~evl~~ 589 (642)
..... ..+.+++..||+.||++||++ +++++|
T Consensus 216 -~~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 -PTWLS---QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCC---HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11112 234567779999999999998 777766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.19 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=188.0
Q ss_pred ccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHH-HHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++.. .+|+.+|+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999995 47899999998643 2233345556655 56778999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|..++. +...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99988874 3457899999999999999999999998 99999999999999999999999999875322211 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ... ....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~-~~~--------~~~~~~~--- 215 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMY-DNI--------LHKPLVL--- 215 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHH-HHH--------HcCCccC---
Confidence 3467999999999999999999999999999999999999998653211 111 111 1111110
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMS----RVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~----evl~~ 589 (642)
.... ...+.+++..|++.+|++||+++ +++++
T Consensus 216 -~~~~---~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 216 -RPGA---SLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred -CCCC---CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 1111 12345677799999999999875 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.34 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=199.5
Q ss_pred CCccccccccccCceEEEEEEcC-----------------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-----------------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRL 374 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 374 (642)
++|+..++||+|+||.||++... ++..+|+|++... .......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 2346899988644 33445689999999999999999999
Q ss_pred eeeeccCCCceEEEeecCCCChhhhhhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCE
Q 006514 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAK--------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446 (642)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NI 446 (642)
++++...+..++||||+++++|.+++..... ...+++...+.++.+++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 235788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCcc
Q 006514 447 LLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT--GRQNNRSKNSEY 523 (642)
Q Consensus 447 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~p~~~~~~~~ 523 (642)
|++.++.++|+|||+++........ ......++..|++||....+.++.++||||||+++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865443221 1222345678999999988899999999999999999998 667765432211
Q ss_pred cchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 524 TDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
........+...... ...+ . ... ....+.+++.+||+.||++||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~~-~~~~-----~--~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 ---VIENTGEFFRDQGRQ-VYLP-----K--PAL---CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHhhcccc-ccCC-----C--CCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111110000 0000 0 111 1135567888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=313.06 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=202.1
Q ss_pred CCccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++..++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 56888899999999999999864 24689999986443 344567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEe
Q 006514 386 LVYEFLPNQSLDRFIFDSA-------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 458 (642)
+||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 9999999999999986432 1235789999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhh
Q 006514 459 FGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 459 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
||+++........ ......++..|+|||.+..+.++.++||||||+++|||++ |+.|+...... ... ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVL----KFVI 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHH----HHHh
Confidence 9999865443321 2233456789999999998899999999999999999998 88887543221 111 1111
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
.+..... .... ...+.+++..||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~~-----------~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLDL-----------PENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCCC-----------CCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110000 1111 235567888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=308.67 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=202.1
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.++|...++||+|+||.||++.+.++..+++|.+... ....+.+.+|+.++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678899999999999999999877888999987543 3345678999999999999999999999877 7789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2456899999999999999999999988 999999999999999999999999999865443322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||++..+.++.++||||||+++|||++ |+.|+...... .+. .....+. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~---------~~ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERGY---------RM 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhCCC---------CC
Confidence 2223345678999999998889999999999999999999 88888643211 111 1111110 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ........+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 P-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C-----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 001122345677889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.63 Aligned_cols=205 Identities=24% Similarity=0.330 Sum_probs=176.5
Q ss_pred HHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC
Q 006514 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 308 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 383 (642)
+....++|+..+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3444578999999999999999999965 6889999988532 22334567889999999999999999999999999
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.++||||+++|+|.+++.. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998843 35788889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCccccChhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
..............||+.|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 7654433333456799999999998753 3789999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.33 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=200.1
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999964 6788899987543 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999843 35689999999999999999999974 5 9999999999999999999999999987543321
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC-----------
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG----------- 538 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 538 (642)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+......................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 234578899999999988889999999999999999999999986433211100000000000000
Q ss_pred ------cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 ------RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ------~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
...++.+........... .......+.+++.+||+.+|++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000000 00012246678889999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=321.79 Aligned_cols=242 Identities=26% Similarity=0.313 Sum_probs=191.2
Q ss_pred ccccccCceEEEEEEc----CCCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 319 NKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999986432 2233457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+|+|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999998843 456899999999999999999999998 99999999999999999999999999886543322 2
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ... .... ....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~---~~~-i~~~--------~~~~-- 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ET---MTM-ILKA--------KLGM-- 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HH---HHH-HHcC--------CCCC--
Confidence 23457899999999999888999999999999999999999998653211 00 000 1010 0000
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQM 589 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 589 (642)
..... ..+.+++..||+.||++||+ +.+++++
T Consensus 218 --p~~~~---~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 218 --PQFLS---PEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred --CCCCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 11112 23446677999999999999 5556554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=309.90 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEcCC-------------CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 319 NKLGQGGFGTVYKGVLPD-------------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358899876555555667899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc-------EEEEe
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR-------AKIAD 458 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~D 458 (642)
+||||+++|+|..++.. +...+++..++.++.||++||.|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 2356899999999999999999999998 999999999999987664 89999
Q ss_pred cCCccccCCCCCcccccccCCccccChhhhc-cCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCcccchhHHHHHHhhh
Q 006514 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIV-TGRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 459 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+........ ..+.
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~ 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFY 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHH
Confidence 9998754322 2245788899999987 466899999999999999998 57777653221100 0000
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... .... .. . ...+.+++..||+.||++||++.+|+++|+
T Consensus 223 ~~~--------~~~~---~~-~---~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ--------CMLV---TP-S---CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC--------ccCC---CC-C---hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 100 0000 11 1 123556788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=308.06 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=201.2
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|+..+.||+|+||.||++... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46788899999999999999875 78999999865544 56789999999999999999999999999899999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999985432 236899999999999999999999998 99999999999999999999999999987633221
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
....+..|+|||++..+.++.++||||||+++|||++ |+.|+...... .+ ......+...+.
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~~-------- 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPHVEKGYRMEA-------- 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhcCCCCCC--------
Confidence 2334667999999998899999999999999999998 98887543211 11 111111100000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... ....+.+++.+||+.+|++||+++||+++|+.
T Consensus 221 ---~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEG---CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 011 12345677889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.27 Aligned_cols=255 Identities=28% Similarity=0.428 Sum_probs=197.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCc--EEEEEEeec-cChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR--EIAVKRLFF-NNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 387 (642)
++|++.+.||+|+||.||+|... ++. .+++|.+.. ......+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 56888899999999999999865 333 468887763 2344556789999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 388 YEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999988 9999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHH
Q 006514 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWK 533 (642)
Q Consensus 455 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 533 (642)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||...... . .+.
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~----~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---E----LYE 229 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHH
Confidence 9999999864322111 111223557999999998889999999999999999998 99998643221 1 111
Q ss_pred hhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 534 HFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 534 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
....+ ..... .... ...+.+++..||+.+|.+||++.+|++.|+..
T Consensus 230 ~~~~~---------~~~~~--~~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 KLPQG---------YRMEK--PRNC---DDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHhcC---------CCCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 00000 1111 12456788899999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=307.48 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=191.8
Q ss_pred cccccCceEEEEEEcC---CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCC
Q 006514 320 KLGQGGFGTVYKGVLP---DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 395 (642)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 45579999886543 334567999999999999999999999875 457899999999999
Q ss_pred hhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc--c
Q 006514 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI--S 473 (642)
Q Consensus 396 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~ 473 (642)
|.+++.. ....+++..++.++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 3457899999999999999999999998 9999999999999999999999999998654433221 1
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
....++..|+|||.+....++.++||||||+++|||++ |+.|+....... .......+... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~- 218 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------D- 218 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------C-
Confidence 12234578999999998889999999999999999997 999986543211 11111111100 0
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. +... ...+.+++..||+.+|++||++.+|.+.|+.
T Consensus 219 ~-~~~~---~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 219 C-PAEC---PPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred C-CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 0 1111 2344567779999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.42 Aligned_cols=242 Identities=25% Similarity=0.342 Sum_probs=188.4
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHH-HHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +|+.||+|++.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 78999999986432 223344555554 56789999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence 999998843 457899999999999999999999998 99999999999999999999999999875322221 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... . .+.......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~-~--------~i~~~~~~~--- 215 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMY-D--------NILNKPLRL--- 215 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHH-H--------HHHcCCCCC---
Confidence 3457999999999999999999999999999999999999998653211 110 1 011111110
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTM----SRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~evl~~ 589 (642)
.... ...+.+++..||+.||++||++ .+++++
T Consensus 216 -~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 216 -KPNI---SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -CCCC---CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1111 2235567779999999999987 466654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.99 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=202.4
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+|+..+.||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999985 478999999987666556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++. ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999883 245889999999999999999999998 999999999999999999999999998765433221
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||....... .+. ....... . .
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~----~~~~~~~-~-----~---- 235 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATNGT-P-----E---- 235 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH----HHhcCCC-C-----C----
Confidence 223468899999999998889999999999999999999999986543211 000 0000000 0 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.+|++||++.+|+++
T Consensus 236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 ---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00011122345567789999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.29 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=191.2
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||+|+||.||++..+ +|+.+|+|++.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999885321 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 476 (642)
.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9887543 2345899999999999999999999998 99999999999999999999999999886644322 2335
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
.|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ ...... ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~---------~~~~~~---~~~ 220 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL---------EDEVKF---EHQ 220 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh---------cccccc---ccc
Confidence 6899999999999988999999999999999999999998653322111 11111101 000000 011
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ..+.+++..||+.||++||+++|+++.
T Consensus 221 ~~~---~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 221 NFT---EESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cCC---HHHHHHHHHHhccCHhhCCCCccchhh
Confidence 112 234567779999999999999777644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=313.60 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=201.3
Q ss_pred cCCccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCc
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 384 (642)
.++|+..+.||+|+||.||++..+ ++..||+|.+.... .....++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999886442 34456799999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhccc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCC
Q 006514 385 LLVYEFLPNQSLDRFIFDSA-------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (642)
++|+||+++|+|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1235788999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 006514 446 ILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEY 523 (642)
Q Consensus 446 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~ 523 (642)
|++++++.+||+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999998765433221 1222345678999999998999999999999999999998 77777533211
Q ss_pred cchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 524 TDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. ......+.. ... ... ....+.+++.+||+.+|++|||+.||++.|++
T Consensus 240 --~~----~~~~~~~~~--------~~~---~~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EV----IYYVRDGNV--------LSC---PDN---CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH----HHHHhcCCC--------CCC---CCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 011111111 000 011 12356678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.54 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=202.6
Q ss_pred cCCccccccccccCceEEEEEEc--------CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL--------PDGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 381 (642)
.++|.+.+.||+|+||.||++.. .++..||+|.+... ......++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688889999999999999973 13457999988543 234456789999999999 899999999999999
Q ss_pred CCceEEEeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl 448 (642)
...++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999996532 1246889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 006514 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDS 526 (642)
Q Consensus 449 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~ 526 (642)
++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 99999999999999876543322 1223346678999999998889999999999999999998 77776432211
Q ss_pred hHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCC
Q 006514 527 LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQL 596 (642)
Q Consensus 527 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 596 (642)
.+ ......+... .. .... ...+.+++..||+.+|++|||+.||++.|+....+
T Consensus 247 --~~-~~~~~~~~~~---------~~--~~~~---~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 --EL-FKLLKEGHRM---------DK--PANC---TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --HH-HHHHHcCCcC---------CC--CCCC---CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11 1111111100 00 1111 23455677899999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.69 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=200.6
Q ss_pred HcCCccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 383 (642)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999743 24579999875433 2334568899999999999999999999999999
Q ss_pred ceEEEeecCCCChhhhhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK-------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 244678889999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006514 457 ADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKH 534 (642)
Q Consensus 457 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 534 (642)
+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~---- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF---- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----
Confidence 999998865433221 1222345678999999999999999999999999999999 67777543211 11110
Q ss_pred hhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
+.+...... ... ....+.+++.+|++.||++|||+.++++.|...
T Consensus 234 --------~~~~~~~~~---~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 --------VMDGGYLDQ---PDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHcCCCCCC---CCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 011100000 011 123566788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.23 Aligned_cols=268 Identities=22% Similarity=0.364 Sum_probs=197.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|...++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999986443 22334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 787777432 345889999999999999999999998 99999999999999999999999999976543322
Q ss_pred cccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhhhcCcch
Q 006514 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------TWKHFQAGRVE 541 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~~ 541 (642)
. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .|+.+....
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND-- 236 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh--
Confidence 1 223467899999999865 4689999999999999999999999875443211111110 111111100
Q ss_pred hhccccccccccCC--CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 542 ELYDKNLMLHNYHD--SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 ~~~d~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..+.......... .........+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000000 0000112234578889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=308.41 Aligned_cols=255 Identities=31% Similarity=0.482 Sum_probs=203.9
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.++|.+.+.||+|+||.||++.+++++.|+||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788999999999999999998888899999886433 34567999999999999999999999999888999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999998542 2356899999999999999999999998 999999999999999999999999999876543222
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+ ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~---------~~~ 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE----QVERG---------YRM 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC---------CCC
Confidence 2222335678999999998889999999999999999999 89888543211 1111 11100 000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .... ...+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~--~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PR--PPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC--CCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 0111 2345678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.53 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=199.8
Q ss_pred HHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 309 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
+.+++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445667777789999999999999954 6788999988766666677899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-CCcEEEEecCCccccC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQ 466 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~ 466 (642)
+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322222378888999999999999999998 999999999999986 6799999999987654
Q ss_pred CCCCcccccccCCccccChhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.... ......+++.|+|||++.... ++.++||||||+++|||++|+.|+........ ..+.......
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~----- 229 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGMFKI----- 229 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhhhcc-----
Confidence 3222 122346889999999987644 78999999999999999999999854321110 0010000000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+.+ .... ...+.+++.+||+.+|++|||+.||+++
T Consensus 230 ~~~~------~~~~---~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 HPEI------PESL---SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCC------Cccc---CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000 1111 2234567789999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=309.91 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=199.7
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHH--HHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
|+..+.||+|+||+||+++.. +++.+|+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999965 5678999999766544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++. +...+++..++.++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTS
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999995 4567899999999999999999999998 99999999999999999999999999986522 222
Q ss_pred ccccccCCccccChhhhc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||++. +..++.++||||+|+++|+|++|..|+............. ..... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~----~~~~~---- 222 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR----PLPSS---- 222 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT----HHHHH----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc----ccccc----
Confidence 334567899999999998 7889999999999999999999999987641111111000 00000 00000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++..||+.||++||++.+++++
T Consensus 223 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 ----SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ----TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ----ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011566778889999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=327.28 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=200.0
Q ss_pred cCCccccccccccCceEEEEEEcC------CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPE 383 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 383 (642)
.++|...++||+|+||.||+|++. .++.||||++.... ....+.+.+|+.++.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356778899999999999999853 34689999996542 333457889999999997 9999999999999999
Q ss_pred ceEEEeecCCCChhhhhhcccc----------------------------------------------------------
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK---------------------------------------------------------- 405 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 405 (642)
.++|+||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864211
Q ss_pred -------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE
Q 006514 406 -------------------------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 406 -------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl 448 (642)
...+++...+.++.+++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124678889999999999999999987 9999999999999
Q ss_pred cCCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 006514 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDS 526 (642)
Q Consensus 449 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~ 526 (642)
++++.+||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |+.|+.......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 99999999999999865432221 1223456789999999998889999999999999999998 888875432111
Q ss_pred hHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 527 LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 527 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
........+ ..... .... ...+.+++..||+.+|++||+++||++.|+.
T Consensus 350 ---~~~~~~~~~---------~~~~~--p~~~---~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 ---QFYNAIKRG---------YRMAK--PAHA---SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ---HHHHHHHcC---------CCCCC--CCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011111111 00000 1111 1245567779999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.81 Aligned_cols=252 Identities=26% Similarity=0.475 Sum_probs=200.3
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
.+|+..+.||+|+||.||++.+.+++.+|+|.+.... ....++.+|++++++++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577888999999999999998778899999885432 234578999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++.. ....++++.+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999998853 2346889999999999999999999998 9999999999999999999999999987654332222
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.|+...... . .... ...+. ....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~---~~~~-~~~~~--~~~~------ 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---E---VVET-INAGF--RLYK------ 222 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H---HHHH-HhCCC--CCCC------
Confidence 222335678999999998899999999999999999998 88887643211 1 1110 11100 0000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... ....+.+++.+||+.+|++|||+.+|+++|.
T Consensus 223 ---~~~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ---PRL---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCC---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111 1235667888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.46 Aligned_cols=250 Identities=28% Similarity=0.410 Sum_probs=201.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|+..+.||+|+||.||++... +++.+++|.+..... .+++.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888999999999999999976 478999998865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++.. ....+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999843 2457899999999999999999999998 99999999999999999999999999887654332
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ....... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~---- 218 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKP-----PPT---- 218 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCC-----CCC----
Confidence 223345788999999999889999999999999999999999998653221100 0000000 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.||++|||+.||+++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 ---LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred ---CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00111112345677789999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.32 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=194.6
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 388 (642)
+|...+.||+|+||.||++... +++.||||.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 57899999986432 23334567788888877 5899999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 356899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ...... .
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~----~i~~~~--------~ 218 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ----SIMEHN--------V 218 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCC--------C
Confidence 22 223467999999999999999999999999999999999999998654321 1111 111111 1
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM-----SRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~~ 589 (642)
.. +... ...+.+++.+|++.||++|++. .++++|
T Consensus 219 ~~----p~~~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 AY----PKSM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CC----CCcC---CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 00 1111 2244567789999999999984 777765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.07 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=189.2
Q ss_pred ccccccCceEEEEEEcC---CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 319 NKLGQGGFGTVYKGVLP---DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999854 34578999886543 334457899999999999999999999999999999999999999
Q ss_pred Chhhhhhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-
Q 006514 395 SLDRFIFDSA--KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH- 471 (642)
Q Consensus 395 ~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 471 (642)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2235678888899999999999999998 999999999999999999999999998754433222
Q ss_pred ccccccCCccccChhhhccC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 472 ISTAIAGTLGYMAPEYLAHG-------QLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
......++..|+|||++... .++.++||||||+++|||++ |+.||....... ...... .+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh----hcccCCC
Confidence 12234578889999998642 35889999999999999997 999986433211 111111 0111111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
.++.+ ...... .+.+++..|+ .+|++|||+.||+..|+
T Consensus 231 ~~~~~------~~~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL------KLPLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc------CCCCCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 011112 2344566788 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=311.99 Aligned_cols=239 Identities=25% Similarity=0.386 Sum_probs=186.5
Q ss_pred cccccCceEEEEEEcCC-------------------------CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeee
Q 006514 320 KLGQGGFGTVYKGVLPD-------------------------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 374 (642)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998865555556678999999999999999999
Q ss_pred eeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC--
Q 006514 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-- 452 (642)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-- 452 (642)
++++......++||||+++|+|..++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998853 2357899999999999999999999988 99999999999997644
Q ss_pred -----cEEEEecCCccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCcccc
Q 006514 453 -----RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIV-TGRQNNRSKNSEYTD 525 (642)
Q Consensus 453 -----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~ell-tG~~p~~~~~~~~~~ 525 (642)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3899999987643222 12356788999998875 56899999999999999995 68888764322111
Q ss_pred hhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 526 SLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 526 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
.. .+....... .. . ...+.+++..||+.+|++|||+.+|++.|+
T Consensus 231 --~~-------------~~~~~~~~~---~~-~---~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ER-------------FYEKKHRLP---EP-S---CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HH-------------HHHhccCCC---CC-C---ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 001000000 00 1 124567888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.79 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=174.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 6899999998642 2334456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2356899999999999999999999998 999999999999999999999999998766544
Q ss_pred CCcccccccCCccccChhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 469 KSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
.........||+.|+|||++.. +.++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 3333334569999999999873 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=314.98 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=201.1
Q ss_pred CCccccccccccCceEEEEEEc------CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
++|...+.||+|+||.||++.. ..+..||||.+.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999974 134579999886443 34456789999999999 799999999999999999
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++||||+++|+|.+++... ....+++.++..++.+++.||.|||+++ ++|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999998542 2234899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
....... ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+....... ... .....+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~---- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEG---- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcC----
Confidence 5443321 1222346778999999999999999999999999999998 888875432210 010 111111
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
..... .... ...+.+++..|++.+|++|||+.||++.|+.
T Consensus 261 -----~~~~~--~~~~---~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 -----YRMAQ--PEHA---PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -----CcCCC--CCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00000 1111 2345678889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=317.62 Aligned_cols=242 Identities=25% Similarity=0.342 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhc-CCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISS-VEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||+|... +++.||||++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 57899999986432 2334456678888876 4899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+++.+...++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999998843 356899999999999999999999998 99999999999999999999999999875332221 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....... +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~------~~~----- 215 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF----QSIRMDN------PCY----- 215 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------CCC-----
Confidence 3457899999999999989999999999999999999999998653321 111 1010000 000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMS-RVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~~ 589 (642)
..... ..+.+++..||+.||++||++. +++++
T Consensus 216 -~~~~~---~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 216 -PRWLT---REAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -CccCC---HHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 11111 2345677799999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=320.90 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=197.4
Q ss_pred CCccccccccccCceEEEEEEc------CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcC-CccceeeeeeeeccC-CC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG-PE 383 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 383 (642)
++|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788999999999999999973 357889999986532 33456788999999999 689999999987654 45
Q ss_pred ceEEEeecCCCChhhhhhcccc----------------------------------------------------------
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK---------------------------------------------------------- 405 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 405 (642)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998854210
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccC
Q 006514 406 ------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAG 478 (642)
Q Consensus 406 ------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~g 478 (642)
...+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 124788899999999999999999998 999999999999999999999999999865433221 1222345
Q ss_pred CccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCC
Q 006514 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSN 557 (642)
Q Consensus 479 t~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 557 (642)
+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ......+... .. ...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~---------~~--~~~ 306 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRM---------RA--PDY 306 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCC---------CC--CCC
Confidence 678999999998899999999999999999997 88887543211 000 1111111000 00 011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 558 VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 558 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ...+.+++..||+.||++|||+.||+++|+.
T Consensus 307 ~---~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 307 T---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred C---CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 1245678889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.05 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=189.2
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +|+.||+|.+.... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999986432 22345567788888754 899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 999988843 356899999999999999999999998 99999999999999999999999999875322111 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....... +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~~------~~~----- 215 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVDT------PHY----- 215 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------CCC-----
Confidence 3467999999999999999999999999999999999999998654321 111 1111000 000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMS-RVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~~ 589 (642)
..... ..+.+++..||+.||++||++. ++++|
T Consensus 216 -~~~~~---~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 216 -PRWIT---KESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -CCCCC---HHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11112 2345667799999999999984 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=331.04 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=191.5
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccC--------C
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--------P 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 382 (642)
..+|+..+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999964 68899999885432 2234799999999999999998876432 1
Q ss_pred CceEEEeecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-cEEEEecC
Q 006514 383 ESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFG 460 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfG 460 (642)
..++||||+++ +|.+++... .....+++.....++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 676666432 23467899999999999999999999998 99999999999999665 79999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||....... .+.... .......
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTPT 291 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCC
Confidence 9987644322 2235689999999998764 68999999999999999999999987543221 111111 1111100
Q ss_pred chhhc--cccc---cccccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 540 VEELY--DKNL---MLHNYHDSNV-----KYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 540 ~~~~~--d~~~---~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
...+. .+.. .......... ......+++++.+||+.||.+|||+.|+++|-
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 00000 0000 0000000000 01123566788899999999999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.92 Aligned_cols=197 Identities=27% Similarity=0.432 Sum_probs=160.7
Q ss_pred cccccccCceEEEEEEcC---CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeecc--CCCceEEEeecC
Q 006514 318 ANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLVYEFLP 392 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 392 (642)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 56789999885432 23457789999999999999999998754 445789999985
Q ss_pred CCChhhhhhccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE----cCCCcEEEEecCCc
Q 006514 393 NQSLDRFIFDSA------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLA 462 (642)
Q Consensus 393 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 462 (642)
++|.+++.... +...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57777764211 2235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCCCc--ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
+........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543222 22346789999999998774 58999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.44 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=200.1
Q ss_pred CCccccccccccCceEEEEEEcC-C---CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-D---GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
.+|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3378999885432 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++++|.+++... ...+++.+.+.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 356899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccc--cccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 468 DKSHIST--AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 468 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
....... ...++..|+|||++.+..++.++||||||+++||+++ |+.||....... .. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~----- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGY----- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCC-----
Confidence 4332211 2233568999999998899999999999999999887 999886533211 11 1111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .. ... ....+.+++.+|++.+|++||+|.++++.|+.
T Consensus 227 ~~----~~--~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 RL----PA--PMD---CPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred cC----CC--CCC---CCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00 00 011 12245678889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=312.59 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=198.9
Q ss_pred CccccccccccCceEEEEEEc-----CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCce
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-----PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESL 385 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 385 (642)
.|...+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467888999999999999973 357889999986443 44456799999999999999999999988765 5678
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+||||+++++|.+++... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999998432 246899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc--------hhHHHHHHhh
Q 006514 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD--------SLLTITWKHF 535 (642)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~--------~l~~~~~~~~ 535 (642)
...... ......++..|+|||.+.+..++.++||||||+++|||++++.|.......... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-- 237 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH--
Confidence 543321 122345677899999999888999999999999999999987764332111000 00000000
Q ss_pred hcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.+....... ........+.+++.+||+.||++||++.+|++.|+.
T Consensus 238 -------~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 -------VLEEGKRLP-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred -------HHHcCccCC-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 000000000 001122356778889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=316.20 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=199.3
Q ss_pred CCccccccccccCceEEEEEEcC--------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 382 (642)
++|.+.+.||+|+||.||++... ++..+|+|.+... ......++.+|+.++.++ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999742 2356999988644 234456788999999999 7999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~ 449 (642)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999965321 235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 006514 450 SRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSL 527 (642)
Q Consensus 450 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l 527 (642)
.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... .+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HH
Confidence 9999999999998765432211 1122234568999999998889999999999999999998 77887543211 11
Q ss_pred HHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 528 LTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 528 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. ......... .. .... ...+.+++..||+.+|++||+|.+|++.|+.
T Consensus 252 ~----~~~~~~~~~---------~~--~~~~---~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 252 F----KLLKEGHRM---------DK--PSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred H----HHHHcCCCC---------CC--CCcC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1 111111000 00 1111 2345567889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=342.96 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=199.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.++||+|+||.||+|... +|+.||||++... .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 6899999998643 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 389 EFLPNQSLDRFIFDSA--------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 1234667888999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCC-----------------cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 006514 461 LARSFQEDKS-----------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY 523 (642)
Q Consensus 461 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~ 523 (642)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01123579999999999999999999999999999999999999986532211
Q ss_pred cchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcc
Q 006514 524 TDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-TMSRVLQMLTT 592 (642)
Q Consensus 524 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~ 592 (642)
. ... . .+.++... .+ .......+.+++.+|++.||++|| ++.++++.|+.
T Consensus 239 i------~~~----~---~i~~P~~~-~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I------SYR----D---VILSPIEV-AP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h------hhh----h---hccChhhc-cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 000 0 00000000 00 001112345677899999999996 67777777765
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=318.16 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +++.||||++... .......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999998643 233445677899999888 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999988843 347999999999999999999999998 99999999999999999999999999875322222 12
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... ....
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~----~~~i~~~--------~~~~--- 215 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---EL----FQSILED--------EVRY--- 215 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HH----HHHHHcC--------CCCC---
Confidence 3356899999999999999999999999999999999999998653311 11 1111111 0000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTM-----SRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~~ 589 (642)
..... ..+.+++.+||+.||++||++ .+++++
T Consensus 216 -~~~~~---~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 -PRWLS---KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCcCC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11111 234567779999999999999 999876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.66 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChh
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLD 397 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 397 (642)
++||+|+||.||++.+.+++.|++|.+..... .....+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998865433 35578999999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc-ccc
Q 006514 398 RFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAI 476 (642)
Q Consensus 398 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 476 (642)
+++... ...+++..++.++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 346889999999999999999999998 99999999999999999999999999986543222111 122
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHD 555 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 555 (642)
.++..|+|||.+.++.++.++||||||+++|||+| |..|+....... . ...... .....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~----~~~~~~---------~~~~~---- 215 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---T----RERIES---------GYRMP---- 215 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---H----HHHHhc---------CCCCC----
Confidence 34667999999998899999999999999999999 777775432211 0 000100 00000
Q ss_pred CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 556 SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 556 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
........+.+++.+|++.+|++|||+.||++.|+
T Consensus 216 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00111234667888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.22 Aligned_cols=269 Identities=23% Similarity=0.366 Sum_probs=197.6
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999964 68999999885432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++ ++|.+++........+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888755444467999999999999999999999998 99999999999999999999999999976543322
Q ss_pred cccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchh--------HHHHHHhhhcC-cc
Q 006514 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSL--------LTITWKHFQAG-RV 540 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l--------~~~~~~~~~~~-~~ 540 (642)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||........... ....|+..... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12234578899999988754 578999999999999999999999875432110000 00001000000 00
Q ss_pred hhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
...+.. ...... ..........+.+++.+||+.||++|||+.+|+++
T Consensus 236 ~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPK-WKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred Hhhccc-cCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 000000 00000012244577889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.23 Aligned_cols=248 Identities=30% Similarity=0.458 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEcCC--C--cEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLPD--G--REIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998643 3 3689999876555 566789999999999999999999999888 888999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc--
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-- 471 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 471 (642)
++|.+++.+... ..+++...+.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865332 57899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... ..... .... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~~-------~~~~- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKI---DKEG-------ERLE- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HhcC-------CcCC-
Confidence 1223457789999999999899999999999999999999 999985432211 11100 0000 0000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
........+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111234667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.59 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHH-HHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVN-IISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 68899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|...+. +...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence 99988874 3456888899999999999999999998 99999999999999999999999999875322221 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+ . . .+.......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~---~-~--------~i~~~~~~~--- 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QM---Y-D--------NILHKPLQL--- 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HH---H-H--------HHhcCCCCC---
Confidence 3457899999999999889999999999999999999999998654211 11 0 0 011111110
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTM----SRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~evl~~ 589 (642)
... ....+.+++.+||+.||++||+. .+++++
T Consensus 216 -~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 216 -PGG---KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred -CCC---CCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 111 12245567789999999999875 466554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=309.71 Aligned_cols=253 Identities=26% Similarity=0.491 Sum_probs=198.3
Q ss_pred CccccccccccCceEEEEEEcC-CC---cEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DG---REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.|...+.||+|+||.||+|.+. ++ ..||||.+... ......+|.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999964 23 36999988644 3445678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++... ...+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998542 356899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCcc--ccccc--CCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 469 KSHI--STAIA--GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 469 ~~~~--~~~~~--gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
.... ..... .+..|+|||++.++.++.++||||||+++|||++ |..||...... ..... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~----i~~~----- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINA----IEQD----- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHH----HHcC-----
Confidence 2211 11111 2457999999999999999999999999999987 99888643221 11111 1100
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. . .. ... ....+.+++..||+.+|++||++.+|+.+|+.
T Consensus 228 ~~--~--~~--~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 228 YR--L--PP--PMD---CPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred Cc--C--CC--ccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 0 00 011 12235678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.91 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=196.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCc--EEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 387 (642)
++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +||||+++++++......++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888899999999999999964 454 4577776533 344556789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 388 YEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1236899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHH
Q 006514 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWK 533 (642)
Q Consensus 455 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 533 (642)
||+|||++....... ......++..|+|||++.+..++.++||||||+++|||+| |..||...... ... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----E 234 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHH----H
Confidence 999999986432111 1112234667999999988889999999999999999998 99988543221 000 0
Q ss_pred hhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 534 HFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 534 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
....+ ..... .... ...+.+++.+||+.+|++||++.+++++|+.
T Consensus 235 ~~~~~---------~~~~~--~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 235 KLPQG---------YRLEK--PLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHhcC---------CcCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01110 00000 0011 1235678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.50 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=202.1
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+|+..+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 578999999987665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++. ...+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999883 246899999999999999999999998 999999999999999999999999998865443322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||........ . . . ........+..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~---~-~-~~~~~~~~~~~------ 237 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L---Y-L-IATNGTPELQN------ 237 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---H-H-HHhcCCcccCC------
Confidence 2234688899999999988899999999999999999999999865432110 0 0 0 00000000000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ...+.+++.+||+.||++||++.+|+++
T Consensus 238 ---~~~~---~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 ---PEKL---SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---cccC---CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1111 1234567789999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.32 Aligned_cols=199 Identities=30% Similarity=0.425 Sum_probs=168.5
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-----
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----- 382 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 382 (642)
..++|+..+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 6899999998543 3344567889999999999999999999886443
Q ss_pred -CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 383 -ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 5555552 34788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 97543322 2234578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.86 Aligned_cols=249 Identities=33% Similarity=0.517 Sum_probs=200.3
Q ss_pred ccccccCceEEEEEEcCC----CcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|+..+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 788999998654333 367899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 394 QSLDRFIFDSAK------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 394 g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
++|.+++..... ...+++..++.++.+++.||.|||+++ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 367999999999999999999999998 99999999999999999999999999987655
Q ss_pred CCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 468 DKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 468 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
... .......++..|+|||.+....++.++||||||++++||++ |..|+...... . .+.....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---E----VLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCC-----
Confidence 432 12234567889999999998899999999999999999999 58888654211 1 1111111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
. .........+.+++.+||+.+|++|||+.+++++|+
T Consensus 226 --~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 --L-------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --C-------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 001111235667788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.33 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=202.3
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999995 479999999997665556677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++. ...+++.++..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999883 246889999999999999999999998 999999999999999999999999998765443222
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .. . ...+ .+.
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~-~---~~~~------~~~---- 234 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL-I---ATNG------TPE---- 234 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--ee-e---ccCC------CCC----
Confidence 22346888999999999988999999999999999999999998653321110 00 0 0000 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.+|++||++.+|+++
T Consensus 235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 ---LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111112234567789999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.81 Aligned_cols=258 Identities=27% Similarity=0.378 Sum_probs=200.3
Q ss_pred CCccccccccccCceEEEEEEcC--------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 382 (642)
.+|.+.+.||+|+||.||++... .+..||+|.+... .....+++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45888899999999999999742 1236899987643 334567899999999999 7999999999999999
Q ss_pred CceEEEeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~ 449 (642)
..++++||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 2345889999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 006514 450 SRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSL 527 (642)
Q Consensus 450 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l 527 (642)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 9999999999999865443222 1122334568999999999999999999999999999998 77877543211
Q ss_pred HHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCC
Q 006514 528 LTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 528 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 594 (642)
. .......+...+ . .. .....+.+++..||+.+|++||++.|+++.|+...
T Consensus 244 -~-~~~~~~~~~~~~---------~--~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 -E-LFKLLKEGHRMD---------K--PA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -H-HHHHHHcCCCCC---------C--CC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1 111111110000 0 11 11224567788999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.20 Aligned_cols=198 Identities=29% Similarity=0.406 Sum_probs=168.1
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC------
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 381 (642)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 6889999988643 334456788999999999999999999987643
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 246899999965 5666552 34889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98654322 223457899999999999989999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.16 Aligned_cols=194 Identities=25% Similarity=0.339 Sum_probs=167.4
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
...|.+.+.||+|+||.||++.+. .++.||||... ...+.+|+.++++++|+||+++++++......++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 57889999642 23456899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+. ++|.+++.. ....++|.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 788887743 2347999999999999999999999998 99999999999999999999999999986543322
Q ss_pred c-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 006514 471 H-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517 (642)
Q Consensus 471 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~ 517 (642)
. ......||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2 2234579999999999999999999999999999999999887653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.30 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=197.3
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999964 68899999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988542 2346899999999999999999999988 99999999999999999999999999876543222
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||............ ..... .... ..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~-----~~~~-~~-- 224 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVK-----EVQE-EY-- 224 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhh-----hhhh-hc--
Confidence 12346899999999999999999999999999999999999999754322111000 00000 0000 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 589 (642)
...... .+.+++..||+.||++||| +.|+++|
T Consensus 225 ----~~~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 ----SEKFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----CccCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 011112 3456677899999999999 8999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.77 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=191.4
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcC---CccceeeeeeeeccC-----C
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSV---EHKNLVRLLGCSCSG-----P 382 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 382 (642)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 68899999886432 12223456777777665 699999999987642 3
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
..++|+||++ ++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 4888877542 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh---cCc
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ---AGR 539 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~ 539 (642)
........ .....|+..|+|||++.+..++.++|||||||++|||++|++||........ +.. ...... ...
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDD 230 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhh
Confidence 86543222 2345689999999999988999999999999999999999999865432211 101 000000 000
Q ss_pred chhhc---cccccccccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 540 VEELY---DKNLMLHNYH--DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 540 ~~~~~---d~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+.... .......... ..........+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000000000 00000112345678889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.78 Aligned_cols=248 Identities=29% Similarity=0.442 Sum_probs=191.7
Q ss_pred ccccccCceEEEEEEcC-CCc--EEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36999999999999975 343 4688887643 344556789999999999 799999999999999999999999999
Q ss_pred CChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 394 QSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 394 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
|+|.+++.... ....+++..+..++.+++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 1235889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||...... . .......+.
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~----~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E----LYEKLPQGY 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---H----HHHHHhCCC
Confidence 986322111 1111233567999999988889999999999999999997 99988543211 0 111111110
Q ss_pred chhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 540 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.... ... ....+.+++..||+.+|.+|||+.++++.|+.
T Consensus 229 ---------~~~~--~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 ---------RLEK--PLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ---------CCCC--CCc---CCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0000 001 11245678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.25 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEcC--C--CcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP--D--GREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
++||+|+||.||+|++. + +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 26899998865433 34567999999999999999999999875 5568999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999953 347899999999999999999999998 99999999999999999999999999987654333211
Q ss_pred --ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 474 --TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 474 --~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
....++..|+|||.+....++.++||||||+++|||++ |..||...... .+... ........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~----~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAM----LESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHcCCcCC--------
Confidence 11223567999999998999999999999999999998 89988653221 11111 11111000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
. ... ....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 219 -~--~~~---~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -R--PEE---CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -C--CCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0 011 113456788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.16 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=197.6
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999965 5778899988766666677899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|..++.. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence 999988753 2357899999999999999999999998 99999999999999999999999999876533221 22
Q ss_pred ccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 474 TAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
....++..|+|||++. +..++.++|||||||++|||++|+.||...... ..... ........+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~--- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTLAQ--- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHH-HhhcCCCCCCC---
Confidence 3356889999999984 345788999999999999999999998643211 00000 00000000000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.+++..||+.||++||++.+++++
T Consensus 231 ------~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ------PSR---WSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------ccc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 11245577789999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.16 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=204.0
Q ss_pred ccccccccccCceEEEEEEcC--CCc--EEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 315 FDEANKLGQGGFGTVYKGVLP--DGR--EIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
....++||+|.||.|++|.|+ +|+ .||||.+...... ...+|++|+.+|-+|+|||+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344678999999999999975 455 4799999766544 67899999999999999999999999987 78899999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++.|+|.+-|++ .....|-...+..++.|||.||.||.++. +|||||..+|+||.....+||+||||.+......
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999977 45677888889999999999999999987 9999999999999999999999999999877655
Q ss_pred Cc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 470 SH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 470 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
.. ......-...|.|||.+....++.++|||+|||.||||+| |+.||-.-... .+.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccc
Confidence 43 2233445678999999999999999999999999999999 66776543321 22233343
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.-.+. ....-..++.+++..||..+|++|||+..|.+.+
T Consensus 331 ~erLp-----RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLP-----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCC-----CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22221 1223345667888899999999999999997554
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.37 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=197.6
Q ss_pred HHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccC------
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG------ 381 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 381 (642)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999964 68889999886543 3345788999999998 699999999988653
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++||||+++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3478999999999999988542 3456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
+........ ......|++.|+|||++. +..++.++|||||||++|||++|+.|+....... .. .. ..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~-~~-~~ 229 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL-FL-IP 229 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH-HH-Hh
Confidence 886543222 223457899999999986 3458889999999999999999999985432110 00 00 00
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ..... .... ...+.+++.+||+.+|.+|||+.+|+++
T Consensus 230 ~~~-----~~~~~-----~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNP-----APRLK-----SKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCC-----CCCCC-----CCCc---CHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 00000 1111 1245677789999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=309.25 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=199.4
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|...+.||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999985 468899999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++.. ...+++.+...++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999998843 457899999999999999999999998 99999999999999999999999999876543222
Q ss_pred ccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 472 ISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
......|+..|+|||++. .+.++.++|||||||++|||++|+.|+........ .+... ..... .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~-~~~~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMT-KSNFQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhh-ccCCC---CCcc
Confidence 123457899999999974 45688999999999999999999999754332110 00000 00000 0000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. . .......+.+++..|++.+|++||++.+|+++
T Consensus 232 ~-----~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 K-----D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c-----c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 0 00011235567889999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.88 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=196.7
Q ss_pred ccccccccccCceEEEEEEc-CCCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 315 FDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
|+..+.||+|+||+||++.+ .+++.+|+|.+.... ......+.+|+.++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999996 478899999885432 22344578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888543 2346999999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... . ......... ..
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~-~~~~~~~~~--------~~- 223 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--E-VDRRVLETE--------EV- 223 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHhhhccc--------cc-
Confidence 234578999999999998899999999999999999999999987543211100 0 000000000 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 589 (642)
. ..... ..+.+++..|++.||++||+ +.+++++
T Consensus 224 --~-~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 --Y-SAKFS---EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --c-CccCC---HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 01111 23456777899999999999 7788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.84 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=198.2
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666788999999999999864 57889999886443 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999883 356899999999999999999999988 99999999999999999999999999976543322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ... ..... .+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~~~-----~~----- 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-IPKNS-----PP----- 219 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-hhcCC-----CC-----
Confidence 12234678899999999988899999999999999999999999764322110 000 00000 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+||+.+|++||+|.+|+++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 ----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0001122345677889999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.55 Aligned_cols=269 Identities=23% Similarity=0.353 Sum_probs=199.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|+..+.||+|+||.||++.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999975 68999999885432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|++++.|..++. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888763 3346899999999999999999999988 9999999999999999999999999998765433
Q ss_pred CcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc-
Q 006514 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN- 547 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~- 547 (642)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..................+.. ...+..+..
T Consensus 155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (286)
T cd07847 155 DD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQ 232 (286)
T ss_pred cc-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhccccc
Confidence 21 223457889999999876 55889999999999999999999998654322111000000000000 000000000
Q ss_pred ----ccccccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 ----LMLHNYHDSN-----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ----~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.......... .......+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000 00112456678889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.03 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=193.6
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 388 (642)
+|+..+.||+|+||.||++... +|+.||+|++... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999964 6889999998643 2233456778999998885 577888999999989999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 356999999999999999999999998 999999999999999999999999998754332
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +.....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~------------i~~~~~ 218 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQS------------IMEHNV 218 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHhCCC
Confidence 22 223456899999999999999999999999999999999999998754321 11110 111110
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 589 (642)
.. .... ...+.+++.+|++.+|.+|++ ..++.+|
T Consensus 219 ~~----p~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 219 SY----PKSL---SKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred CC----CccC---CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 00 0111 124456778999999999997 4566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.41 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=196.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCc----EEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778889999999999999863 444 47888875442 33345788999999999999999999988654 5679
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998542 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ....+ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~----- 228 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKGE----- 228 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCC-----
Confidence 43322 1222345778999999998899999999999999999998 88887543211 11111 11100
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.... ... ....+.+++..||..+|++||++.+|+++|+..
T Consensus 229 ----~~~~--~~~---~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 ----RLPQ--PPI---CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----CCCC--CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000 011 123456788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.34 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=198.1
Q ss_pred cCCccccccccccCceEEEEEEcC---CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
..+|.+.+.||+|+||.||++... .++.|++|.+... ..+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 4578999987532 23468999999999999999999999989999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
|++. ++|.+++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 6788877 33467999999999999999999999998 999999999999999999999999999765543
Q ss_pred CCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcch------
Q 006514 469 KSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE------ 541 (642)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 541 (642)
... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+.............
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 322 2234679999999999999999999999999999999999999987654332211111111111100000
Q ss_pred -hh------ccccccccccCCCCc--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 542 -EL------YDKNLMLHNYHDSNV--KYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 -~~------~d~~~~~~~~~~~~~--~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+ +.............. ......+.+++..||+.||++|||+.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000000000 0012244567789999999999999999987
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.23 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+.|++.++||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999965 58899999987776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998877432 356899999999999999999999988 99999999999999999999999999875433221
Q ss_pred ccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 472 ISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
......+++.|+|||++. ...++.++||||||+++|||++|+.|+...... ..... .........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~--- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTL--- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHH-HhcCCCccC---
Confidence 122346788999999985 345788999999999999999999998643211 10001 111100000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 236 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ---------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0011112245667789999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.69 Aligned_cols=270 Identities=26% Similarity=0.414 Sum_probs=202.7
Q ss_pred CCccccccccccCceEEEEEEcC-----CCcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeecc--CCCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-----DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCS--GPES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 384 (642)
..|...+.||+|+||.||++.+. +++.+|||.+...... ..+.|.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3688999998655443 56789999999999999999999998877 5578
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998542 236999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
....... ......++..|++||.+....++.++||||||+++|||++|+.|+............. .........+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 6533221 1122345667999999998899999999999999999999998875533221110000 000000000111
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.+....... ........+.+++.+||+.+|++||||.||+++|+..
T Consensus 238 ~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLP-----RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCC-----CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111100 0011124566788899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.72 Aligned_cols=238 Identities=26% Similarity=0.443 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEcCCCc-----------EEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 319 NKLGQGGFGTVYKGVLPDGR-----------EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 4788876544333 6789999999999999999999999888 788999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-------cEEEEecC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-------RAKIADFG 460 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DfG 460 (642)
+||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 27899999999999999999999988 99999999999999888 79999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhccC--CCCCcchHHHHHHHHHHHHhC-CCCCCCCCCcccchhHHHHHHhhhc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTG-RQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
++...... ....++..|+|||++... .++.++||||||+++|||++| ..|+........ ...+.
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~- 220 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQ- 220 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHh-
Confidence 99865431 223567789999999876 789999999999999999994 666544321100 00010
Q ss_pred CcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
..... . ... ...+.+++..||+.+|++|||+.+|++.|+
T Consensus 221 -------~~~~~-~---~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------DQHRL-P---MPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------cCCCC-C---CCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0 000 145667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.98 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=199.9
Q ss_pred CCccccccccccCceEEEEEEcC--------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP--------DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 382 (642)
++|.+.+.||+|+||.||++... ....+|+|.+... ......++.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 2456899988643 334456789999999999 6999999999999888
Q ss_pred CceEEEeecCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~ 449 (642)
..++|+||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996532 1346899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 006514 450 SRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSL 527 (642)
Q Consensus 450 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l 527 (642)
.++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||...... .+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---EL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 9999999999999866433221 1122234567999999998899999999999999999999 88887543211 11
Q ss_pred HHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 528 LTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 528 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
. .....+...+. ... ....+.+++.+||+.+|++|||+.++++.|...
T Consensus 246 ~----~~~~~~~~~~~-----------~~~---~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 F----KLLREGHRMDK-----------PSN---CTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred H----HHHHcCCCCCC-----------CCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 11111110000 011 122455778899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=305.54 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=185.6
Q ss_pred cccccCceEEEEEEcCC---CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCC
Q 006514 320 KLGQGGFGTVYKGVLPD---GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQS 395 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 395 (642)
+||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997533 3568888775433 3445678899999999999999999999999999999999999999
Q ss_pred hhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-c
Q 006514 396 LDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-I 472 (642)
Q Consensus 396 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 472 (642)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865332 234578888999999999999999998 999999999999999999999999998754332221 1
Q ss_pred cccccCCccccChhhhcc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 473 STAIAGTLGYMAPEYLAH-------GQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.....++..|+|||++.. ..++.++||||||+++|||++ |..|+....... . ........ ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhcc-CccCC
Confidence 223346778999998753 356889999999999999999 677775432110 0 11111111 01111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
++.+ ..... ..+.+++..|+ .||++|||+++|++.|.
T Consensus 232 ~~~~------~~~~~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL------DLKYS---DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc------cccCC---HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 11111 22334556777 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.94 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=200.7
Q ss_pred CCccccccccccCceEEEEEEcC------CCcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCce
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 385 (642)
.+|+..+.||+|+||.||+++.+ +.+.|++|.+...... ..+++.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999953 3467899988654433 4577999999999999999999999999989999
Q ss_pred EEEeecCCCChhhhhhccccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEec
Q 006514 386 LVYEFLPNQSLDRFIFDSAKA------KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 459 (642)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 26899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcC
Q 006514 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAG 538 (642)
Q Consensus 460 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 538 (642)
|++...............++..|+|||.+.++.++.++||||||+++|||++ |..||...... .. ......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~----~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EV----LNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HH----HHHHHcC
Confidence 9987544333222233456778999999988889999999999999999999 77777532211 11 1111111
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
...... .... ...+.+++.+||+.+|++||++.+++.+|+
T Consensus 235 ~~~~~~----------~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPV----------PEGC---PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCC----------CCCC---CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000 0111 124567888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.28 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=173.4
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..++||+|+||.||++..+ +++.+|+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999965 5778999988532 2233445888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 346899999999999999999999998 999999999999999999999999999765443
Q ss_pred CCcccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 469 KSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
.........||+.|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 333333457999999999986 346899999999999999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.26 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=195.3
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeec-cCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSC-SGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~ 391 (642)
.+|...+.||+|+||.||++..+ |+.+++|.+... ...+.+.+|+.++++++|+|++++++++. .....++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999874 788999987543 23457899999999999999999999754 456689999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++..++.++.+++.||.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998543 2345899999999999999999999998 9999999999999999999999999987543322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+... ...+.....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~~~~------- 220 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGYKMDA------- 220 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhcCCCCCC-------
Confidence 22344668999999998899999999999999999998 88887543211 11111 111100000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... ....+.+++.+|++.+|++|||+.+++++|+.
T Consensus 221 ----~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 ----PDG---CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011 12345567789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.14 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=201.0
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788889999999999999964 68899999876543 34457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++.. .+.+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998843 3568999999999999999999997 45 9999999999999999999999999986543221
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc-----hhHHHHHHhhhcCcchhhc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD-----SLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~-----~l~~~~~~~~~~~~~~~~~ 544 (642)
.....|+..|+|||++.++.++.++|||||||++|||++|+.||......... .+.......... .
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P----- 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----
Confidence 12357899999999998889999999999999999999999998764432111 111111111100 0
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.+.+. . ......+.+++.+|++.||++|||+.||++++
T Consensus 230 ~~~~~-----~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP-----S---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC-----c---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000 0 11123456677899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.63 Aligned_cols=270 Identities=21% Similarity=0.316 Sum_probs=196.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|...++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999865 68899999886443 22344678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++ ++|.+++... ...+++.....++.|+++||.|||+.+ ++|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887542 346889999999999999999999998 99999999999999999999999999976543222
Q ss_pred cccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc-
Q 006514 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL- 548 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~- 548 (642)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......................+..+.....
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1 1234568899999998754 578899999999999999999999875432111000000000000001111111000
Q ss_pred ---cccccCCCC----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 ---MLHNYHDSN----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ---~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
......... .......+.+++.+|++.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000 00011234567889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.00 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=203.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999964 57889999987666566788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988542 257899999999999999999999998 99999999999999999999999999876544321
Q ss_pred ccccccCCccccChhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHG---QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
......++..|+|||.+... .++.++||||||+++|||++|+.|+........ ... .... +.....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~-----~~~~---~~~~~~- 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL-----ISKS---NFPPPK- 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhc---cCCCcc-
Confidence 12335688899999999776 889999999999999999999999865332110 000 0000 000000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.+|++|||+.+|+.+
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 ------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01112223456788889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=292.37 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=200.0
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++.|++-+.||+|.|+.||+... ++|+.+|+|.+... .....+++.+|+.+-+.|+||||++|++.+.+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788888999999999999884 57999999877432 3346678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC---CcEEEEecCCcccc
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSF 465 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~ 465 (642)
|+|.|++|..-+.. +...++...-..+.||+++|.|+|.++ |||||+||+|+||.+. .-+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999765533 245677778889999999999999998 9999999999999543 35999999999988
Q ss_pred CCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
+ ........+|||+|||||++...+|+..+|||+-|||||-|+.|.+||...... ..++....+..
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~y----- 229 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAY----- 229 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhcccc-----
Confidence 7 233345578999999999999999999999999999999999999999763211 01111222211
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
......-+...++.. +++.+||..||++|.|+.|.++|
T Consensus 230 ---d~~~~~w~~is~~Ak---~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 ---DYPSPEWDTVTPEAK---SLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ---CCCCcccCcCCHHHH---HHHHHHhccChhhhccHHHHhCC
Confidence 111111223334444 45668999999999999999976
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.81 Aligned_cols=267 Identities=25% Similarity=0.406 Sum_probs=198.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|+..++||+|+||.||++.++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999975 58999999875432 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++++|.++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 345899999999999999999999998 9999999999999999999999999988654433
Q ss_pred CcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHH--HhhhcCcchhhccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW--KHFQAGRVEELYDK 546 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~d~ 546 (642)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++|+...... ..+..... ..+.. ...+..+.
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~ 230 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLGNLIP-RHQEIFQK 230 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhCCCch-hhHHHhcc
Confidence 2 2233567889999999875 45788999999999999999999888643321 11111000 00000 00000000
Q ss_pred c-----ccccccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 N-----LMLHNYHDSN-----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~-----~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. .......... .......+.+++.+||+.+|++||++.+|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000 00113456778889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.38 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=201.0
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||.|++|.||+|... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788889999999999999965 68899999886543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++.. ..+++.....++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999843 37899999999999999999999998 99999999999999999999999999987654422
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......+++.|+|||++.+..++.++||||||+++|||++|+.|+...... .... .........+.
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~----~~~~~~~~~~~------ 219 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLF----LIPKNNPPSLE------ 219 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHH----HhhhcCCCCCc------
Confidence 223356888999999999888999999999999999999999998653311 0000 01111000000
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.+++..||+.+|++|||+++++++
T Consensus 220 ----~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 ----GNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 12235567789999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.65 Aligned_cols=202 Identities=26% Similarity=0.419 Sum_probs=174.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... +++.||||++... .......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999964 6899999998643 2334456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CC----------------------------------cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCC
Q 006514 469 KS----------------------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514 (642)
Q Consensus 469 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~ 514 (642)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 01123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 006514 515 NNRSKN 520 (642)
Q Consensus 515 p~~~~~ 520 (642)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.61 Aligned_cols=238 Identities=24% Similarity=0.331 Sum_probs=183.9
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHH-HHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEV-NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 67889999986432 22233444444 456788999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. ...+.+.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999998843 356788888899999999999999998 99999999999999999999999999975432221 22
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . +... .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~----~~~i--------~~~~~~~--- 215 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M----YDNI--------LNKPLQL--- 215 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---H----HHHH--------HhCCcCC---
Confidence 34679999999999999999999999999999999999999986533211 0 0101 1111110
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSR 585 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 585 (642)
...... .+.+++..|++.||.+||++.+
T Consensus 216 -~~~~~~---~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 216 -KPNITN---SARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred -CCCCCH---HHHHHHHHHcccCHHHCCCCCC
Confidence 111222 3445667899999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.77 Aligned_cols=266 Identities=26% Similarity=0.347 Sum_probs=197.5
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccChh-----hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH-----RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
+|+..+.||+|+||.||+|... +|+.|+||++...... ....+.+|++++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999964 6899999998654322 345577899999999999999999999998899999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985422 37999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC--------
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG-------- 538 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 538 (642)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|.++|....+.. ............
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhc
Confidence 3222 122356788999999865 457899999999999999999977765433211 111110000000
Q ss_pred -cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 -RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 -~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........................+.+++.+||+.+|++|||+.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000000011123456788889999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.11 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=196.9
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333457999999999999864 6889999998766656667799999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|.+++. ...+++.....++.+|+.||.|||+++ ++||||||+||++++++.++|+|||++......... .
T Consensus 104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~ 175 (292)
T cd06658 104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-R 175 (292)
T ss_pred CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-C
Confidence 99999873 245899999999999999999999998 999999999999999999999999998765432221 2
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... .... .. ..+......
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~----~~-----~~~~~~~~~--- 240 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRR----IR-----DNLPPRVKD--- 240 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HH-----hcCCCcccc---
Confidence 23568899999999988889999999999999999999999986432210 0000 00 001111100
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
...... .+..++..|++.||++|||+.+++++
T Consensus 241 -~~~~~~---~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSS---VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCH---HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001112 34456678999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.65 Aligned_cols=197 Identities=27% Similarity=0.428 Sum_probs=160.1
Q ss_pred cccccccCceEEEEEEcC---CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeecc--CCCceEEEeecC
Q 006514 318 ANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLVYEFLP 392 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 392 (642)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 45789999885432 23457889999999999999999998854 456789999986
Q ss_pred CCChhhhhhcc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE----cCCCcEEEEecCCc
Q 006514 393 NQSLDRFIFDS------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL----DSRLRAKIADFGLA 462 (642)
Q Consensus 393 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 462 (642)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676666321 12245889999999999999999999998 9999999999999 56679999999999
Q ss_pred cccCCCCCc--ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
+........ ......||+.|+|||++.+ ..++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876543322 2234578999999999876 458999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.78 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=194.3
Q ss_pred HHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccC-----
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG----- 381 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 381 (642)
...++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 468899999885432 23345678999999999999999999987543
Q ss_pred -CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 382 -PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 382 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 788888773 356999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..+ ...... .
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~-~~~~~~-~ 235 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRI-MEVVGT-P 235 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHH-HHHhCC-C
Confidence 99865432 223568999999999876 568999999999999999999999986533211 00000 000000 0
Q ss_pred chhhcccc--------cc-ccccCCCCc----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 540 VEELYDKN--------LM-LHNYHDSNV----KYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 540 ~~~~~d~~--------~~-~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+..... +. ......... ......+.+++.+|++.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 000000000 0011235678889999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=331.55 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=204.0
Q ss_pred cccccccccCceEEEEEEc-CCCc----EEEEEEeec-cChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 316 DEANKLGQGGFGTVYKGVL-PDGR----EIAVKRLFF-NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
...++||+|+||+||||.+ ++|+ +||+|++.. ...+...++++|+-.|.+++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4467899999999999995 5554 578998754 35566788999999999999999999999998776 889999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
||+.|.|.++++. .+..+..+..+.|..|||+||.|||++. ++||||.++||||.+-..+||.|||+++....+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 4567889999999999999999999987 9999999999999999999999999999988776
Q ss_pred Ccccc-cccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 470 SHIST-AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 470 ~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
..... ...-.+.|||-|.+....|+.++|||||||.+||++| |..|.....-++ +.+++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhcc
Confidence 65332 2344668999999999999999999999999999999 888876544322 22222222
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
..+. .+..-..++..+++.||..|+..||+++++...+..
T Consensus 917 eRLs-----qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 ERLS-----QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ccCC-----CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2211 112223455667789999999999999999887755
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.17 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=201.4
Q ss_pred ChhhHHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-Cccceeeeeeeec--
Q 006514 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSC-- 379 (642)
Q Consensus 304 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~-- 379 (642)
.++.+..+.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556677889999999999999999999864 67899999875432 2335678899999999 6999999999874
Q ss_pred ---cCCCceEEEeecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEE
Q 006514 380 ---SGPESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (642)
Q Consensus 380 ---~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k 455 (642)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 345679999999999999987542 23456899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCCCcccccccCCccccChhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH
Q 006514 456 IADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530 (642)
Q Consensus 456 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 530 (642)
|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....... .+
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~--- 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL--- 238 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH---
Confidence 999999886543222 1233468999999999853 457899999999999999999999986432110 00
Q ss_pred HHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 531 TWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 531 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
............+ ... ....+.+++.+||+.||++|||+.||++++
T Consensus 239 --~~~~~~~~~~~~~---------~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 --FKIPRNPPPTLHQ---------PEL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --hhccccCCCcccC---------CCC---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000000000000 001 112456778899999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=304.17 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=198.1
Q ss_pred CccccccccccCceEEEEEEcCCCcEEEEEEeeccC------hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999998889999999885432 22335688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 346889999999999999999999998 99999999999999999999999999876532
Q ss_pred CC-----CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 468 DK-----SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 468 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
.. ........++..|+|||++.+..++.++||||||+++|||++|+.||....... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~-- 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLM-- 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCC--
Confidence 11 111233568899999999998889999999999999999999999986432110 000000000000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+.+ ... ....+.+++.+||+.+|++||++.+++++
T Consensus 228 ---~~~------~~~---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 ---PRL------PDS---FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ---CCC------CCC---CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 111 12234567789999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=300.98 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=200.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999964 6889999988543 3345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ....+++...+.++.+++.||.|||+++ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999887532 3456889999999999999999999998 99999999999999999999999999876643322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ...+....+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~-------- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-VCQGSYKPL-------- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-HhcCCCCCC--------
Confidence 223456889999999999888999999999999999999999998643211 11111 111111100
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.+++.+||+.||++||++.+|+..
T Consensus 221 ---~~~---~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSH---YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---Ccc---cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 11235567789999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=300.77 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=202.2
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||.++. .+++.+++|.+... +.....++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999884 46889999987543 345567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 456899999999999999999999998 99999999999999999999999999987644432
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... ..+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~~-------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNYTP-------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCCCC--------
Confidence 223456899999999998888999999999999999999999998643211 111111 1111100
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
........+.+++..||+.+|++||++.++++++
T Consensus 221 ------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 ------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0011123455677799999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=299.15 Aligned_cols=271 Identities=24% Similarity=0.267 Sum_probs=215.1
Q ss_pred CCccccccccccCceEEEEEEcCC-CcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
+.|+..+.||.|.-|+||++.+.+ +..+|+|++... .+........|-+||+.++||.++.|++.+..+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346777899999999999999764 588999999654 3444556778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC-
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE- 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~- 467 (642)
|||+||+|..+++. +..+.+++..+.-++.+++-||+|||-.| ||+|||||+||||-++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999998755 45678999999999999999999999999 99999999999999999999999998643210
Q ss_pred ---------------------------------CC---------------------CcccccccCCccccChhhhccCCC
Q 006514 468 ---------------------------------DK---------------------SHISTAIAGTLGYMAPEYLAHGQL 493 (642)
Q Consensus 468 ---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 493 (642)
.. ...+...+||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 001223589999999999999999
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhc
Q 006514 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCT 573 (642)
Q Consensus 494 s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl 573 (642)
+.++|.|+|||+||||+.|+.||.+...... +..++.+.+... ........+-+||...|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp-----~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFP-----EEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCC-----CCCcchhHHHHHHHHHh
Confidence 9999999999999999999999987654321 223333333211 11233445566777899
Q ss_pred ccCCCCCCC----HHHHHHHhc--c-CCCCCCCCCCCcccc
Q 006514 574 QENPSLRPT----MSRVLQMLT--T-EEQLPGPTSPPFIDE 607 (642)
Q Consensus 574 ~~~P~~RPs----~~evl~~L~--~-~~~~~~p~~p~~~~~ 607 (642)
.+||++|.- +.||-+|-. + ...+..-..||++..
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~ 413 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK 413 (459)
T ss_pred ccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence 999999998 999998843 3 344555666666543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.81 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=198.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+|+..+.||+|+||.||++... +++.||+|.+... .......+.+|++++.+++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999975 7899999988653 3344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++++|..++........+++..+..++.+++.||.|||+. + ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999886543345789999999999999999999974 5 9999999999999999999999999987653322
Q ss_pred cccccccCCccccChhhhccC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 471 HISTAIAGTLGYMAPEYLAHG------QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .... . ..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~-~--------~~~~ 223 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQ-L--------SAIV 223 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHH-H--------HHHh
Confidence 2234678899999998654 35889999999999999999999986432111 0000 0 0011
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+... ..........+.+++.+||+.+|++||++.+++.+
T Consensus 224 ~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGDP------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcCC------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1000 00111122345567789999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.50 Aligned_cols=191 Identities=26% Similarity=0.380 Sum_probs=163.8
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
..+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999965 5678999964322 235699999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+. ++|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 94 688887743 3457899999999999999999999998 9999999999999999999999999987533221
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~ 516 (642)
......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456899999999999999999999999999999999976654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.38 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=201.1
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|++.+.||+|+||.||++.+. +++.+|+|.+........+.+.+|++++++++||||+++++.+......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56888999999999999999964 68899999987776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999988542 346899999999999999999999998 999999999999999999999999998765432221
Q ss_pred ccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 472 ISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.|+...... ... .........
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~-----~~~~~~~~~----- 226 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVL-----LKILKSEPP----- 226 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHH-----HHHhcCCCC-----
Confidence 22346889999999975 345788999999999999999999998653211 000 011111000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+. ..... ...+.+++..||+.+|++||++.+|+++
T Consensus 227 ~~~----~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLD----QPSKW---SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcC----CcccC---CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 00111 1234567779999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=303.57 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=200.5
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677889999999999999964 68899999886443 455678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++. ...+++.+...++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999883 346889999999999999999999988 99999999999999999999999999976544322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........ . ..+.....
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~----------~~~~~~~~-- 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------L----------FLIPKNNP-- 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------h----------hhhhcCCC--
Confidence 12334678899999999988899999999999999999999999864322110 0 00000000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++..||+.+|++||++.+++++
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11112233456678889999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=302.60 Aligned_cols=248 Identities=30% Similarity=0.432 Sum_probs=188.9
Q ss_pred ccccccCceEEEEEEcC----CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeec-cCCCceEEEeecC
Q 006514 319 NKLGQGGFGTVYKGVLP----DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSC-SGPESLLVYEFLP 392 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~ 392 (642)
+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999853 2457999988543 3445678899999999999999999999765 4556789999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc-
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH- 471 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 471 (642)
+|+|.+++... ...+++..+..++.++++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 345678888999999999999999988 999999999999999999999999999765432211
Q ss_pred --ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 472 --ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-QNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 --~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
......++..|+|||.+....++.++||||||+++|||++|. +|+..... ..+....+ .+. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~----~~~--------~ 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL----QGR--------R 220 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----cCC--------C
Confidence 112334577899999999889999999999999999999964 44432211 11111110 100 0
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .... ....+.+++..||+.+|++||++.+|++.|+.
T Consensus 221 ~~---~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 221 LL---QPEY---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CC---CCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00 0011 11246678889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=302.18 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=199.7
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeeccC------hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
+|+..+.||+|++|.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 578999999886432 2235678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-cEEEEecCCcccc
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSF 465 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 465 (642)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+++ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 356899999999999999999999998 99999999999998776 5999999998776
Q ss_pred CCCCCc---ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 466 QEDKSH---ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 466 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
...... ......++..|+|||.+.+..++.++||||+|++++||++|+.|+........ ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~--- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATT--- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCC---
Confidence 543221 12234688899999999888899999999999999999999999864322111 111111000000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. ..........+.+++..|++.+|++||++.+++++
T Consensus 229 --~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 --A---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --C---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0 11111223456678889999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.18 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=198.6
Q ss_pred CccccccccccCceEEEEEEcCC--CcEEEEEEeecc----------ChhhHHHHHHHHHHHhc-CCccceeeeeeeecc
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPD--GREIAVKRLFFN----------NRHRAANFYNEVNIISS-VEHKNLVRLLGCSCS 380 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 380 (642)
+|+..+.||+|+||.||++.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 688999987532 22334567889988875 799999999999999
Q ss_pred CCCceEEEeecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcCCCcEEEEe
Q 006514 381 GPESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIAD 458 (642)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~D 458 (642)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 234578999999999999999999996 55 99999999999999999999999
Q ss_pred cCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC
Q 006514 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538 (642)
Q Consensus 459 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 538 (642)
||++....... ......|+..|++||.+.++.++.++||||||+++|||++|+.|+...... .... ....+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~-~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLAT-KIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHH-HHhhc
Confidence 99998755433 223456889999999999888999999999999999999999998543211 1110 01111
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... + ..... ....+.+++.+||+.||++||++.||..+|.
T Consensus 229 ~~~----~------~~~~~---~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----P------LPEGM---YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----c------CCccc---CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 100 0 00101 1134556778999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=328.13 Aligned_cols=271 Identities=20% Similarity=0.213 Sum_probs=192.8
Q ss_pred hHHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCc------cceeeeeeeec
Q 006514 307 TLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEH------KNLVRLLGCSC 379 (642)
Q Consensus 307 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~ 379 (642)
++...+++|++.++||+|+||.||++.+. .++.||||++.... ....++..|+.++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455688999999999999999999964 67889999985432 233455667777776654 45888888887
Q ss_pred cC-CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCC-----
Q 006514 380 SG-PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRL----- 452 (642)
Q Consensus 380 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~----- 452 (642)
.. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 54 4578999988 7788887743 35799999999999999999999974 7 99999999999998765
Q ss_pred -----------cEEEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 453 -----------RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 453 -----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998764322 22346799999999999999999999999999999999999999976443
Q ss_pred cccchhHHHH-------HHhh-hcCcchhhcccccccccc----------CCCC--cHHHHHHHHHHHHHhcccCCCCCC
Q 006514 522 EYTDSLLTIT-------WKHF-QAGRVEELYDKNLMLHNY----------HDSN--VKYEVLRAIHVGLLCTQENPSLRP 581 (642)
Q Consensus 522 ~~~~~l~~~~-------~~~~-~~~~~~~~~d~~~~~~~~----------~~~~--~~~~~~~~~~l~~~Cl~~~P~~RP 581 (642)
.....++... |... ......++++........ .... .......+++|+..||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 2111111100 0000 000000111110000000 0000 001123466889999999999999
Q ss_pred CHHHHHHH
Q 006514 582 TMSRVLQM 589 (642)
Q Consensus 582 s~~evl~~ 589 (642)
|++|+++|
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999987
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.75 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=203.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+||+++++.+......++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 68899999886432 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++........+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433357899999999999999999999998 99999999999999999999999999876654332
Q ss_pred c---ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 471 H---ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 471 ~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
. ......|+..|+|||++... .++.++||||||+++|||++|+.|+....... ........ . .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-~-----~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN-D-----PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC-C-----CC
Confidence 2 22345689999999999877 78999999999999999999999986543211 01111110 0 00
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... . ..........+.+++..||+.||++||++.+|+++
T Consensus 226 ~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLE-T---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcC-C---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 0 00001112345677789999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.20 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=198.9
Q ss_pred CCccccccccccCceEEEEEEcCC----CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
.+|...+.||+|+||.||+|.+.+ ...|+||...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999876544 4556789999999999999999999998865 567899
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++|+|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 346899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
..........++..|+|||.+....++.++||||||+++|||++ |+.||...... .... ....+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~----~~~~~~~------ 226 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIG----RIENGER------ 226 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH----HHHcCCc------
Confidence 43322223345568999999988889999999999999999996 99998654321 1111 1111100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.. . ..... ..+.+++.+|+..+|++|||+.++++.|+..
T Consensus 227 -~~---~-~~~~~---~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 -LP---M-PPNCP---PTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -CC---C-CCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0 11111 2455677799999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.96 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=203.0
Q ss_pred cChhhHHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-Cccceeeeeeeecc
Q 006514 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS 380 (642)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 380 (642)
+...++..++++|+..+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44556667789999999999999999999996 468899999885432 2345677899999999 79999999998865
Q ss_pred C-----CCceEEEeecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 381 G-----PESLLVYEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 381 ~-----~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
. ...++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3478999999999999988542 23457899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccCCccccChhhhccCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHH
Q 006514 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ-----LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529 (642)
Q Consensus 455 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 529 (642)
||+|||++......... .....|+..|+|||.+.... ++.++|||||||++|||++|+.|+...... ..+.
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~- 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF- 243 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH-
Confidence 99999998865432221 22346888999999986543 689999999999999999999998643211 0110
Q ss_pred HHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 530 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. ........+.+ .......+.+++.+||+.+|++||++.|++++
T Consensus 244 ---~-~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 ---K-IPRNPPPTLLH------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---H-HhcCCCCCCCc------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 10111111100 11122346678889999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.53 Aligned_cols=249 Identities=33% Similarity=0.525 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEcCC-------CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 319 NKLGQGGFGTVYKGVLPD-------GREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2578999875432 24456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-----cEEEEecCC
Q 006514 391 LPNQSLDRFIFDSA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-----RAKIADFGL 461 (642)
Q Consensus 391 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DfGl 461 (642)
+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2245889999999999999999999988 99999999999999887 899999999
Q ss_pred ccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 462 ARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 462 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
+......... ......++..|+|||++.++.++.++||||||+++|||++ |+.|+...... .... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ----HVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH----HHhcCC
Confidence 9765432221 1223345778999999999999999999999999999998 99887543211 1111 010100
Q ss_pred chhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 540 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
... ..... ...+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 -------~~~----~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -------RLQ----KPENC---PDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------ccC----Ccccc---hHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 01111 234567888999999999999999999985
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.28 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=206.5
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh---hhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCce
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 385 (642)
....|+..+.||+|.||.||+++.+ +|+.+|+|.+..... ...+.+.+|+.+|++++ |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999976 499999999965433 23468899999999998 999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC----CcEEEEecCC
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFGL 461 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGl 461 (642)
+|||++.+|.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998654 3999999999999999999999998 9999999999999643 4799999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcch
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... ....+.+
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 998776 334566899999999999999999999999999999999999999998765432211 1111111
Q ss_pred hhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
............ .+-+++..++..||.+|+|+.++++|
T Consensus 256 -------~f~~~~w~~is~---~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -------DFTSEPWDDISE---SAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------CCCCCCccccCH---HHHHHHHHhcccCcccCCCHHHHhcC
Confidence 101000112222 33456678999999999999999997
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=302.31 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=192.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-----ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 384 (642)
.+|+..+.||+|+||.||++... +++.|++|++... .......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 6889999988533 123345688999999999999999999987653 456
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 346899999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCCc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... .. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhcCC----
Confidence 5432111 112345888999999999888999999999999999999999998643211 00 00000000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+ .........++.++.||..+|++||+++||++|
T Consensus 226 -~~~----------~~~~~~~~~~~~li~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 -TNP----------QLPSHISEHARDFLGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -CCC----------CCchhcCHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 001111122233336999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.87 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=168.7
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC------
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 381 (642)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999954 6889999998643 334456788999999999999999999987543
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346899999965 6666662 34788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 98654322 2234578999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.13 Aligned_cols=199 Identities=21% Similarity=0.310 Sum_probs=165.5
Q ss_pred cccccccc--CceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 317 EANKLGQG--GFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 317 ~~~~LG~G--~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
..++||+| +|++||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999986 47899999998643 2334456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985422 345899999999999999999999998 999999999999999999999999875443211110
Q ss_pred ------ccccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 472 ------ISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 472 ------~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1112356778999999976 45899999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.46 Aligned_cols=268 Identities=23% Similarity=0.327 Sum_probs=201.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|+..+.||+|+||.||++.++ +++.|++|++... .....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 6889999988543 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|++++.+..++. +...+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877776552 3355899999999999999999999998 9999999999999999999999999998765544
Q ss_pred CcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHH--HhhhcCcchhhc--
Q 006514 470 SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW--KHFQAGRVEELY-- 544 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~-- 544 (642)
........++..|+|||++... .++.++||||||+++|||++|+.|+....... .+..... ....... ....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSH-QELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH-hhhccc
Confidence 3233445688899999999887 78999999999999999999999886543211 1111100 0000000 0000
Q ss_pred cccccc---cccCCC------CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLML---HNYHDS------NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~---~~~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..... ...... ........+.+++..||+.+|++||++++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000000 000113456778889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.81 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEcCC--------CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 319 NKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+.||+|+||.||+|.... ..+|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888887655555567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc--------EEEEecCCc
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--------AKIADFGLA 462 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DfGla 462 (642)
+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 246899999999999999999999998 999999999999987765 699999988
Q ss_pred cccCCCCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCC-CCCCCCCCcccchhHHHHHHhhhcCcc
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGR-QNNRSKNSEYTDSLLTITWKHFQAGRV 540 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~ 540 (642)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~--- 219 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYE--- 219 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHH---
Confidence 654322 234578899999999874 5799999999999999999995 4443221110 000000
Q ss_pred hhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
..... ... ....+.+++..||+.||++|||+++|++.|+
T Consensus 220 -----~~~~~----~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -----DRHQL----PAP---KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----ccccC----CCC---CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 001 1124567788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=300.55 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=200.0
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||++.. .+|+.|++|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999985 47899999998643 234456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++... ....+++.+.+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988542 2346789999999999999999999988 99999999999999999999999999986544322
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
. .....|++.|+|||++.++.++.++||||||++++||++|+.|+...... ....... .+...
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~--------- 219 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII-RGSYP--------- 219 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh-cCCCC---------
Confidence 1 22346888999999999889999999999999999999999998643211 1111111 11100
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0011112345567779999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.03 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=197.7
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..+...++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344557999999999999864 7899999998665555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|.+++. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~ 174 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-R 174 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-c
Confidence 99998773 356899999999999999999999998 999999999999999999999999998765433221 2
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ... ......... ..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~----~~~~~~~~~-----~~---- 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK----RLRDSPPPK-----LK---- 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHhccCCCC-----cc----
Confidence 33568899999999998899999999999999999999999986432110 000 011100000 00
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ....+.+++..||+.+|++||++.+|+++
T Consensus 239 ~~~~---~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHK---ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCC---CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001 11234567779999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=301.82 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=196.6
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh---------hhHHHHHHHHHHHhcCCccceeeeeeeeccCCC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---------HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 383 (642)
+|.....||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 688999998754321 223568899999999999999999999999999
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.++|+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 356889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-----ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC
Q 006514 464 SFQEDKSH-----ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538 (642)
Q Consensus 464 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 538 (642)
........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~-~~~-~~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----A-IFK-IGE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----H-HHH-Hhc-
Confidence 76532211 1123458889999999998889999999999999999999999986532110 0 000 000
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
...+.+ ... ....+.+++.+||+.||.+||++.||+++
T Consensus 227 ----~~~~~~------~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ----NASPEI------PSN---ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----cCCCcC------Ccc---cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000000 111 12344566779999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.27 Aligned_cols=248 Identities=29% Similarity=0.460 Sum_probs=198.8
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-----hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-----RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999975 78999999886433 33556789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999876544
Q ss_pred CCCcccccccCCccccChhhhccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
.. ......++..|++||.+.... ++.++|+||||+++|||++|+.||...... ...+..........+
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~--- 223 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPPI--- 223 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCCc---
Confidence 33 223456889999999988776 899999999999999999999998653310 111111100000000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.+++.+||+.+|++||++.+++++
T Consensus 224 --------~~~---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 --------PDH---LSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------CCC---cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111 12344567789999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=306.89 Aligned_cols=266 Identities=22% Similarity=0.348 Sum_probs=200.8
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||+|.+. +|+.|++|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999964 78999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+ +++|.+++... ...+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988543 256999999999999999999999998 99999999999999999999999999987655433
Q ss_pred cccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC-----------
Q 006514 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG----------- 538 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 538 (642)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++...... .........+...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCc
Confidence 223345689999999998654 4689999999999999999997777543321 1111111111000
Q ss_pred -cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 -RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 -~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....+..+....... ..........+.+++.+|++.+|++||+++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPL-EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchH-HHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000000 00000112456678889999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=338.90 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=197.9
Q ss_pred HHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC--C
Q 006514 308 LEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--P 382 (642)
Q Consensus 308 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~ 382 (642)
.+...++|.+.++||+|+||.||++... +++.+|+|.+... .......|..|+.++.+++||||+++++++... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999964 5778899987543 334456789999999999999999999987543 4
Q ss_pred CceEEEeecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEeccCCCCEEEcC-------
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSK----IRIIHRDIKASNILLDS------- 450 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~iiH~Dlkp~NILl~~------- 450 (642)
..+|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 5789999999999999986432 23579999999999999999999998541 34999999999999964
Q ss_pred ----------CCcEEEEecCCccccCCCCCcccccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 006514 451 ----------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (642)
Q Consensus 451 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~ 518 (642)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999986543322 234579999999999864 4589999999999999999999999864
Q ss_pred CCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 519 KNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 519 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ..+. ..+... +.+. .... ...+.+++..||+.+|.+||++.+++.+
T Consensus 246 ~~~~--~qli----~~lk~~-------p~lp-----i~~~---S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNF--SQLI----SELKRG-------PDLP-----IKGK---SKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcH--HHHH----HHHhcC-------CCCC-----cCCC---CHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 3221 1111 111110 0000 0111 2345567789999999999999999964
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=306.64 Aligned_cols=266 Identities=25% Similarity=0.377 Sum_probs=208.6
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
++|+..+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788899999999999999985 468899999986555555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998842 45789999999999999999999998 999999999999999999999999998765443322
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....+++.|+|||.+.++.++.++||||||+++|||++|+.||......... .. . ...+. +
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~-~---~~~~~------~----- 233 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL-I---ATNGT------P----- 233 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--ee-h---hcCCC------C-----
Confidence 22346888999999999888999999999999999999999998654321110 00 0 00000 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFI 605 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p~~p~~~ 605 (642)
. ..........+.+++..||+.+|++||++.+++.|-.-....|.-+.||.+
T Consensus 234 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~ 285 (293)
T cd06647 234 E--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLI 285 (293)
T ss_pred C--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccchH
Confidence 0 001111122455677899999999999999999984443344444444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=305.21 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=199.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCc----EEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
.+|...+.||+|+||.||+|.++ +|+ .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999864 333 58999876543 3455778999999999999999999999887 78899
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCccc-ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 467 EDKSHIS-TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
....... ....++..|+|||.+....++.++||||||+++|||++ |+.|+....... +.. ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~----- 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD----LLEKGE----- 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----HHhCCC-----
Confidence 4332211 12234568999999988899999999999999999999 999986543211 111 111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.... ... ....+.+++..||..+|.+||++.++++.|+..
T Consensus 229 ----~~~~--~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 ----RLPQ--PPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ----CCCC--CCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000 011 112455677899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.73 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=202.6
Q ss_pred CccccccccccCceEEEEEEcC---CCc--EEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP---DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~---~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
.....++||+|-||.||+|... .|+ .||||..+.+ .....+.|+.|..+|++++||||++|+|+|.+ ...|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3455678999999999999943 333 4788988663 45567889999999999999999999999865 468999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
||.++.|.|..+|.. +...|+......++.||+.||.|||++. +|||||..+||||.+..-+||+|||+++....
T Consensus 469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999954 4467889999999999999999999987 99999999999999999999999999998887
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
+.....+...-+..|||||.+....++.+||||-|||.+||+++ |.+||......+. .-.++.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I~~iEn 607 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------IGHIEN 607 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------EEEecC
Confidence 77665555566778999999999999999999999999999988 9999875432211 111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.-..+ -++.-...+..+..+||..+|.+||.+.|+...|+.
T Consensus 608 GeRlP-----~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 608 GERLP-----CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCC-----CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 11111 111122345567789999999999999999876643
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.43 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=200.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh--hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|...+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 789999999865543 3667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 345889999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccc---ccccCCccccChhhhccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 471 HIS---TAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 471 ~~~---~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
... ....++..|+|||++.... ++.++||||||+++|||++|+.||....... ...+... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-AGH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-cCC-----
Confidence 221 1356788999999998766 8999999999999999999999986432111 1111000 000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+.+ .. .......+.+++.+||+.+|++||++.+++.+
T Consensus 224 ~~~~------~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 KPPI------PD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCC------Cc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 00 01112334567789999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.10 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=198.4
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC-CCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-PESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 389 (642)
+|+..+.||+|++|.||++..+ +++.|++|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999964 5789999998543 234456788999999999999999999887644 35789999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++++|.+++... ....+++.++..++.+++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988642 3456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+...... ..... ...+....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~-~~~~~~~~------- 221 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR-IIEGKLPP------- 221 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcCCCC-------
Confidence 2 223456889999999999999999999999999999999999998643211 11111 11111100
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
........+.+++.+|++.||++||++.+++++
T Consensus 222 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001112345677889999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.28 Aligned_cols=245 Identities=30% Similarity=0.439 Sum_probs=200.3
Q ss_pred cccccCceEEEEEEcCC-CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChhh
Q 006514 320 KLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 398 (642)
.||+|.||+||.|++.+ ...+|||.+...+....+.+.+|+.+.++|+|+|||+++|++.+++..-|.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999754 55789999977776777788999999999999999999999999999999999999999999
Q ss_pred hhhcccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc-CCCcEEEEecCCccccCCCCCccccc
Q 006514 399 FIFDSAKAKTL--TWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTA 475 (642)
Q Consensus 399 ~l~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~ 475 (642)
+|.. +-+++ .+...-.+.+||++||.|||++. |||||||-.||||+ -.|.+||+|||-++....-.. .+.+
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TET 735 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTET 735 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-cccc
Confidence 9953 34555 66777788999999999999998 99999999999997 468999999999887654332 3456
Q ss_pred ccCCccccChhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 476 IAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 476 ~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
..||..|||||++..|+ |..++|||||||.+.||.||++||.....+.. .++.-.+ -..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----------------AMFkVGm--yKv 796 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----------------AMFKVGM--YKV 796 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----------------hhhhhcc--eec
Confidence 78999999999998764 89999999999999999999999865433211 0111111 111
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+++.+.+....+-.++++|+.++|.+||+++++++.
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 233445555667779999999999999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.34 Aligned_cols=245 Identities=28% Similarity=0.431 Sum_probs=197.6
Q ss_pred ccccccccccCceEEEEEEc-CCCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 315 FDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
|+..+.||.|+||.||.+.+ .+.+.||||+...+ +.+.+.+++.|+.+|.+++|||++.+.||+..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66778899999999999995 47788999998654 445677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
| -|+-.|++. ...+++.+.++..|..+.+.||.|||+++ .||||||+.||||++.|.+||+|||.|......
T Consensus 108 C-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 C-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred H-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 9 556666663 23468899999999999999999999998 999999999999999999999999999876554
Q ss_pred cccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
..++|||.|||||++. .|+|+-|+||||+|+...||...++|....+. ....+ ++... ++.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALY-HIAQN------esP 243 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALY-HIAQN------ESP 243 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHH-HHHhc------CCC
Confidence 3478999999999875 58899999999999999999999998654321 11111 11111 110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.. ...+-...+.+++-.||+.-|.+|||..++++|-
T Consensus 244 tL-------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 244 TL-------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CC-------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 00 0112233455666789999999999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.89 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=202.8
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeec--cChhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFF--NNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 388 (642)
...|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+|+ |.+|++|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 345899999999999999999988888899987743 35667788999999999995 999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||= +-+|..+|.... .....| .+..+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||+|.....+
T Consensus 440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 975 668999985532 233445 67788999999999999999 999999999999865 58999999999998887
Q ss_pred CCc-ccccccCCccccChhhhccC-----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh
Q 006514 469 KSH-ISTAIAGTLGYMAPEYLAHG-----------QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
... .....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..... .|.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~a--- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIA--- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHH---
Confidence 765 44567999999999998643 256899999999999999999999864321 122
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
++..+.|+....+....+. ..+ +++++..||++||.+|||..|+|++-
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~-~~~---li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPE-NDE---LIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred --HHHhhcCCCccccccCCCC-chH---HHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 2234445533222211111 111 77888899999999999999999874
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.36 Aligned_cols=251 Identities=33% Similarity=0.530 Sum_probs=197.8
Q ss_pred ccccccccccCceEEEEEEcCC-----CcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 315 FDEANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
+++.+.||+|+||.||++.+.+ +..||+|.+...... ..+.+.+|+.++.+++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999999753 488999998654433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999985422 122899999999999999999999998 999999999999999999999999999876654
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.........+++.|+|||.+....++.++||||||++++||++ |+.|+...... .... ........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~------ 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLE----YLKKGYRL------ 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCCCC------
Confidence 3322222346789999999988889999999999999999999 77776542211 1111 11111100
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.. ... ....+.+++.+|++.+|++|||+.++++.|
T Consensus 224 ---~~--~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PK--PEN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CC--CCc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 111 223456678899999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.93 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=196.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC----------hhhHHHHHHHHHHHhcCCccceeeeeeeeccCC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN----------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 382 (642)
+|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 68999999875321 112346788999999999999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999843 357899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-ccccccCCccccChhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 463 RSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 463 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
......... ......++..|+|||.+.... ++.++||||||+++|||++|..|+...... ...+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-
Confidence 765432221 223456889999999987654 899999999999999999999998532210 1111100000
Q ss_pred chhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 540 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....+. ..........+.+++..||+.+|++||++.+|+++
T Consensus 229 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIP---------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCC---------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000 00111112345567779999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=300.29 Aligned_cols=261 Identities=26% Similarity=0.330 Sum_probs=200.9
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 388 (642)
++|+..+.||.|++|.||++.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999974 68899999886442 34556799999999999999999999988654 3578999
Q ss_pred eecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 389 EFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
||+++++|.+++... .....+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23456899999999999999999999998 99999999999999999999999999875433
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...............+ ........+.+.
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~- 231 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--IVNMPNPELKDE- 231 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH--HhcCCchhhccC-
Confidence 221 23457889999999999999999999999999999999999987653311111111111 111111111110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.+|++|||+.||+++
T Consensus 232 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 -------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00001122346678889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.09 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=194.7
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
.+|+..+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++.+++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3578889999999999999976 67889999885432 345788999999999999999999988654 5799999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998643 2346899999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....+..|+|||.+.++.++.++||||||+++|||++ |+.||...... .+ ......+ ....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~---------~~~~ 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EV----KECVEKG---------YRME 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HH----HHHHhCC---------CCCC
Confidence 12234568999999998899999999999999999998 88887543211 11 0111111 0000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. .. .....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 218 ~--~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 P--PE---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C--CC---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 11 112345578889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=301.14 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=201.1
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||+|+||.||++.+. +++.+++|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999975 68999999886543 34556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++.... ..+++.....++.+++.||.|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 678999999999999999999999 77 9999999999999999999999999987653322
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ........ ...... +.+
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~-----~~~- 224 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQY-IVNEPP-----PRL- 224 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHH-HhcCCC-----CCC-
Confidence 11 25688899999999998999999999999999999999999865432111 11111111 000000 000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. ......+.+++..||..||++|||+.+++.+
T Consensus 225 -----~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 -----PS--GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -----Ch--hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00 0022345677789999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.92 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=193.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-----ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 384 (642)
.+|+..+.||+|+||.||++... +++.|+||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 6899999987532 123356788999999999999999999988764 346
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
+++|||+++++|.+++.. ...+++...+.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 799999999999998843 345788999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCCCc--ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~-~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIF-KIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHH-HHhcCCC---
Confidence 5432111 123356888999999998888999999999999999999999998643111 1110 0000000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. ...+......+..++..|+ .+|++||+++||+++
T Consensus 227 --~---------~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --N---------PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred --C---------CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 0 1111222234445666777 499999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.04 Aligned_cols=266 Identities=24% Similarity=0.349 Sum_probs=195.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||++... +|+.+++|++.... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999964 68999999886432 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++ ++|.+++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 577777643 2356899999999999999999999998 99999999999999999999999999986543322
Q ss_pred cccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc------chhh
Q 006514 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR------VEEL 543 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 543 (642)
. .....+++.|+|||.+.+. .++.++||||||+++|||+||+.|+....+.. .. ............ +.+.
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQ-LKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HH-HHHHHHHhCCCChHHhHHhhhc
Confidence 1 2234578899999998765 47899999999999999999999865433211 01 010000000000 0000
Q ss_pred ccccccccccCCC-----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 544 YDKNLMLHNYHDS-----NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 ~d~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+.... ...... ........+.+++..||+.||++|||+.+++++
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 000000 000112344567889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.76 Aligned_cols=271 Identities=24% Similarity=0.361 Sum_probs=199.6
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+|+..++||+|++|.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 688999998865432 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 88888865444467999999999999999999999998 999999999999999999999999999765433221
Q ss_pred ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
.....++..|++||.+.+. .++.++||||||+++|||++|+.||...............+.......+..+.+.....
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 2234578899999998664 57899999999999999999999987654321110000000000000000000000000
Q ss_pred cccCC-------CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHD-------SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..... .........+.+++..|++.||++||++.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0000112345678889999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.85 Aligned_cols=202 Identities=26% Similarity=0.357 Sum_probs=172.6
Q ss_pred HHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC-c-----cceeeeeeeeccCC
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-H-----KNLVRLLGCSCSGP 382 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~ 382 (642)
....+|++.+.||+|.||.|-++.+ .+++.||||+++. ......+-..|+.+|..|+ | -|+|++++++...+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3344789999999999999999995 4699999998854 4455566778999999996 4 48999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC--cEEEEecC
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL--RAKIADFG 460 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DfG 460 (642)
+.+||+|.+ .-+|.++|... +-..++......++.||+.||.+||+.+ |||+||||+||||.+-. .+||+|||
T Consensus 262 HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 999999998 66999999653 3456999999999999999999999998 99999999999997644 79999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
.+......-. +..-+.-|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+
T Consensus 337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9986544322 45667789999999999999999999999999999999887766554
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.86 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=199.0
Q ss_pred ccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 315 FDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 47889999998766555667789999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|.+++.. ..+++..+..++.+++.||.|||+++ ++||||+|+||+++.++.++|+|||++......... .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~ 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-R 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-c
Confidence 999998843 46899999999999999999999998 999999999999999999999999988765433221 2
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ....... .+...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~-~~~~~~~-----~~~~~---- 236 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAM-KRIRDNL-----PPKLK---- 236 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHH-HHHHhcC-----CCCCc----
Confidence 2356889999999999888999999999999999999999998643211 100 0011110 00000
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
........+.+++.+||+.+|++||++.+++++
T Consensus 237 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 ---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ---ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000112346678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.20 Aligned_cols=268 Identities=22% Similarity=0.354 Sum_probs=196.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 689999999864332 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++ +|.+++... ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 898887542 246899999999999999999999998 99999999999999999999999999875432221
Q ss_pred cccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc---chhhc--
Q 006514 471 HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR---VEELY-- 544 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~-- 544 (642)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+....... .....
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 122346888999999875 458999999999999999999999986543211 11111111111000 00000
Q ss_pred ----ccc---ccccccCC-CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 ----DKN---LMLHNYHD-SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 ----d~~---~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ........ .........+.+++..|++.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00000000 0000112455678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.87 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=204.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..+.||+|++|.||+++.. +++.|+||++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 589999999865543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++.. ...+++..++.++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999853 3678999999999999999999999 87 9999999999999999999999999998765433
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
... ....++..|+|||.+....++.++||||||+++|||++|+.|+..........+.... ..... +..
T Consensus 155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~-----~~~- 223 (264)
T cd06623 155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPP-----PSL- 223 (264)
T ss_pred Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCC-----CCC-
Confidence 321 2356788999999999999999999999999999999999998665421111111111 00000 000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... .....+.+++..||+.+|++||++.+++++
T Consensus 224 -----~~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -----PAE--EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----Ccc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001 022355667789999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.96 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=195.5
Q ss_pred ccccccccccCceEEEEEEcC----CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC------
Q 006514 315 FDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 382 (642)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3688999988543 3445677899999999999999999999876532
Q ss_pred CceEEEeecCCCChhhhhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEec
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSA---KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 459 (642)
..++++||+++|+|.+++.... +...+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 2235789999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhhhc
Q 006514 460 GLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 460 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+...... .+... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHH----HHc
Confidence 999876443322 1223345678999999998889999999999999999999 78887543211 11111 111
Q ss_pred CcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
... .. . . ......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 231 ~~~-------~~-~---~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNR-------LK-Q---P---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCc-------CC-C---C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 100 00 0 0 0112356778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.90 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=185.9
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcC---CccceeeeeeeeccCCCceEEEeecCC
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
||+|+||.||+++.. +++.||||++.... ......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999964 68999999985432 22234455677777655 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++. +...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99998884 3457899999999999999999999998 99999999999999999999999999875433222 22
Q ss_pred ccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .+.....+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~--------~~~- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKV--------RFP- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCC--------CCC-
Confidence 346799999999998765 4899999999999999999999998653211 0 1111111110 000
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRP----TMSRVLQM 589 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP----s~~evl~~ 589 (642)
...... .+.+++.+||+.||++|| ++.++++|
T Consensus 218 --~~~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 --KNVLSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --CccCCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 111122 334567799999999998 67888775
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=297.71 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=185.5
Q ss_pred ccccccCceEEEEEEcCCC---cEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 319 NKLGQGGFGTVYKGVLPDG---REIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
++||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 345677665433 345578999999999999999999999999999999999999999
Q ss_pred Chhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC-Ccc
Q 006514 395 SLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK-SHI 472 (642)
Q Consensus 395 ~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 472 (642)
+|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986532 2345677788899999999999999988 9999999999999999999999999986432211 112
Q ss_pred cccccCCccccChhhhcc-------CCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 473 STAIAGTLGYMAPEYLAH-------GQLTEKADVYSFGMLLLEIVTG-RQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... .... . ...+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~-~~~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLN---H-VIKDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHhhcccccC
Confidence 234567889999998753 2457899999999999999985 5566432211 1111 1 1111112222
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
++.+. . ... .++.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~-----~-~~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE-----L-PYS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC-----C-CCc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22221 1 111 23445666798 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=293.98 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=206.1
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
|.+.++||+|.||.|||+.++ .|+.+|||.+... ...+++..|+.++++.+.|++|+++|.+.....+++||||+..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 677889999999999999965 7999999988654 3467899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+..+++.. ++++|.+.++..++...++||+|||... -||||||+.||||+-+|.+||+|||.|-....... ..
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 999999954 5689999999999999999999999886 79999999999999999999999999876543222 23
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
.++.||+-|||||++..-.|+.++||||+|+...||..|++|+....+- ..++--... .++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM------------------RAIFMIPT~-PPP 247 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM------------------RAIFMIPTK-PPP 247 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc------------------ceeEeccCC-CCC
Confidence 4678999999999999999999999999999999999999998653221 011110000 111
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
....+..-...+-+++..||-.+|++|-|+.++++|-
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 1222333345566788899999999999999999873
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.41 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=199.3
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeecc--CCCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 388 (642)
+|+..+.||+|+||.||++.. .+++.+++|++... .....+.+.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477888999999999999985 46889999988643 34445678899999999999999999997754 34568999
Q ss_pred eecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 389 EFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLH-----EQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 389 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
||+++++|.+++... .....+++..++.++.+++.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998543 22467899999999999999999999 665 999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
......... .....+++.|+|||.+....++.++||||||+++|+|++|+.|+...... .+. .....+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~- 228 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGKFR- 228 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCCCC-
Confidence 876544321 23356899999999999988999999999999999999999998754311 111 111111100
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+|++.+|++||++.+|+++
T Consensus 229 -------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111122356678889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.10 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=200.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh---hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 589999999865432 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+.+++|.+++.. .....+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23467899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCc----------------------------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 469 KSH----------------------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 469 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 111 1113468889999999998889999999999999999999999986543
Q ss_pred CcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 006514 521 SEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT----MSRVLQM 589 (642)
Q Consensus 521 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~evl~~ 589 (642)
... . + .++.+...... ........+.+++.+||+.||++||| +.|++.+
T Consensus 237 ~~~--~-----~--------~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE--T-----F--------SNILKKEVTFP-----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH--H-----H--------HHHhcCCccCC-----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 0 0 11111111100 00012234566777999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.68 Aligned_cols=255 Identities=21% Similarity=0.313 Sum_probs=196.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999964 57899999886443 234457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 356899999999999999999999998 999999999999999999999999998742111
Q ss_pred CC--------------cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006514 469 KS--------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534 (642)
Q Consensus 469 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 534 (642)
.. .......++..|+|||++....++.++||||||+++|||++|+.||...... . . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~---~-~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---E---L-FGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H---H-HHH
Confidence 00 0112245788999999998888999999999999999999999998643211 1 1 111
Q ss_pred hhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
...+... .+.. .... ...+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 ~~~~~~~---~~~~------~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIE---WPEG------DEAL---PADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccC---CCCc------cccC---CHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111000 0000 0011 1234567779999999999996555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.53 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=197.4
Q ss_pred ccccccccccCceEEEEEEc-CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 315 FDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66778899999999999985 468899999875432 3445678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++. ...+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 999999883 346899999999999999999999998 99999999999999999999999999876543221 2
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..... ........ +
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~-----~---- 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-IPKNNPPT-----L---- 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-HhcCCCCC-----C----
Confidence 23356788999999999888999999999999999999999998543211 00000 11110000 0
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. .....+.+++.+||+.+|++||++.+++++
T Consensus 222 --~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 --EG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --Cc---ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01 112345567789999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.73 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=199.9
Q ss_pred ChhhHHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-Cccceeeeeeeecc-
Q 006514 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS- 380 (642)
Q Consensus 304 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~- 380 (642)
+..++....+.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3445556678899999999999999999996 468899999885543 3345688899999998 69999999998853
Q ss_pred -----CCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEE
Q 006514 381 -----GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAK 455 (642)
Q Consensus 381 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k 455 (642)
....+++|||+++|+|.+++... +...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 34578999999999999988542 3356888889999999999999999998 99999999999999999999
Q ss_pred EEecCCccccCCCCCcccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH
Q 006514 456 IADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530 (642)
Q Consensus 456 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 530 (642)
|+|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||........ ...
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFL- 237 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhh-
Confidence 999999876543222 123356889999999875 34688899999999999999999999854321100 000
Q ss_pred HHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 531 TWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 531 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. ......... . ......+.+++..||+.||.+||++.||+++
T Consensus 238 ----~-----~~~~~~~~~-----~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 ----I-----PRNPPPKLK-----S---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----H-----hhCCCCCCc-----c---cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000000000 0 1112346677889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.49 Aligned_cols=269 Identities=22% Similarity=0.327 Sum_probs=196.3
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++++|...+.||+|+||.||+|... +|+.|++|++..... .....+.+|+.++++++|+||+++++++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999854 688999999864432 22346788999999999999999999999988999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+. ++|.+++.. ....+.+..+..++.|++.||.|||+.+ ++|+||||+|||++.++++||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 677666643 2346788889999999999999999998 999999999999999999999999998764332
Q ss_pred CCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC---------
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG--------- 538 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 538 (642)
... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ......|..+...
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence 211 2234578899999998764 57889999999999999999999987543321 1111111111100
Q ss_pred ----cchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 ----RVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ----~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
...+....... .... ..........+.+++.+|++.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKP-QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCC-cchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000 0000 00000012344567789999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.66 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=198.4
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||++.. .+++.+|+|++... .......+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999986 46889999988643 234456789999999999999999999999988999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++... ....+++..+..++.++++||.|||+++ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2356899999999999999999999998 9999999999999865 468999999998765432
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... .. ... ........+
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~---~~~-~~~~~~~~~------ 221 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---AL---VLK-IMSGTFAPI------ 221 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HH---HHH-HHhcCCCCC------
Confidence 2 22356888999999999888999999999999999999999998653221 01 100 000000000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. .....+.+++..||+.+|++|||+.|++++
T Consensus 222 -----~~---~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -----SD---RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CC---CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 112245577789999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.59 Aligned_cols=271 Identities=21% Similarity=0.337 Sum_probs=197.8
Q ss_pred CccccccccccCceEEEEEEcC---CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCce
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP---DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESL 385 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 385 (642)
+|+..++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777889999999999999964 47899999986532 33446678899999999999999999999887 7789
Q ss_pred EEEeecCCCChhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC----CCcEEEEec
Q 006514 386 LVYEFLPNQSLDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS----RLRAKIADF 459 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~Df 459 (642)
+||||+++ +|.+++..... ...+++...+.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666543222 236889999999999999999999998 999999999999999 999999999
Q ss_pred CCccccCCCCCc--ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccch------hHHH
Q 006514 460 GLARSFQEDKSH--ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDS------LLTI 530 (642)
Q Consensus 460 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~------l~~~ 530 (642)
|++......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999876443321 22345678899999988764 58999999999999999999999997654432100 0000
Q ss_pred HHHhhhcC------------cchhhccccccccccCCCCcH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 531 TWKHFQAG------------RVEELYDKNLMLHNYHDSNVK-------YEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 531 ~~~~~~~~------------~~~~~~d~~~~~~~~~~~~~~-------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....+... ......+.... ......... .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccC-CCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 00000000000 000000111 122356788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.55 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=201.4
Q ss_pred CccccccccccCceEEEEEEcCCCc-EEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPDGR-EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
-|+++..||.|+||.||+++.++.. ..|.|++...+....++|+-|++||+...||+||+|++.+...+.++|..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4777888999999999999976543 346788877788888999999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
||..+.++... ...|.+.++.-+..+++.||.|||++. |||||||+.|||++-+|.++|+|||.+....... ..
T Consensus 113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK 186 (1187)
T ss_pred CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence 99999988653 468999999999999999999999998 9999999999999999999999999875432211 12
Q ss_pred cccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 473 STAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
...+.|||.|||||+.+ ..+|+.++||||||+.|.||..+.+|-...+. ..+.-.+......-+..+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLLQPS 259 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCCcccCcc
Confidence 34578999999999875 46799999999999999999999988543221 1111111111222222221
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.-...+-++...||..||+.||++.++++|-
T Consensus 260 ------------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 260 ------------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred ------------hhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 1222344556689999999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.93 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=198.3
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceEEEe
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVYE 389 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 389 (642)
|+..++||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999965 58899999997552 33446788999999999999999999999887 78999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++ +|.+++... ...+++..++.++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 888887432 257899999999999999999999998 9999999999999999999999999998765544
Q ss_pred CcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhc---Ccchhhcc
Q 006514 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA---GRVEELYD 545 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d 545 (642)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .......... ..+....+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence 322333457888999998765 4579999999999999999999999865443211 1111110000 00000000
Q ss_pred ----ccccccccCCCC----cHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 546 ----KNLMLHNYHDSN----VKY-EVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 546 ----~~~~~~~~~~~~----~~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
............ ... ....+++++..||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000000 000 13466788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.59 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=203.3
Q ss_pred HHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
..++.|+..+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999976 689999999876544 5677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999995432 47999999999999999999999988 999999999999999999999999998755432
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. ......++..|++||++.+..++.++||||||+++|||++|+.|+....... .... .........
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~-----~~~~~~~~~----- 236 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL-----ITTKGIPPL----- 236 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhcCCCCC-----
Confidence 22 1223457889999999998889999999999999999999999986432210 0000 000000000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+||+.+|.+||++.+|+++
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 -------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0001012345567889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=291.72 Aligned_cols=250 Identities=31% Similarity=0.469 Sum_probs=202.4
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++... ...+++..+..++.++++||.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999988542 257899999999999999999999988 99999999999999999999999999987655432
Q ss_pred cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
.....++..|+|||.+....++.++||||||++++||++|+.|+....... .... ........+.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~~~~-------- 218 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFK----IATNGPPGLR-------- 218 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHH----HHhcCCCCcC--------
Confidence 234568889999999998889999999999999999999999986532110 0000 0000000000
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. .......+.+++..||+.||++|||+.+++++
T Consensus 219 --~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 --N--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --c--ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00012345677789999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=298.52 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=199.1
Q ss_pred HHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCC-----
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP----- 382 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~----- 382 (642)
..+++|+..+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999974 678899998865443 346789999999999 6999999999987644
Q ss_pred -CceEEEeecCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 383 -ESLLVYEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 383 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3799999999999999885422 2467899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhcc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhh
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-----GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 535 (642)
++........ ......|+..|+|||++.. ..++.++||||||++++||++|+.||...... ..+.. .
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-----~ 230 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK-----I 230 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH-----h
Confidence 9876543222 1233568899999998753 34788999999999999999999998643211 11100 0
Q ss_pred hcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....... ..........+.+++.+||+.||++|||+.+|+++
T Consensus 231 ~~~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPT------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCC------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0100000 00111122345677889999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=301.30 Aligned_cols=270 Identities=22% Similarity=0.318 Sum_probs=196.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 387 (642)
++|+..+.||+|+||.||+|..+ +++.+++|.+.... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 68899999986443 22234577899999999999999999988777 789999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+||++ ++|.+++... ...+++...+.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5888887542 246899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhH--------HHHHHhhhcC
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL--------TITWKHFQAG 538 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~ 538 (642)
.... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||............ ...|..+..-
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 4221 1234578899999998764 4689999999999999999999998754332111000 0011111100
Q ss_pred cchh-hccccccccccCCCCcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEE-LYDKNLMLHNYHDSNVKY-EVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~-~~d~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ..-............... ....+.+++..||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000000000000000000 12345567789999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=300.01 Aligned_cols=245 Identities=25% Similarity=0.332 Sum_probs=199.3
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|+..+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999964 6899999988543 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 357899999999999999999999988 999999999999999999999999999876544
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.|+...... ........+. .
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~--------~ 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGK--------V 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC--------c
Confidence 23356889999999998888999999999999999999999998653311 0111111111 0
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
.. .... ...+.+++..||+.||.+|| +++|++++
T Consensus 216 ~~----~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RF----PSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cC----CccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 00 1111 23445677799999999999 88888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.12 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=195.4
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-----Cc
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 384 (642)
+++|++.++||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 47899999988542 2334566889999999999999999998765443 46
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++|+||++ ++|.+++ ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 4777766 3357999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCc--ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC---
Q 006514 465 FQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG--- 538 (642)
Q Consensus 465 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 538 (642)
....... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 5433221 1233568899999998754 568999999999999999999999986432110 000000001000
Q ss_pred cchhhccccc----cccccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEELYDKNL----MLHNYHDSN-----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~~~d~~~----~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+..+.+... ......... .......+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000000000 00113346678889999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.96 Aligned_cols=269 Identities=22% Similarity=0.331 Sum_probs=194.4
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCC-----
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPE----- 383 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 383 (642)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999964 68999999875432 223457889999999995 6999999998877665
Q ss_pred ceEEEeecCCCChhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-CCcEEEEecC
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFG 460 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfG 460 (642)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+++ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78888754322 356899999999999999999999998 999999999999998 8899999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
++......... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....... .+.... .......
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCC
Confidence 98865432221 122356888999998865 457999999999999999999999986533211 111100 0000000
Q ss_pred ---chhhcccccc--ccccCCC----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 540 ---VEELYDKNLM--LHNYHDS----NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 540 ---~~~~~d~~~~--~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.......... ....... ........+.+++..||+.||++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 0000000 001122345678889999999999999999976
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=298.59 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=191.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHH-HhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNI-ISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|++.+.||+|+||.||++... +|+.||+|++.... .....++..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 68999999886542 2334456666665 566789999999999999999999999
Q ss_pred ecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 390 FLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 390 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|++ |+|.+++... .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877542 2345789999999999999999999987 6 99999999999999999999999999886543
Q ss_pred CCCcccccccCCccccChhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAH----GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .. ..... .+..
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~----~~~~~-~~~~--- 225 (283)
T cd06617 157 SVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQ----LKQVV-EEPS--- 225 (283)
T ss_pred ccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HH----HHHHH-hcCC---
Confidence 221 223467889999998864 456889999999999999999999985422110 00 00000 0000
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+.+. .... ...+.+++..||+.+|++||++.+|+++
T Consensus 226 --~~~~-----~~~~---~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 --PQLP-----AEKF---SPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCCC-----cccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111 1245567789999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=300.67 Aligned_cols=266 Identities=25% Similarity=0.401 Sum_probs=195.7
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|++|.||+++.. +|+.|+||++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 68999999886432 22335788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+. ++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6888887543 3457899999999999999999999998 99999999999999999999999999876543322
Q ss_pred cccccccCCccccChhhhccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH----------HHHhhhcC-
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI----------TWKHFQAG- 538 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~----------~~~~~~~~- 538 (642)
. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||....... .+... .|......
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 22335688999999887644 6889999999999999999999986543211 11110 01000000
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.....+.. ...... ..........+.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPK-WARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhccc-ccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000 000000 00000011234567889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=296.41 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=197.5
Q ss_pred CccccccccccCceEEEEEEc-CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCC---ccceeeeeeeeccCCCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 388 (642)
.|+..+.||+|+||.||+|.+ .+++.|++|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 57899999988644 3344567889999999996 999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.. ..+++...+.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998833 37899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||........ .. ..... ..+.
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~~~~~-----~~~~ 221 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-LIPKS-----KPPR 221 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-ccccC-----CCCC
Confidence 322 2334688999999998764 468999999999999999999999864321100 00 00000 0000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+. ... ....+.+++.+||+.||++||++.+++++
T Consensus 222 ~~-----~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LE-----DNG---YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CC-----ccc---CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 10 111 12345667789999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=295.23 Aligned_cols=249 Identities=27% Similarity=0.340 Sum_probs=200.5
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 68999999886432 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 257899999999999999999999998 9999999999999999999999999988765432
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. .....|+..|+|||.+....++.++||||||+++|+|++|+.|+.......... ....... ....
T Consensus 155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~--------~~~~ 220 (258)
T cd05578 155 L--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET--------ADVL 220 (258)
T ss_pred c--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc--------cccc
Confidence 1 233568889999999998889999999999999999999999987654321111 1110100 0000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM--SRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~--~evl~~ 589 (642)
. .. .....+.+++.+||+.||.+||++ +|++++
T Consensus 221 ---~-~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 221 ---Y-PA---TWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ---C-cc---cCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 0 11 112455677789999999999999 777653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=306.18 Aligned_cols=271 Identities=27% Similarity=0.364 Sum_probs=196.8
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccC--CCc
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG--PES 384 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 384 (642)
..++|+..+.||+|+||.||+|.+. +|+.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999965 6889999988532 233445678899999999 999999999987653 357
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888732 37889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCC----cccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH--------H
Q 006514 465 FQEDKS----HISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------T 531 (642)
Q Consensus 465 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~ 531 (642)
...... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.............. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 644332 12234568999999998765 4578999999999999999999999865332111000000 0
Q ss_pred HHhhhcCcchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 532 WKHFQAGRVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 532 ~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..+......++++......... ..........+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000111111000000000 00000113356778889999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=293.09 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=198.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||++..+ +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 68899999885431 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-cEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2346799999999999999999999998 99999999999999885 56999999998765432
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.|+..... ........ .+.....
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~------ 222 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-QGYFAPI------ 222 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cccCCCC------
Confidence 2 22234688999999999988899999999999999999999999864321 11111111 1111000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ...+.+++.+|++.+|++|||+.+|+++
T Consensus 223 -----~~~~---~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -----SPNF---SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCC---CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111 1245567789999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=301.30 Aligned_cols=270 Identities=25% Similarity=0.360 Sum_probs=193.7
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC------
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE------ 383 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 383 (642)
++|+..++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56899999999999999999964 68999999885432 2223456789999999999999999998876543
Q ss_pred --ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 384 --SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 384 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
.++||||+. ++|.+.+.. ....+++.+.+.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 489999996 477777643 2346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhc
Q 006514 462 ARSFQEDKSH---ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 462 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 11234578899999988764 4788999999999999999999988654322111111111100000
Q ss_pred Ccch-----hhccccccccccCCCCcH------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 538 GRVE-----ELYDKNLMLHNYHDSNVK------YEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~~~~-----~~~d~~~~~~~~~~~~~~------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... +..+........ ..... .....+.+++..||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQ-KRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCcc-chhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 000000000000 00000 012245678889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=321.61 Aligned_cols=201 Identities=23% Similarity=0.397 Sum_probs=160.8
Q ss_pred HcCCccccccccccCceEEEEEEcCC--CcEEEEE------------------EeeccChhhHHHHHHHHHHHhcCCccc
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLPD--GREIAVK------------------RLFFNNRHRAANFYNEVNIISSVEHKN 370 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 370 (642)
..++|++.++||+|+||+||++.++. +...++| .+ .........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987532 2222222 11 112233456889999999999999
Q ss_pred eeeeeeeeccCCCceEEEeecCCCChhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE
Q 006514 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 371 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl 448 (642)
|+++++++...+..++|+|++. ++|.+++..... ...........++.||+.||.|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 567776643211 122345667789999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 006514 449 DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516 (642)
Q Consensus 449 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~ 516 (642)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999877554433344567999999999999999999999999999999999987643
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.12 Aligned_cols=246 Identities=27% Similarity=0.415 Sum_probs=194.7
Q ss_pred cccccccccCceEEEEEEcC-CCcEEEEEEee----ccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC--ceEEE
Q 006514 316 DEANKLGQGGFGTVYKGVLP-DGREIAVKRLF----FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE--SLLVY 388 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~----~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~ 388 (642)
.....||+|.|-+||||.+. +|-+||--.+. ..+....+.|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34567999999999999974 57777643332 2245556889999999999999999999999887665 67999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCCccccCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~ 467 (642)
|.+..|+|..++.+ .+.++.+...+|+.||++||.|||++. +||||||||-.||+|+.+ |.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999944 456888999999999999999999985 799999999999999865 8999999999998765
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.... .++|||.|||||... ..|++.+||||||+.++||+|+.-|+..-... .. .++....|...+-+.+
T Consensus 199 s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQ-IYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 199 SHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQ-IYKKVTSGIKPAALSK- 267 (632)
T ss_pred cccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HH-HHHHHHcCCCHHHhhc-
Confidence 4433 478999999999887 78999999999999999999999987543221 11 2233333332222221
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
-...++. ++|-.|+.. .++|||+.|+|++
T Consensus 268 ---------V~dPevr---~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 ---------VKDPEVR---EFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---------cCCHHHH---HHHHHHhcC-chhccCHHHHhhC
Confidence 1122343 455689999 9999999999986
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.20 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=194.8
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
..|...+.||+|+||.||+|... +++.||+|.+... .....+++.+|+.+++.++||||+++++++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999964 6899999988543 2344467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 567666632 2346899999999999999999999998 999999999999999999999999998754332
Q ss_pred CCcccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcc
Q 006514 469 KSHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
....+++.|+|||.+. .+.++.++||||||+++|||++|+.|+....... .... ......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCCC-----
Confidence 2346788999999874 4568899999999999999999999986432110 0000 000000
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
+ ..........+.+++.+||+.+|++||++.+|+.+..
T Consensus 232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 P--------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred C--------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0 0001112234667788999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=288.35 Aligned_cols=251 Identities=28% Similarity=0.415 Sum_probs=203.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceEEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLLVY 388 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 388 (642)
+|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+..+++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 78999999886544 24567899999999999999999999999888 7889999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999854 238999999999999999999999988 999999999999999999999999999876654
Q ss_pred CCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 469 KSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... ......++..|+|||.+.....+.++||||||+++++|++|+.|+..... .....+.........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~------ 223 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEPP------ 223 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCCc------
Confidence 431 12345688899999999988899999999999999999999999875441 111111111000000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++.+|++.||++||++.+++++
T Consensus 224 --------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 --------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0111113456677889999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.22 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=196.3
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
|+..+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999954 6889999988643 233445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
++ |+|.+++.. ....+++.++..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 577776643 2356899999999999999999999998 999999999999999999999999998754332
Q ss_pred cccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
....++..|+|||++. .+.++.++||||||+++|||++|+.|+....... .+ ........
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~-----~~~~~~~~------- 241 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL-----YHIAQNES------- 241 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HH-----HHHHhccC-------
Confidence 2346888999999974 4568999999999999999999999976432110 00 00111000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCC
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 597 (642)
. ...... ....+.+++.+||+.+|.+||++.+|++++......+
T Consensus 242 -~--~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 242 -P--TLQSNE---WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -C--CCCCcc---ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0 000111 1223556777999999999999999999876644444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.86 Aligned_cols=267 Identities=23% Similarity=0.330 Sum_probs=196.8
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC-----CC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----PE 383 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 383 (642)
.++|...+.||+|+||.||++.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999995 46899999988542 233445678899999999999999999987644 34
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.++|+||+. ++|.+++. ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 68888873 3457999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhh-------
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF------- 535 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~------- 535 (642)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... .........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHH
Confidence 764432 22233567889999998865 468999999999999999999999986543211 111111100
Q ss_pred ----hcCcchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 536 ----QAGRVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 536 ----~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
......+.+.......... ..........+.+++.+||+.+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0111111000000000000 00001123446788889999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.22 Aligned_cols=267 Identities=26% Similarity=0.337 Sum_probs=197.0
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC------
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------ 381 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 381 (642)
..++|+..+.||+|+||.||++... +|+.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 7899999988532 334456788999999999999999999987643
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34689999995 577777632 2889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhH-------------
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL------------- 528 (642)
Q Consensus 462 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~------------- 528 (642)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 986543322 23346788999999999999999999999999999999999998654321100000
Q ss_pred --HHHHHhhhcC-------cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 529 --TITWKHFQAG-------RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 529 --~~~~~~~~~~-------~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
......+... ...+++........ ...........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPD-SESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcc-cccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 00111111100000 000011223445678889999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=298.54 Aligned_cols=265 Identities=26% Similarity=0.379 Sum_probs=195.2
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
|+..++||+|++|.||+|... +|+.|++|++.... ......+.+|++++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999964 79999999886543 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
+ ++|.+++.... ...+++..++.++.|+++||.|||+++ ++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68988884422 246899999999999999999999988 999999999999999999999999999765433221
Q ss_pred ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH----------HHHhhhcCcc
Q 006514 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI----------TWKHFQAGRV 540 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~----------~~~~~~~~~~ 540 (642)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+... .|..... .
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~ 230 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTS--L 230 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhh--c
Confidence 1223568899999988764 57899999999999999999999986543211 11110 0100000 0
Q ss_pred hhhcccccccc-ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 541 EELYDKNLMLH-NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 541 ~~~~d~~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+......... .............+.+++.+|++.+|++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 00000000111346678889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.64 Aligned_cols=270 Identities=26% Similarity=0.389 Sum_probs=195.3
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh--hhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCceE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PESLL 386 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 386 (642)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357899999999999999999964 689999998864322 2233567899999999999999999998654 45799
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
||||+. ++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4788877432 357899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHhhhc
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT--------ITWKHFQA 537 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~ 537 (642)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............. ..|+.+..
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 43221 122345788999999875 457999999999999999999999987543221110000 00111100
Q ss_pred CcchhhccccccccccCC--CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 538 GRVEELYDKNLMLHNYHD--SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
......+. +....... .........+.+++..|++.||++|||+.++++|-
T Consensus 239 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 239 LPLVGKFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cccccccc--ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000000 00000000 00000123445678899999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=300.01 Aligned_cols=271 Identities=25% Similarity=0.351 Sum_probs=196.8
Q ss_pred HHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCC----
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP---- 382 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 382 (642)
...++|++.+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578999999999999999999975 68899999986542 233356788999999999999999999887654
Q ss_pred ------CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 383 ------ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 383 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 67899999976 66666633 2347899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhh
Q 006514 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535 (642)
Q Consensus 457 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 535 (642)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ..+ .......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~-~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQL-ELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHH-HHHHHHh
Confidence 9999998765433222223356778999998865 35789999999999999999999998653321 111 1111110
Q ss_pred hcC---cchhhcc--------ccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 536 QAG---RVEELYD--------KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 536 ~~~---~~~~~~d--------~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.. ...................+.+++..||+.||++||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000000 00000000000000012345678889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.16 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 318 ANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
..+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 47899999998665555667799999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 476 (642)
.+++. ...+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 98773 245899999999999999999999998 99999999999999999999999999876543322 12335
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
.|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... .... ....+.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~----~~~~-----~~~~~~------- 237 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM----IRDN-----LPPKLK------- 237 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhh-----CCcccC-------
Confidence 6889999999998888999999999999999999999998643221 00010 0000 000000
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
........+.+++.+||+.+|.+||++.+|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 000112234566779999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.29 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=184.0
Q ss_pred cccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHh---cCCccceeeeeeeeccCCCceEEEeecC
Q 006514 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIIS---SVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 68899999885432 222233445544443 3479999999999999899999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999998843 356999999999999999999999998 99999999999999999999999999875543221
Q ss_pred cccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
....|+..|+|||.+.. ..++.++||||||+++|||++|+.||..........+ ...... ....+
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~------~~~~~--- 218 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------VNVEL--- 218 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhc------CCcCC---
Confidence 23468999999999874 5589999999999999999999999865432211110 000000 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
.... ...+.+++..||+.||++|| +++|+++|
T Consensus 219 ---~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ---PDSF---SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---cccc---CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1111 22445667799999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.95 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=202.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..++||+|+||.||+++.. +++.+++|.+... ......++.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 7889999988643 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++.+.. ....+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885522 2357899999999999999999999998 9999999999999999999999999998765541
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
.....+++.|++||.+.+..++.++|+||||+++|||++|+.|+...... .... ....+...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~-------- 219 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRY-KVQRGKYP-------- 219 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhcCCCC--------
Confidence 22346788999999999989999999999999999999999998653321 0000 01111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.........+.+++..|++.+|++||++.+++++
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111233456778889999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=290.75 Aligned_cols=243 Identities=25% Similarity=0.338 Sum_probs=194.2
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||.|+||.||+++.. +++.+++|++.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 58999999886432 23456799999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 476 (642)
.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999843 345899999999999999999999988 9999999999999999999999999998765432 12335
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
.+++.|++||.+....++.++|+||||+++|||++|+.|+.....+.. ... . ++.+..... .. ..
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~-~--------~~~~~~~~~-~~-~~ 217 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIY-N--------DILKGNGKL-EF-PN 217 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHH-H--------HHhccCCCC-CC-Cc
Confidence 688899999999888899999999999999999999999876542111 100 0 111000000 00 11
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQM 589 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 589 (642)
.. ...+.+++..||+.+|++||+ ++|++++
T Consensus 218 ~~---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 218 YI---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cc---CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 11 235567788999999999999 8888875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=294.96 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=207.3
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.+-|...+.||+|.|..|-++++ -.|+.||||++.+.. ......+++|+..|+.++|||||+|+.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688889999999999999984 489999999996553 334457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc-CCCcEEEEecCCccccCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~ 467 (642)
|.=.+|+|.++|.++ ...+.+....+++.||+.|+.|+|+.. +|||||||+||.+- .-|-+||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999654 457899999999999999999999887 99999999998875 568999999999988776
Q ss_pred CCCcccccccCCccccChhhhccCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLT-EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
... .++.+|+..|-|||++.+..|+ +++||||+|||||.|+.|+.||...++.+. +.-+.|-
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 544 3567999999999999998885 578999999999999999999986654322 1122232
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. ..+......|-+||..||+.||.+|.+.+||...
T Consensus 235 KY-------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY-------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc-------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 21 1233445566778889999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.54 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=191.4
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccC--CCceEEEe
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSG--PESLLVYE 389 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e 389 (642)
|+..++||+|+||.||++... +++.||+|++.... ........+|+..+.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999954 68999999886432 222234567899999885 99999999999877 78899999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 577777743 2357899999999999999999999998 999999999999999 999999999998654332
Q ss_pred CcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHH-----------hhhc
Q 006514 470 SHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWK-----------HFQA 537 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~~ 537 (642)
.. ....++..|+|||++.. +.++.++|||||||++|||++|+.||....... ....... ....
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 21 23457889999997654 557899999999999999999999986543211 1111100 0000
Q ss_pred CcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
........+....... ..........+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000000 00001123566788889999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=281.57 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=202.8
Q ss_pred cChhhHHHHcCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC-ccceeeeeeeecc
Q 006514 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCS 380 (642)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 380 (642)
-++.++-+.|+ +.||+|+|+.|--++ +.+|.++|||++.+........+.+|++++.+.+ |+||++|+++|.+
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 34555555553 579999999999888 6789999999998887777888999999999985 9999999999999
Q ss_pred CCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC---cEEEE
Q 006514 381 GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIA 457 (642)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 457 (642)
+...|||||-|.||+|...|. +.+.+++.++-.+..+|+.||.|||.++ |.||||||+|||-.+.. -+||+
T Consensus 148 d~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred cceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999884 4567999999999999999999999999 99999999999986554 48999
Q ss_pred ecCCccccCC--CCCc----ccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc-
Q 006514 458 DFGLARSFQE--DKSH----ISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD- 525 (642)
Q Consensus 458 DfGla~~~~~--~~~~----~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~- 525 (642)
||.++.-... +-+. ...+.+|+..|||||+.. ...|+.++|.||||||||-|++|.+||....+....
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988754322 1111 223568999999999864 235899999999999999999999999776553321
Q ss_pred ---hhHH----HHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 526 ---SLLT----ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 526 ---~l~~----~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ..+..++++..+ ..|+. -.....+..+++ ...+-.|+.+|.++.+++.+
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYe-FPdkd-------WahIS~eakdli---snLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYE-FPDKD-------WAHISSEAKDLI---SNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCc-CChhh-------hHHhhHHHHHHH---HHHHhccHHhhhhhhhccCC
Confidence 1111 112222222221 11111 112334455544 45556999999999999985
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.10 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=194.2
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|+..+.||+|++|.||+|... +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 78999999885432 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-CCcEEEEecCCccccCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQED 468 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~ 468 (642)
|++ ++|.+++... ....+++.....++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 5777776432 2234678888999999999999999998 999999999999985 567999999999765433
Q ss_pred CCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc---
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY--- 544 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--- 544 (642)
... .....+++.|+|||++.+. .++.++||||||+++|||+||+.||....... .+.. ....+... ..+..
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~-~~~~~~~~-~~~~~~~~ 231 (294)
T PLN00009 157 VRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFK-IFRILGTP-NEETWPGV 231 (294)
T ss_pred ccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCC-Chhhcccc
Confidence 221 2234578899999998764 57899999999999999999999987543211 1110 00000000 00000
Q ss_pred ----cccccccccCCCC----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 ----DKNLMLHNYHDSN----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 ----d~~~~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+-........... .......+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 00112235678889999999999999999985
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=294.59 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=191.9
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC-hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556778999999999999964 68999999886432 344567889999999996 99999999999988899999999
Q ss_pred cCCCChhhhhhc--ccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 391 LPNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 391 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+.. ++.++... ......+++.....++.+++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55443321 12236789999999999999999999975 6 99999999999999999999999999976543
Q ss_pred CCCcccccccCCccccChhhhccC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHG---QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.... ....|+..|+|||.+... .++.++||||||+++|||++|+.||..... ......... .+..
T Consensus 161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~---- 228 (288)
T cd06616 161 SIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGDP---- 228 (288)
T ss_pred CCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCCC----
Confidence 3221 234678899999999876 689999999999999999999999864321 111111100 0000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+.+. ..........+.+++.+||+.+|++|||+.+|+++
T Consensus 229 -~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0010 01101122346677889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=296.29 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=194.3
Q ss_pred ccccccccCceEEEEEEcCCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344566667777777665 6899999998654 4456678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC----
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS---- 470 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~---- 470 (642)
+|.+++... ....+++.....++.|+++||.|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998643 2346889999999999999999999998 99999999999999999999999998875432211
Q ss_pred --cccccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHh----hhc-----
Q 006514 471 --HISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH----FQA----- 537 (642)
Q Consensus 471 --~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~----~~~----- 537 (642)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+....... +..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 11123457788999999876 358899999999999999999999987543211 111100000 000
Q ss_pred --Ccchh----hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 538 --GRVEE----LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 --~~~~~----~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..... ..+.... ..............+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNR-DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchh-hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0000000 000111122233456788899999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.44 Aligned_cols=272 Identities=23% Similarity=0.334 Sum_probs=197.9
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeecc----CCCc
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 384 (642)
..+|+..+.||+|+||.||++... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367899999999999999999954 68999999986432 2345677889999999999999999998753 3457
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++|+||+. ++|.+++. ....+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68888874 3456999999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCCc---ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH--------HH
Q 006514 465 FQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------TW 532 (642)
Q Consensus 465 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~ 532 (642)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.............. .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5433221 1234578899999999865 4689999999999999999999999865432111000000 00
Q ss_pred HhhhcCcchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 533 KHFQAGRVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.......+.+..+......... ..........+.+++..||+.+|++||++.+++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000011111111000000000 000011234567788899999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.48 Aligned_cols=265 Identities=24% Similarity=0.364 Sum_probs=198.3
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh--hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456778999999999999964 788999998864432 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
++ +|.+++... ...+++..+..++.++++||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 888877442 257899999999999999999999998 99999999999999999999999999987655431
Q ss_pred ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC---cchhhcc--
Q 006514 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG---RVEELYD-- 545 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d-- 545 (642)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ +... ....... .+..+.+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKI-FRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHcCCCchHhcccchhhh
Confidence 12234578899999998876 789999999999999999999998865432111 0000 0000000 0000000
Q ss_pred -cc-ccccccC----CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 546 -KN-LMLHNYH----DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 546 -~~-~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. ....... ..........+.+++..||+.||.+||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0000000 00011223456788899999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=284.78 Aligned_cols=248 Identities=27% Similarity=0.477 Sum_probs=200.5
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh--hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++.+++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999865 678999999865543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998843 367999999999999999999999998 99999999999999999999999999987655433
Q ss_pred cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccc
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
. .....++..|+|||...+..++.++||||||+++|||++|+.|+...... ...+.... .... ..
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~-----~~-- 219 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQ-DDHP-----PL-- 219 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-cCCC-----CC--
Confidence 2 23356888999999998888899999999999999999999998643210 11111110 0000 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... ...+.+++.+||+.+|++||++.+++.+
T Consensus 220 ----~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 ----PEGI---SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCCC---CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1111 2344567789999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=291.07 Aligned_cols=265 Identities=27% Similarity=0.362 Sum_probs=193.6
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcC---CccceeeeeeeeccCCC-----
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPE----- 383 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 383 (642)
|++.+.||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 58999999986432 22234566788777666 59999999999988776
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.+++|||++ ++|.+++.... ...+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 47888775422 246899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+.. .............
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEEW 230 (287)
T ss_pred eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHhc
Confidence 76443221 23357889999999999999999999999999999999998886543211 1111 1010000000000
Q ss_pred c-cc-----ccccccc--CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 544 Y-DK-----NLMLHNY--HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 ~-d~-----~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. .. ....... ...........+.+++.+||+.||++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00 0000000 000111223456678889999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.94 Aligned_cols=267 Identities=27% Similarity=0.389 Sum_probs=194.0
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh--hhHHHHHHHHHHHhcCCccceeeeeeeeccCC------
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 382 (642)
.++|+..++||+|+||.||++... +++.++||++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999964 689999998854322 22346788999999999999999999875443
Q ss_pred --CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 383 --ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 383 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
..++|+||+.. +|...+.. ....+++..+..++.|+++||.|||+++ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 66666633 2357999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCc----------ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHH
Q 006514 461 LARSFQEDKSH----------ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529 (642)
Q Consensus 461 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 529 (642)
++......... ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~--- 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH--- 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 99865433221 11234678889999988654 58999999999999999999999986544321111
Q ss_pred HHHHhhhcC---c------chhhccccccccccCCCCc----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 530 ITWKHFQAG---R------VEELYDKNLMLHNYHDSNV----KYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 530 ~~~~~~~~~---~------~~~~~d~~~~~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+...... . +....+..... .. .... ......+.+++.+|++.||++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFT-NY-PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCC-CC-CccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111111000 0 00000000000 00 0000 0111356678889999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.15 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=187.2
Q ss_pred HHcCCccccccc--cccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCce
Q 006514 310 KATGSFDEANKL--GQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 310 ~~~~~~~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 385 (642)
...++|++.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++++...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334566676666 99999999999954 678899998754321111 22222222 6999999999999999999
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-cEEEEecCCccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARS 464 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~ 464 (642)
+||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999999843 248999999999999999999999998 99999999999999998 999999999876
Q ss_pred cCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
..... ...++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+... . .
T Consensus 160 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~-~------- 224 (267)
T PHA03390 160 IGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKR-Q-Q------- 224 (267)
T ss_pred cCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHh-h-c-------
Confidence 54322 24578899999999998999999999999999999999999874432211 11111110 0 0
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-MSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~~ 589 (642)
... .........+.+++..||+.+|.+||+ +++++++
T Consensus 225 -~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 -KKL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -ccC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000 001112234566777999999999995 6999975
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=289.98 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=190.7
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||+|+||+||++... +|+.+++|.+.... ......+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999854 68999999886432 22344577899999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 476 (642)
.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence 99885432 246899999999999999999999998 99999999999999999999999999876543221 2234
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
.++..|+|||.+.++.++.++||||||++++||++|+.||.......... . ...... ..... . ..
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-----~~~~~~----~~~~~---~-~~ 219 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-----LKRRTL----EMAVE---Y-PD 219 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-----HHhccc----ccccc---C-Cc
Confidence 67889999999988889999999999999999999999986543311110 0 000000 00000 0 11
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
.. ...+.+++..||+.||++|| ++.++++|
T Consensus 220 ~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 220 KF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cC---CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 11 22445677799999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.07 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=202.4
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
.+.|.+...||+|.|+.|.+++.. ++.+||||.+... +......+.+|+++|..++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467899999999999999999954 7999999988654 3334455889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||..+|.+.+++... +.........++.|+..|++|+|+++ |+|||||++||||+.++++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999543 44555788889999999999999998 999999999999999999999999999987633
Q ss_pred CCcccccccCCccccChhhhccCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
....+.+|++.|.|||++.+.+| .+++|+||+|++||-|+.|..||+...- .++-++.
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~rv 267 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRPRV 267 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccchh
Confidence 34467899999999999998775 6799999999999999999999975432 1111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
+......+.... ..+-+++...+-.+|.+|+++.++.++-
T Consensus 268 l~gk~rIp~~ms---~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRGKYRIPFYMS---CDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeeeecccceee---chhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111111111122 2333455678889999999999998764
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=292.55 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=194.9
Q ss_pred CccccccccccCceEEEEEEc----CCCcEEEEEEeeccC----hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 314 SFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
+|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 368999999986432 22346688899999999 599999999999988889
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 356889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccCCccccChhhhccC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
.............|+..|+|||.+... .++.++||||||+++|||++|+.|+........ ...+........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC----
Confidence 654333323345688999999998753 478899999999999999999999864322111 111111100000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
+ +. .... ...+.+++..||+.||++|| ++.+++.+
T Consensus 229 ---~-----~~-~~~~---~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---P-----PY-PQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---C-----CC-CccC---CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 00 1111 12345677799999999997 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.55 Aligned_cols=205 Identities=29% Similarity=0.463 Sum_probs=178.1
Q ss_pred CCccccccccccCceEEEEEEc-CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC------Cc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~ 384 (642)
..|...+.||+|+||.||+|+. ..|+.||||.+... .....+.+.+|+++|++++|+|||+++++-.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3466678899999999999995 57999999988653 3445567889999999999999999999765543 56
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc--CCC--cEEEEecC
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD--SRL--RAKIADFG 460 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DfG 460 (642)
.+||||+.+|+|...|.+..+...|++.+.+.+...+..||.|||+++ |+||||||.||++- ++| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999998888889999999999999999999999998 99999999999983 334 47999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~ 522 (642)
.|+....+. .....+||+.|++||.... +.|+..+|.|||||++||..||..||.....+
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999876655 4467899999999999985 78999999999999999999999999765443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.73 Aligned_cols=269 Identities=25% Similarity=0.335 Sum_probs=200.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCC-----Cce
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-----ESL 385 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 385 (642)
+|.+.+.||+|+||.||+++.. +++.|+||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 58999999886543 445567899999999999999999999988765 789
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+||||++ ++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 578888743 347999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCC--cccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHH--------HHh
Q 006514 466 QEDKS--HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT--------WKH 534 (642)
Q Consensus 466 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~ 534 (642)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 55432 122335678899999999887 7899999999999999999999998765432111000000 000
Q ss_pred hhcCcchhhcccccccccc-CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 535 FQAGRVEELYDKNLMLHNY-HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.......+.+......... ...........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000111111100000000 000001123345678889999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=291.72 Aligned_cols=259 Identities=20% Similarity=0.259 Sum_probs=181.4
Q ss_pred cCCccccccccccCceEEEEEEcCC----CcEEEEEEeeccChhhH-----------HHHHHHHHHHhcCCccceeeeee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRHRA-----------ANFYNEVNIISSVEHKNLVRLLG 376 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~ 376 (642)
.++|.+.+.||+|+||.||+|...+ +..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999999654 34566665432221110 11223444556678999999999
Q ss_pred eeccCCC----ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC
Q 006514 377 CSCSGPE----SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452 (642)
Q Consensus 377 ~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~ 452 (642)
++..... .++++|++. .++.+.+.. ....++..+..++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 7655432 356777663 355555522 234578889999999999999999998 99999999999999999
Q ss_pred cEEEEecCCccccCCCCCc------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 006514 453 RAKIADFGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDS 526 (642)
Q Consensus 453 ~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~ 526 (642)
.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-- 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-- 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence 9999999999876432211 11234699999999999999999999999999999999999999976532211
Q ss_pred hHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 527 LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 527 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
+.......+ +..+...... ..... ..+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~----~~~~~~~~~~-----~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDF----IKRLHEGKIK-----IKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHH----HHHhhhhhhc-----cCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111110000 0111111111 11112 23456667899999999999999998763
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.73 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=191.1
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC------
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 382 (642)
.++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999995 46899999988543 2233456889999999999999999999886543
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
..++|+||+.. +|.+++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 666554 236899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHh-------
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH------- 534 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------- 534 (642)
+...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+ ...+..
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~-~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QL-TQILKVTGVPGPE 237 (342)
T ss_pred cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHHHHhcCCCCHH
Confidence 7643221 23467889999999876 468999999999999999999999997543211 11 100100
Q ss_pred ----hhcCcchhhccc--cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 535 ----FQAGRVEELYDK--NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 535 ----~~~~~~~~~~d~--~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+........+.. ....... ..........+.+++..||+.||++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 0000000 00000112345678889999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=294.38 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=191.1
Q ss_pred CCccccccccccCceEEEEEEcCC-CcEEEEEEeeccC-hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEe
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 389 (642)
++|+..+.||+|+||.||++.+++ ++.||||.+.... .....++..|+.++.+.. ||||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999764 8999999986432 234456777887777664 9999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
|++ ++|.+++... ...+++..+..++.+++.||.|||+. + ++||||+|+||++++++.+||+|||++......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 4777766432 34789999999999999999999974 6 999999999999999999999999998765433
Q ss_pred CCcccccccCCccccChhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
... ....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ......... ....
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-~~~~-- 238 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQE-EPPS-- 238 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcC-CCCC--
Confidence 222 233578899999998754 38899999999999999999999986422110 000010110 0000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. ... .....+.+++.+||+.||++||++.+++++
T Consensus 239 ---~~----~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ---LP----PNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CC----CCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 112345677789999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.79 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=188.2
Q ss_pred HHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC-----
Q 006514 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG----- 381 (642)
Q Consensus 309 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 381 (642)
.....+|++.+.||+||||.|||++.+ ||+.+|||++... +......+.+|+.++++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345577999999999999999999976 8999999999655 344456788999999999999999987421000
Q ss_pred --------------------------------------------------------------------------------
Q 006514 382 -------------------------------------------------------------------------------- 381 (642)
Q Consensus 382 -------------------------------------------------------------------------------- 381 (642)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CCceEEEeecCCCChhhhhhcccccCCC-CHHHHHHHHHHHHHHHH
Q 006514 382 ----------------------------------PESLLVYEFLPNQSLDRFIFDSAKAKTL-TWEKRYEIILGTVEGLV 426 (642)
Q Consensus 382 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l-~~~~~~~i~~~ia~~l~ 426 (642)
..+||-||||+...|.+++.+. ... .....++++.+|++||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence 0135678888887777777432 222 46778999999999999
Q ss_pred HHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC---C--------------CCCcccccccCCccccChhhhc
Q 006514 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ---E--------------DKSHISTAIAGTLGYMAPEYLA 489 (642)
Q Consensus 427 ~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~---~--------------~~~~~~~~~~gt~~y~aPE~~~ 489 (642)
|+|+++ +|||||||.||+||++..+||+|||+|+... . ......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 9999999999999999999999999998721 0 0111335678999999999997
Q ss_pred cC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHH
Q 006514 490 HG---QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAI 566 (642)
Q Consensus 490 ~~---~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 566 (642)
+. .|+.|+|+||+|||++||+. ||....+. ..+...+..+.+..- ......+...-.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~-----------~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP-----------ADFFDPEHPEEA 848 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC-----------cccccccchHHH
Confidence 64 49999999999999999996 34332211 011111222222211 111222333345
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 006514 567 HVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 567 ~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+++.++++.||.+|||+.|+|..
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhc
Confidence 67889999999999999999964
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=298.69 Aligned_cols=270 Identities=23% Similarity=0.352 Sum_probs=196.5
Q ss_pred HHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC--
Q 006514 308 LEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP-- 382 (642)
Q Consensus 308 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 382 (642)
+....++|+..+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999985 47899999988532 2334456889999999999999999999887554
Q ss_pred ----CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEe
Q 006514 383 ----ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (642)
Q Consensus 383 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 458 (642)
..++||||+ +++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 348999998 778888773 356899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhHH-------
Q 006514 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD-SLLT------- 529 (642)
Q Consensus 459 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~-~l~~------- 529 (642)
||++....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ....
T Consensus 162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99988654322 23457889999999876 45889999999999999999999998754321100 0000
Q ss_pred HHHHhhhcCcchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 530 ITWKHFQAGRVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 530 ~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+..+................... ..........+.+++.+|++.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000111100000000000000000 00000112245678889999999999999999976
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=285.46 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=202.7
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|+..+.||+|+||.||++... +++.+++|++.... ......+.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999965 68999999986543 35566789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2467999999999999999999999998 9999999999999999999999999998765543
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
.......|++.|+|||.+....++.++||||||+++++|++|+.|+...... ..... ........+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~------ 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALK-ILKGQYPPI------ 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHH-HhcCCCCCC------
Confidence 1223356888999999999888999999999999999999999998643311 11111 111111000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ....+.+++.+||+.+|++||++.+++++
T Consensus 224 -----~~~---~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -----PSQ---YSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCC---CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 12345567789999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=286.87 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=193.4
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc-----ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC--CCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--PES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 384 (642)
.+|+..+.||+|+||.||++.+. +++.|++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 6899999987432 233456788999999999999999999988664 347
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++++||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 345889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCC--cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKS--HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~~~~~-- 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-IFKIATQPTK-- 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-HHHHHcCCCC--
Confidence 543211 1122356889999999999888999999999999999999999998643211 00 0010100000
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+ ........ .+.+++..|++ +|..||+..+++.|
T Consensus 228 ---~------~~p~~~~~---~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 ---P------MLPDGVSD---ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---C------CCCcccCH---HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0 00111222 34456668998 57999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=289.24 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=192.5
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccCh---hhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNNR---HRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999998864432 4556789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC------
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS------ 470 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~------ 470 (642)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999854 247899999999999999999999998 99999999999999999999999999876543321
Q ss_pred -cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 471 -HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 471 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
.......++..|++||.......+.++||||||+++|||++|+.|+...... ..... ...+. ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~--------~~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-ILNGK--------IE 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCC--------cC
Confidence 1223356788999999998888999999999999999999999998654321 11100 10000 00
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 591 (642)
..........+.+++..||+.+|++|||+.++.+.|+
T Consensus 220 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 -----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000001234567778999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=291.80 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=196.9
Q ss_pred CccccccccccCceEEEEEEc----CCCcEEEEEEeeccC----hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 314 SFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFNN----RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
+|+..+.||+|++|.||+++. .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999884 357889999886432 22345688999999999 599999999999988899
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 356899999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCCCcccccccCCccccChhhhccCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchh
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQ--LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
.............|+..|+|||.+.+.. .+.++||||||+++|||++|..|+........ .......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~--------- 223 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRR--------- 223 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHH---------
Confidence 5544333233456889999999987665 78899999999999999999999864322111 0111100
Q ss_pred hccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
+...... ...... ..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 224 ~~~~~~~----~~~~~~---~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKSKPP----FPKTMS---AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHccCCC----CCcccC---HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000000 011111 234567779999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=290.61 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=195.0
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNR-HRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
|++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+.+++ ||||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578899998854322 22334567999999998 999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
+|+|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988875432 357899999999999999999999998 99999999999999999999999999986544322
Q ss_pred ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchh--------HHHHHHhhhcCcchh
Q 006514 472 ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSL--------LTITWKHFQAGRVEE 542 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l--------~~~~~~~~~~~~~~~ 542 (642)
.....++..|+|||.+.. ..++.++||||||++++||++|+.||........... ....|.... ...+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 231 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY--KLAS 231 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh--hhhc
Confidence 123467889999998754 4589999999999999999999998865432111000 000000000 0000
Q ss_pred hccccccccccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 543 LYDKNLMLHNYH--DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~~d~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+......... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 00000112457788899999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=289.37 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=200.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 387 (642)
++|...+.||+|+||.||++... +++.|++|++... .....+.+.+|++++.+++ ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999965 7899999988542 2344567889999999998 99999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 347999999999999999999999998 99999999999999999999999999986654
Q ss_pred CCC-------------------cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhH
Q 006514 468 DKS-------------------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL 528 (642)
Q Consensus 468 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~ 528 (642)
... .......++..|+|||.+....++.++||||||++++|+++|+.|+...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHH
Confidence 332 1122346788999999998888999999999999999999999998754311 000
Q ss_pred HHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 006514 529 TITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM----SRVLQM 589 (642)
Q Consensus 529 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~evl~~ 589 (642)
. ...+..... ... ....+.+++..||+.+|++||++ ++++++
T Consensus 232 ----~--------~~~~~~~~~----~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 ----Q--------KILKLEYSF----PPN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----H--------HHHhcCCCC----CCc---cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 000000000 111 12345677889999999999999 888875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.61 Aligned_cols=197 Identities=23% Similarity=0.357 Sum_probs=162.7
Q ss_pred cccccc--CceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQG--GFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G--~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
..||+| +||+||++.+ .+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 8999999996 47899999988643 334457789999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc-
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI- 472 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 472 (642)
++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885532 345899999999999999999999998 9999999999999999999999998654332211110
Q ss_pred -----cccccCCccccChhhhccC--CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 006514 473 -----STAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSK 519 (642)
Q Consensus 473 -----~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG~~p~~~~ 519 (642)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1112346679999999764 4789999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.67 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=185.2
Q ss_pred ccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHH-hcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNII-SSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.||+|+||.||++... +|+.||+|.+.... ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 68999999885432 22223445555544 455899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999843 356899999999999999999999998 99999999999999999999999999875433 2
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
....++..|+|||.+.+..++.++||||||+++|||++|..|+...... . .+......... ..
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~--------~~-- 213 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---A----VFDNILSRRIN--------WP-- 213 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhcccC--------CC--
Confidence 2346888999999998888999999999999999999999998643221 0 11111111100 00
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 554 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
..........+.+++..||+.+|++||++.++.+.|
T Consensus 214 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 214 -EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000001123455677899999999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=300.97 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=194.0
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccC---------
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG--------- 381 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 381 (642)
..+|...+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999964 6899999998766666667889999999999999999999876543
Q ss_pred -----CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc-CCCcEE
Q 006514 382 -----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAK 455 (642)
Q Consensus 382 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~k 455 (642)
...++|+||++ ++|.+++. ...+++.....++.||++||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 24689999997 58888773 346899999999999999999999998 99999999999997 456799
Q ss_pred EEecCCccccCCCCCc--ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006514 456 IADFGLARSFQEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 456 l~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 532 (642)
|+|||++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......... .....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH
Confidence 9999999765432221 1123457889999998754 45888999999999999999999999654321110 00000
Q ss_pred Hhh--hcCcchhh---ccccccccccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 533 KHF--QAGRVEEL---YDKNLMLHNYHDSNV-----KYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 533 ~~~--~~~~~~~~---~d~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
... ......+. ............... ......+.+++..||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 00000000 000000000000000 0112345678889999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=298.21 Aligned_cols=270 Identities=24% Similarity=0.347 Sum_probs=196.9
Q ss_pred hhHHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC-
Q 006514 306 STLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG- 381 (642)
Q Consensus 306 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~- 381 (642)
.++...+++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34566778999999999999999999985 57899999988643 233456788999999999999999999987543
Q ss_pred -----CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 382 -----PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 382 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
...+++++++ +++|.+++. ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3357778776 788988773 346899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHH----
Q 006514 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT---- 531 (642)
Q Consensus 457 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~---- 531 (642)
+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+....
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVG 235 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 999998764322 223567889999999866 568899999999999999999999986433211 110000
Q ss_pred ------HHhhhcCcchhhccc--cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 532 ------WKHFQAGRVEELYDK--NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 532 ------~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
+..+........+.. ......+ ..........+.+++..|++.||.+||++.+++.+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000000000000 0000000 000000123456788899999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.49 Aligned_cols=268 Identities=24% Similarity=0.309 Sum_probs=194.5
Q ss_pred CCccc-cccccccCceEEEEEEcC-CCcEEEEEEeeccChhh--------------HHHHHHHHHHHhcCCccceeeeee
Q 006514 313 GSFDE-ANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHR--------------AANFYNEVNIISSVEHKNLVRLLG 376 (642)
Q Consensus 313 ~~~~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 376 (642)
++|.. .+.||+|+||.||++... +++.||||.+....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999964 68999999885432211 124778999999999999999999
Q ss_pred eeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 377 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
++...+..++||||+. |+|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 68888884 3456899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccCCCC-------------CcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCc
Q 006514 457 ADFGLARSFQEDK-------------SHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (642)
Q Consensus 457 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~ 522 (642)
+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 0111223567889999998764 4789999999999999999999998755432
Q ss_pred ccchhHHHHHHhhhcCc---chhhcccccc--ccccCCCC----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 523 YTDSLLTITWKHFQAGR---VEELYDKNLM--LHNYHDSN----VKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 523 ~~~~l~~~~~~~~~~~~---~~~~~d~~~~--~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
. ............. +....+.... ........ .......+.+++..||+.+|++|||+.|++.+-
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 1111111111000 0000000000 00000000 001123466788899999999999999999863
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.85 Aligned_cols=269 Identities=23% Similarity=0.309 Sum_probs=196.5
Q ss_pred HHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeecc-CCCc
Q 006514 309 EKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPES 384 (642)
Q Consensus 309 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 384 (642)
...+++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446788999999999999999999854 7899999987532 23345678899999999999999999998865 5578
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++|+||+ +++|.+++. ...+++.....++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888773 346788889999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHhh
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT--------ITWKHF 535 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~ 535 (642)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. -.+..+
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 123457889999998766 568999999999999999999999986543211100000 000000
Q ss_pred hcCcchhhccccccccccCC-CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 536 QAGRVEELYDKNLMLHNYHD-SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+...+++........... .........+.+++.+|++.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111111100000000000 0000112356678889999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.46 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=198.1
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
|+..+.||+|++|.||+|+.. +++.+++|.+.... ....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999965 58999999986542 334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999885422 46899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc-hh-------HHHHHHhhhcCc-ch
Q 006514 472 ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD-SL-------LTITWKHFQAGR-VE 541 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~-~l-------~~~~~~~~~~~~-~~ 541 (642)
.....++..|+|||.+... .++.++||||||+++|||++|+.||......... .. ....|..+..-. ..
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2233457789999998776 7899999999999999999999988654321110 00 001111111100 00
Q ss_pred hhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+. ....... ..........+.+++..||+.+|++||++.+|+.+
T Consensus 234 ~~~~-~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFP-KFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccc-ccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0000000 00000113457788889999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.17 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=184.9
Q ss_pred cccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHH---HHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 320 KLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVN---IISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
.||+|+||.||++... +++.||+|.+.... ......+.+|.. .+....||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68899999885432 122223444443 4444579999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++. +...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999998884 3457999999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 473 STAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
....|+..|+|||.+.++ .++.++||||||+++|||++|+.||........... ...... ....+
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~--- 218 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVEL--- 218 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCC---
Confidence 234689999999999755 689999999999999999999999875432211110 000000 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
.... ...+.+++..|++.+|++|| ++.+++++
T Consensus 219 ---~~~~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 ---PDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---CCcC---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1111 23455677799999999999 99999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.36 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=202.0
Q ss_pred HHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCc
Q 006514 308 LEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 308 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 384 (642)
+...+-+|.-..+||.|.||.||.+.. .+|+-.|||.+.... ......+.+|..++..++|||+|+.+|+-.+.++.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 445566788889999999999999994 578889999876543 33445688999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
+|.|||+++|+|.+++.. +...++.....+..|++.|+.|||++| ||||||||.||||+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999843 344666666778899999999999999 99999999999999999999999999988
Q ss_pred cCCCCCc---ccccccCCccccChhhhccCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC
Q 006514 465 FQEDKSH---ISTAIAGTLGYMAPEYLAHGQ---LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538 (642)
Q Consensus 465 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 538 (642)
....... ......||+-|||||++.+.. ...+.||||+|||++||+||++||...+.+... .-+...+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI------My~V~~g 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI------MYHVAAG 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH------HhHHhcc
Confidence 7655322 223568999999999998643 456899999999999999999999765443211 1111122
Q ss_pred cchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....+ +.....+-. +++-.|++.||+.|-++.|++++
T Consensus 1458 h~Pq~-----------P~~ls~~g~---dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKPQI-----------PERLSSEGR---DFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCC-----------chhhhHhHH---HHHHHHHhcCchhhhHHHHHHHh
Confidence 21111 112233333 45558999999999999999987
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.29 Aligned_cols=203 Identities=30% Similarity=0.417 Sum_probs=180.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
+.|..-+.||+||||.||-++.. +|+-+|.|++... .++...-.++|-.+|.+++.+.||.+--.+.+.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888889999999999999854 7899999988432 3444556789999999999999999998999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
..|+||+|.-+|.+... ..+++....-++.+|+.||++||+.. ||+|||||+|||||+.|+++|+|+|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999976543 68999999999999999999999998 999999999999999999999999999988766
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
... ...+||.+|||||+++.+.|+...|-||+||+||||+.|+.||....+
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 554 234899999999999999999999999999999999999999986543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=289.97 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=193.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
.|+..+.||+|+||.||+|+.. +++.+++|.+... ......++.+|+++++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4677788999999999999964 6788999988532 33445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
|+. |+|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 677776643 2346899999999999999999999998 999999999999999999999999998765432
Q ss_pred CcccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 470 SHISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
....+++.|+|||.+. .+.++.++||||||+++|||++|+.|+....... ... ....+...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~~~~~----- 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNESP----- 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHH-HHhhcCCC-----
Confidence 2346788999999974 3568889999999999999999999875432110 000 01110000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .... ....+.+++.+||+.+|++||++.+|+++...
T Consensus 233 ~~-----~~~~---~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 AL-----QSGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred Cc-----Cccc---ccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00 0111 12234567779999999999999999988544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=270.89 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=192.7
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+.+..||.|..|.|++.... .|..+|||....+ +.+..+.++..+.++..-+ .|.||+.+|+|..+...++-||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 445667999999999999965 6889999988654 5566677888888877664 899999999999999999999988
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 471 (642)
. .-++.++.. ..+++++..+-++...+++||.||.++. .|+|||+||+|||+|+.|++||||||++-.+-....+
T Consensus 174 s-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 174 S-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 3 345565533 2356888888899999999999998776 4999999999999999999999999999766544332
Q ss_pred ccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 472 ISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
+...|-+.|||||.+. ...|+.++||||||+.|+||.||+-|+..-..+.. .++.+.. + .. +.+
T Consensus 249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkvln---~-eP-----P~L 315 (391)
T KOG0983|consen 249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKVLN---E-EP-----PLL 315 (391)
T ss_pred --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHHHh---c-CC-----CCC
Confidence 4567899999999986 35699999999999999999999999876443321 1111111 0 00 111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. ... -...++++...||+.|+.+||...++++|
T Consensus 316 ~~----~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PG----HMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cc----ccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 011 12345567778999999999999999987
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=275.80 Aligned_cols=205 Identities=28% Similarity=0.445 Sum_probs=171.3
Q ss_pred CCccccccccccCceEEEEEEcC---C--CcEEEEEEeeccCh--hhHHHHHHHHHHHhcCCccceeeeeeeecc-CCCc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP---D--GREIAVKRLFFNNR--HRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPES 384 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 384 (642)
..|+...+||+|.||.||++.-+ + .+.+|+|++...+. .......+|+.+++.++|||++.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45888899999999999999632 2 34789998864422 223457899999999999999999999988 6778
Q ss_pred eEEEeecCCCChhhhhhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC----CcEEEEe
Q 006514 385 LLVYEFLPNQSLDRFIFDS--AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIAD 458 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~D 458 (642)
+|++||.+. +|..+|+.. .+.+.++......|+.||+.|+.|||++. |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 777777532 33467899999999999999999999998 9999999999999887 8999999
Q ss_pred cCCccccCCCCCc--ccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 459 FGLARSFQEDKSH--ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 459 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
||+++.+...-.. ....++-|.+|.|||.+.+. .||.+.|||+.|||+.||+|-++.|.....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9999998765443 33457889999999999875 599999999999999999999988866543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=288.69 Aligned_cols=244 Identities=28% Similarity=0.425 Sum_probs=190.3
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
|...++||+|+||.||+|+.. +|+.|++|++... .......+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 6889999988643 233446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+. |+|.+++.. ....+++.++..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 577776643 2356899999999999999999999998 99999999999999999999999999864322
Q ss_pred cccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.....|+..|+|||++. .+.++.++||||||+++|||++|+.|+...... ....... .......
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~---- 240 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNDSPTL---- 240 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHH-hcCCCCC----
Confidence 12356888999999984 466899999999999999999999997653211 0011000 0000000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
. .... ...+.+++.+||+.+|.+||++.+++.+
T Consensus 241 -~-----~~~~---~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -Q-----SNEW---TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -C-----cccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0011 1235567789999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.38 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=202.5
Q ss_pred HcCCccccccccccCceEEEEEEcC----C----CcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-Cccceeeeeeeecc
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP----D----GREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCS 380 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 380 (642)
..++..+.+.||+|.||.|++|... . ...||||.+... .....+.+..|+++|..+ +|+||+.++|++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3344556669999999999999842 1 457999998643 335667899999999999 69999999999999
Q ss_pred CCCceEEEeecCCCChhhhhhccc-----c------c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEE
Q 006514 381 GPESLLVYEFLPNQSLDRFIFDSA-----K------A--KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (642)
Q Consensus 381 ~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NIL 447 (642)
....++|.||++.|+|.++|++.+ . . ..+.....+.++.|||.|++||++.. +|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997644 0 0 23889999999999999999999987 999999999999
Q ss_pred EcCCCcEEEEecCCccccCCCCCccccccc--CCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 006514 448 LDSRLRAKIADFGLARSFQEDKSHISTAIA--GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYT 524 (642)
Q Consensus 448 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~ 524 (642)
+..+..+||+|||+++.............. -+..|||||.+....|+.|||||||||+||||+| |..|+..... .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence 999999999999999976555444322222 3456999999999999999999999999999999 6666643110 0
Q ss_pred chhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 525 DSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 525 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. .++...++...+. +... ...+.+++..||+.+|++||++.++.+.++.
T Consensus 529 ---~~-l~~~l~~G~r~~~-----------P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 ---EE-LLEFLKEGNRMEQ-----------PEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred ---HH-HHHHHhcCCCCCC-----------CCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 1223333322111 1122 2344577889999999999999999999887
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.48 Aligned_cols=269 Identities=23% Similarity=0.316 Sum_probs=190.4
Q ss_pred CccccccccccCceEEEEEEcC-C--CcEEEEEEeecc--ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccC----CC
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-D--GREIAVKRLFFN--NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG----PE 383 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 383 (642)
+|+..+.||+|+||.||++... . ++.||+|++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999964 3 788999988532 223356788999999999 599999999875432 34
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 68888873 3457899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc---ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchh-H-------HHH
Q 006514 464 SFQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSL-L-------TIT 531 (642)
Q Consensus 464 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l-~-------~~~ 531 (642)
........ ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........... . ...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65433221 1223578999999998765 4689999999999999999999999865432110000 0 000
Q ss_pred HHhhhcCcchhhcccccccccc-CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 532 WKHFQAGRVEELYDKNLMLHNY-HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 532 ~~~~~~~~~~~~~d~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..+.................. ...........+.+++.+|++.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000000000 000000012345678889999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.27 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=197.2
Q ss_pred HHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC---
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE--- 383 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--- 383 (642)
...++|+..+.||+|++|.||+|... +++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34578999999999999999999965 6889999988542 23344667889999999999999999998776654
Q ss_pred ---ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 384 ---SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 384 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
.++|+||+ +++|.+++. ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 678988873 356899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhHH-------HH
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD-SLLT-------IT 531 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~-~l~~-------~~ 531 (642)
++...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||......... .+.. ..
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99865433 223467889999999865 36789999999999999999999998654321100 0000 00
Q ss_pred HHhhhcCcchhhccccccccccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 532 WKHFQAGRVEELYDKNLMLHNYH-DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 532 ~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..+................... ..........+.+++.+||+.+|++|||+.||+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 01111100000100000000000 00000113456788889999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=280.51 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=192.1
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc-----ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
+|.+.+.||+|+||.||++... .+..+++|.+... .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778889999999999999864 3444555554321 222344577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 388 YEFLPNQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
+||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988542 23467999999999999999999999998 999999999999976 569999999987654
Q ss_pred CCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccc
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.|+..... ...... ...+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~-~~~~~~------ 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR-IVEGPT------ 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HHcCCC------
Confidence 3322 22345678899999999888899999999999999999999999853221 111111 001100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.+|++||++.|++++
T Consensus 223 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 --------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00111122345667789999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=312.14 Aligned_cols=276 Identities=25% Similarity=0.309 Sum_probs=215.2
Q ss_pred hHHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeec---cChhhHHHHHHHHHHHhcCCccceeeeeeeeccCC
Q 006514 307 TLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFF---NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP 382 (642)
Q Consensus 307 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 382 (642)
.++...++|++.+.||+|+||.|..++.+ .++.+|+|++.+ -.+....-|..|-.+|..-+.+=|++|+-.|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44455678999999999999999999975 578889999865 23445566888999999888899999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
.+|+|||||+||+|-.++.+ -..+++..+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999943 337899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCccccChhhhc----c-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhc
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLA----H-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
..+..++...+...+|||.|++||++. + +.|...+|.||+||++|||+.|..||.... ++.-.-+
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~K---- 292 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGK---- 292 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHH----
Confidence 998888877778889999999999986 3 679999999999999999999999986532 2211111
Q ss_pred CcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhccC---CCCCCCCCCCcccc
Q 006514 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT---MSRVLQMLTTE---EQLPGPTSPPFIDE 607 (642)
Q Consensus 538 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~~L~~~---~~~~~p~~p~~~~~ 607 (642)
+.+-.-....+.......+...+|+ .+.| +|+.|.. +.++-.|.... ..-.....|||+.+
T Consensus 293 -----Im~hk~~l~FP~~~~VSeeakdLI~-~ll~---~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 293 -----IMNHKESLSFPDETDVSEEAKDLIE-ALLC---DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred -----HhchhhhcCCCcccccCHHHHHHHH-HHhc---ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 1111000111112234455666554 2224 7888887 99999886541 22234455666654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=269.87 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=200.1
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 387 (642)
.++|+..+.||+|.||+|-+++-+ .|+.+|+|++++. .+.....-+.|-.+|+..+||.+..|--.+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999854 7899999988643 344455567789999999999999998889999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||..||.|.-+| .+...+++.....+-..|+.||.|||+++ ||+||||.+|.|||.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998888 44567888888889999999999999998 99999999999999999999999999986433
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... ...+.+|||.|+|||++....|..++|-|.+||++|||++|+.||.....+....|+.. .+
T Consensus 321 ~g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------ed----- 384 (516)
T KOG0690|consen 321 YGD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------ED----- 384 (516)
T ss_pred ccc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh----------hh-----
Confidence 332 34568999999999999999999999999999999999999999987654432222211 11
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 589 (642)
+.. +.....+...++ ...|..||.+|. .++||.++
T Consensus 385 ~kF----Pr~ls~eAktLL---sGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 LKF----PRTLSPEAKTLL---SGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccC----CccCCHHHHHHH---HHHhhcChHhhcCCCchhHHHHHhh
Confidence 110 122333444433 356789999994 57777765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=311.14 Aligned_cols=145 Identities=26% Similarity=0.363 Sum_probs=130.5
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
++|.+.++||+|+||.||+|.+. +++.||||++... .......+.+|+.++..++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999965 6899999998643 2334467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
||+++++|.+++.. ...+++...+.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 346889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=273.18 Aligned_cols=240 Identities=28% Similarity=0.359 Sum_probs=191.9
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCCh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
||+|+||.||++... +++.+++|.+.... ....+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999965 58999999886442 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 476 (642)
.+++.. ...+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999843 346899999999999999999999988 99999999999999999999999999987544321 12345
Q ss_pred cCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 477 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
.++..|++||.+.+...+.++|+||||+++|||++|+.|+...... .. ... +....... ..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~---~~~---------~~~~~~~~----~~ 214 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EI---YEK---------ILKDPLRF----PE 214 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH---HHH---------HhcCCCCC----CC
Confidence 6788999999998888999999999999999999999998654321 10 000 00000000 11
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPTM---SRVLQM 589 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~---~evl~~ 589 (642)
.. ...+.+++..||+.||++||++ .+++++
T Consensus 215 ~~---~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 215 FL---SPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CC---CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 11 2345677789999999999999 666654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=272.19 Aligned_cols=264 Identities=23% Similarity=0.361 Sum_probs=205.4
Q ss_pred hhhHHHHcCCccccccccccCceEEEEEEcC------CCcEEEEEEeecc-ChhhHHHHHHHHHHHhcCCccceeeeeee
Q 006514 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGC 377 (642)
Q Consensus 305 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 377 (642)
..++.....++.....+-+|.||.||+|.|. +.+.|-||.+... ++.+...++.|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3445555667888888999999999999653 3466778877543 55566778999999999999999999998
Q ss_pred eccC-CCceEEEeecCCCChhhhhh-----cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC
Q 006514 378 SCSG-PESLLVYEFLPNQSLDRFIF-----DSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (642)
Q Consensus 378 ~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~ 451 (642)
+.+. ...+++|.++.-|+|..||. +....+.++..+...++.|++.|+.|||+++ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 7764 55689999999999999997 4444567888899999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccCCCCCc-ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHH
Q 006514 452 LRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLT 529 (642)
Q Consensus 452 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~ 529 (642)
.++||+|-.+++..-..... .......+..||+||.+....|+.++|||||||+||||+| |+.|+...++.+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---- 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---- 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence 99999999999976554443 3334456778999999999999999999999999999999 88776543321110
Q ss_pred HHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 530 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
.. +.|.....+++. .++ ++..++.-||...|++||+++++..-|..
T Consensus 509 ---~y--------lkdGyRlaQP~N---CPD---eLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 ---HY--------LKDGYRLAQPFN---CPD---ELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---HH--------HhccceecCCCC---CcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 112222222221 222 34556677999999999999999987754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=291.43 Aligned_cols=203 Identities=24% Similarity=0.348 Sum_probs=154.9
Q ss_pred cCCccccccccccCceEEEEEEc-----------------CCCcEEEEEEeeccChhhHHHHH--------------HHH
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-----------------PDGREIAVKRLFFNNRHRAANFY--------------NEV 360 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~~--------------~E~ 360 (642)
.++|++.++||+|+||.||+|.+ .+++.||||++........++|. .|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999963 24568999998654433333343 466
Q ss_pred HHHhcCCccce-----eeeeeeecc--------CCCceEEEeecCCCChhhhhhccc---------------------cc
Q 006514 361 NIISSVEHKNL-----VRLLGCSCS--------GPESLLVYEFLPNQSLDRFIFDSA---------------------KA 406 (642)
Q Consensus 361 ~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~ 406 (642)
.++.+++|.++ +++++++.. ....+|||||+++++|.++++... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766654 667777653 356799999999999999886421 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCccccChh
Q 006514 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486 (642)
Q Consensus 407 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 486 (642)
..++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23578889999999999999999998 999999999999999999999999999765443222222234578999999
Q ss_pred hhccCCC----------------------CCcchHHHHHHHHHHHHhCCC-CCC
Q 006514 487 YLAHGQL----------------------TEKADVYSFGMLLLEIVTGRQ-NNR 517 (642)
Q Consensus 487 ~~~~~~~----------------------s~~sDv~S~Gvll~elltG~~-p~~ 517 (642)
.+..... ..+.||||+||+++||++|.. |+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 8764321 235799999999999999875 543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=287.47 Aligned_cols=241 Identities=30% Similarity=0.357 Sum_probs=190.3
Q ss_pred cCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEe
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 389 (642)
+..|+....+|.|+|+.|-++.. .+++..+||++... ..+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56788888899999999999885 47889999998544 22334677666665 79999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE-cCCCcEEEEecCCccccCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-DSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~~~ 468 (642)
++.++-+.+-+.. ......++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999888776632 22233777889999999999999998 9999999999999 68999999999999876654
Q ss_pred CCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccc
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
..+.+-|..|.|||++....|++++|+||||++||+|++|+.|+...... .++ ......+..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~~~~-------- 531 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQMPKF-------- 531 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcCCcc--------
Confidence 22345688999999999999999999999999999999999999775543 111 111111111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
......+.. +|+.+||+.||.+||+|.++..+-
T Consensus 532 ------s~~vS~~AK---dLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 532 ------SECVSDEAK---DLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred ------ccccCHHHH---HHHHHhccCChhhCcChhhhccCc
Confidence 122333444 455689999999999999999873
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-34 Score=267.80 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=191.0
Q ss_pred ccccccccccCceEEEEEEc-CCCcEEEEEEeeccC-hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+....||.|.||+|+|-.+ +.|+..|||++.... ....++++.|.+...+- +.||||+++|.+..+...||-||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34456899999999999885 479999999997654 45667788888876655 6999999999999999999999999
Q ss_pred CCCChhhhhhc--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 392 PNQSLDRFIFD--SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 392 ~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
.-+|+.+-.. ......+++...-+|....++||.||.+.- +|||||+||+|||||..|.+||||||++-.....-
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 5566654321 123456888888888888999999998754 69999999999999999999999999986543322
Q ss_pred CcccccccCCccccChhhhcc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAH--GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
..+.-.|-..|||||.+.. ..|+.+|||||||+.|+|+.||+-|+....+. .+++...+ .+ |+.
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~~Vv-----~g------dpp 288 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLCQVV-----IG------DPP 288 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHHHHH-----cC------CCC
Confidence 2244568889999999863 35999999999999999999999998654321 11111111 11 111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.... +.........+++++-.|+-+|-++||...+++++
T Consensus 289 ~l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 11112233445666778999999999999999876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=270.04 Aligned_cols=225 Identities=23% Similarity=0.167 Sum_probs=175.4
Q ss_pred cCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChhhhhhc
Q 006514 324 GGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402 (642)
Q Consensus 324 G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 402 (642)
|.+|.||++.+. +++.+|+|++.... .+.+|...+....||||+++++++......++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 78999999986432 233455555566799999999999999999999999999999998843
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCccc
Q 006514 403 SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482 (642)
Q Consensus 403 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 482 (642)
...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.++++|||++....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 345899999999999999999999998 9999999999999999999999999876554321 123456789
Q ss_pred cChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHH
Q 006514 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEV 562 (642)
Q Consensus 483 ~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 562 (642)
+|||.+.+..++.++||||+|+++|||++|+.|+........ .... +.. .... .
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~--~~~----~~~~---~ 202 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTT--LNI----PEWV---S 202 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccc--cCC----cccC---C
Confidence 999999888899999999999999999999987643211100 0000 000 1111 1
Q ss_pred HHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 006514 563 LRAIHVGLLCTQENPSLRPTM-----SRVLQM 589 (642)
Q Consensus 563 ~~~~~l~~~Cl~~~P~~RPs~-----~evl~~ 589 (642)
..+.+++.+|++.||++||++ .++++|
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 234567779999999999996 566543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=275.48 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=197.2
Q ss_pred HcCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccC--hh-----hHHHHHHHHHHHhcCCccceeeeeeeecc-C
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN--RH-----RAANFYNEVNIISSVEHKNLVRLLGCSCS-G 381 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~--~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~ 381 (642)
..++|-..++||+|||+.||++. +...+.||||+-..+. +. ..+...+|..+.+.|.||.||++++++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34568888999999999999999 4577889999754332 11 12346689999999999999999999865 4
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC---CCcEEEEe
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIAD 458 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~D 458 (642)
+..+-|+||++|.+|+-+|. ..+.++++++..|+.||+.||.||.+. +++|||-||||.||||.+ -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 56789999999999999994 346789999999999999999999987 578999999999999954 47899999
Q ss_pred cCCccccCCCCCc------ccccccCCccccChhhhccC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhH
Q 006514 459 FGLARSFQEDKSH------ISTAIAGTLGYMAPEYLAHG----QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL 528 (642)
Q Consensus 459 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~ 528 (642)
||+++.+..+... .+....||.+|++||.+.-+ +++.|+||||.|||+|..+.|+.||.........
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--- 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--- 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---
Confidence 9999988655432 34456899999999987644 5799999999999999999999999875433211
Q ss_pred HHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 529 TITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 529 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+....+...-.-... ..+....+. -.++.+||+..-++|-...++..+
T Consensus 694 ------LqeNTIlkAtEVqFP----~KPvVsseA---kaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 ------LQENTILKATEVQFP----PKPVVSSEA---KAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ------HhhhchhcceeccCC----CCCccCHHH---HHHHHHHHHhhhhhhhhHHHHccC
Confidence 111111111111111 111222333 346679999999999988887754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=261.83 Aligned_cols=270 Identities=22% Similarity=0.257 Sum_probs=202.0
Q ss_pred HcCCcccc-ccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccC----CC
Q 006514 311 ATGSFDEA-NKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG----PE 383 (642)
Q Consensus 311 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 383 (642)
.+++|.+. +.||-|-.|.|-.+..+ +|+.+|+|++... ....+|+++.-.. .|||||.+++++.+. .-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34555543 46999999999998864 7899999988433 2345788876655 699999999988653 34
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC---CCcEEEEecC
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFG 460 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfG 460 (642)
+.+|||.|+||.|..-+.++ ....++++++-.|+.||..|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 67999999999999988654 3467999999999999999999999998 999999999999964 4579999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcc
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRV 540 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 540 (642)
+|+....... ..+.+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||......... .+--
T Consensus 210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------pgMk 276 (400)
T KOG0604|consen 210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK 276 (400)
T ss_pred cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------hhHH
Confidence 9997654322 34567899999999999999999999999999999999999999765542211 1100
Q ss_pred hhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFI 605 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p~~p~~~ 605 (642)
..+..... .+..+.-........+++...|..+|.+|.|+.+++.+-.-....-.|..|.+.
T Consensus 277 ~rI~~gqy---~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 277 RRIRTGQY---EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred hHhhccCc---cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence 11111111 111222233344455677788899999999999999885444444455555554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=240.70 Aligned_cols=267 Identities=25% Similarity=0.355 Sum_probs=194.8
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+|...++||+|.||+||+++.+ .++.||+|++...+ +..-...++|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999954 67889999986543 33346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+ ..+|..+.. .-++.++.+....++.|+++||.+.|+++ +.||||||.|.||+.+|+.|++|||+++.++-.-.
T Consensus 83 c-dqdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9 557777653 23578999999999999999999999998 99999999999999999999999999998876543
Q ss_pred cccccccCCccccChhhhccCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHh--hhcCcchhh---c
Q 006514 471 HISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH--FQAGRVEEL---Y 544 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--~~~~~~~~~---~ 544 (642)
.. ...+-|..|.+|.++.+.+ |+...|+||-|||+.|+.....|..... +..+++..+.|.. ..+..+..+ .
T Consensus 157 cy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred ee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccCC
Confidence 32 3345789999999988765 8889999999999999998555543332 2233444444322 112222221 1
Q ss_pred cccccccccCC-CCcHHHHHHH----HHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHD-SNVKYEVLRA----IHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~-~~~~~~~~~~----~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
|-... +.+.. ....+.+.++ -++....+.-+|.+|.++++.+++
T Consensus 235 dyk~y-p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPY-PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccc-CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11110 00100 0111111111 122233444599999999999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=264.40 Aligned_cols=239 Identities=28% Similarity=0.366 Sum_probs=191.1
Q ss_pred CceEEEEEEcC-CCcEEEEEEeeccChhh-HHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChhhhhhc
Q 006514 325 GFGTVYKGVLP-DGREIAVKRLFFNNRHR-AANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402 (642)
Q Consensus 325 ~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 402 (642)
+||.||++... +|+.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999987654443 67899999999999999999999999999999999999999999998844
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCccc
Q 006514 403 SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482 (642)
Q Consensus 403 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 482 (642)
. ..+++..++.++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 23899999999999999999999998 9999999999999999999999999998765543 22345678899
Q ss_pred cChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHH
Q 006514 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEV 562 (642)
Q Consensus 483 ~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 562 (642)
++||.+....++.++||||||++++||++|..|+...... ... ........... ........
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~----~~~~~~~~~~~------------~~~~~~~~ 214 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL----FKKIGKPKPPF------------PPPEWKIS 214 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH----HHHHhccCCCC------------ccccccCC
Confidence 9999999888999999999999999999999988653111 111 11111110000 00000022
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 563 LRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 563 ~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..+.+++.+|+..+|++||++.+++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhhC
Confidence 356678889999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=288.78 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=208.3
Q ss_pred hhHHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-Cccceeeeeeeec----
Q 006514 306 STLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSC---- 379 (642)
Q Consensus 306 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~---- 379 (642)
+.+..-++.|++.+.||.|.+|.||+++. ++++.+|+|++.... ...++...|.++++.+ .|||++.++|++.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33444567799999999999999999994 578889999875443 3446677899999988 6999999999875
Q ss_pred -cCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEe
Q 006514 380 -SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (642)
Q Consensus 380 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 458 (642)
.++++|||||||.+|+..|++..-. ...+.|+.+..|+..++.|+.+||... ++|||||-.|||++.++.+||.|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 3578999999999999999986644 778999999999999999999999887 99999999999999999999999
Q ss_pred cCCccccCCCCCcccccccCCccccChhhhccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHH
Q 006514 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG-----QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWK 533 (642)
Q Consensus 459 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 533 (642)
||.+........ ...+.+||+.|||||++... .|+.++|+||+|++..||--|.+|+....+-
T Consensus 167 FGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------- 234 (953)
T KOG0587|consen 167 FGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------- 234 (953)
T ss_pred eeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----------
Confidence 999876554332 23457899999999999743 4788999999999999999999997653321
Q ss_pred hhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 534 HFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 534 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
..++-. ...+++.......-..++.+++..||..|-++||++.++++|
T Consensus 235 -------raLF~I-pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 -------RALFLI-PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------hhhccC-CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111 011111223345567788899999999999999999999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=297.04 Aligned_cols=264 Identities=19% Similarity=0.213 Sum_probs=169.6
Q ss_pred HcCCccccccccccCceEEEEEEcC-C----CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeee------ec
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-D----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC------SC 379 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 379 (642)
..++|+..+.||+|+||.||+|++. + +..||||++..... .+.+.+| .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999975 4 68999998753221 1112222 1122222222222211 24
Q ss_pred cCCCceEEEeecCCCChhhhhhcccc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccC
Q 006514 380 SGPESLLVYEFLPNQSLDRFIFDSAK-----------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442 (642)
Q Consensus 380 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk 442 (642)
...+.++|+||+++++|.+++..... ........+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999998854211 011123345679999999999999998 9999999
Q ss_pred CCCEEEcC-CCcEEEEecCCccccCCCCCcccccccCCccccChhhhccC----------------------CCCCcchH
Q 006514 443 ASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG----------------------QLTEKADV 499 (642)
Q Consensus 443 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDv 499 (642)
|+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987655444444556889999999976422 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcC-----cchhhcccccccccc-CCCCcHHHHHHHHHHHHHhc
Q 006514 500 YSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG-----RVEELYDKNLMLHNY-HDSNVKYEVLRAIHVGLLCT 573 (642)
Q Consensus 500 ~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~d~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl 573 (642)
|||||+||||+++..++... +...... +... .+...+.+....... .............+++.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQ-LKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHH-HHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999976553221 1111000 0000 000011110000000 00000001123346888999
Q ss_pred ccCCCCCCCHHHHHHH
Q 006514 574 QENPSLRPTMSRVLQM 589 (642)
Q Consensus 574 ~~~P~~RPs~~evl~~ 589 (642)
+.||++|||+.++++|
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=260.64 Aligned_cols=274 Identities=23% Similarity=0.366 Sum_probs=197.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC--hhhHHHHHHHHHHHhcCCccceeeeeeeeccC--------
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-------- 381 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 381 (642)
+.|+...+||+|.||.||++..+ +|+.||+|++...+ ...-...++|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 44666788999999999999954 67889998765432 22234568999999999999999999987642
Q ss_pred CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCC
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 461 (642)
...++|+++++. +|.-+|.+ ....++..++.+++.++.+||.|+|+.. |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 236899999965 67777733 3367899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCc---ccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhc
Q 006514 462 ARSFQEDKSH---ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 462 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
++.+...... ..+..+-|..|.+||.+.+ .+|+++.|||.-|||+.||.||.+-+....+.....++...-..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9887654433 2345677999999998876 57999999999999999999998877665544333333322111222
Q ss_pred Ccchhhccccccc----cccC---CCCcHHHHH------HHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 538 GRVEELYDKNLML----HNYH---DSNVKYEVL------RAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 538 ~~~~~~~d~~~~~----~~~~---~~~~~~~~~------~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
+.+.++..-.+.. ++.. .....+... ..++++-.++..||.+|+.+.+++.|-..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 2222221111100 0000 000111111 23455557888999999999999988654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=277.43 Aligned_cols=245 Identities=26% Similarity=0.358 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEc-CCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCC
Q 006514 318 ANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
.+.||+|-||+||-|+. ++|+.||||++.+- .......+.+|+.+|+++.||.||.|.-.++..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 46899999999999995 58999999988543 3444578899999999999999999999999999999999999 56
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC---CcEEEEecCCccccCCCCCc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~ 471 (642)
+..++|... ..+.|++..-..++.||+.||.|||.++ |+|.||||+||||.+. -.+||||||+|+..++...
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 666666543 3467888888899999999999999998 9999999999999654 4799999999998876443
Q ss_pred ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccc
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
...++|||.|+|||++....|...-|+||.|||+|--++|.-||....+- ..-+. +...+..
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQ---------------NAaFMyP 784 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQ---------------NAAFMYP 784 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhh---------------ccccccC
Confidence 35689999999999999999999999999999999999999998653321 11111 1111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+..-... ....++++-..||..-++|.|...-+.|
T Consensus 785 p~PW~ei---s~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 785 PNPWSEI---SPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCchhhc---CHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111112 2234555567778888999988877654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=268.02 Aligned_cols=276 Identities=21% Similarity=0.291 Sum_probs=206.6
Q ss_pred cChhhHHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCC--ccc----eeeee
Q 006514 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE--HKN----LVRLL 375 (642)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~n----iv~l~ 375 (642)
+.+..-...+++|.+..++|+|.||.|-.+.+. .+..||||+++...+. .+.-+-|+++++++. .|+ +|++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 444444556889999999999999999999864 4688999988544333 344567999999993 233 78888
Q ss_pred eeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-----
Q 006514 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS----- 450 (642)
Q Consensus 376 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~----- 450 (642)
+++.-.+..+||+|.+ |.|+.++|.. .+..+++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 9999999999999988 6799999954 24467899999999999999999999998 999999999999932
Q ss_pred ---------------CCcEEEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCC
Q 006514 451 ---------------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515 (642)
Q Consensus 451 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p 515 (642)
+..+||+|||.|+...+.. ..++.|..|.|||++.+-.++..+||||+||||.|+.||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 3458999999998765544 347789999999999999999999999999999999999998
Q ss_pred CCCCCCcccchhHHHH--------------HHhhhcCcc-----------hhhccccccccccCCCCcHHHHHHHHHHHH
Q 006514 516 NRSKNSEYTDSLLTIT--------------WKHFQAGRV-----------EELYDKNLMLHNYHDSNVKYEVLRAIHVGL 570 (642)
Q Consensus 516 ~~~~~~~~~~~l~~~~--------------~~~~~~~~~-----------~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~ 570 (642)
|......+...+...+ .+.+..+.+ ..+.+........ -...+.+...+++|+.
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~-~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY-MLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH-hccCcHHHhHHHHHHH
Confidence 8654421111010000 111111111 1111111111111 1233456778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 006514 571 LCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 571 ~Cl~~~P~~RPs~~evl~~ 589 (642)
.+|..||.+|+|++|++.|
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=264.08 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=170.6
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 387 (642)
.+|..+..||+|+||.|-++..+ +.+.+|||++...- ....+--+.|-.+|+.. +-|.+++++.++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888889999999999999865 45678999886431 12222234577777766 578899999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
|||+.+|+|--.+. .-+.+.+..+.-++.+||-||-+||+++ ||+||||..||+||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999987774 4456788889999999999999999999 99999999999999999999999999985332
Q ss_pred CCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
+. ..+.+.+|||.|+|||++...+|...+|.|||||+||||+.|++||+...+
T Consensus 503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 22 234568999999999999999999999999999999999999999987554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=253.17 Aligned_cols=270 Identities=24% Similarity=0.348 Sum_probs=200.0
Q ss_pred CccccccccccCceEEEEEEcC-CCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccC-----CCce
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----PESL 385 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 385 (642)
+.+..+.||-|.||.||..+++ +|+.||+|++..- +-...+.+.+|+.+|..++|.|++..++.-... .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455678999999999999975 8999999988532 334457799999999999999999988875533 3568
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+++|.| ..+|++++ .....++.....-+..||++||.|||+.+ |.||||||.|.|++++..+||+|||+++..
T Consensus 134 V~TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 889988 45788877 34567888888889999999999999998 999999999999999999999999999988
Q ss_pred CCCCCcccccccCCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhhh
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------TWKHFQ 536 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~ 536 (642)
..+.....+..+-|-.|.|||++++. .|+.+.||||.|||+.||+..+..|....+-...+++.- ..+..-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 77777666666778899999999985 599999999999999999998888876554333222221 112222
Q ss_pred cCcchhhccccccccccC----CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 537 AGRVEELYDKNLMLHNYH----DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
++.-..++........+. ...........+.+...++..||++|.+..+.+.++
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 222222222222111110 011111111223445567899999999999988775
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=266.93 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=205.6
Q ss_pred CccccccccccCceEEEEEEcCCCc-EEEEEEeec---cChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPDGR-EIAVKRLFF---NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
+++.+..||-|+||.|=+...++.. .+|+|.+++ .+....+.+..|-.+|.+.+.|.||+|+..+.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455667999999999998865433 367776643 356667788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
-+-||.|...|. +++.++......++..+.+|++|||+++ ||+|||||+|.+||.+|-+||.|||+|+......
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999994 4567888888899999999999999999 9999999999999999999999999999887654
Q ss_pred CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
. +.+.+|||.|.|||++.....+.++|.||+|+++|||++|.+||...++-...+++- . -+|..
T Consensus 575 K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-------k-----Gid~i-- 638 (732)
T KOG0614|consen 575 K--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-------K-----GIDKI-- 638 (732)
T ss_pred c--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-------h-----hhhhh--
Confidence 4 356899999999999999999999999999999999999999998765322211111 0 11110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhc--c-------CCCCCCCCCCCcc
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQMLT--T-------EEQLPGPTSPPFI 605 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~L~--~-------~~~~~~p~~p~~~ 605 (642)
..+........+++......+|.+|.- +.+|-+|-. + ...+|+|-.|+..
T Consensus 639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va 702 (732)
T KOG0614|consen 639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA 702 (732)
T ss_pred ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence 011112223445555666889999965 778877642 1 2455655555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=281.98 Aligned_cols=246 Identities=29% Similarity=0.431 Sum_probs=186.6
Q ss_pred ccccccccccCceEE-EEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEeecC
Q 006514 315 FDEANKLGQGGFGTV-YKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 315 ~~~~~~LG~G~fg~V-y~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
|...+.+|.|..|+| |+|.. +|++||||++.. ....-..+|+..|+.- +|||||++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 555667899998765 99998 589999999843 2334457899999888 6999999999988899999999999
Q ss_pred CCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC---C--CcEEEEecCCccccC
Q 006514 393 NQSLDRFIFDS-AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---R--LRAKIADFGLARSFQ 466 (642)
Q Consensus 393 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DfGla~~~~ 466 (642)
..+|++++... .......-...+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999653 11111111345678899999999999987 999999999999975 3 579999999999987
Q ss_pred CCCCcc--cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCcccchhHHHHHHhhhcCcchhh
Q 006514 467 EDKSHI--STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG-RQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 467 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
.+.... .....||.+|+|||++....-+.++||||+|||+|+.++| .+||+....... .+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-----------------NI 725 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-----------------NI 725 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-----------------hh
Confidence 766543 3456899999999999988888899999999999999996 889876432211 01
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+......... .+.... ...+|+-.|++.+|..||++.+|+.|
T Consensus 726 l~~~~~L~~L-~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 726 LTGNYTLVHL-EPLPDC---EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hcCccceeee-ccCchH---HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1110000000 111111 34466679999999999999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=245.20 Aligned_cols=204 Identities=24% Similarity=0.347 Sum_probs=175.9
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeec---cChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFF---NNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 386 (642)
..+|...+.||+|+|.+|-.+.++ +.+.+|+|++++ ++.+..+-...|-.+..+- +||.+|.|+.|+..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999965 567889998753 3344444566677777776 79999999999999999999
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
|.||+++|+|--++ .+...++++.+..+..+|..||.|||+.+ ||+||||..|||+|.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996555 45567999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~ 522 (642)
.+.. .+.+.+|||.|+|||++.+..|...+|.|++||+++||+.|+.||+....+
T Consensus 403 ~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~ 457 (593)
T KOG0695|consen 403 GPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD 457 (593)
T ss_pred CCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC
Confidence 3332 345789999999999999999999999999999999999999999765433
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=264.98 Aligned_cols=204 Identities=25% Similarity=0.378 Sum_probs=175.2
Q ss_pred CccccccccccCceEEEEEE-cCCCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEe
Q 006514 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 389 (642)
-|..++.||-|+||.|.++. .++...+|+|.|.+.+ +.....++.|-.||+.-..+=||+|+-.|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47788899999999999988 4456678999886543 4455678889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC-
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED- 468 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~- 468 (642)
|++||++-.+| .+.+.+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||.||||+.-+...
T Consensus 710 YIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999998 45567889999999999999999999999 999999999999999999999999998644210
Q ss_pred -------C------------------Cc---------------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHH
Q 006514 469 -------K------------------SH---------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLE 508 (642)
Q Consensus 469 -------~------------------~~---------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~e 508 (642)
. .. .....+||+.|+|||++....|+..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 00 0012479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCcc
Q 006514 509 IVTGRQNNRSKNSEY 523 (642)
Q Consensus 509 lltG~~p~~~~~~~~ 523 (642)
|+.|+.||......+
T Consensus 864 m~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGE 878 (1034)
T ss_pred HhhCCCCccCCCCCc
Confidence 999999998765443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=234.55 Aligned_cols=209 Identities=28% Similarity=0.419 Sum_probs=170.3
Q ss_pred HHHHcCCccccccccccCceEEEEEEc-CCCcEEEEEEeecc-ChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 308 LEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 308 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
++...+.......||+|++|.|-+-++ .+|+..|+|++... +.+..+..++|+.+..+- .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 334445556677899999999988874 58999999999654 345567788899877665 799999999999999999
Q ss_pred eEEEeecCCCChhhhhhc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 385 LLVYEFLPNQSLDRFIFD-SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
++.||.| ..+|+.+-.+ ..++..+++..+=+|+..+..||.|||++- .+||||+||+|||++.+|++||||||++-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 5577766543 234577899999999999999999999975 59999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCccccChhhhcc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAH----GQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
.....-.. +...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|+.....
T Consensus 198 ~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 65443221 22457788999999863 3699999999999999999999999876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=235.56 Aligned_cols=211 Identities=36% Similarity=0.588 Sum_probs=182.4
Q ss_pred ccccCceEEEEEEcC-CCcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChhh
Q 006514 321 LGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 398 (642)
||+|.+|.||++... +++++++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999998655432 35678999999999999999999999999899999999999999999
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-CCcEEEEecCCccccCCCCCccccccc
Q 006514 399 FIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIA 477 (642)
Q Consensus 399 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 477 (642)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 984321 46899999999999999999999998 999999999999999 89999999999987654432 122345
Q ss_pred CCccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCC
Q 006514 478 GTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556 (642)
Q Consensus 478 gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 556 (642)
+...|++||.+... ..+.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999887 888999999999999999
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 557 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
..+.+++..|++.+|++||++.+++++|
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2455677789999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=227.38 Aligned_cols=263 Identities=19% Similarity=0.327 Sum_probs=194.7
Q ss_pred cCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCC--CceEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGP--ESLLV 387 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lv 387 (642)
.++|++.+++|+|.++.||.|. ..++++++||.++ +-..+.+.+|+.+|..|. ||||++|+++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999999 5678999999995 344567889999999996 999999999887654 45799
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCCccccC
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQ 466 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~ 466 (642)
+||+.+.+...+- +.++...+...+.+++.||.|+|+.| |.|||+||.|++||.. -.++|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876654 46777778889999999999999999 9999999999999965 469999999999876
Q ss_pred CCCCcccccccCCccccChhhhcc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHH-----------h
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWK-----------H 534 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-----------~ 534 (642)
..... ...+.+.-|--||.+-. ..|+..-|+|||||+|.+|+-.+.||....+. .++++.++.- .
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHH
Confidence 65443 23456677889998865 55788899999999999999999998765543 3344433310 0
Q ss_pred h---hcCcchhhccccc---cccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 535 F---QAGRVEELYDKNL---MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 535 ~---~~~~~~~~~d~~~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+ .+....+++.... +..........-.....++++-..|..|-.+|||++|...|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 1112222222111 10011111111111334455557778999999999999976
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=237.96 Aligned_cols=264 Identities=28% Similarity=0.353 Sum_probs=194.9
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeec--cChhhHHHHHHHHHHHhcCCccceeeeeeeeccC------C
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFF--NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------P 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 382 (642)
..+|.....+|.|.- .|-.+.+. .++.||+|++.. ......+...+|..++..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788898888 56666543 689999998743 2445567788999999999999999999988643 3
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
+.++|||+| ..+|...+. -.++-+....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 568999999 668888874 34667788899999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccc----------------h
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD----------------S 526 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~----------------~ 526 (642)
+.-..+ -..+..+.|.-|.|||++.+..+.+.+||||.||++.||++|+..|.+...-.+. .
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865443 3456788899999999999888999999999999999999999887654321110 1
Q ss_pred hHHHHH------HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 527 LLTITW------KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 527 l~~~~~------~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
+...+. +.+..-...+.+...+.....+. .......+-+++.+||-.||++|-|..++|+|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~--~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG--SKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccC--CccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111 00111112222222222111111 11223334467788999999999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=253.64 Aligned_cols=195 Identities=27% Similarity=0.407 Sum_probs=166.4
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHH---------HHHHHHHHHhcCC---ccceeeeeeeec
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAA---------NFYNEVNIISSVE---HKNLVRLLGCSC 379 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~---H~niv~l~~~~~ 379 (642)
.+|...+.||+|+||.|+.+.++ +..+|+||.+.+.. --.+ .+-.|+.+|..++ |+||++++++|+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR-IL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER-ILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhh-hhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 35888899999999999999975 56789999885432 1112 2345999999997 999999999999
Q ss_pred cCCCceEEEeecC-CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEe
Q 006514 380 SGPESLLVYEFLP-NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458 (642)
Q Consensus 380 ~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 458 (642)
+.+.++|+||-.. +-+|.++| ...+.+++.+..-|+.||+.|+++||+++ |||||||-+||.|+.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999764 45888988 45578999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCcccccccCCccccChhhhccCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 006514 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNR 517 (642)
Q Consensus 459 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~p~~ 517 (642)
||.+........ ...+||.+|.|||++.+.+| ...-|||++|++||-++....|+.
T Consensus 714 fgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876554433 35789999999999998887 556799999999999998887764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=233.39 Aligned_cols=199 Identities=32% Similarity=0.492 Sum_probs=172.3
Q ss_pred ccccccccccCceEEEEEEcCC-CcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecC
Q 006514 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 899999998765444 56789999999999999999999999999899999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 472 (642)
+++|.+++.... ..+++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999985422 12899999999999999999999997 9999999999999999999999999998776543112
Q ss_pred cccccCCccccChhhh-ccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 006514 473 STAIAGTLGYMAPEYL-AHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~-~~~~~s~~sDv~S~Gvll~elltG~~p~~~ 518 (642)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2335678889999998 666788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=234.42 Aligned_cols=131 Identities=31% Similarity=0.444 Sum_probs=110.7
Q ss_pred CCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCC-----c---cceeeeeeeecc---
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----H---KNLVRLLGCSCS--- 380 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--- 380 (642)
++|...++||.|.|++||++.+. +.+.||+|+.+. .+...+..+.||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 78999999999999999999964 667899998743 3445566789999999983 3 469999998864
Q ss_pred -CCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE
Q 006514 381 -GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 381 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl 448 (642)
+.+.+||+|++ |-+|..+|... .-+.++.....+|+.||+.||.|||.+. .|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56789999999 66888887543 4567999999999999999999999987 69999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=242.45 Aligned_cols=209 Identities=22% Similarity=0.240 Sum_probs=178.0
Q ss_pred hhhHHHHcCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCC------ccceeeeeee
Q 006514 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVE------HKNLVRLLGC 377 (642)
Q Consensus 305 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~ 377 (642)
+.--+....+|.+....|+|-|++|.+|.+. -|+.||||++..+. ...+.=+.|+++|++|+ .-|.++|+..
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3334556678888889999999999999964 57899999996553 33455678999999995 3578999999
Q ss_pred eccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEE
Q 006514 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKI 456 (642)
Q Consensus 378 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl 456 (642)
|...++++||+|-+ ..+|.++|....++-.|.......++.|+.-||..|-..+ |+|.||||.||||++. ..+||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 99999999999987 6789999988888888999999999999999999999988 9999999999999876 46899
Q ss_pred EecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 457 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
||||.|......... ...-+.-|.|||++.+-.|+...|+||.||.||||.||+..|.+...
T Consensus 579 CDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 579 CDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 999999876655443 33445679999999999999999999999999999999988866543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=249.03 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=199.1
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
.++|+....+|+|.+|.|||+++. .++..|||+++........-..+|+.+++..+||||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999964 7899999999877666677788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
+.+|+|++.-+ -...+++.++..+..+.++||+|||+++ =+|||||-.|||+++.|.+|++|||.+..+...-.
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 99999998653 3467899999999999999999999998 79999999999999999999999998865543222
Q ss_pred cccccccCCccccChhhhc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccc
Q 006514 471 HISTAIAGTLGYMAPEYLA---HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
......||+.|||||+.. .+.|..++|||+.|+...|+-.-++|....... ..+.......+. ...+-|+.
T Consensus 168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS~~q---pp~lkDk~ 241 (829)
T KOG0576|consen 168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKSGFQ---PPTLKDKT 241 (829)
T ss_pred -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhccCCC---CCcccCCc
Confidence 234578999999999874 577999999999999999998777664322110 011111111111 11111221
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....-+-+++..|+-.+|.+||+++.++.|
T Consensus 242 ------------kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 242 ------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ------------cchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 122234456678999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=217.48 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=186.7
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-Cccceeeeeee-eccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC-SCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lv~ 388 (642)
.+.|.+.+.||+|.||.+-++.++ +.+.+++|.+.. .....++|.+|..---.| .|.||+.-+++ +...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 357888999999999999999975 567889997743 344567899998766666 48999988765 56667778999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc--CCCcEEEEecCCccccC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD--SRLRAKIADFGLARSFQ 466 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~ 466 (642)
||+|.|+|.+-+. ...+.+....+++.|++.||.|||+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999988773 356778888899999999999999998 99999999999993 34589999999987654
Q ss_pred CCCCcccccccCCccccChhhhcc---C--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcch
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAH---G--QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
..-. ...-+..|.+||.... + ...+.+|||.||+|++.++||+.||.... ......|.|..|..+...
T Consensus 175 ~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred ceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhcccCc
Confidence 3222 1234567999997653 2 34678999999999999999999997432 223345666667666544
Q ss_pred hhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.+.+. .....+...++. .+-+..+|++|=-..++.++-
T Consensus 248 ~~P~~--------F~~fs~~a~r~F---kk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKK--------FNPFSEKALRLF---KKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchh--------hcccCHHHHHHH---HHhcCCcccccchhHHHHHHH
Confidence 33222 111223333443 356788999996666655543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=230.98 Aligned_cols=204 Identities=26% Similarity=0.472 Sum_probs=168.3
Q ss_pred HHHHcCCccccccccccCceEEEEEEcC----CCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCC
Q 006514 308 LEKATGSFDEANKLGQGGFGTVYKGVLP----DGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (642)
Q Consensus 308 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 382 (642)
+....+.|..+++||+|.|++||++++. ..+.||+|.+...+ ....+.+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344567888999999999999999953 46789999885443 234578999999999 5999999999999999
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCC
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGL 461 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGl 461 (642)
...+|+||+++-...++. ..++..++..++..+..||.++|.+| ||||||||+|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999998887 34678889999999999999999999 9999999999999854 5789999999
Q ss_pred ccccCCCC---------------------------------Cc----------ccccccCCccccChhhhcc-CCCCCcc
Q 006514 462 ARSFQEDK---------------------------------SH----------ISTAIAGTLGYMAPEYLAH-GQLTEKA 497 (642)
Q Consensus 462 a~~~~~~~---------------------------------~~----------~~~~~~gt~~y~aPE~~~~-~~~s~~s 497 (642)
|....... .. ......||++|.|||++.. +..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 00 0012479999999999875 5679999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCc
Q 006514 498 DVYSFGMLLLEIVTGRQNNRSKNSE 522 (642)
Q Consensus 498 Dv~S~Gvll~elltG~~p~~~~~~~ 522 (642)
||||-|||++-+++++.||....++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred ceeeccceeehhhccccccccCccc
Confidence 9999999999999999999766554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=268.85 Aligned_cols=197 Identities=19% Similarity=0.248 Sum_probs=137.8
Q ss_pred cCCc-cceeeeeeee-------ccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006514 365 SVEH-KNLVRLLGCS-------CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436 (642)
Q Consensus 365 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 436 (642)
.++| +||+++++++ .+....++++|++ +++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5788888876 2234567788887 66999999532 356999999999999999999999998 9
Q ss_pred EEeccCCCCEEEcCC-------------------CcEEEEecCCccccCCCCC---------------cccccccCCccc
Q 006514 437 IHRDIKASNILLDSR-------------------LRAKIADFGLARSFQEDKS---------------HISTAIAGTLGY 482 (642)
Q Consensus 437 iH~Dlkp~NILl~~~-------------------~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 482 (642)
+||||||+||||+.. +.+||+|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666653211000 001124578899
Q ss_pred cChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHH
Q 006514 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEV 562 (642)
Q Consensus 483 ~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 562 (642)
||||++.+..++.++|||||||+||||++|..|+..... ....... ....+. .....
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~---------~~~~~~----------~~~~~ 238 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH---------RVLPPQ----------ILLNW 238 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH---------hhcChh----------hhhcC
Confidence 999999999999999999999999999998876532110 0000000 000000 01112
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 563 LRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 563 ~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
.....++.+||+.+|.+||+|.||+++-
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 2345677789999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=209.73 Aligned_cols=166 Identities=23% Similarity=0.246 Sum_probs=123.4
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|+|.+++.. +...+++.+++.|+.|++.||.|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688898853 2456999999999999999999999875 999999999999999 99988654422
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccccccc
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 553 (642)
..|++.|||||++.+..++.++|||||||++|||++|+.|+....... .............. + .
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~------~ 127 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------P------R 127 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------c------c
Confidence 258899999999999999999999999999999999999986432211 11111100000000 0 0
Q ss_pred CCCCcHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 554 HDSNVKYEV--LRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 554 ~~~~~~~~~--~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
......... ..+.+++.+||+.+|++||++.|+++++..
T Consensus 128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 000111111 247788899999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=218.89 Aligned_cols=178 Identities=21% Similarity=0.225 Sum_probs=136.8
Q ss_pred hhHHHHcCCccccccccccCceEEEEEEcC--CCcEEEEEEeecc-----ChhhHHHHHHHHHHHhcCCccceee-eeee
Q 006514 306 STLEKATGSFDEANKLGQGGFGTVYKGVLP--DGREIAVKRLFFN-----NRHRAANFYNEVNIISSVEHKNLVR-LLGC 377 (642)
Q Consensus 306 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~~~ 377 (642)
+......++|...+.||+|+||+||+|.+. +++.||||++... .....+.|.+|++++++++|+|+++ ++++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 344566788999999999999999999864 5777899987532 2233566899999999999999985 4432
Q ss_pred eccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecc-CCCCEEEcCCCcEEE
Q 006514 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI-KASNILLDSRLRAKI 456 (642)
Q Consensus 378 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl-kp~NILl~~~~~~kl 456 (642)
...++||||+++++|.... ... ...++.++++||.|||+++ |+|||| ||+|||++.++.+||
T Consensus 91 ----~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred ----CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 4579999999999996321 101 1467889999999999998 999999 999999999999999
Q ss_pred EecCCccccCCCCCcc-------cccccCCccccChhhhccCC------CCCcchHH
Q 006514 457 ADFGLARSFQEDKSHI-------STAIAGTLGYMAPEYLAHGQ------LTEKADVY 500 (642)
Q Consensus 457 ~DfGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~s~~sDv~ 500 (642)
+|||+++.+....... -+...+++.|+|||++...+ .+..+|-|
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999775443211 13467888999999986432 23446665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=198.49 Aligned_cols=248 Identities=21% Similarity=0.350 Sum_probs=182.7
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeecc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCC
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
....+|.+...|..|+|++. |..+++|++... .....++|..|.-.|+-+.||||+.++|.|...+...+|..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 33457899999999999995 566777877543 334456799999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc-cCCCCCcc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS-FQEDKSHI 472 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~-~~~~~~~~ 472 (642)
|+|..+|++. ..-..+-.+..+++.++++|++|||+.. +-|.---|.+..|+||++.+++|+-=. ++. +..
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad-~kfsfqe----- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMAD-TKFSFQE----- 343 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccc-ceeeeec-----
Confidence 9999999763 3456778889999999999999999986 223344689999999999998885211 111 111
Q ss_pred cccccCCccccChhhhccCCC---CCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhcccccc
Q 006514 473 STAIAGTLGYMAPEYLAHGQL---TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~---s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 549 (642)
....-.|.||+||.++..+- -.++|+|||.++||||.|...||....+-+....+ --..+.
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------------aleglr 407 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------------ALEGLR 407 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------------hhcccc
Confidence 11234678999999987653 34789999999999999999999764432211100 001111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
.. .++.....+. +++--|++.||.+||.+..|+-.|++.
T Consensus 408 v~--ippgis~hm~---klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VH--IPPGISRHMN---KLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cc--CCCCccHHHH---HHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11 1223333444 444569999999999999999888763
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=177.85 Aligned_cols=98 Identities=38% Similarity=0.697 Sum_probs=75.5
Q ss_pred ccccC-C--ccc-CCCCchHHHHHHHHHHHHHhhhc---CCceeeeecCCCCceEEEEeccCCCChhhhHHHHHHHHhhC
Q 006514 28 NITCG-H--QLE-HNSSIFVPNFVTTMENISEQMRT---SGFGLAVTGSGLDINYGLAQCYGDLSLLDCVLCYAEARTLL 100 (642)
Q Consensus 28 ~~~C~-~--~~~-~~~~~f~~nl~~l~~~l~~~~~~---~~f~~~~~g~~~~~vy~~~~C~~d~~~~~C~~Cl~~a~~~~ 100 (642)
|+.|+ + +++ +++++|+.|+++||+.|...++. .+|++++.|.+++++||++||++|+++++|..||+.|+..+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 46798 3 366 57888999999999999999775 38999988999999999999999999999999999999999
Q ss_pred c-cCCCCCcEEEEcCceeeccccCCC
Q 006514 101 P-QCYPYNGGRIYLDGCFMRSENYSF 125 (642)
Q Consensus 101 ~-~c~~~~~~~~~~~~C~~ry~~~~f 125 (642)
. .|+.+++|+||++.|+||||+++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 9 899999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=203.57 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=188.5
Q ss_pred CccccccccccCceEEEEEEcCCC--cEEEEEEeeccChhhHHHHHHHHHHHhcCCc----cceeeeeeee-ccCCCceE
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPDG--REIAVKRLFFNNRHRAANFYNEVNIISSVEH----KNLVRLLGCS-CSGPESLL 386 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 386 (642)
+|.+.++||+|+||.||++...+. ..+|+|............+..|..++..+++ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 4788887755433333367789999988873 5888888888 46777899
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-----CcEEEEecCC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-----LRAKIADFGL 461 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DfGl 461 (642)
||+.+ +.+|.++..... .+.++....+.|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999775433 578999999999999999999999999 9999999999999865 4699999999
Q ss_pred cc--ccCCCCCc------c-cccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006514 462 AR--SFQEDKSH------I-STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 462 a~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 532 (642)
++ .+...... . .....||..|.++....+...+.+.|+||++.++.|++.|..||...........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~----- 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK----- 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-----
Confidence 99 33222211 1 1235699999999999999999999999999999999999999865433211110
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
+........... .......+...+.. .+-..+..++|....+...|..
T Consensus 249 --~~~~~~~~~~~~-------~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 249 --FEKDPRKLLTDR-------FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred --HHHHhhhhcccc-------ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHH
Confidence 000000111110 01122233333333 2334689999999999888765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-21 Score=196.87 Aligned_cols=260 Identities=29% Similarity=0.397 Sum_probs=194.4
Q ss_pred ccccccccccCceEEEEEEcCCCcEEEEEEeeccChh---hHHHHHHHHHHHhcCCcc-ceeeeeeeeccCCCceEEEee
Q 006514 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHK-NLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 390 (642)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 78899988654322 467899999999999988 799999999666667999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC-cEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 469 (642)
+.++++.+++........+.......++.+++.++.|+|+.+ ++|||+||+||+++..+ .++++|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976633211136889999999999999999999998 99999999999999998 79999999998655443
Q ss_pred Cc-----ccccccCCccccChhhhcc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc-ccchhHHHHHHhhhcCcc
Q 006514 470 SH-----ISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE-YTDSLLTITWKHFQAGRV 540 (642)
Q Consensus 470 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 540 (642)
.. ......|+..|++||.+.+ ..++...|+||+|++++++++|..|+...... .........+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 32 2356789999999999987 57899999999999999999999996544321 011111111111100
Q ss_pred hhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....... ..........+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLS-----PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccC-----ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001112344566778889999999999988765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=181.43 Aligned_cols=203 Identities=21% Similarity=0.358 Sum_probs=169.4
Q ss_pred cCCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCc-cceeeeeeeeccCCCceEEEe
Q 006514 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|..+++||.|+||.+|.|. ..+|++||||.-... ...-.+..|..+...|+| ..|..+..+..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3679999999999999999999 678999999976433 223456789999999975 677778888888899999999
Q ss_pred ecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC---CcEEEEecCCccccC
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQ 466 (642)
Q Consensus 390 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~ 466 (642)
.+ +.+|.++..- -...++.+..+-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+++.+.
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 7899887743 2356888899999999999999999999 9999999999998654 368999999999875
Q ss_pred CCCCc------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc
Q 006514 467 EDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522 (642)
Q Consensus 467 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~ 522 (642)
...+. ......||..|.+=-...+-..+.+.|+-|+|.+|.++.-|..||..-...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 44322 234568999999988888888899999999999999999999999775443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-22 Score=218.52 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=185.4
Q ss_pred cccccccccCceEEEEEEcC-CCcEEEEEEee----cc--ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 316 DEANKLGQGGFGTVYKGVLP-DGREIAVKRLF----FN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~----~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
...+.+|.|.+|.|+..... ..+..+.|... .. .......+..|+-+-..++|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977777632 33334444322 11 1122223566777888899999998888887777776669
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
||+++ +|..++.. ...+...++..++.|+..|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99998833 347888889999999999999999999 999999999999999999999999999877654
Q ss_pred CC---cccccccCCccccChhhhccCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhc
Q 006514 469 KS---HISTAIAGTLGYMAPEYLAHGQLTE-KADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 469 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~-~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.. ......+|+..|+|||.+...+|.+ ..||||.|+++..|++|+.||.......... ... -.... ..+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~----~~~~~-~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN----NYSDQ-RNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh----ccccc-cccc
Confidence 43 3455678999999999999999877 4699999999999999999987654432211 000 00000 0000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
.. ..............++.++|+.||.+|-|+.+|++.
T Consensus 548 ~~-------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EG-------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cC-------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00 011122223344567788999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-20 Score=180.25 Aligned_cols=201 Identities=20% Similarity=0.352 Sum_probs=168.6
Q ss_pred CCccccccccccCceEEEEEE-cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCceEEEee
Q 006514 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
-.|.+.++||+|.||..+.|+ +-+++.||||.-...+ ..-++..|....+.| ..++|...+-+..++-...||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468999999999999999999 4579999999553322 233566788888887 478999999888888899999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-----CcEEEEecCCcccc
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-----LRAKIADFGLARSF 465 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DfGla~~~ 465 (642)
+ +-+|.|+..- -...++.+...-++.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7788887632 2457999999999999999999999998 9999999999999643 35899999999987
Q ss_pred CCCCCc------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 466 QEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 466 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
....+. ......||..||+=....+.+.+.+.|+-|+|-++++.|-|..||..-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 655443 23456899999999999999999999999999999999999999976543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-21 Score=181.41 Aligned_cols=141 Identities=17% Similarity=0.164 Sum_probs=109.3
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChh--h-------H-----------------HHHHHHHHHHhcCCccce
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--R-------A-----------------ANFYNEVNIISSVEHKNL 371 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~ni 371 (642)
...||+|+||.||+|..++|+.||||++...... . . ....+|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998643211 0 0 122359999999988776
Q ss_pred eeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeccCCCCEEEcC
Q 006514 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL-HEQSKIRIIHRDIKASNILLDS 450 (642)
Q Consensus 372 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiH~Dlkp~NILl~~ 450 (642)
.....+. ....+|||||++++++...+. ....+++.....++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433222 223489999999887765432 235688999999999999999999 6887 99999999999998
Q ss_pred CCcEEEEecCCccccCC
Q 006514 451 RLRAKIADFGLARSFQE 467 (642)
Q Consensus 451 ~~~~kl~DfGla~~~~~ 467 (642)
++.++|+|||++.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-21 Score=184.13 Aligned_cols=172 Identities=12% Similarity=0.100 Sum_probs=133.5
Q ss_pred HcCCccccccccccCceEEEEEEcCCCcEEEEEEeeccCh---hhHHH------HHHHHHHHhcCCccceeeeeeeeccC
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR---HRAAN------FYNEVNIISSVEHKNLVRLLGCSCSG 381 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~---~~~~~------~~~E~~~l~~l~H~niv~l~~~~~~~ 381 (642)
..++|...+.||.|+||.||.... ++..+|||.+..... ..... +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999655 577899999854322 22222 57899999999999999998875533
Q ss_pred --------CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc
Q 006514 382 --------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR 453 (642)
Q Consensus 382 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 453 (642)
...+|||||++|.+|.++. .++. ....+++.+|..+|+.+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999998764 1222 24568999999999998 99999999999999988
Q ss_pred EEEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh
Q 006514 454 AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (642)
Q Consensus 454 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 511 (642)
++|+|||.......+... ..++....+..++||||||+.+..+..
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999988765332221 114444556789999999999876643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-20 Score=174.73 Aligned_cols=141 Identities=21% Similarity=0.183 Sum_probs=111.2
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChh--------------------------hHHHHHHHHHHHhcCCccce
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--------------------------RAANFYNEVNIISSVEHKNL 371 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 371 (642)
...||+|+||.||+|.+.+|+.||||++...... ....+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998654210 01224578999999999987
Q ss_pred eeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcC
Q 006514 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDS 450 (642)
Q Consensus 372 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~ 450 (642)
.....+... ..+|||||++++++..... ....++......++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433322 3589999999886544321 22457788899999999999999999 88 99999999999999
Q ss_pred CCcEEEEecCCccccCC
Q 006514 451 RLRAKIADFGLARSFQE 467 (642)
Q Consensus 451 ~~~~kl~DfGla~~~~~ 467 (642)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-21 Score=212.03 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=180.5
Q ss_pred CccccccccccCceEEEEEEcCCCcEEEEEEeeccC-hhhHHHHHHHHHH--HhcCCccceeeeeeeeccCCCceEEEee
Q 006514 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN-RHRAANFYNEVNI--ISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++...+.||++.|=+|.++++++|. |+||++.... ....+.|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998887 9999986554 4445555554443 4455899999988887777778899999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc--CCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF--QED 468 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~--~~~ 468 (642)
..+ +|.|-| ..+..+...+...|+.|++.||.-+|..+ |+|||||.+||||++-.-+.|+||-.-+.. .++
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 855 677766 44567888888999999999999999999 999999999999999999999999877643 222
Q ss_pred CCc----ccccccCCccccChhhhccC-----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006514 469 KSH----ISTAIAGTLGYMAPEYLAHG-----------QLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITW 532 (642)
Q Consensus 469 ~~~----~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 532 (642)
... ...+...-..|+|||.+-.. ..+++.||||+||++.||++ |+++|.- .+|..+-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 211 11222334579999987431 26788999999999999998 5666642 12222111
Q ss_pred HhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 006514 533 KHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 533 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 592 (642)
. .....+.++. ..++. .+-++++.|+|.||++|.++++.|+.-.+
T Consensus 250 ~--~~~~~e~~Le------~Ied~-------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 G--NADDPEQLLE------KIEDV-------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred c--CccCHHHHHH------hCcCc-------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1 0111111111 11111 33467788999999999999999987433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=168.25 Aligned_cols=187 Identities=16% Similarity=0.065 Sum_probs=141.5
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccChhh----HHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEee
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHR----AANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
.....|++|+||+||.+.. .+.+++.+.+....... ...+.+|+++|++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 67888877775443311 125789999999995 5889999886 456999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecc-CCCCEEEcCCCcEEEEecCCccccCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDI-KASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~~~ 469 (642)
+.+.+|.+.+.. ....++.+++++|.++|+++ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654311 11357789999999999999 999999 7999999999999999999998655433
Q ss_pred Cc----c--------cccccCCccccChhhhccC-CCC-CcchHHHHHHHHHHHHhCCCCCCCCC
Q 006514 470 SH----I--------STAIAGTLGYMAPEYLAHG-QLT-EKADVYSFGMLLLEIVTGRQNNRSKN 520 (642)
Q Consensus 470 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~sDv~S~Gvll~elltG~~p~~~~~ 520 (642)
.. . ......++.|++|+...-- ..+ ...+-++-|.-+|.++|++.++..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 21 0 1123468888999865432 233 46788999999999999998865543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=188.05 Aligned_cols=215 Identities=27% Similarity=0.418 Sum_probs=161.2
Q ss_pred HhcCCccceeeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccC
Q 006514 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442 (642)
Q Consensus 363 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk 442 (642)
|+.+.|.|+.+++|.+.+++..++|.+|+..|+|.+.+.. ....++|.....++..|+.||.|||... . ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4578899999999999999999999999999999999965 4568999999999999999999999864 2 2999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccCCC-CCcccccccCCccccChhhhccC-------CCCCcchHHHHHHHHHHHHhCCC
Q 006514 443 ASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYLAHG-------QLTEKADVYSFGMLLLEIVTGRQ 514 (642)
Q Consensus 443 p~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~S~Gvll~elltG~~ 514 (642)
+.|+++|....+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766431 11111112234579999998763 14778999999999999999999
Q ss_pred CCCCCCCcccc-hhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhccC
Q 006514 515 NNRSKNSEYTD-SLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 515 p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 593 (642)
||......... .++..+.. .....+.+.+... .+....++.++..||..+|++||++++|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99875543332 22222111 1111122222110 01122567788899999999999999999887663
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=166.60 Aligned_cols=136 Identities=17% Similarity=0.257 Sum_probs=106.2
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-----CccceeeeeeeeccCC---C-ceE
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-----EHKNLVRLLGCSCSGP---E-SLL 386 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~l 386 (642)
...+.||+|+||.||. +++....+||+.........+.+.+|+.++.++ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 443333479988665445567899999999999 5799999999998864 2 237
Q ss_pred EEee--cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeccCCCCEEEcC----CCcEEEEec
Q 006514 387 VYEF--LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL-VYLHEQSKIRIIHRDIKASNILLDS----RLRAKIADF 459 (642)
Q Consensus 387 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~Df 459 (642)
|+|| .++|+|.+++.+ ..+++. ..++.+++.++ .|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 558999999943 235554 35677888777 9999998 999999999999974 348999995
Q ss_pred CCc
Q 006514 460 GLA 462 (642)
Q Consensus 460 Gla 462 (642)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=189.79 Aligned_cols=185 Identities=28% Similarity=0.306 Sum_probs=153.9
Q ss_pred ccccCceEEEEEE----cCCCcEEEEEEeeccChhh--HHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEeecCC
Q 006514 321 LGQGGFGTVYKGV----LPDGREIAVKRLFFNNRHR--AANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 321 LG~G~fg~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+|+|.||.|+... .+.|+-+|+|++....... ......|..++...+ ||.++++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999998765 2357778888875432111 114556888888886 99999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473 (642)
Q Consensus 394 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 473 (642)
|.|...+ .+...++..........++-+++++|+.+ ++|||+|++||+++.+|++++.|||+.+..-.....
T Consensus 82 g~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9998777 33455666667777888999999999998 999999999999999999999999998865443332
Q ss_pred ccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 006514 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (642)
Q Consensus 474 ~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~ 518 (642)
+||..|||||++. .....+|-||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999998 567889999999999999999999865
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=170.69 Aligned_cols=199 Identities=20% Similarity=0.282 Sum_probs=132.6
Q ss_pred ccccccccccCceEEEEEEcC-CCcEEEEEEeeccC---hhhHHHHHHHHHHHhcCCc----------cceeeeeeee--
Q 006514 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIISSVEH----------KNLVRLLGCS-- 378 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~-- 378 (642)
+...+.||.|+++.||.+++. +|+++|||+..... ....+++++|......+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455678999999999999976 58999999885432 3456778888766666432 1222212211
Q ss_pred -------ccCC--------CceEEEeecCCCChhhhhhc---ccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 006514 379 -------CSGP--------ESLLVYEFLPNQSLDRFIFD---SAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHR 439 (642)
Q Consensus 379 -------~~~~--------~~~lv~e~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~ 439 (642)
.... ..+++|+-+ .++|.+++.- ... ...+....++.+..|+++.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1111 235677766 5688777632 111 123445667788899999999999999 9999
Q ss_pred ccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCccccChhhhccC--------CCCCcchHHHHHHHHHHHHh
Q 006514 440 DIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG--------QLTEKADVYSFGMLLLEIVT 511 (642)
Q Consensus 440 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~sDv~S~Gvll~ellt 511 (642)
||+|+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999877654432211 2345789999977542 47889999999999999999
Q ss_pred CCCCCCCCCC
Q 006514 512 GRQNNRSKNS 521 (642)
Q Consensus 512 G~~p~~~~~~ 521 (642)
|+.||.....
T Consensus 246 ~~lPf~~~~~ 255 (288)
T PF14531_consen 246 GRLPFGLSSP 255 (288)
T ss_dssp SS-STCCCGG
T ss_pred ccCCCCCCCc
Confidence 9999976543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=180.81 Aligned_cols=123 Identities=28% Similarity=0.487 Sum_probs=110.9
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
..+|.|+++...+|.++|.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999877777788999999999999999999 66 999999999999999999999999999
Q ss_pred cccCCCC-----CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh
Q 006514 463 RSFQEDK-----SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (642)
Q Consensus 463 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 511 (642)
....... ....+...||..||+||++.+..|+.|+||||||+||+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8776655 223356789999999999999999999999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=162.21 Aligned_cols=144 Identities=18% Similarity=0.194 Sum_probs=111.6
Q ss_pred CccccccccccCceEEEEEE--cCCCcEEEEEEeeccChh------------------------hHHHHHHHHHHHhcCC
Q 006514 314 SFDEANKLGQGGFGTVYKGV--LPDGREIAVKRLFFNNRH------------------------RAANFYNEVNIISSVE 367 (642)
Q Consensus 314 ~~~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 367 (642)
-|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 568999999988643210 1123568999999997
Q ss_pred ccc--eeeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCC
Q 006514 368 HKN--LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASN 445 (642)
Q Consensus 368 H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~N 445 (642)
+.. +.++++. ...++||||+++++|..... ....+.......++.+++.+|.+||+++ +++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 533 3344442 24589999999988876542 2234566667889999999999999886 49999999999
Q ss_pred EEEcCCCcEEEEecCCccccCC
Q 006514 446 ILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 446 ILl~~~~~~kl~DfGla~~~~~ 467 (642)
|+++ ++.++|+|||++.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999875433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=156.46 Aligned_cols=140 Identities=21% Similarity=0.241 Sum_probs=110.1
Q ss_pred CCccccccccccCceEEEEEEcCCCcEEEEEEeeccCh----------------------hhHHHHHHHHHHHhcCCccc
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR----------------------HRAANFYNEVNIISSVEHKN 370 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~n 370 (642)
..|...+.||+|+||.||++..++|+.||||++..... .....+.+|+.++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34777889999999999999988899999998654320 01123667899999998774
Q ss_pred --eeeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE
Q 006514 371 --LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 371 --iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl 448 (642)
+.+.++ ....++||||+++++|.++... .....++.+++.++.++|+.+ ++||||||+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 444443 2455899999999998765420 234578899999999999988 9999999999999
Q ss_pred cCCCcEEEEecCCccccCCC
Q 006514 449 DSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 449 ~~~~~~kl~DfGla~~~~~~ 468 (642)
++++.++|+|||++......
T Consensus 159 ~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cCCCcEEEEECCccccCCCc
Confidence 99999999999999765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=159.03 Aligned_cols=134 Identities=22% Similarity=0.272 Sum_probs=112.7
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccC--------hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
+.||+|++|.||+|.+ .|..+++|+..... ......+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 67889999764321 11224578899999999999988777777777888999999
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988431 12 78899999999999999998 99999999999999 78999999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=185.22 Aligned_cols=194 Identities=21% Similarity=0.240 Sum_probs=156.1
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC---ccceeeeeeeeccCCCceEEE
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 388 (642)
...|.+.+.||+|+||+||+|...+|+.||+|+-....... |.=-.+++.+|+ -+.|+.+...+.-.+..+||+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 35688889999999999999998889999999765443221 222233444444 234555556666677889999
Q ss_pred eecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEc-------CCCcEEEEecCC
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-------SRLRAKIADFGL 461 (642)
Q Consensus 389 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~-------~~~~~kl~DfGl 461 (642)
||.+.|+|.+++. ..+.++|.....++.+++.-+.+||..+ |||+||||+|.||. ++.-++|+|||.
T Consensus 774 ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 9999999999994 6678999999999999999999999998 99999999999994 234699999999
Q ss_pred ccccCCCCC-cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCC
Q 006514 462 ARSFQEDKS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514 (642)
Q Consensus 462 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~ 514 (642)
+..+..-.. ......++|-.+--+|...+..++...|-|.+.-+++-||-|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 876543222 23345678889999999999999999999999999999999964
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=154.52 Aligned_cols=130 Identities=21% Similarity=0.321 Sum_probs=106.2
Q ss_pred cccccCceEEEEEEcCCCcEEEEEEeeccC--------hhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.||+|+||.||+|.+ +|..+++|+..... ......+.+|++++..++|+++.....+.......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999864321 112356788999999999887665555555667789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873311 0 78999999999999998 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=178.87 Aligned_cols=138 Identities=20% Similarity=0.268 Sum_probs=112.2
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeecc--------ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCC
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--------NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 383 (642)
...|...+.||+|+||.||+|.+.+. .+++|+.... .....+.+.+|++++.+++|++++....+......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987544 4444433211 11223568899999999999999888777777778
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998873 35678999999999999998 9999999999999 67799999999987
Q ss_pred cc
Q 006514 464 SF 465 (642)
Q Consensus 464 ~~ 465 (642)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-16 Score=154.89 Aligned_cols=196 Identities=25% Similarity=0.322 Sum_probs=132.3
Q ss_pred CccceeeeeeeeccC---------------------------CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHH
Q 006514 367 EHKNLVRLLGCSCSG---------------------------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419 (642)
Q Consensus 367 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 419 (642)
+|||||++.+.|.+. ...|+||... ..+|.+++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence 599999998876432 2346777766 3478888743 4566677777999
Q ss_pred HHHHHHHHHHhCCCCCeEEeccCCCCEEE--cCCC--cEEEEecCCccccCCCCC-----cccccccCCccccChhhhcc
Q 006514 420 GTVEGLVYLHEQSKIRIIHRDIKASNILL--DSRL--RAKIADFGLARSFQEDKS-----HISTAIAGTLGYMAPEYLAH 490 (642)
Q Consensus 420 ~ia~~l~~LH~~~~~~iiH~Dlkp~NILl--~~~~--~~kl~DfGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~ 490 (642)
|+++|+.|||.++ |.|||+|++|||| |+|+ .+.|+|||.+-......- ......-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999998 4444 578999998764333111 11223457788999999864
Q ss_pred C--C----CCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHH
Q 006514 491 G--Q----LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLR 564 (642)
Q Consensus 491 ~--~----~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 564 (642)
. + --.|+|.|+.|.+.||+++...||....+- .+.. ..+.+..+..+- +.....
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~---r~Yqe~qLPalp-----------~~vpp~--- 485 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDT---RTYQESQLPALP-----------SRVPPV--- 485 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eech---hhhhhhhCCCCc-----------ccCChH---
Confidence 3 2 245899999999999999999998763211 1111 112222222111 111222
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 565 AIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 565 ~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
+-+++...++.||++||+..-....|
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHH
Confidence 23456678899999999876555444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-16 Score=172.29 Aligned_cols=167 Identities=23% Similarity=0.380 Sum_probs=119.5
Q ss_pred cCCccccccccccCceEEEEEEcC-CCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEee
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 390 (642)
..+|+.++.|..|++|.||..+++ ..+.+|+| +.+++ .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 467889999999999999999876 35677874 32111 01110 22222233222
Q ss_pred cCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 470 (642)
|+=...+. ..+.++.. ++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+.+.......
T Consensus 136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 23223331 11233322 278899999998 99999999999999999999999999875321111
Q ss_pred c--------------ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 006514 471 H--------------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521 (642)
Q Consensus 471 ~--------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~ 521 (642)
. ....++||+.|.|||++....|...+|.|++|+|+||.+-|..||..+..
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 0 12346899999999999999999999999999999999999999987644
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.4e-16 Score=134.16 Aligned_cols=89 Identities=35% Similarity=0.665 Sum_probs=70.4
Q ss_pred CchhHHHHHHHHHHHHHHhCCCC--CCceeEeeeecCCCCcceEEEecccccccccchHHHHHHHHHhhhccCC-CCCCe
Q 006514 144 KNSSFQESARKAVMRAVASAPSN--GGYARVQVQVSGAANKSAYVLVNCWKTLNSSSCEACLANASASILGCLP-WSEGR 220 (642)
Q Consensus 144 ~~~~f~~~~~~l~~~l~~~a~~~--~~~~~~~~~~~~~~~~~vy~l~QC~~dls~~~C~~Cl~~~~~~~~~c~~-~~~g~ 220 (642)
+++.|...+..+|..|...++.. .+|+++.. +.+..++|||+||++||++.+|..||+.++..++.||+ ..+|+
T Consensus 15 ~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~---~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~ 91 (106)
T PF01657_consen 15 DNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA---GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGR 91 (106)
T ss_dssp TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE-----ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEE
T ss_pred CCchHHHHHHHHHHHHHHHHhhccccCcEEeec---CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEE
Confidence 34569999999999999887653 57877763 44678999999999999999999999999999999776 78999
Q ss_pred eeccccccccCCCcc
Q 006514 221 ALNTGCFMRYSDKDF 235 (642)
Q Consensus 221 ~~~~~C~lRy~~~~f 235 (642)
++..+|++||+.++|
T Consensus 92 v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 92 VWYDSCFLRYENYPF 106 (106)
T ss_dssp EEESSEEEEEESS--
T ss_pred EECCCEEEEEECCCC
Confidence 999999999999887
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=144.10 Aligned_cols=138 Identities=20% Similarity=0.269 Sum_probs=97.3
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChh--hHHHH----------------------HHHHHHHhcCCccc--e
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANF----------------------YNEVNIISSVEHKN--L 371 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--i 371 (642)
.+.||+|+||.||++...+|+.||||++...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643211 11111 24555555554332 3
Q ss_pred eeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeccCCCCEEEcC
Q 006514 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDS 450 (642)
Q Consensus 372 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiH~Dlkp~NILl~~ 450 (642)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 333332 246899999999654322111000 11 5678899999999999999 77 99999999999999
Q ss_pred CCcEEEEecCCccccCC
Q 006514 451 RLRAKIADFGLARSFQE 467 (642)
Q Consensus 451 ~~~~kl~DfGla~~~~~ 467 (642)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.7e-15 Score=135.27 Aligned_cols=135 Identities=24% Similarity=0.242 Sum_probs=113.9
Q ss_pred ccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCc--cceeeeeeeeccCCCceEEEeecCCC
Q 006514 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999854 7899998754433 4678899999999976 58889998888888899999999888
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
.+..+ +......++.+++++|.+||......++|+|++|+||+++..+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5566778899999999999986545599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=142.60 Aligned_cols=136 Identities=18% Similarity=0.238 Sum_probs=104.3
Q ss_pred ccccc-ccCceEEEEEEcCCCcEEEEEEeeccC-------------hhhHHHHHHHHHHHhcCCccce--eeeeeeeccC
Q 006514 318 ANKLG-QGGFGTVYKGVLPDGREIAVKRLFFNN-------------RHRAANFYNEVNIISSVEHKNL--VRLLGCSCSG 381 (642)
Q Consensus 318 ~~~LG-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 381 (642)
...|| .|+.|+||+.... +..++||++.... ......+.+|+.++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34687 8999999998874 7789999874311 1223467889999999998875 6677664432
Q ss_pred CC----ceEEEeecCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 382 PE----SLLVYEFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 382 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
.. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688888732 234443 3568999999999999 999999999999999999999
Q ss_pred EecCCcccc
Q 006514 457 ADFGLARSF 465 (642)
Q Consensus 457 ~DfGla~~~ 465 (642)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.3e-15 Score=166.65 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=183.1
Q ss_pred CCccccccccccCceEEEEEEcCC--CcEEEEEEeeccC--hhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEE
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD--GREIAVKRLFFNN--RHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 387 (642)
..|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999998877543 3445666554332 223334445777777776 99999999999999999999
Q ss_pred EeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEeccCCCCEEEcCCC-cEEEEecCCcccc
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH-EQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSF 465 (642)
Q Consensus 388 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 465 (642)
.+|..++++.+.+.. ......+....-..+.|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999887731 11114455556678899999999999 777 99999999999999999 9999999999987
Q ss_pred CC-CCCc-ccccccC-CccccChhhhccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcch
Q 006514 466 QE-DKSH-ISTAIAG-TLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 466 ~~-~~~~-~~~~~~g-t~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
.. .... .....+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.......... .. |....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~-----~~~~~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SS-----WKSNK-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-ee-----ecccc--
Confidence 76 3332 3345678 9999999998874 45678899999999999999999987655433210 00 11100
Q ss_pred hhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
....... ...... ...++...++..+|..|.+.+++-..
T Consensus 248 ~~~~~~~------~~~~~~---~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 GRFTQLP------WNSISD---QAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cccccCc------cccCCh---hhhhcccccccCCchhcccccccccc
Confidence 0000000 011111 22334456777899999999888653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-13 Score=146.95 Aligned_cols=142 Identities=20% Similarity=0.219 Sum_probs=100.0
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChhhH----------------------------------------HHHH
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA----------------------------------------ANFY 357 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 357 (642)
.+.||.|++|+||+|++++|+.||||+......... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999854321110 0244
Q ss_pred HHHHHHhcC----Cccceeeeeeeec-cCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 006514 358 NEVNIISSV----EHKNLVRLLGCSC-SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE-GLVYLHEQ 431 (642)
Q Consensus 358 ~E~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~ 431 (642)
+|+..+.++ +|.+-+.+-.++. .....+|||||++|++|.++..... ...+ +..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhC
Confidence 555555555 2322223222222 2456799999999999988764211 1122 3456666665 46788988
Q ss_pred CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCC
Q 006514 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 432 ~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
+ ++|+|+||.||+++.+++++++|||++.....
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 99999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.9e-13 Score=131.22 Aligned_cols=203 Identities=21% Similarity=0.286 Sum_probs=138.4
Q ss_pred HHhcCCccceeeeeeeecc-----CCCceEEEeecCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006514 362 IISSVEHKNLVRLLGCSCS-----GPESLLVYEFLPNQSLDRFIFDSAK-AKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435 (642)
Q Consensus 362 ~l~~l~H~niv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 435 (642)
-|-++.|.|||+++.|+.+ .....++.|||..|++..+|++-.+ ...+......+|.-||..||.|||+. .++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 3445679999999988754 3456899999999999999975332 45677778889999999999999997 478
Q ss_pred eEEeccCCCCEEEcCCCcEEEEecCCccccCCCC----CcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh
Q 006514 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDK----SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (642)
Q Consensus 436 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 511 (642)
|+|+++.-+-|++..++-+||.---- ....... ........+-++|.+||+=...+.+..+|||+||+-.+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888842211 1111000 001112346789999998777778889999999999999988
Q ss_pred CCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006514 512 GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590 (642)
Q Consensus 512 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 590 (642)
|............. +..+...+ +...+ ... ..++..|++..|..||+|++++.|.
T Consensus 278 lEiq~tnseS~~~~-----------ee~ia~~i---~~len----~lq------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEV-----------EENIANVI---IGLEN----GLQ------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeeh-----------hhhhhhhe---eeccC----ccc------cCcCcccccCCCCCCcchhhhhcCc
Confidence 86543222111100 00001000 00000 000 1233469999999999999998663
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.5e-12 Score=136.14 Aligned_cols=144 Identities=20% Similarity=0.231 Sum_probs=91.6
Q ss_pred CCccccccccccCceEEEEEEcCC-CcEEEEEEeeccChhh----------------------------------HH---
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHR----------------------------------AA--- 354 (642)
Q Consensus 313 ~~~~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 354 (642)
..|+. +.||+|++|+||++++++ |++||||++....... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999887 9999999986432110 11
Q ss_pred ---HHHHHHHHHhcCC----ccceeeeeeeecc-CCCceEEEeecCCCChhhhhhccccc---CCCCHHHHHHHHHHHHH
Q 006514 355 ---NFYNEVNIISSVE----HKNLVRLLGCSCS-GPESLLVYEFLPNQSLDRFIFDSAKA---KTLTWEKRYEIILGTVE 423 (642)
Q Consensus 355 ---~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 423 (642)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.++-.-...+ ..+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 1333443333332 3333333333332 45678999999999998743111111 11222222222333
Q ss_pred HHHHHHhCCCCCeEEeccCCCCEEEcCCC----cEEEEecCCccccCC
Q 006514 424 GLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADFGLARSFQE 467 (642)
Q Consensus 424 ~l~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~~~ 467 (642)
++..+ ++|+|+||.||+++.++ .+++.|||++.....
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34566 99999999999999988 999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.6e-12 Score=136.26 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=177.1
Q ss_pred Cccccccccc--cCceEEEEEEc---CCCcEEEEEEee--ccChhhHHHHHHHHHHHhcC-CccceeeeeeeeccCCCce
Q 006514 314 SFDEANKLGQ--GGFGTVYKGVL---PDGREIAVKRLF--FNNRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 314 ~~~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 385 (642)
.|.....+|. |.+|.||.+.. .++..+|+|+-. .........=.+|+....++ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555677999 99999999986 368889999743 22223333345677777777 4999999888888899999
Q ss_pred EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecC
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE----GLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFG 460 (642)
Q Consensus 386 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfG 460 (642)
+-+|++ +.+|..+.+. ....++....+....+... ||.++|+.. ++|-|+||.||+...+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 999988 4777777643 3344667777777777777 999999998 9999999999999999 899999999
Q ss_pred CccccCCCCCc----ccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCcccchhHHHHHHhhh
Q 006514 461 LARSFQEDKSH----ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536 (642)
Q Consensus 461 la~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 536 (642)
+...+...... ......|...|++||... +.++.++|||++|.++.|..+|-.......-. .|....
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccccc
Confidence 99887765522 122336788899999875 56788999999999999999987654332111 121111
Q ss_pred cCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006514 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 537 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 589 (642)
...+. .+.......++-.+..++++.+|..|++.+.+..+
T Consensus 340 ~~~ip-------------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 340 QGYIP-------------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccCc-------------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11110 00000111122225567899999999998887653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=116.00 Aligned_cols=130 Identities=19% Similarity=0.142 Sum_probs=96.4
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCcccee-eeeeeeccCCCceEEEeecCCCCh
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g~L 396 (642)
.+.|+.|.++.||++... ++.+++|....... ....+.+|+.++..+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999875 78899998744321 223467899999988665544 444443 3346899999999887
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS--KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.+.. . ....+..+++++|..||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5420 0 11245678999999999886 23369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-10 Score=109.62 Aligned_cols=137 Identities=15% Similarity=0.133 Sum_probs=98.7
Q ss_pred ccccccCceEEEEEEcCC-------CcEEEEEEeeccC-----h-----------------hhHHHHH----HHHHHHhc
Q 006514 319 NKLGQGGFGTVYKGVLPD-------GREIAVKRLFFNN-----R-----------------HRAANFY----NEVNIISS 365 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-----~-----------------~~~~~~~----~E~~~l~~ 365 (642)
..||.|.-+.||.|...+ +..+|||...... . ...+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998643 4799999764211 0 0111222 78999988
Q ss_pred CCc--cceeeeeeeeccCCCceEEEeecCCCChhh-hhhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecc
Q 006514 366 VEH--KNLVRLLGCSCSGPESLLVYEFLPNQSLDR-FIFDSAKAKTLTWEKRYEIILGTVEGLVYL-HEQSKIRIIHRDI 441 (642)
Q Consensus 366 l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiH~Dl 441 (642)
+.. -++.+++++ ...+|||||+.+..+.. .+ +...++.++...+..+++.+|..| |+.+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 345556654 56789999997654422 22 122344556677889999999999 7887 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccCC
Q 006514 442 KASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 442 kp~NILl~~~~~~kl~DfGla~~~~~ 467 (642)
++.|||++ ++.+.|+|||.+....+
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46799999999876654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-10 Score=123.23 Aligned_cols=166 Identities=16% Similarity=0.222 Sum_probs=125.1
Q ss_pred cCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHH
Q 006514 334 LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK 413 (642)
Q Consensus 334 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 413 (642)
..++.+|.|...............+-++.|+.++||||++++......+..|||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34788999988866655445567788999999999999999999999999999999863 45555532 22444
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCccccChhhhccCCC
Q 006514 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493 (642)
Q Consensus 414 ~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 493 (642)
..-.+.||+.||.|||+.+ .++|++|....|+|++.|+-||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 5567789999999999776 599999999999999999999999988754332221 011111223467777554322
Q ss_pred CCcchHHHHHHHHHHHHhC
Q 006514 494 TEKADVYSFGMLLLEIVTG 512 (642)
Q Consensus 494 s~~sDv~S~Gvll~elltG 512 (642)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 345999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.6e-10 Score=109.45 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=108.8
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccCh-hhHHHHHHHHHHHhcCCc--cceeeeeeeeccCC---CceEEEeecC
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR-HRAANFYNEVNIISSVEH--KNLVRLLGCSCSGP---ESLLVYEFLP 392 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~~ 392 (642)
+.|+.|..+.||++...+|+.+++|....... .....+.+|+.+++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998754322 134568899999999975 34566777665532 5689999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS---------------------------------------- 432 (642)
Q Consensus 393 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------- 432 (642)
+.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775521 35677778888888888888888521
Q ss_pred -------------CCCeEEeccCCCCEEEcC--CCcEEEEecCCcc
Q 006514 433 -------------KIRIIHRDIKASNILLDS--RLRAKIADFGLAR 463 (642)
Q Consensus 433 -------------~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~ 463 (642)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245899999999999998 6678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-09 Score=98.03 Aligned_cols=143 Identities=22% Similarity=0.263 Sum_probs=105.5
Q ss_pred ccccccccCceEEEEEEcCCCcEEEEEEeecc--------ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEE
Q 006514 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--------NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 388 (642)
....|-+|+-+.|+++.+ .|+...||.-... .+-..+..++|+.++.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999998 4788777754221 1223346788999999886555544444566677778999
Q ss_pred eecCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC---cEEEEecCCccc
Q 006514 389 EFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIADFGLARS 464 (642)
Q Consensus 389 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~ 464 (642)
||+++ .++.+++......... .+....++..|-+.+.-||..+ +||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4788888654332222 2333677888889999999998 99999999999997665 468999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=98.59 Aligned_cols=130 Identities=21% Similarity=0.287 Sum_probs=99.0
Q ss_pred cccccCceEEEEEEcCCCcEEEEEEeecc--------ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeec
Q 006514 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFN--------NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+++|+-+.+|.+.+. |.++++|.-... .+-..+.-.+|+.++.+++--.|.-..-+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5889999999999774 445666643221 1122345678999999886555554455566777889999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
++-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||.+..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888432 2456677777788899999 99999999999998775 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-10 Score=123.75 Aligned_cols=196 Identities=21% Similarity=0.228 Sum_probs=148.2
Q ss_pred HHcCCccccccccccCceEEEEEEc--CCCcEEEEEEeeccChhhHHH--HHHHHHHHhcC-CccceeeeeeeeccCCCc
Q 006514 310 KATGSFDEANKLGQGGFGTVYKGVL--PDGREIAVKRLFFNNRHRAAN--FYNEVNIISSV-EHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 310 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 384 (642)
..+.+|..+..||.|.|+.|++... .++..+++|.+...-.....+ -..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456789999999999999999774 367889999875443222222 23466666666 588888888777777788
Q ss_pred eEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC-CcEEEEecCCcc
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLAR 463 (642)
Q Consensus 385 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~ 463 (642)
++-.||++++++...+ .-...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887655 23456778889999999999999999988 9999999999999886 889999999987
Q ss_pred ccCCCCCcccccccCCcccc--ChhhhccCCCCCcchHHHHHHHHHHHHhCCCC
Q 006514 464 SFQEDKSHISTAIAGTLGYM--APEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p 515 (642)
.+.-... ......+++ +|+......+-.+.|++|||.-+.|.++|..-
T Consensus 416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccceecc----cccccccccccchhhccccccccccccccccccccccccCccc
Confidence 5222111 112233444 44455556788899999999999999998754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.8e-09 Score=108.49 Aligned_cols=170 Identities=23% Similarity=0.350 Sum_probs=130.4
Q ss_pred CceEEEEEEc-CCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccceeeeeeeecc----CCCceEEEeecCC-CChhh
Q 006514 325 GFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPESLLVYEFLPN-QSLDR 398 (642)
Q Consensus 325 ~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 398 (642)
-..+.||++. .||..+++|++.............-++.++++.|+|+|++..++.. +..+++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457799984 4899999999944333332233455788999999999999998873 3457899999987 56766
Q ss_pred hhhcc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 399 FIFDS------------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 399 ~l~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
+-+.. ..+...+++.+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 55431 12345778999999999999999999999 8889999999999999999999999887766
Q ss_pred CCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCC
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN 515 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p 515 (642)
.+... -+.. -.+-|.=-||.+++.|.||...
T Consensus 445 ~d~~~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE---------------PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc---------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 55411 0111 2356888999999999999765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=96.31 Aligned_cols=127 Identities=26% Similarity=0.357 Sum_probs=82.6
Q ss_pred EEEEEEcCCCcEEEEEEeeccC--------------h------------hhHHHHHHHHHHHhcCCcc--ceeeeeeeec
Q 006514 328 TVYKGVLPDGREIAVKRLFFNN--------------R------------HRAANFYNEVNIISSVEHK--NLVRLLGCSC 379 (642)
Q Consensus 328 ~Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 379 (642)
.||.|..++|..+|||...... + .......+|...|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999764321 0 0112356799999999755 455666542
Q ss_pred cCCCceEEEeecC--CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEeccCCCCEEEcCCCcEEE
Q 006514 380 SGPESLLVYEFLP--NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY-LHEQSKIRIIHRDIKASNILLDSRLRAKI 456 (642)
Q Consensus 380 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 456 (642)
...|||||++ +..+..+... .++.+....++.+++..+.. +|..+ ++|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 5689999998 5555443311 11133445667777775555 47887 9999999999999988 9999
Q ss_pred EecCCccccCC
Q 006514 457 ADFGLARSFQE 467 (642)
Q Consensus 457 ~DfGla~~~~~ 467 (642)
+|||.+....+
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.5e-10 Score=124.62 Aligned_cols=205 Identities=22% Similarity=0.264 Sum_probs=144.5
Q ss_pred HcCCccccccccccCceEEEEEEcC-CCcEEEEEEeecc---ChhhHHHHHHHHHHHhcCCccceeeeeeeeccCCCceE
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 386 (642)
..+.+++.+-+.+|.++.++...-. .|...++|..... .....+....+-.++-...||-+++..--+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777778889999999877632 3433344433211 11112222233333333445666655544556778899
Q ss_pred EEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccC
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 466 (642)
+++|..+++|...|+.. ...+.+.....+..+..+++|||... +.|+|++|.|+|...++..++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999888543 34555556667778889999999876 8999999999999999999999998432211
Q ss_pred C---------------------CCC---------cccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 006514 467 E---------------------DKS---------HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNN 516 (642)
Q Consensus 467 ~---------------------~~~---------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~ 516 (642)
. ... .......||+.|.+||...+......+|.|++|+.++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 000 0122357899999999999999999999999999999999999998
Q ss_pred CCCCC
Q 006514 517 RSKNS 521 (642)
Q Consensus 517 ~~~~~ 521 (642)
.....
T Consensus 1036 na~tp 1040 (1205)
T KOG0606|consen 1036 NAETP 1040 (1205)
T ss_pred CCcch
Confidence 76554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.7e-08 Score=98.73 Aligned_cols=134 Identities=17% Similarity=0.097 Sum_probs=96.7
Q ss_pred ceEEEEEEcCCCcEEEEEEeeccChh-hHH----------HHHHHHHHHhcCCccce--eeeeeeecc-----CCCceEE
Q 006514 326 FGTVYKGVLPDGREIAVKRLFFNNRH-RAA----------NFYNEVNIISSVEHKNL--VRLLGCSCS-----GPESLLV 387 (642)
Q Consensus 326 fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~----------~~~~E~~~l~~l~H~ni--v~l~~~~~~-----~~~~~lv 387 (642)
...|.+..+ +|+.+.||+....... ..+ .+.+|...+.++...+| ++++++... ....+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334667666 6789999977433211 111 37789998888854443 344445432 2346899
Q ss_pred EeecCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC-------CCcEEEEec
Q 006514 388 YEFLPNQ-SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-------RLRAKIADF 459 (642)
Q Consensus 388 ~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl~Df 459 (642)
+|++++. +|.+++.+.. ....+...+..++.+++..+.-||+.+ |+|+|++++|||++. +..+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999886 8888874321 234556777889999999999999999 999999999999975 468999999
Q ss_pred CCccc
Q 006514 460 GLARS 464 (642)
Q Consensus 460 Gla~~ 464 (642)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.2e-07 Score=92.60 Aligned_cols=195 Identities=13% Similarity=0.169 Sum_probs=128.6
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-Cccceeeeee------eeccCCC-ceEE
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLG------CSCSGPE-SLLV 387 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~------~~~~~~~-~~lv 387 (642)
...+.||+|+.+.+|-.-- -...+.|+..........+ .+..|... .||-+-.=+. +.-+... .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4567899999999996432 1122446664433322221 22333333 5654322111 1112222 4567
Q ss_pred EeecCCCC-hhhhhh---cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 388 YEFLPNQS-LDRFIF---DSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 388 ~e~~~~g~-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
|..+++.- ...+.. .+..-...+|.-.++.+..++.+.+-||+.| .+-+|+.++|+||.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776542 222221 1223356789999999999999999999999 8999999999999999999999876554
Q ss_pred ccCCCCCcccccccCCccccChhhhc-----cCCCCCcchHHHHHHHHHHHHhC-CCCCCCCC
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTG-RQNNRSKN 520 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG-~~p~~~~~ 520 (642)
....+. ...-.+|...|.+||.-. +-.-+...|-|.+||++++++.| ++|+....
T Consensus 166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 432222 223357889999999765 33457789999999999999886 88987643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-07 Score=92.57 Aligned_cols=137 Identities=21% Similarity=0.262 Sum_probs=93.9
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccCh----------------------hhHHHHHHHHHHHhcCCcc--ce
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNR----------------------HRAANFYNEVNIISSVEHK--NL 371 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~--ni 371 (642)
.+.++||-|.-+.||.|..++|.++|||.-..... .......+|.+.|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 44578999999999999999999999994321100 0112356799999988654 55
Q ss_pred eeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC
Q 006514 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (642)
Q Consensus 372 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~ 451 (642)
.+.+++ +...+||||+++-.|...- ++.+..-.++..|++-+..+-..| +||+|+++-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 555553 4457999999886664432 112222233334444444444556 9999999999999999
Q ss_pred CcEEEEecCCccccCC
Q 006514 452 LRAKIADFGLARSFQE 467 (642)
Q Consensus 452 ~~~kl~DfGla~~~~~ 467 (642)
|.+.++||-.+.....
T Consensus 239 g~~~vIDwPQ~v~~~h 254 (304)
T COG0478 239 GDIVVIDWPQAVPISH 254 (304)
T ss_pred CCEEEEeCcccccCCC
Confidence 9999999977654433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2e-07 Score=101.11 Aligned_cols=141 Identities=18% Similarity=0.230 Sum_probs=92.7
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccChhhHH----------------------------------------HHHH
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----------------------------------------NFYN 358 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~----------------------------------------~~~~ 358 (642)
+.|+.++-|+||+|++++|++||||+...+-....+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999988644211110 1234
Q ss_pred HHHHHhcCC-----ccceeeeeeeec-cCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 006514 359 EVNIISSVE-----HKNLVRLLGCSC-SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG-LVYLHEQ 431 (642)
Q Consensus 359 E~~~l~~l~-----H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~~ 431 (642)
|..-+.++. .+++ ++=.++. -.....|+|||++|-.+.+..... ...++.+.. +..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~i---a~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKEL---AELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHH---HHHHHHHHHHHHHhc
Confidence 444444442 2332 2222333 356778999999999988875322 234443332 2222222 1222235
Q ss_pred CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 432 ~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
+ +.|.|.+|.||+++.++++.+.|||+.......
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 5 999999999999999999999999998776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.9e-07 Score=84.19 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=102.3
Q ss_pred ccccCceEEEEEEcCCCcEEEEEEeeccC------hhhHHHHHHHHHHHhcCCccc--eeeeeeeec--cC--CCceEEE
Q 006514 321 LGQGGFGTVYKGVLPDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKN--LVRLLGCSC--SG--PESLLVY 388 (642)
Q Consensus 321 LG~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~--~~--~~~~lv~ 388 (642)
-|+||.+.|++-.. +|+.+-+|+-...- +.....|.+|+..+.+|..-+ +.++..... .+ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 47789999999776 45679999774211 335567999999999985332 444442211 11 1247999
Q ss_pred eecCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCc--EEEEecCCccc
Q 006514 389 EFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLR--AKIADFGLARS 464 (642)
Q Consensus 389 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~ 464 (642)
|-+++ .+|.+++.+. .....+...+..++.+++..+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 5888887432 2235677788899999999999999999 999999999999986666 99999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.3e-07 Score=86.82 Aligned_cols=124 Identities=23% Similarity=0.251 Sum_probs=90.0
Q ss_pred CCcEEEEEEeeccC-------hhhHHHHHHHHHHHhcCCccc--eeeeeeeeccCC----CceEEEeecCCC-Chhhhhh
Q 006514 336 DGREIAVKRLFFNN-------RHRAANFYNEVNIISSVEHKN--LVRLLGCSCSGP----ESLLVYEFLPNQ-SLDRFIF 401 (642)
Q Consensus 336 ~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~ 401 (642)
.++.+.+|.+...- ........+|...+..+.... ..+.+++..... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45666666543211 122345778888888775433 345555554422 347999999884 7988884
Q ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCC---cEEEEecCCcccc
Q 006514 402 DSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL---RAKIADFGLARSF 465 (642)
Q Consensus 402 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 465 (642)
.. ..++......++.+++..+.-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 111 ~~---~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QW---EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hh---cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 32 22666778889999999999999999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.2e-08 Score=104.67 Aligned_cols=151 Identities=21% Similarity=0.433 Sum_probs=98.4
Q ss_pred HHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCc--------ccccccCCccccChhhhcc
Q 006514 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--------ISTAIAGTLGYMAPEYLAH 490 (642)
Q Consensus 419 ~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 490 (642)
.+++.|+.|+|..- ++||++|.|++|.++.++..||+.|+.+......... ...-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999865 6999999999999999999999999988754432111 1111234567999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCC-CCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHH
Q 006514 491 GQLTEKADVYSFGMLLLEIVTGRQN-NRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVG 569 (642)
Q Consensus 491 ~~~s~~sDv~S~Gvll~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~ 569 (642)
...+.++|+||+|+++|-+..|..+ +........ ..... ...+.... .. ......+..+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~-------~~~~~~~~--~~-s~~~p~el~~~l--- 245 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSR-------NLLNAGAF--GY-SNNLPSELRESL--- 245 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhh-------cccccccc--cc-cccCcHHHHHHH---
Confidence 8889999999999999999955444 322211111 00000 00011000 00 123334444333
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 006514 570 LLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 570 ~~Cl~~~P~~RPs~~evl~~ 589 (642)
.+.+..++.-||++.++...
T Consensus 246 ~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHhcCCcccCcchhhhhcc
Confidence 35778999999988887643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=84.22 Aligned_cols=158 Identities=23% Similarity=0.219 Sum_probs=96.8
Q ss_pred cChhhHHHHcCCccccc---cccccCceEEEEEEcCCCcEEEEEEeeccChhhHH---------HH-------HHHHHHH
Q 006514 303 FKYSTLEKATGSFDEAN---KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA---------NF-------YNEVNII 363 (642)
Q Consensus 303 ~~~~~~~~~~~~~~~~~---~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~---------~~-------~~E~~~l 363 (642)
.+...+.....+..+.. .|+.|.-+.||+|...++..+|||+.........+ .| ...+..+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555555544443 46788899999999888999999988543211111 11 1112222
Q ss_pred hcCCccceeeeeeeeccC------CCceEEEeecCCCCh-hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCC
Q 006514 364 SSVEHKNLVRLLGCSCSG------PESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIR 435 (642)
Q Consensus 364 ~~l~H~niv~l~~~~~~~------~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ 435 (642)
.+-.-.|+-++......- ....|||||+....+ .-.| +.-.+..++...+..++++.+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~--- 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG--- 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC---
Confidence 222223333333332221 234799999965411 1111 11223333566777888888888876 45
Q ss_pred eEEeccCCCCEEEcCCCcEEEEecCCccccCCC
Q 006514 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 436 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 468 (642)
+||+||+.-|||+. ++.+.|+|+|.+....++
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 99999999999999 889999999998766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.3e-06 Score=82.84 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=83.6
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccc--eeeeeeeeccCCCceEEEeecCCCC-
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGCSCSGPESLLVYEFLPNQS- 395 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 395 (642)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567788765422 3345688999998886433 3566777766777789999998863
Q ss_pred hhhhhh--------------------cccccCCCCHHHHHHHH-H----------HHHH-HHHHHHh-CCCCCeEEeccC
Q 006514 396 LDRFIF--------------------DSAKAKTLTWEKRYEII-L----------GTVE-GLVYLHE-QSKIRIIHRDIK 442 (642)
Q Consensus 396 L~~~l~--------------------~~~~~~~l~~~~~~~i~-~----------~ia~-~l~~LH~-~~~~~iiH~Dlk 442 (642)
+.+.+. +..............-. . .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 00000111111111000 0 0001 1122221 123457899999
Q ss_pred CCCEEEcCCCcEEEEecCCcc
Q 006514 443 ASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 443 p~NILl~~~~~~kl~DfGla~ 463 (642)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.1e-06 Score=91.58 Aligned_cols=166 Identities=17% Similarity=0.238 Sum_probs=102.2
Q ss_pred hhhcCCCCCcChhhHHHH------------cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhH--------
Q 006514 294 KTLNDDSLNFKYSTLEKA------------TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA-------- 353 (642)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~-------- 353 (642)
..+.+....++++++... -..|+ .+.||.-+.|.||++++++|+.||||+.+..-+...
T Consensus 131 ~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~ 209 (538)
T KOG1235|consen 131 SELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLR 209 (538)
T ss_pred HHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHH
Confidence 344556566666654332 22233 357999999999999999999999998754321110
Q ss_pred -----------------------------HHHHHHHHHHhcC----Cccce---eeeeeeecc-CCCceEEEeecCCCCh
Q 006514 354 -----------------------------ANFYNEVNIISSV----EHKNL---VRLLGCSCS-GPESLLVYEFLPNQSL 396 (642)
Q Consensus 354 -----------------------------~~~~~E~~~l~~l----~H~ni---v~l~~~~~~-~~~~~lv~e~~~~g~L 396 (642)
-+|.+|++-..++ .|-++ |.+=.++.+ .....|+||||+|..+
T Consensus 210 ~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i 289 (538)
T KOG1235|consen 210 LLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKI 289 (538)
T ss_pred HHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccC
Confidence 0234454433333 34441 112223332 3567899999999988
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEeccCCCCEEEcC----CCcEEEEecCCccccCCC
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVY-LHEQSKIRIIHRDIKASNILLDS----RLRAKIADFGLARSFQED 468 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DfGla~~~~~~ 468 (642)
.+.-. .+...++...... .+.++... +-..| ++|.|-+|.||+++. ++.+.+-|||+.......
T Consensus 290 ~Dl~~--i~~~gi~~~~i~~---~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 290 NDLDA--IDKRGISPHDILN---KLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCHHH--HHHcCCCHHHHHH---HHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 77642 2334455444333 33332222 12335 999999999999984 678999999998866543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=76.44 Aligned_cols=137 Identities=16% Similarity=0.172 Sum_probs=89.8
Q ss_pred cCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHH---------HHHHHHHhcCC---ccceeeeeeee-
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANF---------YNEVNIISSVE---HKNLVRLLGCS- 378 (642)
Q Consensus 312 ~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~~~~- 378 (642)
.++|...+.+-......|.+-.. +|+.+++|.........++.| .+++..+.+++ --.+..++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46777777777777777777666 578999998755433333322 22333333332 22222222221
Q ss_pred ----ccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcE
Q 006514 379 ----CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 379 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 454 (642)
.-....+|+|||++|..|.++. .++. .+...+.+++.-||+.| +.|+|..|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1224457999999998887654 1222 24566778899999999 99999999999999665 9
Q ss_pred EEEecCCccc
Q 006514 455 KIADFGLARS 464 (642)
Q Consensus 455 kl~DfGla~~ 464 (642)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.2e-07 Score=99.29 Aligned_cols=199 Identities=17% Similarity=0.129 Sum_probs=140.7
Q ss_pred cChhhHHHHcCCccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccc-eeeeeeeeccC
Q 006514 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSG 381 (642)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~ 381 (642)
|.-..++..+..+...+.++++..++++|.+-.-.+...++.+... .+..-++++|.+++||| .++.++-+..+
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE 306 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence 3334455556667777789999999999987433344445555322 34456899999999999 67777777777
Q ss_pred CCceEEEeecCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecC
Q 006514 382 PESLLVYEFLPNQ-SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 382 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 460 (642)
+..++++++...+ +-..... .....+..-+...+...-.+++++||+.. =+|+| |||..+ +..|..||+
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred cccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence 7889999999776 2211110 11122333334455566678999999874 48888 777766 578999999
Q ss_pred CccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518 (642)
Q Consensus 461 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~p~~~ 518 (642)
....+.... ......+++.|+|||....+.+..+.|+|+.|+--.+|--|-+|-..
T Consensus 377 v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 377 VPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 887665443 23456799999999999999999999999999877777777666443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-05 Score=79.57 Aligned_cols=143 Identities=22% Similarity=0.209 Sum_probs=83.3
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCcc--ceeeeeeeecc---CCCceEEEeecC
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK--NLVRLLGCSCS---GPESLLVYEFLP 392 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~---~~~~~lv~e~~~ 392 (642)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999876 69999986443 4556777888888888533 24556653322 223589999999
Q ss_pred CCChhh----------------hhh---cc-cccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 006514 393 NQSLDR----------------FIF---DS-AKAKTLTWEK---------RYEI------------ILGTVE-GLVYLHE 430 (642)
Q Consensus 393 ~g~L~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~l~~LH~ 430 (642)
+..+.. .+. .. .....+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 110 01 0111111111 0000 111222 3333332
Q ss_pred ----CCCCCeEEeccCCCCEEEc-CCCcEEEEecCCcc
Q 006514 431 ----QSKIRIIHRDIKASNILLD-SRLRAKIADFGLAR 463 (642)
Q Consensus 431 ----~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~ 463 (642)
.....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=76.37 Aligned_cols=105 Identities=21% Similarity=0.193 Sum_probs=83.8
Q ss_pred HHHHHHHhcCCc-cceeeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006514 357 YNEVNIISSVEH-KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435 (642)
Q Consensus 357 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 435 (642)
.+|.-+++.+++ +++++++|.| ..++|.||.+.+++...-.....--..+|+.|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999998 34789999988766432100012235789999999999999999999865555
Q ss_pred eEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 436 IIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 436 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
+.-.|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.5e-05 Score=76.77 Aligned_cols=139 Identities=13% Similarity=0.106 Sum_probs=83.6
Q ss_pred ccccCc-eEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC-ccceeeeeeeeccCCCceEEEeecCCCChhh
Q 006514 321 LGQGGF-GTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398 (642)
Q Consensus 321 LG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 398 (642)
|-.|.+ ..||+...+ +..+.||+..... .....+|+.++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 788998764 4788888774332 335667888888873 4345567777766667899999999987764
Q ss_pred hhh-------------------cccc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 006514 399 FIF-------------------DSAK-AKTLT--WEKRYEIIL--------------------GTVEGLVYLHE----QS 432 (642)
Q Consensus 399 ~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~l~~LH~----~~ 432 (642)
... .... ..... ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 0000 00111 001110000 01111222211 12
Q ss_pred CCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 433 KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 433 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3559999999999999998778999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00011 Score=86.10 Aligned_cols=147 Identities=13% Similarity=0.235 Sum_probs=91.0
Q ss_pred cccccccCceEEEEEEcCCC---cEEEEEEeeccC-hhhHHHHHHHHHHHhcCC-ccce--eeeeeeeccC---CCceEE
Q 006514 318 ANKLGQGGFGTVYKGVLPDG---REIAVKRLFFNN-RHRAANFYNEVNIISSVE-HKNL--VRLLGCSCSG---PESLLV 387 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv 387 (642)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876544 467777764322 123356889999999995 6665 6777777654 356899
Q ss_pred EeecCCCChhhh--------------------h---hcccc--------cCCCCH--HHHHHHH---------------H
Q 006514 388 YEFLPNQSLDRF--------------------I---FDSAK--------AKTLTW--EKRYEII---------------L 419 (642)
Q Consensus 388 ~e~~~~g~L~~~--------------------l---~~~~~--------~~~l~~--~~~~~i~---------------~ 419 (642)
|||+++..+.+. | +.... .....+ .+...|. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 0 11000 001111 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEEeccCCCCEEEcCC-Cc-EEEEecCCccc
Q 006514 420 GTVEGLVYLHEQSK--------IRIIHRDIKASNILLDSR-LR-AKIADFGLARS 464 (642)
Q Consensus 420 ~ia~~l~~LH~~~~--------~~iiH~Dlkp~NILl~~~-~~-~kl~DfGla~~ 464 (642)
.+.+.+.+|..+-. +.++|+|+++.||+++.+ .. +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23344566744321 349999999999999853 33 57999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00015 Score=69.11 Aligned_cols=129 Identities=23% Similarity=0.343 Sum_probs=89.7
Q ss_pred ccccccccCceEEEEEEcCCCcEEEEEEeeccC----------------hhhHHHHHHHHHHHhcCC------ccceeee
Q 006514 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN----------------RHRAANFYNEVNIISSVE------HKNLVRL 374 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 374 (642)
....||+|+.-.||. +++.....||+..... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999996 4556677888875544 122355666776666555 7889999
Q ss_pred eeeeccCCCceEEEeecCC--C----ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEE
Q 006514 375 LGCSCSGPESLLVYEFLPN--Q----SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 375 ~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl 448 (642)
+|+..+.....+|+|.+.+ | +|.+++ ....++. .....+. +-..||-+.. |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998754 3 466666 3344555 3333333 3445666666 9999999999999
Q ss_pred cCCC----cEEEEe
Q 006514 449 DSRL----RAKIAD 458 (642)
Q Consensus 449 ~~~~----~~kl~D 458 (642)
.... .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00018 Score=68.05 Aligned_cols=125 Identities=29% Similarity=0.436 Sum_probs=90.3
Q ss_pred CCccccccccccCc-eEEEEEEcCCCcEEEEEEeec---cC---------h---------hhHHHHHHHHHHHhcCC---
Q 006514 313 GSFDEANKLGQGGF-GTVYKGVLPDGREIAVKRLFF---NN---------R---------HRAANFYNEVNIISSVE--- 367 (642)
Q Consensus 313 ~~~~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~l~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 367 (642)
.+++..+.||.|.- |.||+..+ +|+.+|+|.... .. . .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67899999999999 99999999 578999998321 10 0 12235788999888885
Q ss_pred ccce--eeeeeeeccC------------------CCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHH
Q 006514 368 HKNL--VRLLGCSCSG------------------PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427 (642)
Q Consensus 368 H~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 427 (642)
+.++ |+.+|+..-. ....||.||++... .+ ...-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4566 8999986322 12347777775533 11 22335567778889
Q ss_pred HHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCc
Q 006514 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 428 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 462 (642)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999986 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=71.30 Aligned_cols=73 Identities=18% Similarity=0.284 Sum_probs=45.3
Q ss_pred ccccccCce-EEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCcc---ceeeeeeeeccC---CCceEEEeec
Q 006514 319 NKLGQGGFG-TVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHK---NLVRLLGCSCSG---PESLLVYEFL 391 (642)
Q Consensus 319 ~~LG~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~---~~~~lv~e~~ 391 (642)
+.|+.|+.. .||+. +..+++|.... ......+.+|++++..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 48975 24567775432 22345788899999887532 233444433322 2347899999
Q ss_pred CCCChh
Q 006514 392 PNQSLD 397 (642)
Q Consensus 392 ~~g~L~ 397 (642)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00045 Score=70.83 Aligned_cols=79 Identities=10% Similarity=0.047 Sum_probs=56.3
Q ss_pred ccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCc---cceeeeeeeecc---CCCceEEE
Q 006514 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH---KNLVRLLGCSCS---GPESLLVY 388 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~---~~~~~lv~ 388 (642)
....+.||+|..+.||+....++ .+.+|.... ......+..|...++.+.- -.+.++++++.. .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456799999999999876555 466676422 1123478899999988842 356778877654 35689999
Q ss_pred eecCCCCh
Q 006514 389 EFLPNQSL 396 (642)
Q Consensus 389 e~~~~g~L 396 (642)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0002 Score=65.53 Aligned_cols=129 Identities=19% Similarity=0.256 Sum_probs=86.8
Q ss_pred cccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCcccee-eeeeeeccCCCceEEEeecCCC
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 316 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g 394 (642)
...+.|++|++|.||+|.+. |.++|+|+-..++ ....+..|+++|..++-.++- +++.+. +.++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34567999999999999985 5689999775443 345688899999888755543 344433 334559999888
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccC-CCCEEEcCCCcEEEEecCCccc
Q 006514 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK-ASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 395 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DfGla~~ 464 (642)
.|.+.-... +- +-+..+++.---|...| |-|+.|. |..++|..+..+.|+||..|+.
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887754211 22 22344555544555666 8888886 4444444444899999998874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00019 Score=72.03 Aligned_cols=138 Identities=14% Similarity=0.141 Sum_probs=78.5
Q ss_pred cccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccce-eeeeeeeccCCCceEEEeecCCCChhh
Q 006514 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPNQSLDR 398 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~ 398 (642)
.+..|-...+|+... +++.+++|..........-+..+|..+++.+....+ .+++... ..++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456788889999874 577888887543322211235678888888854333 3344332 2479999999876642
Q ss_pred h-------h----------hccc-ccCCCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCCeEEeccCCCC
Q 006514 399 F-------I----------FDSA-KAKTLTWEKR-YEIILGT---------VEGLVYLHEQ-----SKIRIIHRDIKASN 445 (642)
Q Consensus 399 ~-------l----------~~~~-~~~~l~~~~~-~~i~~~i---------a~~l~~LH~~-----~~~~iiH~Dlkp~N 445 (642)
. + +... ....++.... .....++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 1110 0111222211 1111111 1112222111 13458999999999
Q ss_pred EEEcCCCcEEEEecCCcc
Q 006514 446 ILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 446 ILl~~~~~~kl~DfGla~ 463 (642)
|++++++ +.|+||+.+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00036 Score=80.30 Aligned_cols=198 Identities=19% Similarity=0.193 Sum_probs=135.3
Q ss_pred HHHHHHHHhcCCccceeeeeeeeccCCCce----EEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 006514 356 FYNEVNIISSVEHKNLVRLLGCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431 (642)
Q Consensus 356 ~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 431 (642)
..-|++.+.+..|+|++.++.+..+....- +..|++..-++...+ .....++....+.+..++.+|+.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344677788889999999998876654332 345777777777776 3446788889999999999999999998
Q ss_pred CCCCeEEeccCCC---CEEEcCCCcEEEE--ecCCccccCCCCCcccccccCCccccChhhhccCCCC--CcchHHHHHH
Q 006514 432 SKIRIIHRDIKAS---NILLDSRLRAKIA--DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT--EKADVYSFGM 504 (642)
Q Consensus 432 ~~~~iiH~Dlkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~sDv~S~Gv 504 (642)
. ..|.-+..+ +...+.++...++ ||+..+......... ...-+..|.+||......++ ...|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 6 666666655 5556677778877 998887665433321 22345578888877665544 4479999999
Q ss_pred HHHHHHhCCCCCCCCCCcccchhHHHHHHhhhcCcchhhccccccccccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006514 505 LLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMS 584 (642)
Q Consensus 505 ll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 584 (642)
++..+..|..+..... .+..+.+.. ... ........|+..++++|++..
T Consensus 381 l~~~~~~~~~i~~~~~------------------~~~~~l~~~----------~~~---~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------------------VPVSLLDVL----------STS---ELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHhhhhhcCccccccc------------------chhhhhccc----------cch---hhhhhhhhhcchhhhhccchh
Confidence 9999999865432110 011111110 000 122334469999999999999
Q ss_pred HHHHHhcc
Q 006514 585 RVLQMLTT 592 (642)
Q Consensus 585 evl~~L~~ 592 (642)
+++.+...
T Consensus 430 ~ll~~~f~ 437 (1351)
T KOG1035|consen 430 ELLTHPFL 437 (1351)
T ss_pred hhhhchhc
Confidence 99988644
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00044 Score=68.39 Aligned_cols=141 Identities=18% Similarity=0.215 Sum_probs=81.2
Q ss_pred cccccccCceEEEEEEcCC--CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccce-eeeeeeeccCCCceEEEeecCCC
Q 006514 318 ANKLGQGGFGTVYKGVLPD--GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g 394 (642)
.+.|..|-...+|+....+ ++.+++|....... ..-+..+|+.++..+...++ +++++... ..++|||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3467888889999998764 67888896643221 11233478888888853333 34444332 24899999987
Q ss_pred Chhhh-------h----------hccccc--------CCC-CHHHHHHHHHH----------------------HHHHHH
Q 006514 395 SLDRF-------I----------FDSAKA--------KTL-TWEKRYEIILG----------------------TVEGLV 426 (642)
Q Consensus 395 ~L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~~----------------------ia~~l~ 426 (642)
++... + +..... ... .|+....+... +.+-+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 1 010000 011 12222222111 111111
Q ss_pred HH----HhC-CCCCeEEeccCCCCEEEcC-CCcEEEEecCCcc
Q 006514 427 YL----HEQ-SKIRIIHRDIKASNILLDS-RLRAKIADFGLAR 463 (642)
Q Consensus 427 ~L----H~~-~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~ 463 (642)
.| ... ....++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 111 2345999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.002 Score=68.30 Aligned_cols=76 Identities=14% Similarity=0.194 Sum_probs=53.9
Q ss_pred cccccccCceEEEEEEcCCC-cEEEEEEeecc-----C--hhhHHHHHHHHHHHhcCC---ccceeeeeeeeccCCCceE
Q 006514 318 ANKLGQGGFGTVYKGVLPDG-REIAVKRLFFN-----N--RHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 386 (642)
.+.||.|.+..||+....+| +.|+||.-... . +...+.+..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998777 58999974311 1 224456777888888762 2456667766 3355789
Q ss_pred EEeecCCCC
Q 006514 387 VYEFLPNQS 395 (642)
Q Consensus 387 v~e~~~~g~ 395 (642)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0051 Score=63.90 Aligned_cols=142 Identities=13% Similarity=0.174 Sum_probs=75.4
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccc--eeeeee------eeccCCCceEEEe
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLG------CSCSGPESLLVYE 389 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~------~~~~~~~~~lv~e 389 (642)
.+.|+.|....+|+....+| .+++|+..... .+....|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45577788889999886555 68888764212 223334555555543211 223222 1122445689999
Q ss_pred ecCCCChhh-----------hh---hcccc--------cCCCCH-HHHHH------------HHHH-HHHHHHHHHhC--
Q 006514 390 FLPNQSLDR-----------FI---FDSAK--------AKTLTW-EKRYE------------IILG-TVEGLVYLHEQ-- 431 (642)
Q Consensus 390 ~~~~g~L~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~~~-ia~~l~~LH~~-- 431 (642)
|++|..+.. .| +.... ...+.| ..... ...+ +...+..+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 10000 011112 11111 1111 11122233211
Q ss_pred --CCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 432 --SKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 432 --~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
-+..++|+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23359999999999999977656899999764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0036 Score=64.27 Aligned_cols=143 Identities=17% Similarity=0.168 Sum_probs=84.8
Q ss_pred ccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccc--eeeeeee------eccCCCceEEE
Q 006514 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC------SCSGPESLLVY 388 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~ 388 (642)
..+.|..|....+|+.... +..+++|+... ........|+.++..+.+.+ +.+++.. ....+..++|+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3556888888899998764 45788887643 22345667788777774332 3444332 12234568999
Q ss_pred eecCCCChhh----hh----------hcccc--------cCCCCHHHHH----------HHHHHHHHHHHHHHh----CC
Q 006514 389 EFLPNQSLDR----FI----------FDSAK--------AKTLTWEKRY----------EIILGTVEGLVYLHE----QS 432 (642)
Q Consensus 389 e~~~~g~L~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~~l~~LH~----~~ 432 (642)
+|++|..+.. .. +.... .....|.... .....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877532 11 10000 0112332211 011123344555543 12
Q ss_pred CCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 433 KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 433 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
...++|+|+.|.|||++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2349999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0033 Score=63.81 Aligned_cols=76 Identities=16% Similarity=0.211 Sum_probs=47.7
Q ss_pred ccccccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC---ccceeeeeeeeccCCCceEEEeec
Q 006514 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+..+.|+.|....+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+.+++++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445679999999999987 568899999765 233345777888777773 445778888887777789999999
Q ss_pred CCC
Q 006514 392 PNQ 394 (642)
Q Consensus 392 ~~g 394 (642)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0029 Score=65.19 Aligned_cols=140 Identities=23% Similarity=0.304 Sum_probs=82.3
Q ss_pred ccccccCceEEEEEEcCC-------CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccce-eeeeeeeccCCCceEEEee
Q 006514 319 NKLGQGGFGTVYKGVLPD-------GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~ 390 (642)
+.|..|-...+|+....+ ++.+++|...... ....+..+|..++..+....+ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456677778999988655 5788899864432 223455678888887753333 34455443 2468999
Q ss_pred cCCCChhhh-h----------------hcccccC------C--CCHHHHHHH--------------------------HH
Q 006514 391 LPNQSLDRF-I----------------FDSAKAK------T--LTWEKRYEI--------------------------IL 419 (642)
Q Consensus 391 ~~~g~L~~~-l----------------~~~~~~~------~--l~~~~~~~i--------------------------~~ 419 (642)
++|..+... + +...... . .-|.....+ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1 1110000 0 011111111 11
Q ss_pred HHHHHHHHHHh------CCCCCeEEeccCCCCEEEcCC----CcEEEEecCCcc
Q 006514 420 GTVEGLVYLHE------QSKIRIIHRDIKASNILLDSR----LRAKIADFGLAR 463 (642)
Q Consensus 420 ~ia~~l~~LH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~ 463 (642)
.+..-+.+|.. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 12222334432 235569999999999999985 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0048 Score=63.72 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=80.6
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCCccc--eeeeeee------eccCCCceEEEe
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN--LVRLLGC------SCSGPESLLVYE 389 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~e 389 (642)
.+.++.|....+|+....+| .+++|+..... ..+....|++++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999876544 57788664321 1234455667666664222 3333331 112345689999
Q ss_pred ecCCCChhhh----h----------hccccc---------CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 006514 390 FLPNQSLDRF----I----------FDSAKA---------KTLTWEKRYE------------IILGTVEGLVYLHE---- 430 (642)
Q Consensus 390 ~~~~g~L~~~----l----------~~~~~~---------~~l~~~~~~~------------i~~~ia~~l~~LH~---- 430 (642)
|++|..+... . +..... ....|..... ....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654211 1 110000 0112221110 01123344555542
Q ss_pred CCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 431 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.....++|+|+++.||+++.++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223459999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0092 Score=60.49 Aligned_cols=31 Identities=26% Similarity=0.508 Sum_probs=25.6
Q ss_pred CCeEEeccCCCCEEEcCCCc-EEEEecCCccc
Q 006514 434 IRIIHRDIKASNILLDSRLR-AKIADFGLARS 464 (642)
Q Consensus 434 ~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~ 464 (642)
..++|+|++|.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0015 Score=65.53 Aligned_cols=137 Identities=16% Similarity=0.193 Sum_probs=93.0
Q ss_pred ccccccccccCceEEEEEEcCCCcEEEEEEeecc---------Ch--------hhH-----HHHHHHHHHHhcCCc-c-c
Q 006514 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN---------NR--------HRA-----ANFYNEVNIISSVEH-K-N 370 (642)
Q Consensus 315 ~~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~---------~~--------~~~-----~~~~~E~~~l~~l~H-~-n 370 (642)
+...++||-|.-+.||.+-..+|++.++|.-... ++ ..+ -...+|+..|+.|.. - -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5778999999999999999999999999932111 00 000 123468888887743 2 1
Q ss_pred eeeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC
Q 006514 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (642)
Q Consensus 371 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~ 450 (642)
+.+.++ ....++|||++.+-.|...- ...+.++++.-+. .-+.-|-.+| +||+|..--||+|++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm---~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLM---GLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeee------ecCChHHHHHHHH---HHHHHHHHcC---ceecccchheeEEec
Confidence 333333 34567999999887775532 1233344443333 3344566777 999999999999999
Q ss_pred CCcEEEEecCCccccCC
Q 006514 451 RLRAKIADFGLARSFQE 467 (642)
Q Consensus 451 ~~~~kl~DfGla~~~~~ 467 (642)
++.++++||-.....+.
T Consensus 238 d~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTSH 254 (465)
T ss_pred CCCEEEeechHhhccCC
Confidence 99999999976655444
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00031 Score=82.56 Aligned_cols=159 Identities=11% Similarity=-0.037 Sum_probs=113.4
Q ss_pred HHHHHHHhcCCccceeeeeeeec--cCCCceEEEeecCCCChhhhhhccccc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Q 006514 357 YNEVNIISSVEHKNLVRLLGCSC--SGPESLLVYEFLPNQSLDRFIFDSAKA-KTLTWEKRYEIILGTVEGLVYLHEQ-- 431 (642)
Q Consensus 357 ~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~-- 431 (642)
..|...+++..|+++.....-.. +..+.+.+++|+..|.+.+.|.++.+. ..++.......-.+......-.|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34555666678998876554433 344568999999999999998764433 3333333332223324444444433
Q ss_pred CCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCccccChhhhccCCCCCcchHHHHHHHHHHHHh
Q 006514 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511 (642)
Q Consensus 432 ~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 511 (642)
+....+|++||+-|.+|..+.++|++++|+.+...+.... .....+++.|+.|++...-.++.++|+|..|+.+|+..-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 2345799999999999999999999999999844333322 234567889999999999999999999999999999988
Q ss_pred CCCCC
Q 006514 512 GRQNN 516 (642)
Q Consensus 512 G~~p~ 516 (642)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 86654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0092 Score=62.57 Aligned_cols=141 Identities=20% Similarity=0.261 Sum_probs=81.4
Q ss_pred cccccccCceEEEEEEcCC-----CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccce-eeeeeeeccCCCceEEEeec
Q 006514 318 ANKLGQGGFGTVYKGVLPD-----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~ 391 (642)
.+.|..|-.-.+|+....+ ++.|++|......... -+-.+|..++..+...++ .++++.+..+ .|+||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3456667788999987532 3678888774433222 223578888888854443 3455655332 689999
Q ss_pred CCCChhhh-------h----------hccc-c--cCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 006514 392 PNQSLDRF-------I----------FDSA-K--AKTLTWEKRYEIILGT-----------------VEGLVYL----HE 430 (642)
Q Consensus 392 ~~g~L~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~i-----------------a~~l~~L----H~ 430 (642)
++.+|... + |... . .....|.+..++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 0 1100 0 0112233333333221 1112222 21
Q ss_pred -CCCCCeEEeccCCCCEEEcC-CCcEEEEecCCcc
Q 006514 431 -QSKIRIIHRDIKASNILLDS-RLRAKIADFGLAR 463 (642)
Q Consensus 431 -~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~ 463 (642)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22346999999999999986 4689999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.023 Score=58.15 Aligned_cols=140 Identities=15% Similarity=0.176 Sum_probs=83.3
Q ss_pred ccccccccCceEEEEEEcCCCcEEEEEEee-ccChhhHHHHHHHHHHHhcCCc--cceeeeeeeeccCC--CceEEEeec
Q 006514 317 EANKLGQGGFGTVYKGVLPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGP--ESLLVYEFL 391 (642)
Q Consensus 317 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lv~e~~ 391 (642)
..+.+..|..-.+|..... ++++++.+-. ...........+|+.+++.+.- --..+.+++|.++. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3444544544555555543 7778887221 2233445566788888887742 22344566666555 568999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHH-HHHHHHHHHHH-----------------------------------------
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEII-LGTVEGLVYLH----------------------------------------- 429 (642)
Q Consensus 392 ~~g~L~~~l~~~~~~~~l~~~~~~~i~-~~ia~~l~~LH----------------------------------------- 429 (642)
++..+.+.+... ... ...+ ..+++.|.-||
T Consensus 108 eGe~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 885433222110 000 0111 23333333333
Q ss_pred ---------hC-----CCCCeEEeccCCCCEEEcCCCcEEEEecCCcccc
Q 006514 430 ---------EQ-----SKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 430 ---------~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 465 (642)
.+ +.+.++|+|+++.||+++.+.-+-|.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22 2456999999999999999988999999998753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.007 Score=61.85 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=91.9
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeecc-----Chh--------------------hHHH-HHHHHHHHhcCCccce
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFN-----NRH--------------------RAAN-FYNEVNIISSVEHKNL 371 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~-----~~~--------------------~~~~-~~~E~~~l~~l~H~ni 371 (642)
...|..|.-+.||.++-.+|..+|||++..+ ++. ..+- ...|+.-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4468899999999999999999999976321 111 0010 1234444555433222
Q ss_pred eeeeeeeccCCCceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCC
Q 006514 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR 451 (642)
Q Consensus 372 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~ 451 (642)
.-.--.. -....|||+|+.... +-....+...++...+..+-.+++.-|.-|-+.+ ++||.||.--|+|+-+
T Consensus 229 P~PePIl--Lk~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 229 PCPEPIL--LKNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCcee--eecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence 1100000 012369999995322 1111224456777788888899999998888777 6999999999999864
Q ss_pred CcEEEEecCCccccCC
Q 006514 452 LRAKIADFGLARSFQE 467 (642)
Q Consensus 452 ~~~kl~DfGla~~~~~ 467 (642)
|.+.|+|-+.+....+
T Consensus 301 G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDH 316 (520)
T ss_pred CEEEEEEccccccCCC
Confidence 5899999987765444
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.038 Score=58.47 Aligned_cols=73 Identities=14% Similarity=0.198 Sum_probs=49.2
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeecc-----C--hhhHHHHHHHHHHHhcCC---ccceeeeeeeeccCCCceEE
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFN-----N--RHRAANFYNEVNIISSVE---HKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv 387 (642)
.+.||.|....||+.... ++.++||+-... . +.....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567999999999998874 567999976411 1 112333344566665553 346777887766 557889
Q ss_pred EeecCC
Q 006514 388 YEFLPN 393 (642)
Q Consensus 388 ~e~~~~ 393 (642)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.03 Score=58.17 Aligned_cols=73 Identities=16% Similarity=0.154 Sum_probs=47.5
Q ss_pred cccccCceEEEEEEcCCC-cEEEEEEeec-------cChhhHHHHHHHHHHHhcCC--cc-ceeeeeeeeccCCCceEEE
Q 006514 320 KLGQGGFGTVYKGVLPDG-REIAVKRLFF-------NNRHRAANFYNEVNIISSVE--HK-NLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~g-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lv~ 388 (642)
.||.|...-||++..++| +.|+||.-.. ..+...+...-|.+.|.... -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999998755 6899996421 11333344556777776653 24 3444443 3455667999
Q ss_pred eecCCC
Q 006514 389 EFLPNQ 394 (642)
Q Consensus 389 e~~~~g 394 (642)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.1 Score=50.20 Aligned_cols=137 Identities=19% Similarity=0.258 Sum_probs=85.8
Q ss_pred cccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC---CccceeeeeeeeccCCCceEEEeecCCC
Q 006514 318 ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV---EHKNLVRLLGCSCSGPESLLVYEFLPNQ 394 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~g 394 (642)
.+++..|.--..|+..+ +..++-||+- ......-|..|+.-|..| +--++.+++.+..+....++|+||++-|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 44566666566666554 5678888854 344456677787766666 3456778888888999999999999987
Q ss_pred Chhhh-----------hhccc---------------ccCCC----CH-----HHHHHHHHHHH--------------HHH
Q 006514 395 SLDRF-----------IFDSA---------------KAKTL----TW-----EKRYEIILGTV--------------EGL 425 (642)
Q Consensus 395 ~L~~~-----------l~~~~---------------~~~~l----~~-----~~~~~i~~~ia--------------~~l 425 (642)
.++.. |+... ...+- +| ++|+.+..+++ ..+
T Consensus 97 ~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v 176 (286)
T COG3001 97 PLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKI 176 (286)
T ss_pred CCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHH
Confidence 77611 11100 00111 22 23333333333 233
Q ss_pred HHHHhC--CCCCeEEeccCCCCEEEcCCCcEEEEec
Q 006514 426 VYLHEQ--SKIRIIHRDIKASNILLDSRLRAKIADF 459 (642)
Q Consensus 426 ~~LH~~--~~~~iiH~Dlkp~NILl~~~~~~kl~Df 459 (642)
.-+-.+ .++.++|+||-..|.....+| +.|.|-
T Consensus 177 ~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP 211 (286)
T COG3001 177 QELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDP 211 (286)
T ss_pred HHHHhcCCCCcceeecccccccccccCCC-Ceeecc
Confidence 333222 247799999999999999998 777664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.062 Score=56.04 Aligned_cols=140 Identities=15% Similarity=0.280 Sum_probs=78.3
Q ss_pred ccccccCceEEEEEEcCC----CcEEEEEEeeccChhhHHHHHHHHHHHhcCCccce-eeeeeeeccCCCceEEEeecCC
Q 006514 319 NKLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~ 393 (642)
+.|..|-...+|+....+ +..|++|....... ..-+-.+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 345557778889887543 23788887644322 22233578888888865444 3455555322 58999977
Q ss_pred CChhh-------hh----------hccc-c-cC-CCCHHHHHHHHHHH----------------------HHHHHH---H
Q 006514 394 QSLDR-------FI----------FDSA-K-AK-TLTWEKRYEIILGT----------------------VEGLVY---L 428 (642)
Q Consensus 394 g~L~~-------~l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~l~~---L 428 (642)
..|.. .+ |... . .. ..-|....++..++ .+-+.. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 11 1100 0 01 11233333332221 111111 1
Q ss_pred H-h-CCCCCeEEeccCCCCEEEcC-CCcEEEEecCCcc
Q 006514 429 H-E-QSKIRIIHRDIKASNILLDS-RLRAKIADFGLAR 463 (642)
Q Consensus 429 H-~-~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~ 463 (642)
. . ..+..+.|.|+.+.|||+++ ++.++++||..|-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 1 12345899999999999975 5789999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.044 Score=57.66 Aligned_cols=74 Identities=14% Similarity=0.112 Sum_probs=49.0
Q ss_pred cccccccCceEEEEEEcCC-CcEEEEEEeec------cChhhHHHHHHHHHHHhcCC--cc-ceeeeeeeeccCCCceEE
Q 006514 318 ANKLGQGGFGTVYKGVLPD-GREIAVKRLFF------NNRHRAANFYNEVNIISSVE--HK-NLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 318 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lv 387 (642)
.+.||.|.-.-||++.+++ ++.|+||.-.. ..+...++..-|.+.|+.+. -| .+.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4579999999999999753 57899996421 11334455666777777663 34 34445543 45566788
Q ss_pred EeecCC
Q 006514 388 YEFLPN 393 (642)
Q Consensus 388 ~e~~~~ 393 (642)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.12 Score=53.33 Aligned_cols=32 Identities=19% Similarity=0.287 Sum_probs=27.9
Q ss_pred CCCeEEeccCCCCEEEcCCCcEEEEecCCccc
Q 006514 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 433 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 464 (642)
...++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.054 Score=56.31 Aligned_cols=62 Identities=19% Similarity=0.209 Sum_probs=43.6
Q ss_pred CceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcC
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450 (642)
Q Consensus 383 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~ 450 (642)
...|+=+|+++-++..++. ....+++...+++.-.++|+.-+---. .++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~----~~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVK----WKSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhh----cccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3457778888888888883 334555566677776677765544322 2999999999999953
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.05 Score=52.75 Aligned_cols=30 Identities=30% Similarity=0.514 Sum_probs=21.2
Q ss_pred CCeEEeccCCCCEEE-cCCCcEEEEecCCcc
Q 006514 434 IRIIHRDIKASNILL-DSRLRAKIADFGLAR 463 (642)
Q Consensus 434 ~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~ 463 (642)
..+.|.|+.|.|||+ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.13 Score=52.95 Aligned_cols=29 Identities=28% Similarity=0.367 Sum_probs=25.0
Q ss_pred CCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 434 IRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 434 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.21 Score=51.71 Aligned_cols=140 Identities=22% Similarity=0.303 Sum_probs=80.5
Q ss_pred cccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcCC---ccc---eeeeee----eeccCCCceEEEe
Q 006514 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE---HKN---LVRLLG----CSCSGPESLLVYE 389 (642)
Q Consensus 320 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~n---iv~l~~----~~~~~~~~~lv~e 389 (642)
.|.+ .-..+|+....+|+. ++|..... ....+...|...+..|. .+= +..+-| ....+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789988877766 88876544 34455666777777663 111 222222 1112236678999
Q ss_pred ecCCCChhh-hh--------------hc---------ccccCCCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 006514 390 FLPNQSLDR-FI--------------FD---------SAKAKTLTWEK-------------RYEIILGTVEGLVYLHEQS 432 (642)
Q Consensus 390 ~~~~g~L~~-~l--------------~~---------~~~~~~l~~~~-------------~~~i~~~ia~~l~~LH~~~ 432 (642)
|++|..+.. .. +. ........|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 11 00 00111234431 0112233344444444321
Q ss_pred ----C---CCeEEeccCCCCEEEcCCCc-EEEEecCCcc
Q 006514 433 ----K---IRIIHRDIKASNILLDSRLR-AKIADFGLAR 463 (642)
Q Consensus 433 ----~---~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~ 463 (642)
. ..+||+|+.|.|||++.+.. +.+.|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 22899999999999999885 8999999764
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.025 Score=40.09 Aligned_cols=44 Identities=25% Similarity=0.380 Sum_probs=30.9
Q ss_pred CCCCCCCCCCCccccccccccCCCCCCCCCCCCC--CCCccCccccccccCC
Q 006514 593 EEQLPGPTSPPFIDERTMELHDNCYDPCCPMNSG--AHASVANMSNSSLYPR 642 (642)
Q Consensus 593 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~r 642 (642)
...||.|++|.|+..+...-.+++ ++.. ...|+|++|+|.+++|
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sS------ss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSS------SSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCC------cccccCCCCCeeeEEEEeEecC
Confidence 457999999999987653322221 1111 3569999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.084 Score=54.19 Aligned_cols=101 Identities=18% Similarity=0.210 Sum_probs=67.9
Q ss_pred ceEEEeecCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCcc
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 463 (642)
.+++|++- ++++. ..+...|++.+.++.+.+.-+.-+..+- ++-|||+.-.||||+ +|++-|+||-+++
T Consensus 301 ~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 301 LYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence 35566654 44442 2245678999999999888877777654 699999999999999 9999999999998
Q ss_pred ccCCCCCcccccccCCccccChhhhccCCCCCcchHHHH
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~ 502 (642)
.-.....- .....--|-.+. |.-+..=|||-+
T Consensus 370 l~~~q~~i------sy~rldhp~lF~-G~dd~QFeIYrl 401 (488)
T COG5072 370 LSYSQGII------SYNRLDHPDLFN-GVDDYQFEIYRL 401 (488)
T ss_pred cccCCcee------eccccCchhhhc-CccceeeeHHHH
Confidence 53322211 111233344444 334666677753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.18 Score=48.28 Aligned_cols=152 Identities=18% Similarity=0.198 Sum_probs=93.0
Q ss_pred CceEEEEEEcCCCcEEEEEEeeccChh-hHHHHHHHHHHHhcCCccceeeeeeeeccCCCceEEEeecCCCChhhhhhcc
Q 006514 325 GFGTVYKGVLPDGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDS 403 (642)
Q Consensus 325 ~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 403 (642)
+..+.-+++-+-| +..+|++....-. ....|.++..++++++ .|++|..- +.-.+-+|.|++..-..
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 3344444443322 3455666433322 4566788999999885 57777732 44456688998733111
Q ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeccCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccCCcccc
Q 006514 404 AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483 (642)
Q Consensus 404 ~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 483 (642)
. -..++..=+++|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+.-.. .+..|.
T Consensus 142 -----~----~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~v 198 (308)
T PF07387_consen 142 -----N----FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMV 198 (308)
T ss_pred -----c----hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEE
Confidence 0 0112222246778888542 3699999999999999999999999875321 111222
Q ss_pred ChhhhccCCCCCcchHHHHHHHHHHHHhCCC
Q 006514 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQ 514 (642)
Q Consensus 484 aPE~~~~~~~s~~sDv~S~Gvll~elltG~~ 514 (642)
--| ....|.++.+-+|=.-+++++...+
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 211 2234777888888888888877543
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.42 Score=57.54 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=76.5
Q ss_pred ccccccCceEEEEEEcCCCcEEEEEEeeccChhhHHHHHHHHHHHhcC-------Cccceeeeee-----eecc-CC--C
Q 006514 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-------EHKNLVRLLG-----CSCS-GP--E 383 (642)
Q Consensus 319 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-------~H~niv~l~~-----~~~~-~~--~ 383 (642)
+.|+ |..-.+|+....+|+.+++|+....... .....|...+..| .-|.+++..+ .... .. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 3457789988778889999988644222 2223344444433 2344443221 1111 12 3
Q ss_pred ceEEEeecCCCChhhhh-------h----------c-------ccccCCCCHHH-----------------HHHHHHHHH
Q 006514 384 SLLVYEFLPNQSLDRFI-------F----------D-------SAKAKTLTWEK-----------------RYEIILGTV 422 (642)
Q Consensus 384 ~~lv~e~~~~g~L~~~l-------~----------~-------~~~~~~l~~~~-----------------~~~i~~~ia 422 (642)
.+.+++|++|..+.+.. . . ......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999997775411 0 0 00012233321 112222333
Q ss_pred HHHH-----HHHhCCCCCeEEeccCCCCEEEcCCC--cEE-EEecCCccc
Q 006514 423 EGLV-----YLHEQSKIRIIHRDIKASNILLDSRL--RAK-IADFGLARS 464 (642)
Q Consensus 423 ~~l~-----~LH~~~~~~iiH~Dlkp~NILl~~~~--~~k-l~DfGla~~ 464 (642)
+... .+. .-+..+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 121 1133499999999999999875 555 999997753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 642 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 411 bits (1060), Expect = e-140
Identities = 121/296 (40%), Positives = 173/296 (58%), Gaps = 11/296 (3%)
Query: 303 FKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA-ANFYNEVN 361
F L+ A+ +F N LG+GGFG VYKG L DG +AVKRL F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 362 IISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILG 420
+IS H+NL+RL G + E LLVY ++ N S+ + + +++ L W KR I LG
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL YLH+ +IIHRD+KA+NILLD A + DFGLA+ +H++TA+ GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN---NRSKNSEYTDSLLTITWKHFQA 537
G++APEYL+ G+ +EK DV+ +G++LLE++TG++ R N + LL +
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV-MLLDWVKGLLKE 258
Query: 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593
++E L D +L NY D EV + I V LLCTQ +P RP MS V++ML +
Sbjct: 259 KKLEALVDVDLQ-GNYKDE----EVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-128
Identities = 106/300 (35%), Positives = 156/300 (52%), Gaps = 25/300 (8%)
Query: 303 FKYSTLEKATGSFDE------ANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAAN- 355
F + L+ T +FDE NK+G+GGFG VYKG + + +AVK+L
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 356 ---FYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
F E+ +++ +H+NLV LLG S G + LVY ++PN SL + L+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-QEDKSH 471
R +I G G+ +LHE IHRDIK++NILLD AKI+DFGLAR+ + ++
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT 531
+++ I GT YMAPE L G++T K+D+YSFG++LLEI+TG LL I
Sbjct: 191 MTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIK 247
Query: 532 WKHFQ-AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ +E+ DK +++ V V C E + RP + +V Q+L
Sbjct: 248 EEIEDEEKTIEDYIDKK--MNDAD----STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-119
Identities = 107/318 (33%), Positives = 164/318 (51%), Gaps = 10/318 (3%)
Query: 281 RKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREI 340
+ NDA + +S LE+AT +FD +G G FG VYKGVL DG ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 341 AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI 400
A+KR + F E+ +S H +LV L+G E +L+Y+++ N +L R +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 401 FDSAKAKT-LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
+ S ++WE+R EI +G GL YLH ++ IIHRD+K+ NILLD KI DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 460 GLARSF-QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRS 518
G+++ + D++H+ST + GTLGY+ PEY G+LTEK+DVYSFG++L E++ R
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 519 KNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPS 578
+L + G++E++ D NL + + + C +
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRPE----SLRKFGDTAVKCLALSSE 298
Query: 579 LRPTMSRVLQMLTTEEQL 596
RP+M VL L +L
Sbjct: 299 DRPSMGDVLWKLEYALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 2e-87
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 24/318 (7%)
Query: 297 NDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANF 356
+ ++ L + +G FG V+K +AVK ++ +
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ-SWQN 65
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGP----ESLLVYEFLPNQSLDRFIFDSAKAKTLTWE 412
EV + ++H+N+++ +G G + L+ F SL F+ KA ++W
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWN 121
Query: 413 KRYEIILGTVEGLVYLHE-------QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465
+ I GL YLHE K I HRDIK+ N+LL + L A IADFGLA F
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 466 QEDKSHI-STAIAGTLGYMAPEYLAHG-----QLTEKADVYSFGMLLLEIVTGRQNNRSK 519
+ KS + GT YMAPE L + D+Y+ G++L E+ +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 520 NSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAI-HVGLLCTQENPS 578
EY +H ++E+ D K+ + + C +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 579 LRPTMSRVLQMLTTEEQL 596
R + V + +T ++L
Sbjct: 302 ARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-69
Identities = 74/337 (21%), Positives = 123/337 (36%), Gaps = 44/337 (13%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEV 360
+ S + +G+G +G VYKG L D R +AVK F NR NF NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEK 56
Query: 361 NI--ISSVEHKNLVRLLGCSCSGPES-----LLVYEFLPNQSLDRFIFDSAKAKTLTWEK 413
NI + +EH N+ R + LLV E+ PN SL +++ T W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112
Query: 414 RYEIILGTVEGLVYLHE------QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-- 465
+ GL YLH K I HRD+ + N+L+ + I+DFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 466 -----QEDKSHISTAIAGTLGYMAPEYL-------AHGQLTEKADVYSFGMLLLEIVTGR 513
++ + + + GT+ YMAPE L ++ D+Y+ G++ EI R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-R 231
Query: 514 QNNRSKNSEYTDSLLTITWKHFQAGRVEELYD----KNLMLHNYHDSNVKYEVLRAIHVG 569
+ + + + E++ + +R++
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL-KE 290
Query: 570 LL--CTQENPSLRPTMSRVLQMLTT-EEQLPGPTSPP 603
+ C ++ R T + + S
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-64
Identities = 84/340 (24%), Positives = 141/340 (41%), Gaps = 46/340 (13%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL 334
+ + + ++ D ++ + L K+G G FGTV++
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-------IKEKIGAGSFGTVHRAEW 58
Query: 335 PDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392
G ++AVK L + H R F EV I+ + H N+V +G P +V E+L
Sbjct: 59 -HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117
Query: 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
SL R + S + L +R + +G+ YLH I+HR++K+ N+L+D +
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKY 176
Query: 453 RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
K+ DFGL+R + S + AGT +MAPE L EK+DVYSFG++L E+ T
Sbjct: 177 TVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 513 RQNNRSKNSEYTDSLLTITWKHFQAGRV-EELYDKNLMLHNYHDSNVKYEVLRAIHVGLL 571
+ W + +V + K L E+ R ++ +
Sbjct: 236 Q----------------QPWGNLNPAQVVAAVGFKCKRL----------EIPRNLNPQVA 269
Query: 572 -----CTQENPSLRPTMSRVLQMLTT--EEQLPGPTSPPF 604
C P RP+ + ++ +L + +P P
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-63
Identities = 77/309 (24%), Positives = 124/309 (40%), Gaps = 43/309 (13%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+ +G+G FG V K +++A+K++ + +A F E+ +S V H N+V+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKL 66
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G C P L V E+ SL + + T L +G+ YLH
Sbjct: 67 YGA-CLNPVCL-VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 435 RIIHRDIKASNILLDSRLR-AKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRD+K N+LL + KI DFG A D T G+ +MAPE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR-------VEELYDK 546
+EK DV+S+G++L E++T R+ E I W R + + +
Sbjct: 181 SEKCDVFSWGIILWEVITRRK----PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--E 234
Query: 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFID 606
+LM C ++PS RP+M +++++T + P
Sbjct: 235 SLMTR--------------------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274
Query: 607 ERTMELHDN 615
L
Sbjct: 275 PCQHSLPPG 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-59
Identities = 79/292 (27%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-------RAANFYNEVNIISSV 366
+ ++G+GGFG V+KG + D +A+K L + + F EV I+S++
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
H N+V+L G + P +V EF+P L + D KA + W + ++L G+
Sbjct: 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIE 136
Query: 427 YLHEQSKIRIIHRDIKASNILLDSR-----LRAKIADFGLARSFQEDKSHISTAIAGTLG 481
Y+ I+HRD+++ NI L S + AK+ADFGL++ H + + G
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQ 191
Query: 482 YMAPEYLA--HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539
+MAPE + TEKAD YSF M+L I+TG + + + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-------PFDE------YSYGKIKF 238
Query: 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
+ + ++ L D + + I LC +P RP S +++ L+
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRNV--IE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 65/318 (20%), Positives = 115/318 (36%), Gaps = 51/318 (16%)
Query: 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
LG+G FG K G + +K L + F EV ++ +EH N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG- 74
Query: 378 SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ L + E++ +L I W +R G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---I 129
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-------------ISTAIAGTLGYM 483
IHRD+ + N L+ +ADFGLAR ++K+ + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQ---NNRSKNSEYTDSLLTITWKHFQAGRV 540
APE + EK DV+SFG++L EI+ + + ++ ++ ++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML-----TTEEQ 595
+ + + C +P RP+ ++ L
Sbjct: 250 PSFFP--ITVR--------------------CCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 596 LPGPTSPPFIDERTMELH 613
LP +D E +
Sbjct: 288 LPLGPQLEQLDRGFWETY 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-58
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 16/203 (7%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLG 376
KL + G ++KG G +I VK L + ++ +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 377 CSCSGPESLL--VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
S P + ++P SL + + + + + L G+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL- 493
I + + ++++D + A+I+ + SFQ S ++APE L
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 494 --TEKADVYSFGMLLLEIVTGRQ 514
AD++SF +LL E+VT
Sbjct: 187 TNRRSADMWSFAVLLWELVTREV 209
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-58
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 52/292 (17%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA----NFYNEVNIISSVEHKNLVRL 374
+G GGFG VY+ G E+AVK + + N E + + ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G P LV EF L+R + K + + + G+ YLH+++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 435 RIIHRDIKASNILLDSRLR--------AKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
IIHRD+K+SNIL+ ++ KI DFGLAR + + AG +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRV-EELYD 545
+ ++ +DV+S+G+LL E++TG + ++ V +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE----------------VPFRGIDGLAVAYGVAM 228
Query: 546 KNLMLHNYHDSNVKYEVLRAIHVGLL-----CTQENPSLRPTMSRVLQMLTT 592
L L + C +P RP+ + +L LTT
Sbjct: 229 NKLAL----------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-57
Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 36/296 (12%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI--ISSVEHKNLVRLLG 376
++G+G +G V+ G G ++AVK F A+ ++ E I + H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRHENILGFIA 98
Query: 377 CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-- 430
G S L+ ++ N SL ++ K+ TL + ++ +V GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 431 ---QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI---STAIAGTLGYMA 484
Q K I HRD+K+ NIL+ IAD GLA F D + + GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 485 PE------YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538
PE H Q AD+YSFG++L E+ R + EY +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 539 RVEELY-DKNL---MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ E+ K L + + ++ + + C NP+ R T RV + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTL 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
++G G FGTVYKG ++AVK L + A F NEV ++ H N++ +
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFM 86
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G + P+ +V ++ SL + +K +I T G+ YLH +S
Sbjct: 87 GY-STAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLAR-SFQEDKSHISTAIAGTLGYMAPEYLAHGQL- 493
IIHRD+K++NI L KI DFGLA + SH ++G++ +MAPE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 494 --TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA-----GRVEELYDK 546
+ ++DVY+FG++L E++TG+ + + + V
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ----------------LPYSNINNRDQIIEMVGRGSLS 244
Query: 547 NLMLHNYHDSNVK-YEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597
+ + + ++ C ++ RP+ R+L + E+L
Sbjct: 245 PDLSKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEI---EELA 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-54
Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 38/297 (12%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI--ISSVEHKNLVRLLG 376
+G+G FG V++G G E+AVK F++R + ++ E I + H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKI--FSSREERS-WFREAEIYQTVMLRHENILGFIA 103
Query: 377 CSC----SGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-- 430
+ + LV ++ + SL ++ T+T E ++ L T GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 431 ---QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI---STAIAGTLGYMA 484
Q K I HRD+K+ NIL+ IAD GLA I GT YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 485 PEYL------AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538
PE L H + ++AD+Y+ G++ EI R + + +Y +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 539 RVEEL-YDKNL--MLHNYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVLQML 590
+ ++ ++ L + N S V+ ++ C N + R T R+ + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAK----IMRECWYANGAARLTALRIKKTL 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-54
Identities = 67/295 (22%), Positives = 122/295 (41%), Gaps = 34/295 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI--ISSVEHKNLVRLLG 376
+G+G +G V++G G +AVK F++R + ++ E + + H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI--FSSRDEKS-WFRETELYNTVMLRHENILGFIA 69
Query: 377 CSCSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-- 430
+ S L+ + SL ++ + TL I+L GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 431 ---QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI---STAIAGTLGYMA 484
Q K I HRD+K+ NIL+ + IAD GLA + + + + GT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 485 PE------YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538
PE + ++ D+++FG++L E+ R + +Y +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 539 RVEEL-YDKNLMLHNYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVLQML 590
+ ++ N + L ++ L+ C +NPS R T R+ + L
Sbjct: 245 DMRKVVCVDQQRP-NIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTL 297
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-53
Identities = 62/313 (19%), Positives = 115/313 (36%), Gaps = 51/313 (16%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--RAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG VY G E+A++ + + + F EV H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+C P L ++ ++L + D L K +I V+G+ YLH +
Sbjct: 97 -ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLAR----SFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+H+D+K+ N+ D+ + I DFGL + G L ++APE +
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 492 QL---------TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542
++ +DV++ G + E+ +K A +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE----------------WPFKTQPAEAIIW 253
Query: 543 LYDKNL---MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGP 599
+ + + ++L C RPT ++++ ML +
Sbjct: 254 QMGTGMKPNLSQIGMGKEIS-DILLF------CWAFEQEERPTFTKLMDMLEKLPKRNRR 306
Query: 600 TSPPFIDERTMEL 612
S P ++ EL
Sbjct: 307 LSHPGHFWKSAEL 319
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 280 ERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGR 338
E + + +D E+L S + ++ + ++G+G F TVYKG+
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTV 52
Query: 339 EIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC---SCSGPESLLVY-EFLP 392
E+A + + F E ++ ++H N+VR + G + +++ E +
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
+ +L ++ + K + + ++GL +LH ++ IIHRD+K NI +
Sbjct: 113 SGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPT 168
Query: 453 -RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
KI D GLA + + A+ GT +MAPE E DVY+FGM +LE+ T
Sbjct: 169 GSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMAT 224
Query: 512 GR 513
Sbjct: 225 SE 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 21/284 (7%)
Query: 319 NKLGQGGFGTVYKGV---LPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG+V L D AVK+L + +F E+ I+ S++H N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 374 LLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
G C +G +L L+ E+LP SL ++ + + K + +G+ YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R IHRD+ NIL+++ R KI DFGL + +DK G + APE L
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ + +DV+SFG++L E+ T + ++S +E+ + + EL N
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 550 LHNYHD-SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
L + Y ++ C N + RP+ + +
Sbjct: 251 LPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 21/284 (7%)
Query: 319 NKLGQGGFGTVYKGV---LPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G FG+V L D AVK+L + +F E+ I+ S++H N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 374 LLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
G C +G +L L+ E+LP SL ++ + + K + +G+ YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R IHRD+ NIL+++ R KI DFGL + +DK + G + APE L
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ + +DV+SFG++L E+ T + ++S +E+ + + EL N
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 550 LHNYHD-SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
L + Y ++ C N + RP+ + +
Sbjct: 282 LPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 60/310 (19%)
Query: 319 NKLGQGGFGTVYKGVL---PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG+G FG V DG AVK L + + + + E++I+ ++ H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 373 RLLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ G C +G SL LV E++P SL ++ ++ + EG+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYL 488
Q IHRD+ A N+LLD+ KI DFGLA++ E + G + APE L
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQN-------NRSKNSEYTDSLLTITWKHFQAGRV 540
+ +DV+SFG+ L E++T + + + + G
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 541 --------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT- 591
E+Y +LM + C + S RPT ++ +L
Sbjct: 270 LPRPDKCPAEVY--HLMKN--------------------CWETEASFRPTFENLIPILKT 307
Query: 592 ----TEEQLP 597
+ Q P
Sbjct: 308 VHEKYQGQAP 317
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 62/299 (20%), Positives = 110/299 (36%), Gaps = 51/299 (17%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
F+ LG+GGFG V++ D A+KR+ NR A EV ++ +EH +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 373 RLLGC---------SCSGPESLLVY---EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
R + +Y + ++L ++ + I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA--- 477
E + +LH + ++HRD+K SNI K+ DFGL + +D+ +
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 478 --------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
GT YM+PE + + K D++S G++L E++ T
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS---------TQMERV 234
Query: 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
T + + L+ + KY + +L +P RP +++
Sbjct: 235 RTLTDVRNLKFPPLFTQ------------KYPCEYVMVQDML--SPSPMERPEAINIIE 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-41
Identities = 74/316 (23%), Positives = 136/316 (43%), Gaps = 66/316 (20%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F E +G GGFG V+K DG+ +KR+ +NN EV ++ ++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVH 68
Query: 374 LLGC-------------SCSGPESLLVY---EFLPNQSLDRFIFDSAKAKTLTWEKRYEI 417
GC + S ++ ++ EF +L+++I + + + L E+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+G+ Y+H + ++I+RD+K SNI L + KI DFGL S + D T
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182
Query: 478 GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537
GTL YM+PE ++ ++ D+Y+ G++L E++ + +TD +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD---------LRD 233
Query: 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597
G + +++DK + + LL + P RP S +L+
Sbjct: 234 GIISDIFDKK---------------EKTLLQKLL--SKKPEDRPNTSEILRT-------- 268
Query: 598 GPTSPPFIDERTMELH 613
+ +++ E +
Sbjct: 269 -----LTVWKKSPEKN 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 54/294 (18%)
Query: 320 KLGQGGFGTVYKGVL-PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVRLLG- 376
++G+G FG V+ G L D +AVK A F E I+ H N+VRL+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
C+ P +V E + F+ + L + +++ G+ YL +
Sbjct: 181 CTQKQP-IYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY----MAPEYLAHGQ 492
IHRD+ A N L+ + KI+DFG++R + + A G APE L +G+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGR 291
Query: 493 LTEKADVYSFGMLLLEIVT-GRQN-NRSKNSEYTDSLLTITWKHFQAGRVE-------EL 543
+ ++DV+SFG+LL E + G N + + + + GR+ +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGRLPCPELCPDAV 344
Query: 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597
+ LM C P RP+ S + Q L + +
Sbjct: 345 FR--LMEQ--------------------CWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE-----IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG G FGTVYKG+ E +A+K L +A +E +++SV++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RLLG C L+ + +P L ++ + + + +G+ YL ++
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHG 491
R++HRD+ A N+L+ + KI DFGLA+ ++ + +MA E + H
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 492 QLTEKADVYSFGMLLLEIVT-GRQ 514
T ++DV+S+G+ + E++T G +
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 320 KLGQGGFGTVYKGVL-PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+LG G FG+V +GV ++I A+K L E I+ +++ +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L +F+ K + + E++ G+ YL E+
Sbjct: 77 GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHGQL 493
+HRD+ A N+LL +R AKI+DFGL+++ D S+ + AG + APE + +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 494 TEKADVYSFGMLLLEIVT-GRQ 514
+ ++DV+S+G+ + E ++ G++
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQK 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLV 372
KLG G FG V +G P G+ + AVK L + +F EVN + S++H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RL G P +V E P SL + + EG+ YL +
Sbjct: 85 RLYGV-VLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
R IHRD+ A N+LL +R KI DFGL R+ ++ H + + APE L
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQ 514
+ +D + FG+ L E+ T G++
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 77/281 (27%), Positives = 119/281 (42%), Gaps = 44/281 (15%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV- 247
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S +V E++ SL F+ K L + ++ G+ Y+ +H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 499 VYSFGMLLLEIVT-GRQ-NNRSKNSEYTDSLLTITWKHFQAGRV-------EELYDKNLM 549
V+SFG+LL E+ T GR N E D + + R+ E L+D LM
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMPCPPECPESLHD--LM 414
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
C ++ P RPT + L
Sbjct: 415 CQ--------------------CWRKEPEERPTFEYLQAFL 435
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 52/299 (17%)
Query: 319 NKLGQGGFGTVYKGV---LPDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++LG+G FG+V L D AVK+L + + +F E+ I+ ++ +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 374 LLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
G G +SL LV E+LP+ L F+ L + +G+ YL +
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLA 489
R +HRD+ A NIL++S KIADFGLA+ DK + G + APE L+
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQ-------NNRSKNSEYTDSLLTITWKHFQAGRV- 540
+ ++DV+SFG++L E+ T + R E L+ + + G+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263
Query: 541 -------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
E+++ LM C +P RP+ S + L
Sbjct: 264 PAPPACPAEVHE--LMKL--------------------CWAPSPQDRPSFSALGPQLDM 300
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 68/300 (22%), Positives = 126/300 (42%), Gaps = 53/300 (17%)
Query: 319 NKLGQGGFGTVYKGVLP-----DGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG+G FG V G ++AVK L + A+ E+ I+ ++ H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 373 RLLG-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ G C+ G + L+ EFLP+ SL ++ + +++ + + +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYL 488
+ + +HRD+ A N+L++S + KI DFGL ++ + DK + + + APE L
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLT---ITWKHF----QAGRV 540
+ +DV+SFG+ L E++T ++ T +T + G+
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 541 --------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
+E+Y LM C + PS R + +++
Sbjct: 262 LPCPPNCPDEVYQ--LMRK--------------------CWEFQPSNRTSFQNLIEGFEA 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-39
Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 46/310 (14%)
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRA 353
+L D + + S + SF + LG G GT+ + D R++AVKR+
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECF 61
Query: 354 ANFYNEVNI-ISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTW 411
+ EV + S EH N++R C+ + + E +L ++ K
Sbjct: 62 SFADREVQLLRESDEHPNVIRYF-CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLG 117
Query: 412 EKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFGLARSFQ 466
+ ++ T GL +LH I+HRD+K NIL+ +++A I+DFGL +
Sbjct: 118 LEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 467 EDKSHIS--TAIAGTLGYMAPEYL---AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNS 521
+ S + + GT G++APE L T D++S G + +++
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-------- 226
Query: 522 EYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLL---CTQENPS 578
H ++ N++L + E + L +P
Sbjct: 227 -----------SHPFGKSLQR--QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQ 273
Query: 579 LRPTMSRVLQ 588
RP+ VL+
Sbjct: 274 KRPSAKHVLK 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-39
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLG G FG V+ ++AVK + + A F E N++ +++H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV- 251
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ ++ EF+ SL F+ + K + EG+ ++ ++ IH
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG---YMAPEYLAHGQLTE 495
RD++A+NIL+ + L KIADFGLAR ++++ TA G + APE + G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 496 KADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL+EIVT GR
Sbjct: 365 KSDVWSFGILLMEIVTYGRI 384
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-39
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 46/283 (16%)
Query: 319 NKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG- 376
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 284
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
C+ P ++ EF+ +L ++ + + + ++ + + YL ++
Sbjct: 285 CTREPP-FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
IHR++ A N L+ K+ADFGL+R D + + APE LA+ + + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 497 ADVYSFGMLLLEIVT-GRQ-NNRSKNSEYTDSLLTITWKHFQAGRV-------EELYDKN 547
+DV++FG+LL EI T G S+ + L + R+ E++Y+
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERPEGCPEKVYE-- 450
Query: 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
LM C Q NPS RP+ + + Q
Sbjct: 451 LMRA--------------------CWQWNPSDRPSFAEIHQAF 473
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-39
Identities = 71/200 (35%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V+ G ++AVK L + A F E N++ ++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV- 76
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ ++ E++ N SL F+ + LT K ++ EG+ ++ E+ IH
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLTE 495
RD++A+NIL+ L KIADFGLAR +++ TA G + APE + +G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 496 KADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL EIVT GR
Sbjct: 190 KSDVWSFGILLTEIVTHGRI 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 6e-39
Identities = 76/281 (27%), Positives = 117/281 (41%), Gaps = 44/281 (15%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV- 330
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S +V E++ SL F K L + ++ G+ Y+ +H
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 499 VYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAG-RV-------EELYDKNLM 549
V+SFG+LL E+ T GR Y + + G R+ E L+D LM
Sbjct: 447 VWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMPCPPECPESLHD--LM 497
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
C ++ P RPT + L
Sbjct: 498 CQ--------------------CWRKEPEERPTFEYLQAFL 518
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 58/291 (19%), Positives = 103/291 (35%), Gaps = 45/291 (15%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLG+GGF V L DG A+KR+ + + E ++ H N++RL+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 379 CSGPES----LLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSK 433
+ L+ F +L I E + ++LG GL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA--------GTLGYMAP 485
HRD+K +NILL + + D G A+ T+ Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 486 EYL---AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH-FQA-GRV 540
E +H + E+ DV+S G +L ++ G + + +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFG--------------------EGPYDMVFQK 252
Query: 541 EELYDKNLMLHNYHDSNVKY-EVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ + + ++ L + ++ +P RP + +L L
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMM--TVDPHQRPHIPLLLSQL 301
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 65/301 (21%), Positives = 132/301 (43%), Gaps = 37/301 (12%)
Query: 294 KTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR 352
++ + N + ++EK + K+G+G FG DGR+ +K + +
Sbjct: 9 SGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 353 AA--NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT 410
EV ++++++H N+V+ +V ++ L + I ++ K
Sbjct: 65 KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQ 123
Query: 411 WEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470
++ + + L ++H++ +I+HRDIK+ NI L ++ DFG+AR
Sbjct: 124 EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI 530
I GT Y++PE + K+D+++ G +L E+ T
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL------------------ 221
Query: 531 TWKH-FQAGRVEELYDKNLMLHNYHDSNVKY-EVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
KH F+AG ++ L K ++ ++ ++ Y LR++ L + NP RP+++ +L+
Sbjct: 222 --KHAFEAGSMKNLVLK-IISGSFPPVSLHYSYDLRSLVSQLF--KRNPRDRPSVNSILE 276
Query: 589 M 589
Sbjct: 277 K 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 62/295 (21%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE----IAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G D + A+K L + A F E ++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNVL 85
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
L+G ++ ++ + L +FI + T + L G+ YL EQ
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYL 488
+ +HRD+ A N +LD K+ADFGLAR + + + + A E L
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQ-----NNRSKNSEYTDSLLTITWKHFQAGRVE- 541
+ T K+DV+SFG+LL E++T G + + T L Q R+
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----DLTHFLA-------QGRRLPQ 249
Query: 542 ------ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
LY +M C + +P++RPT ++ +
Sbjct: 250 PEYCPDSLY--QVMQQ--------------------CWEADPAVRPTFRVLVGEV 282
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 320 KLGQGGFGTVYKGVL-PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL 375
+LG G FG+V +GV ++I A+K L E I+ +++ +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L +F+ K + + E++ G+ YL E+
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAHGQL 493
+HR++ A N+LL +R AKI+DFGL+++ D S+ + AG APE + +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 494 TEKADVYSFGMLLLEIVT-GRQ 514
+ ++DV+S+G+ + E ++ G++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQK 538
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 320 KLGQGGFGTVYKGVL-PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+LG G FGTV KG AVK L N+ E N++ +++ +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G C +LV E L++++ + + + + E++ G+ YL E
Sbjct: 84 IGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES--- 136
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL--GYMAPEYLAHGQ 492
+HRD+ A N+LL ++ AKI+DFGL+++ + D+++ G + APE + + +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 493 LTEKADVYSFGMLLLEIVT-GRQ 514
+ K+DV+SFG+L+ E + G++
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-38
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
+G+G FG V G G ++AVK + + +A F E ++++ + H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVI 255
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
+V E++ SL ++ + L + + L E + YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLT 494
HRD+ A N+L+ AK++DFGL + S+ + + APE L + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 495 EKADVYSFGMLLLEIVT-GRQ 514
K+DV+SFG+LL EI + GR
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 80/292 (27%), Positives = 124/292 (42%), Gaps = 56/292 (19%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G L DG++I AVK L + + F E I+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 89
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LLG C S L+V ++ + L FI + T + L +G+ YL +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYL 488
+ +HRD+ A N +LD + K+ADFGLAR + + + G +MA E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVE---- 541
+ T K+DV+SFG+LL E++T G + + + T LL Q R+
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL-------QGRRLLQPEY 256
Query: 542 ---ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
LY +ML C +RP+ S ++ +
Sbjct: 257 CPDPLY--EVMLK--------------------CWHPKAEMRPSFSELVSRI 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 64/286 (22%), Positives = 121/286 (42%), Gaps = 54/286 (18%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
+LG G FG V G ++A+K + + F E ++ ++ H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVC 88
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
+ P ++ E++ N L ++ ++ E+ E + YL + + +
Sbjct: 89 TKQRP-IFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLT 494
HRD+ A N L++ + K++DFGL+R +D T+ G+ + PE L + + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 495 EKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVE-------ELY 544
K+D+++FG+L+ EI + G+ + NSE + + Q R+ ++Y
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIA-------QGLRLYRPHLASEKVY 251
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+M C E RPT +L +
Sbjct: 252 T--IMYS--------------------CWHEKADERPTFKILLSNI 275
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-CS 378
+LG G FG V G ++AVK + + F+ E + + H LV+ G CS
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
P +V E++ N L ++ + K L + E+ EG+ +L + IH
Sbjct: 74 KEYP-IYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLTE 495
RD+ A N L+D L K++DFG+ R +D + GT + APE + + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 496 KADVYSFGMLLLEIVT-GRQN-NRSKNSEYTDSLLTITWKHFQAGRVE-------ELYDK 546
K+DV++FG+L+ E+ + G+ + NSE + Q R+ +Y
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------QGHRLYRPHLASDTIYQ- 236
Query: 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+M C E P RPT ++L +
Sbjct: 237 -IMYS--------------------CWHELPEKRPTFQQLLSSI 259
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE-----IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG G FGTVYKG+ E +A+K L +A +E +++SV++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RLLG C L+ + +P L ++ + + + + +G+ YL ++
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHG 491
R++HRD+ A N+L+ + KI DFGLA+ ++ + +MA E + H
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 492 QLTEKADVYSFGMLLLEIVT 511
T ++DV+S+G+ + E++T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE-----IAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLV 372
LG G FGTV+KGV E + +K + + ++ + + I S++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
RLLG C G LV ++LP SL + L + + +G+ YL E
Sbjct: 79 RLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHG 491
++HR++ A N+LL S + ++ADFG+A D + + A T + +MA E + G
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 492 QLTEKADVYSFGMLLLEIVT-GRQ 514
+ T ++DV+S+G+ + E++T G +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRAA-NFYNEVNIISSVEHKNLVR 373
+G G G V G L P R++ A+K L R +F +E +I+ +H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L G + +++V E++ N SLD F+ T + ++ G G+ YL +
Sbjct: 115 LEGVVTRGRL-AMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
+HRD+ A N+L+DS L K++DFGL+R ++D T G + APE +A
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRV--------E 541
+ +DV+SFG+++ E++ G + Y + + G
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER-------PYWNMTNRDVISSVEEGYRLPAPMGCPH 281
Query: 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
L+ LML C ++ + RP S+++ +L
Sbjct: 282 ALH--QLMLD--------------------CWHKDRAQRPRFSQIVSVLDA 310
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
LG+G FG VY+GV G +I AVK + F +E I+ +++H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E P L ++ +L L + + YL
Sbjct: 79 IGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESI--- 132
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-----YMAPEYLA 489
+HRDI NIL+ S K+ DFGL+R +++ ++ +M+PE +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASVTRLPIKWMSPESIN 187
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQ 514
+ T +DV+ F + + EI++ G+Q
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 72/320 (22%), Positives = 119/320 (37%), Gaps = 55/320 (17%)
Query: 306 STLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-----RHRAANFYNE 359
S E ++ +G G +G K DG+ + K L + + + +E
Sbjct: 3 SRAED----YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSE 55
Query: 360 VNIISSVEHKNLVRLLGC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YE 416
VN++ ++H N+VR + +V E+ L I K + E+
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 417 IILGTVEGLVYLHEQ--SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
++ L H + ++HRD+K +N+ LD + K+ DFGLAR D S T
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
+ GT YM+PE + EK+D++S G LL E+
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM-------------------PP 215
Query: 535 FQAGRVEELYDKNLMLHNYHDSNVKY-EVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593
F A +EL K + + +Y + L I +L RP++ +L+
Sbjct: 216 FTAFSQKELAGK-IREGKFRRIPYRYSDELNEIITRML--NLKDYHRPSVEEILEN---- 268
Query: 594 EQLPGPTSPPFIDERTMELH 613
P I E H
Sbjct: 269 ---------PLILEHHHHHH 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 54/286 (18%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
++G G FG V+ G + ++A+K + F E ++ + H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 72
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
P LV EF+ + L ++ + E + L EG+ YL E +I
Sbjct: 73 LEQAP-ICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQLT 494
HRD+ A N L+ K++DFG+ R +D T+ GT + +PE + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 495 EKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVE-------ELY 544
K+DV+SFG+L+ E+ + G+ NRS NSE + + R+ +Y
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDIS-------TGFRLYKPRLASTHVY 235
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+M H C +E P RP SR+L+ L
Sbjct: 236 Q--IMNH--------------------CWRERPEDRPAFSRLLRQL 259
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 60/295 (20%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG-C 377
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
+V E++ SL ++ + L + + L E + YL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT---LGYMAPEYLAHGQLT 494
HRD+ A N+L+ AK++DFGL + S+ + + APE L + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKE-------ASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 495 EKADVYSFGMLLLEIVT-GRQN-NRSKNSEYTDSLLTITWKHFQAGRVE-------ELYD 545
K+DV+SFG+LL EI + GR R + + + +++ +Y+
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPAVYE 245
Query: 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVL----QMLTTEEQL 596
+M + C + ++RP+ ++ + T E L
Sbjct: 246 --VMKN--------------------CWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 79/292 (27%), Positives = 123/292 (42%), Gaps = 56/292 (19%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
+G+G FG VY G L DG++I AVK L + + F E I+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 153
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LLG C S L+V ++ + L FI + T + L +G+ +L +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYL 488
+ +HRD+ A N +LD + K+ADFGLAR + + G +MA E L
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 489 AHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVE---- 541
+ T K+DV+SFG+LL E++T G + + + T LL Q R+
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL-------QGRRLLQPEY 320
Query: 542 ---ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
LY +ML C +RP+ S ++ +
Sbjct: 321 CPDPLY--EVMLK--------------------CWHPKAEMRPSFSELVSRI 350
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 13/220 (5%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF 356
D L + Y E LG+G +G VY G L + IA+K + + +
Sbjct: 12 SDLLEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYE 416
+ E+ + ++HKN+V+ LG + E +P SL + +
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSHISTA 475
+EGL YLH+ +I+HRDIK N+L+++ KI+DFG ++ T
Sbjct: 127 YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET- 182
Query: 476 IAGTLGYMAPEYLAHGQL--TEKADVYSFGMLLLEIVTGR 513
GTL YMAPE + G + AD++S G ++E+ TG+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 61/300 (20%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
+G+G FG V++G+ P+ + A+K F E + +H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E L F+ + +L L YL +
Sbjct: 82 IGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-----YMAPEYLA 489
R +HRDI A N+L+ S K+ DFGL+R ++ T + G +MAPE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESIN 190
Query: 490 HGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVE----- 541
+ T +DV+ FG+ + EI+ G + N++ + R+
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE-------NGERLPMPPNC 242
Query: 542 --ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGP 599
LY LM C +PS RP + + L+T +
Sbjct: 243 PPTLYS--LMTK--------------------CWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 57/300 (19%)
Query: 320 KLGQGGFGTVYKGVL--PDGRE---IAVKRLFFNNRHRAA-NFYNEVNIISSVEHKNLVR 373
+G G FG VYKG+L G++ +A+K L + +F E I+ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L G S P +++ E++ N +LD+F+ K + + ++ G G+ YL
Sbjct: 111 LEGVISKYKP-MMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
+HRD+ A NIL++S L K++DFGL+R ++D T G + APE +++
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRV------- 540
+ T +DV+SFG+++ E++T G + S N E K G
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHE--------VMKAINDGFRLPTPMDC 275
Query: 541 -EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGP 599
+Y LM+ C Q+ + RP + ++ +L + P
Sbjct: 276 PSAIYQ--LMMQ--------------------CWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 52/302 (17%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRAA-NFYNEVNIISSVEHKNLVR 373
+G G FG V G L P +EI A+K L + +F E +I+ +H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 374 LLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L G + S P ++V E++ N SLD F+ T + ++ G G+ YL +
Sbjct: 111 LEGVVTKSKP-VMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY--MAPEYLAH 490
+HRD+ A NIL++S L K++DFGL R ++D T G + +PE +A+
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 491 GQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRV--------E 541
+ T +DV+S+G++L E+++ G + Y + K G
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER-------PYWEMSNQDVIKAVDEGYRLPPPMDCPA 277
Query: 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTS 601
LY LML C Q++ + RP +++ +L + PG
Sbjct: 278 ALY--QLMLD--------------------CWQKDRNNRPKFEQIVSILDKLIRNPGSLK 315
Query: 602 PP 603
Sbjct: 316 II 317
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 66/254 (25%), Positives = 101/254 (39%), Gaps = 28/254 (11%)
Query: 271 TRVWKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVY 330
+ W S + +R G + L + Y E+ ++G+G FG V+
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH-WMTHQPRVGRGSFGEVH 75
Query: 331 KGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389
+ G + AVK++ E+ + + +V L G GP + E
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 390 FLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKAS 444
L SL + I +A + L EGL YLH + RI+H D+KA
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQ-----AL---EGLEYLHTR---RILHGDVKAD 179
Query: 445 NILLDSR-LRAKIADFGLARSFQEDKSHISTA----IAGTLGYMAPEYLAHGQLTEKADV 499
N+LL S RA + DFG A Q D S I GT +MAPE + K D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 500 YSFGMLLLEIVTGR 513
+S ++L ++ G
Sbjct: 240 WSSCCMMLHMLNGC 253
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA---ANFYNEV 360
Y+TL F K+G+G F VY+ L DG +A+K++ + A A+ E+
Sbjct: 28 YNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIIL 419
+++ + H N+++ E +V E L R I K K L E+ ++ +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
L ++H + R++HRDIK +N+ + + K+ D GL R F + + + GT
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
YM+PE + K+D++S G LL E+ +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 75/332 (22%), Positives = 133/332 (40%), Gaps = 34/332 (10%)
Query: 282 KRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREI 340
K+ + ++ + + L K E F++ ++LG G G V+K P G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 341 AVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDR 398
A K L R E+ ++ +V G S E + E + SLD+
Sbjct: 62 ARKLIHLEIKPAIRNQII-RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 399 FIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458
+ KA + + ++ + ++GL YL E+ KI +HRD+K SNIL++SR K+ D
Sbjct: 121 VL---KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCD 175
Query: 459 FGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR----Q 514
FG+ S Q S ++ + GT YM+PE L + ++D++S G+ L+E+ GR
Sbjct: 176 FGV--SGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 515 NNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAI---HVGLL 571
+ + + N + +E+L I L
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292
Query: 572 ---------------CTQENPSLRPTMSRVLQ 588
C +NP+ R + +++
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 61/286 (21%), Positives = 110/286 (38%), Gaps = 51/286 (17%)
Query: 320 KLGQGGFGTVYKGVL--PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
+G+G FG V++G+ P+ + A+K F E + +H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E L F+ + +L L YL +
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
R +HRDI A N+L+ S K+ DFGL+R ++ + ++ + +MAPE + + T
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 495 EKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQAGRVE-------ELY 544
+DV+ FG+ + EI+ G + N++ + R+ LY
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE-------NGERLPMPPNCPPTLY 622
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+LM C +PS RP + + L
Sbjct: 623 --SLMTK--------------------CWAYDPSRRPRFTELKAQL 646
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 76/306 (24%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRLFFNN--RHRAANFYNEVNIISSVEHKNLV 372
LG+G FG+V +G L DG + AVK + +N + F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 373 RLLG-CSCSGPES----LLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVEG 424
RLLG C + +++ F+ L ++ S K + + + ++ G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG--- 481
+ YL + +HRD+ A N +L + +ADFGL++ + G +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 482 --YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSEYTDSLLTITW 532
++A E LA T K+DV++FG+ + EI T G QN+ +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------------MY 259
Query: 533 KHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMS 584
+ G +ELY +M C + +P RPT S
Sbjct: 260 DYLLHGHRLKQPEDCLDELY--EIMYS--------------------CWRTDPLDRPTFS 297
Query: 585 RVLQML 590
+ L
Sbjct: 298 VLRLQL 303
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 79/286 (27%), Positives = 125/286 (43%), Gaps = 52/286 (18%)
Query: 319 NKLGQGGFGTVYKGVLPDGR-EIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG- 376
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 77
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
C+ P ++ EF+ +L ++ + ++ + + YL ++
Sbjct: 78 CTREPP-FYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL---GYMAPEYLAHGQL 493
IHRD+ A N L+ K+ADFGL+R D TA AG + APE LA+ +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 494 TEKADVYSFGMLLLEIVT-GRQN-NRSKNSEYTDSLLTITWKHFQAGRVE-------ELY 544
+ K+DV++FG+LL EI T G S+ + L + R+E ++Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERPEGCPEKVY 242
Query: 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ LM C Q NPS RP+ + + Q
Sbjct: 243 E--LMRA--------------------CWQWNPSDRPSFAEIHQAF 266
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 76/323 (23%), Positives = 125/323 (38%), Gaps = 78/323 (24%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
+LG+G FG V+ P+ ++ AVK L + +F E +++ ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRF------------IFDSAKAKTLTWEKRYEIIL 419
R G C+ P L+V+E++ + L+RF + L + +
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
G+VYL +HRD+ N L+ L KI DFG++R G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGG 218
Query: 480 LG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTIT 531
+M PE + + + T ++DV+SFG++L EI T G+Q S N+E
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-NTE--------A 269
Query: 532 WKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583
GR E+Y +M C Q P R ++
Sbjct: 270 IDCITQGRELERPRACPPEVY--AIMRG--------------------CWQREPQQRHSI 307
Query: 584 SRVLQMLTTEEQLPGPTSPPFID 606
V L Q P P ++D
Sbjct: 308 KDVHARLQALAQAP----PVYLD 326
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 75/324 (23%), Positives = 122/324 (37%), Gaps = 78/324 (24%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKN 370
+LGQG FG VY+GV D E A+K + + R R F NE +++ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 89
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRF-------IFDSAKAKTLTWEKRYEIILGTVE 423
+VRLLG G +L++ E + L + + ++ + K ++ +
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY- 482
G+ YL+ + +HRD+ A N ++ KI DFG+ R E G G
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGLL 202
Query: 483 ----MAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSEYTDSLLTIT 531
M+PE L G T +DV+SFG++L EI T G N +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------------V 249
Query: 532 WKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583
+ G + + L+ LM C Q NP +RP+
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLF--ELMRM--------------------CWQYNPKMRPSF 287
Query: 584 SRVLQMLTTEEQLPGPTSPPFIDE 607
++ + E + + E
Sbjct: 288 LEIISSIKEEMEPGFREVSFYYSE 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 45/211 (21%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNL--VRL 374
++G GG V++ + + A+K + ++ NE+ ++ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ +V E N L+ ++ K K++ +R +E + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS-TAIAGTLGYMAPEYL----- 488
I+H D+K +N L+ K+ DFG+A Q D + + + GT+ YM PE +
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 489 ------AHGQLTEKADVYSFGMLLLEIVTGR 513
+ +++ K+DV+S G +L + G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 70/334 (20%), Positives = 117/334 (35%), Gaps = 81/334 (24%)
Query: 319 NKLGQGGFGTVYKGVL--PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLV 372
LG+G FG+V + L DG + AVK L F E + +H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 373 RLLG-CSCSGPES-----LLVYEFLPNQSLDRFIFDS---AKAKTLTWEKRYEIILGTVE 423
+L+G S + +++ F+ + L F+ S L + ++
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-- 481
G+ YL + IHRD+ A N +L + +ADFGL+R G
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----DYYRQGCASKL 201
Query: 482 ---YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSEYTDSLLTIT 531
++A E LA T +DV++FG+ + EI+T G +N
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------------I 248
Query: 532 WKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTM 583
+ + G EE+Y +LM C +P RP+
Sbjct: 249 YNYLIGGNRLKQPPECMEEVY--DLMYQ--------------------CWSADPKQRPSF 286
Query: 584 SRVLQ----MLTTEEQLPGPTSPPFIDERTMELH 613
+ + +L L P +I+ H
Sbjct: 287 TCLRMELENILGHLSVLSTSQDPLYINIERAHHH 320
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 46/211 (21%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNL--VRL 374
++G GG V++ + + A+K + ++ NE+ ++ ++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ +V E N L+ ++ K K++ +R +E + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYL----- 488
I+H D+K +N L+ K+ DFG+A Q D S + + GT+ YM PE +
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 489 ------AHGQLTEKADVYSFGMLLLEIVTGR 513
+ +++ K+DV+S G +L + G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 69/303 (22%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
F+E LGQG FG V K D R A+K++ + +EV +++S+ H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVR 66
Query: 374 LLGCSCSGPESL-------------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY-EIIL 419
+ + E+ N +L I Y +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFR 123
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA-- 477
+E L Y+H Q IIHRD+K NI +D KI DFGLA++ +
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 478 -----------GTLGYMAPEYLA-HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTD 525
GT Y+A E L G EK D+YS G++ E++ + +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL-- 238
Query: 526 SLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSR 585
++L ++ D N + I L +P+ RP
Sbjct: 239 ---------------KKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGART 280
Query: 586 VLQ 588
+L
Sbjct: 281 LLN 283
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 75/308 (24%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
+LG+G FG V+ P ++ AVK L +F E ++++++H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 373 RLLG-CSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEII 418
+ G C P ++V+E++ + L++F L + I
Sbjct: 81 KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
G+VYL Q +HRD+ N L+ + L KI DFG++R + G
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVG 192
Query: 479 TLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTI 530
+M PE + + + T ++DV+SFG++L EI T G+Q S N+E
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTE-------- 243
Query: 531 TWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT 582
+ GRV +E+Y ++ML C Q P R
Sbjct: 244 VIECITQGRVLERPRVCPKEVY--DVMLG--------------------CWQREPQQRLN 281
Query: 583 MSRVLQML 590
+ + ++L
Sbjct: 282 IKEIYKIL 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 60/301 (19%), Positives = 110/301 (36%), Gaps = 42/301 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKNLVRLL 375
LGQG V++G G A+K FNN E ++ + HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 376 GC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ +L+ EF P SL + + + A L + ++ V G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 434 IRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
I+HR+IK NI+ D + K+ DFG AR ++D + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 490 HGQL--------TEKADVYSFGMLLLEIVTGR---------QNNRS---KNSEYTDSLLT 529
L D++S G+ TG + N+ K S
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589
+ + G ++ + ++ + ++ + + +L + + +
Sbjct: 249 SGVQKAENGPID--WSGDMPVSCSLSRGLQVLLTPVL-ANIL--EADQEKCWGFDQFFAE 303
Query: 590 L 590
Sbjct: 304 T 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 74/309 (23%), Positives = 116/309 (37%), Gaps = 65/309 (21%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNI-ISSVEHKNLVR 373
LG G GTV GR +AVKR+ E+ + S +H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVYL 428
CS + L + E L N +L + K ++ G+ +L
Sbjct: 74 YY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 429 HEQSKIRIIHRDIKASNILLDS-------------RLRAKIADFGLARSFQEDKSHISTA 475
H +IIHRD+K NIL+ + LR I+DFGL + +S T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 476 ---IAGTLGYMAPEYL-------AHGQLTEKADVYSFGMLLLEIVT------GRQNNRSK 519
+GT G+ APE L +LT D++S G + I++ G + +R
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 520 NSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSL 579
N I F ++ L+D++L+ A + +P
Sbjct: 249 N---------IIRGIFSLDEMKCLHDRSLIAE-------------ATDLISQMIDHDPLK 286
Query: 580 RPTMSRVLQ 588
RPT +VL+
Sbjct: 287 RPTAMKVLR 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 65/309 (21%), Positives = 112/309 (36%), Gaps = 76/309 (24%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
+LG+ FG VYKG L P + A+K L F +E + + ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 372 VRLLG-CSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEI 417
V LLG + P +++ + + L F D L +
Sbjct: 75 VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 418 ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA 477
+ G+ YL ++H+D+ N+L+ +L KI+D GL R
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKL 186
Query: 478 GTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLT 529
+MAPE + +G+ + +D++S+G++L E+ + G Q S N +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQD------- 238
Query: 530 ITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP 581
+ + +V +Y LM+ C E PS RP
Sbjct: 239 -VVEMIRNRQVLPCPDDCPAWVY--ALMIE--------------------CWNEFPSRRP 275
Query: 582 TMSRVLQML 590
+ L
Sbjct: 276 RFKDIHSRL 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 65/319 (20%), Positives = 119/319 (37%), Gaps = 88/319 (27%)
Query: 320 KLGQGGFGTVYKGVL--------PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL 371
LGQG F ++KGV E+ +K L +R+ + +F+ +++S + HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 372 VRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
V G C C ++LV EF+ SLD ++ + + W+ E+ + +L E
Sbjct: 75 VLNYGVCVCGDE-NILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLEE 131
Query: 431 QSKIRIIHRDIKASNILLDSRLR--------AKIADFGLARSFQEDKSHISTAIAGTLGY 482
+IH ++ A NILL K++D G++ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 483 ------MAPEYLAHGQL-TEKADVYSFGMLLLEIVT-GRQ-----NNRSKNSEYTDSLLT 529
+ PE + + + D +SFG L EI + G + +++ K Y
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE----- 232
Query: 530 ITWKHFQAGRVE-----ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMS 584
++ EL NL+ + C P RP+
Sbjct: 233 ------DRHQLPAPKAAELA--NLINN--------------------CMDYEPDHRPSFR 264
Query: 585 RVLQMLT---TEEQLPGPT 600
+++ L T + +P +
Sbjct: 265 AIIRDLNSLFTPDLVPRGS 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+ K+GQG GTVY + + G+E+A++++ + + NE+ ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
L G E +V E+L SL D + + + ++ L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
++IHRDIK+ NILL K+ DFG ++S ST + GT +MAPE +
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 494 TEKADVYSFGMLLLEIVTG 512
K D++S G++ +E++ G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
D K+G+G G V GR++AVK + + R +NEV I+ +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ G E ++ EFL +L D L E+ + ++ L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+IHRDIK+ +ILL R K++DFG +D + + GT +MAPE ++
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLY 218
Query: 494 TEKADVYSFGMLLLEIVTG 512
+ D++S G++++E+V G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 80/316 (25%), Positives = 111/316 (35%), Gaps = 68/316 (21%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
LG G FG VY+G + D + AVK L + +F E IIS H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVY 427
VR +G S ++ E + L F+ ++ +L + G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 428 LHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY-- 482
L E IHRDI A N LL AKI DFG+AR S G
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLP 208
Query: 483 ---MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQ 536
M PE G T K D +SFG+LL EI + G ++S N E +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQE--------VLEFVT 259
Query: 537 AGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+G +Y +M C Q P RP + +L+
Sbjct: 260 SGGRMDPPKNCPGPVY--RIMTQ--------------------CWQHQPEDRPNFAIILE 297
Query: 589 MLTTEEQLPGPTSPPF 604
+ Q P +
Sbjct: 298 RIEYCTQDPDVINTAL 313
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 73/312 (23%), Positives = 116/312 (37%), Gaps = 78/312 (25%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG G FG V + + +AVK L + R A +E+ ++S + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHM 87
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF---------------IFDSAKAKTLTWEKR 414
N+V LLG G +L++ E+ L F L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
+G+ +L + IHRD+ A NILL KI DFGLAR + D S
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND----SN 200
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDS 526
+ +MAPE + + T ++DV+S+G+ L E+ + G +S+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256
Query: 527 LLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPS 578
+K + G E+YD +M C +P
Sbjct: 257 ----FYKMIKEGFRMLSPEHAPAEMYD--IMKT--------------------CWDADPL 290
Query: 579 LRPTMSRVLQML 590
RPT +++Q++
Sbjct: 291 KRPTFKQIVQLI 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 75/311 (24%), Positives = 117/311 (37%), Gaps = 77/311 (24%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG+G FG V + R +AVK L + A +E+ I+ + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 91
Query: 370 NLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV------ 422
N+V LLG C+ G +++ EF +L ++ ++ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 423 -------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
+G+ +L + + IHRD+ A NILL + KI DFGLAR +D
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDY 204
Query: 476 IAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSL 527
+ +MAPE + T ++DV+SFG+LL EI + G + E+ L
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 528 LTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSL 579
+ G E+Y ML C PS
Sbjct: 265 --------KEGTRMRAPDYTTPEMY--QTMLD--------------------CWHGEPSQ 294
Query: 580 RPTMSRVLQML 590
RPT S +++ L
Sbjct: 295 RPTFSELVEHL 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 70/333 (21%), Positives = 114/333 (34%), Gaps = 85/333 (25%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG G FG V + +AVK L ++ R A +E+ +++ + H+
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHE 109
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE------ 423
N+V LLG L++E+ L ++ + + + E
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 424 --------------GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469
G+ +L +HRD+ A N+L+ KI DFGLAR D
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225
Query: 470 SHISTAIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNS 521
S + +MAPE L G T K+DV+S+G+LL EI + G ++
Sbjct: 226 ---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 522 EYTDSLLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCT 573
+ + Q G EE+Y +M C
Sbjct: 283 NFYKLI--------QNGFKMDQPFYATEEIYI--IMQS--------------------CW 312
Query: 574 QENPSLRPTMSRVLQMLTTEEQLPGPTSPPFID 606
+ RP+ + L QL + +
Sbjct: 313 AFDSRKRPSFPNLTSFL--GCQLADAEEAMYQN 343
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 73/332 (21%), Positives = 116/332 (34%), Gaps = 89/332 (26%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE--------IAVKRL--FFNNRHRAANFYNEVNIISSV-E 367
LG+G FG V + +AVK L + + +E+ ++ + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV----- 422
HKN++ LLG ++ E+ +L ++ + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 423 --------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
G+ YL Q + IHRD+ A N+L+ KIADFGLAR
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY 212
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSE 522
T G +MAPE L T ++DV+SFG+L+ EI T G
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 267
Query: 523 YTDSLLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQ 574
+K + G ELY +M C
Sbjct: 268 --------LFKLLKEGHRMDKPANCTNELY--MMMRD--------------------CWH 297
Query: 575 ENPSLRPTMSRVLQMLTTEEQLPGPTSPPFID 606
PS RPT ++++ L + L T+ ++D
Sbjct: 298 AVPSQRPTFKQLVEDL--DRILTLTTNEEYLD 327
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 49/255 (19%), Positives = 107/255 (41%), Gaps = 24/255 (9%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVL 334
K+ + + R D+ L +D + + + + ++G GG V++ +
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 335 PDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHKNL--VRLLGCSCSGPESLLVYEF 390
+ A+K + ++ NE+ ++ ++ + +RL + +V E
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS 450
N L+ ++ K K++ +R +E + +H+ I+H D+K +N L+
Sbjct: 138 -GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD 190
Query: 451 RLRAKIADFGLARSFQEDKSHIS-TAIAGTLGYMAPEYL-----------AHGQLTEKAD 498
K+ DFG+A Q D + + + G + YM PE + + +++ K+D
Sbjct: 191 G-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 499 VYSFGMLLLEIVTGR 513
V+S G +L + G+
Sbjct: 250 VWSLGCILYYMTYGK 264
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 42/302 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH---RAANFYNEVNIISSVEHKNLVRLL 375
LGQG V++G G A+K FNN E ++ + HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 376 GC--SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ +L+ EF P SL + + + A L + ++ V G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 434 IRIIHRDIKASNILL----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
I+HR+IK NI+ D + K+ DFG AR ++D + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 490 HGQL--------TEKADVYSFGMLLLEIVTGR---------QNNRS---KNSEYTDSLLT 529
L D++S G+ TG + N+ K S
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589
+ + G ++ D M + S +L + +L + + +
Sbjct: 249 SGVQKAENGPIDWSGD---MPVSCSLSRGLQVLLTPVLANIL--EADQEKCWGFDQFFAE 303
Query: 590 LT 591
+
Sbjct: 304 TS 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 79/316 (25%), Positives = 110/316 (34%), Gaps = 68/316 (21%)
Query: 319 NKLGQGGFGTVYKGVL----PDGREI--AVKRLFFNNRHRA-ANFYNEVNIISSVEHKNL 371
LG G FG VY+G + D + AVK L + +F E IIS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFI----FDSAKAKTLTWEKRYEIILGTVEGLVY 427
VR +G S ++ E + L F+ ++ +L + G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 428 LHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY-- 482
L E IHRDI A N LL AKI DFG+AR G
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLP 249
Query: 483 ---MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTITWKHFQ 536
M PE G T K D +SFG+LL EI + G ++S N E +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQE--------VLEFVT 300
Query: 537 AGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+G +Y +M C Q P RP + +L+
Sbjct: 301 SGGRMDPPKNCPGPVY--RIMTQ--------------------CWQHQPEDRPNFAIILE 338
Query: 589 MLTTEEQLPGPTSPPF 604
+ Q P +
Sbjct: 339 RIEYCTQDPDVINTAL 354
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-RAANFYNEVNIISSVEHKNLV 372
F + K+G+G FG V+KG+ + +A+K + + E+ ++S + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQ 431
+ G + ++ E+L S D + L E + IL ++GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYLHSE 138
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+ IHRDIKA+N+LL K+ADFG+A + + +T + GT +MAPE +
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 194
Query: 492 QLTEKADVYSFGMLLLEIVTG 512
KAD++S G+ +E+ G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 73/290 (25%), Positives = 102/290 (35%), Gaps = 56/290 (19%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSV-EHK 369
SF ++LG G +G V+K DGR AVKR R A EV V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIILGTVE 423
VRL G L E SL + A+ + T+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD--------TLL 168
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L +LH Q ++H D+K +NI L R R K+ DFGL + G YM
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYM 223
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH-FQAGRVEE 542
APE L G ADV+S G+ +LE+ + ++
Sbjct: 224 APE-LLQGSYGTAADVFSLGLTILEVACN-------------------MELPHGGEGWQQ 263
Query: 543 LYDKNL---MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589
L L S+ VL + + +P LR T +L +
Sbjct: 264 LRQGYLPPEFTAGL--SSELRSVLV------MMLEPDPKLRATAEALLAL 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 81/306 (26%), Positives = 130/306 (42%), Gaps = 75/306 (24%)
Query: 319 NKLGQGGFGTVYKGVL-PDGREI--AVKRL--FFNNRHRAANFYNEVNIISSV-EHKNLV 372
+ +G+G FG V K + DG + A+KR+ + + +F E+ ++ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLCKLGHHPNII 89
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKRYEIIL 419
LLG L E+ P+ +L F ++ A TL+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
G+ YL S+ + IHRD+ A NIL+ AKIADFGL+R + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKT 199
Query: 480 LG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKNSEYTDSLLTIT 531
+G +MA E L + T +DV+S+G+LL EIV+ G + +E + L
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP--- 255
Query: 532 WKHFQAGRVE-------ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMS 584
Q R+E E+YD LM C +E P RP+ +
Sbjct: 256 ----QGYRLEKPLNCDDEVYD--LMRQ--------------------CWREKPYERPSFA 289
Query: 585 RVLQML 590
++L L
Sbjct: 290 QILVSL 295
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 78/317 (24%), Positives = 125/317 (39%), Gaps = 44/317 (13%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+GGF ++ A K + H+ E++I S+ H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVYLHEQSKIR 435
+V E +SL + K LT E RY + V G YLH R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN---R 161
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
+IHRD+K N+ L+ L KI DFGLA + D + GT Y+APE L+ +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 496 KADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH- 554
+ DV+S G ++ ++ G+ F+ ++E Y + + Y
Sbjct: 221 EVDVWSIGCIMYTLLVGK-------------------PPFETSCLKETY-LRIKKNEYSI 260
Query: 555 DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ-----MLTTEEQLPGP--TSPPFIDE 607
++ I +L Q +P+ RPT++ +L +LP T PP
Sbjct: 261 PKHINPVAASLIQ-KML--QTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 317
Query: 608 RTMELHDNCYDPCCPMN 624
L + P +N
Sbjct: 318 APSSLDPSNRKPLTVLN 334
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 73/312 (23%), Positives = 113/312 (36%), Gaps = 82/312 (26%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG G FG V + + +AVK L + + A +E+ I+S + +H+
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHE 110
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRF-----------IFDSAKAKTLTWEKRYEII 418
N+V LLG G L++ E+ L F + T +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+G+ +L + IHRD+ A N+LL + AKI DFGLAR D S I
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVK 223
Query: 479 TLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSEYTDS 526
+MAPE + T ++DV+S+G+LL EI + G N
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-------- 275
Query: 527 LLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPS 578
+K + G + +Y +M C P+
Sbjct: 276 ----FYKLVKDGYQMAQPAFAPKNIYS--IMQA--------------------CWALEPT 309
Query: 579 LRPTMSRVLQML 590
RPT ++ L
Sbjct: 310 HRPTFQQICSFL 321
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 320 KLGQGGFGTVYKGVLPD---GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
KLG GG TVY D ++A+K + F EV+ S + H+N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
++ LV E++ +L +I L+ + ++G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM-- 130
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
RI+HRDIK NIL+DS KI DFG+A++ E + + GT+ Y +PE
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYT-DSLLTITWKHFQ 536
E D+YS G++L E++ G + ++ ++I KH Q
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP-------PFNGETAVSIAIKHIQ 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRAANFYNEVNII 363
+ G ++ +LG GGFG V + + G ++A+K L NR R + E+ I+
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCLEIQIM 66
Query: 364 SSVEHKNLVRLL------GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI 417
+ H N+V LL E+ L +++ L E
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRT 125
Query: 418 ILG-TVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGLARSFQEDKSHIS 473
+L L YLHE RIIHRD+K NI+L RL KI D G A+ + +
Sbjct: 126 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCT 181
Query: 474 TAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ GTL Y+APE L + T D +SFG L E +TG
Sbjct: 182 EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 60/299 (20%), Positives = 107/299 (35%), Gaps = 57/299 (19%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKR--LFFNNRHRAANFYNEVNIISSV-EHKN 370
F E K+G G FG+V+K V DG A+KR N EV + + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLH 429
+VR L+ E+ SL I ++ + + E +++L GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 430 EQSKIRIIHRDIKASNILLD-------------------SRLRAKIADFGLARSFQEDKS 470
++H DIK SNI + +++ KI D G +
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 471 HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT 529
G ++A E L KAD+++ + ++ R+ +
Sbjct: 190 EE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-------- 236
Query: 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
W + GR+ + S E+L+ + +P RP+ +++
Sbjct: 237 --WHEIRQGRLPRIPQ--------VLSQEFTELLK------VMIHPDPERRPSAMALVK 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 73/236 (30%), Positives = 121/236 (51%), Gaps = 16/236 (6%)
Query: 278 SIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPD 336
S+E + + +L K L++DSL ++ FD KLG+G +G+VYK +
Sbjct: 1 SLETVQLRNPPRRQL-KKLDEDSLT------KQPEEVFDVLEKLGEGSYGSVYKAIHKET 53
Query: 337 GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
G+ +A+K++ E++I+ + ++V+ G + +V E+ S+
Sbjct: 54 GQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI 456
I + KTLT ++ I+ T++GL YLH R IHRDIKA NILL++ AK+
Sbjct: 112 SDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL 166
Query: 457 ADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTG 512
ADFG+A + + +T I GT +MAPE + AD++S G+ +E+ G
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 74/321 (23%), Positives = 121/321 (37%), Gaps = 92/321 (28%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSVEHKN 370
LG+G FG V K + +AVK L + +E N++ V H +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPH 87
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE------- 423
+++L G LL+ E+ SL F+ +S K +++
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 424 --------------GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469
G+ YL ++++++HRD+ A NIL+ + KI+DFGL+R E+
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE- 203
Query: 470 SHISTAIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNR 517
+ + + G +MA E L T ++DV+SFG+LL EIVT G R
Sbjct: 204 ---DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 518 SKNSEYTDSLLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVG 569
+ + G EE+Y LML
Sbjct: 261 -------------LFNLLKTGHRMERPDNCSEEMYR--LMLQ------------------ 287
Query: 570 LLCTQENPSLRPTMSRVLQML 590
C ++ P RP + + + L
Sbjct: 288 --CWKQEPDKRPVFADISKDL 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 71/316 (22%), Positives = 112/316 (35%), Gaps = 87/316 (27%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE--------IAVKRL--FFNNRHRAANFYNEVNIISSV-E 367
LG+G FG V + +AVK L + + +E+ ++ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 145
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRF-------------IFDSAKAKTLTWEKR 414
HKN++ LLG ++ E+ +L + + + +T++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
G+ YL Q + IHRD+ A N+L+ KIADFGLAR
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY 258
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSE 522
T G +MAPE L T ++DV+SFG+L+ EI T G
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313
Query: 523 YTDSLLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQ 574
+K + G ELY +M C
Sbjct: 314 --------LFKLLKEGHRMDKPANCTNELY--MMMRD--------------------CWH 343
Query: 575 ENPSLRPTMSRVLQML 590
PS RPT ++++ L
Sbjct: 344 AVPSQRPTFKQLVEDL 359
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 70/318 (22%), Positives = 125/318 (39%), Gaps = 86/318 (27%)
Query: 319 NKLGQGGFGTVYKGVLPDGRE------IAVKRL--FFNNRHRAANFYNEVNIISSVEHKN 370
+G+G FG V++ P +AVK L + +A +F E +++ ++ N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMAEFDNPN 111
Query: 371 LVRLLG-CSCSGPESLLVYEFLPNQSLDRF---------------------IFDSAKAKT 408
+V+LLG C+ P L++E++ L+ F S
Sbjct: 112 IVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
L+ ++ I G+ YL E+ + +HRD+ N L+ + KIADFGL+R+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 469 KSHISTAIAGTLGY-----MAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ--NNRSKN 520
A M PE + + + T ++DV+++G++L EI + G Q + +
Sbjct: 228 ----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-H 282
Query: 521 SEYTDSLLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLC 572
E + + G + ELY NLM C
Sbjct: 283 EE--------VIYYVRDGNILACPENCPLELY--NLMRL--------------------C 312
Query: 573 TQENPSLRPTMSRVLQML 590
+ P+ RP+ + ++L
Sbjct: 313 WSKLPADRPSFCSIHRIL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 37/274 (13%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+GGF ++ A K + H+ E++I S+ H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVYLHEQSKIR 435
+V E +SL + K LT E RY + V G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN---R 135
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
+IHRD+K N+ L+ L KI DFGLA + D + GT Y+APE L+ +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 496 KADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH- 554
+ DV+S G ++ ++ G+ F+ ++E Y + + Y
Sbjct: 195 EVDVWSIGCIMYTLLVGK-------------------PPFETSCLKETY-LRIKKNEYSI 234
Query: 555 DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
++ I +L Q +P+ RPT++ +L
Sbjct: 235 PKHINPVAASLIQ-KML--QTDPTARPTINELLN 265
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN-NRHRAANFYNEVNII-SSVEHKNL 371
+ ++G+G +G+V K V P G+ +AVKR+ + +++++ S + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLH 429
V+ G + + E + + S D+F + +I L TV+ L +L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
E KI IHRDIK SNILLD K+ DFG+ S Q S T AG YMAPE +
Sbjct: 143 ENLKI--IHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 490 HGQL----TEKADVYSFGMLLLEIVTGR 513
++DV+S G+ L E+ TGR
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN-NRHRAANFYNEVNII- 363
++E + +LG+G +G V K +P G+ +AVKR+ N +++I
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 364 SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-FDSAKAKTLTWEKRYEIILG-- 420
+V+ V G + + E + + SLD+F K +T+ E ILG
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP-----EDILGKI 114
Query: 421 ---TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG----LARSFQEDKSHIS 473
V+ L +LH + + IHRD+K SN+L+++ + K+ DFG L +D
Sbjct: 115 AVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 474 TAIAGTLGYMAPE----YLAHGQLTEKADVYSFGMLLLEIVTGR 513
AG YMAPE L + K+D++S G+ ++E+ R
Sbjct: 170 ---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
++ +LG G FG VYK G A K + + ++ E+ I+++ +H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGLVYLHEQS 432
LLG + ++ EF P ++D + + LT E + +++ +E L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLT-EPQIQVVCRQMLEALNFLHSK- 136
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
RIIHRD+KA N+L+ ++ADFG++ + + I GT +MAPE +
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCET 193
Query: 493 LTE-----KADVYSFGMLLLEIVTG 512
+ + KAD++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 28/219 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC 377
L +GGF VY+ + GRE A+KRL N + EV + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 378 SCSGPES--------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYL 428
+ G E LL+ E Q ++ +++ +I T + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIA----------- 477
H Q K IIHRD+K N+LL ++ K+ DFG A + + +A
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 478 GTLGYMAPE---YLAHGQLTEKADVYSFGMLLLEIVTGR 513
T Y PE ++ + EK D+++ G +L + +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 70/311 (22%), Positives = 129/311 (41%), Gaps = 45/311 (14%)
Query: 320 KLGQGGFGTVYKGVLPD---GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG GG V+ D R++AVK L + F E +++ H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 374 LL--GCSCSGPESL--LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
+ G + + L +V E++ +L + +T ++ E+I + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI--STAIAGTLGYMAPEY 487
+ IIHRD+K +NI++ + K+ DFG+AR+ + + + + A+ GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT-DSLLTITWKHFQAGRVEELYDK 546
+ ++DVYS G +L E++TG +T DS +++ ++H + +
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP-------PFTGDSPVSVAYQHVRE-DPIPPSAR 242
Query: 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT----MSRVLQMLTTEEQLPGPTSP 602
+ + ++ + L +NP R M L + E P
Sbjct: 243 H--------EGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291
Query: 603 PFIDERTMELH 613
ERT L
Sbjct: 292 T-DAERTSLLS 301
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 72/340 (21%), Positives = 112/340 (32%), Gaps = 87/340 (25%)
Query: 319 NKLGQGGFGTVYKGVLPD--------GREIAVKRL--FFNNRHRAANFYNEVNIISSV-E 367
LG+G FG V ++AVK L + + +E+ ++ + +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK 133
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV----- 422
HKN++ LLG ++ E+ +L ++ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 423 --------EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST 474
G+ YL + + IHRD+ A N+L+ KIADFGLAR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DY 246
Query: 475 AIAGTLG-----YMAPEYLAHGQLTEKADVYSFGMLLLEIVT-------GRQNNRSKNSE 522
T G +MAPE L T ++DV+SFG+LL EI T G
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301
Query: 523 YTDSLLTITWKHFQAGRV--------EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQ 574
+K + G ELY +M C
Sbjct: 302 --------LFKLLKEGHRMDKPSNCTNELY--MMMRD--------------------CWH 331
Query: 575 ENPSLRPTMSRVLQMLTTEEQLPGPTSPPFIDERTMELHD 614
PS RPT ++++ L L + +D
Sbjct: 332 AVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYD 371
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEH 368
F N LG+G F VY+ + G E+A+K + NEV I ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVY 427
+++ L LV E N ++R++ + K + E R+ + + G++Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARH-FMHQIITGMLY 127
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH I+HRD+ SN+LL + KIADFGLA + T + GT Y++PE
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEI 183
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR 513
++DV+S G + ++ GR
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 20/236 (8%)
Query: 286 SNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKR 344
S + K L ++ + + ++G G G V+K G IAVK+
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEIND-----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 345 LFFN-NRHRAANFYNEVNII-SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402
+ + N+ +++++ S + +V+ G + + + E + ++
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK-- 114
Query: 403 SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462
+ ++ + V+ L YL E+ + IHRD+K SNILLD R + K+ DFG+
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGI- 171
Query: 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE-----KADVYSFGMLLLEIVTGR 513
S + AG YMAPE + T+ +ADV+S G+ L+E+ TG+
Sbjct: 172 -SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 21/223 (9%)
Query: 320 KLGQGGFGTVYKG---VLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
+G+GG G VY+ V R +A+K + ++ E ++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+ + + + L + L + I+ L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
HRD+K NIL+ + A + DFG+A + ++K GTL YMAPE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536
T +AD+Y+ +L E +TG Y L++ H
Sbjct: 213 TYRADIYALTCVLYECLTGSP-------PYQGDQLSVMGAHIN 248
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 54/315 (17%), Positives = 94/315 (29%), Gaps = 43/315 (13%)
Query: 312 TGSFDEANKLGQG--GFGTVYKGV-LPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSV 366
G ++ +G+G TV P G + V+R+ E+++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 367 EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTVEGL 425
H N+V + E +V F+ S + + + + E IL G ++ L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMN-ELAIAYILQGVLKAL 141
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI------AGT 479
Y+H + HR +KAS+IL+ + ++ S
Sbjct: 142 DYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 480 LGYMAPEYLAHGQL--TEKADVYSFGMLLLEIVTGR----------------QNNRSKNS 521
L +++PE L K+D+YS G+ E+ G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 522 EYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVG--------LLCT 573
+ + +L SN C
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 574 QENPSLRPTMSRVLQ 588
Q NP RP+ S +L
Sbjct: 319 QRNPDARPSASTLLN 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 4e-31
Identities = 25/274 (9%), Positives = 58/274 (21%), Gaps = 42/274 (15%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV- 333
R K + ++ S L + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 334 LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEHKNLVRLLGC------------- 377
+ + A+K N+R + + + ++
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 378 -------------SCSGPESLLVYEFLP---NQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
+ LL+ F + +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG 481
+ L + ++H N+ + R + D A + +
Sbjct: 204 IRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVT 256
Query: 482 YMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGR 513
Y E+L T + + G+ + +
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 15/211 (7%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLV 372
++ +G G V P ++A+KR+ + E+ +S H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-----EGLVY 427
E LV + L S+ I E + T+ EGL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFG----LARSFQEDKSHISTAIAGTLGYM 483
LH+ +I HRD+KA NILL +IADFG LA ++ + GT +M
Sbjct: 137 LHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 484 APEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
APE + + KAD++SFG+ +E+ TG
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 23/203 (11%)
Query: 320 KLGQGGFGTVYKGV--LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLL- 375
+ GG G +Y + +GR + +K L + A A E ++ V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 376 ----GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
P +V E++ QSL R + L + +L + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+++ D+K NI+L + K+ D G + GT G+ APE +
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVRT 251
Query: 492 QLTEKADVYSFGMLLLEIVTGRQ 514
T D+Y+ G L +
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 43/252 (17%), Positives = 87/252 (34%), Gaps = 37/252 (14%)
Query: 349 NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT 408
+ ++ + KN V L S + + ++L ++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
I + E + +LH + ++HRD+K SNI K+ DFGL + +D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 469 KSHISTAIA-----------GTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNR 517
+ + GT YM+PE + + K D++S G++L E++
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS--- 274
Query: 518 SKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENP 577
T + + L+ + KY + +L +P
Sbjct: 275 ------TQMERVRIITDVRNLKFPLLFTQ------------KYPQEHMMVQDML--SPSP 314
Query: 578 SLRPTMSRVLQM 589
+ RP + +++
Sbjct: 315 TERPEATDIIEN 326
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFY---NEVNIISSVEHKN 370
F + ++G G FG VY + + +A+K++ ++ + + EV + + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++ GC + LV E+ + D K L + + G ++GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+IHRD+KA NILL K+ DFG A S + GT +MAPE +
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 224
Query: 491 GQLTE---KADVYSFGMLLLEIVTG 512
+ K DV+S G+ +E+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAER 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA---ANFYNEVNIISSVEH 368
F+ LG+G FG VY +A+K LF +A EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N++RL G L+ E+ P ++ R + K ++ I L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H + R+IHRDIK N+LL S KIADFG + + + GTL Y+ PE +
Sbjct: 126 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMI 179
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
EK D++S G+L E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 36/230 (15%), Positives = 73/230 (31%), Gaps = 23/230 (10%)
Query: 304 KYSTLEKATGSFDEANKLGQGGFGTVYKGV------LPDGREIAVKRLFFNNRHRAANFY 357
+ + + + LG+G F VY+ + ++ +K N
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 358 NEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI--FDSAKAKTLTWEKRY 415
+ + ++ S+LV E +L I + + K +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-----------KIADFGLARS 464
+ + + +H+ IIH DIK N +L + + D G +
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 465 FQ-EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ K I TA T G+ E L++ + D + + ++ G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 33/238 (13%), Positives = 68/238 (28%), Gaps = 53/238 (22%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA------------------------- 354
LGQ + G V +F R +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 355 ---NFYNEVNIISSVEHKNLVRLLGC--SCSGPESLLVYEFLPNQSLDRF--IFD-SAKA 406
F +++ + K ++R+ +Y + + + S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466
K+L R ++ L + L LH ++H ++ +I+LD R + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 467 EDKSHISTAIAGTLGYMAPEYLAH-----------GQLTEKADVYSFGMLLLEIVTGR 513
+ + G+ PE A +T D ++ G+++ I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 312 TGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHK 369
G F+ +G G +G VYKG + G+ A+K + E+N++ H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHR 81
Query: 370 NLVRLLGC-----SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL-GTV 422
N+ G + L LV EF S+ + + K TL E+ I +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK-EEWIAYICREIL 139
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
GL +LH+ ++IHRDIK N+LL K+ DFG++ +T I GT +
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 195
Query: 483 MAPEYLAHGQLTE-----KADVYSFGMLLLEIVTG 512
MAPE +A + + K+D++S G+ +E+ G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 5e-29
Identities = 30/232 (12%), Positives = 60/232 (25%), Gaps = 42/232 (18%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNR-------------------------HRAA 354
LGQ + G V +F R +A
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 355 NFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP-------NQSLDRFIFDSAKA- 406
+ V+ +++ + ++ F Q+ + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466
K+L R ++ L + L LH ++H ++ +I+LD R + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 467 EDKSHISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGR 513
A L +T D ++ G+ + I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN-----EVNI---IS 364
++ ++G G +GTVYK G +A+K + N EV + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 365 SVEHKNLVRLL----GCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIIL 419
+ EH N+VRL+ + LV+E + +Q L ++ D A L E +++
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 127
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ GL +LH I+HRD+K NIL+ S K+ADFGLAR + + T + T
Sbjct: 128 QFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVVT 182
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
L Y APE L D++S G + E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 16/198 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+G+G F V + + G++ AVK + + + E +I ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 374 LLGCSCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LL + S L +V+EF+ L + + + + +E L Y H+
Sbjct: 91 LLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 432 SKIRIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
IIHRD+K +LL S+ + K+ FG+A E GT +MAPE +
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMAPEVV 205
Query: 489 AHGQLTEKADVYSFGMLL 506
+ DV+ G++L
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 26/248 (10%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE------ANKLGQGGFGT 328
ER S L + F + + G+ + LG G FG
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ 104
Query: 329 VYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385
V+K G ++A K R NE+++++ ++H NL++L S + +
Sbjct: 105 VHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 386 LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKAS 444
LV E++ L DR I ++ LT + EG+ ++H+ I+H D+K
Sbjct: 163 LVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPE 216
Query: 445 NILLDSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502
NIL +R KI DFGLAR ++ + GT ++APE + + ++ D++S
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 503 G----MLL 506
G MLL
Sbjct: 275 GVIAYMLL 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 32/223 (14%)
Query: 308 LEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNE 359
++ +T F + LG+G FG V G+E AVK + + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 360 VNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSL-DRFI----FDSAKAKTLTWEK 413
V ++ ++H N+++L LV E L D I F A +
Sbjct: 77 VQLLKQLDHPNIMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII--- 132
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKS 470
+L + Y+H+ I+HRD+K N+LL+S+ +I DFGL+ F+ K
Sbjct: 133 --RQVLSGIT---YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 471 HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
GT Y+APE L HG EK DV+S G++L +++G
Sbjct: 185 M--KDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 56/252 (22%), Positives = 102/252 (40%), Gaps = 30/252 (11%)
Query: 286 SNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRL 345
+ + L N LN +K + L QG F + D + A+K+
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKY 62
Query: 346 F-----------------FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388
+ + + +F NE+ II+ ++++ + G + E ++Y
Sbjct: 63 EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122
Query: 389 EFLPNQSL-----DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKA 443
E++ N S+ F+ D + + II + Y+H ++ I HRD+K
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKP 180
Query: 444 SNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT--EKADVYS 501
SNIL+D R K++DFG + + K S GT +M PE+ ++ K D++S
Sbjct: 181 SNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 502 FGMLLLEIVTGR 513
G+ L +
Sbjct: 238 LGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF---FNNRHRAANFYNEVNIISSVEH 368
FD LG+G FG VY + +A+K LF E+ I S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVE 423
N++R+ L+ EF P L + + FD ++ T E +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LAD 125
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L Y HE+ ++IHRDIK N+L+ + KIADFG + + T + GTL Y+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYL 179
Query: 484 APEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE + EK D++ G+L E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 44/236 (18%)
Query: 306 STLEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVKRL-------------FF 347
+ K G E+ KLG G +G V E A+K +
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 348 NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKA 406
N YNE++++ S++H N+++L + LV EF L F+
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGEL----FEQIIN 139
Query: 407 KTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR---LRAKIA 457
+ ++ I+ + G+ YLH+ + I+HRDIK NILL+++ L KI
Sbjct: 140 R-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191
Query: 458 DFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
DFGL+ F +D GT Y+APE L + EK DV+S G+++ ++ G
Sbjct: 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 29/247 (11%)
Query: 280 ERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGR 338
+ L F S + + KLG G +G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 339 EIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQS 395
E A+K + + + + EV ++ ++H N+++L + LV E
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKGGE 122
Query: 396 LDRFIFDSAKAKTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD 449
L FD + ++ II + G+ YLH+ + I+HRD+K N+LL+
Sbjct: 123 L----FDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170
Query: 450 SR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
S+ KI DFGL+ F+ K GT Y+APE L + EK DV+S G++L
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVL-RKKYDEKCDVWSIGVIL 227
Query: 507 LEIVTGR 513
++ G
Sbjct: 228 FILLAGY 234
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 23/244 (9%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE----ANKLGQGGFGTVY 330
+ + ND +K + + + +E GS + +LG G FG V+
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKK---YVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 331 KGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389
+ V GR K + NE++I++ + H L+ L E +L+ E
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128
Query: 390 FLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448
FL L DR A+ ++ + + EGL ++HE I+H DIK NI+
Sbjct: 129 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMC 182
Query: 449 DSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG--- 503
+++ + KI DFGLA D+ T + APE + + D+++ G
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
Query: 504 -MLL 506
+LL
Sbjct: 241 YVLL 244
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN-----EVNIISSVE 367
+++ + LG+G F TVYK + +A+K++ +R A + N E+ ++ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
H N++ LL LV++F+ L+ I D++ T + K Y +L T++GL Y
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEY 127
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH+ I+HRD+K +N+LLD K+ADFGLA+SF + T T Y APE
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPEL 183
Query: 488 LAHGQL-TEKADVYSFGMLLLEIVTGR 513
L ++ D+++ G +L E++
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--------RAANFYNEVNIISS 365
+ + K+G+G +G VYK GR +A+KR+ + R E++++
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR------EISLLKE 75
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEII 418
+ H N+V L+ L LV+EF+ + L + + ++ K ++
Sbjct: 76 LHHPNIVSLIDV-IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQ------ 127
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+ G+ + H+ RI+HRD+K N+L++S K+ADFGLAR+F T
Sbjct: 128 --LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV 181
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
TL Y AP+ L + + D++S G + E++TG+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLF----FNNRHRAANFYNEVNI 362
T E+ ++ +G G FG V++ L + E+A+K++ F NR E+ I
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR--------ELQI 85
Query: 363 ISSVEHKNLVRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAK-TLTWEK-- 413
+ V+H N+V L S + LV E++P +++ R AK K T+
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIK 144
Query: 414 --RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKS 470
Y+++ L Y+H I I HRDIK N+LLD K+ DFG A+ +
Sbjct: 145 LYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 471 HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
++S I + Y APE + T D++S G ++ E++ G+
Sbjct: 198 NVSY-IC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
KLG G FG V+ G E +K + ++ E+ ++ S++H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 378 SCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
++ +V E L +R + A+ K L+ E++ + L Y H Q
Sbjct: 89 -FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---H 144
Query: 436 IIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
++H+D+K NIL KI DFGLA F+ D+ T AGT YMAPE
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVF-KRD 201
Query: 493 LTEKADVYSFGMLL 506
+T K D++S G+++
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRH--------RAANFYNEVNIISSV 366
+ K+G+G +G VYK G A+K++ R E++I+ +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKEL 57
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEIIL 419
+H N+V+L + L LV+E L Q L + + +S AK+ +
Sbjct: 58 KHSNIVKLYDV-IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ G+ Y H++ R++HRD+K N+L++ KIADFGLAR+F T T
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVT 163
Query: 480 LGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
L Y AP+ L + + D++S G + E+V G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 314 SFDEANKLGQGGFGTVYKG--VLPDGREIAVKRLFFNNRH--------RAANFYNEVNI- 362
++ ++G+G +G V+K + GR +A+KR+ R EV +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------EVAVL 65
Query: 363 --ISSVEHKNLVRLL----GCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
+ + EH N+VRL L LV+E + +Q L ++ D + E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
+++ + GL +LH R++HRD+K NIL+ S + K+ADFGLAR + + T+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TS 178
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ TL Y APE L D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 48/240 (20%), Positives = 90/240 (37%), Gaps = 16/240 (6%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDE----ANKLGQGGFGTVY 330
+ R + + D + +E + +LG G FG V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 331 KGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389
+ G A K + + E+ +S + H LV L E +++YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 390 FLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448
F+ L ++ + ++ ++ E + +GL ++HE + +H D+K NI+
Sbjct: 235 FMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMF 288
Query: 449 DSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
++ K+ DFGL +S GT + APE + D++S G+L
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-----FYNEVNIISSVEHKNLV 372
LG+G FG V K +E AVK + N+ A N EV ++ ++H N++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 373 RLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY------EIILGTVEGL 425
+L S +V E L FD + KR+ II G+
Sbjct: 85 KLFE-ILEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIKQVFSGI 134
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
Y+H+ I+HRD+K NILL+S+ KI DFGL+ FQ++ GT Y
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYY 189
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
+APE L G EK DV+S G++L +++G
Sbjct: 190 IAPEVL-RGTYDEKCDVWSAGVILYILLSGT 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
LG G F V+ G+ A+K + + R ++ NE+ ++ ++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIRII 437
S LV + + L FD + + EK +I + + YLHE I+
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 438 HRDIKASNILL-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
HRD+K N+L +S++ I DFGL++ Q +ST GT GY+APE LA
Sbjct: 129 HRDLKPENLLYLTPEENSKI--MITDFGLSKMEQNGI--MST-ACGTPGYVAPEVLAQKP 183
Query: 493 LTEKADVYSFGMLL 506
++ D +S G++
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 19/196 (9%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRLLGC 377
LG+G FG V++ V + K F + E++I++ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
S E ++++EF+ + +R A L + + E L +LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHN---I 123
Query: 437 IHRDIKASNILLDSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
H DI+ NI+ +R + KI +FG AR + + + Y APE H ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVS 181
Query: 495 EKADVYSFG----MLL 506
D++S G +LL
Sbjct: 182 TATDMWSLGTLVYVLL 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+LG+G F V + V + G+E A + + E I ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 377 CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKI 434
S S L+++ + L F+ A+ E I +E +++ H+
Sbjct: 78 -SISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMG-- 130
Query: 435 RIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
++HR++K N+LL S+L+ K+ADFGLA + ++ AGT GY++PE L
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLRKD 188
Query: 492 QLTEKADVYSFGMLL 506
+ D+++ G++L
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH--------RAANFYNEVNIISS 365
+++ K+G+G +GTV+K +A+KR+ ++ R E+ ++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKE 57
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEII 418
++HKN+VRL + L LV+EF Q L ++ D K+ ++
Sbjct: 58 LKHKNIVRLHDV-LHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
++GL + H + ++HRD+K N+L++ K+A+FGLAR+F +A
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV 163
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQ 514
TL Y P+ L +L + D++S G + E+ +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 35/230 (15%)
Query: 293 VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK----RLFF 347
++ + Y E+ LG G F V K G E A K R
Sbjct: 2 MEPFKQQKVEDFYDIGEE----------LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 348 NNRHRA--ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAK 405
+R EV+I+ V H N++ L + + +L+ E + L FD
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLA 107
Query: 406 AKTLTWEKRYEIILGT-VEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFG 460
K E+ + ++G+ YLH + I H D+K NI+L + K+ DFG
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFG----MLL 506
LA ++ I GT ++APE + + L +AD++S G +LL
Sbjct: 165 LAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
LG+G FG V K +E AVK + EV ++ ++H N+++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST---ILREVELLKKLDHPNIMK 85
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQ 431
L S +V E L FD + E II G+ Y+H+
Sbjct: 86 LFE-ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 432 SKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+ I+HRD+K NILL+S+ KI DFGL+ FQ++ GT Y+APE L
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVL 195
Query: 489 AHGQLTEKADVYSFGMLL 506
G EK DV+S G++L
Sbjct: 196 -RGTYDEKCDVWSAGVIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 24/198 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+LG+G F V + V G E A K +L + + E I ++H N+VR
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVR 69
Query: 374 LLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYLHEQ 431
L S LV++ + L F+ A+ + I +E + Y H
Sbjct: 70 LHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 432 SKIRIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
I+HR++K N+LL S+ + K+ADFGLA + ++ AGT GY++PE L
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVL 179
Query: 489 AHGQLTEKADVYSFGMLL 506
++ D+++ G++L
Sbjct: 180 KKDPYSKPVDIWACGVIL 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRA--ANFYNEVNIISSVEHKNLV 372
+LG G F V K G E A K R +R EV+I+ V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV-EGLVYLHEQ 431
L + + +L+ E + L FD K E+ + + +G+ YLH +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 432 SKIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
I H D+K NI+L + K+ DFGLA ++ I GT ++APE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 488 LAHGQLTEKADVYSFG----MLL 506
+ + L +AD++S G +LL
Sbjct: 190 VNYEPLGLEADMWSIGVITYILL 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--------FFNNRHRAANFYNEVNIISSVEHKN 370
LG G G V +++A++ + A N E+ I+ + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSL-DRFI----FDSAKAKTLTWEKRYEIILGTVEGL 425
++++ + +V E + L D+ + A K Y++ + +
Sbjct: 202 IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQM----LLAV 252
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
YLHE IIHRD+K N+LL S+ KI DFG ++ + S + T + GT Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRT-LCGTPTY 307
Query: 483 MAPEYLAHGQL---TEKADVYSFGMLL 506
+APE L D +S G++L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRA--ANFYNEVNIISSVEHKNLV 372
+LG G F V K G+E A K R ++R EVNI+ + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYLHEQ 431
L + + +L+ E + L FD K +LT ++ + + ++G+ YLH +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 432 SKIRIIHRDIKASNILLDSRLRA----KIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
RI H D+K NI+L + K+ DFG+A + I GT ++APE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 488 LAHGQLTEKADVYSFG----MLL 506
+ + L +AD++S G +LL
Sbjct: 183 VNYEPLGLEADMWSIGVITYILL 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 306 STLEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRAANF 356
+ A+ F + +LG+G F V + V G E A K + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--L 75
Query: 357 YNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKR- 414
E I ++H N+VRL S LV++ + L F+ A+ E
Sbjct: 76 EREARICRKLQHPNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADA 130
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA---KIADFGLARSFQEDKSH 471
I +E + Y H I+HR++K N+LL S+ + K+ADFGLA + ++
Sbjct: 131 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
AGT GY++PE L ++ D+++ G++L
Sbjct: 188 --HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLF----FNNRHRAANFYNEVNII 363
K F GQG FGTV G G +A+K++ F NR E+ I+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--------ELQIM 70
Query: 364 ---SSVEHKNLVRLLGCSCSGPES-------LLVYEFLPNQSLDRFIFDSAKAK-TLTWE 412
+ + H N+V+L + E +V E++P +L R + + +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPI 129
Query: 413 K----RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQE 467
+++I + LH S + + HRDIK N+L++ + K+ DFG A+
Sbjct: 130 LIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 468 DKSHISTAIAGTLGYMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
+ +++ I + Y APE + T D++S G + E++ G
Sbjct: 185 SEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 55/195 (28%), Positives = 82/195 (42%), Gaps = 21/195 (10%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC 377
LG+G F K V + AVK + ++ AN E+ + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIRI 436
+ LV E L L F+ K K E I+ V + ++H+ +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 437 IHRDIKASNILL-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+HRD+K N+L + + KI DFG AR D + T TL Y APE L
Sbjct: 128 VHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQN 184
Query: 492 QLTEKADVYSFGMLL 506
E D++S G++L
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 27/198 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+G+G +G V V A K++ F E+ I+ S++H N++RL +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 74
Query: 379 CSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY------EIILGTVEGLVYLHEQ 431
+ LV E L F+ K + + I+ + + Y H+
Sbjct: 75 FEDNTDIYLVMELCTGGEL----FERVVHK-----RVFRESDAARIMKDVLSAVAYCHKL 125
Query: 432 SKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+ HRD+K N L + K+ DFGLA F+ K GT Y++P+ L
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180
Query: 489 AHGQLTEKADVYSFGMLL 506
G + D +S G+++
Sbjct: 181 -EGLYGPECDEWSAGVMM 197
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 57/233 (24%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN----------RHRAANFYNEVNI 362
+++ K+GQG FG V+K G+++A+K++ N R E+ I
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR--------EIKI 69
Query: 363 ISSVEHKNLVRLLG-------CSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKT 408
+ ++H+N+V L+ S+ LV++F L + F ++ K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR 128
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
+ + GL Y+H +I+HRD+KA+N+L+ K+ADFGLAR+F
Sbjct: 129 VMQM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 469 KSHIS---TAIAGTLGYMAPEYLAHGQLTEKA-----DVYSFGMLLLEIVTGR 513
K+ T TL Y PE L L E+ D++ G ++ E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 53/244 (21%), Positives = 81/244 (33%), Gaps = 53/244 (21%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK-----RLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+GQG +G V + A+K ++ N EV ++ + H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 374 LLGC------------SCSGPE-------------------SLLVYEFLPNQSLDRFIFD 402
L C G + + + I
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 403 SAKAKTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-- 454
S + + I+ L YLH Q I HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 455 KIADFGLARSFQEDKSHIS---TAIAGTLGYMAPEYLAHGQL--TEKADVYSFGMLLLEI 509
K+ DFGL++ F + + T AGT ++APE L K D +S G+LL +
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 510 VTGR 513
+ G
Sbjct: 270 LMGA 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRH-------RAANFYNEVNIISS 365
++ + +KLG+G + TVYKG +A+K + + R EV+++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLKD 56
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI------FDSAKAKTLTWEKRYEII 418
++H N+V L +SL LV+E+L ++ L +++ + K ++
Sbjct: 57 LKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ------ 108
Query: 419 LGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAG 478
+ GL Y H Q +++HRD+K N+L++ R K+ADFGLAR+ +
Sbjct: 109 --LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV 162
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
TL Y P+ L + + D++ G + E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRA--ANFYNEVNIISSVEHKNLV 372
+LG G F V K G + A K R ++R + EV+I+ ++H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYLHEQ 431
L + + +L+ E + L FD K +LT E+ E + + G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 432 SKIRIIHRDIKASNILLDSRLRA----KIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
I H D+K NI+L R KI DFGLA I GT ++APE
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 488 LAHGQLTEKADVYSFG----MLL 506
+ + L +AD++S G +LL
Sbjct: 189 VNYEPLGLEADMWSIGVITYILL 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 41/221 (18%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRH-------RAANFYNEVNIISS 365
F + KLG G + TVYKG+ G +A+K + ++ R E++++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKE 59
Query: 366 VEHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFI-----------FDSAKAKTLTWEK 413
++H+N+VRL L LV+EF+ L +++ + K W+
Sbjct: 60 LKHENIVRLYDV-IHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 414 RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS 473
++GL + HE +I+HRD+K N+L++ R + K+ DFGLAR+F + S
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166
Query: 474 TAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
+ + TL Y AP+ L + + D++S G +L E++TG+
Sbjct: 167 SEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLF----FNNRHRAANFYNE 359
S+ + +G G FG VY+ L G +A+K++ F NR E
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------E 97
Query: 360 VNIISSVEHKNLVRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAK-TLTWE 412
+ I+ ++H N+VRL S E LV +++P +++ R ++AK TL
Sbjct: 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVI 156
Query: 413 K----RYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQE 467
Y++ L Y+H I HRDIK N+LLD K+ DFG A+
Sbjct: 157 YVKLYMYQLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 468 DKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
+ ++S I + Y APE + T DV+S G +L E++ G+
Sbjct: 210 GEPNVSY-IC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 310 KATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVK---------RLFFNNRHRAAN 355
+T F E LG+G V + + P +E AVK +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 356 FYNEVNIISSV-EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAK-TLTWE 412
EV+I+ V H N+++L + LV++ + L FD K TL+ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472
+ +I+ +E + LH+ I+HRD+K NILLD + K+ DFG + +
Sbjct: 125 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL- 180
Query: 473 STAIAGTLGYMAPEYLAHGQL------TEKADVYSFGMLL 506
+ GT Y+APE + ++ D++S G+++
Sbjct: 181 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 57/245 (23%), Positives = 90/245 (36%), Gaps = 36/245 (14%)
Query: 276 QRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEA----NKLGQGGFGTVYK 331
E S + SL Y + + ++LG+G VY+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 332 GV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYE 389
+ A+K E+ ++ + H N+++L P + LV E
Sbjct: 72 CKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKE-IFETPTEISLVLE 128
Query: 390 FLPNQSLDRFIFDSAKAKTLTWEKRY------EIILGTVEGLVYLHEQSKIRIIHRDIKA 443
+ L FD K Y + + +E + YLHE I+HRD+K
Sbjct: 129 LVTGGEL----FDRIVEK-----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKP 176
Query: 444 SNILL-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
N+L D+ L KIADFGL++ + + GT GY APE L + D
Sbjct: 177 ENLLYATPAPDAPL--KIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 499 VYSFG 503
++S G
Sbjct: 233 MWSVG 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--------FFNNRHRAANFYNEVNIISSVEHKN 370
LG G G V +++A+K + A N E+ I+ + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSL-DRFI----FDSAKAKTLTWEKRYEIILGTVEGL 425
++++ + +V E + L D+ + A K Y++ + +
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQM----LLAV 127
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
YLHE IIHRD+K N+LL S+ KI DFG ++ + S + T + GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRT-LCGTPTY 182
Query: 483 MAPEYLAHGQL---TEKADVYSFGMLL 506
+APE L D +S G++L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 314 SFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN--EVNIISSVEHKN 370
+ KLG+G +G VYK + +A+KR+ + EV+++ ++H+N
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 371 LVRLLGCSCSGPESL-LVYEFLPNQSLDRFI-----FDSAKAKTLTWEKRYEIILGTVEG 424
++ L L L++E+ L +++ K+ ++ + G
Sbjct: 95 IIELKSV-IHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ--------LING 144
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRA-----KIADFGLARSFQEDKSHISTAIAGT 479
+ + H + R +HRD+K N+LL + KI DFGLAR+F T T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIIT 200
Query: 480 LGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR 513
L Y PE L + + D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA----NFYNEVNIISSVEH-KNLVR 373
+LG+G F V + + G+E A K F R R +E+ ++ + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 374 LLGCSCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L + E +L+ E+ + + + A+ ++ +I +EG+ YLH+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 433 KIRIIHRDIKASNILLDSR---LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
I+H D+K NILL S KI DFG++R I GT Y+APE L
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILN 206
Query: 490 HGQLTEKADVYSFG----MLL 506
+ +T D+++ G MLL
Sbjct: 207 YDPITTATDMWNIGIIAYMLL 227
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 33/217 (15%)
Query: 306 STLEKATGSFDEA----NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEV 360
L + + F + +G G + + + E AVK + + E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEI 66
Query: 361 NII-SSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY---- 415
I+ +H N++ L G +V E + L D + K +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSERE 117
Query: 416 --EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQEDK 469
++ + + YLH Q ++HRD+K SNIL +I DFG A+ + +
Sbjct: 118 ASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 470 SHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
+ T T ++APE L D++S G+LL
Sbjct: 175 GLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN--EVNIISSVEHKNLVRLL 375
K+G+G +G V+K G+ +A+K+ + E+ ++ ++H NLV LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
LV+E+ + ++ + + K T++ + + H+
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCHKH---N 122
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
IHRD+K NIL+ K+ DFG AR + +A T Y +PE L
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYG 181
Query: 496 KA-DVYSFGMLLLEIVTGR 513
DV++ G + E+++G
Sbjct: 182 PPVDVWAIGCVFAELLSGV 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 320 KLGQGGFGTVYKGV---LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
K+G+G +G VYK D ++ A+K++ +A E+ ++ ++H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 85
Query: 377 -CSCSGPESL-LVYEFL-------------PNQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
+ L++++ + K+L ++ IL
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-----IL-- 138
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA----KIADFGLARSFQEDK---SHIST 474
+G+ YLH ++HRD+K +NIL+ KIAD G AR F + +
Sbjct: 139 -DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 475 AIAGTLGYMAPEYLAHGQL-----TEKADVYSFGMLLLEIVTGR 513
+ T Y APE L L T+ D+++ G + E++T
Sbjct: 195 VVV-TFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 64/237 (27%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK--------------------------RLFFNNRHRA 353
+G+G +G V D A+K R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 354 ANFYNEVNIISSVEHKNLVRLLGCSCSGPESL---------LVYEFLPNQSLDRFIFDSA 404
Y E+ I+ ++H N+V+L+ E L +V+E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-------EVLDDPNEDHLYMVFELVNQGPV----MEVP 129
Query: 405 KAKTLTWEK---RY--EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459
K L+ E Y ++I G +E YLH Q +IIHRDIK SN+L+ KIADF
Sbjct: 130 TLKPLS-EDQARFYFQDLIKG-IE---YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT---EKADVYSFGMLLLEIVTGR 513
G++ F+ + +S GT +MAPE L+ + + DV++ G+ L V G+
Sbjct: 182 GVSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL--------FFNNRHRAANFYNEVNIISSV-EHK 369
+G+G V + V G E AVK + E +I+ V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 370 NLVRLLGCSCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
+++ L+ S + LV++ + L D + L+ ++ I+ +E + +
Sbjct: 161 HIITLID-SYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSF 215
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
LH I+HRD+K NILLD ++ +++DFG + + + + GT GY+APE
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEI 270
Query: 488 LAHGQL------TEKADVYSFGMLL 506
L ++ D+++ G++L
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 69/252 (27%), Positives = 109/252 (43%), Gaps = 31/252 (12%)
Query: 277 RSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKAT-GSFDEANKLGQGGFGTVYKGVLP 335
R + A+ L + L +K+ + T +F + LG+GGFG V +
Sbjct: 147 RLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 336 DGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEF 390
++ A K+L R A NE I+ V + +V L + ++L LV
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTL 265
Query: 391 LPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSKIRIIHRDI 441
+ + + F A+A Y EI G L LH + RI++RD+
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVF------YAAEICCG----LEDLHRE---RIVYRDL 312
Query: 442 KASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYS 501
K NILLD +I+D GLA E ++ GT+GYMAPE + + + T D ++
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 502 FGMLLLEIVTGR 513
G LL E++ G+
Sbjct: 371 LGCLLYEMIAGQ 382
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN--EVNIISSVEHKNLVRLL 375
+G+G +G V K GR +A+K+ ++ + E+ ++ + H+NLV LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 376 GCSCSGPESL-LVYEFLPN---QSLDRF--IFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
C + LV+EF+ + L+ F D + ++ + G+ + H
Sbjct: 91 EV-CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ--------IINGIGFCH 141
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL- 488
IIHRDIK NIL+ K+ DFG AR+ + T Y APE L
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLV 197
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ + DV++ G L+ E+ G
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 20/248 (8%)
Query: 277 RSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKAT-GSFDEANKLGQGGFGTVYKGVLP 335
R++ + E L L +K+ + F + LG+GGFG V+ +
Sbjct: 148 RAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 336 DGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEF 390
++ A K+L R E I++ V + +V L + L LV
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTI 266
Query: 391 LPNQSLDRFIFDSAKAKTLTWEKR---Y--EIILGTVEGLVYLHEQSKIRIIHRDIKASN 445
+ + I++ + E R Y +I+ G L +LH++ II+RD+K N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319
Query: 446 ILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGML 505
+LLD +I+D GLA + ++ AGT G+MAPE L + D ++ G+
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 506 LLEIVTGR 513
L E++ R
Sbjct: 379 LYEMIAAR 386
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 309 EKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK--------RLFFNNRHRAANFYNE 359
+ + + + LG G FG V+ V +E+ VK + + E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 360 VNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY---E 416
+ I+S VEH N++++L + LV E + LD F F + Y +
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
++ V YL + IIHRDIK NI++ K+ DFG A + K T
Sbjct: 139 LVSA-VG---YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF- 189
Query: 477 AGTLGYMAPEYLAHGQLTE--KADVYSFGMLLLEIVTGR 513
GT+ Y APE L G + +++S G+ L +V
Sbjct: 190 CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 32/225 (14%)
Query: 299 DSLNFKYSTLEKATGSFDE-----ANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR 352
L + E + + LG G G V + G++ A+K L +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YD 64
Query: 353 AANFYNEVNIISSV-EHKNLVRLLG----CSCSGPESLLVYEFLPNQSL-DRFIFDSAKA 406
+ EV+ ++V +L L++ E + L R
Sbjct: 65 SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGD 122
Query: 407 KTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL-----DSRLRAKIADFGL 461
+ T + EI+ + +LH + I HRD+K N+L D+ L K+ DFG
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL--KLTDFGF 177
Query: 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
A+ ++ + T T Y+APE L + + D++S G+++
Sbjct: 178 AKETTQNA--LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G FG V D +++ A+K + R+ N + E+ I+ +EH LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 377 CSCSGPESL-LVYEFLPNQSLDRF------IFDSAKAKTLTWEKRY--EIILGTVEGLVY 427
E + +V + L L R+ F K + E+++ L Y
Sbjct: 83 SFQD-EEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKL------FICELVMA----LDY 130
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
L Q RIIHRD+K NILLD I DF +A + + +AGT YMAPE
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 488 LAHGQL---TEKADVYSFGMLLLEIVTGR 513
+ + + D +S G+ E++ GR
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 28/205 (13%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCS 378
LG+G V + L +E AVK + H + + EV ++ + H+N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQSKIRII 437
LV+E + S+ + E ++ L +LH + I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 438 HRDIKASNILL-----DSRLRAKIADFGLARSFQEDKSHISTA------IAGTLGYMAPE 486
HRD+K NIL S + KI DF L + + + G+ YMAPE
Sbjct: 134 HRDLKPENILCEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 487 YLAHGQLT-----EKADVYSFGMLL 506
+ ++ D++S G++L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN---------EVNIISSVEHK- 369
LG GGFG+VY G+ + D +A+K + + R +++ EV ++ V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 370 -NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRY---EIILGTVEGL 425
++RLL +L+ E P D F F + + R +++ E +
Sbjct: 108 SGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVL----EAV 162
Query: 426 VYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
+ H ++HRDIK NIL+D R K+ DFG ++ + + GT Y
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDF-DGTRVYSP 216
Query: 485 PEYLA----HGQLTEKADVYSFGMLLLEIVTGR 513
PE++ HG+ A V+S G+LL ++V G
Sbjct: 217 PEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLL--- 375
LG GG G V+ V + +A+K++ + + E+ II ++H N+V++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 376 -------GCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVE 423
L +V E++ L + + L E R + +
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQGPLLEEHARL-FMYQLLR 131
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHIS--TAIAGTL 480
GL Y+H + ++HRD+K +N+ +++ L KI DFGLAR SH + T
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 481 GYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGR 513
Y +P L+ T+ D+++ G + E++TG+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANF-----YNEVNIISSVEHKNLVRL 374
+G+G F V + GRE+A+K + ++ + + EV I+ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLH 429
+ L+ E+ + FD A EK +I+ V+ Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSA-VQ---YCH 131
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++ RI+HRD+KA N+LLD+ + KIADFG + F + G Y APE
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-CGAPPYAAPELFQ 186
Query: 490 HGQLTE--KADVYSFGMLLLEIVTGR 513
G+ + + DV+S G++L +V+G
Sbjct: 187 -GKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK----RLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG+G +G V + + AVK + + AN E+ ++ + HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 376 G-CSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLT-WE-KRY--EIILGTVEGLVYLH 429
+ + +V E+ + + DS K + Y ++I G +E YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG-LE---YLH 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE--DKSHISTAIAGTLGYMAPEY 487
Q I+H+DIK N+LL + KI+ G+A + T+ G+ + PE
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEI 182
Query: 488 LAHGQLTE--KADVYSFGMLLLEIVTGR 513
K D++S G+ L I TG
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 53/244 (21%), Positives = 93/244 (38%), Gaps = 35/244 (14%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV- 333
Q ++ K + +++ Y + LG G G V +
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFN 83
Query: 334 LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC---SCSGPESL-LVY 388
+ A+K L EV + + ++VR++ +G + L +V
Sbjct: 84 KRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 389 EFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447
E L L R + T + EI+ E + YLH + I HRD+K N+L
Sbjct: 139 ECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 193
Query: 448 L-----DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSF 502
++ L K+ DFG A+ S ++T T Y+APE L + + D++S
Sbjct: 194 YTSKRPNAIL--KLTDFGFAKETTSHNS-LTT-PCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 503 GMLL 506
G+++
Sbjct: 250 GVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNI---ISSVEHKNLVR 373
+G+GGFG VY D ++ A+K L + NE + +S+ + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 374 LLGCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVE 423
+ + P+ L + + + F + Y EIILG
Sbjct: 257 MSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--------YAAEIILG--- 304
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
L ++H + +++RD+K +NILLD +I+D GLA F + K H A GT GYM
Sbjct: 305 -LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 484 APEYLAHGQL-TEKADVYSFGMLLLEIVTG----RQNNRSKNSEYTDSLLT 529
APE L G AD +S G +L +++ G RQ+ E LT
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 49/256 (19%), Positives = 104/256 (40%), Gaps = 68/256 (26%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF----FNNRHRAANFYNEVNI 362
LE ++ + LG G FG V + + G+ A+K++ + NR E++I
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELDI 53
Query: 363 ISSVEHKNLVRLLGCSCSGPESL------------------------------------- 385
+ ++H N+++L+ + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 386 -LVYEFLPNQSLDRFIFDSAKAK-TLTWEK----RYEIILGTVEGLVYLHEQSKIRIIHR 439
++ E++P +L + + ++ ++ Y++ + ++H + I HR
Sbjct: 114 NVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA----VGFIH---SLGICHR 165
Query: 440 DIKASNILLDSRL-RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLTEKA 497
DIK N+L++S+ K+ DFG A+ + ++ I + Y APE L + T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYTPSI 223
Query: 498 DVYSFGMLLLEIVTGR 513
D++S G + E++ G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNL 371
+ +G G G V R +A+K+L F N+ A Y E+ ++ V HKN+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 372 VRLLGCSCSGPESL------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ LL +V E + +L + I L E+ ++ + G+
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGI 140
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y AP
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 195
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E + E D++S G ++ E++ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLF-----------FNNRHRAANFYNEVNIISSVEH 368
+ G +G V GV +G +A+KR+F ++ E+ +++ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 369 KNLVRLLGCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILG 420
N++ L LV E + L + I + ++ + +Y +
Sbjct: 89 PNILGLRDIFV--HFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQY-FMYH 142
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTL 480
+ GL LHE ++HRD+ NILL I DF LAR D T
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHR 197
Query: 481 GYMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
Y APE + T+ D++S G ++ E+ +
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN----EVNIISSVEHKNLVRLL 375
LG+G +G V V +AVK + + RA + E+ I + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRY---EIILGTVEGLVYLHE 430
G G L E+ L FD + + +++ G V YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG-VV---YLHG 123
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYL 488
I HRDIK N+LLD R KI+DFGLA F+ + ++ GTL Y+APE L
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL 179
Query: 489 A----HGQLTEKADVYSFGMLLLEIVTGR 513
H E DV+S G++L ++ G
Sbjct: 180 KRREFHA---EPVDVWSCGIVLTAMLAGE 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 41/220 (18%)
Query: 314 SFDEANKLGQGGFGTVY----KGVLPDGREIAVKRL---FFNNRHRAANFYNEVNIISSV 366
F LG+G F TV RE A+K L ++ E +++S +
Sbjct: 31 DFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAK---AKTLTWEKRY 415
+H V+L + E L + N + + F + A
Sbjct: 88 DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--------- 137
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA 475
EI+ L YLH + IIHRD+K NILL+ + +I DFG A+ +
Sbjct: 138 EIVSA----LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 476 -IAGTLGYMAPEYLAHGQLTEKA-DVYSFGMLLLEIVTGR 513
GT Y++PE L + K+ D+++ G ++ ++V G
Sbjct: 191 SFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 5e-21
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNL 371
+ +G G G V R +A+K+L F N+ A Y E+ ++ V HKN+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 372 VRLLGCSCSGP------ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ LL + LV E + +L + I L E+ ++ + G+
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI-----QMELDHERMSYLLYQMLCGI 177
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH IIHRD+K SNI++ S KI DFGLAR+ S + T T Y AP
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 232
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E + E D++S G ++ E+V +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRL------FFNNRHRAANFYNEVNIISSV----EHK 369
LG+GGFGTV+ G L D ++A+K + ++ + EV ++ V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 370 NLVRLLGCSCSGPESLLVYEF-LPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVE 423
++RLL + +LV E LP Q L FD K E + +++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDL----FDYITEKGPLGEGPSRCFFGQVV----A 150
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
+ + H + ++HRDIK NIL+D R AK+ DFG ++ GT Y
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVY 204
Query: 483 MAPEYLAHGQLT-EKADVYSFGMLLLEIVTGR 513
PE+++ Q A V+S G+LL ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+G G +G+V + G ++A+K+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 376 G--CSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
S + LV F+ L + + K + +Y ++ ++GL Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQY-LVYQMLKGLKYIH 143
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YL 488
++HRD+K N+ ++ KI DFGLAR + T T Y APE L
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVIL 196
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGR 513
+ + D++S G ++ E++TG+
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G V V G ++A+K+L+ F + A Y E+ ++ + H+N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 378 SCSGPESL------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
LV F+ L + + K + L ++ ++ ++GL Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY-LAH 490
IIHRD+K N+ ++ KI DFGLAR + T T Y APE L
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILNW 200
Query: 491 GQLTEKADVYSFGMLLLEIVTGR 513
+ T+ D++S G ++ E++TG+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN----EVNIISSVEHKNLVRLL 375
LG+G +G V V +AVK + + RA + E+ I + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRY---EIILGTVEGLVYLHE 430
G G L E+ L FD + + +++ G V YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG-VV---YLHG 123
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS--HISTAIAGTLGYMAPEYL 488
I HRDIK N+LLD R KI+DFGLA F+ + ++ GTL Y+APE L
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL 179
Query: 489 A----HGQLTEKADVYSFGMLLLEIVTGR 513
H + DV+S G++L ++ G
Sbjct: 180 KRREFHAE---PVDVWSCGIVLTAMLAGE 205
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 46/204 (22%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLG 376
KLG+G + V++ + + + ++ VK L + E+ I+ ++ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 377 CSCSGPES---LLVYEFLPNQSLDRFIFDSAKAKTLT-WEKRYEIILGTVEGLVYLHEQS 432
P S LV+E + N + +TLT ++ R+ + ++ L Y H S
Sbjct: 99 IVKD-PVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRF-YMYEILKALDYCH--S 148
Query: 433 KIRIIHRDIKASNILLDSRLRA-KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I+HRD+K N+++D R ++ D+GLA + + + + + PE L
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 205
Query: 492 QLTEKA-DVYSFGMLLLEIVTGRQ 514
Q+ + + D++S G +L ++ ++
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 32/291 (10%), Positives = 72/291 (24%), Gaps = 61/291 (20%)
Query: 320 KLGQGGFGTVYKGVLPD---GREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVR 373
G ++ + D R++A+ + + +S ++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
+L + L+V E++ SL + + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+ S + + +A M
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
+ D+ G L ++ R S L + G+ E D + +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAG---VRSGLAPAERDTA-GQPIEPADIDRDIP-- 233
Query: 554 HDSNVKYEVLRAIHVGLLCTQENPSLRP--TMSRVLQMLTTEEQLPGPTSP 602
+ A+ + Q + +R T+ ++Q T P
Sbjct: 234 -------FQISAVAARSV--QGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLV 372
+ + +G+G +G V + +A+K++ F ++ E+ I+ H+N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 373 RLLGCSCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEG 424
+ ++ +V + + L + + K + L+ + Y + + G
Sbjct: 89 GIN--DIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY-FLYQILRG 140
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGY 482
L Y+H + ++HRD+K SN+LL++ KI DFGLAR D H T T Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 483 MAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
APE L T+ D++S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK---RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG G FG V G G ++AVK R + E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLHEQ 431
+ + +V E++ L FD E R +I+ V+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSA-VD---YCHRH 130
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
++HRD+K N+LLD+ + AKIADFGL+ + D + T+ G+ Y APE ++ G
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS-CGSPNYAAPEVIS-G 184
Query: 492 QLTE--KADVYSFGMLLLEIVTGR 513
+L + D++S G++L ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGT 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+G G +G+V G +AVK+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 378 SCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
SL LV + L+ + K + LT + +I + GL Y+H
Sbjct: 97 FTP-ARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLA 489
IIHRD+K SN+ ++ KI DFGLAR ++ T T Y APE L
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRAPEIMLN 203
Query: 490 HGQLTEKADVYSFGMLLLEIVTGR 513
+ D++S G ++ E++TGR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF-FNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
LG+G +G V P G +A+K++ F+ A E+ I+ +H+N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 378 SCSGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEGLVYLH 429
P+S ++ E + L R I + L+ + +Y I T+ + LH
Sbjct: 78 QR--PDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY-FIYQTLRAVKVLH 129
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLG-------- 481
+ +IHRD+K SN+L++S K+ DFGLAR E + S G
Sbjct: 130 GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 482 -YMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGR 513
Y APE L + + DV+S G +L E+ R
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 30/207 (14%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+G FG V A+K L + A+ E ++ + H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 377 CSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLV 426
S + L V E+ F D A+ Y EI+ L
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF--------YGAEIVSA----LD 262
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH S+ +++RD+K N++LD KI DFGL + +D + + T GT Y+APE
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
L D + G+++ E++ GR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 31/207 (14%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+G FG V A+K L + A+ E ++ + H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 377 CSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGLV 426
+ + L V E+ F + A+ Y EI+ L
Sbjct: 73 AFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARF--------YGAEIVSA----LE 119
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
YLH + +++RDIK N++LD KI DFGL + D + + T GT Y+APE
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 175
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
L D + G+++ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F+ +G+G FG V L + ++ A+K L R A F E +++ + + K
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 371 LVRLLGCSCSGPESL-LVYEFLP--------NQSLDRFIFDSAKAKTLTWEKRY--EIIL 419
+ L + +L LV ++ ++ DR + A+ Y E+++
Sbjct: 136 ITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF--------YLAEMVI 186
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ +H+ +HRDIK NIL+D ++ADFG ED + S+ GT
Sbjct: 187 A----IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 480 LGYMAPEYLAHGQLTEK-----ADVYSFGMLLLEIVTGR 513
Y++PE L + + D +S G+ + E++ G
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 26/204 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK---RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG+G FG V +++A+K R E++ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLHEQ 431
+ + ++V E+ + +FD K E R+ +II +E Y H
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICA-IE---YCHRH 127
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
+I+HRD+K N+LLD L KIADFGL+ + D + + T+ G+ Y APE + G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPEVIN-G 181
Query: 492 QLTE--KADVYSFGMLLLEIVTGR 513
+L + DV+S G++L ++ GR
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 47/221 (21%), Positives = 86/221 (38%), Gaps = 38/221 (17%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F+ +G+G F V + ++ A+K + R + F E +++ + + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 371 LVRLLGCSCSGPESL-LVYEFLP--------NQSLDRFIFDSAKAKTLTWEKRY--EIIL 419
+ +L + L LV E+ ++ +R + A+ Y EI++
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF--------YLAEIVM 173
Query: 420 GTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGT 479
+ +H +HRDIK NILLD ++ADFG + D + S GT
Sbjct: 174 A----IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 480 LGYMAPEYLAHGQLTEKADVY-------SFGMLLLEIVTGR 513
Y++PE L Y + G+ E+ G+
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 67/269 (24%), Positives = 104/269 (38%), Gaps = 51/269 (18%)
Query: 343 KRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD 402
+ F + + A F + + ++ RL S + +S F+ +SL +
Sbjct: 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL--DSITSSQSSASSGFVEEKSLSDVEEE 179
Query: 403 SA----KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIAD 458
A LT E +G+ +L + + IHRD+ A NILL + KI D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 459 FGLARSFQEDKSHISTAIAGT-LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQ-- 514
FGLAR +D ++ A L +MAPE + T ++DV+SFG+LL EI + G
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 515 NNRSKNSEYTDSLLTITWKHFQAGRVE-------ELYDKNLMLHNYHDSNVKYEVLRAIH 567
+ E+ L + R+ E+Y ML
Sbjct: 297 PGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQ--TMLD---------------- 331
Query: 568 VGLLCTQENPSLRPTMSRVLQMLTTEEQL 596
C PS RPT S +++ L L
Sbjct: 332 ----CWHGEPSQRPTFSELVEHL--GNLL 354
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 42/200 (21%), Positives = 73/200 (36%), Gaps = 27/200 (13%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL--FFNNRHRAANFYNEVNIISSV-EHK 369
LG+G FG V + R +AVK L + A +E+ I+ + H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 86
Query: 370 NLVRLLG-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
N+V LLG C+ G +++ EF +L ++ KR E + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+ + I D+K + S + + F E+KS + ++L
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFV------EEKSLSDVEEEEAPEDLYKDFL 190
Query: 489 AHGQLTEKADVYSFGMLLLE 508
L + + GM L
Sbjct: 191 TLEHLICYSFQVAKGMEFLA 210
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 40/244 (16%), Positives = 91/244 (37%), Gaps = 33/244 (13%)
Query: 275 KQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANK------LGQGGFGT 328
Q+ + + +++ + + +++ + + ++ +G G +G
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 329 VYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385
V + + R +A+K++ F + E+ I++ + H ++V++L P+ +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI--PKDV 126
Query: 386 -------LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEGLVYLHEQSKIRII 437
+V E + LT + ++ + G+ Y+H I+
Sbjct: 127 EKFDELYVVLEIAD-SDFKKLF---RTPVYLTELHIKT-LLYNLLVGVKYVHSA---GIL 178
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH------G 491
HRD+K +N L++ K+ DFGLAR+ ++ S
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
Query: 492 QLTE 495
QLT
Sbjct: 239 QLTG 242
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVK---RLFFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG G FG V G G ++AVK R + E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEK---RY--EIILGTVEGLVYLHEQ 431
+ + +V E++ L FD EK R +I+ G V+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSG-VD---YCHRH 135
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
++HRD+K N+LLD+ + AKIADFGL+ + D + T+ G+ Y APE ++ G
Sbjct: 136 ---MVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS-CGSPNYAAPEVIS-G 189
Query: 492 QLTE--KADVYSFGMLLLEIVTGR 513
+L + D++S G++L ++ G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGT 213
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHK 369
++ +G+G FG V R++ A+K L R +A F+ E +I++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 370 NLVRLLGCSCSGPESL-LVYEFLPN----QSLDRFIFDSAKAKTLTWEKRY--EIILGTV 422
+V+L + L +V E++P + + A+ Y E++L
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF------YTAEVVLA-- 180
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
L +H IHRD+K N+LLD K+ADFG ++ GT Y
Sbjct: 181 --LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 483 MAPEYL----AHGQLTEKADVYSFGMLLLEIVTGR 513
++PE L G + D +S G+ L E++ G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 33/207 (15%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHR--AANFYNEVNIISSVEHKNLVRLLGC 377
+G G FG +AVK + R N E+ S+ H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFD--SAKAKTLTWEKRY---EIILGTVEGLVYLHEQS 432
+ ++ E+ L ++ + E R+ +++ G V Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG-VS---YCHSM- 135
Query: 433 KIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA- 489
+I HRD+K N LLD R KI DFG ++S S + + GT Y+APE L
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLR 191
Query: 490 ---HGQLTEKADVYSFGMLLLEIVTGR 513
G+ ADV+S G+ L ++ G
Sbjct: 192 QEYDGK---IADVWSCGVTLYVMLVGA 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 321 LGQGGFGTVY---KGVLPDGREI-AVKRL----FFNNRHRAANFYNEVNIISSVEHKNLV 372
LG+GG+G V+ K + +I A+K L N A+ E NI+ V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 373 RLLGCSCSGPESL-LVYEFLPNQSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEG 424
L+ + L L+ E+L L IF A Y EI +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF------YLAEISMA---- 133
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L +LH++ II+RD+K NI+L+ + K+ DFGL + D + T GT+ YMA
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE L D +S G L+ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 41/225 (18%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISS-VEHKNLVRL 374
KLG+G +G V+K + G +AVK++F F N A + E+ I++ H+N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 375 LGCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWE-KRYEIILGTVEGLVYLH 429
L + ++ LV++++ L I +A L K+Y ++ ++ + YLH
Sbjct: 75 L--NVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPVHKQY-VVYQLIKVIKYLH 126
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++HRD+K SNILL++ K+ADFGL+RSF + +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 490 HGQLTE--------------------KA-DVYSFGMLLLEIVTGR 513
LT+ K D++S G +L EI+ G+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 67/247 (27%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G+G +G VY + +A+K++ F + E+ I++ ++ ++RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 377 CSCSGPESL-------LVYEFLP---------NQSLD----RFIFDSAKAKTLTWEKRYE 416
P+ L +V E L + I Y
Sbjct: 93 LII--PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-------------YN 137
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
++L G ++HE IIHRD+K +N LL+ K+ DFGLAR+ +K
Sbjct: 138 LLL----GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 477 AGTLG---------------------YMAPEY-LAHGQLTEKADVYSFGMLLLEIVTGRQ 514
Y APE L T+ D++S G + E++ Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 515 NNRSKNS 521
++ + +
Sbjct: 251 SHINDPT 257
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 34/249 (13%)
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGS-FDEANKLGQGGFGTVY---KGVLPDGREI 340
G + E+L+ ++ EK F+ LG G +G V+ K D ++
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 341 -AVKRL----FFNNRHRAANFYNEVNIISSVEHKN-LVRLLGCSCSGPESL-LVYEFLPN 393
A+K L + E ++ + LV L + L L+ +++
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYING 143
Query: 394 QSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446
L R F + + Y EI+L L +LH+ II+RDIK NI
Sbjct: 144 GELFTHLSQRERFTEHEVQI------YVGEIVLA----LEHLHKLG---IIYRDIKLENI 190
Query: 447 LLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL--TEKADVYSFGM 504
LLDS + DFGL++ F D++ + GT+ YMAP+ + G + D +S G+
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 505 LLLEIVTGR 513
L+ E++TG
Sbjct: 251 LMYELLTGA 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 3e-17
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
LG+G FG V E+ AVK L E +++ + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + + L V E++ Q + RF A Y EI +G L
Sbjct: 409 SCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIG----L 455
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+L + II+RD+K N++LDS KIADFG+ + D T GT Y+AP
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 511
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E +A+ + D ++FG+LL E++ G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 58/247 (23%), Positives = 97/247 (39%), Gaps = 33/247 (13%)
Query: 282 KRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGS---FDEANKLGQGGFGTVYKGVLPDGR 338
K+ ++ K + K+ T + T FD LG G FG V +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 339 EI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL-LVYEFLPN 393
A+K L + + NE I+ +V LV+L S +L +V E++
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAG 125
Query: 394 QSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLVYLHEQSKIRIIHRDIKASNI 446
+ F A+ Y +I+L YLH +I+RD+K N+
Sbjct: 126 GEMFSHLRRIGRFSEPHARF------YAAQIVLT----FEYLHSLD---LIYRDLKPENL 172
Query: 447 LLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLL 506
L+D + ++ DFG A+ K T + GT +APE + + D ++ G+L+
Sbjct: 173 LIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 507 LEIVTGR 513
E+ G
Sbjct: 229 YEMAAGY 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 321 LGQGGFGTVY---KGVLPDGREI-AVKRL--FFNNRHRAANFYNEVNIISSVEHKNLVRL 374
LGQG FG V+ K D R++ A+K L E +I+ V H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 375 LGCSCSGPESL-LVYEFLPNQSL-----DRFIFDSAKAKTLTWEKRY--EIILGTVEGLV 426
+ L L+ +FL L +F K Y E+ L L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF------YLAELALA----LD 140
Query: 427 YLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
+LH II+RD+K NILLD K+ DFGL++ + + + GT+ YMAPE
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGR 513
+ T+ AD +SFG+L+ E++TG
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIIS-SVEHKNLVRLL 375
LG+G FG V+ + A+K L E ++S + EH L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
+ E+L V E+L QS +F A Y EIILG L
Sbjct: 85 CTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILG----L 131
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH + I++RD+K NILLD KIADFG+ + + +T GT Y+AP
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 187
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L + D +SFG+LL E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
LG G FG V+ A+K L + + +E ++S V H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 377 CSCSGPESL-LVYEFLPN-------QSLDRFIFDSAK---AKTLTWEKRYEIILGTVEGL 425
+ + + ++ +++ + RF AK A E+ L L
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---------EVCLA----L 119
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLH + II+RD+K NILLD KI DFG A+ T + GT Y+AP
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTPDYIAP 172
Query: 486 EYLA---HGQLTEKA-DVYSFGMLLLEIVTGR 513
E ++ + K+ D +SFG+L+ E++ G
Sbjct: 173 EVVSTKPYN----KSIDWWSFGILIYEMLAGY 200
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
LG+G FG V E+ AVK L E +++ + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + + L V E++ Q + RF A Y EI +G L
Sbjct: 88 SCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIG----L 134
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+L + II+RD+K N++LDS KIADFG+ + D T GT Y+AP
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 190
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E +A+ + D ++FG+LL E++ G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
LG+G FG V + + ++ AVK L E I+S H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C P+ L V EF+ Q RF A+ Y EII L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISA----L 137
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
++LH++ II+RD+K N+LLD K+ADFG+ + + +T GT Y+AP
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAP 193
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D ++ G+LL E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+G+G + V L I A++ + N+ E ++ H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + L V E++ Q + + A+ Y EI L L
Sbjct: 120 SCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--------YSAEISLA----L 166
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLHE+ II+RD+K N+LLDS K+ D+G+ + ST GT Y+AP
Sbjct: 167 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 222
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D ++ G+L+ E++ GR
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNIISSV-EHKNLVRLL 375
+G+G + V L I A+K + N+ E ++ H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAKAKTLTWEKRY--EIILGTVEGL 425
C + L V E++ Q + + A+ Y EI L L
Sbjct: 77 SCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--------YSAEISL----AL 123
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YLHE+ II+RD+K N+LLDS K+ D+G+ + ST GT Y+AP
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 179
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR 513
E L D ++ G+L+ E++ GR
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 34/209 (16%)
Query: 321 LGQGGFGTVYKGVLPDGREI-AVKRL---FFNNRHRAANFYNEVNI-ISSVEHKNLVRLL 375
+G+G FG V AVK L + + +E N+ + +V+H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 376 GCSCSGPESL-LVYEFLPN-------QSLDRFIFDSAK---AKTLTWEKRYEIILGTVEG 424
S + L V +++ Q F+ A+ A EI
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASA---- 151
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMA 484
L YLH + I++RD+K NILLDS+ + DFGL + E S ST GT Y+A
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207
Query: 485 PEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
PE L D + G +L E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNR--HRAANFYNEVNIISSV---------- 366
KLG G F TV+ + + +A+K + ++ AA E+ ++ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAED--EIKLLQRVNDADNTKEDS 82
Query: 367 -EHKNLVRLLGC-SCSGPESL---LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
++++LL + GP + +V+E L ++L I + + + +I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQL 140
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA------KIADFGLARSFQEDKSHISTA 475
+ GL Y+H + IIH DIK N+L++ KIAD G A + ++ H + +
Sbjct: 141 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDE--HYTNS 195
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
I T Y +PE L AD++S L+ E++TG
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 2e-13
Identities = 40/248 (16%), Positives = 69/248 (27%), Gaps = 59/248 (23%)
Query: 311 ATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--------RHRAANFYNEVNI 362
T K+G+G FG V++ + D +A+K + + E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 363 ISSVE---------HKNLVRLLGCSC---SGPESLL----------------VYEFLPNQ 394
+ + + L C S P LL F +Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 395 SLDRFIFDSA-------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447
F+ + K + I+ L +R HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 448 LDSRLRAKIADFGLARSFQEDKSHISTAIA----------GTLGYM---APEYLAHGQLT 494
L K+ +S + +I G + + E L G
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254
Query: 495 EKADVYSF 502
+ D+Y
Sbjct: 255 YQFDIYRL 262
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 26/156 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC 377
LG G G V + + A+K L EV + + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 378 ---SCSGPESL-LVYEFLPNQSL-DRFIFDSAKAKTLTWEKR-YEIILGTVEGLVYLHEQ 431
+G + L +V E L L R + E+ EI+ E + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 432 SKIRIIHRDIKASNILL-----DSRLRAKIADFGLA 462
+ I HRD+K N+L ++ L K+ DFG A
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAIL--KLTDFGFA 167
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 61/256 (23%), Positives = 93/256 (36%), Gaps = 71/256 (27%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE--------HKN 370
KLG G F TV+ + + +A+K + + H +E+ ++ SV +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 371 LVRLLGC-SCSGPESL---LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
+V+LL SG +V+E L L ++I S + L +II ++GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLD 160
Query: 427 YLHEQSKIRIIHRDIKASNILL-------------------------------------- 448
YLH +K RIIH DIK NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 449 -----------DSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKA 497
+L+ KIAD G A + + T Y + E L A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPA 274
Query: 498 DVYSFGMLLLEIVTGR 513
D++S + E+ TG
Sbjct: 275 DIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 59/240 (24%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK-----RLFFN--- 348
D + ++Y L+ +G+G FG V K + +A+K + F
Sbjct: 92 HDHVAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA 141
Query: 349 ---------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGPESLLVYEFLPNQS 395
+ N N ++++ + +N + LL + +YE +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMN--------LYELIKKNK 193
Query: 396 LDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA- 454
F +L +++ + ++ L LH K RIIH D+K NILL + R+
Sbjct: 194 FQGF--------SLPLVRKFAHSI--LQCLDALH---KNRIIHCDLKPENILLKQQGRSG 240
Query: 455 -KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
K+ DFG + ++ + T I + Y APE + + D++S G +L E++TG
Sbjct: 241 IKVIDFGSS-CYEHQ--RVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 35/196 (17%), Positives = 70/196 (35%), Gaps = 39/196 (19%)
Query: 319 NKLGQGGFGTVYKGV---------LPDGREIAVK------RLF----FNNRHRAANFYNE 359
+ + G +Y+ P ++ ++K RLF F R N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 360 VNIISSVEHKNLVRLLGCSCSGPE-SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEI- 417
+ S + +G + LV L +SL D + L+ ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 418 --ILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI--ADFGLARSFQEDKSHI- 472
+L +E +LHE +H ++ A NI +D ++++ A +G A + H+
Sbjct: 166 CRLLDALE---FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 473 -----STAIAGTLGYM 483
+ G L ++
Sbjct: 220 YVEGSRSPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 62/247 (25%)
Query: 275 KQRSIERKRRGSNDAEKL-VKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV 333
++ + + AE+ V + D + + +GQGGFG +Y
Sbjct: 6 AAQAGRQSSAKRHLAEQFAVGEIITDMAAAAW-KVGL---------PIGQGGFGCIYLAD 55
Query: 334 LPDGREIAVKRLFFNNRHRA--------ANFYNEVNIISSVEHKNLVRLLGCS------C 379
+ + + FY ++ R L
Sbjct: 56 MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115
Query: 380 SGPESL-------LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV--------EG 424
SG ++ + L + I+++ K + TV +
Sbjct: 116 SGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANA-KRFS--------RKTVLQLSLRILDI 164
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKI--ADFGLARSFQEDKSHI------STAI 476
L Y+HE +H DIKASN+LL+ + ++ D+GLA + + H
Sbjct: 165 LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 477 AGTLGYM 483
GT+ +
Sbjct: 222 DGTIEFT 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 56/253 (22%), Positives = 94/253 (37%), Gaps = 57/253 (22%)
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVK 343
G +D N + +Y +G+G FG V K + +A+K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSL----------IGKGSFGQVVKAYDRVEQEWVAIK 85
Query: 344 -----RLFFN------------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGP 382
+ F N N+H Y V++ +N LV +L +
Sbjct: 86 IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN---- 141
Query: 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIK 442
+Y+ L N + +L +++ + L++L ++ IIH D+K
Sbjct: 142 ----LYDLLRNTNFRGV--------SLNLTRKFAQQM--CTALLFLA-TPELSIIHCDLK 186
Query: 443 ASNILLDSRLRA--KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVY 500
NILL + R+ KI DFG + I I + Y +PE L D++
Sbjct: 187 PENILLCNPKRSAIKIVDFGSS-CQLGQ--RIYQYIQ-SRFYRSPEVLLGMPYDLAIDMW 242
Query: 501 SFGMLLLEIVTGR 513
S G +L+E+ TG
Sbjct: 243 SLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 43/197 (21%), Positives = 68/197 (34%), Gaps = 46/197 (23%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNR-----HRAANFYNEVN---IISSVEHKN 370
K+G GGFG +Y + A + + FY V I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 371 LVRLLG---CSCSGPESL-------LVYEFLPNQSLDRFIFDSAKA---KT---LTWEKR 414
+ LG SG +V E L L + I T L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIR-- 159
Query: 415 YEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKI--ADFGLARSFQEDKSHI 472
+L +E Y+HE +H DIKA+N+LL + ++ AD+GL+ + + +H
Sbjct: 160 ---MLDVLE---YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 473 ------STAIAGTLGYM 483
GT+ +
Sbjct: 211 QYQENPRKGHNGTIEFT 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 44/225 (19%), Positives = 91/225 (40%), Gaps = 36/225 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGC 377
++G+G FG +++G L + +++A+K + +E + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAK--AKT---LTWEKRYEIILGTVEGLVYLHEQ 431
G ++LV + L SL D K KT + +L V+ +HE+
Sbjct: 75 GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQ-----MLARVQ---SIHEK 125
Query: 432 SKIRIIHRDIKASNILLDSRLRAK-----IADFGLARSF--QEDKSHI----STAIAGTL 480
S +++RDIK N L+ + DFG+ + + K HI ++GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 481 GYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
YM+ + + + D+ + G + + + G Q ++ ++
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGC 377
K+G G FG +Y G + G E+A+K +H + E I ++ + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 73
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAK--AKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G +++V E L SL D F F S K KT+ + + + Y+H ++
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLL-----LADQMISRIEYIHSKN-- 125
Query: 435 RIIHRDIKASNILLDSRLRAK---IADFGLARSF--QEDKSHI----STAIAGTLGYMAP 485
IHRD+K N L+ + I DFGLA+ + HI + + GT Y +
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
+ + + D+ S G +L+ G Q ++
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 26/220 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGC 377
K+G G FG + G L +A+K +R + E + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP--QLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
G + +V E L SL D F +T + + I + + + Y+H ++ +
Sbjct: 74 GPCGKYNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---L 126
Query: 437 IHRDIKASNILLDSRLRAK-----IADFGLARSF--QEDKSHI----STAIAGTLGYMAP 485
I+RD+K N L+ I DF LA+ + E K HI ++ GT YM+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
+ + + D+ + G + + + G Q ++ +
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV-RLLGC 377
K+G G FG +Y G + E+A+K +H E I ++ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRWF 71
Query: 378 SCSGPESLLVYEFLPNQSL-DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
G ++LV + L SL D F F S K T + ++ VE ++H +S
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE---FVHSKS---F 124
Query: 437 IHRDIKASNILLDSRLRAK---IADFGLARSF--QEDKSHI----STAIAGTLGYMAPEY 487
+HRDIK N L+ RA I DFGLA+ + HI + + GT Y +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGR---QNNRSKNSE 522
+ + + D+ S G +L+ + G Q ++ +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 80/639 (12%), Positives = 176/639 (27%), Gaps = 225/639 (35%)
Query: 21 DPRVHTVN-ITCGHQLEHNSSIFVPNFVTTMENISEQMRTSGFGLAVTGSGLDINYGLAQ 79
P + T I +L +++ +F V+ ++ ++R + L + I G+
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY-LKLRQALLELRP-AKNVLI-DGVLG 160
Query: 80 CYGDLSLLDCVLCYAEARTLLPQCYPYNGGRIY-LDGCFMRSENYSFFGEYEGPED---- 134
G + V + QC I+ L+ PE
Sbjct: 161 S-GKTWVALDVC-----LSYKVQCKMDFK--IFWLN-----------LKNCNSPETVLEM 201
Query: 135 ------RAVCGNGTRKNSSFQ-----ESARKAVMRAVASAPSNGGYARVQVQVSGAANKS 183
+ +R + S S + + R + S P Y
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP----YEN-----------C 246
Query: 184 AYVLVNCWKTLNSSSCEACLANASASILGCLPWSEGRALNTGCFM----RY-SDKDFLN- 237
VL+N +A A N C + R+ DFL+
Sbjct: 247 LLVLLNVQ---------------NAKAW--------NAFNLSCKILLTTRFKQVTDFLSA 283
Query: 238 --------KEPGKG----RSRGMIAAIVVSVVSALVVLAVGI------VIGTRV------ 273
+ ++ + L + +I +
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 274 ---WKQRSIERKRRGSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVY 330
WK + ++ + T+ + SLN LE E K+ +
Sbjct: 344 WDNWKHVNCDK-----------LTTIIESSLN----VLE-----PAEYRKM--------F 375
Query: 331 K--GVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388
V P +I + + L + + ++V
Sbjct: 376 DRLSVFPPS----------------------AHIPTIL----LSLIWFDV-IKSDVMVVV 408
Query: 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448
L SL EK+ + E + + I+ ++K +
Sbjct: 409 NKLHKYSL--------------VEKQPK------ESTISIPS------IYLELKV-KLEN 441
Query: 449 DSRLRAKIAD-FGLARSFQED---KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGM 504
+ L I D + + ++F D ++ +G+ +L + + E+ + F M
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH----HLKNIEHPERMTL--FRM 495
Query: 505 LLLE--------IVTGRQNNRSKNSEYTDSLLTITW--KHFQAGRVEELYD---KNLM-- 549
+ L+ N S ++L + + + + Y+ ++
Sbjct: 496 VFLDFRFLEQKIRHDSTAWNAS--GSILNTLQQLKFYKPYIC--DNDPKYERLVNAILDF 551
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
L ++ + + + + L+ E+ ++ + +Q
Sbjct: 552 LPKIEENLICSKYTDLLRIALM--AEDEAIFEEAHKQVQ 588
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 68/294 (23%), Positives = 100/294 (34%), Gaps = 99/294 (33%)
Query: 275 KQRSIERKRRGSN--DAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKG 332
S R+ D LN + + K +G G FG V
Sbjct: 5 HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRK----------MGDGTFGRVLLC 54
Query: 333 V-LPDGREIAVK--RLFFNNR--HRAANFYNEVNIISSV-----EHKNLVRLLGC----- 377
+ + + AVK R N + R+A E +I+ + + N+V+ G
Sbjct: 55 QHIDNKKYYAVKVVR---NIKKYTRSA--KIEADILKKIQNDDINNNNIVKYHGKFMYYD 109
Query: 378 -SCSGPESLLVYEFLPNQSLDRFI-------FDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
C L++E L SL I F K E IL + L YL
Sbjct: 110 HMC------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE-----IL---KALNYLR 154
Query: 430 EQSKIRIIHRDIKASNILLDS-------------------------RLRAKIADFGLARS 464
K+ + H D+K NILLD K+ DFG A +
Sbjct: 155 ---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-T 210
Query: 465 FQEDKSHISTAIAGTLGYMAPE------YLAHGQLTEKADVYSFGMLLLEIVTG 512
F+ D + + I T Y APE + +D++SFG +L E+ TG
Sbjct: 211 FKSD--YHGSIIN-TRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 51/258 (19%), Positives = 85/258 (32%), Gaps = 79/258 (30%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV--LPDGREIAVK-----RLFFN-- 348
D L +Y + LG+G FG V + + ++A+K +
Sbjct: 14 GDWLQERYEIVGN----------LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA 63
Query: 349 ----------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGPESLLVYEFLPNQ 394
N + V + + LLG + +EFL
Sbjct: 64 RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKN--------TFEFLKEN 115
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454
+ + + Y++ L +LH + ++ H D+K NIL +
Sbjct: 116 NFQPYPLPHVRHMA------YQLC----HALRFLH---ENQLTHTDLKPENILFVNSEFE 162
Query: 455 -------------------KIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLT 494
++ADFG A +F + H +T +A T Y PE L G
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHE--HHTTIVA-TRHYRPPEVILELG-WA 217
Query: 495 EKADVYSFGMLLLEIVTG 512
+ DV+S G +L E G
Sbjct: 218 QPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 57/263 (21%), Positives = 94/263 (35%), Gaps = 89/263 (33%)
Query: 298 DDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV--LPDGREIAVK-----RLFFN-- 348
D L+ +Y ++ LG+G FG V + + GR +AVK +
Sbjct: 9 GDVLSARYEIVDT----------LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA 58
Query: 349 ----------NRHRAANFYNEVNIISSVEHKN---LV-RLLGCSCSGPESLLVYEFLPNQ 394
N + + V ++ EH +V LLG S Y+F+
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLS--------TYDFIKEN 110
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---- 450
F D + Y+I + + +LH ++ H D+K NIL
Sbjct: 111 GFLPFRLDHIRKMA------YQIC----KSVNFLH---SNKLTHTDLKPENILFVQSDYT 157
Query: 451 ---------------RLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE------YLA 489
K+ DFG A ++ ++ H ST ++ T Y APE +
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSA-TYDDE--HHSTLVS-TRHYRAPEVILALGW-- 211
Query: 490 HGQLTEKADVYSFGMLLLEIVTG 512
++ DV+S G +L+E G
Sbjct: 212 ----SQPCDVWSIGCILIEYYLG 230
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/158 (15%), Positives = 52/158 (32%), Gaps = 28/158 (17%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVK------RLFFNNR----HRAANFYNEVNIISSVEH 368
+G+G V+ E VK F + + +F + E
Sbjct: 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 155
Query: 369 KNLVRLLGCSCSGPESL----LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEG 424
+ L +L G + + ++ E + + L + + ++ ++IL V
Sbjct: 156 RALQKLQGLAVPKVYAWEGNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAK 208
Query: 425 LVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462
+ I+H D+ N+L+ I DF +
Sbjct: 209 FYHRG------IVHGDLSQYNVLVSEEGIWII-DFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 642 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 1e-68
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 27/290 (9%)
Query: 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
G ++G G FGTVYKG + + + + F NEV ++ H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
+G + P+ +V ++ SL + K +I T +G+ YLH +S
Sbjct: 68 LFMGY-STAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGTLGYMAPEYL--- 488
IIHRD+K++NI L L KI DFGLA SH ++G++ +MAPE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548
+ ++DVY+FG++L E++TG+ + N+ D ++ + + + + + ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDLSKV----- 234
Query: 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT-EEQLP 597
SN + R + C ++ RP ++L + LP
Sbjct: 235 ------RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-66
Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 26/272 (9%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V+ G ++AVK L + A F E N++ ++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV- 76
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ ++ E++ N SL F+ + K LT K ++ EG+ ++ E++ IH
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L KIADFGLAR ++++ + + APE + +G T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 499 VYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNV 558
V+SFG+LL EIVT + + E+ + Y
Sbjct: 193 VWSFGILLTEIVTHGRIP------------------YPGMTNPEVIQN--LERGYRMVRP 232
Query: 559 KYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ LC +E P RPT + +L
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-64
Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 26/276 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
++G G FG V+ G + ++A+K + +F E ++ + H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 65
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G LV+EF+ + L ++ + E + L EG+ YL E
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA--- 120
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
+IHRD+ A N L+ K++DFG+ R +D+ ST + + +PE + + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 495 EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554
K+DV+SFG+L+ E+ + + S E+ + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSN------------------SEVVED--ISTGFR 220
Query: 555 DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ + C +E P RP SR+L+ L
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-64
Identities = 71/285 (24%), Positives = 115/285 (40%), Gaps = 26/285 (9%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLGQG FG V+ G +A+K L A F E ++ + H+ LV+L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV- 80
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S +V E++ SL F+ K L + ++ G+ Y+ +H
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 136
Query: 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKAD 498
RD++A+NIL+ L K+ADFGLAR ++++ + + APE +G+ T K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 499 VYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNV 558
V+SFG+LL E+ T + + E+ D+ + Y
Sbjct: 197 VWSFGILLTELTTKGRVP------------------YPGMVNREVLDQ--VERGYRMPCP 236
Query: 559 KYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPP 603
+ C ++ P RPT + L P P
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-64
Identities = 54/276 (19%), Positives = 110/276 (39%), Gaps = 26/276 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+LG G FG V G ++A+K + + F E ++ ++ H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQL 64
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
G ++ E++ N L ++ + ++ E+ E + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
+ +HRD+ A N L++ + K++DFGL+R +D+ S + + PE L + + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 495 EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554
K+D+++FG+L+ EI + + ++ E + +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK------------------MPYERFTNSETAEH--IAQGLR 219
Query: 555 DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ + C E RPT +L +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-64
Identities = 65/305 (21%), Positives = 127/305 (41%), Gaps = 32/305 (10%)
Query: 308 LEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAAN-FYNEVNIISS 365
+E F++ ++LG G G V+K P G +A K + + N E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 366 VEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+V G S E + E + SLD+ + KA + + ++ + ++GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
YL K +I+HRD+K SNIL++SR K+ DFG++ + + + GT YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545
E L + ++D++S G+ L+E+ GR +++ + + + A
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 546 KNLMLHNYHDSNVKYEVLRAIHVGLL----------------------CTQENPSLRPTM 583
L +Y + + + ++ C +NP+ R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 584 SRVLQ 588
+++
Sbjct: 293 KQLMV 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 3e-62
Identities = 69/319 (21%), Positives = 130/319 (40%), Gaps = 52/319 (16%)
Query: 301 LNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFNNRHRA- 353
LN K +LE + + +G+G FG V++ P +AVK L
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 354 ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD----------- 402
A+F E +++ ++ N+V+LLG G L++E++ L+ F+
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 403 ----------SAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL 452
S L+ ++ I G+ YL E+ + +HRD+ N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 453 RAKIADFGLARSFQE-DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT 511
KIADFGL+R+ D A + +M PE + + + T ++DV+++G++L EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 512 GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLL 571
+ + EE+ + + + L ++ L
Sbjct: 238 YG------------------LQPYYGMAHEEVIYY--VRDGNILACPENCPLELYNLMRL 277
Query: 572 CTQENPSLRPTMSRVLQML 590
C + P+ RP+ + ++L
Sbjct: 278 CWSKLPADRPSFCSIHRIL 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 32/294 (10%)
Query: 320 KLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC-- 377
+G+G FG V++G G E+AVK + R+ E+ + H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 378 --SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ---- 431
+ + + LV ++ + SL ++ T+T E ++ L T GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 432 -SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTA---IAGTLGYMAPEY 487
K I HRD+K+ NIL+ IAD GLA I A GT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 488 L------AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE----YTDSLLTITWKHFQA 537
L H + ++AD+Y+ G++ EI Y + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 538 GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
E+ N+ + + + + + C N + R T R+ + L+
Sbjct: 244 VVCEQKLRPNIP-NRWQSCEALRVMAK---IMRECWYANGAARLTALRIKKTLS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 6e-61
Identities = 65/306 (21%), Positives = 128/306 (41%), Gaps = 43/306 (14%)
Query: 303 FKYSTLEKATGSFDEA---------NKLGQGGFGTVYKGVLP----DGREIAVKRLFFNN 349
F + +A F + +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 350 RHRA-ANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT 408
+ +F +E +I+ +H N++ L G +++ EF+ N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
T + ++ G G+ YL + +HRD+ A NIL++S L K++DFGL+R ++D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 469 KSHI----STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYT 524
S + + + APE + + + T +DV+S+G+++ E
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE---------------- 225
Query: 525 DSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMS 584
+++ + + +++ + + +Y + L C Q++ + RP
Sbjct: 226 --VMSYGERPYWDMTNQDVINA--IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 585 RVLQML 590
+++ L
Sbjct: 282 QIVNTL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 8e-61
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVR 373
+KLG G +G VY+GV +AVK L + F E ++ ++H NLV+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 374 LLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
LLG P ++ EF+ +L ++ + + + ++ + + YL ++
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-- 134
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
IHRD+ A N L+ K+ADFGL+R D + + APE LA+ +
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
+ K+DV++FG+LL EI T + + ++Y L+ +Y
Sbjct: 194 SIKSDVWAFGVLLWEIATYG------------------MSPYPGIDLSQVY--ELLEKDY 233
Query: 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ + + C Q NPS RP+ + + Q
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 5e-60
Identities = 66/299 (22%), Positives = 130/299 (43%), Gaps = 33/299 (11%)
Query: 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDG-----REIAVKRLFFNNRHRA-ANFYNEV 360
T E +G G FG VYKG+L +A+K L + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 361 NIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILG 420
I+ H N++RL G +++ E++ N +LD+F+ + K + + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED--KSHISTAIAG 478
G+ YL +HRD+ A NIL++S L K++DFGL+R ++D ++ ++
Sbjct: 119 IAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 479 TLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538
+ + APE +++ + T +DV+SFG+++ E++T + + +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE------------------RPYWEL 217
Query: 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLP 597
E+ + + + + C Q+ + RP + ++ +L + P
Sbjct: 218 SNHEVMKA--INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-59
Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRL 374
+G+G FG V G G ++AVK + N A F E ++++ + H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 375 LGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSK 433
LG L +V E++ SL ++ + L + + L E + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 434 IRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL 493
+HRD+ A N+L+ AK++DFGL + + + + APE L +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKF 177
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
+ K+DV+SFG+LL EI + + + ++++ + + Y
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVP------------------YPRIPLKDVVPR--VEKGY 217
Query: 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
V C + ++RP+ ++ + L
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 65/281 (23%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 317 EANKLGQGGFGTVYKGVLPD---GREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNL 371
E +LG G FGTV KG + +AVK L N+ E N++ +++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
VR++G C +LV E L++++ + + + + E++ G+ YL E
Sbjct: 71 VRMIGI-CEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST--AIAGTLGYMAPEYLA 489
+HRD+ A N+LL ++ AKI+DFGL+++ + D+++ + + APE +
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ + + K+DV+SFG+L+ E + Q K ++ + E+ +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ------------------KPYRGMKGSEVTAM--L 223
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ LC + RP + V L
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 3e-59
Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 38/281 (13%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F + ++G G FG VY + + +A+K++ + + + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++ GC + LV E+ + D K L + + G ++GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA- 489
+IHRD+KA NILL K+ DFG A S + GT +MAPE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185
Query: 490 --HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547
GQ K DV+S G+ +E+ + + N+ ++ + Q
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESPA------ 233
Query: 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
L + H S + + C Q+ P RPT +L+
Sbjct: 234 --LQSGHWSEYFRNFVDS------CLQKIPQDRPTSEVLLK 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 8e-58
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 320 KLGQGGFGTVYKGVL---PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+LG G FG+V +GV ++A+K L + E I+ +++ +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
G C +LV E L +F+ K + + E++ G+ YL E++
Sbjct: 76 GV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 129
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGYMAPEYLAHGQL 493
+HRD+ A N+LL +R AKI+DFGL+++ D S+ + +A L + APE + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
+ ++DV+S+G+ + E ++ Q K ++ + E+ +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQ------------------KPYKKMKGPEVMAF--IEQGK 229
Query: 554 HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ C RP V Q +
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 9e-58
Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 32/283 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA--ANFYNEVNIISSVEHKNL 371
++ +G G +G K DG+ + K L + + A +EVN++ ++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 372 VRLLGCSCSGPESLL--VYEFLPNQSLDRFIFDSAKAK-TLTWEKRYEIILGTVEGLVYL 428
VR + L V E+ L I K + L E ++ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 429 HEQSKI--RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE 486
H +S ++HRD+K +N+ LD + K+ DFGLAR D S + A GT YM+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPE 184
Query: 487 YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKN-SEYTDSLLTITWKHFQAGRVEELYD 545
+ EK+D++S G LL E+ + + E + ++ +EL +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE 244
Query: 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
++ RP++ +L+
Sbjct: 245 --IITR--------------------MLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 65/297 (21%), Positives = 119/297 (40%), Gaps = 44/297 (14%)
Query: 300 SLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLF--FNNRHRAANF 356
S + ++ + ++G+G F TVYKG+ + E+A L + F
Sbjct: 5 SNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 55
Query: 357 YNEVNIISSVEHKNLVRLLGC---SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWE 412
E ++ ++H N+VR + G + + LV E + + +L ++ + K + +
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIK 112
Query: 413 KRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQEDKSH 471
++GL +LH ++ IIHRD+K NI + KI D GLA ++
Sbjct: 113 VLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRAS 168
Query: 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT 531
+ A+ GT +MAPE + E DVY+FGM +LE+ T
Sbjct: 169 FAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSE------------------ 209
Query: 532 WKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+ + + + S K + + C ++N R ++ +L
Sbjct: 210 -YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 73/278 (26%), Positives = 107/278 (38%), Gaps = 35/278 (12%)
Query: 315 FDEANKLGQGGFGTVYKGVLP-DGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F+ LG+G FG VY +A+K L EV I S + H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++RL G L+ E+ P ++ R + K ++ I L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS 124
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ R+IHRDIK N+LL S KIADFG + + + GTL Y+ PE +
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEG 178
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550
EK D++S G+L E + G+ F+A +E Y + +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRISRV 219
Query: 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
V I + NPS RP + VL+
Sbjct: 220 EFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-57
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 34/282 (12%)
Query: 319 NKLGQGGFGTVYKGVLPD----GREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVR 373
+G+G FG VY G L D AVK L + + F E I+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 374 LLGCSCSGPES-LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
LLG S L+V ++ + L FI + + T + L +G+ +L +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK- 149
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSF---QEDKSHISTAIAGTLGYMAPEYLA 489
+ +HRD+ A N +LD + K+ADFGLAR + D H T + +MA E L
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ T K+DV+SFG+LL E++T + IT Q R+ +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLLQ------- 255
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
+Y V L C +RP+ S ++ ++
Sbjct: 256 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-57
Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 31/276 (11%)
Query: 319 NKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGC 377
+LG G FG VYK + A K + + ++ E++I++S +H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRII 437
++ EF ++D + + + LT + + T++ L YLH+ +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 438 HRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL---- 493
HRD+KA NIL K+ADFG++ + GT +MAPE +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 191
Query: 494 -TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552
KADV+S G+ L+E+ + K
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPP-------------------HHELNPMRVLLKIAKSEP 232
Query: 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+ C ++N R T S++LQ
Sbjct: 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 69/278 (24%), Positives = 108/278 (38%), Gaps = 29/278 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLV 372
+D LG+G +G V V +AVK + N E+ I + H+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
+ G G L E+ L I + + G+VYLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI- 122
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED-KSHISTAIAGTLGYMAPEYLAHG 491
I HRDIK N+LLD R KI+DFGLA F+ + + + + GTL Y+APE L
Sbjct: 123 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 492 QL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550
+ E DV+S G++L ++ G + + ++ + K +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKI-- 232
Query: 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+ +L ENPS R T+ + +
Sbjct: 233 -----DSAPLALLHK------ILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 75/319 (23%), Positives = 132/319 (41%), Gaps = 38/319 (11%)
Query: 290 EKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFN 348
EKL ++ KY+ EK +GQG GTVY + + G+E+A++++
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 349 NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKT 408
+ + NE+ ++ ++ N+V L G E +V E+L SL + +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TC 112
Query: 409 LTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468
+ + + ++ L +LH ++IHRDIK+ NILL K+ DFG +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLL 528
+S ST + GT +MAPE + K D++S G++ +E++ G ++N L
Sbjct: 170 QSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------L 222
Query: 529 TITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
+ G E + L S + + L C + R + +LQ
Sbjct: 223 RALYLIATNGTPELQNPEKL-------SAIFRDFLNR------CLDMDVEKRGSAKELLQ 269
Query: 589 MLTTEEQLPGPTSPPFIDE 607
+ P + P I
Sbjct: 270 HQFLKIAKPLSSLTPLIAA 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 66/301 (21%), Positives = 127/301 (42%), Gaps = 33/301 (10%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGRE----IAVKRLFFNNRHRA-ANFYNEVNIISSVEH 368
F + LG G FGTVYKG+ +P+G + +A+K L +A +E +++SV++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
++ RLL C L+ + +P L ++ + + + + +G+ YL
Sbjct: 71 PHVCRLL-GICLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ-EDKSHISTAIAGTLGYMAPEY 487
++ R++HRD+ A N+L+ + KI DFGLA+ E+K + + + +MA E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547
+ H T ++DV+S+G+ + E++T K + E+
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS------------------KPYDGIPASEISSI- 225
Query: 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFIDE 607
+ + + + C + RP ++ + + P DE
Sbjct: 226 -LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
Query: 608 R 608
R
Sbjct: 285 R 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-56
Identities = 69/286 (24%), Positives = 105/286 (36%), Gaps = 34/286 (11%)
Query: 315 FDEANKLGQGGFGTVYKGVLP----DGREIAVKRL---FFNNRHRAANFYNEVNIISSVE 367
KLG G FG V +G +AVK L + +F EVN + S++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
H+NL+RL G P +V E P SL + + EG+ Y
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGY 126
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH--ISTAIAGTLGYMAP 485
L + R IHRD+ A N+LL +R KI DFGL R+ ++ H + + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 486 EYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545
E L + +D + FG+ L E + T + + ++
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILH 225
Query: 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLT 591
K + + +V + C P RPT + L
Sbjct: 226 K-IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-56
Identities = 71/294 (24%), Positives = 122/294 (41%), Gaps = 43/294 (14%)
Query: 315 FDEANKLGQGGFGTVYKGVLPDG---REIAVKRL-FFNNRHRAANFYNEVNIISSVE-HK 369
+ +G+G FG V K + + A+KR+ + ++ +F E+ ++ + H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFI-------------FDSAKAKTLTWEKRYE 416
N++ LLG L E+ P+ +L F+ ++ A TL+ ++
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAI 476
G+ YL ++ + IHRD+ A NIL+ AKIADFGL+R + T
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186
Query: 477 AGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQ 536
+ +MA E L + T +DV+S+G+LL EIV+ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG------------------GTPYC 228
Query: 537 AGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
ELY+K + Y + C +E P RP+ +++L L
Sbjct: 229 GMTCAELYEK--LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 48/307 (15%)
Query: 319 NKLGQGGFGTVYKGVL------PDGREIAVKRL-FFNNRHRAANFYNEVNIISSVE-HKN 370
LG G FG V + +AVK L + +E+ ++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFD---------------SAKAKTLTWEKRY 415
+V LLG G +L++ E+ L F+ L E
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-IST 474
+G+ +L + IHRD+ A NILL KI DFGLAR + D ++ +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
+ +MAPE + + T ++DV+S+G+ L E+ + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------------ 253
Query: 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594
+ Y ++ + + ++ + C +P RPT +++Q++ E+
Sbjct: 254 -----DSKFY--KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI--EK 304
Query: 595 QLPGPTS 601
Q+ T+
Sbjct: 305 QISESTN 311
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-54
Identities = 71/338 (21%), Positives = 124/338 (36%), Gaps = 54/338 (15%)
Query: 285 GSNDAEKLVKTLNDDSLNFKYSTLEKATGSFDEANKLGQGGFGTVYKGVLPD------GR 338
GS+D E + + K+ E + + LG G FG V
Sbjct: 12 GSSDNEYFYVDFREYEYDLKW---EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 68
Query: 339 EIAVKRLFFN-NRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESLLVYEFLPNQSL 396
++AVK L + +E+ +++ + H+N+V LLG L++E+ L
Sbjct: 69 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 397 DRFIFDSAK--------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
++ + LT+E +G+ +L +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 185
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTE 495
+HRD+ A N+L+ KI DFGLAR D ++ + + +MAPE L G T
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 496 KADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHD 555
K+DV+S+G+LL EI + N + V+ + K L+ + +
Sbjct: 246 KSDVWSYGILLWEIFSLGVN------------------PYPGIPVDANFYK-LIQNGFKM 286
Query: 556 SNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593
Y + C + RP+ + L +
Sbjct: 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 39/305 (12%)
Query: 315 FDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFNNRHRA-ANFYNEVNIISSVE 367
+ +LGQG FG VY+GV +A+K + R F NE +++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIF-------DSAKAKTLTWEKRYEIILG 420
++VRLLG G +L++ E + L ++ ++ + K ++
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 421 TVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE-DKSHISTAIAGT 479
+G+ YL+ + +HRD+ A N ++ KI DFG+ R E D
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539
+ +M+PE L G T +DV+SFG++L EI T + +Q
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------------------PYQGLS 240
Query: 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGP 599
E++ ++ + +C Q NP +RP+ ++ + EE PG
Sbjct: 241 NEQVLRF--VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGF 297
Query: 600 TSPPF 604
F
Sbjct: 298 REVSF 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (464), Expect = 9e-53
Identities = 59/299 (19%), Positives = 112/299 (37%), Gaps = 36/299 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V++ G A K + + E+ +S + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
E +++YEF+ L + D + ++ ++ E + +GL ++HE +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147
Query: 439 RDIKASNILLDSRL--RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
D+K NI+ ++ K+ DFGL +S T GT + APE +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 205
Query: 497 ADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556
D++S G+L +++G +N + T + + + + + S
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDET---------------LRNVKSCDWNMDDSAFS 250
Query: 557 NVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ--------MLTTEEQLPGPTSPPFIDE 607
+ + I +P+ R T+ + L+ + Q+P D
Sbjct: 251 GISEDGKDFI---RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-52
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 31/278 (11%)
Query: 320 KLGQGGFGTVYKGVLPD----GREIAVKRLFFNNRHRA-ANFYNEVNIISSVEHKNLVRL 374
+G+G FG V++G+ +A+K F E + +H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 375 LGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + ++ E L F+ + +L L YL +
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
R +HRDI A N+L+ S K+ DFGL+R ++ + ++ + +MAPE + + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 495 EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554
+DV+ FG+ + EI+ + + R+
Sbjct: 188 SASDVWMFGVCMWEILMHG-----VKPFQGVKNNDVIGRIENGERLPM------------ 230
Query: 555 DSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592
N + + C +PS RP + + L+T
Sbjct: 231 PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 33/279 (11%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F LG+G F TV L RE A+K L ++ E +++S ++H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
V+L + + N L ++I K + V L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF-QEDKSHISTAIAGTLGYMAPEYLA 489
+ IIHRD+K NILL+ + +I DFG A+ E K + + GT Y++PE L
Sbjct: 127 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ +D+++ G ++ ++V G F+AG ++ K +
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP-------------------PFRAGNEYLIFQKIIK 224
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
L + + + + R +
Sbjct: 225 LEYDFPEKFFPKARDLV---EKLLVLDATKRLGCEEMEG 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 8e-49
Identities = 70/326 (21%), Positives = 118/326 (36%), Gaps = 35/326 (10%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
+LG G FG V++ V GR K + NE++I++ + H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
E +L+ EFL L I +A+ ++ + + EGL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 439 RDIKASNILLDSR--LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
DIK NI+ +++ KI DFGLA D+ T T + APE + +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFY 208
Query: 497 ADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556
D+++ G+L +++G F E D
Sbjct: 209 TDMWAIGVLGYVLLSGLSP-------------------FAGEDDLETLQNVKRCDWEFDE 249
Query: 557 NVKYEV-LRAIHVGLLCTQENPSLRPTMSRVLQ---MLTTEEQLPGPTSPPFIDERTMEL 612
+ V A Q+ P R T+ L+ + L ++ ++
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309
Query: 613 HDNCYDPCCPMNSGAHASVANMSNSS 638
+ D P A +AN S+
Sbjct: 310 KEKYADW--PAPQPAIGRIANFSSLR 333
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-48
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 47/296 (15%)
Query: 319 NKLGQGGFGTVYKGVLP--------DGREIAVKRLFFNNRHR-AANFYNEVNIISSV-EH 368
LG+G FG V ++AVK L + + ++ +E+ ++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRY 415
KN++ LLG ++ E+ +L ++ + L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIST- 474
G+ YL + + IHRD+ A N+L+ KIADFGLAR + T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 475 AIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
+ +MAPE L T ++DV+SFG+LL EI T +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------------P 237
Query: 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ VEEL+ + + + C PS RPT ++++ L
Sbjct: 238 YPGVPVEELFKL--LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-48
Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 45/295 (15%)
Query: 319 NKLGQGGFGTVYKGV------LPDGREIAVKRLFFNNRHRAA-NFYNEVNIISSVEHKNL 371
LG+G FG V + R +AVK L H +E+ I+ + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 372 VRLLGCSCSGPES--LLVYEFLPNQSLDRFIF-------------DSAKAKTLTWEKRYE 416
V L +C+ P +++ EF +L ++ + LT E
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 417 IILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI-STA 475
+G+ +L + + IHRD+ A NILL + KI DFGLAR +D ++
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 476 IAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHF 535
L +MAPE + T ++DV+SFG+LL EI + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG------------------ASPY 237
Query: 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+++E + + L Y L C PS RPT S +++ L
Sbjct: 238 PGVKIDEEFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 59/313 (18%), Positives = 118/313 (37%), Gaps = 22/313 (7%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRL-FFNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+ +G+G +G V + +A+K++ F ++ E+ I+ H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ + +L + ++ K + L+ + + + GL Y+H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHIS--TAIAGTLGYMAPEYLAHGQL- 493
+HRD+K SN+LL++ KI DFGLAR D H T T Y APE + + +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 494 TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNY 553
T+ D++S G +L E+++ R K+ + + + + + +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 554 HDSNVKYEVLR---------AIHVGLLCTQENPSLRPTMSRVLQM-----LTTEEQLPGP 599
+ A+ + NP R + + L P
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA 310
Query: 600 TSPPFIDERTMEL 612
+P D +L
Sbjct: 311 EAPFKFDMELDDL 323
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (414), Expect = 2e-46
Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 15/279 (5%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
K+G+G +G VYK G A+K++ + + E++I+ ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 377 CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRI 436
+ +LV+E L L +L + G+ Y H++ R+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 437 IHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
+HRD+K N+L++ KIADFGLAR+F + I + + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 497 ADVYSFGMLLLEIVTGR-----QNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551
D++S G + E+V G + + L T K++ YD N ++
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 552 NYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVLQ 588
+ L + LL + +P+ R T + L+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-46
Identities = 69/287 (24%), Positives = 115/287 (40%), Gaps = 24/287 (8%)
Query: 319 NKLGQGGFGTVYKG--VLPDGREIAVKRLF--FNNRHRAANFYNEVNI---ISSVEHKNL 371
++G+G +G V+K + GR +A+KR+ + EV + + + EH N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDR---FIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
VRL L + +D+ D + E +++ + GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
H R++HRD+K NIL+ S + K+ADFGLAR + + T++ TL Y APE L
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548
D++S G + E+ + R + D L I G + D L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 549 MLHNYHDSNVKYEVLRAIHVGLL-------CTQENPSLRPTMSRVLQ 588
+H + + + L C NP+ R + L
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 25/300 (8%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRA-----ANFYNEVNIISSVEHKNLV 372
+ LG+G F TVYK + +A+K++ +R A E+ ++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
LL LV++F+ + LT +L T++GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 433 KIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQ 492
I+HRD+K +N+LLD K+ADFGLA+SF T T Y APE L +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGAR 176
Query: 493 L-TEKADVYSFGMLLLEIVTGRQ-----NNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546
+ D+++ G +L E++ ++ + + ++L T T + + Y
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 547 NLMLHNYHDSNVKYEVLR-AIHVGLLCTQENPSLRPTMSRVLQM--LTTEEQLPGPTSPP 603
++ + + NP R T ++ L+M + PGPT
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR---PGPTPGC 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 2e-45
Identities = 59/308 (19%), Positives = 113/308 (36%), Gaps = 29/308 (9%)
Query: 305 YSTLEKATGSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNN-RHRAANFYNEVNI 362
+ E +D + LG G F V + +A+K + + + NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 363 ISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTV 422
+ ++H N+V L SG L+ + + L I + T +I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 423 EGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGY 482
+ + YLH+ + + LD + I+DFGL++ ED + + GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGY 175
Query: 483 MAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542
+APE LA ++ D +S G++ ++ G F +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-------------------PPFYDENDAK 216
Query: 543 LYDKNLMLHNYHDSNVKYEV-LRAIHVGLLCTQENPSLRPTMSRVLQM--LTTEEQLPGP 599
L+++ L DS ++ A +++P R T + LQ + + L
Sbjct: 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 600 TSPPFIDE 607
++
Sbjct: 277 IHQSVSEQ 284
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 3e-45
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 17/228 (7%)
Query: 315 FDEANKLGQGGFGTVYKGVLPD-GREIAVKRL------FFNNRHRAANFYNEVNIISSVE 367
F +G+GGFG VY D G+ A+K L A N ++++S+ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 368 HKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVY 427
+V + + + + + + L + + + + GL +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEH 122
Query: 428 LHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEY 487
+H + +++RD+K +NILLD +I+D GLA F + K H S GT GYMAPE
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176
Query: 488 LAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534
L G AD +S G +L +++ G R ++ + +T
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-45
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 31/273 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
LG+G FG V++ V + K + + E++I++ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
S E ++++EF+ + I + A L + + E L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 439 RDIKASNILLDSR--LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEK 496
DI+ NI+ +R KI +FG AR + + + Y APE H ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 497 ADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDS 556
D++S G L+ +++G F A +++ + + D
Sbjct: 184 TDMWSLGTLVYVLLSGI-------------------NPFLAETNQQIIENIMNAEYTFDE 224
Query: 557 NVKYEV-LRAIHVGLLCTQENPSLRPTMSRVLQ 588
E+ + A+ + R T S LQ
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-45
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 17/285 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNL 371
F + K+G+G +G VYK G +A+K RL + E++++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 372 VRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
V+LL + + LV+EFL D++ + + ++GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAH 490
R++HRD+K N+L+++ K+ADFGLAR+F + + TL Y APE L
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 491 GQLTEKADVYSFGMLLLEIVTGR-----QNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545
+ D++S G + E+VT R + + +L T + Y
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 546 KNLMLHNYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVLQ 588
+ D + L LL +P+ R + L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 9e-45
Identities = 58/293 (19%), Positives = 112/293 (38%), Gaps = 47/293 (16%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---------FFNNRHRAANFYNEVNIIS 364
++ LG+G V + + P +E AVK + + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 365 SV-EHKNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVE 423
V H N+++L + LV++ + L ++ + TL+ ++ +I+ +E
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121
Query: 424 GLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYM 483
+ LH+ I+HRD+K NILLD + K+ DFG + + + GT Y+
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176
Query: 484 APEYLA------HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537
APE + H ++ D++S G+++ ++ G + ++ F +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 538 GRVEELYD--KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
++ D K+L+ P R T L
Sbjct: 237 PEWDDYSDTVKDLVSR--------------------FLVVQPQKRYTAEEALA 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 76/325 (23%), Positives = 122/325 (37%), Gaps = 32/325 (9%)
Query: 314 SFDEANKLGQGGFGTVYKGVLPD-GREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLV 372
S+ + +G G FG VY+ L D G +A+K++ + R E+ I+ ++H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 373 RLLGCSCSGPES------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLV 426
RL S E LV +++P S +TL + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 427 YLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
Y+H I HRDIK N+LLD K+ DFG A+ + ++S + Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAP 191
Query: 486 -EYLAHGQLTEKADVYSFGMLLLEIVTGR-----QNNRSKNSEYTDSLLTITWKHFQAGR 539
T DV+S G +L E++ G+ + + E L T T + +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVLQ------MLT 591
K + + + V + L + P+ R T +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 592 TEEQLP-GPTSPPFIDERTMELHDN 615
+LP G +P + T EL N
Sbjct: 312 PNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (396), Expect = 5e-44
Identities = 63/282 (22%), Positives = 121/282 (42%), Gaps = 35/282 (12%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
LG GG V+ L R++AVK L + F E +++ H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 376 GC----SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ 431
+ +GP +V E++ +L + +T ++ E+I + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN 130
Query: 432 SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI--STAIAGTLGYMAPEYLA 489
IIHRD+K +NI++ + K+ DFG+AR+ + + + + A+ GT Y++PE
Sbjct: 131 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ ++DVYS G +L E++TG DS +++ ++H + +
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIPPSAR---- 237
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-TMSRVLQML 590
+ ++ + L +NP R T + + L
Sbjct: 238 -----HEGLSADLDAVV---LKALAKNPENRYQTAAEMRADL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (393), Expect = 3e-43
Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 36/275 (13%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
F LG G FG V+ +GR A+K L + + +E ++S V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++R+ G + ++ +++ L + S + + + L YLH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC---LALEYLHS 122
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ II+RD+K NILLD KI DFG A+ + + GT Y+APE ++
Sbjct: 123 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVST 175
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550
+ D +SFG+L+ E++ G F + Y+K L
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKILNA 216
Query: 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSR 585
+V + + S R +
Sbjct: 217 ELRFPPFFNEDVKDLLS---RLITRDLSQRLGNLQ 248
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-43
Identities = 68/302 (22%), Positives = 107/302 (35%), Gaps = 40/302 (13%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIIS-SVEHK 369
F LG+G FG V+ + A+K L E ++S + EH
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 370 NLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLH 429
L + + V E+L L I + + GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH 120
Query: 430 EQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
+ I++RD+K NILLD KIADFG+ + + +T GT Y+APE L
Sbjct: 121 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ D +SFG+LL E++ G+ F EEL+ M
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS-------------------PFHGQDEEELFHSIRM 217
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVL------QMLTTEEQLPGPTSPP 603
+ ++ ++ E + P R + + + + EE PP
Sbjct: 218 DNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 274
Query: 604 FI 605
F
Sbjct: 275 FR 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 9e-43
Identities = 48/281 (17%), Positives = 99/281 (35%), Gaps = 31/281 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
K+G G FG +Y G + G E+A+K +H + E I ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 71
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
+ + ++ L SL+ ++ + + + + + Y+H + IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 439 RDIKASNILLDSR---LRAKIADFGLARSFQEDKSHI------STAIAGTLGYMAPEYLA 489
RD+K N L+ I DFGLA+ +++ ++H + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 490 HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ + + D+ S G +L+ G + + + + +E L
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK---- 242
Query: 550 LHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ L C +P S + Q+
Sbjct: 243 ----GYPSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 42/300 (14%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRL------FFNNRHRAANFYNEVNIISSVEHKNLV 372
+LG G F V K G + A K + + EV+I+ ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 373 RLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS 432
L + + +L+ E + L F+ + ++LT E+ E + + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL- 132
Query: 433 KIRIIHRDIKASNILLDSR----LRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYL 488
+I H D+K NI+L R R KI DFGLA I GT ++APE +
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIV 188
Query: 489 AHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548
+ L +AD++S G++ +++G + T + + N
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---------------LANVSAVNY 233
Query: 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVL-----QMLTTEEQLPGPTSPP 603
+ + SN I ++P R T+ L + T++ L S P
Sbjct: 234 EFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 2e-41
Identities = 38/283 (13%), Positives = 99/283 (34%), Gaps = 33/283 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
++G+G FG +++G L + +++A+K R A +E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 379 CSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438
++ L SL+ + + + + + + +HE+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVY 124
Query: 439 RDIKASNILLDSRLR-----AKIADFGLARSFQEDKSHI------STAIAGTLGYMAPEY 487
RDIK N L+ + DFG+ + +++ + ++GT YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 488 LAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547
+ + + D+ + G + + + G + + T K+ + G ++
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA------TNKQKYERIGEKKQSTPLR 238
Query: 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQML 590
+ + + E + +H P + +
Sbjct: 239 ELCAGFPE-----EFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 39/302 (12%)
Query: 321 LGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSV-EHKNLVRLLGC- 377
LG G G V + + A+K L EV + + ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 378 --SCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+G + L +V E L L I D + T + EI+ E + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 435 RIIHRDIKASNILLDSRL---RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHG 491
I HRD+K N+L S+ K+ DFG A+ S + T Y+APE L
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 492 QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551
+ + D++S G+++ ++ G S + L I+ R+ + N
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM-----LTTEEQLPGPTSPPFID 606
+ + + P+ R T++ + T Q P TS +
Sbjct: 243 EVSEE--------VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294
Query: 607 ER 608
++
Sbjct: 295 DK 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-41
Identities = 62/281 (22%), Positives = 108/281 (38%), Gaps = 17/281 (6%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVK--RLFFNNRHRAANFYNEVNIISSVEHKNLVRLL 375
K+G+G +GTV+K +A+K RL ++ ++ E+ ++ ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 376 GCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
S + LV+EF F + L E + ++GL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTE 495
++HRD+K N+L++ K+A+FGLAR+F S + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 496 KADVYSFGMLLLEIVTGR------QNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
D++S G + E+ + + L T T + + + Y M
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 550 LHNYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVLQ 588
L A LL + NP R + LQ
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 62/280 (22%), Positives = 102/280 (36%), Gaps = 47/280 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF------FNNRHRAANFYNEVNIISSV--EHKN 370
LG GGFG+VY G+ + D +A+K + + EV ++ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
++RLL +L+ E + L E +E + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN 128
Query: 431 QSKIRIIHRDIKASNILLD-SRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLA 489
++HRDIK NIL+D +R K+ DFG ++ + T GT Y PE++
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIR 182
Query: 490 HGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548
+ + A V+S G+LL ++V G F+ EE+ +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHD--EEIIRGQV 221
Query: 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQ 588
S ++ + C PS RPT +
Sbjct: 222 FFRQRVSSECQHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 67/301 (22%), Positives = 122/301 (40%), Gaps = 31/301 (10%)
Query: 313 GSFDEANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAA--NFYNEVNIISSVEHK 369
+++ K+GQG FG V+K G+++A+K++ N E+ I+ ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 370 NLVRLLGCSCSGPES--------LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGT 421
N+V L+ + LV++F + K T + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 422 VEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS---HISTAIAG 478
+ GL Y+H +I+HRD+KA+N+L+ K+ADFGLAR+F K+ + T
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 479 TLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGR--------QNNRSKNSEYTDSLLT 529
TL Y PE L + D++ G ++ E+ T Q+ + S+ S+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 530 ITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLL--CTQENPSLRPTMSRVL 587
W + + E + +K V + L+ +P+ R L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 588 Q 588
Sbjct: 304 N 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-39
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 315 FDEANKLGQGGFGTVYKGV-LPDGREIAVKRL---FFNNRHRAANFYNEVNIISSVEHKN 370
FD LG+G FG V GR A+K L + A+ E ++ + H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 371 LVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
L L + V E+ L + ++ + T E+ V L YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
+ +++RDIK N++LD KI DFGL + D + GT Y+APE L
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSE 522
D + G+++ E++ GR +++ E
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 69/317 (21%), Positives = 122/317 (38%), Gaps = 38/317 (11%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G G +G V V G ++A+K+L+ F + A Y E+ ++ + H+N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 377 CSCSGPESLLVYEF-LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIR 435
+F L + + K + L ++ ++ ++GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---G 141
Query: 436 IIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPE-YLAHGQLT 494
IIHRD+K N+ ++ KI DFGLAR + T T Y APE L + T
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197
Query: 495 EKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYH 554
+ D++S G ++ E++TG+ + + + A V+ L +
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 555 DSNVKYEVLRAIH-------VGLL--CTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFI 605
++ + +I V LL + R T L P+
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH-------------PYF 304
Query: 606 DERTMELHDNCYDPCCP 622
+ LHD +P
Sbjct: 305 E----SLHDTEDEPQVQ 317
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 3e-37
Identities = 52/239 (21%), Positives = 92/239 (38%), Gaps = 19/239 (7%)
Query: 284 RGSNDAEKLVKTLNDDSLNF--KYSTLEKATGS---FDEANKLGQGGFGTVYKGV-LPDG 337
+ ++ E + + L +F K+ T + T FD LG G FG V G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 338 REIAVKRL---FFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNQ 394
A+K L + + NE I+ +V LV+L +V E++
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 395 SLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454
+ + + + V YLH +I+RD+K N+L+D +
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180
Query: 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR 513
++ DFG A+ + + GT +APE + + D ++ G+L+ E+ G
Sbjct: 181 QVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (332), Expect = 1e-34
Identities = 51/311 (16%), Positives = 113/311 (36%), Gaps = 39/311 (12%)
Query: 303 FKYSTLEKATGSFDE---ANKLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYN 358
+ Y + G+ D+ KLG+G + V++ + + + ++ VK L +
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKR 78
Query: 359 EVNIISSV-EHKNLVRLLGCSCSGPESL--LVYEFLPNQSLDRFIFDSAKAKTLTWEKRY 415
E+ I+ ++ N++ L LV+E + N + +TLT
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132
Query: 416 EIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR-LRAKIADFGLARSFQEDKSHIST 474
+ ++ L Y H I+HRD+K N+++D + ++ D+GLA + + +
Sbjct: 133 FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 187
Query: 475 AIAGTLGYMAPE-YLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEY------TDSL 527
+ + PE + + D++S G +L ++ ++ + Y L
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 528 LTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLL----------CTQENP 577
T + EL + + H + + + L+ + +
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307
Query: 578 SLRPTMSRVLQ 588
R T ++
Sbjct: 308 QSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 5e-33
Identities = 64/317 (20%), Positives = 120/317 (37%), Gaps = 36/317 (11%)
Query: 319 NKLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLL 375
+ +G G +G+V G +AVK+L F + A Y E+ ++ ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 376 G-CSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKI 434
+ + +L + + + K + LT + +I + GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140
Query: 435 RIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLT 494
IIHRD+K SN+ ++ KI DFGLAR + ++ +A L
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 197
Query: 495 EKADVYSFGMLLLEIVTGR-----QNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLM 549
+ D++S G ++ E++TGR ++ + + T + + E +
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 550 LHNYHDSNVKYEVLRAIHVG--LL--CTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPFI 605
L N + A + LL + R T ++ L +
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-------------AYF 304
Query: 606 DERTMELHDNCYDPCCP 622
+ HD +P
Sbjct: 305 A----QYHDPDDEPVAD 317
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 6e-32
Identities = 71/332 (21%), Positives = 118/332 (35%), Gaps = 51/332 (15%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLF--FNNRHRAANFYNEVNIISSVEHKNLVRLLG 376
+G G G V R +A+K+L F N+ A Y E+ ++ V HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 377 C------SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE 430
+ LV E + L E+ ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS 137
Query: 431 QSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAH 490
IIHRD+K SNI++ S KI DFGLAR+ S + T T Y APE +
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 192
Query: 491 GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550
E D++S G ++ E+V + ++ + E + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 551 HNYHDSNVKYEVLR-----------------------AIHVGLLCTQENPSLRPTMSRVL 587
NY ++ KY L A + +P+ R ++ L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 588 Q-----MLTTEEQLPGPTSPPFIDERTMELHD 614
Q + ++ P + + H
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHT 341
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 315 FDEANKLGQGGFGTVYKGVL----PDGREIAVKRL----FFNNRHRAANFYNEVNIISSV 366
F+ LG G +G V+ G+ A+K L + E ++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 367 EHKNLVRLLGCSCSGPESL-LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ L + L L+ +++ L + + T + + V L
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLAL 142
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHISTAIAGTLGYMAP 485
+LH+ II+RDIK NILLDS + DFGL++ F D++ + GT+ YMAP
Sbjct: 143 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 486 EYLAHGQ--LTEKADVYSFGMLLLEIVTGR 513
+ + G + D +S G+L+ E++TG
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 2e-28
Identities = 55/315 (17%), Positives = 109/315 (34%), Gaps = 53/315 (16%)
Query: 320 KLGQGGFGTVYKGV-LPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCS 378
KLG G F TV+ + + +A+K + ++ +E+ ++ V + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 379 CSGPESLLVY-------------EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGL 425
+ LL + F + + + + +I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 426 VYLHEQSKIRIIHRDIKASNILLDSR------LRAKIADFGLARSFQEDKSHISTAIAGT 479
Y+H + IIH DIK N+L++ ++ KIAD G A + E ++ T
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192
Query: 480 LGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-----------QNNRSKNSEYTDSLL 528
Y +PE L AD++S L+ E++TG + ++ + L
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 529 TITWKHFQAGR-VEELYDKNLMLHNYHDSNV---------KYEVLRAIHVGLL-----CT 573
+ + G+ ++ +L N KY+ + +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 574 QENPSLRPTMSRVLQ 588
Q +P R ++
Sbjct: 313 QLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 4e-21
Identities = 25/157 (15%), Positives = 47/157 (29%), Gaps = 20/157 (12%)
Query: 319 NKLGQGGFGTVYKGVLPDGREIAVKRL----------FFNNRHRAANFYNEVNIISSVEH 368
+G+G V+ E VK + +F + E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 369 KNLVRLLGCSCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYL 428
+ L +L G + Y + N L I + E++ +E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 429 HEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465
+ + I+H D+ N+L+ I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 642 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.65 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.07 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.38 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=206.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEEC
Q ss_conf 8963235126667168999781-899689999820447565999999999983088561310110111489732899506
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.+|+..++||+|+||.||++.. .+|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99980245310246689999999999999999999998379997498036889889769993999732785023789973
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~ 471 (642)
++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+|||+++.......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 79808988641----59999999999999999999999879---72267768886887899686425156413213666-
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCC
Q ss_conf 10155677542474222249989731178899999999949989999998456404789998630386012213222234
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+........ .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~--------- 235 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E--------- 235 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C---------
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHCCCC-C---------
T ss_conf 444444477736826644799880120313729999980488998997999------999999857999-8---------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 46998709999999999997325599999999999998
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.||++|||+.|+++|
T Consensus 236 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 ---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---88855379999999999866996689099999649
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.91 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=213.2
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCC
Q ss_conf 2569987089632351266671689997818-996899998204475659999999999830885613101101114897
Q 006514 305 YSTLEKATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 305 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 383 (642)
+++.+...++|+..++||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCE
T ss_conf 7651745799398659820888089999999999699999977761-039999999999986799988267752745785
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 32899506999802453102466899999999999999999999983799974980368898897699939997327850
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
.++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 47876314676067775303-5541579999999999999788898789---3057604576899899928983244546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHH
Q ss_conf 23789973101556775424742222499897311788999999999499899999984564047899986303860122
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
..............|++.|+|||++.++.++.++||||||+++|||++|..|+....... . .+.....+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~----~~~~i~~~~---- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q----VYELLEKDY---- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H----HHHHHHTTC----
T ss_pred ECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHHCCC----
T ss_conf 537887221035566546669278727999810430217899999986799887742599--9----999985588----
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 132222344699870999999999999732559999999999999862599
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 594 (642)
.... .... ...+.+++.+||+.||++|||+.||++.|+...
T Consensus 234 -----~~~~--~~~~---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 -----RMER--PEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -----CCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----CCCC--CCCC---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf -----8888--7433---099999999975779768939999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.38 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=204.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCC---EEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEE
Q ss_conf 89632351266671689997818-996---8999982044-756599999999998308856131011011148973289
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR---EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 387 (642)
.+|+..+.||+|+||.||+|.++ +++ .||||.+... .....+.|.+|+.++++++||||++++|++......++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95069998024531024668999999999999999999999837999749803688988976999399973278502378
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~ 467 (642)
|||+++|+|.+++.. ....+++.+++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 972279853002104--5679999999999999999889885279---83576150448988999199888443157567
Q ss_pred CCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHH
Q ss_conf 99731----015567754247422224998973117889999999994-9989999998456404789998630386012
Q 006514 468 DKSHI----STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 468 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
..... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+.. ....+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~----~i~~~~--- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN----AIEQDY--- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTC---
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHCCC---
T ss_conf 777653650256668830038788836997861214453578999986799999999999---9999----997378---
Q ss_pred HCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 2132222344699870999999999999732559999999999999862599
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 594 (642)
.... .... ...+.+++.+||+.||++||||.||++.|+...
T Consensus 251 ------~~~~--~~~~---~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 251 ------RLPP--PMDC---PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ------CCCC--CTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCC--CCCC---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ------8999--7422---699999999975879768929999999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.27 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=207.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEECC
Q ss_conf 89632351266671689997818996899998204475659999999999830885613101101114897328995069
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
.+|+..+.||+|+||.||+|.+.+++.||||++.... ...++|.+|++++++++||||++++|++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99802453102466899999999999999999999983799974980368898897699939997327850237899731
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~~ 472 (642)
+|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEE
T ss_conf 9918997520--1347889999999999999877653164---3104431532666688776865532100236887335
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCCC
Q ss_conf 01556775424742222499897311788999999999499899999984564047899986303860122132222344
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHN 552 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 552 (642)
.....||+.|+|||++.+..++.++||||||+++|||+|+..|+...... ..... ....+.. ...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~----~i~~~~~--~~~------- 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVE----DISTGFR--LYK------- 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHH----HHHHTCC--CCC-------
T ss_pred ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH--HHHHH----HHHHCCC--CCC-------
T ss_conf 04300176667857860799984033210599999998789888778999--99999----9980688--899-------
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 69987099999999999973255999999999999986259
Q 006514 553 YHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 553 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
+... ...+.+++.+||+.||++||||+||+++|+..
T Consensus 224 --p~~~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 --PRLA---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf --5436---79999999997657976891999999999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.13 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=204.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEE
Q ss_conf 0896323512666716899978189968999982044--75659999999999830885613101101114897328995
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|++.+.||+|+||.||+|.++ ..||||++... +....+.|.+|+.++.+++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 06999802453102466899999999999999999999983799974980368898897699939997327850237899
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~ 469 (642)
|+++|+|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf 5899888999852--3578999999999999999988875099---9516147899798189978875002213335567
Q ss_pred C-CCCCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCC
Q ss_conf 7-31015567754247422224---9989731178899999999949989999998456404789998630386012213
Q 006514 470 S-HISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 470 ~-~~~~~~~gt~~y~aPE~~~~---~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
. .......||+.|||||++.+ +.++.++|||||||++|||+||+.||....... ................++
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~~~-- 234 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKV-- 234 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCGGGS--
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCCCCCHHC--
T ss_conf 7631256655743179999950568999953151635999999997889989989699--999999658889860003--
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 222234469987099999999999973255999999999999986259
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
..... ..+.+++.+||+.||++||||.||+++|+..
T Consensus 235 ---------~~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 235 ---------RSNCP---KAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp ---------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---------65554---9999999997588976892999999999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.96 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=205.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEEC
Q ss_conf 08963235126667168999781899689999820447565999999999983088561310110111489732899506
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++||||++++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99980245310246689999999999999999999998379997498036889889769993999732785023789973
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~ 471 (642)
++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf 898288887514-7898878899999999999999997489---546756422515620244042341014773588644
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCC
Q ss_conf 10155677542474222249989731178899999999949989999998456404789998630386012213222234
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......|++.|+|||++.++.++.++||||||+++|||+||..|+....... . .......+.. .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~----~~~~i~~~~~-----~----- 229 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--E----VIQNLERGYR-----M----- 229 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTTCC-----C-----
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH--H----HHHHHHHCCC-----C-----
T ss_conf 2035677444458289837999824564525799999996898888888999--9----9999970688-----8-----
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 46998709999999999997325599999999999998625
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
..+.... ..+.+++.+||+.||++||||.+|++.|+.
T Consensus 230 -~~p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 -VRPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -8965571---999999999758897689399999998611
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.09 Aligned_cols=253 Identities=27% Similarity=0.378 Sum_probs=204.4
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCC-HHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEE
Q ss_conf 089632351266671689997818-99689999820447-5659999999999830885613101101114897328995
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|++.+.||+|+||.||++..+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 06999802453102466899999999999999999999983799974980368898897699939997327850237899
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~ 469 (642)
|+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 458980899975---3799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred C-CCCCCCCCCCCCCCHHHHCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCC
Q ss_conf 7-31015567754247422224998-973117889999999994998999999845640478999863038601221322
Q 006514 470 S-HISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 470 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
. ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||......... .. ........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~----~~~~~~~~------ 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS----DWKEKKTY------ 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HH----HHHTTCTT------
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH--HH----HHHCCCCC------
T ss_conf 6531113255747428728618999997101617379999998299788889859999--99----98638887------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 223446998709999999999997325599999999999998
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.||++|||+.|+++|
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------88644699999999999767996689099999619
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.85 Aligned_cols=269 Identities=23% Similarity=0.359 Sum_probs=206.5
Q ss_pred HCCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 708963235126667168999781-89968999982044-7565999999999983088561310110111489732899
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
..++|+..++||+|+||.||++.. .+|+.||+|++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 5069998024531024668999999999999999999999837-999749803688988976999399973278502378
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQ-SKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~ 467 (642)
||+++|+|.+++.+ ...+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++....
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 76799868998742---4999999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH--------------
Q ss_conf 997310155677542474222249989731178899999999949989999998456404789998--------------
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWK-------------- 533 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~-------------- 533 (642)
.. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.................
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CC---CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 86---211137714119468758998948889989999999998889989988789999998875177545774212333
Q ss_pred ---------HHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---------63038601221322223446998709999999999997325599999999999998
Q 006514 534 ---------HFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 534 ---------~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
........+..+......+. ..........+.+++.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 22111122235413477887665026876-67644489999999999868994679089999609
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.08 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=205.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCC-C-----CEEEEEEEECC-CHHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCCC
Q ss_conf 0896323512666716899978189-9-----68999982044-756599999999998308-85613101101114897
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD-G-----REIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPE 383 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 383 (642)
.++|++.+.||+|+||.||+|.+.. + ..||+|.+... .......+.+|+.++.++ +||||+++++++.....
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred CEEEEEECCCCCHHHHHHCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCC
Q ss_conf 3289950699980245310246--------------------68999999999999999999999837999749803688
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAK--------------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKA 443 (642)
Q Consensus 384 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp 443 (642)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 9889769993999732785023789973-1015567754247422224998973117889999999994-9989999998
Q 006514 444 SNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNS 521 (642)
Q Consensus 444 ~NILi~~~~~~ki~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~ 521 (642)
+|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 45640478999863038601221322223446998709999999999997325599999999999998625
Q 006514 522 EYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 522 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
.. .+. .....+. .... +.... ..+.+++.+||+.||++|||+.||+++|.-
T Consensus 273 ~~--~~~----~~~~~~~---------~~~~--p~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DA--NFY----KLIQNGF---------KMDQ--PFYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SH--HHH----HHHHTTC---------CCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHH----HHHHCCC---------CCCC--CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 99--999----9985699---------8998--87678---999999999758896689399999999748
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.96 Aligned_cols=267 Identities=26% Similarity=0.390 Sum_probs=212.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEEC
Q ss_conf 08963235126667168999781899689999820447565999999999983088561310110111489732899506
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
.++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++.+++||||+++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEEC
T ss_conf 79979846993079809999999999999999988044-88899999999998666678868999982-39759999944
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99980245310246689999999999999999999998379997498036889889769993999732785023789973
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~ 471 (642)
++|+|..++... ....++|.+++.++.+|+.||.|||+++ ++||||||+|||++.++.+||+|||+++........
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE
T ss_conf 799435420000-3553059999999999999999875411---433531230799989992998442555425688733
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCC
Q ss_conf 10155677542474222249989731178899999999949989999998456404789998630386012213222234
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
......|++.|+|||++..+.++.++||||||+++|||++|..|+...... ...... ...+. ...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~----i~~~~-----~~~---- 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGY-----RMP---- 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTC-----CCC----
T ss_pred EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHHCC-----CCC----
T ss_conf 524545566545808983799891774132358999998689999988889--999999----98268-----999----
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 46998709999999999997325599999999999998625999999999984
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQLPGPTSPPF 604 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~ 604 (642)
. ..... ..+.+++.+||+.||++||+|.+|+++|+.......|..+|.
T Consensus 235 -~-~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 235 -C-PPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp -C-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred -C-CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf -9-83237---999999999756697589199999998766623899999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=355.53 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=206.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEE
Q ss_conf 08963235126667168999781-89968999982044756599999999998308856131011011148973289950
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 390 (642)
-++|++.+.||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 699980245310246689999999999999999999998379997498036889889769--993999732785023789
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS--RLRAKIADFGLARSFQED 468 (642)
Q Consensus 391 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~--~~~~ki~Dfgl~~~~~~~ 468 (642)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+|||++. ++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 799889999976--2378999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf 97310155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||...... ... .. .......
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~---~~-i~~~~~~------- 243 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL---RN-VKSCDWN------- 243 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-HHHTCCC-------
T ss_pred CC--CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HH-HHHCCCC-------
T ss_conf 43--20006862421889975899872676554659999998598998997999---999---99-9847889-------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 23446998709999999999997325599999999999998
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.. ..........+.+++.+||+.||++|||+.|+++|
T Consensus 244 -~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 -MD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -SC---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CC---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -89---42235899999999999756896679089998629
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.26 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=209.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEECC
Q ss_conf 89632351266671689997818996899998204475659999999999830885613101101114897328995069
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLP 392 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 392 (642)
++|+..++||+|+||.||+|.+++++.||||++.... ...++|.+|+.++++++||||++++|++.+....++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475-778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99802453102466899999999999999999999983799974980368898897699939997327850237899731
Q 006514 393 NQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSHI 472 (642)
Q Consensus 393 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~~ 472 (642)
+|+|..++.. ....+++..+.+++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEE
T ss_conf 9938886410--2467768999999999999999875468---4346654135887699847988614420235787225
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCC
Q ss_conf 015567754247422224998973117889999999994-9989999998456404789998630386012213222234
Q 006514 473 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLH 551 (642)
Q Consensus 473 ~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 551 (642)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... .... ...+.. +..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~-i~~~~~--~~~------ 222 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEH-IAQGLR--LYR------ 222 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHH-HHTTCC--CCC------
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH------HHHH-HHHCCC--CCC------
T ss_conf 2465788775780786379988521033643246739755999988999999------9999-980797--899------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 46998709999999999997325599999999999998625
Q 006514 552 NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 552 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
+.... ..+.+++.+||+.||++|||+.+|+++|..
T Consensus 223 ---p~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 ---PHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf ---65465---999999999766897689399999987418
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.74 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=203.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEEC
Q ss_conf 8963235126667168999781-899689999820447565999999999983088561310110111489732899506
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 391 (642)
+.|++.+.||+|+||.||++.+ .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99980245310246689999999999999999999998379997498036889889769993999732785023789973
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~ 471 (642)
++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCC-
T ss_conf 99818899986--2899999999999999999999999889---88714070031487899989971612303577864-
Q ss_pred CCCCCCCCCCCCCHHHHC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCC
Q ss_conf 101556775424742222-----499897311788999999999499899999984564047899986303860122132
Q 006514 472 ISTAIAGTLGYMAPEYLA-----HGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDK 546 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 546 (642)
......||+.|+|||++. ...|+.++|||||||++|||++|+.||........ ..... .+....
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~-~~~~~~---- 234 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIA-KSEPPT---- 234 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHH-HSCCCC----
T ss_pred CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-CCCCCC----
T ss_conf 1001025626479999832025788888066578789999998208899999899999------99997-079987----
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 2223446998709999999999997325599999999999998
Q 006514 547 NLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
..........+.+++.+||+.||++|||+.|+++|
T Consensus 235 --------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 --------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------77656699999999999766996689199999629
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=351.61 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=206.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEE
Q ss_conf 08963235126667168999781-89968999982044756599999999998308856131011011148973289950
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 390 (642)
.++|++.+.||+|+||.||++.. .+|+.||+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 69998024531024668999999999999999999999837999749803688988976--9993999732785023789
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD--SRLRAKIADFGLARSFQED 468 (642)
Q Consensus 391 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~--~~~~~ki~Dfgl~~~~~~~ 468 (642)
+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 899808888986--3899899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf 97310155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... .. .. .......
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~-i~~~~~~------- 246 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QN-VKRCDWE------- 246 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-HHHCCCC-------
T ss_pred CC--EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HH-HHHCCCC-------
T ss_conf 72--010047645348999747998976333898999999996889989979999---99---99-9847889-------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 23446998709999999999997325599999999999998
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.. ..........+.+++.+||+.||.+|||+.|+++|
T Consensus 247 -~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 -FD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CC---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -89---30024799999999999756996689189999609
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.87 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=205.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCC-----CEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCE
Q ss_conf 08963235126667168999781899-----68999982044-7565999999999983088561310110111489732
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPDG-----REIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 385 (642)
...|+..+.||+|+||.||+|.++.+ ..||||++... .......|.+|+.++.+++||||++++|++.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 89950699980245310246689999999999999999999998379997498036889889769993999732785023
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~ 465 (642)
+|+||+.++++.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEECCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 99972135740222102--3454208999999999998541212123---425765644278889984998455103003
Q ss_pred CCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHH
Q ss_conf 789973--101556775424742222499897311788999999999499899999984564047899986303860122
Q 006514 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
...... ......||+.|+|||++.++.++.++||||||+++|||+++..|+....... .. ......+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~----~~~i~~~~---- 230 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EV----MKAINDGF---- 230 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH----HHHHHTTC----
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--HH----HHHHHCCC----
T ss_conf 578765267426777734348888704999973556344898999996798865568999--99----99986357----
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 1322223446998709999999999997325599999999999998625999
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ 595 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 595 (642)
.... +.. ....+.+++.+||+.||++||||.||+++|+...+
T Consensus 231 -----~~~~--~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 -----RLPT--PMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CCCC--CTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCC--CHH---HHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -----8998--504---57999999999776797689399999999999866
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.56 Aligned_cols=246 Identities=29% Similarity=0.421 Sum_probs=202.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 89632351266671689997818-9968999982044---7565999999999983088561310110111489732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||++..+ +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 50699980245310246689999999999999999999998379997498036889889769993999732785023789
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~ 468 (642)
||+++|+|.+++. +...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875---0489999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf 97310155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+........
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~-------- 221 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF-------- 221 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred C---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCC--------
T ss_conf 5---235578876349999758998931440467599999832999988899999-------9999971899--------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 23446998709999999999997325599999999999998
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. .+....+ .+.+++.+||+.||++|||+.|+++|
T Consensus 222 ~----~p~~~s~---~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 T----FPDFVTE---GARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C----CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C----CCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9----9866899---99999999764797689099999719
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.73 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=202.3
Q ss_pred CCCCCCC-CCCCCCCEEEEEEECC---CCCEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEE
Q ss_conf 8963235-1266671689997818---9968999982044-756599999999998308856131011011148973289
Q 006514 313 GSFDEAN-KLGQGGFGTVYKGVLP---DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 387 (642)
+++...+ +||+|+||.||+|.++ ++..||||++... .....+.|.+|++++.+++||||++++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95069998024531024668999999999999999999999837999749803688988976999399973278502378
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~ 467 (642)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 980789968997521--2569999999999999999878998688---10576764660454688542033134211554
Q ss_pred CCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHC
Q ss_conf 9973--1015567754247422224998973117889999999994-998999999845640478999863038601221
Q 006514 468 DKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 468 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
.... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||....... .. .....+...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~~~~- 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRMEC- 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCCCCC-
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHCCCCCCC-
T ss_conf 34321135621137433586887279999541232201789999938999999979999---99----99981899999-
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 322223446998709999999999997325599999999999998625
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
+.... ..+.+++.+||+.||++||||.+|++.|+.
T Consensus 234 ----------p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 234 ----------PPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ----------CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ----------97678---999999999757797689099999999999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.09 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=204.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECC--CCCCEEE
Q ss_conf 8963235126667168999781-89968999982044--75659999999999830885613101101114--8973289
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--GPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 387 (642)
++|++.+.||+|+||.||++.. .+|+.||+|.+... .....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 95069998024531024-6689999999999999999999998379--99749803688988976999399973278502
Q 006514 388 YEFLPNQSLDRFIFDSA-KAKTLTWEKRYEIILGTVEGLVYLHEQS--KIRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 388 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~--~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~ 464 (642)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHC
Q ss_conf 37899731015567754247422224998973117889999999994998999999845640478999863038601221
Q 006514 465 FQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 465 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ......+....+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~-~~~i~~~~~~~~- 234 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------EL-AGKIREGKFRRI- 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHHTCCCCC-
T ss_pred CCCCCC-CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH------HH-HHHHHCCCCCCC-
T ss_conf 245777-556677882327999983999993898875278999980188998998999------99-999971899889-
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 322223446998709999999999997325599999999999998
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.....+ .+.+++.+||+.||++|||+.|+++|
T Consensus 235 ----------~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 ----------PYRYSD---ELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------CCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ----------743599---99999999767995579189999729
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=354.90 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=203.9
Q ss_pred HCCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCC-HHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 7089632351266671689997818-99689999820447-565999999999983088561310110111489732899
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
..+.|++.+.||+|+||.||++..+ +++.||||.+.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf 5069998024531024668999999999999999999999837999749803688988976---9993999732785023
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD---SRLRAKIADFGLARSF 465 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~---~~~~~ki~Dfgl~~~~ 465 (642)
||+++|+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||+. .++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 5268984888653---0367887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCC
Q ss_conf 78997310155677542474222249989731178899999999949989999998456404789998630386012213
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
..... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... . +........
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~-~~~i~~~~~----- 226 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------L-FEQILKAEY----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHTTCC-----
T ss_pred CCCCE--EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHCCCC-----
T ss_conf 58970--440032842259188737999807873451599999985979999989999------9-999861687-----
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 22223446998709999999999997325599999999999998
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.......... ...+.+++.+||+.||++|||+.|+++|
T Consensus 227 ---~~~~~~~~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 ---EFDSPYWDDI---SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCTTTTTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---7787666678---9999999999760897579189998629
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.14 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=197.5
Q ss_pred CCCCCCCCEEEEEEECC---CCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEECCC
Q ss_conf 51266671689997818---9968999982044--756599999999998308856131011011148973289950699
Q 006514 319 NKLGQGGFGTVYKGVLP---DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPN 393 (642)
Q Consensus 319 ~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 393 (642)
++||+|+||.||+|.+. .++.||||++... +....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC--
Q ss_conf 980245310246689999999999999999999998379997498036889889769993999732785023789973--
Q 006514 394 QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH-- 471 (642)
Q Consensus 394 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~-- 471 (642)
|+|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 96899975---2257899999999999999976687479---55677761131023567512341345331343234432
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCC
Q ss_conf 1015567754247422224998973117889999999994-998999999845640478999863038601221322223
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
......||+.|+|||.+.++.++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~----~~i~~~~~~~-------- 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGERMG-------- 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC--------
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHCCCCCC--------
T ss_conf 2445677842039166537999843443034031328965899999998999---999----9998289999--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 446998709999999999997325599999999999998625
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
. +.... ..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 231 --~-p~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 --C-PAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --C-CTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --C-CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf --9-86567---999999999758897689098999998528
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=353.08 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=199.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCC---HHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 8963235126667168999781-899689999820447---565999999999983088561310110111489732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
..|+..++||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 50699980245310246689999999999999999999998379997498036889889769993999732785023789
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~ 468 (642)
||+.+|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC
T ss_conf 8069994578997---3799999999999999999999998689---766678842179879997898443653346778
Q ss_pred CCCCCCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCC
Q ss_conf 9731015567754247422224---9989731178899999999949989999998456404789998630386012213
Q 006514 469 KSHISTAIAGTLGYMAPEYLAH---GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||...... ......... ....+
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~-~~~~~-- 234 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPAL-- 234 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCC--
T ss_pred -----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHC-CCCCC--
T ss_conf -----7313476636889983467888672145455899999998788999997999------999999828-99988--
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 22223446998709999999999997325599999999999998
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. ..... ..+.+++.+||+.||++|||+.|+++|
T Consensus 235 ---~-----~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 ---Q-----SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---S-----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---C-----CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ---8-----78889---999999999773796579189999719
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.24 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=195.3
Q ss_pred CCC-CCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECC----CCCC
Q ss_conf 896-32351266671689997818-9968999982044--75659999999999830885613101101114----8973
Q 006514 313 GSF-DEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS----GPES 384 (642)
Q Consensus 313 ~~~-~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 384 (642)
++| ...++||+|+||.||++.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEE
T ss_conf 87788516970082849999999999959999998512279899999999999998579998506999984033458889
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC-CCCCEEEEECCCCC
Q ss_conf 28995069998024531024668999999999999999999999837999749803688988976-99939997327850
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLD-SRLRAKIADFGLAR 463 (642)
Q Consensus 385 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~-~~~~~ki~Dfgl~~ 463 (642)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||||+|||++ .++.+||+|||+++
T Consensus 88 ~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf 999957898948999751---355469999999999999999999789-9799687674351166799988980057654
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHH
Q ss_conf 23789973101556775424742222499897311788999999999499899999984564047899986303860122
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEEL 543 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 543 (642)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ........+.....
T Consensus 164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPAS 233 (270)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGG
T ss_pred ECCCC---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHCCCCCCC
T ss_conf 23687---6677553813008988478-99986711007999999987889998765599------99999973899865
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 1322223446998709999999999997325599999999999998
Q 006514 544 YDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 ~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
++ ..... .+.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~----------~~~~~---~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FD----------KVAIP---EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG----------GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC----------CCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 67----------55789---99999999763797589299999677
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=348.69 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=210.0
Q ss_pred HHHHHCCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEC
Q ss_conf 69987089632351266671689997818------9968999982044-7565999999999983088561310110111
Q 006514 307 TLEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSC 379 (642)
Q Consensus 307 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 379 (642)
+++...++|++.+.||+|+||.||+|.++ +++.||||++... .....+.|.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 11389889388679820788399999988876577882999999882108579999999999999668997655246660
Q ss_pred CCCCCEEEEEECCCCCHHHHHHCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 4897328995069998024531024---------------------6689999999999999999999998379997498
Q 006514 380 SGPESLLVYEFLPNQSLDRFIFDSA---------------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIH 438 (642)
Q Consensus 380 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH 438 (642)
.....++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ ++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578---685
Q ss_pred ECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC-CC
Q ss_conf 036889889769993999732785023789973-1015567754247422224998973117889999999994998-99
Q 006514 439 RDIKASNILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ-NN 516 (642)
Q Consensus 439 ~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~-p~ 516 (642)
|||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCC
T ss_conf 48840116898999289833144211367764111577776767679899726889805630252362999980689999
Q ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 999984564047899986303860122132222344699870999999999999732559999999999999862599
Q 006514 517 RSKNSEYTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 517 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 594 (642)
...... ..... ...+..... +.... ..+.+++.+||+.+|++||||.||+++|+...
T Consensus 244 ~~~~~~------e~~~~-v~~~~~~~~-----------p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHE------EVIYY-VRDGNILAC-----------PENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHH------HHHHH-HHTTCCCCC-----------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHH------HHHHH-HHCCCCCCC-----------CCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 998999------99999-973997888-----------73252---99999999974889657939999999999842
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.85 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 8963235126667168999781-89968999982044---7565999999999983088561310110111489732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||++.. .+++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 50699980245310246689999999999999999999998379997498036889889769993999732785023789
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~ 468 (642)
||+++|+|.+++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653---1599999999999999999997621650---884767741236688853886032102422567
Q ss_pred CC-CCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCC
Q ss_conf 97-31015567754247422224998973117889999999994998999999845640478999863038601221322
Q 006514 469 KS-HISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 469 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... . .........
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~-~~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------I-FQKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHTTCC-------
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHCCCC-------
T ss_conf 76433355567755258440026898966623045699999803889989959999------9-999971899-------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 223446998709999999999997325599999999999998
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. + +.... ..+.+++.+||+.||++|||++|++.+
T Consensus 228 -~---~-p~~~s---~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 -D---F-PEKFF---PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -C---C-CTTCC---HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -C---C-CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf -9---9-85479---999999999855797689197897377
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.03 Aligned_cols=254 Identities=23% Similarity=0.431 Sum_probs=203.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCC----EEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEE
Q ss_conf 89632351266671689997818-996----8999982044-75659999999999830885613101101114897328
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR----EIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 386 (642)
.+|+..+.||+|+||.||+|.+. +|+ .||+|++... .....+.+.+|+.++++++||||++++|++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961-98369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99506999802453102466899999999999999999999983799974980368898897699939997327850237
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~ 466 (642)
++|++.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 9984268740101113--3457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHC
Q ss_conf 89973-1015567754247422224998973117889999999994-998999999845640478999863038601221
Q 006514 467 EDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 467 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
..... ......||+.|+|||++.++.++.++||||||+++|||+| |++||....... +... ...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~----i~~~~----- 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE----- 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH----HHHTC-----
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHCCC-----
T ss_conf 44453223651058644670887469998356544079999999977999999999899---9999----97599-----
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 3222234469987099999999999973255999999999999986259
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
... .+.... ..+.+++.+||+.||++|||+.||+++|+..
T Consensus 231 ----~~~--~p~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ----RLP--QPPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCC--CCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC--CCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----899--985568---9999999984789934691999999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=341.52 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=197.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCC---HHHHHHHH---HHHHHHHCCCCCCEEEEEEEECCCCCCE
Q ss_conf 89632351266671689997818-99689999820447---56599999---9999983088561310110111489732
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFY---NEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~ 385 (642)
++|++.+.||+|+||.||++... +|+.||+|++.... ......+. +++.+++.++||||+++++++......+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 89950699980245310246689999999999999999999998379997498036889889769993999732785023
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~ 465 (642)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 99991489838999873---255327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHC
Q ss_conf 78997310155677542474222249-98973117889999999994998999999845640478999863038601221
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELY 544 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 544 (642)
..... ....||+.|+|||++..+ .++.++|||||||++|||++|+.||......... ..... .
T Consensus 158 ~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~-~--------- 221 (364)
T d1omwa3 158 SKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRM-T--------- 221 (364)
T ss_dssp SSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHH-S---------
T ss_pred CCCCC---CCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHH-C---------
T ss_conf 78864---33113455421687603899984410467789999998599988889989999---99986-0---------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHH
Q ss_conf 32222344699870999999999999732559999999-----99999986
Q 006514 545 DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQML 590 (642)
Q Consensus 545 d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L 590 (642)
............. .+.+++.+||+.||++||| +.|+++|-
T Consensus 222 ---~~~~~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 222 ---LTMAVELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp ---SSCCCCCCSSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred ---CCCCCCCCCCCCH---HHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCC
T ss_conf ---4688878877899---99999999856698880887435799997491
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.52 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=203.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCC------HHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCC
Q ss_conf 08963235126667168999781-899689999820447------56599999999998308856131011011148973
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN------RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 384 (642)
.+.|++.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC----CEEEEECC
Q ss_conf 28995069998024531024668999999999999999999999837999749803688988976999----39997327
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL----RAKIADFG 460 (642)
Q Consensus 385 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~----~~ki~Dfg 460 (642)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 999986778643100103---564215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 85023789973101556775424742222499897311788999999999499899999984564047899986303860
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRV 540 (642)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 540 (642)
++........ .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... . +........
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~-~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T-LANVSAVNY 233 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHTTCC
T ss_pred HHHHCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH------H-HHHHHHCCC
T ss_conf 4210577763--122477774309999818999976652214099999970889988999999------9-999981688
Q ss_pred HHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 1221322223446998709999999999997325599999999999998
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. .. ..........+.+++.+||+.||++|||+.|+++|
T Consensus 234 ~--------~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 E--------FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C--------CC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--------CC---CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8--------87---01047889999999999863896689199999619
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=340.02 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=202.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 8963235126667168999781-89968999982044---7565999999999983088561310110111489732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 50699980245310246689999999999999999999998379997498036889889769993999732785023789
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~ 468 (642)
||+++|+|..++. ....+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432---2221110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf 97310155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
. ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... ...+. .
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~-i~~~~--------~ 218 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEK-ILNAE--------L 218 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHCC--------C
T ss_pred C----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH------HHHHH-HHCCC--------C
T ss_conf 6----4345763435999983899980430465333689997598999996999------99999-97089--------8
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 234469987099999999999973255999999-----99999998
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 589 (642)
.. +..... .+.+++.+||+.||++|| |+.++++|
T Consensus 219 ~~----p~~~s~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 RF----PPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CC----CTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC----CCCCCH---HHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 89----977899---9999999995449976664310219999819
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.64 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=204.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 8963235126667168999781-89968999982044---7565999999999983088561310110111489732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 50699980245310246689999999999999999999998379997498036889889769993999732785023789
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~ 468 (642)
||+++|+|.+++. +...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 0357986055553---2567759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf 97310155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... +. .....+.+
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~----~~i~~~~~-------- 222 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF----ELILMEEI-------- 222 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCC--------
T ss_pred CC-CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHCCCC--------
T ss_conf 86-2055100889966665048988833310223067889987899999969999---99----99852899--------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHH
Q ss_conf 2344699870999999999999732559999999-----99999986
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPT-----MSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L 590 (642)
. + +..... .+.+++.+||+.||++||+ +.|+++|-
T Consensus 223 ~---~-p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 223 R---F-PRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp C---C-CTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred C---C-CCCCCH---HHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCC
T ss_conf 8---9-866899---99999986663893442256523499997291
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=341.69 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=202.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEE
Q ss_conf 8963235126667168999781-89968999982044---7565999999999983088561310110111489732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 388 (642)
++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 50699980245310246689999999999999999999998379997498036889889769993999732785023789
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQED 468 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~ 468 (642)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 23346622666751---589899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf 97310155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 469 KSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 469 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||...... ..... ...+..
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~-i~~~~~-------- 255 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEK-IVSGKV-------- 255 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCC--------
T ss_pred C----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHCCCC--------
T ss_conf 6----4336763567889971799885331145007899997588998995999------99999-861798--------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC-----CCHHHHHHHH
Q ss_conf 23446998709999999999997325599999-----9999999986
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLR-----PTMSRVLQML 590 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-----Ps~~evl~~L 590 (642)
.. ..... ..+.+++.+||+.||.+| ||+.++++|-
T Consensus 256 ~~----p~~~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 256 RF----PSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CC----CTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CC----CCCCC---HHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCC
T ss_conf 89----76689---999999999834099860655345499997190
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.26 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=203.6
Q ss_pred HHHHHCCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEEEECC-CHHHHHHHHHHHHHHHCC-CCCCEEEEEEEE
Q ss_conf 69987089632351266671689997818------9968999982044-756599999999998308-856131011011
Q 006514 307 TLEKATGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCS 378 (642)
Q Consensus 307 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 378 (642)
..+...++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE
T ss_conf 52616799798449841678399999986777555783999999860017178999999999988614998499741154
Q ss_pred CCC-CCCEEEEEECCCCCHHHHHHCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCC
Q ss_conf 148-973289950699980245310246-------------689999999999999999999998379997498036889
Q 006514 379 CSG-PESLLVYEFLPNQSLDRFIFDSAK-------------AKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKAS 444 (642)
Q Consensus 379 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~ 444 (642)
... ...++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCC
T ss_conf 04797579999845899299999853666665322202332146899999999999999999887379---717867731
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCC
Q ss_conf 889769993999732785023789973-101556775424742222499897311788999999999499-899999984
Q 006514 445 NILLDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-QNNRSKNSE 522 (642)
Q Consensus 445 NILi~~~~~~ki~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~-~p~~~~~~~ 522 (642)
|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||++|. +||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 06577998289845752001135665222475166721020368646889966322136789999986889999899989
Q ss_pred CCCHHHHHHHHHHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 56404789998630386012213222234469987099999999999973255999999999999986259
Q 006514 523 YTDSLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 523 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
.. .......+..... .... ...+.+++.+||+.||++|||+.||+++|+..
T Consensus 244 --~~----~~~~~~~~~~~~~-----------~~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 244 --EE----FCRRLKEGTRMRA-----------PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp --HH----HHHHHHHTCCCCC-----------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HH----HHHHHHCCCCCCC-----------CCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf --99----9999963898888-----------8657---89999999997677966791999999999799
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.30 Aligned_cols=267 Identities=24% Similarity=0.287 Sum_probs=197.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC----CCEEEE
Q ss_conf 8963235126667168999781899689999820447565999999999983088561310110111489----732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----ESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 388 (642)
.+|...+.||+|+||.||+|++ +|+.||||++..... .......|+..+..++||||+++++++.... ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-998999999872004-67999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 50699980245310246689999999999999999999998379-----9974980368898897699939997327850
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS-----KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-----~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
||+++|+|.+++.. ..++|..++.++.+++.||.|+|+.. .++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 64669898999865----89998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCHHHHCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCH--------
Q ss_conf 23789973---101556775424742222499------8973117889999999994998999999845640--------
Q 006514 464 SFQEDKSH---ISTAIAGTLGYMAPEYLAHGQ------LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDS-------- 526 (642)
Q Consensus 464 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~-------- 526 (642)
........ ......||+.|+|||++.+.. ++.++||||||++||||+||..|+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred HHHHHHHHHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 4789998630386012213222234469987099999999999973255999999999999986259
Q 006514 527 LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 527 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
...........+ ..++.+. ...........+.+++.+||+.||++|||+.||+++|+..
T Consensus 237 ~~~~~~~~~~~~----~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQ----KLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHCC----CCCCCCC----CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 099999987502----4688877----6557768999999999997606985895999999999988
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.19 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=203.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCC--EEEEEEEECC-CHHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCCCCEEE
Q ss_conf 89632351266671689997818-996--8999982044-756599999999998308-856131011011148973289
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGR--EIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 387 (642)
++|+..+.||+|+||.||+|.++ ++. .||||++... .....+.+.+|++++.++ +||||+++++++......++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf 9506999802453102-------------466899999999999999999999983799974980368898897699939
Q 006514 388 YEFLPNQSLDRFIFDS-------------AKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRA 454 (642)
Q Consensus 388 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ 454 (642)
|||+++|+|.++++.. .....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHHH
Q ss_conf 997327850237899731015567754247422224998973117889999999994998-9999998456404789998
Q 006514 455 KIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQ-NNRSKNSEYTDSLLTITWK 533 (642)
Q Consensus 455 ki~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~-p~~~~~~~~~~~l~~~~~~ 533 (642)
||+|||+++....... .....||..|+|||.+.++.++.++||||||+++|||++|.. ||...... .. ..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~~-~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YE 237 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH-HH
T ss_pred EECCCCCCCCCCCCCC--CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH------HH-HH
T ss_conf 8743443224442234--553013775555387526999962215313889999983689999999999------99-99
Q ss_pred HHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 6303860122132222344699870999999999999732559999999999999862599
Q 006514 534 HFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEE 594 (642)
Q Consensus 534 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 594 (642)
....+.. + . ...... ..+.+++.+||+.||++||||.||+++|+...
T Consensus 238 ~i~~~~~-----~----~--~~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 238 KLPQGYR-----L----E--KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HGGGTCC-----C----C--CCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHCCC-----C----C--CCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9982688-----8----8--876678---99999999976789668949999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.32 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=204.8
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCC----CCEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEE
Q ss_conf 0896323512666716899978189----968999982044-75659999999999830885613101101114897328
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD----GREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 386 (642)
.++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99506999802453102466899999999999999999999983799974980368898897699939997327850237
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQ 466 (642)
Q Consensus 387 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~ 466 (642)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf 9984069807765422--4789999999999999987752302267---4414102655320678967876503421336
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCC
Q ss_conf 899731015567754247422224998973117889999999994-9989999998456404789998630386012213
Q 006514 467 EDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYD 545 (642)
Q Consensus 467 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 545 (642)
...........||+.|+|||.+.++.++.++||||||+++|||++ |.+||....... +.. ....+....
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----~i~~~~~~~--- 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERLP--- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC---
T ss_pred CCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHCCCCCC---
T ss_conf 7762330540058310326675169988745244424789999826999988899999---999----998189998---
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 22223446998709999999999997325599999999999998625
Q 006514 546 KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
. ..... ..+.+++.+||+.||++|||+.||+++|+.
T Consensus 230 -------~-~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 230 -------M-PPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -------C-CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------C-CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -------9-87779---999999999768797689299999999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.64 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=199.7
Q ss_pred CCCCCCCCCEEEEEEECCCC----CEEEEEEEEC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCC-CCCEEEEEEC
Q ss_conf 35126667168999781899----6899998204-4756599999999998308856131011011148-9732899506
Q 006514 318 ANKLGQGGFGTVYKGVLPDG----REIAVKRLFF-NNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-PESLLVYEFL 391 (642)
Q Consensus 318 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 391 (642)
.++||+|+||+||+|.+.++ ..||||++.. .+....+.|.+|++++++++||||++++|++... ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99980245310246689999999999999999999998379997498036889889769993999732785023789973
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~ 471 (642)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 06741442101--3454048999999999887652003367---625776687576779998899106523225566555
Q ss_pred ---CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCC
Q ss_conf ---10155677542474222249989731178899999999949989999998456404789998630386012213222
Q 006514 472 ---ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNL 548 (642)
Q Consensus 472 ---~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 548 (642)
......||..|+|||.+..+.++.++||||||+++|||++|+.|+....... ...... ..+... ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~~~--~~--- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRRL--LQ--- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCC--CC---
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HCCCCC--CC---
T ss_conf 3100256555645567688743799974574661999999997899998889999--999999----808988--99---
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 234469987099999999999973255999999999999986259
Q 006514 549 MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
+.... ..+.+++.+||+.||++||+|.||+++|+..
T Consensus 256 ------p~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 ------PEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ------64475---9999999997688976893999999999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.10 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=206.5
Q ss_pred HCCCCCCCCCCCCCCCEEEEEEEC------CCCCEEEEEEEECC-CHHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCC
Q ss_conf 708963235126667168999781------89968999982044-756599999999998308-8561310110111489
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVL------PDGREIAVKRLFFN-NRHRAANFYNEVNIISSV-EHKNLVRLLGCSCSGP 382 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 382 (642)
..++|+..+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++.++ +||||+++++++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred CCEEEEEECCCCCHHHHHHCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf 7328995069998024531024---------------6689999999999999999999998379997498036889889
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSA---------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNIL 447 (642)
Q Consensus 383 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NIL 447 (642)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf 78999973799879999985356654444453322233458899999999999999999887579---266624102100
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC-CCCCCCCCCC
Q ss_conf 769993999732785023789973-10155677542474222249989731178899999999949989-9999984564
Q 006514 448 LDSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQN-NRSKNSEYTD 525 (642)
Q Consensus 448 i~~~~~~ki~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p-~~~~~~~~~~ 525 (642)
++.++.+|++|||+++........ ......|++.|+|||.+.++.++.++||||||+++|||+|+..| +...... .
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~ 255 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--S 255 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--H
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--H
T ss_conf 00257521023401023367886158620135968767788617999974001025899999985899887789989--9
Q ss_pred HHHHHHHHHHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 0478999863038601221322223446998709999999999997325599999999999998625
Q 006514 526 SLLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 526 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
. .+.....+ ..... .... ...+.+++.+||+.||++||||.+|+++|+.
T Consensus 256 ~----~~~~i~~~---------~~~~~--~~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 K----FYKMIKEG---------FRMLS--PEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp H----HHHHHHHT---------CCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHHHHCC---------CCCCC--CCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 9----99998668---------98898--5436---5999999999757796579299999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.42 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=197.3
Q ss_pred CCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCCHH-----HHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEE
Q ss_conf 2351266671689997818-9968999982044756-----599999999998308856131011011148973289950
Q 006514 317 EANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRH-----RAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 317 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 390 (642)
..++||+|+||.||++..+ +|+.||||++...... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998024531024668999999999999999999999837999749803688988976999399973278502378997
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~ 470 (642)
+.++++..+. .....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3450776554---12667789999999999999998863163---55035776258853778411465761000578755
Q ss_pred CCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCC--
Q ss_conf 310155677542474222249-98973117889999999994998999999845640478999863038601221322--
Q 006514 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN-- 547 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-- 547 (642)
. ....+||+.|+|||++..+ .++.++|||||||++|||++|+.||....... .+..+ .+...........+..
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i-~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRI-FETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHHHCCCCTTTSSSTTSS
T ss_pred C-CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH--HHHHH-HHHCCCCCHHHCCCHHCC
T ss_conf 4-3302047333639997267788805643630428999985969999999999--99999-985189972545210002
Q ss_pred ---CCCCCCCCCCCH----HHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---223446998709----999999999997325599999999999998
Q 006514 548 ---LMLHNYHDSNVK----YEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ---~~~~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
............ .....+.+++.+||+.||++|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1344303478988678565689999999999763894569089999679
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.74 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=207.4
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCC
Q ss_conf 089632351266671689997818------9968999982044-756599999999998308856131011011148973
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP------DGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPES 384 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 384 (642)
.++|...+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||+++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEE
Q ss_conf 28995069998024531024-------66899999999999999999999983799974980368898897699939997
Q 006514 385 LLVYEFLPNQSLDRFIFDSA-------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (642)
Q Consensus 385 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~ 457 (642)
++|+||+++|+|.+++.... ....+++..+..++.++++||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876479---6543286775403599649994
Q ss_pred ECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 32785023789973-101556775424742222499897311788999999999499-8999999845640478999863
Q 006514 458 DFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGR-QNNRSKNSEYTDSLLTITWKHF 535 (642)
Q Consensus 458 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~-~p~~~~~~~~~~~l~~~~~~~~ 535 (642)
|||+++........ ......|++.|+|||.+.++.++.++||||||+++|||+||. +|+...... .+ ....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~-~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV-LRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH-HHHH
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH------HH-HHHH
T ss_conf 2454202357763031340231632378888736998833344437899999996899999998999------99-9999
Q ss_pred HCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 038601221322223446998709999999999997325599999999999998625999
Q 006514 536 QAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTEEQ 595 (642)
Q Consensus 536 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 595 (642)
..+..... .... ...+.+++.+||+.+|++||||.+|+++|+...+
T Consensus 249 ~~~~~~~~-----------p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDK-----------PDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCC-----------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHCCCCCC-----------CCCC---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 80888888-----------6335---3999999999757796589399999999787617
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.58 Aligned_cols=258 Identities=27% Similarity=0.376 Sum_probs=207.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCC--------CCEEEEEEEECCC-HHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCC
Q ss_conf 0896323512666716899978189--------9689999820447-56599999999998308-856131011011148
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLPD--------GREIAVKRLFFNN-RHRAANFYNEVNIISSV-EHKNLVRLLGCSCSG 381 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 381 (642)
.++|++.+.||+|+||.||++.... +..||||++.... .....++.+|...+.++ +||||+++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CCCEEEEEECCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEE
Q ss_conf 97328995069998024531024-------------66899999999999999999999983799974980368898897
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSA-------------KAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILL 448 (642)
Q Consensus 382 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi 448 (642)
...++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCH
Q ss_conf 69993999732785023789973-1015567754247422224998973117889999999994-998999999845640
Q 006514 449 DSRLRAKIADFGLARSFQEDKSH-ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDS 526 (642)
Q Consensus 449 ~~~~~~ki~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~ 526 (642)
+.++.+||+|||+++........ ......+++.|+|||.+.++.|+.++||||||+++|||++ |++||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH----
T ss_conf 4789767622111011355555431466788846632667517988825554775888887401798989999999----
Q ss_pred HHHHHHHHHHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 4789998630386012213222234469987099999999999973255999999999999986259
Q 006514 527 LLTITWKHFQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 527 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
..+..+..+..... +.... ..+.+++.+||+.||++|||+.||++.|+..
T Consensus 245 ---~~~~~i~~~~~~~~-----------p~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKLLKEGHRMDK-----------PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHHTTCCCCC-----------CSSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHCCCCCCC-----------CCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---99999972888898-----------74352---9999999997667976793999999999888
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.09 Aligned_cols=254 Identities=29% Similarity=0.428 Sum_probs=202.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC--CC--CEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCE
Q ss_conf 89632351266671689997818--99--68999982044---7565999999999983088561310110111489732
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP--DG--REIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 385 (642)
++|+..+.||+|+||.||+|... ++ ..||||++... .....+.|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 89950699980245310246689999999999999999999998379997498036889889769993999732785023
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~ 465 (642)
+|+||+++|++.+.+.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 14654238612544421--2689999999999999999998752178---752056688815655654332561155530
Q ss_pred CCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHH
Q ss_conf 789973--1015567754247422224998973117889999999994-9989999998456404789998630386012
Q 006514 466 QEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
...... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||....... ........+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~~- 234 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERL- 234 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCC-
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHHCCCCC-
T ss_conf 3588752654763257310799998379999421566148999999968999999969999------999998479999-
Q ss_pred HCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 21322223446998709999999999997325599999999999998625
Q 006514 543 LYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 543 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
. ...... ..+.+++.+||+.||++||||.||++.|..
T Consensus 235 --------~--~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 --------P--RPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --------C--CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------C--CCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf --------9--854453---999999999768896679299999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=333.83 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=202.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCC---------HHHHHHHHHHHHHHHCCC-CCCEEEEEEEECC
Q ss_conf 08963235126667168999781-899689999820447---------565999999999983088-5613101101114
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN---------RHRAANFYNEVNIISSVE-HKNLVRLLGCSCS 380 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 380 (642)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf 89732899506999802453102466899999999999999999999983799974980368898897699939997327
Q 006514 381 GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFG 460 (642)
Q Consensus 381 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfg 460 (642)
....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 7605999976898668999986---599999999999999999999998759---9432346254898689983871240
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 850237899731015567754247422224------99897311788999999999499899999984564047899986
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAH------GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH 534 (642)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~ 534 (642)
++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~ 226 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRM 226 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred HEEECCCCCC--EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH-------HHHH
T ss_conf 3167268872--134524678889888605344567889923318565602310322888988999999-------9999
Q ss_pred HHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 3038601221322223446998709999999999997325599999999999998
Q 006514 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
...+... .. ..........+.+++.+||+.||++|||+.|+++|
T Consensus 227 i~~~~~~--------~~---~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQ--------FG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCC--------CC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHCCCC--------CC---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9818988--------89---85434689999999999765896689199999739
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=335.50 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=205.9
Q ss_pred HCCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCC---
Q ss_conf 708963235126667168999781-89968999982044---75659999999999830885613101101114897---
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN---NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPE--- 383 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 383 (642)
..++|++.+.||+|+||.||++.. .+|+.||+|.+... +......+.+|+.+++.++||||+++++++.....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf 06206986899608992999999999998999999855664698999999999999985699988731143543268876
Q ss_pred -CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf -3289950699980245310246689999999999999999999998379997498036889889769993999732785
Q 006514 384 -SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 384 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~ 462 (642)
.++||||+++++|.+++. ..+.+++..++.++.|++.||.|||+++ ++||||||+|||++.++..+|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEEECCCCCEEHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 6999997788987101120---3589999999999999999999998579---527634675566575432010034443
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 023789973--101556775424742222499897311788999999999499899999984564047899986303860
Q 006514 463 RSFQEDKSH--ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRV 540 (642)
Q Consensus 463 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 540 (642)
......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH------HHHHHHHHCCCC
T ss_conf 22123544333346425762436999983999996632026528999997697998996999------999999846999
Q ss_pred HHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHCC
Q ss_conf 12213222234469987099999999999973255999999-99999998625
Q 006514 541 EELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-TMSRVLQMLTT 592 (642)
Q Consensus 541 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~ 592 (642)
... . ...... ..+.+++.+||+.||++|| |+.++++.|.+
T Consensus 233 ~~~----~-----~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 PPS----A-----RHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CGG----G-----TSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC----H-----HCCCCC---HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 971----0-----034789---9999999998667976777399999999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.87 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=200.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECC-CCCCEEEEEEC
Q ss_conf 89632351266671689997818996899998204475659999999999830885613101101114-89732899506
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCS-GPESLLVYEFL 391 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 391 (642)
++|+..+.||+|+||.||+|.++ |+.||||++... ...+.+.+|++++++++||||++++|++.+ ....++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 99488579820798089999999-909999998857--779999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99980245310246689999999999999999999998379997498036889889769993999732785023789973
Q 006514 392 PNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKSH 471 (642)
Q Consensus 392 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~~ 471 (642)
++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC--
T ss_conf 999899998745-7888899999999999985232113376---5536665676014689977632456003447877--
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCC
Q ss_conf 1015567754247422224998973117889999999994-998999999845640478999863038601221322223
Q 006514 472 ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVT-GRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKNLML 550 (642)
Q Consensus 472 ~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 550 (642)
....++..|+|||++.++.++.++||||||+++|||+| |++|+....... .... ...+...+
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~~-------- 220 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMD-------- 220 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCCC--------
T ss_pred --CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHCCCCCC--------
T ss_conf --655666467781787279888588777579999999978999999999999---9999----98089999--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 4469987099999999999973255999999999999986259
Q 006514 551 HNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTTE 593 (642)
Q Consensus 551 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 593 (642)
. ..... ..+.+++.+||+.||++||||.+++++|+..
T Consensus 221 --~-~~~~~---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 221 --A-PDGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --C-CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C-CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf --9-76579---9999999997566976893999999999999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.18 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=199.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCC---HHHHHHHHHHHHHHH-CCCCCCEEEEEEEECCCCCCEEE
Q ss_conf 89632351266671689997818-99689999820447---565999999999983-08856131011011148973289
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN---RHRAANFYNEVNIIS-SVEHKNLVRLLGCSCSGPESLLV 387 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 387 (642)
++|++.+.||+|+||.||++..+ +++.||||++.... ....+.+..|..++. .++||||+++++++.+....++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95069998024531024668999999999999999999999837999749803688988976999399973278502378
Q 006514 388 YEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQE 467 (642)
Q Consensus 388 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~ 467 (642)
|||+++|+|.+++.. ...+++.++..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 750379808998640---478999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCC
Q ss_conf 99731015567754247422224998973117889999999994998999999845640478999863038601221322
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+.....+..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------- 220 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------- 220 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred CCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCC-------
T ss_conf 653-3454578777689999827998832320112278989873889999989999-------9999971899-------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH
Q ss_conf 2234469987099999999999973255999999999-99998
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMS-RVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~~ 589 (642)
..+.... ..+.+++.+||+.||++||++. ++++|
T Consensus 221 -----~~p~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 -----FYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -----CCCTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----CCCCCCC---HHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf -----8975679---9999999996544898783889999809
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.89 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=203.0
Q ss_pred HCCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEE
Q ss_conf 7089632351266671689997818-996899998204475659999999999830885613101101114897328995
Q 006514 311 ATGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 311 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 389 (642)
..++|++.+.||+|+||.||++.++ +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 7010588789831778399999998999699999975786-659999999999985799798909899988998899995
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC--CCEEEEECCCCCCCCC
Q ss_conf 06999802453102466899999999999999999999983799974980368898897699--9399973278502378
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSR--LRAKIADFGLARSFQE 467 (642)
Q Consensus 390 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~--~~~ki~Dfgl~~~~~~ 467 (642)
|+++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||++.....
T Consensus 82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 3899808899875--3899999999999999999999998769---9751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCC
Q ss_conf 99731015567754247422224998973117889999999994998999999845640478999863038601221322
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEELYDKN 547 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 547 (642)
... .....+++.|+|||.+.+..++.++||||+||++|||++|+.||....... .... ....... ++..
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~-i~~~~~~--~~~~ 225 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIEN-IMNAEYT--FDEE 225 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHHTCCC--CCHH
T ss_pred CCC--CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHHCCCC--CCHH
T ss_conf 775--321223322234021048777840113027999999982899999989999------9999-9838999--8802
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 223446998709999999999997325599999999999998
Q 006514 548 LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. ... ....+.+++.+||+.||++|||+.|+++|
T Consensus 226 ~------~~~---~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 A------FKE---ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H------HTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred H------CCC---CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2------367---89999999999866996689099999639
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.17 Aligned_cols=253 Identities=22% Similarity=0.235 Sum_probs=196.2
Q ss_pred CCCCCCCC-CCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEECC----CCCC
Q ss_conf 08963235-126667168999781-8996899998204475659999999999830-885613101101114----8973
Q 006514 312 TGSFDEAN-KLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISS-VEHKNLVRLLGCSCS----GPES 384 (642)
Q Consensus 312 ~~~~~~~~-~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 384 (642)
.++|.+.. .||+|+||.||++.. .+++.||||++... ..+.+|+.++.+ .+||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCEEEEECCC
Q ss_conf 289950699980245310246689999999999999999999998379997498036889889769---99399973278
Q 006514 385 LLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGL 461 (642)
Q Consensus 385 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~---~~~~ki~Dfgl 461 (642)
++||||+++|+|.+++... ....+++.++..++.|++.||.|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778998499999862-7877579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCH
Q ss_conf 50237899731015567754247422224998973117889999999994998999999845640478999863038601
Q 006514 462 ARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 462 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
++....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||........... .....
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i------ 229 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI------ 229 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC------
T ss_pred EEECCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH---HHHHH------
T ss_conf 233368886--4322677563792777489888888887645167788658899889887788999---99998------
Q ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 221322223446998709999999999997325599999999999998
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
..... .+...........+.+++.+||+.||++|||+.|+++|
T Consensus 230 --~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 --RMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CSCSS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HCCCC---CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --53888---88985434699999999999756996579099999709
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.99 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=200.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCC--HHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEE
Q ss_conf 8963235126667168999781-899689999820447--5659999999999830885613101101114897328995
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 389 (642)
++|++.++||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 06999802453102466899999999999999999999983799974980368898897699939997327850237899
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~ 469 (642)
|+.++.+ .++.. .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHH-HHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 2377445-55442-02568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH--HHCCCCHHHC--
Q ss_conf 73101556775424742222499-897311788999999999499899999984564047899986--3038601221--
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH--FQAGRVEELY-- 544 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~-- 544 (642)
. ......|++.|+|||.+.... ++.++||||+||++|||++|+.||....... .+....... ..........
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred C-CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHH--HHHHHHHHCCCCCHHHCCCCCCC
T ss_conf 4-10010365215411221366577742210333313427966879989889999--99999983289833314442224
Q ss_pred -CCCCCCCCCCCCCCH----HHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -322223446998709----999999999997325599999999999998
Q 006514 545 -DKNLMLHNYHDSNVK----YEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 545 -d~~~~~~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
+.............. .....+.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21243454322220444166789999999999763995579189999678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=331.72 Aligned_cols=267 Identities=24% Similarity=0.359 Sum_probs=203.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCC--HHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEEE
Q ss_conf 8963235126667168999781899689999820447--56599999999998308856131011011148973289950
Q 006514 313 GSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN--RHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 390 (642)
++|+..++||+|+||.||++.+++|+.||||++.... ....+.+.+|+.++++++||||+++++++......++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998024531024668999999999999999999999837999749803688988976999399973278502378997
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDKS 470 (642)
Q Consensus 391 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~~ 470 (642)
+.++.+..+. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998---60477514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCC---CCHHHCC-
Q ss_conf 310155677542474222249-98973117889999999994998999999845640478999863038---6012213-
Q 006514 471 HISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG---RVEELYD- 545 (642)
Q Consensus 471 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d- 545 (642)
. .....+++.|+|||.+... .++.++||||+|+++|||++|+.||........ +..+ +...... .......
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i-~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRI-FRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH-HHHHCCCCTTTSTTGGGS
T ss_pred C-CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH--HHHH-HHHHCCCCHHHCCCHHHH
T ss_conf 4-10102431101378871788888410021117589999779799898898999--9999-986389971104212333
Q ss_pred ----CCCCCCCC--CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ----22223446--998709999999999997325599999999999998
Q 006514 546 ----KNLMLHNY--HDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 546 ----~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
........ ...........+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 22143333356764666512589999999999866896689099998569
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.07 Aligned_cols=266 Identities=24% Similarity=0.340 Sum_probs=193.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CC-CCEEEEEEEECCC--HHHHHHHHHHHHHHHCC---CCCCEEEEEEEECC----
Q ss_conf 08963235126667168999781-89-9689999820447--56599999999998308---85613101101114----
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PD-GREIAVKRLFFNN--RHRAANFYNEVNIISSV---EHKNLVRLLGCSCS---- 380 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 380 (642)
.++|++.++||+|+||.||++.+ ++ ++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf -8973289950699980245310246689999999999999999999998379997498036889889769993999732
Q 006514 381 -GPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADF 459 (642)
Q Consensus 381 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Df 459 (642)
....++++|++.++.+..... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 6746999997405871444443--03789998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCC-
Q ss_conf 7850237899731015567754247422224998973117889999999994998999999845640478999863038-
Q 006514 460 GLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG- 538 (642)
Q Consensus 460 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~- 538 (642)
|++....... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||....... .+..+........
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCG
T ss_pred HHHHHHCCCC--CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHHCCCCH
T ss_conf 0101100234--5777654851148310017988811100032899999987879989989899--99999984079961
Q ss_pred -CCHH-------HC-CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -6012-------21-322223446998709999999999997325599999999999998
Q 006514 539 -RVEE-------LY-DKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 539 -~~~~-------~~-d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.+.. .. .............. ...+.+|+.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDI---DELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSC---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 10532111103330223456454404458---9999999999874896679189999669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.77 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=192.5
Q ss_pred CCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCC------CCCEE
Q ss_conf 9632351266671689997818-9968999982044756599999999998308856131011011148------97328
Q 006514 314 SFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------PESLL 386 (642)
Q Consensus 314 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 386 (642)
+|...++||+|+||+||++.+. +|+.||||++...... ..+|+.++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 995069998024531024668999999999999999999999837999749803688988976999-3999732785023
Q 006514 387 VYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSF 465 (642)
Q Consensus 387 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~-~~ki~Dfgl~~~~ 465 (642)
||||++++.+..+.........+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH----------HHH
Q ss_conf 7899731015567754247422224-99897311788999999999499899999984564047899----------986
Q 006514 466 QEDKSHISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT----------WKH 534 (642)
Q Consensus 466 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~----------~~~ 534 (642)
...... ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+..+. +..
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred CCCCCC--CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH--HHHHHHHHHCCCHHHHHHH
T ss_conf 477653--200255555682776404688821000246527785502879989879999--9999999748981776543
Q ss_pred HHCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 3038601221322223446998709999999999997325599999999999998
Q 006514 535 FQAGRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 535 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
....... ..-+.....+............+.+|+.+||+.||++|||+.|+++|
T Consensus 250 ~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTE-FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---C-CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCCHHH-CCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 0621011-03554456744443156899999999999765895579299999669
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.47 Aligned_cols=271 Identities=23% Similarity=0.326 Sum_probs=199.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECC--------C
Q ss_conf 8963235126667168999781-89968999982044--75659999999999830885613101101114--------8
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCS--------G 381 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 381 (642)
++|++.++||+|+||+||+|.+ .+|+.||||++... .......+.+|++++++++|||++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 97328995069998024531024668999999999999999999999837999749803688988976999399973278
Q 006514 382 PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGL 461 (642)
Q Consensus 382 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl 461 (642)
...++|+||+.++.+.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 6389998535787410122---20344330899999999999998852299---88567672220366899687631350
Q ss_pred CCCCCCCCCC---CCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 5023789973---10155677542474222249-9897311788999999999499899999984564047899986303
Q 006514 462 ARSFQEDKSH---ISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA 537 (642)
Q Consensus 462 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 537 (642)
+......... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 02235544432113566024978742899707999891787006786466174487998998999999999984189982
Q ss_pred CCCHHHCCCC----CCCCCCCCCCCHHH------HHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 8601221322----22344699870999------9999999997325599999999999998
Q 006514 538 GRVEELYDKN----LMLHNYHDSNVKYE------VLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~~~~~~~d~~----~~~~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.......... .............. ...+++++.+||+.||++|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.98 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=198.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC----CCE
Q ss_conf 08963235126667168999781-89968999982044-7565999999999983088561310110111489----732
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN-NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP----ESL 385 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 385 (642)
+.+|++.++||+|+||+||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 89950699980245310246689999999999999999999998379997498036889889769993999732785023
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSF 465 (642)
Q Consensus 386 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~ 465 (642)
++++++.+|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99996259865664405----89999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCC--CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCHH
Q ss_conf 789973--1015567754247422224-9989731178899999999949989999998456404789998630386012
Q 006514 466 QEDKSH--ISTAIAGTLGYMAPEYLAH-GQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVEE 542 (642)
Q Consensus 466 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 542 (642)
...... ......|++.|+|||++.. ..++.++||||+|+++|||++|+.||............... ........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HCSCCHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHH---CCCCCHHH
T ss_conf 477764101011026520003878604788874101004670133776697997888889999987652---06997566
Q ss_pred H--------CCCCCCCCCCCCCCCH----HHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 2--------1322223446998709----999999999997325599999999999998
Q 006514 543 L--------YDKNLMLHNYHDSNVK----YEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 543 ~--------~d~~~~~~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. ................ .....+++++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 42343322220244677557787778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.81 Aligned_cols=265 Identities=23% Similarity=0.366 Sum_probs=197.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC------
Q ss_conf 08963235126667168999781-89968999982044--7565999999999983088561310110111489------
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGP------ 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 382 (642)
.++|+..++||+|+||.||++.. .+|+.||||++... +....+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 73289950699980245310246689999999999999999999998379997498036889889769993999732785
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~ 462 (642)
..++||||+ +.+|..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-521899987----402269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH--------HH
Q ss_conf 02378997310155677542474222249-9897311788999999999499899999984564047899--------98
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT--------WK 533 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~--------~~ 533 (642)
+...... +...|++.|+|||.+.+. .++.++||||+||++|||++|+.||............... +.
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ECCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf 2068763----102455333588998178789965010300389999997869988897689999998503788488886
Q ss_pred HHHCCCCHHHCC--CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 630386012213--22223446998709999999999997325599999999999998
Q 006514 534 HFQAGRVEELYD--KNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 534 ~~~~~~~~~~~d--~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
............ +....... ..........+++|+.+||+.||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCHHHHHHHCCCCCCCCCCH-HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5300034433115786665566-77556899999999999772995579299999639
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.17 Aligned_cols=241 Identities=27% Similarity=0.400 Sum_probs=193.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCH------HHHHHHHHHHHHHHCCC--CCCEEEEEEEECCCC
Q ss_conf 08963235126667168999781-8996899998204475------65999999999983088--561310110111489
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNR------HRAANFYNEVNIISSVE--HKNLVRLLGCSCSGP 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 382 (642)
.++|++.+.||+|+||.||++.. .+|+.||||++..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCEEEEEECCC-CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-CCCEEEEECC
Q ss_conf 73289950699-980245310246689999999999999999999998379997498036889889769-9939997327
Q 006514 383 ESLLVYEFLPN-QSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-RLRAKIADFG 460 (642)
Q Consensus 383 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~-~~~~ki~Dfg 460 (642)
..++||||+.+ +++.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 68999983368622899986---1589999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 850237899731015567754247422224998-9731178899999999949989999998456404789998630386
Q 006514 461 LARSFQEDKSHISTAIAGTLGYMAPEYLAHGQL-TEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGR 539 (642)
Q Consensus 461 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 539 (642)
++....... .+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ....
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~- 219 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG- 219 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC-
T ss_pred CCEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH-------------HHHC-
T ss_conf 535324445---56656587747999984899788653325540345367568899887367-------------7615-
Q ss_pred CHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 01221322223446998709999999999997325599999999999998
Q 006514 540 VEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 540 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.... ..... ..+.+++.+||+.||++|||+.|+++|
T Consensus 220 -------~~~~----~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 -------QVFF----RQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -------CCCC----SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCC----CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------4477----87799---999999999760897589399998539
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.28 Aligned_cols=265 Identities=25% Similarity=0.306 Sum_probs=200.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCC------C
Q ss_conf 089632351266671689997818-9968999982044--756599999999998308856131011011148------9
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG------P 382 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 382 (642)
.++|.+.++||+|+||+||+|.+. +|+.||||++... +......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred CCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 73289950699980245310246689999999999999999999998379997498036889889769993999732785
Q 006514 383 ESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLA 462 (642)
Q Consensus 383 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~ 462 (642)
..++||||+.++.+. .+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEEECCCHHHHH-HH-----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 269998414467787-65-----038999999999999999998865221---124567763211365443132010232
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH--------HHHH
Q ss_conf 02378997310155677542474222249989731178899999999949989999998456404789--------9986
Q 006514 463 RSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTI--------TWKH 534 (642)
Q Consensus 463 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~--------~~~~ 534 (642)
+....... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.............. .|..
T Consensus 167 ~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred HCCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 11466655--3322146555581331477778774333566257898659899888977889999997205898799987
Q ss_pred --------HHC------CCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --------303------8601221322223446998709999999999997325599999999999998
Q 006514 535 --------FQA------GRVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 535 --------~~~------~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
... ............ .............+.+|+.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLF--PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 65667777641754356664212643335--43210133379999999999876994579089999669
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=313.50 Aligned_cols=263 Identities=17% Similarity=0.276 Sum_probs=196.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCC-CCCEEEEEEEECC--CCCCEEEE
Q ss_conf 8963235126667168999781-899689999820447565999999999983088-5613101101114--89732899
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCS--GPESLLVY 388 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 388 (642)
++|++.++||+|+||+||++.. .+|+.||||++.... .+.+.+|+.++..++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 5069998024531024668999999999999999999999837999749803688988976999-399973278502378
Q 006514 389 EFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRL-RAKIADFGLARSFQE 467 (642)
Q Consensus 389 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~-~~ki~Dfgl~~~~~~ 467 (642)
||+.+++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH---------HHHHHHHC
Q ss_conf 997310155677542474222249-98973117889999999994998999999845640478---------99986303
Q 006514 468 DKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLT---------ITWKHFQA 537 (642)
Q Consensus 468 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~---------~~~~~~~~ 537 (642)
... .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||............. ..+.....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 874--443224864247610268888884523233545558760488999887601899999999878841555554225
Q ss_pred CCC-H---HHCCCCC---CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 860-1---2213222---23446998709999999999997325599999999999998
Q 006514 538 GRV-E---ELYDKNL---MLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~~~-~---~~~d~~~---~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
... . ....... ................+.+|+.+||+.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44474300000333433112115521124489999999999866995689089999649
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.42 Aligned_cols=268 Identities=23% Similarity=0.299 Sum_probs=203.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCCCEEEEE
Q ss_conf 8963235126667168999781-89968999982044--75659999999999830885613101101114897328995
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 389 (642)
++|++.++||+|+||+||++++ .+++.||||++... .......+.+|+.+++.++||||+++++++......+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 06999802453102466899999999999999999999983799974980368898897699939997327850237899
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLARSFQEDK 469 (642)
Q Consensus 390 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~~~~~~ 469 (642)
++.++++..++. ..+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212---3565403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHC---CCCHHH--
Q ss_conf 73101556775424742222499-897311788999999999499899999984564047899986303---860122--
Q 006514 470 SHISTAIAGTLGYMAPEYLAHGQ-LTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQA---GRVEEL-- 543 (642)
Q Consensus 470 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~-- 543 (642)
.. .....++..|+|||.+.... ++.++||||+||++|||++|+.||........ ........... ......
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred CC-CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHHHCCCCCHHHHHHHHH
T ss_conf 51-00103443101466750698888044402654188998518999988999999--9999986118997355134432
Q ss_pred -CCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -1322----223446998709999999999997325599999999999998
Q 006514 544 -YDKN----LMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 544 -~d~~----~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
.+.. .................+.+++.+||+.||.+|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 221133444544310433065689999999999864996689099999649
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=309.45 Aligned_cols=258 Identities=19% Similarity=0.290 Sum_probs=195.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCE-EEEEEEECCCCCCEEEEEE
Q ss_conf 8963235126667168999781-8996899998204475659999999999830885613-1011011148973289950
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVYEF 390 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 390 (642)
++|++.+.||+|+||.||+|.+ .+|+.||||.+..... ...+..|+++++.++|+++ +.+.++.......++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCEEEEECCCCCCCCC
Q ss_conf 699980245310246689999999999999999999998379997498036889889769---99399973278502378
Q 006514 391 LPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS---RLRAKIADFGLARSFQE 467 (642)
Q Consensus 391 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~---~~~~ki~Dfgl~~~~~~ 467 (642)
+ ++++.+.+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++. +..+||+|||+++....
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-8713332443--0688768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCC------CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCH
Q ss_conf 9973------1015567754247422224998973117889999999994998999999845640478999863038601
Q 006514 468 DKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 468 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 221322223446998709999999999997325599999999999998625
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
.+ ..... ..+.+++..||+.+|++||++.++.+.|+.
T Consensus 239 ~~-----------~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 239 VL-----------CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HH-----------TTTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HH-----------CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 75-----------34788---999999999843995579199999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.33 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=201.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC----CCCCEEEEEEEECC----CHHHHHHHHHHHHHHHCCCC-CCEEEEEEEECCCCC
Q ss_conf 8963235126667168999781----89968999982044----75659999999999830885-613101101114897
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL----PDGREIAVKRLFFN----NRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPE 383 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 383 (642)
++|+..+.||+|+||.||++.. .+|+.||+|.+... +....+.+.+|+.++++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 32899506999802453102466899999999999999999999983799974980368898897699939997327850
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
.++++||+.+|+|.+++. ....+.+.....++.|++.||.|+|+++ ++||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987---3045437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCH
Q ss_conf 2378997310155677542474222249--98973117889999999994998999999845640478999863038601
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG--QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAGRVE 541 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 541 (642)
.+............|++.|++||.+.+. .++.++||||+||+||||++|+.||............. ........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~---~~~~~~~~- 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSEP- 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHCCC-
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---HHCCCCCC-
T ss_conf 20344443221222333331068760577688713251777799999976899988887777999999---83356899-
Q ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 2213222234469987099999999999973255999999-----99999998
Q 006514 542 ELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRP-----TMSRVLQM 589 (642)
Q Consensus 542 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 589 (642)
..... ....+.+++.+||+.||++|| |++|+++|
T Consensus 254 -----------~~~~~---~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 -----------PYPQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----------CCCTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----------CCCCC---CCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf -----------88654---7999999999974458988199974509999749
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.33 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=197.1
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEECCC-----CC
Q ss_conf 08963235126667168999781-89968999982044--756599999999998308856131011011148-----97
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFN--NRHRAANFYNEVNIISSVEHKNLVRLLGCSCSG-----PE 383 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 383 (642)
.++|++.++||+|+||+||++.. .+|+.||||++... +....+.+.+|+.+++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 32899506999802453102466899999999999999999999983799974980368898897699939997327850
Q 006514 384 SLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 384 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
.+++++++.+|+|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 499999625886232002----245309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH-----HHC
Q ss_conf 2378997310155677542474222249-9897311788999999999499899999984564047899986-----303
Q 006514 464 SFQEDKSHISTAIAGTLGYMAPEYLAHG-QLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKH-----FQA 537 (642)
Q Consensus 464 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~-----~~~ 537 (642)
.... ......|+..|+|||...+. .++.++||||+|+++|||++|+.||.................. ...
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred CCCC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 2575----444434543555835533775678551243205899999768899788988999999997307997577320
Q ss_pred C---CCHHHCCCCCCCCCCCCCCC----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 8---60122132222344699870----9999999999997325599999999999998
Q 006514 538 G---RVEELYDKNLMLHNYHDSNV----KYEVLRAIHVGLLCTQENPSLRPTMSRVLQM 589 (642)
Q Consensus 538 ~---~~~~~~d~~~~~~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 589 (642)
. ........... ...... ......+.+++.+||+.||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQ---MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCC---CCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHCCC---CCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 010244544430355---78755566267899999999999775883459389998559
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=302.23 Aligned_cols=259 Identities=15% Similarity=0.229 Sum_probs=199.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCC-CCEEEEEEEECCCCCCEEEEE
Q ss_conf 089632351266671689997818-996899998204475659999999999830885-613101101114897328995
Q 006514 312 TGSFDEANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNNRHRAANFYNEVNIISSVEH-KNLVRLLGCSCSGPESLLVYE 389 (642)
Q Consensus 312 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 389 (642)
.++|.+.+.||+|+||.||+|++. +|+.||||.+.... ....+.+|++.+..++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-----CCCEEEEECCCCCC
Q ss_conf 0699980245310246689999999999999999999998379997498036889889769-----99399973278502
Q 006514 390 FLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDS-----RLRAKIADFGLARS 464 (642)
Q Consensus 390 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~-----~~~~ki~Dfgl~~~ 464 (642)
|+ +++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHH--HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-8887999975--2031106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCC------CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 3789973------1015567754247422224998973117889999999994998999999845640478999863038
Q 006514 465 FQEDKSH------ISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTITWKHFQAG 538 (642)
Q Consensus 465 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 538 (642)
....... ......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 601221322223446998709999999999997325599999999999998625
Q 006514 539 RVEELYDKNLMLHNYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSRVLQMLTT 592 (642)
Q Consensus 539 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 592 (642)
...++. ...+. .+.+++..|++.+|++||++..+.+.|+.
T Consensus 236 ~~~~l~-----------~~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRELC-----------AGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHHHT-----------TTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CHHHHC-----------CCCCH---HHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 958965-----------79989---99999999843993008599999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=282.19 Aligned_cols=269 Identities=20% Similarity=0.190 Sum_probs=193.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCC-----------CCCEEEEEEEECC
Q ss_conf 8963235126667168999781-899689999820447565999999999983088-----------5613101101114
Q 006514 313 GSFDEANKLGQGGFGTVYKGVL-PDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-----------HKNLVRLLGCSCS 380 (642)
Q Consensus 313 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 380 (642)
++|.+.++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred C--CCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCC-----
Q ss_conf 8--9732899506999802453102466899999999999999999999983-7999749803688988976999-----
Q 006514 381 G--PESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRL----- 452 (642)
Q Consensus 381 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlkp~NILi~~~~----- 452 (642)
. ...++++++...+..............+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred -CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf -3999732785023789973101556775424742222499897311788999999999499899999984564047899
Q 006514 453 -RAKIADFGLARSFQEDKSHISTAIAGTLGYMAPEYLAHGQLTEKADVYSFGMLLLEIVTGRQNNRSKNSEYTDSLLTIT 531 (642)
Q Consensus 453 -~~ki~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDi~SlGvil~elltg~~p~~~~~~~~~~~l~~~~ 531 (642)
.++++|||.+....... ....|++.|+|||++....++.++||||+|++++||++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CEEEEEECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 305675314421234454----2236652105713214667776432012378999998788998987554321026899
Q ss_pred ---HHHHHC---------CCCHHHCCCCCCCC--------------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf ---986303---------86012213222234--------------4699870999999999999732559999999999
Q 006514 532 ---WKHFQA---------GRVEELYDKNLMLH--------------NYHDSNVKYEVLRAIHVGLLCTQENPSLRPTMSR 585 (642)
Q Consensus 532 ---~~~~~~---------~~~~~~~d~~~~~~--------------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 585 (642)
...+.. .......+...... .............+.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHHH
Q ss_conf 9998
Q 006514 586 VLQM 589 (642)
Q Consensus 586 vl~~ 589 (642)
+++|
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HHCC
T ss_conf 9669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.5e-26 Score=161.36 Aligned_cols=163 Identities=16% Similarity=0.181 Sum_probs=119.4
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCC------------------HHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 3235126667168999781899689999820447------------------5659999999999830885613101101
Q 006514 316 DEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNN------------------RHRAANFYNEVNIISSVEHKNLVRLLGC 377 (642)
Q Consensus 316 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 377 (642)
.+.++||+|+||.||+|...+|+.||||.+.... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred ECCCCCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEE
Q ss_conf 11489732899506999802453102466899999999999999999999983799974980368898897699939997
Q 006514 378 SCSGPESLLVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQSKIRIIHRDIKASNILLDSRLRAKIA 457 (642)
Q Consensus 378 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlkp~NILi~~~~~~ki~ 457 (642)
. ..+++||++++..+.+ ++......++.+++.++.|||+++ ++||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred C----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEE
T ss_conf 2----8889999504565420----------015789999999999999982688---8983689036114289-89998
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHCCCCCCCCCHHHHHHHHH
Q ss_conf 3278502378997310155677542474------222249989731178899999
Q 006514 458 DFGLARSFQEDKSHISTAIAGTLGYMAP------EYLAHGQLTEKADVYSFGMLL 506 (642)
Q Consensus 458 Dfgl~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~sDi~SlGvil 506 (642)
|||++....+.... .|... +.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCCCCCCCCCCH---------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
T ss_conf 77884308998709---------99987799999997-57899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.12 E-value=2.6e-10 Score=71.60 Aligned_cols=148 Identities=16% Similarity=0.097 Sum_probs=98.8
Q ss_pred HHHHHCCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCC-CCCEEEEEEEECCCCCCE
Q ss_conf 6998708963235126667168999781899689999820447565999999999983088-561310110111489732
Q 006514 307 TLEKATGSFDEANKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVE-HKNLVRLLGCSCSGPESL 385 (642)
Q Consensus 307 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 385 (642)
++...-..|...+..+.+....||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+.......+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 9997513527997678998771899990-898699998488765325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q ss_conf 89950699980245310246689999999999999999999998379---------------------------------
Q 006514 386 LVYEFLPNQSLDRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS--------------------------------- 432 (642)
Q Consensus 386 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~--------------------------------- 432 (642)
+||+++++..+.+.... ... ...++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~-----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED-----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT-----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEECCCCCCCCCCCC-----CCC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 99986043343543344-----026---9999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -----------------------9974980368898897699939997327850
Q 006514 433 -----------------------KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 433 -----------------------~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
...++|+|+.|.|||++++..+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 323200579999999984498678178986004764236499659996023144
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.65 E-value=2.2e-07 Score=55.32 Aligned_cols=130 Identities=16% Similarity=0.123 Sum_probs=83.2
Q ss_pred CCCCCC-CEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCC--CCEEEEEEEECCCCCCEEEEEECCCCCH
Q ss_conf 126667-1689997818996899998204475659999999999830885--6131011011148973289950699980
Q 006514 320 KLGQGG-FGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEH--KNLVRLLGCSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 320 ~LG~G~-~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 396 (642)
.+..|. ...||+....++..+.+|....... ..+..|...++.+.. -.+.+++.+.......++|++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------------
Q ss_conf 245310246689999999999999999999998379--------------------------------------------
Q 006514 397 DRFIFDSAKAKTLTWEKRYEIILGTVEGLVYLHEQS-------------------------------------------- 432 (642)
Q Consensus 397 ~~~l~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-------------------------------------------- 432 (642)
.+.. .... ....++...|.-||+..
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------2689---9999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----------CCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -----------9974980368898897699939997327850
Q 006514 433 -----------KIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 433 -----------~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
.+.++|+|+.|.||+++++..+-|.||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 999871876579567867888763577379658999853326
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.44 E-value=9.6e-07 Score=51.85 Aligned_cols=77 Identities=14% Similarity=0.151 Sum_probs=48.0
Q ss_pred CCCCCCCCCEEEEEEECC-CCCEEEEEEEECCC-------HHHHHHHHHHHHHHHCCC-C--CCEEEEEEEECCCCCCEE
Q ss_conf 351266671689997818-99689999820447-------565999999999983088-5--613101101114897328
Q 006514 318 ANKLGQGGFGTVYKGVLP-DGREIAVKRLFFNN-------RHRAANFYNEVNIISSVE-H--KNLVRLLGCSCSGPESLL 386 (642)
Q Consensus 318 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 386 (642)
.+.||.|....||+.... +++.+++|.-...- .........|...+..+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9950699980
Q 006514 387 VYEFLPNQSL 396 (642)
Q Consensus 387 v~e~~~~gsL 396 (642)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.97 E-value=5.3e-05 Score=42.20 Aligned_cols=138 Identities=17% Similarity=0.124 Sum_probs=71.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCE-----EEEEE--EECCCCCCEEEEEECCCCCH
Q ss_conf 671689997818996899998204475659999999999830885613-----10110--11148973289950699980
Q 006514 324 GGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-----VRLLG--CSCSGPESLLVYEFLPNQSL 396 (642)
Q Consensus 324 G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l~~--~~~~~~~~~lv~e~~~~gsL 396 (642)
+..-.||+...++|+.+++|..... ....+.+..|...+..|...++ +..-+ ........+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 6120269998389997999984787-788999999999999998559987875206898056653479999865277688
Q ss_pred HH----HH----------HC------CCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCC
Q ss_conf 24----53----------10------2466899999----------------------9999999999999999-83799
Q 006514 397 DR----FI----------FD------SAKAKTLTWE----------------------KRYEIILGTVEGLVYL-HEQSK 433 (642)
Q Consensus 397 ~~----~l----------~~------~~~~~~l~~~----------------------~~~~i~~~i~~al~yL-H~~~~ 433 (642)
.. .. |. ......+++. .....+..+...+.-. .+...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9749803688988976999399973278502
Q 006514 434 IRIIHRDIKASNILLDSRLRAKIADFGLARS 464 (642)
Q Consensus 434 ~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~~ 464 (642)
..++|+|+.+.|||++++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.80 E-value=6.6e-05 Score=41.69 Aligned_cols=74 Identities=16% Similarity=0.313 Sum_probs=46.7
Q ss_pred CCCCCCCCCEEEEEEECCCC--------CEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCE-EEEEEEECCCCCCEEEE
Q ss_conf 35126667168999781899--------6899998204475659999999999830885613-10110111489732899
Q 006514 318 ANKLGQGGFGTVYKGVLPDG--------REIAVKRLFFNNRHRAANFYNEVNIISSVEHKNL-VRLLGCSCSGPESLLVY 388 (642)
Q Consensus 318 ~~~LG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 388 (642)
.+.|+.|-.-.+|+...+++ +.|.++... .. .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CC-CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 9991785334348999688775445789817999659-96-1165899999999999757999808998189----5699
Q ss_pred EECCCCCHH
Q ss_conf 506999802
Q 006514 389 EFLPNQSLD 397 (642)
Q Consensus 389 e~~~~gsL~ 397 (642)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.07 E-value=0.0049 Score=31.37 Aligned_cols=157 Identities=12% Similarity=0.066 Sum_probs=73.4
Q ss_pred CHHHHHHHCCCCCCC-----CCCCCCCCEEEEEEECCCCCEEEEEEEECCCHHHHHHHHHHHHHHHCCCCCC-----EEE
Q ss_conf 925699870896323-----5126667168999781899689999820447565999999999983088561-----310
Q 006514 304 KYSTLEKATGSFDEA-----NKLGQGGFGTVYKGVLPDGREIAVKRLFFNNRHRAANFYNEVNIISSVEHKN-----LVR 373 (642)
Q Consensus 304 ~~~~~~~~~~~~~~~-----~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-----iv~ 373 (642)
+-++++....+|.+. +.|..|---+.|+....+| .+++|...... ...++..|..++..+...+ .+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf 999999999867999856852378885267389997897-28999807899--988999999998754302555455641
Q ss_pred EE-E--EECCCCCCEEEEEECCCCCHHHHH--------------HCC------CCCCCC------------------CHH
Q ss_conf 11-0--111489732899506999802453--------------102------466899------------------999
Q 006514 374 LL-G--CSCSGPESLLVYEFLPNQSLDRFI--------------FDS------AKAKTL------------------TWE 412 (642)
Q Consensus 374 l~-~--~~~~~~~~~lv~e~~~~gsL~~~l--------------~~~------~~~~~l------------------~~~ 412 (642)
.. | ..........++.+..+....... +.. ...... ...
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCH
T ss_conf 04897621341255024531146553332046788888998764544432024531011101200245677776531141
Q ss_pred HHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 999999999999999983-799974980368898897699939997327850
Q 006514 413 KRYEIILGTVEGLVYLHE-QSKIRIIHRDIKASNILLDSRLRAKIADFGLAR 463 (642)
Q Consensus 413 ~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlkp~NILi~~~~~~ki~Dfgl~~ 463 (642)
.....+......+...+. .-+..++|+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 2799999998764204855454503337863656402045412674222123
|